data_1yel_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yel _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.414 -2.274 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -123.7 143.92 49.97 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.447 ' CE2' ' HG2' ' A' ' 25' ' ' PRO . 72.2 t80 -148.24 151.89 36.23 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.3 ptm -121.22 141.79 50.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -135.94 129.4 18.13 Favored Pre-proline 0 C--N 1.295 -1.786 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.786 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.66 133.94 10.69 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.436 2.091 . . . . 0.0 109.006 170.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 43.4 m-85 -102.64 139.31 38.4 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -176.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.6 mt -104.71 110.26 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.7 t -57.41 -30.42 64.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.342 0.591 . . . . 0.0 111.003 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.35 -34.18 73.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.22 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -103.03 -29.93 11.08 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.527 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 t -70.27 -11.26 60.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.84 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 p -60.55 -30.44 69.77 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.568 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -136.11 -9.72 2.01 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.9 p -157.27 145.1 19.01 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.5 tt -99.44 119.52 38.13 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.77 122.39 32.81 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.097 0.475 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.7 mm -95.53 124.51 52.83 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.447 ' HG2' ' CE2' ' A' ' 9' ' ' PHE . 84.2 Cg_exo -50.8 134.03 40.52 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.539 2.826 . . . . 0.0 112.073 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.54 -43.03 89.1 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.592 0.757 . . . . 0.0 111.209 -173.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.32 -32.26 83.61 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.83 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.558 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 74.9 t80 -82.8 -36.16 25.81 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.5 HD22 ' HA ' ' A' ' 60' ' ' LYS . 13.7 t30 -59.86 -43.55 94.62 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.968 0.907 . . . . 0.0 110.693 175.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.73 -22.22 66.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.912 0.863 . . . . 0.0 110.587 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.558 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 92.6 t80 -75.63 -26.72 58.02 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.729 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -134.01 93.85 19.41 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 119.433 -0.907 . . . . 0.0 113.065 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.423 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.6 Cg_exo -81.63 136.2 9.53 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 121.592 1.528 . . . . 0.0 110.269 171.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.49 153.34 32.1 Favored Pre-proline 0 C--N 1.283 -2.305 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.684 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.27 154.59 62.32 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 121.977 1.785 . . . . 0.0 109.156 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -68.67 126.08 92.4 Favored Pre-proline 0 N--CA 1.419 -1.985 0 CA-C-O 121.231 0.538 . . . . 0.0 110.915 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -87.47 160.54 8.08 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 122.442 2.094 . . . . 0.0 111.243 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.73 -59.14 2.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.4 p -134.6 151.7 51.26 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.487 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -128.82 148.15 33.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -109.94 136.85 48.57 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.201 -0.599 . . . . 0.0 111.53 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.5 mt -108.39 122.53 47.2 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.07 137.75 39.02 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -113.42 139.35 48.98 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.266 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -58.92 -21.64 58.25 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -85.89 -13.23 48.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.587 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.04 -9.22 7.53 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 119.843 -1.17 . . . . 0.0 114.68 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -88.07 157.85 18.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.567 0.683 . . . . 0.0 111.239 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.7 p -143.04 136.21 28.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 18.1 m-90 -114.73 126.77 55.24 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.391 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.0 m -89.09 114.76 26.04 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -112.15 156.47 13.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.118 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -101.9 120.43 40.38 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.573 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -123.95 137.07 54.67 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.074 -172.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.573 ' HD2' ' C ' ' A' ' 54' ' ' MET . 4.5 mptp? -133.9 140.68 46.97 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.019 0.438 . . . . 0.0 112.069 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 33' ' ' PRO . 54.6 tttp -105.49 107.89 19.12 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 172.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -108.79 99.87 9.17 Favored 'General case' 1 C--N 1.243 -4.064 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.325 -172.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.44 -116.75 6.76 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.47 -21.16 22.0 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.5 ' HA ' HD22 ' A' ' 29' ' ' ASN . 17.7 ptpt -112.21 165.87 11.78 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -168.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.8 m -134.56 146.33 31.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.551 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -142.02 136.55 30.36 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.774 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 3.1 mp -96.75 104.04 16.0 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 169.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.2 p -94.49 -98.7 0.15 Allowed 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -169.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.5 133.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.655 0.74 . . . . 0.0 110.625 -175.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.05 -37.66 3.63 Favored Glycine 0 CA--C 1.481 -2.074 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -63.01 -25.62 68.47 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.851 0.834 . . . . 0.0 109.254 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.518 ' HA ' HG11 ' A' ' 71' ' ' VAL . 16.9 pt-20 -68.58 -26.32 65.33 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.57 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -68.99 -31.64 70.62 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.543 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -74.3 -52.04 13.45 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 68' ' ' GLU . 7.2 p -59.73 -46.88 93.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.431 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.24 -43.35 64.51 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -77.24 -40.2 45.72 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.201 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.466 ' ND2' HG12 ' A' ' 96' ' ' ILE . 7.3 t30 -84.83 -18.47 34.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.24 0.543 . . . . 0.0 109.582 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 50.4 t30 60.11 90.96 0.05 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.182 1.393 . . . . 0.0 112.846 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.402 ' CD1' HG23 ' A' ' 71' ' ' VAL . 3.8 pp -127.18 151.13 49.09 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -144.06 172.65 12.6 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.637 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 12.2 t70 -53.05 120.42 5.86 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.47 -25.15 6.67 Favored Glycine 0 C--N 1.306 -1.122 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -80.8 147.54 30.42 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -126.6 140.65 52.26 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.415 HD13 ' CE1' ' A' ' 13' ' ' PHE . 61.4 mt -119.66 147.4 44.59 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.103 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 14.9 mm100 -110.72 124.85 52.74 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -112.51 117.67 33.01 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 123.556 0.535 . . . . 0.0 109.761 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.438 ' O ' ' HD1' ' A' ' 93' ' ' TYR . 2.0 mp -103.91 122.67 56.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.423 ' HE2' ' CE2' ' A' ' 92' ' ' PHE . 64.2 m-85 -109.45 144.61 37.46 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -88.37 -97.47 0.09 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.673 173.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -154.11 20.27 0.5 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 16.2 t70 -143.56 -154.61 0.54 Allowed 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -174.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.5 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 5.6 mpt_? -95.58 29.15 2.7 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.11 0.964 . . . . 0.0 109.252 -175.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -101.98 116.61 33.06 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.313 0.578 . . . . 0.0 110.394 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.423 ' CE2' ' HE2' ' A' ' 86' ' ' TYR . 1.5 m-30 -116.43 122.29 44.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.034 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.438 ' HD1' ' O ' ' A' ' 85' ' ' ILE . 38.5 m-85 -105.74 120.09 40.8 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 32.6 t -111.08 134.32 53.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.995 0.426 . . . . 0.0 112.068 -173.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 2.1 mp -116.2 131.47 68.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.466 HG12 ' ND2' ' A' ' 74' ' ' ASN . 2.8 mp -105.92 128.01 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 122.432 0.293 . . . . 0.0 111.005 -174.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 C--N 1.311 -1.068 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.89 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.44 146.6 52.03 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -142.05 148.97 39.33 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.442 ' HG2' ' HG2' ' A' ' 83' ' ' GLN . 64.2 mtt -114.88 137.59 51.79 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 11' ' ' LYS . 1.8 ttpm? -142.06 130.8 12.01 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.11 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.61 147.38 86.24 Favored 'Trans proline' 0 C--O 1.248 1.005 0 C-N-CA 122.86 2.373 . . . . 0.0 111.066 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.464 ' CE2' ' HA ' ' A' ' 15' ' ' SER . 76.8 t80 -95.41 117.99 31.34 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.1 mm -97.32 106.87 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.772 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.576 ' HB2' ' N ' ' A' ' 78' ' ' ASP . 20.2 t -55.89 -37.57 69.02 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.549 0.531 . . . . 0.0 111.416 -172.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -61.17 -44.01 97.98 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 123.633 0.583 . . . . 0.0 110.626 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -86.46 -40.77 15.0 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.171 -173.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 21' ' ' SER . 26.1 m -84.21 11.9 7.44 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.516 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.3 m -63.13 -33.45 75.49 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 168.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -121.54 -41.83 2.47 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.499 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 18' ' ' SER . 45.7 m -144.84 152.81 40.87 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.189 -175.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 54.9 mt -87.91 132.03 34.37 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-O 121.171 0.51 . . . . 0.0 111.657 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -96.07 117.36 30.54 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.809 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.3 mm -98.49 132.61 23.82 Favored Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.533 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -56.24 142.13 87.65 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 123.195 2.597 . . . . 0.0 112.052 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.526 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 5.7 tt -54.17 -38.98 66.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.984 0.914 . . . . 0.0 111.761 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.5 -35.41 85.35 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.877 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -88.3 -25.02 23.01 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' A' ' 26' ' ' LEU . 87.8 m-20 -62.71 -46.27 88.88 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.581 0.705 . . . . 0.0 110.034 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -73.68 -12.04 60.6 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.608 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -75.99 -28.7 57.92 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . 0.251 24.7 p90 -130.97 68.28 81.75 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -57.0 135.45 70.93 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 121.957 1.771 . . . . 0.0 111.046 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.69 161.3 29.56 Favored Pre-proline 0 C--N 1.278 -2.516 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.646 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.55 148.94 60.71 Favored 'Trans proline' 0 C--O 1.25 1.12 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 167.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -67.85 121.42 79.52 Favored Pre-proline 0 N--CA 1.413 -2.321 0 CA-C-O 121.626 0.727 . . . . 0.0 111.709 -171.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 90' ' ' ARG . 66.4 Cg_endo -96.76 160.74 1.12 Allowed 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 123.628 2.885 . . . . 0.0 112.697 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -108.01 -38.71 4.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.237 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 64.0 p -123.86 159.97 28.46 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.212 0.53 . . . . 0.0 111.9 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 90' ' ' ARG . 7.1 p -146.02 141.88 21.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 173.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -110.0 131.78 54.75 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.158 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -109.92 126.42 53.86 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.92 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.8 145.27 31.4 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.103 0.477 . . . . 0.0 111.914 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.531 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 19.2 t70 -113.87 154.93 26.65 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 173.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -91.67 -5.72 53.3 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.6 t -92.55 -23.44 19.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.909 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.87 -37.93 0.76 Allowed Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 118.896 -1.621 . . . . 0.0 114.196 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 84.6 mtm-85 -78.92 158.84 27.96 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 117.849 0.824 . . . . 0.0 113.123 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.6 m -146.38 150.44 35.67 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.284 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.531 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 12.8 m-90 -132.03 120.78 22.87 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.0 m -92.57 114.22 26.71 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 174.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 66' ' ' GLY . 18.2 m -114.83 158.79 15.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.642 -174.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 99.5 mtt180 -99.73 127.4 45.87 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.504 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.409 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 56.5 ttp -114.73 144.33 43.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.414 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -128.9 127.81 42.54 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -99.12 124.53 44.22 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.85 102.03 3.95 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.6 -105.22 0.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.352 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.28 -0.79 52.56 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 123.331 0.652 . . . . 0.0 112.151 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 84.8 tttt -142.17 147.09 36.03 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 118.515 -1.274 . . . . 0.0 112.922 -172.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.0 t -109.31 132.48 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -121.88 132.01 54.34 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 5.8 mp -101.19 102.61 13.55 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.269 168.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -85.21 -150.52 0.13 Allowed 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 124.62 1.168 . . . . 0.0 111.271 -170.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 62.0 t -55.47 125.9 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-O 121.838 0.827 . . . . 0.0 109.124 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 52' ' ' VAL . . . 135.22 -40.85 1.51 Allowed Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 -169.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -65.48 -24.84 67.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.729 -0.735 . . . . 0.0 109.64 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.494 ' HA ' HG11 ' A' ' 71' ' ' VAL . 37.2 tt0 -61.29 -30.34 70.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.382 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -58.56 -44.59 89.76 Favored 'General case' 0 C--O 1.198 -1.63 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.757 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -73.0 -46.43 52.28 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.081 0.553 . . . . 0.0 110.062 -176.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.494 HG11 ' HA ' ' A' ' 68' ' ' GLU . 9.7 p -62.76 -43.25 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.571 0.7 . . . . 0.0 110.058 -175.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -72.07 -43.22 65.2 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.273 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.96 -40.37 54.06 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -86.11 -21.01 27.86 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 57.8 94.89 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.577 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -142.73 146.18 34.08 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.696 -0.628 . . . . 0.0 111.993 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.21 170.86 8.2 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.188 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.576 ' N ' ' HB2' ' A' ' 15' ' ' SER . 14.8 t70 -53.52 136.74 37.85 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.568 1.147 . . . . 0.0 111.923 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.91 -11.39 22.79 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.421 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.51 161.38 16.25 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.388 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -125.81 137.74 53.79 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.24 144.65 48.49 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.257 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.442 ' HG2' ' HG2' ' A' ' 10' ' ' MET . 50.0 mt-30 -109.72 126.22 53.49 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -110.39 117.33 33.33 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 65.5 mt -97.95 122.51 49.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -105.75 123.4 47.87 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -125.64 80.25 1.88 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 52.25 30.11 7.5 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.285 170.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 14.8 t70 -161.7 -177.56 5.97 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 40' ' ' VAL . 42.2 ttm180 -95.52 41.74 1.1 Allowed 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 87.5 m -127.14 132.63 50.51 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.802 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 95.7 m-85 -125.29 140.09 53.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.134 0.492 . . . . 0.0 110.805 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.44 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 82.0 m-85 -101.76 126.43 48.62 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.8 t -108.1 119.49 57.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.177 0.513 . . . . 0.0 112.298 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.0 mt -112.08 123.82 68.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.6 tt -114.66 139.25 41.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 120.947 0.403 . . . . 0.0 110.667 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.868 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.439 -0.984 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -132.91 154.43 50.41 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -172.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -124.77 147.76 48.5 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.21 -1.359 . . . . 0.0 107.552 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -140.18 134.02 30.58 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -153.91 151.1 24.09 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.542 174.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -77.08 136.75 16.63 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.752 2.301 . . . . 0.0 108.69 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 24.5 p90 -103.09 137.39 41.33 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.188 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.97 123.75 55.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.501 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 19.5 m -53.49 -25.31 15.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.005 0.922 . . . . 0.0 112.584 -173.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.73 -40.49 92.57 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.277 1.031 . . . . 0.0 110.655 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -103.05 -36.78 8.04 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.574 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 89.4 p -66.05 -8.07 21.13 Favored 'General case' 0 C--O 1.215 -0.763 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -172.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.0 m -73.9 -17.66 61.01 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.8 173.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -134.55 -33.35 0.97 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 p -147.36 170.23 17.78 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -171.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.428 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 3.1 tm? -133.72 113.44 12.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.8 131.49 35.91 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.533 ' HB ' HG23 ' A' ' 61' ' ' VAL . 58.8 mt -113.41 132.48 22.47 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -57.14 148.79 67.36 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 123.126 2.55 . . . . 0.0 113.407 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.5 tt -62.74 -33.87 76.03 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.064 0.946 . . . . 0.0 108.871 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.25 -35.96 86.79 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.511 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.431 ' CE2' ' HE1' ' A' ' 32' ' ' PHE . 57.8 t80 -80.15 -20.51 44.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.364 0.602 . . . . 0.0 109.551 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -66.51 -43.34 85.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.3 -11.14 60.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.491 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -72.18 -25.31 61.63 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.431 ' HE1' ' CE2' ' A' ' 28' ' ' PHE . 5.1 p90 -167.74 95.94 0.63 Allowed Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 121.063 0.459 . . . . 0.0 111.683 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.99 135.35 13.89 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.852 1.702 . . . . 0.0 110.202 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.77 160.38 31.16 Favored Pre-proline 0 C--N 1.28 -2.427 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -175.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.54 153.61 73.83 Favored 'Trans proline' 0 C--O 1.251 1.168 0 C-N-CA 121.449 1.433 . . . . 0.0 108.386 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -69.07 131.8 90.55 Favored Pre-proline 0 N--CA 1.411 -2.412 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.444 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.6 156.18 28.04 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 122.211 1.941 . . . . 0.0 110.313 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.3 mm -83.53 -39.76 15.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -154.75 160.5 41.36 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.464 ' HA ' ' NH2' ' A' ' 90' ' ' ARG . 34.2 m -135.5 158.75 40.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -113.35 134.4 54.65 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.876 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -108.89 120.73 43.37 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -104.22 157.61 17.01 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.479 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 4.5 t70 -111.74 146.06 38.23 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.09 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -64.72 -26.88 68.56 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.789 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 m -89.89 -47.69 7.72 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 122.33 -0.231 . . . . 0.0 111.023 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.22 -8.21 0.05 OUTLIER Glycine 0 CA--C 1.525 0.707 0 C-N-CA 119.396 -1.383 . . . . 0.0 114.679 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -73.76 159.47 32.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.162 0.481 . . . . 0.0 111.501 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 p -147.13 136.72 22.89 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.479 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 16.8 m-90 -131.64 142.41 49.85 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.826 0.346 . . . . 0.0 110.378 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 73.4 m -106.59 114.44 28.54 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.2 m -125.74 156.94 35.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.391 -174.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -100.85 128.68 46.79 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.277 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 1.1 tmt? -127.84 143.73 51.11 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -135.0 143.57 46.88 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.012 0.434 . . . . 0.0 111.899 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HA ' HG12 ' A' ' 61' ' ' VAL . 29.1 mmmt -92.43 121.27 33.73 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 102.873 -3.01 . . . . 0.0 102.873 169.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -134.65 98.0 3.94 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.374 -170.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.45 -109.82 3.12 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.947 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.608 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -105.86 -7.93 17.98 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.979 0.419 . . . . 0.0 110.275 -178.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 61' ' ' VAL . 41.7 ttmt -118.78 167.7 11.44 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.533 HG23 ' HB ' ' A' ' 24' ' ' ILE . 32.7 m -128.65 142.27 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -140.74 132.39 27.2 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -173.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.428 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 5.5 tt -97.47 115.81 28.49 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 176.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.7 t -101.31 -142.73 0.34 Allowed 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.085 -170.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.6 m -56.1 143.78 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 124.397 1.079 . . . . 0.0 112.811 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.89 -31.86 6.31 Favored Glycine 0 N--CA 1.421 -2.357 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.428 ' HB2' HD21 ' A' ' 63' ' ' LEU . 57.1 t-105 -54.61 -27.04 36.51 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.609 0.719 . . . . 0.0 110.467 177.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.48 ' HA ' HG12 ' A' ' 71' ' ' VAL . 13.8 pt-20 -63.83 -26.63 68.7 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.204 -175.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -61.58 -37.71 84.89 Favored 'General case' 0 C--O 1.2 -1.552 0 CA-C-O 120.973 0.415 . . . . 0.0 110.098 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -73.95 -48.13 32.7 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.825 0.85 . . . . 0.0 110.765 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.48 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.2 p -65.54 -42.25 92.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.351 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -71.29 -39.81 71.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.752 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -71.8 -38.62 70.22 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -95.56 0.27 52.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.5 t30 55.63 82.81 0.1 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.99 0.9 . . . . 0.0 109.681 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 92.8 mt -120.86 136.0 55.03 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.891 -173.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -138.78 158.67 43.8 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -54.32 128.32 30.96 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 124.348 1.03 . . . . 0.0 111.009 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.24 -35.75 1.93 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -92.56 164.31 13.48 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -132.67 154.4 50.17 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -174.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -113.2 147.59 37.17 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.403 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.451 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 49.5 tt0 -115.25 123.98 50.19 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 171.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 86.2 m-85 -109.2 116.32 31.68 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 8' ' ' GLN . 49.3 mt -110.64 125.29 67.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.402 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 34.3 p90 -119.72 155.58 32.18 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.025 -1.47 . . . . 0.0 108.844 173.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -96.31 -79.92 0.44 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.271 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -143.42 16.49 1.85 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.909 0.385 . . . . 0.0 110.053 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.559 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 33.6 t70 -133.44 -175.07 3.69 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -174.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.559 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -95.09 20.51 8.97 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 125.439 1.495 . . . . 0.0 111.762 -177.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.3 t -110.33 132.98 53.7 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.402 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 81.3 m-85 -112.96 140.57 47.66 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.185 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -98.32 117.6 33.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 43.1 t -104.67 134.63 45.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.325 0.584 . . . . 0.0 112.258 -173.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.2 mt -120.29 134.33 64.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.65 121.5 51.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 120.643 0.259 . . . . 0.0 110.465 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 83' ' ' GLN . 97.1 m-85 . . . . . 0 CA--C 1.506 -0.739 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.869 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.421 -1.891 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -137.04 151.81 49.37 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.743 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -142.66 149.37 38.8 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.9 ptp -138.23 154.74 49.08 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.57 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 24.3 ttpp -152.98 145.96 17.61 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.42 142.7 16.86 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.102 2.534 . . . . 0.0 111.341 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.433 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 71.4 t80 -110.75 123.88 50.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.4 mt -126.26 113.09 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' A' ' 78' ' ' ASP . 12.6 p -58.38 -9.46 1.58 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -81.4 -28.23 34.42 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 122.148 -0.345 . . . . 0.0 110.921 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -110.61 -38.01 5.3 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.321 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 21' ' ' SER . 65.0 p -75.24 -0.45 19.51 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.225 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.5 p -75.18 -25.08 57.98 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.513 0.673 . . . . 0.0 110.409 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -115.94 -37.45 3.87 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.492 -175.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 18' ' ' SER . 34.5 p -153.67 169.6 22.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -171.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 4.2 tt -108.04 115.13 29.57 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.57 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 14.8 pt-20 -75.15 115.51 14.87 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.46 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 61' ' ' VAL . 68.0 mt -106.63 123.42 38.75 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.54 147.11 88.27 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 123.396 2.731 . . . . 0.0 114.376 -176.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 tt -59.12 -39.78 83.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.513 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.51 -31.16 69.85 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.749 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -82.62 -24.22 33.94 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.5 0.667 . . . . 0.0 109.759 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -76.08 -46.3 29.7 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.54 -20.0 66.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.038 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.39 -26.98 65.83 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.717 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -168.54 103.24 0.52 Allowed Pre-proline 0 C--O 1.248 1.009 0 CA-C-O 121.239 0.542 . . . . 0.0 110.555 177.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.21 135.14 14.9 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 120.968 1.112 . . . . 0.0 109.797 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.65 148.97 21.39 Favored Pre-proline 0 C--N 1.276 -2.6 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.74 133.85 41.18 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 121.811 1.674 . . . . 0.0 108.534 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.58 ' HB3' ' H ' ' A' ' 56' ' ' LYS . 39.4 p90 -69.78 139.92 88.78 Favored Pre-proline 0 N--CA 1.414 -2.268 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -75.72 158.63 39.3 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.874 2.383 . . . . 0.0 109.905 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.36 -54.89 12.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.5 p -133.44 150.44 51.75 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.601 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 m -131.94 157.18 43.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -109.98 139.59 44.91 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.641 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.7 mt -108.24 121.89 45.82 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.3 137.96 38.95 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.94 150.95 29.79 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.024 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.58 -22.95 65.66 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.281 0.633 . . . . 0.0 112.445 -175.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.9 t -82.46 3.05 29.81 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.099 0.476 . . . . 0.0 110.175 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 8.9 67.66 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 121.358 -0.448 . . . . 0.0 112.264 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -89.27 154.97 19.68 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.1 p -141.19 137.84 32.94 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 120.863 0.363 . . . . 0.0 111.402 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -124.3 142.13 51.51 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.217 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.5 m -100.18 120.39 39.82 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.455 HG13 ' C ' ' A' ' 66' ' ' GLY . 22.9 m -123.31 157.25 29.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.596 -174.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -101.2 139.82 36.35 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.829 0.347 . . . . 0.0 110.258 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 25.3 ttt -134.26 127.22 31.4 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.517 -172.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -120.69 124.93 46.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.018 0.437 . . . . 0.0 111.31 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.58 ' H ' ' HB3' ' A' ' 36' ' ' PHE . 25.3 mmmt -100.39 105.49 16.99 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 175.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -149.93 115.47 5.53 Favored 'General case' 0 C--N 1.265 -3.102 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.94 -120.17 5.15 Favored Glycine 0 N--CA 1.418 -2.541 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.441 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -96.03 -27.97 14.86 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.521 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -120.99 170.32 9.62 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.883 0.849 . . . . 0.0 112.876 -172.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.536 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 47.5 t -120.69 127.3 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 173.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -119.8 129.1 54.29 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 6.6 tt -103.96 118.09 35.86 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.4 p -99.16 -144.38 0.32 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.9 m -54.77 144.88 5.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.89 1.276 . . . . 0.0 113.154 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.455 ' C ' HG13 ' A' ' 52' ' ' VAL . . . 114.94 -41.54 2.14 Favored Glycine 0 N--CA 1.418 -2.532 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 -170.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.489 ' CZ3' HD12 ' A' ' 22' ' ' LEU . 58.0 t-105 -62.38 -26.9 68.71 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 114.259 -0.971 . . . . 0.0 109.248 174.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.449 ' HA ' HG13 ' A' ' 71' ' ' VAL . 30.5 tt0 -69.39 -26.77 64.81 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.524 -177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -70.28 -30.84 67.96 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.423 ' HB3' ' O ' ' A' ' 67' ' ' TRP . 53.1 t80 -73.03 -52.47 14.26 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 124.527 1.131 . . . . 0.0 109.278 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' A' ' 68' ' ' GLU . 8.1 p -64.61 -41.21 91.61 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.973 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -70.59 -48.14 56.69 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.679 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.83 -40.36 69.15 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.709 -173.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -88.62 -19.08 26.71 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.973 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 56.22 92.38 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.041 0.936 . . . . 0.0 110.993 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.433 HD11 ' CZ ' ' A' ' 13' ' ' PHE 0.289 0.9 OUTLIER -142.09 132.1 24.55 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -176.977 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.83 173.46 9.54 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 125.849 1.66 . . . . 0.0 109.017 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 15' ' ' SER . 31.4 t70 -52.71 135.92 34.29 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.693 0.62 . . . . 0.0 110.54 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.68 -28.22 3.27 Favored Glycine 0 C--N 1.301 -1.414 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -107.67 150.47 26.88 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.834 -0.683 . . . . 0.0 109.447 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -122.31 146.65 47.1 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.1 mt -110.76 135.88 50.67 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.104 0.478 . . . . 0.0 112.004 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -118.02 124.42 48.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.87 117.88 34.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.936 0.398 . . . . 0.0 110.969 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.547 HG13 ' HB2' ' A' ' 93' ' ' TYR . 11.7 pt -105.36 130.19 57.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -106.41 143.77 34.05 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.267 0.556 . . . . 0.0 111.41 -173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -92.59 -0.75 57.27 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 74.96 8.4 4.13 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.932 1.693 . . . . 0.0 109.175 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.601 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 31.5 t70 -106.08 -159.36 0.7 Allowed 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.601 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 53.4 ttp180 -95.7 11.95 31.61 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 p -108.39 117.84 35.22 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.626 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -107.42 126.46 52.52 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.491 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.547 ' HB2' HG13 ' A' ' 85' ' ' ILE . 78.9 m-85 -104.27 126.98 51.83 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.1 p -119.32 135.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.167 0.508 . . . . 0.0 111.724 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.1 mt -114.45 123.01 69.71 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.4 mt -103.56 112.69 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.578 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 25.2 p90 . . . . . 0 C--N 1.307 -1.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.807 176.655 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -125.23 159.6 31.22 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-O 121.082 0.468 . . . . 0.0 112.195 -172.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -148.89 148.83 30.32 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.9 ptp -138.28 141.01 39.85 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.652 0.263 . . . . 0.0 111.348 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.66 157.05 31.39 Favored Pre-proline 0 C--N 1.312 -1.025 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.82 132.53 15.79 Favored 'Trans proline' 0 N--CA 1.439 -1.728 0 C-N-CA 120.989 1.126 . . . . 0.0 109.681 172.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.478 ' CE2' HD13 ' A' ' 76' ' ' LEU . 30.3 p90 -84.44 140.47 31.49 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 123.564 0.746 . . . . 0.0 110.232 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.6 mt -90.59 120.88 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 28.8 t -53.44 -37.11 62.28 Favored 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.716 0.635 . . . . 0.0 111.89 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.76 -40.57 97.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -87.02 -39.32 15.75 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.823 0.821 . . . . 0.0 108.933 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 21' ' ' SER . 48.4 m -76.04 4.14 9.0 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 114.45 -1.25 . . . . 0.0 113.016 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.1 m -71.61 -20.02 62.04 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.227 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -136.22 -36.17 0.74 Allowed 'General case' 0 C--O 1.214 -0.808 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.631 ' O ' ' HA ' ' A' ' 18' ' ' SER . 58.4 p -138.95 168.06 20.66 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.608 -0.437 . . . . 0.0 112.138 -175.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.07 131.73 47.34 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -89.34 131.82 35.24 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 121.41 0.624 . . . . 0.0 111.922 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 47.3 mm -94.89 132.93 27.28 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.1 144.43 69.42 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.883 2.389 . . . . 0.0 112.984 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.0 tp -65.58 -33.41 75.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.326 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.66 -36.21 93.04 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.472 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . 45.2 m-85 -77.84 -25.71 48.92 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -59.21 -46.33 88.74 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.19 -31.98 62.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.211 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.472 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 64.0 t80 -68.81 -28.55 66.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.369 -174.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -151.09 93.51 3.64 Favored Pre-proline 0 C--O 1.247 0.95 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -83.64 136.0 7.16 Favored 'Trans proline' 0 N--CA 1.429 -2.274 0 C-N-CA 122.264 1.976 . . . . 0.0 108.812 167.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.71 160.53 31.54 Favored Pre-proline 0 C--N 1.264 -3.127 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -175.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.2 132.78 53.3 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 107.342 -1.83 . . . . 0.0 107.342 172.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -68.22 115.74 32.16 Favored Pre-proline 0 N--CA 1.41 -2.446 0 CA-C-O 121.285 0.564 . . . . 0.0 112.002 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -80.45 135.48 10.58 Favored 'Trans proline' 0 N--CA 1.433 -2.079 0 C-N-CA 121.942 1.762 . . . . 0.0 110.062 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.9 mm -81.48 -28.79 10.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.6 p -127.66 148.73 50.39 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 121.497 0.665 . . . . 0.0 110.15 173.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 90' ' ' ARG . 53.4 t -142.83 147.31 20.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -115.83 133.96 55.49 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.725 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt -108.15 121.78 45.56 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -101.23 137.47 39.54 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.962 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -113.11 141.6 46.71 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.242 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -57.93 -29.78 65.42 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 125.353 1.461 . . . . 0.0 113.717 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.5 t -86.1 -4.57 59.2 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 122.094 -0.379 . . . . 0.0 110.487 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.21 -4.85 23.62 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.651 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -80.73 158.51 25.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.775 0.322 . . . . 0.0 110.568 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 p -156.34 135.38 11.98 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.219 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -125.51 135.77 52.64 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.687 0.279 . . . . 0.0 110.91 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.2 m -92.32 114.8 27.45 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.402 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 33.6 m -115.63 157.66 16.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.343 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -101.34 127.39 47.98 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.398 0.618 . . . . 0.0 109.768 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.5 ttt -110.13 144.33 38.9 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.547 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -139.32 125.69 20.3 Favored 'General case' 0 N--CA 1.412 -2.366 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.156 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.423 ' HD2' HG23 ' A' ' 61' ' ' VAL . 28.5 mmmt -92.01 113.25 25.47 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -135.84 97.99 3.78 Favored 'General case' 0 C--N 1.272 -2.79 0 CA-C-O 120.985 0.421 . . . . 0.0 112.096 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.92 -87.92 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 116.638 1.415 . . . . 0.0 116.638 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -89.57 -24.84 21.62 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.614 -0.293 . . . . 0.0 111.612 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -154.08 171.09 19.65 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.927 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.486 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 48.5 t -108.31 131.3 59.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -120.97 132.48 54.95 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 tt -102.34 103.8 14.27 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 53.4 p -95.03 -103.65 0.15 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.5 m -69.84 144.21 14.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.455 0.645 . . . . 0.0 112.083 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 109.61 -37.77 3.63 Favored Glycine 0 CA--C 1.483 -1.954 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.405 ' O ' ' HB3' ' A' ' 70' ' ' PHE . 63.6 t-105 -61.23 -24.9 66.69 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 122.084 0.945 . . . . 0.0 109.191 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.419 ' HA ' HG12 ' A' ' 71' ' ' VAL . 13.0 pt-20 -65.68 -30.12 70.77 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.357 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -74.68 -29.46 61.24 Favored 'General case' 0 C--O 1.202 -1.413 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.405 ' HB3' ' O ' ' A' ' 67' ' ' TRP . 16.1 t80 -73.28 -52.36 14.24 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 124.763 1.225 . . . . 0.0 108.454 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.1 p -61.1 -45.32 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.443 -177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -71.91 -34.06 68.8 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.21 -39.55 63.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.387 -174.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -90.25 -18.75 25.09 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.898 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.1 t30 54.82 83.92 0.08 Allowed 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.164 0.986 . . . . 0.0 109.698 -172.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.478 HD13 ' CE2' ' A' ' 13' ' ' PHE . 1.3 pp -133.98 148.54 51.15 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -175.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -143.85 172.31 13.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.126 -174.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 15' ' ' SER . 5.4 p-10 -56.78 141.11 45.52 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 123.704 0.627 . . . . 0.0 111.38 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 117.51 -16.01 12.75 Favored Glycine 0 C--N 1.302 -1.318 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -174.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -104.39 159.22 15.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.454 ' HB2' ' HB2' ' A' ' 97' ' ' TYR . 33.2 m-85 -120.99 136.82 54.89 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -173.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.498 ' O ' HD11 ' A' ' 82' ' ' LEU . 1.8 pp -114.92 138.97 50.19 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.966 176.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.541 ' NE2' HD13 ' A' ' 95' ' ' ILE . 27.2 tt0 -124.24 124.01 41.5 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.437 ' CE2' HD13 ' A' ' 82' ' ' LEU . 86.9 m-85 -108.7 131.86 54.5 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 59.2 mt -97.65 116.05 39.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.416 ' HD2' ' CE1' ' A' ' 92' ' ' PHE . 53.8 m-85 -107.05 126.79 52.8 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -110.63 16.95 21.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 118.596 -1.241 . . . . 0.0 109.282 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 63.75 80.4 0.23 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.583 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 22.6 t70 -172.82 -168.67 0.51 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.45 ' O ' HG11 ' A' ' 40' ' ' VAL . 51.5 ptt85 -107.55 24.87 12.21 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 118.412 0.551 . . . . 0.0 109.749 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -129.27 117.35 20.54 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.416 ' CE1' ' HD2' ' A' ' 86' ' ' TYR . 26.9 m-85 -121.45 137.88 54.53 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.576 -176.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -100.4 125.99 46.72 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.6 p -109.66 137.98 39.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-O 121.599 0.714 . . . . 0.0 112.5 -175.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.541 HD13 ' NE2' ' A' ' 83' ' ' GLN . 66.7 mt -118.61 125.89 74.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.6 mt -113.01 125.43 70.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.549 0.69 . . . . 0.0 111.158 -174.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.454 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 62.6 m-85 . . . . . 0 C--N 1.294 -1.845 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.444 -0.751 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -121.84 148.01 45.24 Favored 'General case' 0 N--CA 1.406 -2.652 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -147.09 148.95 32.14 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -134.68 138.54 44.52 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.571 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -148.48 144.88 19.07 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.9 133.56 5.02 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 121.988 1.792 . . . . 0.0 108.105 168.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -100.3 142.34 31.91 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 122.336 -0.227 . . . . 0.0 110.621 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' A' ' 17' ' ' LYS . 81.5 mt -88.36 114.67 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.441 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 28.9 t -53.68 -34.18 57.85 Favored 'General case' 0 C--O 1.212 -0.872 0 O-C-N 123.648 0.592 . . . . 0.0 111.121 -174.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.5 -39.83 89.15 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.667 -177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HG2' ' HB ' ' A' ' 14' ' ' ILE . 20.7 ptmt -104.77 -26.88 12.08 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.811 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 21' ' ' SER . 68.4 m -92.56 14.44 16.86 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.8 m -74.2 -16.39 60.98 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 118.885 -1.126 . . . . 0.0 109.919 166.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -114.51 -47.67 2.9 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 18' ' ' SER . 49.2 m -143.35 168.68 19.23 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 122.972 0.509 . . . . 0.0 110.39 -172.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.484 HD23 ' CZ3' ' A' ' 67' ' ' TRP . 43.9 tp -126.24 142.17 51.63 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.305 0.242 . . . . 0.0 110.751 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -98.37 124.69 43.17 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 120.681 0.276 . . . . 0.0 110.661 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 2.1 mp -97.25 133.38 24.02 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.53 139.29 17.89 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 123.925 3.083 . . . . 0.0 114.787 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.5 tt -62.7 -41.08 98.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.163 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.1 -36.11 92.45 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -73.72 -34.2 64.69 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -63.51 -46.46 85.94 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.853 0.835 . . . . 0.0 110.021 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -72.88 -11.07 60.45 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.842 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -74.76 -27.68 60.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.377 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -147.07 121.07 5.05 Favored Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.817 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.74 134.64 15.2 Favored 'Trans proline' 0 N--CA 1.44 -1.676 0 C-N-CA 121.832 1.688 . . . . 0.0 108.87 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.08 138.46 11.59 Favored Pre-proline 0 C--N 1.271 -2.805 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.92 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 143.85 96.72 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 106.557 -2.132 . . . . 0.0 106.557 167.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -68.79 121.93 83.08 Favored Pre-proline 0 N--CA 1.41 -2.471 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.162 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.09 152.56 62.47 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 121.913 1.742 . . . . 0.0 110.086 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.0 mm -86.78 -59.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -124.72 151.01 45.58 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.706 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.48 162.29 29.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 91' ' ' THR . 24.8 t70 -124.89 140.09 53.24 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.042 -175.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.3 mt -107.79 127.58 53.83 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.15 147.72 25.91 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.798 0.809 . . . . 0.0 111.793 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 2.3 t70 -112.14 137.14 50.63 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.528 173.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -70.31 -8.88 53.87 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.5 t -92.18 -41.73 10.28 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.87 0.03 0.11 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.11 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 17.9 mmt180 -88.88 158.95 17.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 117.643 0.722 . . . . 0.0 110.731 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.7 p -149.51 146.56 27.45 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CE3' ' HD1' ' A' ' 70' ' ' PHE . 24.3 m-90 -130.04 123.71 31.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.415 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.9 m -89.68 117.0 28.22 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 63' ' ' LEU . 22.2 m -124.95 157.23 33.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.686 -172.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -102.62 122.93 45.39 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.255 0.55 . . . . 0.0 111.517 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 50.8 ttp -124.82 131.18 53.47 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.63 161.84 38.15 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.493 ' HG2' HG23 ' A' ' 61' ' ' VAL . 78.8 mttt -91.29 129.86 37.23 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -132.11 103.15 6.11 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.392 0.615 . . . . 0.0 110.951 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.27 -101.27 0.73 Allowed Glycine 0 N--CA 1.431 -1.65 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.565 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.414 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 39.7 mt-10 -95.23 -20.68 19.0 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.383 -0.408 . . . . 0.0 111.061 -175.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -131.56 166.64 20.94 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.487 0.66 . . . . 0.0 112.623 -170.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.493 HG23 ' HG2' ' A' ' 56' ' ' LYS . 90.1 t -97.42 136.92 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 170.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -135.19 132.88 38.48 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.132 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.45 HD22 ' HB ' ' A' ' 52' ' ' VAL . 3.7 tt -99.14 116.86 32.31 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.3 p -90.0 -92.16 0.13 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.67 145.15 8.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 C-N-CA 124.967 1.307 . . . . 0.0 113.205 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.412 ' C ' HG12 ' A' ' 52' ' ' VAL . . . 109.28 -36.4 4.36 Favored Glycine 0 CA--C 1.477 -2.311 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.566 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.484 ' CZ3' HD23 ' A' ' 22' ' ' LEU . 64.5 t-105 -58.68 -26.15 63.54 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.706 0.765 . . . . 0.0 109.906 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.485 ' HA ' HG13 ' A' ' 71' ' ' VAL . 15.8 pt-20 -72.39 -26.22 61.8 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.535 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -71.99 -37.92 69.76 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.457 ' HD1' ' CE3' ' A' ' 50' ' ' TRP . 69.0 t80 -72.89 -51.29 19.21 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.072 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -62.66 -44.59 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.65 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -73.47 -43.72 59.6 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.12 -40.05 78.55 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.532 -0.867 . . . . 0.0 112.891 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -85.14 -14.56 46.63 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t30 60.77 82.75 0.16 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 125.204 1.402 . . . . 0.0 112.173 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -115.64 159.08 21.79 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.388 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -143.96 165.06 28.8 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.441 ' H ' ' HB2' ' A' ' 15' ' ' SER . 14.1 t70 -53.16 120.95 6.56 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 124.072 0.858 . . . . 0.0 109.414 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.98 -29.38 3.73 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -80.85 154.48 27.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.468 ' C ' HD12 ' A' ' 82' ' ' LEU . 94.8 m-85 -122.05 135.15 54.8 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 81' ' ' TYR . 6.4 mp -123.26 130.75 53.18 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.111 0.481 . . . . 0.0 111.224 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -112.83 124.11 51.84 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -108.99 118.04 35.77 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.355 -173.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.416 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 63.2 mt -98.23 118.29 44.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.29 -0.413 . . . . 0.0 109.937 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -106.47 123.48 48.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -81.79 -78.78 0.18 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -176.82 24.23 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 32.2 t70 -119.59 -172.99 2.43 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.427 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -94.97 29.44 2.4 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-O 121.638 0.732 . . . . 0.0 109.078 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 17.5 p -125.38 136.66 53.67 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.078 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -118.13 135.25 54.33 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.375 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.416 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 57.2 m-85 -100.48 113.64 26.59 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.0 t -98.7 124.79 52.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.693 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.1 mm -105.75 116.46 49.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.4 ' N ' HD13 ' A' ' 96' ' ' ILE . 3.0 mp -102.15 130.28 52.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--N 1.304 -1.378 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.223 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 9.8 pt20 -121.9 146.1 47.44 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.37 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 83' ' ' GLN . 88.6 t80 -129.63 148.59 51.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -124.9 146.24 49.43 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 120.641 0.257 . . . . 0.0 110.676 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -154.14 139.88 12.32 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.03 146.19 81.6 Favored 'Trans proline' 0 C--O 1.257 1.467 0 C-N-CA 122.032 1.821 . . . . 0.0 110.709 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -78.62 119.45 21.9 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.1 mt -107.52 120.2 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.239 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.1 t -66.74 -10.9 51.87 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 123.273 0.629 . . . . 0.0 111.413 -172.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.5 -46.18 33.85 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.531 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.486 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 3.5 mppt? -113.17 -41.89 3.62 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 118.394 -1.322 . . . . 0.0 113.543 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 21' ' ' SER . 15.6 m -69.43 -3.74 15.68 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 123.57 0.544 . . . . 0.0 111.091 -174.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.0 p -74.31 -25.51 59.62 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -133.13 -23.33 1.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.975 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.561 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 51.0 m -150.48 169.16 22.15 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 63' ' ' LEU 0.308 42.7 mt -103.86 131.35 51.15 Favored 'General case' 0 CA--C 1.488 -1.408 0 CA-C-O 122.391 1.091 . . . . 0.0 113.875 177.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.486 ' OE2' ' HB2' ' A' ' 17' ' ' LYS . 6.7 pt-20 -91.33 111.27 22.68 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 112.324 -2.216 . . . . 0.0 108.973 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.86 121.68 36.46 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.614 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.51 153.75 76.87 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 123.045 2.497 . . . . 0.0 113.154 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.88 -34.8 74.05 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.882 -175.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.21 -28.8 73.96 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.688 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -75.88 -31.21 59.14 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.276 0.631 . . . . 0.0 110.166 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -76.16 -26.23 56.04 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.565 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -75.32 -17.42 60.26 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.662 0.744 . . . . 0.0 109.324 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -74.1 -28.24 61.27 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.92 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -161.35 80.45 2.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 121.617 0.722 . . . . 0.0 112.1 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.37 140.62 15.43 Favored 'Trans proline' 0 N--CA 1.43 -2.244 0 C-N-CA 122.343 2.029 . . . . 0.0 111.499 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.8 159.21 36.36 Favored Pre-proline 0 C--N 1.278 -2.519 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.93 146.34 87.24 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 121.888 1.725 . . . . 0.0 108.935 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -69.05 117.42 51.63 Favored Pre-proline 0 N--CA 1.415 -2.178 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -175.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.66 159.84 31.61 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.878 2.385 . . . . 0.0 111.534 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.17 -41.34 22.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -137.03 150.53 48.15 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.671 0.748 . . . . 0.0 112.219 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.578 HG11 ' O ' ' A' ' 90' ' ' ARG . 74.2 t -132.45 160.04 42.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.88 130.96 34.63 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.48 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.7 mt -109.62 133.81 52.67 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.208 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.44 143.32 32.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.877 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 9.7 t70 -112.9 147.69 36.51 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.681 174.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -60.34 -23.81 64.55 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 124.228 1.011 . . . . 0.0 112.866 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -80.28 -12.75 59.58 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.847 -0.533 . . . . 0.0 110.404 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.25 1.35 25.02 Favored Glycine 0 C--O 1.239 0.445 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.299 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.408 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 98.1 mtt180 -80.6 157.42 26.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.2 p -150.53 136.75 18.62 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 120.59 0.233 . . . . 0.0 110.512 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 15.8 m-90 -124.53 130.47 52.52 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.145 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.1 m -89.98 114.48 26.33 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.403 ' HB ' HD23 ' A' ' 63' ' ' LEU . 28.6 m -112.03 156.81 13.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.814 -173.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -102.79 119.96 39.76 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 60.4 ttp -124.62 123.72 40.67 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HB3' ' HZ2' ' A' ' 55' ' ' LYS . 9.8 mtpm? -136.75 162.68 32.53 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -174.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HD3' HG23 ' A' ' 61' ' ' VAL . 29.7 mmtp -88.72 128.62 35.62 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 175.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.49 100.62 5.21 Favored 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -175.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.84 -112.2 3.61 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -175.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -112.3 -5.77 14.12 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.886 0.85 . . . . 0.0 110.321 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -113.69 170.67 8.09 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.213 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.471 HG23 ' HD3' ' A' ' 56' ' ' LYS . 57.9 t -108.58 127.28 65.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -126.68 130.59 50.7 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.561 ' O ' ' HB3' ' A' ' 21' ' ' SER . 6.7 tt -103.15 120.96 41.66 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.6 t -96.43 -144.55 0.28 Allowed 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 123.161 0.584 . . . . 0.0 111.546 -172.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.47 143.88 6.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 125.43 1.492 . . . . 0.0 111.689 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.35 -48.42 0.96 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -65.36 -24.91 67.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.394 -0.903 . . . . 0.0 110.176 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.432 ' O ' HG11 ' A' ' 71' ' ' VAL . 35.2 tt0 -65.5 -29.87 70.57 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.796 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -69.48 -35.89 76.02 Favored 'General case' 0 C--O 1.198 -1.634 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.347 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -68.57 -49.7 57.41 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 123.409 0.683 . . . . 0.0 109.204 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 6.8 p -63.67 -33.68 63.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.223 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -71.23 -48.64 50.07 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.039 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -72.34 -39.56 68.06 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -96.96 -10.0 27.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.749 -0.595 . . . . 0.0 111.278 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 7.9 t30 53.99 94.86 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.233 1.413 . . . . 0.0 112.932 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 71' ' ' VAL . 3.8 mp -122.21 133.75 54.72 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.749 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.09 169.99 10.65 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 124.21 1.004 . . . . 0.0 108.979 174.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.66 141.47 56.73 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.216 0.531 . . . . 0.0 111.302 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.09 -29.45 5.99 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -80.84 154.33 27.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.862 0.363 . . . . 0.0 110.404 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -122.56 140.73 52.46 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mp -124.51 144.12 50.29 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.745 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 8.9 pt20 -116.23 137.27 52.28 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 85.9 m-85 -111.81 117.61 33.29 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 48.9 mt -97.62 114.72 35.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.471 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 24.3 p90 -130.56 157.86 41.55 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.734 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -107.66 25.1 11.92 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.61 13.49 2.94 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 125.145 1.378 . . . . 0.0 111.82 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.551 ' OD2' HG22 ' A' ' 91' ' ' THR . 7.8 p-10 -96.35 -159.63 0.74 Allowed 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.578 ' O ' HG11 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -105.5 15.72 26.64 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -176.012 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.551 HG22 ' OD2' ' A' ' 89' ' ' ASP . 5.5 t -121.41 139.8 52.98 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 117.789 -1.564 . . . . 0.0 109.197 172.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.471 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 71.6 m-85 -128.13 136.46 51.17 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 122.122 -0.361 . . . . 0.0 110.67 -175.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.408 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 61.3 m-85 -94.59 120.46 34.85 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.5 t -103.71 117.71 49.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 120.99 0.424 . . . . 0.0 111.496 -174.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.428 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 65.0 mt -114.61 124.49 71.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 96' ' ' ILE . 2.6 mp -94.15 140.66 16.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 121.583 0.706 . . . . 0.0 111.328 177.928 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -116.42 145.63 43.11 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.019 0.438 . . . . 0.0 111.781 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -140.37 149.81 43.14 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.481 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 23.6 ptp -126.18 144.47 50.75 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' NZ ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.57 146.2 18.61 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 178.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.35 147.21 28.81 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.692 2.262 . . . . 0.0 109.257 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -108.4 136.07 48.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.1 mp -110.13 114.1 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -61.93 -11.93 15.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.547 0.739 . . . . 0.0 112.797 -170.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -77.15 -28.05 54.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -107.13 -35.76 6.76 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 120.815 0.34 . . . . 0.0 110.932 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.5 p -75.73 3.48 9.71 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.899 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 p -74.19 -30.96 62.47 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -120.0 -42.06 2.62 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.58 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.9 p -134.93 146.22 48.94 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -173.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.526 HD12 ' CZ ' ' A' ' 84' ' ' PHE . 3.3 tt -91.93 115.05 27.73 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.1 125.35 30.75 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.549 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.1 mm -100.13 119.25 59.79 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.54 143.71 97.89 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.919 2.413 . . . . 0.0 111.671 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.454 ' O ' ' HG3' ' A' ' 30' ' ' GLU . 62.9 tp -51.09 -41.73 60.17 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.626 0.77 . . . . 0.0 112.468 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.86 -34.08 76.43 Favored Glycine 0 C--N 1.319 -0.391 0 N-CA-C 113.926 0.33 . . . . 0.0 113.926 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -88.68 -22.72 23.25 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -72.76 -43.6 62.67 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.255 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 45.1 mt-10 -61.99 -17.24 56.47 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.257 0.623 . . . . 0.0 110.483 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -77.89 -27.28 49.58 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.59 -174.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -147.18 72.95 12.08 Favored Pre-proline 0 CA--C 1.56 1.348 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -54.36 136.49 69.24 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.806 1.671 . . . . 0.0 110.304 165.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.06 160.64 31.69 Favored Pre-proline 0 C--N 1.277 -2.567 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.269 -173.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.86 137.96 83.61 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 108.232 -1.488 . . . . 0.0 108.232 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -69.46 117.24 50.84 Favored Pre-proline 0 N--CA 1.416 -2.164 0 CA-C-O 121.1 0.476 . . . . 0.0 111.375 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -91.86 159.23 3.39 Favored 'Trans proline' 0 N--CA 1.429 -2.269 0 C-N-CA 122.289 1.993 . . . . 0.0 111.672 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mp -98.6 -31.75 3.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 m -137.6 151.91 48.84 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.278 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.8 t -147.97 157.67 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 126.719 2.008 . . . . 0.0 106.969 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -119.48 140.45 50.45 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 118.765 0.711 . . . . 0.0 111.704 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.0 mt -111.61 126.3 54.86 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.021 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.1 147.67 26.7 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -111.97 136.98 50.6 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -67.52 -15.45 63.67 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.353 -173.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.8 t -96.71 -14.29 22.14 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.426 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.81 -23.9 2.9 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 119.848 -1.168 . . . . 0.0 114.115 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -67.8 159.22 30.74 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -150.86 136.82 18.26 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.427 ' HE1' ' HB3' ' A' ' 73' ' ' ASP . 32.3 m-90 -130.67 137.19 49.46 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.661 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.6 m -93.26 125.31 37.8 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.404 HG22 ' N ' ' A' ' 67' ' ' TRP . 14.2 p -125.58 155.91 34.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.111 0.481 . . . . 0.0 111.213 -173.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -104.52 120.27 40.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -126.86 127.5 45.05 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.93 134.52 54.84 Favored 'General case' 0 C--O 1.25 1.08 0 O-C-N 123.38 0.425 . . . . 0.0 111.035 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HA ' ' CG1' ' A' ' 61' ' ' VAL . 13.3 mmmm -91.91 112.01 23.77 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 175.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -147.47 120.86 9.02 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.99 -136.73 18.13 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.428 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -111.28 -3.49 15.31 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.115 0.484 . . . . 0.0 111.495 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -128.85 129.15 45.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.177 0.513 . . . . 0.0 109.691 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.471 ' CG1' ' HA ' ' A' ' 56' ' ' LYS . 16.4 m -111.49 146.69 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.97 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -137.58 142.38 41.31 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.017 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 4.7 mp -88.05 103.26 15.56 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 170.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.8 p -78.21 -141.53 0.03 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 124.269 1.028 . . . . 0.0 111.652 -173.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.3 p -55.57 140.64 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.546 0.689 . . . . 0.0 109.875 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.0 -40.02 2.5 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 -171.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.458 ' CZ3' HD11 ' A' ' 22' ' ' LEU . 54.3 t-105 -67.24 -21.02 65.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.685 0.755 . . . . 0.0 109.147 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.443 ' HA ' HG13 ' A' ' 71' ' ' VAL . 41.9 tt0 -68.01 -32.75 73.35 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.777 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -65.15 -33.11 75.24 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-O 121.394 0.616 . . . . 0.0 109.844 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.28 -52.53 18.42 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.359 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.504 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 6.8 p -64.06 -40.54 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.804 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -71.16 -48.38 52.21 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.84 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.427 ' HB3' ' HE1' ' A' ' 50' ' ' TRP . 28.5 t70 -77.1 -35.57 56.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -173.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -86.6 -20.94 27.16 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 56.74 83.82 0.1 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.578 1.151 . . . . 0.0 111.543 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.504 ' CD2' ' HA ' ' A' ' 71' ' ' VAL . 1.6 pt? -125.44 155.39 40.53 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.832 0.825 . . . . 0.0 112.282 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.49 172.43 12.97 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.18 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -58.74 130.21 45.82 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.35 -20.35 7.02 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -99.2 146.27 26.35 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.48 ' C ' HD11 ' A' ' 82' ' ' LEU . 96.4 m-85 -119.96 140.93 50.16 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -175.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.48 HD11 ' C ' ' A' ' 81' ' ' TYR . 4.9 mp -131.85 137.8 48.21 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.005 0.431 . . . . 0.0 111.008 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.481 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 42.9 mt-30 -111.87 135.08 52.96 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.95 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.526 ' CZ ' HD12 ' A' ' 22' ' ' LEU . 95.0 m-85 -115.19 125.04 52.93 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.4 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 2.4 mp -105.0 118.98 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 88' ' ' ARG . 87.3 t80 -106.74 124.64 49.9 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 7.9 p-10 -107.52 12.87 27.36 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -175.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.472 ' HA ' ' CE2' ' A' ' 86' ' ' TYR 0.27 6.1 mpt_? 84.47 -0.05 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 12.4 t70 -101.13 -165.18 1.18 Allowed 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.435 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.5 OUTLIER -102.48 39.26 1.54 Allowed 'General case' 0 C--N 1.256 -3.486 0 CA-C-O 121.839 0.828 . . . . 0.0 108.817 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -126.01 117.93 24.27 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.148 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.81 126.8 52.6 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 174.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.465 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 68.6 m-85 -91.7 118.9 31.07 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.66 125.72 62.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 120.787 0.327 . . . . 0.0 111.067 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.479 ' CG2' ' HB2' ' A' ' 83' ' ' GLN . 13.9 tt -112.54 118.41 57.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.411 HG12 ' HG ' ' A' ' 82' ' ' LEU . 55.6 mt -103.48 133.84 46.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.734 -173.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.798 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.445 -0.699 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -130.81 149.46 52.44 Favored 'General case' 0 N--CA 1.415 -2.196 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.57 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -137.98 149.31 46.01 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.618 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 47.6 ttm -136.51 136.48 39.41 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -154.37 133.06 6.97 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-O 119.832 -0.128 . . . . 0.0 111.181 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.43 132.32 17.48 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 N-CA-C 108.259 -1.477 . . . . 0.0 108.259 168.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -100.01 140.52 34.12 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 120.58 0.229 . . . . 0.0 110.558 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.429 HG23 ' H ' ' A' ' 16' ' ' GLU . 63.7 mt -103.44 124.49 57.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.7 t -62.77 -11.54 18.4 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.858 0.863 . . . . 0.0 111.895 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.429 ' H ' HG23 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -73.96 -45.28 51.17 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -110.5 -40.65 4.56 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.983 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 21' ' ' SER . 15.8 m -72.58 0.08 11.49 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 m -74.62 -16.24 60.79 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HG3' ' OE2' ' A' ' 68' ' ' GLU . 54.8 tttp -125.84 -28.19 3.25 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 118.93 -1.108 . . . . 0.0 111.176 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 18' ' ' SER . 46.4 m -151.98 148.75 28.1 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.516 HD11 ' CH2' ' A' ' 67' ' ' TRP . 5.6 tt -101.73 119.21 38.43 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -82.02 131.57 35.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.714 -178.699 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 48.0 mm -96.06 126.45 44.42 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.71 144.6 86.0 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.931 2.42 . . . . 0.0 112.267 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -62.17 -32.43 73.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.506 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.22 -31.2 69.05 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.393 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -80.61 -29.28 36.85 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.42 -38.28 84.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.877 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.04 -28.76 70.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -67.98 -27.42 66.56 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.816 -175.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -157.17 116.01 1.98 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 120.406 -0.518 . . . . 0.0 112.101 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.51 145.04 32.96 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.284 1.989 . . . . 0.0 109.756 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.86 143.0 16.26 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.91 156.39 64.57 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.543 2.162 . . . . 0.0 110.045 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -68.72 115.08 27.05 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.676 0.274 . . . . 0.0 111.221 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -95.73 160.02 1.47 Allowed 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 123.308 2.672 . . . . 0.0 111.186 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -90.19 -62.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.7 p -126.76 151.38 48.29 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.965 0.412 . . . . 0.0 111.997 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 90' ' ' ARG . 22.1 m -136.52 162.34 35.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -113.59 143.99 43.63 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.033 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -108.86 120.1 41.5 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.63 137.61 43.2 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.205 0.526 . . . . 0.0 111.16 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.43 ' OD2' ' HB3' ' A' ' 46' ' ' SER . 0.1 OUTLIER -112.46 145.87 39.44 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.048 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -73.43 -19.14 61.04 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.703 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.43 ' HB3' ' OD2' ' A' ' 44' ' ' ASP . 38.6 t -74.79 -36.77 62.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.37 -0.32 2.23 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.204 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 97.7 mtt180 -89.53 157.94 17.87 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.241 0.543 . . . . 0.0 111.642 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.8 p -142.56 136.64 29.45 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.501 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -121.08 131.77 54.47 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.5 m -96.92 120.24 36.89 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.492 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 7.7 p -110.29 153.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -100.78 122.12 42.85 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.5 ttt -110.02 130.44 55.53 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.422 -170.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -121.16 125.47 47.26 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.339 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -106.9 126.63 52.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -133.36 97.45 3.97 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.025 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.73 -97.75 0.04 OUTLIER Glycine 0 C--N 1.304 -1.218 0 O-C-N 124.174 0.921 . . . . 0.0 115.012 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -95.81 -6.5 39.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.5 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -138.13 163.69 31.02 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 67.2 t -134.46 145.39 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -128.34 132.4 48.6 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.679 0.276 . . . . 0.0 110.569 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.98 103.39 15.31 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.7 p -94.01 -106.49 0.13 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -169.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.15 136.11 27.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.305 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 108.75 -47.2 1.07 Allowed Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.516 ' CH2' HD11 ' A' ' 22' ' ' LEU . 36.5 t-105 -62.46 -31.95 72.75 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 41.1 tt0 -61.78 -33.65 74.48 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 113.548 -1.66 . . . . 0.0 109.917 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -69.07 -37.76 78.67 Favored 'General case' 0 C--O 1.197 -1.68 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.414 ' CE2' HD22 ' A' ' 76' ' ' LEU . 85.5 t80 -73.0 -47.47 44.87 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 123.706 0.802 . . . . 0.0 110.683 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -61.06 -44.76 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.62 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 31.6 mmmt -72.41 -48.25 42.79 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.403 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.85 -38.15 67.15 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -84.39 -18.72 35.19 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.34 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 64.18 95.18 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.86 0.838 . . . . 0.0 112.067 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.414 HD22 ' CE2' ' A' ' 70' ' ' PHE 0.261 1.5 pp -152.18 134.75 15.35 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.192 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -132.96 170.89 14.69 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -54.47 126.15 22.35 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.244 0.545 . . . . 0.0 111.112 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.25 -21.29 4.89 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -94.72 163.34 13.4 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -134.01 138.86 45.66 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.941 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -136.4 149.52 48.34 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.92 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -127.29 135.77 51.02 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -107.23 129.94 54.8 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.432 0.158 . . . . 0.0 111.057 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.21 125.89 60.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.412 ' HE2' ' CE2' ' A' ' 92' ' ' PHE . 58.5 m-85 -109.58 126.91 54.09 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -87.5 9.36 21.2 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 72.24 81.31 0.14 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.892 1.277 . . . . 0.0 109.304 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 21.8 t70 -179.2 -160.75 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 -174.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.468 ' HB2' HG11 ' A' ' 40' ' ' VAL . 34.1 ptt180 -104.78 23.08 14.01 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -103.65 117.79 35.22 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.107 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.412 ' CE2' ' HE2' ' A' ' 86' ' ' TYR . 2.0 m-85 -105.83 122.61 46.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.764 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -100.29 116.7 32.88 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.88 121.3 49.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.759 0.79 . . . . 0.0 112.913 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.1 mt -105.9 116.25 49.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.1 mt -99.63 140.29 19.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 C--N 1.295 -1.777 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.658 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.441 -0.894 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -137.65 163.7 30.63 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -151.4 149.53 29.41 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.757 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 25.5 ptm -132.03 142.33 49.53 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -153.04 159.68 31.91 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.72 146.6 97.01 Favored 'Trans proline' 0 C--O 1.258 1.525 0 C-N-CA 122.894 2.396 . . . . 0.0 114.455 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -105.13 136.58 44.36 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 16' ' ' GLU . 6.4 tp -122.42 125.01 72.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 175.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' SER . 19.5 m -61.67 -20.43 63.42 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 121.179 0.514 . . . . 0.0 111.316 -176.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.46 ' H ' HG13 ' A' ' 14' ' ' ILE . 34.6 tt0 -79.66 -44.33 21.09 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.451 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 13.4 mptt -95.94 -40.19 9.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.11 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 21' ' ' SER . 25.8 m -77.07 10.11 2.57 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.319 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 15' ' ' SER . 37.9 t -70.19 -27.23 64.34 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 171.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -135.99 -29.4 1.02 Allowed 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.826 179.048 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' A' ' 18' ' ' SER . 29.0 p -142.38 153.72 44.02 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -175.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 34.7 mt -89.6 126.18 35.52 Favored 'General case' 0 CA--C 1.481 -1.711 0 CA-C-O 121.318 0.58 . . . . 0.0 110.095 171.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.01 108.92 20.69 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -177.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 61' ' ' VAL . 66.8 mt -106.41 120.26 49.16 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.42 158.23 37.12 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.5 2.8 . . . . 0.0 114.156 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.65 -39.19 64.83 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.376 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.54 -36.85 79.68 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.721 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -88.47 -29.17 20.36 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.567 -0.453 . . . . 0.0 109.81 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.12 -45.61 93.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.685 0.755 . . . . 0.0 109.107 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.88 -21.58 63.32 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.815 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -67.92 -28.05 67.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.238 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -149.15 84.33 6.3 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-O 121.77 0.795 . . . . 0.0 111.711 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -86.6 134.34 3.94 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 C-N-CA 121.896 1.73 . . . . 0.0 111.559 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.47 161.13 29.94 Favored Pre-proline 0 C--N 1.275 -2.672 0 CA-C-N 114.051 -1.431 . . . . 0.0 107.199 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -55.23 140.18 81.22 Favored 'Trans proline' 0 C--N 1.354 0.849 0 N-CA-C 107.603 -1.73 . . . . 0.0 107.603 170.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.438 ' HB3' ' HB2' ' A' ' 56' ' ' LYS . 54.1 p90 -69.09 124.2 89.86 Favored Pre-proline 0 N--CA 1.413 -2.302 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -171.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -84.86 160.51 11.97 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 123.08 2.52 . . . . 0.0 108.796 172.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.04 -46.83 13.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.888 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 m -128.73 151.89 49.03 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.702 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 m -146.95 163.24 8.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 125.543 1.537 . . . . 0.0 107.857 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -118.91 143.26 47.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.3 mt -109.26 120.94 44.04 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.49 139.54 47.98 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.05 0.452 . . . . 0.0 110.79 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -120.86 156.02 32.87 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.896 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.33 -12.24 59.93 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 m -91.21 8.84 33.84 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.242 0.544 . . . . 0.0 110.393 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.01 -6.87 69.56 Favored Glycine 0 CA--C 1.497 -1.058 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.559 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -73.53 146.84 44.53 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.6 p -152.11 137.8 17.88 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -132.06 115.73 16.16 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.8 m -86.02 114.76 23.16 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.492 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 9.5 p -116.68 152.87 18.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.403 -172.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -101.07 129.0 46.87 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.419 0.628 . . . . 0.0 110.796 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.457 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 25.2 ttt -110.0 138.13 46.81 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.172 -172.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.2 OUTLIER -130.91 127.09 37.78 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.938 175.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 27.3 mmmt -92.73 116.8 29.35 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 169.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -144.79 103.86 3.95 Favored 'General case' 0 C--N 1.269 -2.929 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.046 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.85 -106.07 1.28 Allowed Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.885 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.44 -18.02 26.14 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.153 -0.524 . . . . 0.0 111.464 -175.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -137.01 170.39 16.19 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -172.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 58.8 t -113.56 129.22 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 174.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -118.32 130.48 56.05 Favored 'General case' 0 C--N 1.28 -2.428 0 C-N-CA 119.086 -1.045 . . . . 0.0 108.959 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 92.5 mt -103.06 102.96 13.0 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.1 p -87.54 -127.01 0.05 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.68 139.68 15.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.681 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 115.26 -44.13 1.54 Allowed Glycine 0 N--CA 1.417 -2.629 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -172.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -67.98 -27.98 67.04 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.46 ' HA ' HG11 ' A' ' 71' ' ' VAL 0.264 0.0 OUTLIER -68.17 -26.37 65.72 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.922 -179.733 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -72.25 -32.72 66.94 Favored 'General case' 0 C--O 1.196 -1.756 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -70.8 -51.64 25.57 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 122.959 0.504 . . . . 0.0 110.161 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 7.7 p -59.61 -39.52 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.2 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' A' ' 72' ' ' LYS . 9.7 mmpt? -72.5 -48.01 44.03 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.487 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.49 -39.65 74.06 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.05 -18.75 24.05 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.509 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.5 t30 50.98 89.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.085 1.354 . . . . 0.0 112.965 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.8 mt -129.18 169.12 15.18 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.045 0.45 . . . . 0.0 111.475 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -143.6 170.39 15.93 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 124.363 1.065 . . . . 0.0 108.652 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -65.58 139.97 58.49 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.619 0.574 . . . . 0.0 109.57 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.05 -36.73 3.33 Favored Glycine 0 C--N 1.299 -1.488 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -93.22 147.31 23.01 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -124.39 158.76 31.96 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.497 -170.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.498 ' CD1' HG23 ' A' ' 96' ' ' ILE . 1.8 mm? -119.1 129.33 55.0 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.536 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.517 ' CG ' ' HB ' ' A' ' 95' ' ' ILE . 19.0 pt20 -111.87 124.77 53.06 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 169.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -107.08 130.48 54.67 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.7 mt -96.92 123.2 49.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -106.68 129.59 54.55 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.48 -167.77 1.84 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -91.64 -10.35 40.7 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.801 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -102.15 -162.43 0.92 Allowed 'General case' 0 N--CA 1.41 -2.47 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.217 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -94.94 36.31 1.21 Allowed 'General case' 0 C--N 1.283 -2.292 0 CA-C-O 121.047 0.451 . . . . 0.0 111.663 -170.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.6 p -113.09 117.55 32.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.956 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -105.68 132.93 51.22 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -109.24 122.83 48.17 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.25 126.96 56.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.517 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 40.1 mm -116.77 118.09 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.498 HG23 ' CD1' ' A' ' 82' ' ' LEU . 31.4 pt -93.41 139.05 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.29 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--N 1.3 -1.558 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.621 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.502 -0.871 0 CA-C-O 120.624 0.25 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -121.55 144.4 48.75 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -142.15 147.5 36.75 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -139.84 139.1 36.25 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.99 159.49 31.76 Favored Pre-proline 0 C--N 1.312 -1.045 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.12 147.25 93.98 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.136 2.557 . . . . 0.0 113.082 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' A' ' 82' ' ' LEU . 25.4 m-85 -119.74 139.7 51.88 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.48 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.9 mt -104.08 123.47 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.463 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 23.9 t -61.07 -29.98 70.06 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.12 0.263 . . . . 0.0 111.59 -173.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.84 -43.89 97.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.066 0.46 . . . . 0.0 110.448 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -80.68 -40.34 25.62 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.39 0.614 . . . . 0.0 109.521 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -72.06 -5.53 35.88 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.912 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.2 t -70.9 -23.18 62.23 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 120.884 0.373 . . . . 0.0 110.08 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -127.22 -44.41 1.59 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.595 -174.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.5 p -136.68 151.03 48.82 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 4.1 tt -86.47 114.04 22.9 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.16 126.31 31.91 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.923 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -109.08 127.68 26.83 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.69 137.04 79.5 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.597 2.198 . . . . 0.0 111.148 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.518 ' HA ' HD21 ' A' ' 29' ' ' ASN . 53.3 tp -54.05 -38.74 65.54 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.389 0.676 . . . . 0.0 112.145 -175.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.0 -28.57 72.28 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.578 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 64.2 t80 -87.37 -22.95 24.74 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.518 HD21 ' HA ' ' A' ' 26' ' ' LEU . 52.9 m-80 -73.71 -23.88 59.85 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.787 0.803 . . . . 0.0 109.423 175.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.97 -16.53 59.32 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.421 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 65.6 t80 -77.11 -27.03 53.93 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.108 -177.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -140.88 104.5 6.25 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.76 136.89 15.55 Favored 'Trans proline' 0 N--CA 1.439 -1.699 0 C-N-CA 122.015 1.81 . . . . 0.0 108.064 168.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.17 145.89 19.36 Favored Pre-proline 0 C--N 1.28 -2.434 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.698 -173.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.1 156.02 36.55 Favored 'Trans proline' 0 C--O 1.241 0.655 0 C-N-CA 122.902 2.402 . . . . 0.0 110.085 173.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -69.15 115.28 30.35 Favored Pre-proline 0 N--CA 1.429 -1.516 0 CA-C-O 120.858 0.361 . . . . 0.0 111.874 -176.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -93.88 161.0 2.22 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 123.355 2.704 . . . . 0.0 111.122 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.8 mm -101.25 -53.19 7.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.1 p -129.13 151.43 49.81 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.618 0.723 . . . . 0.0 112.3 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.15 145.84 35.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -109.85 125.86 53.22 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.426 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.17 124.71 52.05 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.726 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.73 142.95 33.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.232 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -110.16 154.63 23.06 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.405 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -59.16 -30.1 67.92 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 124.984 1.313 . . . . 0.0 111.989 -175.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.2 t -82.47 -12.61 57.71 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.732 0.301 . . . . 0.0 110.793 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.32 -2.93 25.17 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.225 -0.988 . . . . 0.0 115.28 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -88.33 149.39 23.79 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 118.138 0.969 . . . . 0.0 110.201 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 p -118.7 146.28 44.85 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.608 0.242 . . . . 0.0 111.538 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.476 ' CE3' ' HD1' ' A' ' 70' ' ' PHE . 23.0 m-90 -131.57 124.95 31.08 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.861 173.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.0 m -92.34 114.03 26.47 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.8 t -105.46 157.6 6.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.234 -174.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -100.0 120.32 39.63 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.7 ttt -115.69 130.26 56.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.954 -173.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -130.7 135.67 48.05 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.477 ' HZ2' ' HB3' ' A' ' 56' ' ' LYS . 1.4 mmmp? -92.73 129.55 38.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -140.12 98.72 3.51 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.134 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.61 -99.31 0.12 Allowed Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.585 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -89.42 -23.29 22.19 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.512 -0.344 . . . . 0.0 110.563 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -134.69 169.79 16.79 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -168.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.402 ' HB ' ' OD1' ' A' ' 29' ' ' ASN . 42.1 t -134.89 142.19 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.81 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -138.09 144.64 41.0 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 6.2 mp -91.44 106.37 18.44 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 172.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.6 p -72.56 -155.23 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.939 -1.028 . . . . 0.0 113.149 -173.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 p -57.78 128.26 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-O 121.743 0.782 . . . . 0.0 111.2 -172.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 136.66 -38.6 1.74 Allowed Glycine 0 CA--C 1.485 -1.79 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -60.87 -26.85 67.7 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.143 0.973 . . . . 0.0 108.864 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.513 ' O ' HG13 ' A' ' 71' ' ' VAL . 33.5 tt0 -56.61 -36.65 69.67 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.887 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.439 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 87.5 m-20 -66.41 -36.25 82.35 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.476 ' HD1' ' CE3' ' A' ' 50' ' ' TRP . 92.2 t80 -72.68 -44.9 61.2 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.909 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 68' ' ' GLU . 7.3 p -62.62 -43.83 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 68' ' ' GLU 0.324 0.0 OUTLIER -72.37 -38.45 68.52 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 177.76 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -77.54 -39.36 46.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -84.18 -19.59 33.81 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.9 t30 65.61 90.3 0.09 Allowed 'General case' 0 C--O 1.247 0.969 0 C-N-CA 124.753 1.221 . . . . 0.0 110.935 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.5 mt -130.72 139.81 50.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.884 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.34 171.1 14.88 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.463 ' H ' ' HB2' ' A' ' 15' ' ' SER . 4.5 p30 -65.99 136.95 56.75 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.217 0.532 . . . . 0.0 110.629 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.31 -30.09 3.93 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -89.39 153.35 20.92 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.402 ' C ' HD13 ' A' ' 82' ' ' LEU . 77.4 m-85 -122.74 147.21 46.75 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -178.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.404 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 6.1 mp -122.34 134.09 54.65 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.136 -177.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -111.07 126.45 54.82 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -114.82 126.93 55.38 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.2 mt -98.06 116.97 42.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.421 ' HA ' ' CD1' ' A' ' 92' ' ' PHE . 64.8 m-85 -106.87 123.92 48.87 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.305 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -105.59 -161.52 0.81 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -93.92 13.55 22.35 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.892 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 13.8 t70 -102.87 -162.91 0.95 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.446 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER -111.44 23.72 13.64 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 m -117.97 118.65 32.54 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 86' ' ' TYR . 19.1 m-85 -122.81 152.4 40.72 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.326 -177.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -111.15 126.49 54.9 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.952 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.15 129.88 55.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.53 0.681 . . . . 0.0 111.44 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.61 119.8 62.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.5 pt -93.26 139.79 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 CA-C-O 121.072 0.463 . . . . 0.0 110.557 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 C--N 1.297 -1.677 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.543 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.429 -1.5 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -114.51 144.17 43.79 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.123 0.487 . . . . 0.0 110.392 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -145.5 148.26 33.04 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.497 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 26.7 ptm -139.17 152.22 47.23 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.377 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -154.65 158.66 32.26 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.77 146.21 71.77 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.877 1.718 . . . . 0.0 110.634 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -84.43 122.68 29.31 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.2 mm -110.47 117.06 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.138 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 p -60.61 -12.32 9.78 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -76.28 -44.7 35.95 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -105.3 -42.54 5.23 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.402 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.649 ' HA ' ' O ' ' A' ' 21' ' ' SER . 9.7 m -72.01 0.61 8.96 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.331 -173.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.498 ' O ' HG13 ' A' ' 71' ' ' VAL . 27.7 t -75.04 -28.12 60.31 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 175.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -136.9 -14.4 1.6 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.649 ' O ' ' HA ' ' A' ' 18' ' ' SER . 50.3 m -149.15 169.56 20.43 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 23' ' ' GLU . 2.6 tm? -128.17 133.57 48.93 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.354 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.425 ' N ' HD11 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -98.7 129.39 45.16 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.322 -174.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' A' ' 61' ' ' VAL . 46.4 mm -113.05 129.71 24.26 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -65.48 141.96 69.73 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 122.41 2.073 . . . . 0.0 110.061 172.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 6.7 mp -63.23 -22.92 67.18 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.69 -36.41 91.62 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.369 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 68.0 t80 -83.89 -32.92 24.91 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . 17.6 t30 -60.55 -47.89 84.2 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.374 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.77 -11.95 60.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.447 -175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 82.3 t80 -75.17 -25.9 58.67 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.135 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.11 91.93 18.84 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.57 135.88 7.17 Favored 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 122.093 1.862 . . . . 0.0 109.704 171.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.27 160.74 30.58 Favored Pre-proline 0 C--N 1.28 -2.42 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.38 141.95 80.82 Favored 'Trans proline' 0 C--O 1.246 0.881 0 N-CA-C 106.914 -1.995 . . . . 0.0 106.914 166.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -69.02 120.78 78.73 Favored Pre-proline 0 N--CA 1.414 -2.253 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.355 -173.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.59 144.62 50.14 Favored 'Trans proline' 0 C--O 1.256 1.424 0 C-N-CA 122.33 2.02 . . . . 0.0 110.629 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.4 mm -80.9 -57.34 4.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 m -126.94 156.5 41.41 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.168 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 90' ' ' ARG . 74.5 t -137.18 149.18 25.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 125.013 1.325 . . . . 0.0 107.827 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -121.95 145.83 47.73 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.06 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.42 ' CD2' ' HB2' ' A' ' 92' ' ' PHE . 66.3 mt -108.93 138.45 45.25 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.45 153.25 19.86 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.597 0.713 . . . . 0.0 112.905 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.5 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 9.0 t70 -111.25 161.8 15.64 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.992 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.463 ' HH ' ' HA ' ' A' ' 95' ' ' ILE . 28.5 m-85 -70.22 -32.9 70.99 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.437 -173.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 m -102.6 -56.45 2.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.57 -6.43 0.03 OUTLIER Glycine 0 C--N 1.321 -0.274 0 C-N-CA 118.332 -1.89 . . . . 0.0 115.53 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HE ' ' HA ' ' A' ' 48' ' ' ARG . 1.8 mmp_? -73.17 157.69 36.71 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 118.104 0.952 . . . . 0.0 110.918 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.4 m -144.07 134.74 24.95 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.5 ' CH2' ' HB2' ' A' ' 44' ' ' ASP . 19.4 m-90 -112.74 117.52 32.43 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.836 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.6 m -85.89 114.54 22.89 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.681 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.55 154.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.39 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -104.31 118.78 37.46 Favored 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 119.756 -0.778 . . . . 0.0 108.99 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.415 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 55.8 ttp -111.14 146.48 36.77 Favored 'General case' 0 CA--C 1.475 -1.919 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.544 ' HB2' ' HZ2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -140.48 132.37 27.62 Favored 'General case' 0 N--CA 1.406 -2.659 0 C-N-CA 117.814 -1.554 . . . . 0.0 112.065 -176.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.7 ' HD2' ' CG1' ' A' ' 61' ' ' VAL . 29.1 mmmt -91.19 107.72 19.39 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 170.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -120.59 98.8 6.2 Favored 'General case' 0 C--N 1.252 -3.674 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.42 -108.79 2.6 Favored Glycine 0 N--CA 1.422 -2.254 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.213 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.71 2.25 20.0 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 122.969 -0.136 . . . . 0.0 110.926 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -131.31 156.24 45.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.7 ' CG1' ' HD2' ' A' ' 56' ' ' LYS . 16.3 m -122.51 134.46 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 CA-C-O 121.699 0.762 . . . . 0.0 112.221 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -142.81 139.63 31.02 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 54' ' ' MET . 5.6 mp -90.49 109.1 20.24 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.4 p -79.68 -152.25 0.07 Allowed 'General case' 0 N--CA 1.425 -1.723 0 O-C-N 123.846 0.716 . . . . 0.0 111.74 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.13 143.26 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.173 0.989 . . . . 0.0 111.147 -175.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.61 -38.45 2.44 Favored Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -59.64 -23.93 63.44 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.97 0.89 . . . . 0.0 110.24 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.46 ' HA ' HG12 ' A' ' 71' ' ' VAL . 39.1 tt0 -64.03 -26.04 68.39 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.299 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.52 -37.32 87.13 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.266 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.408 ' HA ' ' CD1' ' A' ' 50' ' ' TRP . 66.7 t80 -73.17 -50.13 24.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.699 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 19' ' ' SER . 9.9 p -62.2 -45.1 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.372 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.02 -41.53 67.43 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.89 -39.82 95.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.983 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.54 -13.86 33.75 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.288 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.8 t30 55.29 79.87 0.14 Allowed 'General case' 0 C--O 1.235 0.305 0 O-C-N 124.119 0.887 . . . . 0.0 109.958 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 pp -136.34 158.64 43.94 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.74 174.96 10.35 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.112 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -51.65 142.18 15.05 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 124.051 0.845 . . . . 0.0 111.187 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.04 -27.22 5.93 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -95.21 163.19 13.38 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -128.8 144.1 51.08 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.546 -175.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 0.9 OUTLIER -136.65 145.86 45.29 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.312 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.497 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 69.7 mt-30 -111.53 142.78 43.37 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -108.61 117.42 34.12 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.04 115.8 41.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.437 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 92.7 t80 -119.57 124.98 47.69 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.641 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -114.3 162.05 17.09 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -66.46 89.07 0.14 Allowed 'General case' 0 C--O 1.244 0.777 0 CA-C-N 119.196 0.907 . . . . 0.0 111.83 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -165.36 -157.81 0.35 Allowed 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.506 ' O ' HG11 ' A' ' 40' ' ' VAL . 68.6 mtm180 -124.98 30.43 5.88 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 t -136.71 141.43 43.07 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.467 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 64.9 m-85 -115.62 148.61 39.44 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.354 0.597 . . . . 0.0 111.187 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -108.66 131.57 54.77 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 172.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 61.9 t -112.24 130.71 65.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.034 0.445 . . . . 0.0 112.147 -173.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.463 ' HA ' ' HH ' ' A' ' 45' ' ' TYR . 74.6 mt -105.78 116.14 48.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -100.76 140.24 20.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.14 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 N--CA 1.429 -1.495 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.777 172.917 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.438 -1.068 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -130.47 143.12 50.56 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.532 ' CZ ' ' HG3' ' A' ' 25' ' ' PRO . 79.1 t80 -142.2 148.87 38.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 82.6 mtp -123.66 140.57 52.86 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -144.38 157.96 55.26 Favored Pre-proline 0 C--N 1.31 -1.144 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.759 178.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.09 147.11 11.61 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.703 2.269 . . . . 0.0 110.363 174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -87.34 126.46 34.87 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.29 117.71 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.6 p -65.9 -14.62 61.85 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -83.82 -37.1 22.96 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.94 0.4 . . . . 0.0 111.104 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -106.2 -41.79 5.25 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.015 -174.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' SER . 19.5 m -77.96 0.41 24.4 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.874 -173.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.9 m -75.38 -18.31 59.98 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.848 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.8 -23.22 0.86 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.975 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 18' ' ' SER . 21.1 m -132.52 142.07 49.03 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.22 0.533 . . . . 0.0 111.523 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 4.1 tt -93.89 126.83 39.32 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -95.83 114.38 26.1 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 123.452 0.701 . . . . 0.0 110.764 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.9 mt -106.36 126.31 30.78 Favored Pre-proline 0 C--O 1.248 1.022 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.083 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.532 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 9.4 Cg_endo -53.55 139.96 65.55 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 123.706 2.937 . . . . 0.0 113.335 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 6.3 tt -58.85 -43.7 90.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.817 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.07 -24.16 71.62 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.299 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.544 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 73.6 t80 -81.73 -34.48 30.5 Favored 'General case' 0 C--O 1.212 -0.871 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.481 HD21 ' C ' ' A' ' 59' ' ' GLU . 41.2 t30 -76.28 -33.51 59.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.295 0.569 . . . . 0.0 109.949 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.44 -24.26 66.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.895 0.855 . . . . 0.0 109.572 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.544 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 24.7 t80 -68.32 -26.4 65.6 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.181 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -143.23 98.32 5.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-O 121.223 0.535 . . . . 0.0 112.313 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.92 133.72 10.27 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 N-CA-C 110.095 -0.771 . . . . 0.0 110.095 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.13 160.33 31.09 Favored Pre-proline 0 C--N 1.274 -2.716 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.689 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.99 144.26 63.44 Favored 'Trans proline' 0 C--O 1.246 0.916 0 N-CA-C 107.467 -1.782 . . . . 0.0 107.467 168.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.431 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 45.1 p90 -68.93 138.48 90.22 Favored Pre-proline 0 N--CA 1.418 -2.029 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -173.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.7 160.76 27.93 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.766 2.311 . . . . 0.0 109.778 173.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.417 ' N ' HD13 ' A' ' 38' ' ' ILE . 2.2 mp -93.22 -37.5 8.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -150.64 152.86 34.64 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.62 163.95 22.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 124.513 1.125 . . . . 0.0 108.846 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -120.11 137.44 54.14 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.261 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.5 mt -108.7 123.42 48.96 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.97 141.84 34.18 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.262 0.553 . . . . 0.0 110.994 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -113.23 145.6 40.73 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -58.43 -27.12 64.03 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.7 t -79.59 -4.58 52.17 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.105 0.478 . . . . 0.0 110.511 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.46 2.16 50.43 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.005 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -82.55 150.66 26.8 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.3 p -144.44 136.64 26.33 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.196 0.522 . . . . 0.0 111.709 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -120.1 123.94 44.61 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.511 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.3 m -89.93 117.73 28.96 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.16 157.94 33.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.613 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -99.68 120.13 39.21 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.046 0.45 . . . . 0.0 110.624 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.411 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 23.7 ttt -122.3 124.16 43.1 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 124.277 1.031 . . . . 0.0 110.044 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -125.51 130.88 52.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.886 0.374 . . . . 0.0 111.916 178.603 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' H ' ' HB2' ' A' ' 36' ' ' PHE . 55.9 tttp -98.05 122.68 41.47 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 122.121 0.963 . . . . 0.0 109.451 173.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -147.7 98.66 3.0 Favored 'General case' 0 C--N 1.252 -3.65 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.51 -164.29 30.42 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -174.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.481 ' C ' HD21 ' A' ' 29' ' ' ASN . 14.9 mm-40 -90.97 2.39 56.32 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.44 142.68 49.02 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.4 HG23 ' ND2' ' A' ' 29' ' ' ASN . 95.6 t -114.49 131.84 65.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.136 0.493 . . . . 0.0 111.043 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 97.4 m-85 -119.42 131.55 55.67 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 21' ' ' SER . 6.5 mp -86.83 112.3 21.6 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 p -66.11 -164.49 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.138 0 O-C-N 124.777 1.298 . . . . 0.0 112.902 -176.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.24 143.12 10.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.493 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.57 -38.61 2.58 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -173.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 20.1 t-105 -58.48 -24.42 60.37 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.015 0.912 . . . . 0.0 109.636 173.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 71' ' ' VAL . 11.5 pt-20 -57.74 -30.0 65.23 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.39 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -62.24 -35.86 80.23 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.129 0.49 . . . . 0.0 110.668 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -74.29 -48.01 31.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.603 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 68' ' ' GLU . 9.9 p -64.7 -40.38 88.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.19 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -71.07 -33.02 69.83 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.621 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.31 -40.14 45.37 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.062 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -97.94 -1.74 42.14 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.2 m120 42.22 80.1 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -176.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.4 mt -103.23 147.35 27.15 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.21 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.8 171.65 13.92 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.107 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.11 138.3 58.51 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.15 -19.66 24.63 Favored Glycine 0 C--N 1.301 -1.392 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -173.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -96.58 159.22 15.05 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -134.1 150.95 51.19 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -173.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HG ' HG21 ' A' ' 96' ' ' ILE . 4.6 mp -130.35 137.11 49.74 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.454 ' CG ' ' HB ' ' A' ' 95' ' ' ILE . 11.6 pt20 -118.75 138.57 52.57 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -116.32 131.0 57.07 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.324 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 65.2 mt -101.54 116.03 44.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 172.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.659 ' CZ ' ' HA ' ' A' ' 88' ' ' ARG . 48.8 t80 -122.07 123.81 42.46 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.757 -173.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -84.26 -1.38 55.16 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.659 ' HA ' ' CZ ' ' A' ' 86' ' ' TYR . 67.8 ttt180 70.08 81.94 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -171.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 20.4 t70 -177.26 -155.24 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 -167.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.489 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -107.38 11.15 29.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.3 m -109.64 126.37 53.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.54 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -127.62 135.13 49.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.641 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.435 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 84.7 m-85 -109.25 123.49 49.35 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.54 124.15 64.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.433 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.454 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 2.4 mp -114.05 116.85 53.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.421 HG21 ' HG ' ' A' ' 82' ' ' LEU . 35.1 pt -100.8 140.64 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 123.218 0.607 . . . . 0.0 112.231 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.304 -1.411 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 173.673 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.436 -1.145 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -130.64 143.05 50.49 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -149.7 147.0 27.54 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.624 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.423 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 23.3 ptp -141.61 134.93 29.46 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.418 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.6 159.57 31.53 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 166.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.627 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 33.4 Cg_exo -60.82 132.73 43.98 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 N-CA-C 108.295 -1.463 . . . . 0.0 108.295 173.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -86.01 140.26 30.45 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.354 -175.082 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.432 HG23 ' H ' ' A' ' 16' ' ' GLU . 2.0 mp -90.69 125.08 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.467 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 11.9 p -60.57 -19.03 56.31 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.826 0.85 . . . . 0.0 112.708 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 14' ' ' ILE . 41.4 tt0 -63.48 -44.78 93.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.703 176.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -87.73 -40.47 14.08 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.487 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.577 ' HB2' ' CD1' ' A' ' 13' ' ' PHE . 35.6 t -61.96 -10.0 8.53 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 124.119 0.887 . . . . 0.0 112.285 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.5 p -57.85 -43.49 85.93 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.899 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -144.38 -2.05 0.89 Allowed 'General case' 0 C--N 1.344 0.359 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -148.11 153.79 39.33 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 118.943 0.792 . . . . 0.0 112.476 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 5.2 tt -101.21 113.42 26.44 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -71.54 113.99 9.15 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.162 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 61' ' ' VAL . 65.6 mt -93.7 128.5 41.65 Favored Pre-proline 0 C--N 1.288 -2.096 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.448 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 58.7 Cg_exo -53.71 137.74 67.32 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.959 2.439 . . . . 0.0 112.198 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.429 ' O ' HD21 ' A' ' 26' ' ' LEU . 5.8 tt -64.67 -32.4 74.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.48 -29.39 73.31 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.614 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 25' ' ' PRO . 46.6 t80 -65.41 -49.59 68.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -65.8 -39.75 91.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.567 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.06 -38.17 87.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.395 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -73.15 -28.68 62.37 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.947 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -166.18 127.1 1.29 Allowed Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 120.634 0.254 . . . . 0.0 111.629 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.33 136.79 24.72 Favored 'Trans proline' 0 N--CA 1.42 -2.81 0 N-CA-C 107.872 -1.626 . . . . 0.0 107.872 168.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.43 146.86 55.85 Favored Pre-proline 0 C--N 1.266 -3.047 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.536 ' O ' ' HD3' ' A' ' 37' ' ' PRO . 14.3 Cg_endo -59.64 140.68 94.82 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.019 1.813 . . . . 0.0 109.884 175.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -83.45 110.63 25.64 Favored Pre-proline 0 N--CA 1.407 -2.602 0 CA-C-O 121.115 0.483 . . . . 0.0 111.287 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 35' ' ' PRO . 27.1 Cg_endo -87.83 136.02 3.58 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 122.554 2.169 . . . . 0.0 111.57 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.22 -52.74 54.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.245 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.5 p -123.95 150.11 45.15 Favored 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.904 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.3 t -135.9 157.13 38.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -126.46 135.97 52.04 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.678 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.9 mt -108.54 127.52 54.01 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.86 138.16 42.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 120.908 0.385 . . . . 0.0 110.206 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -112.68 142.18 45.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -69.87 -3.71 17.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -175.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -82.86 -14.53 54.12 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.64 -13.88 10.77 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.263 -0.97 . . . . 0.0 115.505 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.424 ' HD3' ' CZ2' ' A' ' 50' ' ' TRP . 75.7 ttt180 -89.97 153.13 20.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.718 1.259 . . . . 0.0 110.806 -176.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.3 p -127.37 140.92 51.86 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.212 0.605 . . . . 0.0 110.963 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CZ2' ' HD3' ' A' ' 48' ' ' ARG . 15.9 m-90 -125.85 128.13 47.14 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.419 0.287 . . . . 0.0 110.227 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.1 m -92.07 121.17 33.38 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.43 0.633 . . . . 0.0 109.779 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 63' ' ' LEU . 34.7 m -126.05 158.34 35.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 124.792 1.237 . . . . 0.0 111.589 -172.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -102.36 127.42 49.37 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.085 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.2 ttt -111.23 120.81 43.5 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -124.95 125.31 43.72 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.713 -175.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -107.9 115.5 30.25 Favored 'General case' 0 CA--C 1.479 -1.761 0 CA-C-O 122.156 0.979 . . . . 0.0 110.038 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -148.82 102.48 3.28 Favored 'General case' 0 C--N 1.247 -3.866 0 CA-C-N 113.45 -1.705 . . . . 0.0 108.408 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.88 -143.53 15.82 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.024 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.88 -6.03 54.73 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.71 0.291 . . . . 0.0 111.641 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.1 170.07 13.96 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 121.004 0.431 . . . . 0.0 110.834 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.412 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 40.9 t -132.46 129.6 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -124.61 131.68 53.46 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 5.7 tt -102.93 113.5 27.01 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 175.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -103.49 -98.47 0.3 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -169.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.25 135.42 28.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -172.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.02 -42.19 1.98 Allowed Glycine 0 N--CA 1.425 -2.081 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.475 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 55.7 t-105 -59.18 -26.45 64.82 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.513 0.673 . . . . 0.0 110.426 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 17.1 pt-20 -71.24 -26.52 62.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.315 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -68.97 -29.42 67.64 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.379 0.609 . . . . 0.0 109.636 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -73.97 -49.16 25.8 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 124.593 1.157 . . . . 0.0 109.388 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.453 HG11 ' HA ' ' A' ' 68' ' ' GLU . 9.8 p -63.47 -37.91 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.275 0.56 . . . . 0.0 109.977 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 68.4 mttm -65.3 -46.71 79.3 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.579 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -77.52 -40.84 41.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.032 -1.067 . . . . 0.0 113.737 -172.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -86.77 -15.12 40.31 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.141 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 46.35 72.7 0.21 Allowed 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.371 1.068 . . . . 0.0 112.629 -174.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.429 HD13 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -112.64 137.52 50.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.757 179.083 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -122.01 164.7 17.2 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.9 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.581 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 7.8 p-10 -55.77 132.56 49.61 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 123.998 0.811 . . . . 0.0 111.896 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.93 -44.63 1.19 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.627 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 33.9 mtmm -80.67 155.03 27.0 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.0 131.26 43.99 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.262 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.424 ' HG ' HG13 ' A' ' 96' ' ' ILE . 6.9 mp -114.45 132.87 56.11 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -109.86 125.91 53.27 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CE1' HD12 ' A' ' 22' ' ' LEU . 91.4 m-85 -114.27 117.54 31.42 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.47 117.9 47.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -120.47 127.22 52.02 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 123.495 0.497 . . . . 0.0 110.114 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -84.07 -100.2 0.05 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -150.43 16.5 0.81 Allowed 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 16.6 t70 -110.16 -177.55 3.28 Favored 'General case' 0 N--CA 1.405 -2.717 0 CA-C-N 114.294 -1.321 . . . . 0.0 107.796 -172.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 8.7 mpt_? -95.91 32.08 1.97 Allowed 'General case' 0 C--N 1.264 -3.112 0 C-N-CA 124.3 1.04 . . . . 0.0 108.512 -178.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.3 m -127.74 122.79 33.76 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.326 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -112.8 143.94 43.19 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -111.59 120.44 42.08 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.0 t -111.2 135.41 50.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.779 0.323 . . . . 0.0 111.426 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.4 mt -130.46 124.39 57.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.424 HG13 ' HG ' ' A' ' 82' ' ' LEU . 1.8 mp -96.5 125.16 49.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 . . . . . 0 C--N 1.305 -1.338 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.099 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.439 -0.975 0 CA-C-O 120.955 0.407 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -112.02 144.79 40.79 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -146.26 149.26 33.54 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.8 ptm -127.73 145.44 50.9 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.644 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 25.9 ttpp -153.48 143.35 15.26 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.425 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.72 146.47 83.93 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.5 2.133 . . . . 0.0 109.999 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 8.3 m-85 -103.32 139.25 38.99 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.2 mp -118.72 117.43 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.457 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 20.3 m -57.48 -22.16 41.98 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.782 0.833 . . . . 0.0 112.576 -173.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.07 -38.88 92.67 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.199 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.06 -41.98 8.85 Favored 'General case' 0 CA--C 1.487 -1.46 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.731 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.457 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 79.3 p -65.4 -11.33 41.42 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -170.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.6 t -69.63 -24.03 63.58 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.39 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -138.56 -24.36 0.94 Allowed 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -176.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 77.2 p -143.25 153.76 43.12 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 tt -96.81 122.54 39.88 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.644 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -92.97 122.77 35.67 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.874 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.402 ' HB ' HD22 ' A' ' 29' ' ' ASN . 61.5 mt -103.68 132.15 21.33 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -57.54 139.26 89.63 Favored 'Trans proline' 0 C--O 1.254 1.311 0 C-N-CA 122.19 1.926 . . . . 0.0 110.622 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.493 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.7 tt -56.57 -30.08 62.76 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.187 0.595 . . . . 0.0 110.885 -175.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.41 -31.5 63.01 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.727 -0.273 . . . . 0.0 112.838 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -87.89 -29.92 20.5 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 122.278 -0.543 . . . . 0.0 110.099 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.45 ' ND2' ' HB ' ' A' ' 61' ' ' VAL . 13.4 m120 -65.82 -34.35 77.95 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.505 0.669 . . . . 0.0 109.638 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -74.83 -27.07 60.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.612 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -78.97 -28.08 43.56 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.166 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . 0.267 31.5 p90 -134.51 78.81 55.69 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 177.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -83.97 135.13 6.43 Favored 'Trans proline' 0 N--CA 1.425 -2.551 0 C-N-CA 121.016 1.144 . . . . 0.0 110.204 170.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.66 160.11 31.59 Favored Pre-proline 0 C--N 1.273 -2.752 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -63.02 136.74 58.19 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 N-CA-C 107.505 -1.767 . . . . 0.0 107.505 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -68.81 120.4 75.74 Favored Pre-proline 0 N--CA 1.418 -2.048 0 CA-C-O 121.356 0.598 . . . . 0.0 112.593 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.49 136.67 12.57 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.69 2.26 . . . . 0.0 110.852 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -64.77 -38.59 83.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.019 0.438 . . . . 0.0 110.078 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.3 p -130.88 150.64 51.95 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 121.241 0.543 . . . . 0.0 110.852 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.4 t -141.72 149.39 20.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 125.473 1.509 . . . . 0.0 107.163 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.52 135.37 52.18 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.075 0.464 . . . . 0.0 111.494 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 49' ' ' SER . 79.1 mt -108.84 132.0 54.44 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.64 143.99 32.33 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.267 0.556 . . . . 0.0 112.154 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.466 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 16.7 t70 -110.35 165.32 11.87 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.36 176.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -53.32 -50.82 64.17 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 125.232 1.413 . . . . 0.0 110.273 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.6 m -73.68 -10.32 59.57 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.788 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.0 9.88 35.95 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.496 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -66.94 150.82 48.68 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 74.8 p -138.2 136.33 36.49 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.412 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.466 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 25.5 m-90 -121.15 131.76 54.44 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.829 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.2 m -89.62 114.15 25.71 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.34 157.85 17.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.668 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -102.01 130.98 48.69 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 28.0 ttt -112.3 136.31 51.9 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -142.12 125.88 17.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.389 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -105.17 128.35 53.35 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.98 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.55 100.03 4.84 Favored 'General case' 0 C--N 1.266 -3.039 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.78 -120.75 11.31 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.259 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -90.33 -7.8 52.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -174.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.76 152.73 32.7 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.45 ' HB ' ' ND2' ' A' ' 29' ' ' ASN . 47.4 t -133.97 124.31 46.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -130.37 153.73 48.42 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 21' ' ' SER . 5.9 mp -93.37 103.82 16.02 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.6 t -79.3 -153.82 0.08 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 124.235 0.959 . . . . 0.0 111.008 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.07 121.85 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-O 122.442 1.115 . . . . 0.0 110.939 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 143.77 -38.62 1.34 Allowed Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 -169.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -60.56 -24.2 65.23 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.042 -1.079 . . . . 0.0 109.278 173.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.473 ' O ' HG13 ' A' ' 71' ' ' VAL . 39.0 tt0 -56.2 -39.79 73.0 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.589 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -59.21 -37.06 76.53 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-O 120.918 0.39 . . . . 0.0 110.715 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.511 ' CZ ' HG13 ' A' ' 94' ' ' VAL . 78.6 t80 -74.08 -48.66 28.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 68' ' ' GLU . 9.0 p -62.48 -34.83 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 122.131 0.967 . . . . 0.0 109.165 -177.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.64 -47.07 56.91 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.917 -1.492 . . . . 0.0 111.65 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -77.64 -40.77 40.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -172.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -88.08 -16.2 34.18 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.402 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.9 t30 54.11 95.35 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 O-C-N 124.157 0.91 . . . . 0.0 112.204 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 pp -127.12 158.21 37.64 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.285 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -143.8 168.21 20.47 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.415 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 5.8 p-10 -59.08 133.89 56.5 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.227 0.954 . . . . 0.0 110.038 175.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.7 -18.98 12.73 Favored Glycine 0 C--N 1.307 -1.064 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -101.13 162.81 12.63 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -128.04 140.36 52.0 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.63 142.55 51.45 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.064 0.459 . . . . 0.0 110.786 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -114.19 124.68 52.65 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -112.2 130.7 55.83 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.41 116.0 47.38 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -106.22 123.77 48.55 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.12 -171.21 3.48 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.309 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -86.41 -5.87 59.06 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 23.4 t70 -89.27 -150.74 0.21 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 175.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.541 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 16.7 ptt180 -113.03 17.71 18.62 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 92.5 m -101.81 127.22 48.7 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.56 -170.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.65 131.75 54.79 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.643 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -101.84 127.61 48.57 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.511 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 38.3 t -104.21 119.87 53.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.11 124.24 72.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.4 tt -111.97 137.27 45.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 121.316 0.579 . . . . 0.0 110.103 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 N--CA 1.424 -1.735 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.484 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.442 -0.857 0 CA-C-O 121.259 0.552 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -111.74 145.74 38.8 Favored 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.954 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -143.55 153.91 43.06 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 61.3 mtm -128.13 158.02 39.17 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -154.26 159.9 31.48 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -64.65 135.44 45.31 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.096 1.864 . . . . 0.0 109.843 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 70.6 t80 -100.16 122.97 43.83 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -114.63 102.15 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.489 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 33.5 t -53.83 -31.8 50.61 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 123.241 0.616 . . . . 0.0 111.367 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.83 -37.39 79.09 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.414 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -101.35 -33.1 10.15 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.907 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 21' ' ' SER . 49.8 p -81.2 1.76 30.7 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.5 m -65.42 -24.77 67.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 119.499 -0.881 . . . . 0.0 111.215 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -116.15 -48.82 2.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.636 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 18' ' ' SER . 43.4 p -130.87 144.98 51.85 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -173.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.446 ' HB2' ' CE2' ' A' ' 67' ' ' TRP . 3.0 tm? -103.0 115.18 30.12 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.79 125.27 28.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.7 mt -95.31 131.01 30.7 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.3 132.71 40.36 Favored 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 122.852 2.368 . . . . 0.0 112.137 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.411 ' O ' HD21 ' A' ' 26' ' ' LEU . 6.7 tt -63.37 -32.71 74.21 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.856 -175.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.46 -32.41 81.67 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.172 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -75.07 -35.8 61.82 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -70.72 -31.64 68.56 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.115 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -74.82 -30.38 61.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.42 -27.63 66.37 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.577 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -160.57 87.16 1.82 Allowed Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.317 0.579 . . . . 0.0 111.713 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.21 142.76 21.82 Favored 'Trans proline' 0 N--CA 1.439 -1.704 0 C-N-CA 121.75 1.634 . . . . 0.0 110.396 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.42 153.04 36.67 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.41 144.52 98.28 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 122.489 2.126 . . . . 0.0 109.969 175.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.421 ' HB3' ' H ' ' A' ' 56' ' ' LYS . 26.8 p90 -70.28 121.33 82.91 Favored Pre-proline 0 N--CA 1.41 -2.474 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.91 159.63 18.49 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.394 2.73 . . . . 0.0 110.219 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.2 mm -70.4 -59.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.349 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.5 p -125.53 151.41 46.38 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.459 HG23 ' SD ' ' A' ' 54' ' ' MET . 97.2 t -139.78 151.42 22.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.53 136.2 52.34 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.557 -0.857 . . . . 0.0 113.285 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' A' ' 92' ' ' PHE . 3.3 mm? -108.54 120.2 41.73 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.03 153.18 20.14 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.121 0.486 . . . . 0.0 110.735 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.492 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 11.5 t70 -112.06 149.22 32.39 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.885 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -70.71 -26.71 63.52 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.734 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.8 m -95.13 -45.87 7.03 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.759 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.07 -32.06 0.04 OUTLIER Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 118.244 -1.932 . . . . 0.0 114.785 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -60.83 158.52 12.84 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 p -149.09 135.78 19.59 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 173.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.492 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 23.7 m-90 -125.75 124.09 40.25 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.546 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.1 m -89.18 114.26 25.54 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 174.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.5 t -115.26 157.77 15.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.944 -172.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -99.91 128.32 46.01 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.459 ' SD ' HG23 ' A' ' 40' ' ' VAL . 27.5 ttt -111.56 123.23 49.8 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -176.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -130.5 129.99 43.6 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.747 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.421 ' H ' ' HB3' ' A' ' 36' ' ' PHE . 27.6 tptp -92.62 127.54 38.15 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 125.003 1.321 . . . . 0.0 108.772 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -142.94 103.85 4.24 Favored 'General case' 0 C--N 1.261 -3.275 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.532 -174.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.74 -121.26 5.94 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -108.98 2.9 21.65 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.427 0.632 . . . . 0.0 109.692 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 37.1 ttpt -122.58 159.12 28.45 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.316 -175.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.83 141.04 47.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.502 ' CZ ' ' HE3' ' A' ' 60' ' ' LYS . 96.7 m-85 -123.12 136.45 54.8 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.043 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 98.4 mt -81.93 103.49 11.62 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 167.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.545 HG23 ' H ' ' A' ' 65' ' ' VAL . 2.0 m -86.15 -154.45 0.21 Allowed 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.917 -167.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.545 ' H ' HG23 ' A' ' 64' ' ' THR . 7.7 p -56.44 122.82 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 121.998 0.904 . . . . 0.0 111.639 -172.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.58 -37.2 2.06 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -171.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.446 ' CE2' ' HB2' ' A' ' 22' ' ' LEU . 12.6 t-105 -57.26 -26.2 60.4 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.554 -0.823 . . . . 0.0 110.774 175.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -53.29 -27.43 22.81 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.07 -174.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -63.01 -29.76 71.07 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -73.73 -54.66 7.56 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.581 0.705 . . . . 0.0 109.545 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 57.9 t -67.64 -34.76 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.529 -176.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -71.91 -37.92 69.99 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 174.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.6 -40.67 41.33 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.869 -0.733 . . . . 0.0 112.779 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -84.77 -20.84 30.39 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 60.2 t30 49.13 82.45 0.04 OUTLIER 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.167 1.387 . . . . 0.0 111.757 -176.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.426 ' HG ' ' CZ ' ' A' ' 13' ' ' PHE . 1.9 pt? -127.45 142.81 51.31 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.447 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -113.99 170.39 8.31 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 15' ' ' SER . 6.1 p-10 -60.56 133.51 56.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 172.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.57 -28.15 5.06 Favored Glycine 0 C--N 1.3 -1.442 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 -172.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -100.08 146.74 26.42 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.445 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 95.0 m-85 -133.81 158.63 42.88 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.68 -174.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.496 HD13 ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -125.94 155.72 40.88 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.281 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -129.14 127.24 41.01 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.236 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.496 ' CE2' HD13 ' A' ' 82' ' ' LEU . 99.9 m-85 -106.09 130.73 53.94 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 59.0 mt -107.36 119.8 57.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -106.12 125.27 50.79 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.371 0.605 . . . . 0.0 112.258 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.73 146.21 27.52 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -66.08 83.28 0.08 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.201 0.455 . . . . 0.0 111.722 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 173.54 -148.71 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.483 ' HD2' ' N ' ' A' ' 90' ' ' ARG . 6.3 mpt_? -100.3 24.44 8.78 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 118.426 0.557 . . . . 0.0 109.744 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.0 m -103.54 119.91 39.83 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.461 ' HB2' HD13 ' A' ' 42' ' ' LEU . 80.3 m-85 -125.27 130.71 52.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.39 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.428 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 95.7 m-85 -104.22 132.08 50.84 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.3 t -109.76 124.21 66.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.575 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.15 139.8 34.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.7 mt -115.28 131.74 66.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 120.973 0.416 . . . . 0.0 110.109 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 81' ' ' TYR . 43.7 p90 . . . . . 0 C--N 1.297 -1.71 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.428 -1.541 0 CA-C-O 121.142 0.496 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 13.5 pt20 -106.23 144.42 32.95 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.897 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -150.19 148.57 29.09 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 25.9 ptm -103.72 133.92 47.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.66 128.72 25.09 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.44 133.2 44.65 Favored 'Trans proline' 0 C--O 1.248 1.005 0 C-N-CA 122.522 2.148 . . . . 0.0 112.882 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -93.65 124.64 37.78 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.9 mt -125.8 115.93 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.425 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 15.2 t -66.67 -11.57 54.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.313 0.577 . . . . 0.0 111.35 -172.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -61.19 -43.14 99.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.796 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -108.68 -40.39 5.09 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.937 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 21' ' ' SER . 18.2 m -74.17 8.6 2.03 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -172.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.451 ' O ' HG12 ' A' ' 71' ' ' VAL . 29.2 t -75.02 -19.23 60.14 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -141.63 -33.91 0.49 Allowed 'General case' 0 C--N 1.353 0.748 0 C-N-CA 119.874 -0.731 . . . . 0.0 112.641 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 18' ' ' SER . 63.4 p -139.04 162.61 34.51 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 120.958 0.409 . . . . 0.0 111.35 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 81.5 mt -103.28 118.21 36.25 Favored 'General case' 0 CA--C 1.485 -1.538 0 O-C-N 120.892 -1.13 . . . . 0.0 113.483 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -77.09 113.98 15.4 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 168.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.477 ' HB ' HG22 ' A' ' 61' ' ' VAL . 66.5 mt -113.18 130.97 23.09 Favored Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 121.49 -0.084 . . . . 0.0 110.827 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -44.36 139.14 6.87 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 124.654 3.569 . . . . 0.0 114.538 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.77 -46.22 90.52 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.133 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.42 -32.73 85.17 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.769 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 76.7 t80 -76.78 -34.9 57.98 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -66.12 -44.7 83.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.991 0.424 . . . . 0.0 110.804 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.85 -13.62 61.8 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.914 0.864 . . . . 0.0 110.457 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 87.2 t80 -74.68 -18.97 60.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.386 176.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -137.92 94.3 11.51 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -83.13 134.01 6.76 Favored 'Trans proline' 0 N--CA 1.432 -2.144 0 C-N-CA 121.549 1.499 . . . . 0.0 110.417 172.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.75 152.98 28.18 Favored Pre-proline 0 C--N 1.272 -2.776 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.486 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -61.87 150.41 86.21 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 107.786 -1.659 . . . . 0.0 107.786 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -68.12 119.63 68.67 Favored Pre-proline 0 N--CA 1.416 -2.142 0 CA-C-O 121.309 0.576 . . . . 0.0 111.712 -174.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -87.28 159.89 8.32 Favored 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.758 2.306 . . . . 0.0 111.084 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.418 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 51.3 mm -85.88 -59.25 2.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.3 p -131.3 156.43 45.46 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.136 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.35 162.44 39.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.27 134.97 55.18 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.688 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.0 mt -108.0 125.53 51.65 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.65 137.53 39.84 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.084 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' OD2' ' HB2' ' A' ' 46' ' ' SER . 0.1 OUTLIER -112.96 142.34 45.75 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 123.517 0.727 . . . . 0.0 110.719 178.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -67.35 -22.16 65.6 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.242 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.457 ' HB2' ' OD2' ' A' ' 44' ' ' ASP . 4.3 m -74.1 -32.46 63.24 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.53 -2.55 4.18 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.962 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -86.28 158.72 19.62 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.043 0.537 . . . . 0.0 110.331 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.8 p -149.66 140.09 22.39 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.6 m-90 -129.32 127.22 40.67 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.786 0.327 . . . . 0.0 111.447 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.8 m -87.66 114.83 24.65 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.3 m -122.17 158.16 26.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.662 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.513 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 25.3 ttp180 -101.16 133.93 44.97 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -177.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 55.8 ttp -131.64 148.12 52.57 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.554 ' HB2' ' HZ2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -152.27 146.27 25.27 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.119 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 63.5 mttm -91.84 128.83 37.82 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -137.45 107.82 6.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.48 -118.59 4.76 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -111.15 -5.46 14.74 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.452 ' HD2' ' CZ ' ' A' ' 62' ' ' PHE . 19.0 ptpt -117.58 170.09 9.03 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.491 0.662 . . . . 0.0 111.273 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' A' ' 24' ' ' ILE . 8.4 m -109.62 141.31 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.417 171.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.452 ' CZ ' ' HD2' ' A' ' 60' ' ' LYS . 97.4 m-85 -114.49 131.56 56.59 Favored 'General case' 0 C--N 1.268 -2.978 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 169.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 6.8 tt -88.13 102.07 14.43 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 173.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.513 ' OG1' ' HG2' ' A' ' 53' ' ' ARG . 20.5 p -71.73 -163.67 0.11 Allowed 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -168.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.403 ' H ' ' HB ' ' A' ' 64' ' ' THR . 27.7 t -65.96 122.29 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.356 -168.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.37 -31.62 1.04 Allowed Glycine 0 CA--C 1.481 -2.032 0 N-CA-C 107.506 -2.238 . . . . 0.0 107.506 -174.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.458 ' HB2' HD22 ' A' ' 63' ' ' LEU . 59.2 t-105 -58.14 -23.78 56.42 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 113.864 -1.168 . . . . 0.0 109.947 173.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 28.5 tt0 -56.51 -32.31 64.93 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.133 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -64.5 -35.87 82.37 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 122.633 0.373 . . . . 0.0 110.956 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -73.55 -49.99 23.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.456 HG11 ' HA ' ' A' ' 68' ' ' GLU . 8.2 p -61.71 -47.48 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.499 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 68' ' ' GLU 0.277 25.6 pttm -73.1 -30.98 64.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 178.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.24 -39.99 65.02 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.591 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -87.24 -21.48 25.81 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 54.22 88.7 0.04 OUTLIER 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.233 1.413 . . . . 0.0 110.438 -176.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.7 165.77 26.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -141.52 172.14 13.1 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.128 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' H ' ' HB2' ' A' ' 15' ' ' SER . 5.9 p-10 -58.71 120.79 9.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.494 0.664 . . . . 0.0 109.925 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.85 -41.01 0.58 Allowed Glycine 0 C--N 1.294 -1.755 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -94.72 155.94 16.62 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -130.42 156.6 44.47 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.964 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.22 153.95 51.07 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 -175.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.538 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 87.3 mt-30 -111.87 145.54 39.31 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.382 176.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -117.36 120.17 37.36 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 23.3 mt -97.49 114.65 35.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -128.47 139.69 52.2 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -129.42 167.71 17.4 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 168.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.587 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 5.3 mpt_? -65.01 96.65 0.2 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 123.394 0.434 . . . . 0.0 110.205 -174.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 20.1 t70 179.27 -159.43 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.448 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 10.5 mpt_? -117.97 19.11 13.78 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.4 m -106.59 117.88 35.2 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.701 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -118.03 133.41 55.94 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.485 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 60.3 m-85 -101.7 116.13 32.05 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 174.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 7.8 p -99.9 132.0 46.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 120.827 0.346 . . . . 0.0 110.422 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.538 ' CG2' ' HB2' ' A' ' 83' ' ' GLN . 11.3 tt -131.74 128.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.183 0.516 . . . . 0.0 109.981 177.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.0 tt -96.66 142.02 14.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.363 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 N--CA 1.442 -0.862 0 CA-C-O 121.973 0.892 . . . . 0.0 108.699 176.312 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.433 -1.296 0 CA-C-O 121.518 0.675 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.4 145.59 45.07 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.377 -175.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -142.25 147.33 36.31 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.3 ptm -135.29 143.72 46.38 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' H ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -155.01 159.27 31.96 Favored Pre-proline 0 N--CA 1.433 -1.286 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.24 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -48.76 148.79 8.28 Favored 'Trans proline' 0 C--O 1.251 1.126 0 C-N-CA 124.14 3.227 . . . . 0.0 114.839 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -129.68 124.54 33.87 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.5 117.91 56.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.512 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 26.1 t -59.96 -20.49 57.86 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -172.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -73.11 -44.19 60.65 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.948 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.75 -37.11 11.96 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.678 0.752 . . . . 0.0 109.831 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 21' ' ' SER . 14.5 m -84.98 15.23 4.16 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.634 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 15' ' ' SER . 46.2 t -74.44 -21.95 59.37 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.82 -28.18 1.1 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.15 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.669 ' O ' ' HA ' ' A' ' 18' ' ' SER . 21.3 p -147.33 152.79 38.81 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -172.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.404 HD13 HD23 ' A' ' 63' ' ' LEU . 54.0 mt -111.37 141.86 44.36 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 120.793 0.33 . . . . 0.0 111.602 176.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -100.52 125.26 46.84 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.422 ' CB ' ' HB ' ' A' ' 61' ' ' VAL . 48.1 mm -105.2 132.09 21.19 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.608 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.93 147.06 83.99 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 123.142 2.562 . . . . 0.0 111.919 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 mp -58.5 -38.29 77.34 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.121 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.38 -28.14 66.73 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.568 -0.742 . . . . 0.0 113.28 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -85.79 -25.69 26.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.126 0.488 . . . . 0.0 110.04 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -69.47 -45.74 68.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.107 0.479 . . . . 0.0 110.105 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.54 -10.51 59.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.811 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -68.35 -27.49 66.31 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.756 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -158.72 103.64 1.62 Allowed Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 120.959 0.409 . . . . 0.0 111.814 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.58 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 6.0 Cg_exo -82.59 134.89 7.74 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.07 1.847 . . . . 0.0 111.08 172.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.95 159.24 32.53 Favored Pre-proline 0 C--N 1.271 -2.809 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.54 130.07 35.52 Favored 'Trans proline' 0 C--O 1.26 1.58 0 N-CA-C 107.843 -1.637 . . . . 0.0 107.843 172.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -71.71 128.48 89.6 Favored Pre-proline 0 N--CA 1.403 -2.818 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -172.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.89 160.1 40.9 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.225 2.616 . . . . 0.0 112.344 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.81 -48.53 15.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 174.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.0 p -136.46 151.63 49.68 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.932 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.15 162.37 38.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.76 137.98 52.35 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.53 0.681 . . . . 0.0 111.844 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 49' ' ' SER . 65.1 mt -109.17 122.78 48.05 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.29 148.08 31.6 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.368 0.604 . . . . 0.0 111.662 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -111.75 165.15 12.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.384 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -52.27 -38.26 57.77 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.805 0.842 . . . . 0.0 110.782 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 m -67.06 -10.29 48.33 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.139 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.27 7.64 63.58 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.418 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -80.37 138.03 36.63 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 35.1 p -124.78 135.26 52.81 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 123.463 0.477 . . . . 0.0 110.594 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -113.88 130.65 56.47 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.4 m -90.86 119.35 30.99 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -119.64 156.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.531 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 65' ' ' VAL . 68.6 mtt180 -100.82 120.18 39.75 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.416 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 20.4 ttt -133.07 121.69 23.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.855 -173.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.2 OUTLIER -132.26 142.32 49.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.029 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.58 ' NZ ' ' HA ' ' A' ' 33' ' ' PRO . 26.2 mtmt -92.08 126.41 37.15 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -130.21 98.89 4.86 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.652 -172.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.22 -107.22 2.42 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.45 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.94 -1.99 16.18 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.866 0.365 . . . . 0.0 110.317 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -132.53 160.17 37.3 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-O 121.271 0.558 . . . . 0.0 111.169 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.422 ' HB ' ' CB ' ' A' ' 24' ' ' ILE . 53.0 t -105.57 142.2 19.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 173.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -135.71 131.39 35.57 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.404 HD23 HD13 ' A' ' 22' ' ' LEU . 6.2 mp -96.02 113.92 25.58 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.7 p -82.41 -170.24 2.84 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.421 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.545 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 47.9 t -66.42 122.09 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.68 0.752 . . . . 0.0 110.496 -173.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.53 -27.24 1.07 Allowed Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.4 ' CH2' HD11 ' A' ' 22' ' ' LEU . 41.4 t-105 -60.75 -21.38 62.95 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 113.577 -1.312 . . . . 0.0 110.184 172.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.72 ' O ' ' HG2' ' A' ' 72' ' ' LYS 0.293 0.0 OUTLIER -63.54 -26.53 68.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -175.859 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -56.18 -38.06 70.42 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.543 0.737 . . . . 0.0 110.114 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -74.05 -49.05 25.92 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.446 -175.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.446 HG11 ' HA ' ' A' ' 68' ' ' GLU . 8.7 p -67.52 -40.69 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.361 -175.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.72 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 20.5 ptmt -70.41 -38.77 74.67 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.771 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.59 -38.08 62.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.258 -0.977 . . . . 0.0 112.528 -175.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -86.12 -20.77 28.18 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.838 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.1 t30 50.87 83.53 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.15 0.98 . . . . 0.0 111.432 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 pp -138.8 174.67 10.28 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -143.19 172.04 13.27 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.867 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.512 ' HB3' ' H ' ' A' ' 15' ' ' SER . 9.3 p-10 -65.79 142.1 58.08 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.145 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.24 -21.55 15.05 Favored Glycine 0 C--N 1.295 -1.7 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -173.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -116.54 134.46 54.82 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 87.2 m-85 -130.28 158.91 38.48 Favored 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.264 -170.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 pp -132.29 144.59 50.69 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.537 ' CG ' ' HB ' ' A' ' 95' ' ' ILE . 10.3 pt20 -119.02 145.85 45.52 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.909 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.02 124.28 51.17 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.5 mt -106.31 117.18 51.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.406 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 30.6 p90 -127.68 152.76 47.3 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.531 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -81.16 -78.75 0.17 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.162 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -162.23 24.32 0.11 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 21.1 t70 -120.55 -168.93 1.72 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -174.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.459 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 11.3 mpt_? -95.83 15.76 19.43 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 123.496 0.718 . . . . 0.0 110.186 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.7 m -102.76 116.11 31.91 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.406 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 82.8 m-85 -117.13 132.08 56.75 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.884 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -101.55 129.2 47.59 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -98.71 141.08 16.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -174.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.537 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 57.8 mt -127.06 117.66 48.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.97 113.9 41.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 81' ' ' TYR . 49.2 p90 . . . . . 0 N--CA 1.422 -1.84 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 CA--C 1.522 -0.134 0 CA-C-O 121.09 0.472 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -99.85 146.97 26.02 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.469 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -142.98 149.21 38.03 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.6 ttt -131.7 144.78 51.24 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 24.1 ttpp -146.86 143.78 19.03 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.42 146.35 42.0 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 123.056 2.504 . . . . 0.0 111.632 173.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -122.07 121.69 37.54 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt -128.32 115.98 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.506 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 24.0 t -61.29 -17.49 53.82 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.925 0.89 . . . . 0.0 112.369 -171.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.22 -42.07 93.83 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.428 ' HD2' ' CD ' ' A' ' 23' ' ' GLU . 37.5 ttmt -101.48 -30.3 11.5 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.212 -177.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.9 p -80.08 7.31 9.42 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 120.927 0.394 . . . . 0.0 111.386 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.9 p -72.18 -29.87 64.42 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.436 0.636 . . . . 0.0 109.631 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -114.28 -39.79 3.8 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.382 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.2 p -157.5 155.39 30.25 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.659 -174.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 76.9 mt -96.25 138.7 33.46 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.947 0.403 . . . . 0.0 110.744 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.483 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 39.5 mt-10 -79.24 117.81 20.6 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.432 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.9 mt -97.19 118.92 64.15 Favored Pre-proline 0 C--N 1.281 -2.382 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 174.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.74 138.8 32.84 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.581 2.854 . . . . 0.0 114.635 -171.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.05 -37.83 88.77 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.72 -28.91 73.47 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.334 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -72.86 -42.89 63.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -62.98 -40.12 96.78 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.71 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.22 -25.46 68.34 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.649 0.779 . . . . 0.0 110.328 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -80.61 -27.58 37.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.165 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -173.4 100.5 0.32 Allowed Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.433 ' CB ' ' HE2' ' A' ' 56' ' ' LYS . 14.4 Cg_endo -89.06 149.19 5.65 Favored 'Trans proline' 0 N--CA 1.426 -2.5 0 C-N-CA 121.377 1.384 . . . . 0.0 111.297 171.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.0 158.66 36.69 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.25 137.07 76.6 Favored 'Trans proline' 0 C--N 1.354 0.816 0 N-CA-C 107.68 -1.7 . . . . 0.0 107.68 172.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -70.95 127.41 91.74 Favored Pre-proline 0 N--CA 1.407 -2.609 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -172.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.38 136.91 45.12 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.563 2.175 . . . . 0.0 110.338 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.23 -48.71 87.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.201 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.463 ' O ' ' HD3' ' A' ' 90' ' ' ARG . 25.6 p -127.53 150.69 49.58 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.356 176.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.8 t -132.1 155.2 41.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -108.42 125.14 51.42 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 120.746 0.308 . . . . 0.0 110.361 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.6 mt -109.18 120.16 41.7 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 173.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.61 149.88 26.75 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 120.852 0.358 . . . . 0.0 110.375 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.468 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 11.3 t70 -111.27 158.78 18.59 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.428 ' CE1' HG13 ' A' ' 95' ' ' ILE . 26.9 p90 -73.68 -13.28 60.96 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.253 0.549 . . . . 0.0 111.676 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.2 t -93.52 -162.28 0.92 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.71 6.79 44.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.115 -0.564 . . . . 0.0 114.113 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -81.41 145.61 30.7 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.1 p -150.01 136.52 19.07 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 113.903 -1.498 . . . . 0.0 107.921 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.468 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 23.3 m-90 -126.97 140.3 52.42 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.169 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -96.68 114.29 25.92 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.2 t -125.25 155.62 34.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.0 -174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -101.84 139.41 37.51 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.0 ttt -120.12 138.76 53.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -143.84 132.42 22.32 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.254 -0.978 . . . . 0.0 112.58 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.433 ' HE2' ' CB ' ' A' ' 33' ' ' PRO . 48.8 tttp -91.88 128.08 37.58 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -138.86 98.24 3.5 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.302 -173.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.08 -134.72 13.56 Favored Glycine 0 N--CA 1.422 -2.259 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.875 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -90.89 -0.47 57.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.214 0.53 . . . . 0.0 110.48 -175.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -132.52 171.05 14.29 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.7 t -124.84 148.01 29.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -124.42 137.13 54.48 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.4 tp -91.69 102.95 15.58 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.419 ' HB ' ' H ' ' A' ' 65' ' ' VAL . 34.9 p -78.94 -157.38 0.12 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -170.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' H ' ' HB ' ' A' ' 64' ' ' THR . 13.5 p -55.9 144.73 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.154 0.981 . . . . 0.0 111.834 -173.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.28 -36.26 3.59 Favored Glycine 0 CA--C 1.485 -1.816 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 -172.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.401 ' CZ2' HG23 ' A' ' 71' ' ' VAL . 12.0 t-105 -59.76 -25.29 64.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.704 -1.248 . . . . 0.0 109.382 171.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.491 ' OE2' ' HD3' ' A' ' 72' ' ' LYS . 2.8 tm-20 -53.23 -31.41 43.14 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.605 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.444 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 2.1 m-20 -67.29 -30.55 70.44 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 123.346 0.659 . . . . 0.0 111.991 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -73.44 -53.06 11.58 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 40.2 t -63.63 -39.1 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.98 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.491 ' HD3' ' OE2' ' A' ' 68' ' ' GLU . 59.9 pttt -71.46 -39.01 71.21 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.4 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -77.64 -40.66 41.06 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -175.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.424 HD22 HD11 ' A' ' 96' ' ' ILE . 45.7 t-20 -84.96 -20.87 29.92 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 20.2 t-20 47.65 88.73 0.02 OUTLIER 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.794 1.637 . . . . 0.0 112.374 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.79 168.8 24.51 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.849 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -143.56 174.24 10.94 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 124.073 0.949 . . . . 0.0 108.97 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 15' ' ' SER . 5.6 p-10 -51.95 130.6 29.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.941 0.877 . . . . 0.0 111.717 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.51 -39.93 1.25 Allowed Glycine 0 C--N 1.294 -1.756 0 N-CA-C 107.189 -2.365 . . . . 0.0 107.189 -175.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -94.42 146.14 24.28 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -118.98 158.94 24.77 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.204 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.1 mt -110.57 137.44 48.25 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.526 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.498 ' HB3' ' CG2' ' A' ' 95' ' ' ILE . 57.8 tt0 -111.68 130.71 55.68 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -109.57 117.33 33.67 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 62.5 mt -99.65 114.18 37.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 106.185 -1.784 . . . . 0.0 106.185 174.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -129.11 154.06 47.07 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -172.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -143.56 149.69 37.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 93.9 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.334 1.054 . . . . 0.0 111.82 -177.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.496 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 23.2 t70 -174.64 -159.04 0.08 Allowed 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -176.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.496 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 36.7 ttm180 -116.39 25.45 10.62 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.4 m -125.69 125.97 43.9 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.405 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -119.89 132.9 55.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.49 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 93.7 m-85 -104.97 115.04 29.61 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 174.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.77 149.48 8.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-O 121.357 0.599 . . . . 0.0 112.137 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.498 ' CG2' ' HB3' ' A' ' 83' ' ' GLN . 13.2 tt -142.06 135.44 28.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.424 HD11 HD22 ' A' ' 74' ' ' ASN . 38.1 pt -93.71 141.63 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.471 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 . . . . . 0 C--N 1.3 -1.586 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.033 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.425 -1.676 0 CA-C-O 121.398 0.618 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 85' ' ' ILE . 8.6 pt20 -136.95 144.91 43.65 Favored 'General case' 0 N--CA 1.399 -3.022 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.361 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 83' ' ' GLN . 67.9 t80 -136.26 148.99 48.29 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.511 -174.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.418 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 27.1 ptm -102.56 157.29 17.03 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -154.57 144.32 15.43 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.83 134.79 16.85 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 122.856 2.37 . . . . 0.0 112.343 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.448 ' CE2' ' HG ' ' A' ' 22' ' ' LEU . 32.0 m-85 -107.11 140.34 40.11 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.659 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.9 mt -120.17 113.52 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 t -56.92 -31.79 65.29 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 123.411 0.444 . . . . 0.0 111.473 -173.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.76 -44.17 97.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -89.09 -40.07 13.19 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.7 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 21' ' ' SER . 25.8 m -75.22 4.55 6.8 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.372 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.2 t -74.26 -17.08 60.92 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -135.25 -35.97 0.82 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.555 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 18' ' ' SER . 26.5 p -144.23 144.0 31.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.402 0.62 . . . . 0.0 112.63 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.448 ' HG ' ' CE2' ' A' ' 13' ' ' PHE . 3.3 tt -100.05 121.11 40.88 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -86.11 127.02 34.62 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.982 0.42 . . . . 0.0 110.607 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.43 ' HB ' HG23 ' A' ' 61' ' ' VAL . 45.7 mm -97.56 132.7 24.71 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.45 148.15 87.61 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.266 1.977 . . . . 0.0 111.384 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.64 -22.51 66.66 Favored 'General case' 0 C--O 1.213 -0.819 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.97 -21.62 61.51 Favored Glycine 0 C--O 1.22 -0.734 0 C-N-CA 121.342 -0.456 . . . . 0.0 111.984 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.437 ' HE2' ' CZ ' ' A' ' 86' ' ' TYR . 28.3 t80 -76.44 -51.72 11.25 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -68.18 -35.86 78.69 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.449 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -69.17 -26.42 64.84 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -85.35 -28.23 25.35 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.379 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -172.87 114.67 0.37 Allowed Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 176.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 1.9 Cg_endo -85.0 150.83 10.96 Favored 'Trans proline' 0 N--CA 1.427 -2.396 0 C-N-CA 121.646 1.564 . . . . 0.0 109.672 168.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.68 152.07 67.6 Favored Pre-proline 0 C--N 1.282 -2.34 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.4 130.54 32.34 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 N-CA-C 108.212 -1.495 . . . . 0.0 108.212 175.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -69.71 114.18 22.72 Favored Pre-proline 0 N--CA 1.412 -2.337 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -172.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -78.61 136.63 13.88 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.798 2.332 . . . . 0.0 110.618 177.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.452 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 47.4 mm -69.93 -46.44 73.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.746 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.5 p -123.38 148.98 45.52 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.736 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.2 t -134.87 143.39 37.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -115.4 131.34 56.96 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.811 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.9 mt -109.24 129.15 55.51 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.39 152.4 20.77 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.584 0.707 . . . . 0.0 112.328 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.511 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 12.3 t70 -112.1 166.91 10.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.196 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HH ' ' HA ' ' A' ' 95' ' ' ILE . 18.3 m-85 -76.54 -49.31 16.77 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.747 0.819 . . . . 0.0 110.717 -175.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 m -80.58 -50.51 9.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.568 -172.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -174.04 -11.29 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 118.263 -1.922 . . . . 0.0 114.716 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -73.72 157.86 35.73 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.1 p -150.94 135.3 16.96 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.511 ' CH2' ' HB2' ' A' ' 44' ' ' ASP . 18.7 m-90 -128.7 134.52 48.5 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.461 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.2 m -98.39 120.05 38.14 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 67' ' ' TRP . 8.5 p -119.18 155.24 21.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.471 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 77.7 ttt180 -103.25 135.95 43.94 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.9 ttt -117.53 146.0 43.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -147.55 131.45 17.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.506 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 33' ' ' PRO . 53.4 tttp -114.47 110.56 20.03 Favored 'General case' 0 CA--C 1.471 -2.082 0 CA-C-O 122.198 0.999 . . . . 0.0 109.089 173.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -140.66 104.82 4.81 Favored 'General case' 1 C--N 1.242 -4.071 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.81 -158.32 20.78 Favored Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -173.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -94.81 3.38 55.07 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.643 0.735 . . . . 0.0 109.55 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -112.73 156.65 22.45 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.43 HG23 ' HB ' ' A' ' 24' ' ' ILE . 27.5 m -129.6 139.89 50.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.897 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -136.91 148.06 46.79 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.024 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 5.9 mp -100.7 109.93 22.01 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.4 p -89.48 -144.55 0.16 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.858 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -55.73 129.06 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 121.484 0.659 . . . . 0.0 109.78 -175.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.92 -38.4 2.11 Favored Glycine 0 N--CA 1.414 -2.796 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 -170.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.437 ' N ' HG23 ' A' ' 52' ' ' VAL . 60.9 t-105 -66.23 -25.5 66.93 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.685 -0.758 . . . . 0.0 109.188 174.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.664 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 32.1 tt0 -59.58 -37.0 77.32 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.201 -178.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -57.45 -39.55 76.52 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 123.716 0.807 . . . . 0.0 110.935 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -74.05 -50.88 17.73 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.825 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 68' ' ' GLU . 7.8 p -62.43 -47.15 94.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.544 -174.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 64.2 pttt -72.44 -33.57 67.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.13 -40.39 38.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 118.575 -1.25 . . . . 0.0 113.471 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -88.25 -19.91 26.17 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.579 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.9 t30 57.73 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.902 1.281 . . . . 0.0 112.061 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 pp -139.45 155.25 47.71 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.638 0.732 . . . . 0.0 112.845 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.94 171.96 13.64 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.78 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -60.94 141.46 57.24 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.612 0.57 . . . . 0.0 110.587 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.76 -6.05 13.95 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -121.1 153.0 38.03 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -132.54 139.65 47.96 Favored 'General case' 0 CA--C 1.474 -1.964 0 CA-C-O 121.043 0.449 . . . . 0.0 109.839 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.435 ' N ' HD23 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -135.55 144.38 46.21 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.979 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 75.9 mt-30 -110.5 145.0 38.47 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.155 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -112.92 131.14 55.85 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' HB3' ' A' ' 8' ' ' GLN . 59.3 mt -95.31 121.49 45.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.437 ' CZ ' ' HE2' ' A' ' 28' ' ' PHE . 23.0 m-85 -105.5 123.42 47.86 Favored 'General case' 0 N--CA 1.421 -1.925 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -104.37 14.5 30.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.583 0.706 . . . . 0.0 109.638 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.12 72.7 0.49 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.612 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.43 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 18.2 t70 -175.67 -171.49 0.47 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.459 ' HD2' ' N ' ' A' ' 90' ' ' ARG . 5.5 mpt_? -106.56 26.93 9.33 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.6 m -127.51 117.81 22.79 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -125.26 155.23 40.45 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.337 0.589 . . . . 0.0 110.906 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -115.07 135.11 54.57 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -104.55 129.63 56.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.112 0.482 . . . . 0.0 112.271 -174.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.454 ' HA ' ' HH ' ' A' ' 45' ' ' TYR . 51.7 mm -111.99 115.29 49.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 174.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.5 tt -118.12 137.87 50.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.431 0.634 . . . . 0.0 112.7 -173.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 . . . . . 0 N--CA 1.433 -1.282 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.846 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 CA--C 1.517 -0.323 0 CA-C-O 120.984 0.421 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.56 102.36 10.7 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.981 0.419 . . . . 0.0 110.631 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -154.59 105.92 2.67 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.6 m -72.28 -45.23 60.96 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.553 0.692 . . . . 0.0 110.307 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.79 134.9 3.12 Favored Glycine 0 N--CA 1.402 -3.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.01 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 35.0 tt0 -155.05 97.23 1.91 Allowed 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m -108.25 139.28 31.13 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.525 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -123.7 143.92 49.97 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.447 ' CE2' ' HG2' ' A' ' 25' ' ' PRO . 72.2 t80 -148.24 151.89 36.23 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.3 ptm -121.22 141.79 50.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -135.94 129.4 18.13 Favored Pre-proline 0 C--N 1.295 -1.786 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.786 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.66 133.94 10.69 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.436 2.091 . . . . 0.0 109.006 170.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 43.4 m-85 -102.64 139.31 38.4 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -176.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.6 mt -104.71 110.26 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.7 t -57.41 -30.42 64.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.342 0.591 . . . . 0.0 111.003 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.35 -34.18 73.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.22 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -103.03 -29.93 11.08 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.527 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 t -70.27 -11.26 60.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.84 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 p -60.55 -30.44 69.77 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.568 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -136.11 -9.72 2.01 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.9 p -157.27 145.1 19.01 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.5 tt -99.44 119.52 38.13 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.77 122.39 32.81 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.097 0.475 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.7 mm -95.53 124.51 52.83 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.447 ' HG2' ' CE2' ' A' ' 9' ' ' PHE . 84.2 Cg_exo -50.8 134.03 40.52 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.539 2.826 . . . . 0.0 112.073 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.54 -43.03 89.1 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.592 0.757 . . . . 0.0 111.209 -173.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.32 -32.26 83.61 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.83 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.558 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 74.9 t80 -82.8 -36.16 25.81 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.5 HD22 ' HA ' ' A' ' 60' ' ' LYS . 13.7 t30 -59.86 -43.55 94.62 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.968 0.907 . . . . 0.0 110.693 175.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.73 -22.22 66.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.912 0.863 . . . . 0.0 110.587 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.558 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 92.6 t80 -75.63 -26.72 58.02 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.729 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -134.01 93.85 19.41 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 119.433 -0.907 . . . . 0.0 113.065 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.423 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.6 Cg_exo -81.63 136.2 9.53 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 121.592 1.528 . . . . 0.0 110.269 171.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.49 153.34 32.1 Favored Pre-proline 0 C--N 1.283 -2.305 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.684 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.27 154.59 62.32 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 121.977 1.785 . . . . 0.0 109.156 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -68.67 126.08 92.4 Favored Pre-proline 0 N--CA 1.419 -1.985 0 CA-C-O 121.231 0.538 . . . . 0.0 110.915 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -87.47 160.54 8.08 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 122.442 2.094 . . . . 0.0 111.243 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.73 -59.14 2.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.4 p -134.6 151.7 51.26 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.487 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -128.82 148.15 33.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -109.94 136.85 48.57 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.201 -0.599 . . . . 0.0 111.53 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.5 mt -108.39 122.53 47.2 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.07 137.75 39.02 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -113.42 139.35 48.98 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.266 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -58.92 -21.64 58.25 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -85.89 -13.23 48.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.587 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.04 -9.22 7.53 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 119.843 -1.17 . . . . 0.0 114.68 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -88.07 157.85 18.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.567 0.683 . . . . 0.0 111.239 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.7 p -143.04 136.21 28.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 18.1 m-90 -114.73 126.77 55.24 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.391 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.0 m -89.09 114.76 26.04 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -112.15 156.47 13.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.118 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -101.9 120.43 40.38 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.573 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -123.95 137.07 54.67 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.074 -172.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.573 ' HD2' ' C ' ' A' ' 54' ' ' MET . 4.5 mptp? -133.9 140.68 46.97 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.019 0.438 . . . . 0.0 112.069 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 33' ' ' PRO . 54.6 tttp -105.49 107.89 19.12 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 172.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -108.79 99.87 9.17 Favored 'General case' 1 C--N 1.243 -4.064 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.325 -172.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.44 -116.75 6.76 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.47 -21.16 22.0 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.5 ' HA ' HD22 ' A' ' 29' ' ' ASN . 17.7 ptpt -112.21 165.87 11.78 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -168.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.8 m -134.56 146.33 31.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.551 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -142.02 136.55 30.36 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.774 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 3.1 mp -96.75 104.04 16.0 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 169.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.2 p -94.49 -98.7 0.15 Allowed 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -169.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.5 133.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.655 0.74 . . . . 0.0 110.625 -175.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.05 -37.66 3.63 Favored Glycine 0 CA--C 1.481 -2.074 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -63.01 -25.62 68.47 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.851 0.834 . . . . 0.0 109.254 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.518 ' HA ' HG11 ' A' ' 71' ' ' VAL . 16.9 pt-20 -68.58 -26.32 65.33 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.57 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -68.99 -31.64 70.62 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.543 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -74.3 -52.04 13.45 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 68' ' ' GLU . 7.2 p -59.73 -46.88 93.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.431 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.24 -43.35 64.51 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -77.24 -40.2 45.72 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.201 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.466 ' ND2' HG12 ' A' ' 96' ' ' ILE . 7.3 t30 -84.83 -18.47 34.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.24 0.543 . . . . 0.0 109.582 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 50.4 t30 60.11 90.96 0.05 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.182 1.393 . . . . 0.0 112.846 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.402 ' CD1' HG23 ' A' ' 71' ' ' VAL . 3.8 pp -127.18 151.13 49.09 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -144.06 172.65 12.6 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.637 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 12.2 t70 -53.05 120.42 5.86 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.47 -25.15 6.67 Favored Glycine 0 C--N 1.306 -1.122 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -80.8 147.54 30.42 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -126.6 140.65 52.26 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.415 HD13 ' CE1' ' A' ' 13' ' ' PHE . 61.4 mt -119.66 147.4 44.59 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.103 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 14.9 mm100 -110.72 124.85 52.74 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -112.51 117.67 33.01 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 123.556 0.535 . . . . 0.0 109.761 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.438 ' O ' ' HD1' ' A' ' 93' ' ' TYR . 2.0 mp -103.91 122.67 56.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 64.2 m-85 -109.45 144.61 37.46 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -88.37 -97.47 0.09 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.673 173.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -154.11 20.27 0.5 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 16.2 t70 -143.56 -154.61 0.54 Allowed 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -174.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.5 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 5.6 mpt_? -95.58 29.15 2.7 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.11 0.964 . . . . 0.0 109.252 -175.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -101.98 116.61 33.06 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.313 0.578 . . . . 0.0 110.394 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.423 ' CE2' ' HE2' ' A' ' 86' ' ' TYR . 1.5 m-30 -116.43 122.29 44.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.034 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.438 ' HD1' ' O ' ' A' ' 85' ' ' ILE . 38.5 m-85 -105.74 120.09 40.8 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 32.6 t -111.08 134.32 53.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.995 0.426 . . . . 0.0 112.068 -173.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 2.1 mp -116.2 131.47 68.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.466 HG12 ' ND2' ' A' ' 74' ' ' ASN . 2.8 mp -105.92 128.01 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 122.432 0.293 . . . . 0.0 111.005 -174.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -102.51 119.3 38.58 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.19 -85.13 0.15 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.131 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 170.89 -42.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -177.51 -32.08 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -135.04 155.64 50.4 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.478 -1.692 . . . . 0.0 106.633 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.8 m . . . . . 0 C--N 1.295 -1.799 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.903 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 CA--C 1.509 -0.597 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.36 133.02 53.36 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.246 0.341 . . . . 0.0 110.473 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -117.67 110.25 17.64 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.5 p -74.79 -72.91 0.26 Allowed 'General case' 0 N--CA 1.409 -2.518 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.955 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.75 50.61 3.28 Favored Glycine 0 CA--C 1.495 -1.214 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.763 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.03 153.25 20.27 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 114.597 -0.802 . . . . 0.0 109.766 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.9 m -130.43 157.03 42.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.44 146.6 52.03 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -142.05 148.97 39.33 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.442 ' HG2' ' HG2' ' A' ' 83' ' ' GLN . 64.2 mtt -114.88 137.59 51.79 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 11' ' ' LYS . 1.8 ttpm? -142.06 130.8 12.01 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.11 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.61 147.38 86.24 Favored 'Trans proline' 0 C--O 1.248 1.005 0 C-N-CA 122.86 2.373 . . . . 0.0 111.066 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.464 ' CE2' ' HA ' ' A' ' 15' ' ' SER . 76.8 t80 -95.41 117.99 31.34 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.1 mm -97.32 106.87 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.772 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.576 ' HB2' ' N ' ' A' ' 78' ' ' ASP . 20.2 t -55.89 -37.57 69.02 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.549 0.531 . . . . 0.0 111.416 -172.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -61.17 -44.01 97.98 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 123.633 0.583 . . . . 0.0 110.626 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -86.46 -40.77 15.0 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.171 -173.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 21' ' ' SER . 26.1 m -84.21 11.9 7.44 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.516 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.3 m -63.13 -33.45 75.49 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 168.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -121.54 -41.83 2.47 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.499 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 18' ' ' SER . 45.7 m -144.84 152.81 40.87 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.189 -175.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 54.9 mt -87.91 132.03 34.37 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-O 121.171 0.51 . . . . 0.0 111.657 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -96.07 117.36 30.54 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.809 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.3 mm -98.49 132.61 23.82 Favored Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.533 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -56.24 142.13 87.65 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 123.195 2.597 . . . . 0.0 112.052 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.526 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 5.7 tt -54.17 -38.98 66.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.984 0.914 . . . . 0.0 111.761 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.5 -35.41 85.35 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.877 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -88.3 -25.02 23.01 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' A' ' 26' ' ' LEU . 87.8 m-20 -62.71 -46.27 88.88 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.581 0.705 . . . . 0.0 110.034 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -73.68 -12.04 60.6 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.608 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -75.99 -28.7 57.92 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . 0.251 24.7 p90 -130.97 68.28 81.75 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -57.0 135.45 70.93 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 121.957 1.771 . . . . 0.0 111.046 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.69 161.3 29.56 Favored Pre-proline 0 C--N 1.278 -2.516 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.646 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.55 148.94 60.71 Favored 'Trans proline' 0 C--O 1.25 1.12 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 167.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -67.85 121.42 79.52 Favored Pre-proline 0 N--CA 1.413 -2.321 0 CA-C-O 121.626 0.727 . . . . 0.0 111.709 -171.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 90' ' ' ARG . 66.4 Cg_endo -96.76 160.74 1.12 Allowed 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 123.628 2.885 . . . . 0.0 112.697 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -108.01 -38.71 4.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.237 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 64.0 p -123.86 159.97 28.46 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.212 0.53 . . . . 0.0 111.9 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 90' ' ' ARG . 7.1 p -146.02 141.88 21.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 173.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -110.0 131.78 54.75 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.158 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -109.92 126.42 53.86 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.92 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.8 145.27 31.4 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.103 0.477 . . . . 0.0 111.914 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.531 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 19.2 t70 -113.87 154.93 26.65 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 173.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -91.67 -5.72 53.3 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.6 t -92.55 -23.44 19.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.909 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.87 -37.93 0.76 Allowed Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 118.896 -1.621 . . . . 0.0 114.196 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 84.6 mtm-85 -78.92 158.84 27.96 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 117.849 0.824 . . . . 0.0 113.123 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.6 m -146.38 150.44 35.67 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.284 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.531 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 12.8 m-90 -132.03 120.78 22.87 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.0 m -92.57 114.22 26.71 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 174.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 66' ' ' GLY . 18.2 m -114.83 158.79 15.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.642 -174.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 99.5 mtt180 -99.73 127.4 45.87 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.504 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.409 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 56.5 ttp -114.73 144.33 43.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.414 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -128.9 127.81 42.54 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -99.12 124.53 44.22 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.85 102.03 3.95 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.6 -105.22 0.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.352 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.28 -0.79 52.56 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 123.331 0.652 . . . . 0.0 112.151 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 84.8 tttt -142.17 147.09 36.03 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 118.515 -1.274 . . . . 0.0 112.922 -172.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.0 t -109.31 132.48 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -121.88 132.01 54.34 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 5.8 mp -101.19 102.61 13.55 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.269 168.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -85.21 -150.52 0.13 Allowed 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 124.62 1.168 . . . . 0.0 111.271 -170.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 62.0 t -55.47 125.9 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-O 121.838 0.827 . . . . 0.0 109.124 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 52' ' ' VAL . . . 135.22 -40.85 1.51 Allowed Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 -169.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -65.48 -24.84 67.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.729 -0.735 . . . . 0.0 109.64 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.494 ' HA ' HG11 ' A' ' 71' ' ' VAL . 37.2 tt0 -61.29 -30.34 70.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.382 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -58.56 -44.59 89.76 Favored 'General case' 0 C--O 1.198 -1.63 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.757 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -73.0 -46.43 52.28 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.081 0.553 . . . . 0.0 110.062 -176.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.494 HG11 ' HA ' ' A' ' 68' ' ' GLU . 9.7 p -62.76 -43.25 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.571 0.7 . . . . 0.0 110.058 -175.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -72.07 -43.22 65.2 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.273 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.96 -40.37 54.06 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -86.11 -21.01 27.86 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 57.8 94.89 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.577 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -142.73 146.18 34.08 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.696 -0.628 . . . . 0.0 111.993 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.21 170.86 8.2 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.188 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.576 ' N ' ' HB2' ' A' ' 15' ' ' SER . 14.8 t70 -53.52 136.74 37.85 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.568 1.147 . . . . 0.0 111.923 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.91 -11.39 22.79 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.421 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.51 161.38 16.25 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.388 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -125.81 137.74 53.79 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.24 144.65 48.49 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.257 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.442 ' HG2' ' HG2' ' A' ' 10' ' ' MET . 50.0 mt-30 -109.72 126.22 53.49 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -110.39 117.33 33.33 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 65.5 mt -97.95 122.51 49.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -105.75 123.4 47.87 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -125.64 80.25 1.88 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 52.25 30.11 7.5 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.285 170.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 14.8 t70 -161.7 -177.56 5.97 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 40' ' ' VAL . 42.2 ttm180 -95.52 41.74 1.1 Allowed 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 87.5 m -127.14 132.63 50.51 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.802 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 95.7 m-85 -125.29 140.09 53.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.134 0.492 . . . . 0.0 110.805 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.44 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 82.0 m-85 -101.76 126.43 48.62 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.8 t -108.1 119.49 57.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.177 0.513 . . . . 0.0 112.298 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.0 mt -112.08 123.82 68.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.6 tt -114.66 139.25 41.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 120.947 0.403 . . . . 0.0 110.667 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -87.58 113.37 23.2 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.74 67.75 1.02 Allowed Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -93.21 113.43 25.64 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.974 0.416 . . . . 0.0 110.362 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -72.14 125.84 28.31 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.91 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 51.9 ttm -113.57 -8.18 13.33 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.547 0.689 . . . . 0.0 110.102 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 C--O 1.254 1.292 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.53 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.363 0.125 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.4 89.51 0.09 Allowed 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.872 0.844 . . . . 0.0 111.64 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -88.54 153.88 20.79 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.5 m -55.04 -37.78 67.13 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.044 0.449 . . . . 0.0 111.077 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.92 -52.62 3.64 Favored Glycine 0 CA--C 1.498 -0.978 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.67 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.38 93.85 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.022 0 C-N-CA 125.879 1.672 . . . . 0.0 111.838 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.68 140.0 45.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -132.91 154.43 50.41 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -172.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -124.77 147.76 48.5 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.21 -1.359 . . . . 0.0 107.552 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -140.18 134.02 30.58 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -153.91 151.1 24.09 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.542 174.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -77.08 136.75 16.63 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.752 2.301 . . . . 0.0 108.69 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 24.5 p90 -103.09 137.39 41.33 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.188 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.97 123.75 55.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.501 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 19.5 m -53.49 -25.31 15.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.005 0.922 . . . . 0.0 112.584 -173.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.73 -40.49 92.57 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.277 1.031 . . . . 0.0 110.655 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -103.05 -36.78 8.04 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.574 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 89.4 p -66.05 -8.07 21.13 Favored 'General case' 0 C--O 1.215 -0.763 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -172.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.0 m -73.9 -17.66 61.01 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.8 173.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -134.55 -33.35 0.97 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 p -147.36 170.23 17.78 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -171.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.428 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 3.1 tm? -133.72 113.44 12.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.8 131.49 35.91 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.533 ' HB ' HG23 ' A' ' 61' ' ' VAL . 58.8 mt -113.41 132.48 22.47 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -57.14 148.79 67.36 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 123.126 2.55 . . . . 0.0 113.407 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.5 tt -62.74 -33.87 76.03 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.064 0.946 . . . . 0.0 108.871 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.25 -35.96 86.79 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.511 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.431 ' CE2' ' HE1' ' A' ' 32' ' ' PHE . 57.8 t80 -80.15 -20.51 44.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.364 0.602 . . . . 0.0 109.551 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -66.51 -43.34 85.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.3 -11.14 60.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.491 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -72.18 -25.31 61.63 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.431 ' HE1' ' CE2' ' A' ' 28' ' ' PHE . 5.1 p90 -167.74 95.94 0.63 Allowed Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 121.063 0.459 . . . . 0.0 111.683 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.99 135.35 13.89 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.852 1.702 . . . . 0.0 110.202 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.77 160.38 31.16 Favored Pre-proline 0 C--N 1.28 -2.427 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -175.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.54 153.61 73.83 Favored 'Trans proline' 0 C--O 1.251 1.168 0 C-N-CA 121.449 1.433 . . . . 0.0 108.386 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -69.07 131.8 90.55 Favored Pre-proline 0 N--CA 1.411 -2.412 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.444 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.6 156.18 28.04 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 122.211 1.941 . . . . 0.0 110.313 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.3 mm -83.53 -39.76 15.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -154.75 160.5 41.36 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.464 ' HA ' ' NH2' ' A' ' 90' ' ' ARG . 34.2 m -135.5 158.75 40.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -113.35 134.4 54.65 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.876 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -108.89 120.73 43.37 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -104.22 157.61 17.01 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.479 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 4.5 t70 -111.74 146.06 38.23 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.09 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -64.72 -26.88 68.56 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.789 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 m -89.89 -47.69 7.72 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 122.33 -0.231 . . . . 0.0 111.023 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.22 -8.21 0.05 OUTLIER Glycine 0 CA--C 1.525 0.707 0 C-N-CA 119.396 -1.383 . . . . 0.0 114.679 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -73.76 159.47 32.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.162 0.481 . . . . 0.0 111.501 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 p -147.13 136.72 22.89 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.479 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 16.8 m-90 -131.64 142.41 49.85 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.826 0.346 . . . . 0.0 110.378 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 73.4 m -106.59 114.44 28.54 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.2 m -125.74 156.94 35.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.391 -174.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -100.85 128.68 46.79 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.277 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 1.1 tmt? -127.84 143.73 51.11 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -135.0 143.57 46.88 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.012 0.434 . . . . 0.0 111.899 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HA ' HG12 ' A' ' 61' ' ' VAL . 29.1 mmmt -92.43 121.27 33.73 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 102.873 -3.01 . . . . 0.0 102.873 169.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -134.65 98.0 3.94 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.374 -170.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.45 -109.82 3.12 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.947 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.608 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -105.86 -7.93 17.98 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.979 0.419 . . . . 0.0 110.275 -178.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 61' ' ' VAL . 41.7 ttmt -118.78 167.7 11.44 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.533 HG23 ' HB ' ' A' ' 24' ' ' ILE . 32.7 m -128.65 142.27 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -140.74 132.39 27.2 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -173.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.428 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 5.5 tt -97.47 115.81 28.49 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 176.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.7 t -101.31 -142.73 0.34 Allowed 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.085 -170.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.6 m -56.1 143.78 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 124.397 1.079 . . . . 0.0 112.811 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.89 -31.86 6.31 Favored Glycine 0 N--CA 1.421 -2.357 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.428 ' HB2' HD21 ' A' ' 63' ' ' LEU . 57.1 t-105 -54.61 -27.04 36.51 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.609 0.719 . . . . 0.0 110.467 177.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.48 ' HA ' HG12 ' A' ' 71' ' ' VAL . 13.8 pt-20 -63.83 -26.63 68.7 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.204 -175.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -61.58 -37.71 84.89 Favored 'General case' 0 C--O 1.2 -1.552 0 CA-C-O 120.973 0.415 . . . . 0.0 110.098 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -73.95 -48.13 32.7 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.825 0.85 . . . . 0.0 110.765 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.48 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.2 p -65.54 -42.25 92.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.351 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -71.29 -39.81 71.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.752 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -71.8 -38.62 70.22 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -95.56 0.27 52.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.5 t30 55.63 82.81 0.1 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.99 0.9 . . . . 0.0 109.681 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 92.8 mt -120.86 136.0 55.03 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.891 -173.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -138.78 158.67 43.8 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -54.32 128.32 30.96 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 124.348 1.03 . . . . 0.0 111.009 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.24 -35.75 1.93 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -92.56 164.31 13.48 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -132.67 154.4 50.17 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -174.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -113.2 147.59 37.17 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.403 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.451 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 49.5 tt0 -115.25 123.98 50.19 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 171.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 86.2 m-85 -109.2 116.32 31.68 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 8' ' ' GLN . 49.3 mt -110.64 125.29 67.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.402 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 34.3 p90 -119.72 155.58 32.18 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.025 -1.47 . . . . 0.0 108.844 173.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -96.31 -79.92 0.44 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.271 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -143.42 16.49 1.85 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.909 0.385 . . . . 0.0 110.053 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.559 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 33.6 t70 -133.44 -175.07 3.69 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -174.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.559 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -95.09 20.51 8.97 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 125.439 1.495 . . . . 0.0 111.762 -177.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.3 t -110.33 132.98 53.7 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.402 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 81.3 m-85 -112.96 140.57 47.66 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.185 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -98.32 117.6 33.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 43.1 t -104.67 134.63 45.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.325 0.584 . . . . 0.0 112.258 -173.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.2 mt -120.29 134.33 64.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.65 121.5 51.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 120.643 0.259 . . . . 0.0 110.465 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 83' ' ' GLN . 97.1 m-85 -85.22 160.41 19.89 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.869 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 102' ' ' CYS . . . -179.55 -133.58 2.0 Favored Glycine 0 N--CA 1.417 -2.592 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -144.08 -48.46 0.28 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.522 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -76.95 -19.46 57.33 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.39 0.614 . . . . 0.0 110.611 -175.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 27.5 ttt 169.83 -44.94 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.509 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 74.0 m . . . . . 0 N--CA 1.417 -2.117 0 CA-C-N 111.83 -2.441 . . . . 0.0 104.755 170.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.25 106.45 9.88 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -76.51 129.1 36.0 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.377 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 32.5 m -71.09 -34.85 71.52 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.62 65.54 0.26 Allowed Glycine 0 CA--C 1.483 -1.964 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.374 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.77 101.68 7.72 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -128.01 146.7 33.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -137.04 151.81 49.37 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.743 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -142.66 149.37 38.8 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.9 ptp -138.23 154.74 49.08 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.57 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 24.3 ttpp -152.98 145.96 17.61 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.42 142.7 16.86 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.102 2.534 . . . . 0.0 111.341 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.433 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 71.4 t80 -110.75 123.88 50.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.4 mt -126.26 113.09 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' A' ' 78' ' ' ASP . 12.6 p -58.38 -9.46 1.58 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -81.4 -28.23 34.42 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 122.148 -0.345 . . . . 0.0 110.921 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -110.61 -38.01 5.3 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.321 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 21' ' ' SER . 65.0 p -75.24 -0.45 19.51 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.225 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.5 p -75.18 -25.08 57.98 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.513 0.673 . . . . 0.0 110.409 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -115.94 -37.45 3.87 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.492 -175.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 18' ' ' SER . 34.5 p -153.67 169.6 22.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -171.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 4.2 tt -108.04 115.13 29.57 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.57 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 14.8 pt-20 -75.15 115.51 14.87 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.46 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 61' ' ' VAL . 68.0 mt -106.63 123.42 38.75 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.54 147.11 88.27 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 123.396 2.731 . . . . 0.0 114.376 -176.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 tt -59.12 -39.78 83.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.513 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.51 -31.16 69.85 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.749 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -82.62 -24.22 33.94 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.5 0.667 . . . . 0.0 109.759 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -76.08 -46.3 29.7 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.54 -20.0 66.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.038 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.39 -26.98 65.83 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.717 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -168.54 103.24 0.52 Allowed Pre-proline 0 C--O 1.248 1.009 0 CA-C-O 121.239 0.542 . . . . 0.0 110.555 177.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.21 135.14 14.9 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 120.968 1.112 . . . . 0.0 109.797 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.65 148.97 21.39 Favored Pre-proline 0 C--N 1.276 -2.6 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.74 133.85 41.18 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 121.811 1.674 . . . . 0.0 108.534 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.58 ' HB3' ' H ' ' A' ' 56' ' ' LYS . 39.4 p90 -69.78 139.92 88.78 Favored Pre-proline 0 N--CA 1.414 -2.268 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -75.72 158.63 39.3 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.874 2.383 . . . . 0.0 109.905 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.36 -54.89 12.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.5 p -133.44 150.44 51.75 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.601 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 m -131.94 157.18 43.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -109.98 139.59 44.91 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.641 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.7 mt -108.24 121.89 45.82 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.3 137.96 38.95 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.94 150.95 29.79 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.024 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.58 -22.95 65.66 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.281 0.633 . . . . 0.0 112.445 -175.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.9 t -82.46 3.05 29.81 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.099 0.476 . . . . 0.0 110.175 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 8.9 67.66 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 121.358 -0.448 . . . . 0.0 112.264 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -89.27 154.97 19.68 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.1 p -141.19 137.84 32.94 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 120.863 0.363 . . . . 0.0 111.402 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -124.3 142.13 51.51 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.217 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.5 m -100.18 120.39 39.82 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.455 HG13 ' C ' ' A' ' 66' ' ' GLY . 22.9 m -123.31 157.25 29.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.596 -174.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -101.2 139.82 36.35 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.829 0.347 . . . . 0.0 110.258 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 25.3 ttt -134.26 127.22 31.4 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.517 -172.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -120.69 124.93 46.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.018 0.437 . . . . 0.0 111.31 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.58 ' H ' ' HB3' ' A' ' 36' ' ' PHE . 25.3 mmmt -100.39 105.49 16.99 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 175.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -149.93 115.47 5.53 Favored 'General case' 0 C--N 1.265 -3.102 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.94 -120.17 5.15 Favored Glycine 0 N--CA 1.418 -2.541 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.441 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -96.03 -27.97 14.86 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.521 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -120.99 170.32 9.62 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.883 0.849 . . . . 0.0 112.876 -172.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.536 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 47.5 t -120.69 127.3 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 173.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -119.8 129.1 54.29 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 6.6 tt -103.96 118.09 35.86 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.4 p -99.16 -144.38 0.32 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.9 m -54.77 144.88 5.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.89 1.276 . . . . 0.0 113.154 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' C ' HG13 ' A' ' 52' ' ' VAL . . . 114.94 -41.54 2.14 Favored Glycine 0 N--CA 1.418 -2.532 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 -170.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.489 ' CZ3' HD12 ' A' ' 22' ' ' LEU . 58.0 t-105 -62.38 -26.9 68.71 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 114.259 -0.971 . . . . 0.0 109.248 174.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.449 ' HA ' HG13 ' A' ' 71' ' ' VAL . 30.5 tt0 -69.39 -26.77 64.81 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.524 -177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -70.28 -30.84 67.96 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.423 ' HB3' ' O ' ' A' ' 67' ' ' TRP . 53.1 t80 -73.03 -52.47 14.26 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 124.527 1.131 . . . . 0.0 109.278 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' A' ' 68' ' ' GLU . 8.1 p -64.61 -41.21 91.61 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.973 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -70.59 -48.14 56.69 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.679 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.83 -40.36 69.15 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.709 -173.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -88.62 -19.08 26.71 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.973 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 56.22 92.38 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.041 0.936 . . . . 0.0 110.993 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.433 HD11 ' CZ ' ' A' ' 13' ' ' PHE 0.289 0.9 OUTLIER -142.09 132.1 24.55 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -176.977 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.83 173.46 9.54 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 125.849 1.66 . . . . 0.0 109.017 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 15' ' ' SER . 31.4 t70 -52.71 135.92 34.29 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.693 0.62 . . . . 0.0 110.54 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.68 -28.22 3.27 Favored Glycine 0 C--N 1.301 -1.414 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -107.67 150.47 26.88 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.834 -0.683 . . . . 0.0 109.447 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -122.31 146.65 47.1 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.1 mt -110.76 135.88 50.67 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.104 0.478 . . . . 0.0 112.004 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -118.02 124.42 48.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.87 117.88 34.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.936 0.398 . . . . 0.0 110.969 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.547 HG13 ' HB2' ' A' ' 93' ' ' TYR . 11.7 pt -105.36 130.19 57.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -106.41 143.77 34.05 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.267 0.556 . . . . 0.0 111.41 -173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -92.59 -0.75 57.27 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 4' ' ' THR . 7.3 tpt180 74.96 8.4 4.13 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.932 1.693 . . . . 0.0 109.175 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.601 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 31.5 t70 -106.08 -159.36 0.7 Allowed 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.601 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 53.4 ttp180 -95.7 11.95 31.61 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 p -108.39 117.84 35.22 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.626 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -107.42 126.46 52.52 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.491 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.547 ' HB2' HG13 ' A' ' 85' ' ' ILE . 78.9 m-85 -104.27 126.98 51.83 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.1 p -119.32 135.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.167 0.508 . . . . 0.0 111.724 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.1 mt -114.45 123.01 69.71 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.4 mt -103.56 112.69 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.578 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -126.62 167.59 15.47 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.807 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.97 117.71 1.46 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.614 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 49.8 m80 65.51 -74.88 0.05 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.719 1.208 . . . . 0.0 112.167 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -169.68 85.65 0.13 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.26 -40.18 8.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 84.2 m . . . . . 0 C--N 1.313 -0.986 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 174.589 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 111.209 0.077 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.27 124.69 20.84 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 68.42 78.39 0.23 Allowed 'General case' 0 C--O 1.245 0.847 0 O-C-N 124.332 1.02 . . . . 0.0 109.868 -172.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.8 m -83.43 -41.08 18.51 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.426 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.78 -154.24 20.44 Favored Glycine 0 N--CA 1.416 -2.669 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 59.97 29.6 19.16 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 122.088 0.947 . . . . 0.0 110.052 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.29 140.7 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -125.23 159.6 31.22 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-O 121.082 0.468 . . . . 0.0 112.195 -172.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -148.89 148.83 30.32 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.9 ptp -138.28 141.01 39.85 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.652 0.263 . . . . 0.0 111.348 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.66 157.05 31.39 Favored Pre-proline 0 C--N 1.312 -1.025 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.82 132.53 15.79 Favored 'Trans proline' 0 N--CA 1.439 -1.728 0 C-N-CA 120.989 1.126 . . . . 0.0 109.681 172.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.478 ' CE2' HD13 ' A' ' 76' ' ' LEU . 30.3 p90 -84.44 140.47 31.49 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 123.564 0.746 . . . . 0.0 110.232 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.6 mt -90.59 120.88 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 28.8 t -53.44 -37.11 62.28 Favored 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.716 0.635 . . . . 0.0 111.89 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.76 -40.57 97.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -87.02 -39.32 15.75 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.823 0.821 . . . . 0.0 108.933 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 21' ' ' SER . 48.4 m -76.04 4.14 9.0 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 114.45 -1.25 . . . . 0.0 113.016 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.1 m -71.61 -20.02 62.04 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.227 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -136.22 -36.17 0.74 Allowed 'General case' 0 C--O 1.214 -0.808 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.631 ' O ' ' HA ' ' A' ' 18' ' ' SER . 58.4 p -138.95 168.06 20.66 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.608 -0.437 . . . . 0.0 112.138 -175.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.07 131.73 47.34 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -89.34 131.82 35.24 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 121.41 0.624 . . . . 0.0 111.922 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 47.3 mm -94.89 132.93 27.28 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.1 144.43 69.42 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.883 2.389 . . . . 0.0 112.984 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.0 tp -65.58 -33.41 75.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.326 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.66 -36.21 93.04 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.472 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . 45.2 m-85 -77.84 -25.71 48.92 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -59.21 -46.33 88.74 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.19 -31.98 62.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.211 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.472 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 64.0 t80 -68.81 -28.55 66.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.369 -174.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -151.09 93.51 3.64 Favored Pre-proline 0 C--O 1.247 0.95 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -83.64 136.0 7.16 Favored 'Trans proline' 0 N--CA 1.429 -2.274 0 C-N-CA 122.264 1.976 . . . . 0.0 108.812 167.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.71 160.53 31.54 Favored Pre-proline 0 C--N 1.264 -3.127 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -175.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.2 132.78 53.3 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 107.342 -1.83 . . . . 0.0 107.342 172.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -68.22 115.74 32.16 Favored Pre-proline 0 N--CA 1.41 -2.446 0 CA-C-O 121.285 0.564 . . . . 0.0 112.002 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -80.45 135.48 10.58 Favored 'Trans proline' 0 N--CA 1.433 -2.079 0 C-N-CA 121.942 1.762 . . . . 0.0 110.062 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.9 mm -81.48 -28.79 10.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.6 p -127.66 148.73 50.39 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 121.497 0.665 . . . . 0.0 110.15 173.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 90' ' ' ARG . 53.4 t -142.83 147.31 20.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -115.83 133.96 55.49 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.725 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt -108.15 121.78 45.56 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -101.23 137.47 39.54 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.962 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -113.11 141.6 46.71 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.242 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -57.93 -29.78 65.42 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 125.353 1.461 . . . . 0.0 113.717 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.5 t -86.1 -4.57 59.2 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 122.094 -0.379 . . . . 0.0 110.487 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.21 -4.85 23.62 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.651 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -80.73 158.51 25.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.775 0.322 . . . . 0.0 110.568 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 p -156.34 135.38 11.98 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.219 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -125.51 135.77 52.64 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.687 0.279 . . . . 0.0 110.91 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.2 m -92.32 114.8 27.45 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.402 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 33.6 m -115.63 157.66 16.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.343 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -101.34 127.39 47.98 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.398 0.618 . . . . 0.0 109.768 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.5 ttt -110.13 144.33 38.9 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.547 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -139.32 125.69 20.3 Favored 'General case' 0 N--CA 1.412 -2.366 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.156 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.423 ' HD2' HG23 ' A' ' 61' ' ' VAL . 28.5 mmmt -92.01 113.25 25.47 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -135.84 97.99 3.78 Favored 'General case' 0 C--N 1.272 -2.79 0 CA-C-O 120.985 0.421 . . . . 0.0 112.096 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.92 -87.92 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 116.638 1.415 . . . . 0.0 116.638 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -89.57 -24.84 21.62 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.614 -0.293 . . . . 0.0 111.612 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -154.08 171.09 19.65 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.927 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.486 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 48.5 t -108.31 131.3 59.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -120.97 132.48 54.95 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 tt -102.34 103.8 14.27 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 53.4 p -95.03 -103.65 0.15 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.5 m -69.84 144.21 14.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.455 0.645 . . . . 0.0 112.083 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 109.61 -37.77 3.63 Favored Glycine 0 CA--C 1.483 -1.954 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.405 ' O ' ' HB3' ' A' ' 70' ' ' PHE . 63.6 t-105 -61.23 -24.9 66.69 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 122.084 0.945 . . . . 0.0 109.191 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.419 ' HA ' HG12 ' A' ' 71' ' ' VAL . 13.0 pt-20 -65.68 -30.12 70.77 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.357 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -74.68 -29.46 61.24 Favored 'General case' 0 C--O 1.202 -1.413 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.405 ' HB3' ' O ' ' A' ' 67' ' ' TRP . 16.1 t80 -73.28 -52.36 14.24 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 124.763 1.225 . . . . 0.0 108.454 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.1 p -61.1 -45.32 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.443 -177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -71.91 -34.06 68.8 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.21 -39.55 63.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.387 -174.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -90.25 -18.75 25.09 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.898 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.1 t30 54.82 83.92 0.08 Allowed 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.164 0.986 . . . . 0.0 109.698 -172.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.478 HD13 ' CE2' ' A' ' 13' ' ' PHE . 1.3 pp -133.98 148.54 51.15 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -175.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -143.85 172.31 13.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.126 -174.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 15' ' ' SER . 5.4 p-10 -56.78 141.11 45.52 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 123.704 0.627 . . . . 0.0 111.38 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 117.51 -16.01 12.75 Favored Glycine 0 C--N 1.302 -1.318 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -174.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -104.39 159.22 15.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.454 ' HB2' ' HB2' ' A' ' 97' ' ' TYR . 33.2 m-85 -120.99 136.82 54.89 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -173.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.498 ' O ' HD11 ' A' ' 82' ' ' LEU . 1.8 pp -114.92 138.97 50.19 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.966 176.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.541 ' NE2' HD13 ' A' ' 95' ' ' ILE . 27.2 tt0 -124.24 124.01 41.5 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.437 ' CE2' HD13 ' A' ' 82' ' ' LEU . 86.9 m-85 -108.7 131.86 54.5 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 59.2 mt -97.65 116.05 39.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.416 ' HD2' ' CE1' ' A' ' 92' ' ' PHE . 53.8 m-85 -107.05 126.79 52.8 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -110.63 16.95 21.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 118.596 -1.241 . . . . 0.0 109.282 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 63.75 80.4 0.23 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.583 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 22.6 t70 -172.82 -168.67 0.51 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.45 ' O ' HG11 ' A' ' 40' ' ' VAL . 51.5 ptt85 -107.55 24.87 12.21 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 118.412 0.551 . . . . 0.0 109.749 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -129.27 117.35 20.54 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.416 ' CE1' ' HD2' ' A' ' 86' ' ' TYR . 26.9 m-85 -121.45 137.88 54.53 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.576 -176.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -100.4 125.99 46.72 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.6 p -109.66 137.98 39.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-O 121.599 0.714 . . . . 0.0 112.5 -175.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.541 HD13 ' NE2' ' A' ' 83' ' ' GLN . 66.7 mt -118.61 125.89 74.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.6 mt -113.01 125.43 70.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.549 0.69 . . . . 0.0 111.158 -174.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.454 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 62.6 m-85 -98.58 119.47 37.35 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.6 82.37 1.61 Allowed Glycine 0 C--N 1.294 -1.789 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 -170.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -125.99 147.87 49.42 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.835 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -64.88 121.09 13.8 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.8 ttt -81.43 81.36 7.58 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.467 0.651 . . . . 0.0 110.597 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.6 m . . . . . 0 C--N 1.303 -1.432 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.402 179.097 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 CA--C 1.504 -0.822 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.78 91.56 8.68 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.206 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.8 t70 71.08 149.29 0.09 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.307 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.1 m -92.88 -22.7 19.11 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.552 0.691 . . . . 0.0 109.907 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.51 -42.89 1.09 Allowed Glycine 0 CA--C 1.48 -2.124 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.36 166.58 16.5 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 113.612 -1.294 . . . . 0.0 109.042 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.4 m -129.21 140.3 49.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -121.84 148.01 45.24 Favored 'General case' 0 N--CA 1.406 -2.652 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -147.09 148.95 32.14 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -134.68 138.54 44.52 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.571 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -148.48 144.88 19.07 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.9 133.56 5.02 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 121.988 1.792 . . . . 0.0 108.105 168.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -100.3 142.34 31.91 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 122.336 -0.227 . . . . 0.0 110.621 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' A' ' 17' ' ' LYS . 81.5 mt -88.36 114.67 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.441 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 28.9 t -53.68 -34.18 57.85 Favored 'General case' 0 C--O 1.212 -0.872 0 O-C-N 123.648 0.592 . . . . 0.0 111.121 -174.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.5 -39.83 89.15 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.667 -177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HG2' ' HB ' ' A' ' 14' ' ' ILE . 20.7 ptmt -104.77 -26.88 12.08 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.811 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 21' ' ' SER . 68.4 m -92.56 14.44 16.86 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.8 m -74.2 -16.39 60.98 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 118.885 -1.126 . . . . 0.0 109.919 166.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -114.51 -47.67 2.9 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 18' ' ' SER . 49.2 m -143.35 168.68 19.23 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 122.972 0.509 . . . . 0.0 110.39 -172.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.484 HD23 ' CZ3' ' A' ' 67' ' ' TRP . 43.9 tp -126.24 142.17 51.63 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.305 0.242 . . . . 0.0 110.751 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -98.37 124.69 43.17 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 120.681 0.276 . . . . 0.0 110.661 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 2.1 mp -97.25 133.38 24.02 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.53 139.29 17.89 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 123.925 3.083 . . . . 0.0 114.787 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.5 tt -62.7 -41.08 98.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.163 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.1 -36.11 92.45 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -73.72 -34.2 64.69 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -63.51 -46.46 85.94 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.853 0.835 . . . . 0.0 110.021 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -72.88 -11.07 60.45 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.842 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -74.76 -27.68 60.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.377 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -147.07 121.07 5.05 Favored Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.817 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.74 134.64 15.2 Favored 'Trans proline' 0 N--CA 1.44 -1.676 0 C-N-CA 121.832 1.688 . . . . 0.0 108.87 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.08 138.46 11.59 Favored Pre-proline 0 C--N 1.271 -2.805 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.92 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 143.85 96.72 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 106.557 -2.132 . . . . 0.0 106.557 167.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -68.79 121.93 83.08 Favored Pre-proline 0 N--CA 1.41 -2.471 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.162 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.09 152.56 62.47 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 121.913 1.742 . . . . 0.0 110.086 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.0 mm -86.78 -59.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -124.72 151.01 45.58 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.706 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.48 162.29 29.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 91' ' ' THR . 24.8 t70 -124.89 140.09 53.24 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.042 -175.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.3 mt -107.79 127.58 53.83 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.15 147.72 25.91 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.798 0.809 . . . . 0.0 111.793 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 2.3 t70 -112.14 137.14 50.63 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.528 173.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -70.31 -8.88 53.87 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.5 t -92.18 -41.73 10.28 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.87 0.03 0.11 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.11 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 17.9 mmt180 -88.88 158.95 17.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 117.643 0.722 . . . . 0.0 110.731 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.7 p -149.51 146.56 27.45 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CE3' ' HD1' ' A' ' 70' ' ' PHE . 24.3 m-90 -130.04 123.71 31.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.415 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.9 m -89.68 117.0 28.22 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 63' ' ' LEU . 22.2 m -124.95 157.23 33.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.686 -172.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -102.62 122.93 45.39 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.255 0.55 . . . . 0.0 111.517 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 50.8 ttp -124.82 131.18 53.47 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.63 161.84 38.15 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.493 ' HG2' HG23 ' A' ' 61' ' ' VAL . 78.8 mttt -91.29 129.86 37.23 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -132.11 103.15 6.11 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.392 0.615 . . . . 0.0 110.951 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.27 -101.27 0.73 Allowed Glycine 0 N--CA 1.431 -1.65 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.565 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.414 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 39.7 mt-10 -95.23 -20.68 19.0 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.383 -0.408 . . . . 0.0 111.061 -175.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -131.56 166.64 20.94 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.487 0.66 . . . . 0.0 112.623 -170.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.493 HG23 ' HG2' ' A' ' 56' ' ' LYS . 90.1 t -97.42 136.92 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 170.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -135.19 132.88 38.48 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.132 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.45 HD22 ' HB ' ' A' ' 52' ' ' VAL . 3.7 tt -99.14 116.86 32.31 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.3 p -90.0 -92.16 0.13 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.67 145.15 8.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 C-N-CA 124.967 1.307 . . . . 0.0 113.205 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.412 ' C ' HG12 ' A' ' 52' ' ' VAL . . . 109.28 -36.4 4.36 Favored Glycine 0 CA--C 1.477 -2.311 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.566 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.484 ' CZ3' HD23 ' A' ' 22' ' ' LEU . 64.5 t-105 -58.68 -26.15 63.54 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.706 0.765 . . . . 0.0 109.906 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.485 ' HA ' HG13 ' A' ' 71' ' ' VAL . 15.8 pt-20 -72.39 -26.22 61.8 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.535 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -71.99 -37.92 69.76 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.457 ' HD1' ' CE3' ' A' ' 50' ' ' TRP . 69.0 t80 -72.89 -51.29 19.21 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.072 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -62.66 -44.59 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.65 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -73.47 -43.72 59.6 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.12 -40.05 78.55 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.532 -0.867 . . . . 0.0 112.891 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -85.14 -14.56 46.63 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t30 60.77 82.75 0.16 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 125.204 1.402 . . . . 0.0 112.173 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -115.64 159.08 21.79 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.388 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -143.96 165.06 28.8 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' H ' ' HB2' ' A' ' 15' ' ' SER . 14.1 t70 -53.16 120.95 6.56 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 124.072 0.858 . . . . 0.0 109.414 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.98 -29.38 3.73 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -80.85 154.48 27.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.468 ' C ' HD12 ' A' ' 82' ' ' LEU . 94.8 m-85 -122.05 135.15 54.8 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 81' ' ' TYR . 6.4 mp -123.26 130.75 53.18 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.111 0.481 . . . . 0.0 111.224 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -112.83 124.11 51.84 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -108.99 118.04 35.77 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.355 -173.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.416 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 63.2 mt -98.23 118.29 44.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.29 -0.413 . . . . 0.0 109.937 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -106.47 123.48 48.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -81.79 -78.78 0.18 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -176.82 24.23 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 32.2 t70 -119.59 -172.99 2.43 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -94.97 29.44 2.4 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-O 121.638 0.732 . . . . 0.0 109.078 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 17.5 p -125.38 136.66 53.67 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.078 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -118.13 135.25 54.33 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.375 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.416 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 57.2 m-85 -100.48 113.64 26.59 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.0 t -98.7 124.79 52.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.693 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.1 mm -105.75 116.46 49.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.4 ' N ' HD13 ' A' ' 96' ' ' ILE . 3.0 mp -102.15 130.28 52.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -85.39 112.72 21.1 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.38 -83.98 0.19 Allowed Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 68.04 125.9 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.227 1.011 . . . . 0.0 113.709 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -89.62 129.68 36.03 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.55 112.04 16.42 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -176.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 46.2 t . . . . . 0 C--N 1.312 -1.039 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.43 113.24 25.88 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 120.992 0.425 . . . . 0.0 110.78 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -114.13 97.43 6.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.609 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.9 m -99.72 -34.65 10.09 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.52 -145.11 9.29 Favored Glycine 0 N--CA 1.422 -2.278 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 42.76 80.95 0.03 OUTLIER 'General case' 0 C--O 1.256 1.42 0 C-N-CA 124.963 1.305 . . . . 0.0 113.573 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.27 140.68 46.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.902 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 9.8 pt20 -121.9 146.1 47.44 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.37 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 83' ' ' GLN . 88.6 t80 -129.63 148.59 51.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -124.9 146.24 49.43 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 120.641 0.257 . . . . 0.0 110.676 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -154.14 139.88 12.32 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.03 146.19 81.6 Favored 'Trans proline' 0 C--O 1.257 1.467 0 C-N-CA 122.032 1.821 . . . . 0.0 110.709 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -78.62 119.45 21.9 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.1 mt -107.52 120.2 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.239 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.1 t -66.74 -10.9 51.87 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 123.273 0.629 . . . . 0.0 111.413 -172.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.5 -46.18 33.85 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.531 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.486 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 3.5 mppt? -113.17 -41.89 3.62 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 118.394 -1.322 . . . . 0.0 113.543 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 21' ' ' SER . 15.6 m -69.43 -3.74 15.68 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 123.57 0.544 . . . . 0.0 111.091 -174.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.0 p -74.31 -25.51 59.62 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -133.13 -23.33 1.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.975 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.561 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 51.0 m -150.48 169.16 22.15 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 63' ' ' LEU 0.308 42.7 mt -103.86 131.35 51.15 Favored 'General case' 0 CA--C 1.488 -1.408 0 CA-C-O 122.391 1.091 . . . . 0.0 113.875 177.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.486 ' OE2' ' HB2' ' A' ' 17' ' ' LYS . 6.7 pt-20 -91.33 111.27 22.68 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 112.324 -2.216 . . . . 0.0 108.973 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.86 121.68 36.46 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.614 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.51 153.75 76.87 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 123.045 2.497 . . . . 0.0 113.154 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.88 -34.8 74.05 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.882 -175.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.21 -28.8 73.96 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.688 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -75.88 -31.21 59.14 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.276 0.631 . . . . 0.0 110.166 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -76.16 -26.23 56.04 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.565 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -75.32 -17.42 60.26 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.662 0.744 . . . . 0.0 109.324 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -74.1 -28.24 61.27 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.92 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -161.35 80.45 2.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 121.617 0.722 . . . . 0.0 112.1 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.37 140.62 15.43 Favored 'Trans proline' 0 N--CA 1.43 -2.244 0 C-N-CA 122.343 2.029 . . . . 0.0 111.499 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.8 159.21 36.36 Favored Pre-proline 0 C--N 1.278 -2.519 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.93 146.34 87.24 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 121.888 1.725 . . . . 0.0 108.935 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -69.05 117.42 51.63 Favored Pre-proline 0 N--CA 1.415 -2.178 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -175.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.66 159.84 31.61 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.878 2.385 . . . . 0.0 111.534 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.17 -41.34 22.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -137.03 150.53 48.15 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.671 0.748 . . . . 0.0 112.219 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.578 HG11 ' O ' ' A' ' 90' ' ' ARG . 74.2 t -132.45 160.04 42.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.88 130.96 34.63 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.48 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.7 mt -109.62 133.81 52.67 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.208 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.44 143.32 32.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.877 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 9.7 t70 -112.9 147.69 36.51 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.681 174.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -60.34 -23.81 64.55 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 124.228 1.011 . . . . 0.0 112.866 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -80.28 -12.75 59.58 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.847 -0.533 . . . . 0.0 110.404 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.25 1.35 25.02 Favored Glycine 0 C--O 1.239 0.445 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.299 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.408 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 98.1 mtt180 -80.6 157.42 26.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.2 p -150.53 136.75 18.62 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 120.59 0.233 . . . . 0.0 110.512 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 15.8 m-90 -124.53 130.47 52.52 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.145 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.1 m -89.98 114.48 26.33 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.403 ' HB ' HD23 ' A' ' 63' ' ' LEU . 28.6 m -112.03 156.81 13.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.814 -173.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -102.79 119.96 39.76 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 60.4 ttp -124.62 123.72 40.67 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HB3' ' HZ2' ' A' ' 55' ' ' LYS . 9.8 mtpm? -136.75 162.68 32.53 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -174.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HD3' HG23 ' A' ' 61' ' ' VAL . 29.7 mmtp -88.72 128.62 35.62 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 175.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.49 100.62 5.21 Favored 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -175.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.84 -112.2 3.61 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -175.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -112.3 -5.77 14.12 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.886 0.85 . . . . 0.0 110.321 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -113.69 170.67 8.09 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.213 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.471 HG23 ' HD3' ' A' ' 56' ' ' LYS . 57.9 t -108.58 127.28 65.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -126.68 130.59 50.7 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.561 ' O ' ' HB3' ' A' ' 21' ' ' SER . 6.7 tt -103.15 120.96 41.66 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.6 t -96.43 -144.55 0.28 Allowed 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 123.161 0.584 . . . . 0.0 111.546 -172.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.47 143.88 6.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 125.43 1.492 . . . . 0.0 111.689 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.35 -48.42 0.96 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -65.36 -24.91 67.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.394 -0.903 . . . . 0.0 110.176 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.432 ' O ' HG11 ' A' ' 71' ' ' VAL . 35.2 tt0 -65.5 -29.87 70.57 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.796 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -69.48 -35.89 76.02 Favored 'General case' 0 C--O 1.198 -1.634 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.347 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -68.57 -49.7 57.41 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 123.409 0.683 . . . . 0.0 109.204 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 6.8 p -63.67 -33.68 63.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.223 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -71.23 -48.64 50.07 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.039 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -72.34 -39.56 68.06 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -96.96 -10.0 27.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.749 -0.595 . . . . 0.0 111.278 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 7.9 t30 53.99 94.86 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.233 1.413 . . . . 0.0 112.932 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 71' ' ' VAL . 3.8 mp -122.21 133.75 54.72 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.749 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.09 169.99 10.65 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 124.21 1.004 . . . . 0.0 108.979 174.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.66 141.47 56.73 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.216 0.531 . . . . 0.0 111.302 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.09 -29.45 5.99 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -80.84 154.33 27.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.862 0.363 . . . . 0.0 110.404 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -122.56 140.73 52.46 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mp -124.51 144.12 50.29 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.745 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 8.9 pt20 -116.23 137.27 52.28 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 85.9 m-85 -111.81 117.61 33.29 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 48.9 mt -97.62 114.72 35.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.471 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 24.3 p90 -130.56 157.86 41.55 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.734 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -107.66 25.1 11.92 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.61 13.49 2.94 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 125.145 1.378 . . . . 0.0 111.82 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.551 ' OD2' HG22 ' A' ' 91' ' ' THR . 7.8 p-10 -96.35 -159.63 0.74 Allowed 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.578 ' O ' HG11 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -105.5 15.72 26.64 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -176.012 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.551 HG22 ' OD2' ' A' ' 89' ' ' ASP . 5.5 t -121.41 139.8 52.98 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 117.789 -1.564 . . . . 0.0 109.197 172.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.471 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 71.6 m-85 -128.13 136.46 51.17 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 122.122 -0.361 . . . . 0.0 110.67 -175.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.408 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 61.3 m-85 -94.59 120.46 34.85 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.5 t -103.71 117.71 49.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 120.99 0.424 . . . . 0.0 111.496 -174.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.428 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 65.0 mt -114.61 124.49 71.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 96' ' ' ILE . 2.6 mp -94.15 140.66 16.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -84.45 141.78 30.56 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.583 0.706 . . . . 0.0 111.328 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.91 173.32 21.49 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -98.46 -47.28 5.45 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -160.08 100.79 1.4 Allowed 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 69.9 mtm -61.89 113.26 2.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.417 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.249 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.498 -1.037 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.53 94.55 1.59 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -111.37 92.72 4.15 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.801 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.6 m -88.78 -14.37 37.25 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.837 0.827 . . . . 0.0 109.774 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.3 -114.74 1.04 Allowed Glycine 0 N--CA 1.425 -2.08 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.889 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.425 ' HB2' ' CG2' ' A' ' 85' ' ' ILE . 11.3 pt-20 -90.23 129.03 36.53 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.107 0.479 . . . . 0.0 111.973 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.3 m -118.68 142.29 34.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 175.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -116.42 145.63 43.11 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.019 0.438 . . . . 0.0 111.781 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -140.37 149.81 43.14 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.481 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 23.6 ptp -126.18 144.47 50.75 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' NZ ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.57 146.2 18.61 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 178.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.35 147.21 28.81 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.692 2.262 . . . . 0.0 109.257 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -108.4 136.07 48.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.1 mp -110.13 114.1 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -61.93 -11.93 15.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.547 0.739 . . . . 0.0 112.797 -170.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -77.15 -28.05 54.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -107.13 -35.76 6.76 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 120.815 0.34 . . . . 0.0 110.932 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.5 p -75.73 3.48 9.71 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.899 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 p -74.19 -30.96 62.47 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -120.0 -42.06 2.62 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.58 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.9 p -134.93 146.22 48.94 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -173.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.526 HD12 ' CZ ' ' A' ' 84' ' ' PHE . 3.3 tt -91.93 115.05 27.73 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.1 125.35 30.75 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.549 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.1 mm -100.13 119.25 59.79 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.54 143.71 97.89 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.919 2.413 . . . . 0.0 111.671 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.454 ' O ' ' HG3' ' A' ' 30' ' ' GLU . 62.9 tp -51.09 -41.73 60.17 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.626 0.77 . . . . 0.0 112.468 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.86 -34.08 76.43 Favored Glycine 0 C--N 1.319 -0.391 0 N-CA-C 113.926 0.33 . . . . 0.0 113.926 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -88.68 -22.72 23.25 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -72.76 -43.6 62.67 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.255 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 45.1 mt-10 -61.99 -17.24 56.47 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.257 0.623 . . . . 0.0 110.483 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -77.89 -27.28 49.58 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.59 -174.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -147.18 72.95 12.08 Favored Pre-proline 0 CA--C 1.56 1.348 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -54.36 136.49 69.24 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.806 1.671 . . . . 0.0 110.304 165.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.06 160.64 31.69 Favored Pre-proline 0 C--N 1.277 -2.567 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.269 -173.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.86 137.96 83.61 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 108.232 -1.488 . . . . 0.0 108.232 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -69.46 117.24 50.84 Favored Pre-proline 0 N--CA 1.416 -2.164 0 CA-C-O 121.1 0.476 . . . . 0.0 111.375 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -91.86 159.23 3.39 Favored 'Trans proline' 0 N--CA 1.429 -2.269 0 C-N-CA 122.289 1.993 . . . . 0.0 111.672 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mp -98.6 -31.75 3.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 m -137.6 151.91 48.84 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.278 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.8 t -147.97 157.67 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 126.719 2.008 . . . . 0.0 106.969 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -119.48 140.45 50.45 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 118.765 0.711 . . . . 0.0 111.704 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.0 mt -111.61 126.3 54.86 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.021 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.1 147.67 26.7 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -111.97 136.98 50.6 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -67.52 -15.45 63.67 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.353 -173.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.8 t -96.71 -14.29 22.14 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.426 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.81 -23.9 2.9 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 119.848 -1.168 . . . . 0.0 114.115 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -67.8 159.22 30.74 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -150.86 136.82 18.26 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.427 ' HE1' ' HB3' ' A' ' 73' ' ' ASP . 32.3 m-90 -130.67 137.19 49.46 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.661 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.6 m -93.26 125.31 37.8 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.404 HG22 ' N ' ' A' ' 67' ' ' TRP . 14.2 p -125.58 155.91 34.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.111 0.481 . . . . 0.0 111.213 -173.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -104.52 120.27 40.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -126.86 127.5 45.05 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.93 134.52 54.84 Favored 'General case' 0 C--O 1.25 1.08 0 O-C-N 123.38 0.425 . . . . 0.0 111.035 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HA ' ' CG1' ' A' ' 61' ' ' VAL . 13.3 mmmm -91.91 112.01 23.77 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 175.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -147.47 120.86 9.02 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.99 -136.73 18.13 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.428 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -111.28 -3.49 15.31 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.115 0.484 . . . . 0.0 111.495 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -128.85 129.15 45.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.177 0.513 . . . . 0.0 109.691 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.471 ' CG1' ' HA ' ' A' ' 56' ' ' LYS . 16.4 m -111.49 146.69 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.97 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -137.58 142.38 41.31 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.017 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 4.7 mp -88.05 103.26 15.56 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 170.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.8 p -78.21 -141.53 0.03 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 124.269 1.028 . . . . 0.0 111.652 -173.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.3 p -55.57 140.64 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.546 0.689 . . . . 0.0 109.875 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.0 -40.02 2.5 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 -171.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.458 ' CZ3' HD11 ' A' ' 22' ' ' LEU . 54.3 t-105 -67.24 -21.02 65.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.685 0.755 . . . . 0.0 109.147 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.443 ' HA ' HG13 ' A' ' 71' ' ' VAL . 41.9 tt0 -68.01 -32.75 73.35 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.777 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -65.15 -33.11 75.24 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-O 121.394 0.616 . . . . 0.0 109.844 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.28 -52.53 18.42 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.359 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.504 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 6.8 p -64.06 -40.54 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.804 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -71.16 -48.38 52.21 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.84 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.427 ' HB3' ' HE1' ' A' ' 50' ' ' TRP . 28.5 t70 -77.1 -35.57 56.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -173.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -86.6 -20.94 27.16 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 56.74 83.82 0.1 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.578 1.151 . . . . 0.0 111.543 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.504 ' CD2' ' HA ' ' A' ' 71' ' ' VAL . 1.6 pt? -125.44 155.39 40.53 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.832 0.825 . . . . 0.0 112.282 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.49 172.43 12.97 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.18 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -58.74 130.21 45.82 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.35 -20.35 7.02 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -99.2 146.27 26.35 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.48 ' C ' HD11 ' A' ' 82' ' ' LEU . 96.4 m-85 -119.96 140.93 50.16 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -175.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.48 HD11 ' C ' ' A' ' 81' ' ' TYR . 4.9 mp -131.85 137.8 48.21 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.005 0.431 . . . . 0.0 111.008 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.481 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 42.9 mt-30 -111.87 135.08 52.96 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.95 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.526 ' CZ ' HD12 ' A' ' 22' ' ' LEU . 95.0 m-85 -115.19 125.04 52.93 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.4 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 2.4 mp -105.0 118.98 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 88' ' ' ARG . 87.3 t80 -106.74 124.64 49.9 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 7.9 p-10 -107.52 12.87 27.36 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -175.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.472 ' HA ' ' CE2' ' A' ' 86' ' ' TYR 0.27 6.1 mpt_? 84.47 -0.05 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 12.4 t70 -101.13 -165.18 1.18 Allowed 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.435 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.5 OUTLIER -102.48 39.26 1.54 Allowed 'General case' 0 C--N 1.256 -3.486 0 CA-C-O 121.839 0.828 . . . . 0.0 108.817 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -126.01 117.93 24.27 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.148 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.81 126.8 52.6 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 174.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.465 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 68.6 m-85 -91.7 118.9 31.07 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.66 125.72 62.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 120.787 0.327 . . . . 0.0 111.067 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.479 ' CG2' ' HB2' ' A' ' 83' ' ' GLN . 13.9 tt -112.54 118.41 57.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.411 HG12 ' HG ' ' A' ' 82' ' ' LEU . 55.6 mt -103.48 133.84 46.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.734 -173.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -105.87 113.88 27.7 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.03 114.41 2.56 Favored Glycine 0 N--CA 1.424 -2.156 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -139.65 134.79 32.51 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -85.29 135.76 33.78 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 123.277 0.361 . . . . 0.0 110.261 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 50.3 ttm -102.12 -32.71 9.99 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 120.957 0.408 . . . . 0.0 110.686 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.253 1.267 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.831 -178.506 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.85 -22.52 62.3 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.383 1.087 . . . . 0.0 109.094 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -89.01 103.51 16.11 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 113.453 -1.703 . . . . 0.0 108.66 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.3 m -95.21 -62.54 1.29 Allowed 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.825 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.04 52.88 0.04 OUTLIER Glycine 0 CA--C 1.486 -1.773 0 C-N-CA 119.276 -1.44 . . . . 0.0 113.537 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -164.95 120.93 1.42 Allowed 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 123.551 0.74 . . . . 0.0 109.064 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m -135.24 151.55 30.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -130.81 149.46 52.44 Favored 'General case' 0 N--CA 1.415 -2.196 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.57 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -137.98 149.31 46.01 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.618 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 47.6 ttm -136.51 136.48 39.41 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -154.37 133.06 6.97 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-O 119.832 -0.128 . . . . 0.0 111.181 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.43 132.32 17.48 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 N-CA-C 108.259 -1.477 . . . . 0.0 108.259 168.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -100.01 140.52 34.12 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 120.58 0.229 . . . . 0.0 110.558 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.429 HG23 ' H ' ' A' ' 16' ' ' GLU . 63.7 mt -103.44 124.49 57.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.7 t -62.77 -11.54 18.4 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.858 0.863 . . . . 0.0 111.895 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.429 ' H ' HG23 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -73.96 -45.28 51.17 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -110.5 -40.65 4.56 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.983 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 21' ' ' SER . 15.8 m -72.58 0.08 11.49 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 m -74.62 -16.24 60.79 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HG3' ' OE2' ' A' ' 68' ' ' GLU . 54.8 tttp -125.84 -28.19 3.25 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 118.93 -1.108 . . . . 0.0 111.176 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 18' ' ' SER . 46.4 m -151.98 148.75 28.1 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.516 HD11 ' CH2' ' A' ' 67' ' ' TRP . 5.6 tt -101.73 119.21 38.43 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -82.02 131.57 35.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.714 -178.699 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 48.0 mm -96.06 126.45 44.42 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.71 144.6 86.0 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.931 2.42 . . . . 0.0 112.267 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -62.17 -32.43 73.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.506 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.22 -31.2 69.05 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.393 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -80.61 -29.28 36.85 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.42 -38.28 84.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.877 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.04 -28.76 70.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -67.98 -27.42 66.56 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.816 -175.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -157.17 116.01 1.98 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 120.406 -0.518 . . . . 0.0 112.101 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.51 145.04 32.96 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.284 1.989 . . . . 0.0 109.756 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.86 143.0 16.26 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.91 156.39 64.57 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.543 2.162 . . . . 0.0 110.045 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -68.72 115.08 27.05 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.676 0.274 . . . . 0.0 111.221 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -95.73 160.02 1.47 Allowed 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 123.308 2.672 . . . . 0.0 111.186 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -90.19 -62.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.7 p -126.76 151.38 48.29 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.965 0.412 . . . . 0.0 111.997 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 90' ' ' ARG . 22.1 m -136.52 162.34 35.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -113.59 143.99 43.63 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.033 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -108.86 120.1 41.5 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.63 137.61 43.2 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.205 0.526 . . . . 0.0 111.16 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.43 ' OD2' ' HB3' ' A' ' 46' ' ' SER . 0.1 OUTLIER -112.46 145.87 39.44 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.048 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -73.43 -19.14 61.04 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.703 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.43 ' HB3' ' OD2' ' A' ' 44' ' ' ASP . 38.6 t -74.79 -36.77 62.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.37 -0.32 2.23 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.204 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 97.7 mtt180 -89.53 157.94 17.87 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.241 0.543 . . . . 0.0 111.642 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.8 p -142.56 136.64 29.45 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.501 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -121.08 131.77 54.47 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.5 m -96.92 120.24 36.89 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.492 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 7.7 p -110.29 153.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -100.78 122.12 42.85 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.5 ttt -110.02 130.44 55.53 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.422 -170.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -121.16 125.47 47.26 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.339 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -106.9 126.63 52.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -133.36 97.45 3.97 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.025 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.73 -97.75 0.04 OUTLIER Glycine 0 C--N 1.304 -1.218 0 O-C-N 124.174 0.921 . . . . 0.0 115.012 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -95.81 -6.5 39.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.5 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -138.13 163.69 31.02 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 67.2 t -134.46 145.39 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -128.34 132.4 48.6 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.679 0.276 . . . . 0.0 110.569 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.98 103.39 15.31 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.7 p -94.01 -106.49 0.13 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -169.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.15 136.11 27.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.305 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 108.75 -47.2 1.07 Allowed Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.516 ' CH2' HD11 ' A' ' 22' ' ' LEU . 36.5 t-105 -62.46 -31.95 72.75 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 41.1 tt0 -61.78 -33.65 74.48 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 113.548 -1.66 . . . . 0.0 109.917 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -69.07 -37.76 78.67 Favored 'General case' 0 C--O 1.197 -1.68 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.414 ' CE2' HD22 ' A' ' 76' ' ' LEU . 85.5 t80 -73.0 -47.47 44.87 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 123.706 0.802 . . . . 0.0 110.683 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -61.06 -44.76 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.62 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 31.6 mmmt -72.41 -48.25 42.79 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.403 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.85 -38.15 67.15 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -84.39 -18.72 35.19 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.34 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 64.18 95.18 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.86 0.838 . . . . 0.0 112.067 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.414 HD22 ' CE2' ' A' ' 70' ' ' PHE 0.261 1.5 pp -152.18 134.75 15.35 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.192 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -132.96 170.89 14.69 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -54.47 126.15 22.35 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.244 0.545 . . . . 0.0 111.112 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.25 -21.29 4.89 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 101' ' ' MET . 92.0 mttt -94.72 163.34 13.4 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -134.01 138.86 45.66 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.941 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -136.4 149.52 48.34 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.92 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -127.29 135.77 51.02 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -107.23 129.94 54.8 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.432 0.158 . . . . 0.0 111.057 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.21 125.89 60.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.412 ' HE2' ' CE2' ' A' ' 92' ' ' PHE . 58.5 m-85 -109.58 126.91 54.09 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -87.5 9.36 21.2 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 72.24 81.31 0.14 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.892 1.277 . . . . 0.0 109.304 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 21.8 t70 -179.2 -160.75 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 -174.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.468 ' HB2' HG11 ' A' ' 40' ' ' VAL . 34.1 ptt180 -104.78 23.08 14.01 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -103.65 117.79 35.22 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.107 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.412 ' CE2' ' HE2' ' A' ' 86' ' ' TYR . 2.0 m-85 -105.83 122.61 46.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.764 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -100.29 116.7 32.88 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.88 121.3 49.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.759 0.79 . . . . 0.0 112.913 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.1 mt -105.9 116.25 49.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.1 mt -99.63 140.29 19.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -84.36 124.51 31.37 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.6 -167.33 42.52 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 107.756 -2.137 . . . . 0.0 107.756 -169.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -86.53 -47.55 9.14 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.255 -1.378 . . . . 0.0 107.609 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 42.2 t30 171.86 113.76 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.447 ' O ' ' HE2' ' A' ' 80' ' ' LYS . 28.0 ttt -72.36 89.31 1.22 Allowed 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.361 0.601 . . . . 0.0 109.728 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.291 -1.938 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -177.275 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.507 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.28 -16.37 59.8 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 1' ' ' MET . 19.6 t70 -105.46 168.44 9.09 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.4 m -77.22 -28.6 53.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 118.93 0.787 . . . . 0.0 110.386 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.64 94.23 0.2 Allowed Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -76.31 119.74 20.61 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 123.211 0.605 . . . . 0.0 111.06 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.2 139.91 50.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -137.65 163.7 30.63 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -151.4 149.53 29.41 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.757 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 25.5 ptm -132.03 142.33 49.53 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -153.04 159.68 31.91 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.72 146.6 97.01 Favored 'Trans proline' 0 C--O 1.258 1.525 0 C-N-CA 122.894 2.396 . . . . 0.0 114.455 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -105.13 136.58 44.36 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 16' ' ' GLU . 6.4 tp -122.42 125.01 72.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 175.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' SER . 19.5 m -61.67 -20.43 63.42 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 121.179 0.514 . . . . 0.0 111.316 -176.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' H ' HG13 ' A' ' 14' ' ' ILE . 34.6 tt0 -79.66 -44.33 21.09 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.451 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 13.4 mptt -95.94 -40.19 9.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.11 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 21' ' ' SER . 25.8 m -77.07 10.11 2.57 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.319 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 15' ' ' SER . 37.9 t -70.19 -27.23 64.34 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 171.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -135.99 -29.4 1.02 Allowed 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.826 179.048 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' A' ' 18' ' ' SER . 29.0 p -142.38 153.72 44.02 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -175.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 34.7 mt -89.6 126.18 35.52 Favored 'General case' 0 CA--C 1.481 -1.711 0 CA-C-O 121.318 0.58 . . . . 0.0 110.095 171.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.01 108.92 20.69 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -177.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 61' ' ' VAL . 66.8 mt -106.41 120.26 49.16 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.42 158.23 37.12 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.5 2.8 . . . . 0.0 114.156 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.65 -39.19 64.83 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.376 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.54 -36.85 79.68 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.721 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -88.47 -29.17 20.36 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.567 -0.453 . . . . 0.0 109.81 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.12 -45.61 93.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.685 0.755 . . . . 0.0 109.107 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.88 -21.58 63.32 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.815 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -67.92 -28.05 67.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.238 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -149.15 84.33 6.3 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-O 121.77 0.795 . . . . 0.0 111.711 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -86.6 134.34 3.94 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 C-N-CA 121.896 1.73 . . . . 0.0 111.559 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.47 161.13 29.94 Favored Pre-proline 0 C--N 1.275 -2.672 0 CA-C-N 114.051 -1.431 . . . . 0.0 107.199 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -55.23 140.18 81.22 Favored 'Trans proline' 0 C--N 1.354 0.849 0 N-CA-C 107.603 -1.73 . . . . 0.0 107.603 170.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.438 ' HB3' ' HB2' ' A' ' 56' ' ' LYS . 54.1 p90 -69.09 124.2 89.86 Favored Pre-proline 0 N--CA 1.413 -2.302 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -171.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -84.86 160.51 11.97 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 123.08 2.52 . . . . 0.0 108.796 172.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.04 -46.83 13.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.888 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 m -128.73 151.89 49.03 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.702 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 m -146.95 163.24 8.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 125.543 1.537 . . . . 0.0 107.857 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -118.91 143.26 47.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.3 mt -109.26 120.94 44.04 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.49 139.54 47.98 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.05 0.452 . . . . 0.0 110.79 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -120.86 156.02 32.87 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.896 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.33 -12.24 59.93 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 m -91.21 8.84 33.84 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.242 0.544 . . . . 0.0 110.393 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.01 -6.87 69.56 Favored Glycine 0 CA--C 1.497 -1.058 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.559 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -73.53 146.84 44.53 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.6 p -152.11 137.8 17.88 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -132.06 115.73 16.16 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.8 m -86.02 114.76 23.16 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.492 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 9.5 p -116.68 152.87 18.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.403 -172.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -101.07 129.0 46.87 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.419 0.628 . . . . 0.0 110.796 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.457 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 25.2 ttt -110.0 138.13 46.81 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.172 -172.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.2 OUTLIER -130.91 127.09 37.78 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.938 175.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 27.3 mmmt -92.73 116.8 29.35 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 169.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -144.79 103.86 3.95 Favored 'General case' 0 C--N 1.269 -2.929 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.046 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.85 -106.07 1.28 Allowed Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.885 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.44 -18.02 26.14 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.153 -0.524 . . . . 0.0 111.464 -175.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -137.01 170.39 16.19 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -172.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 58.8 t -113.56 129.22 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 174.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -118.32 130.48 56.05 Favored 'General case' 0 C--N 1.28 -2.428 0 C-N-CA 119.086 -1.045 . . . . 0.0 108.959 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 92.5 mt -103.06 102.96 13.0 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.1 p -87.54 -127.01 0.05 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.68 139.68 15.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.681 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 115.26 -44.13 1.54 Allowed Glycine 0 N--CA 1.417 -2.629 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -172.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -67.98 -27.98 67.04 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.46 ' HA ' HG11 ' A' ' 71' ' ' VAL 0.264 0.0 OUTLIER -68.17 -26.37 65.72 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.922 -179.733 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -72.25 -32.72 66.94 Favored 'General case' 0 C--O 1.196 -1.756 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -70.8 -51.64 25.57 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 122.959 0.504 . . . . 0.0 110.161 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 7.7 p -59.61 -39.52 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.2 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' A' ' 72' ' ' LYS . 9.7 mmpt? -72.5 -48.01 44.03 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.487 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.49 -39.65 74.06 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.05 -18.75 24.05 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.509 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.5 t30 50.98 89.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.085 1.354 . . . . 0.0 112.965 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.8 mt -129.18 169.12 15.18 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.045 0.45 . . . . 0.0 111.475 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -143.6 170.39 15.93 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 124.363 1.065 . . . . 0.0 108.652 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -65.58 139.97 58.49 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.619 0.574 . . . . 0.0 109.57 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.05 -36.73 3.33 Favored Glycine 0 C--N 1.299 -1.488 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -93.22 147.31 23.01 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -124.39 158.76 31.96 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.497 -170.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.498 ' CD1' HG23 ' A' ' 96' ' ' ILE . 1.8 mm? -119.1 129.33 55.0 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.536 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.517 ' CG ' ' HB ' ' A' ' 95' ' ' ILE . 19.0 pt20 -111.87 124.77 53.06 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 169.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -107.08 130.48 54.67 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.7 mt -96.92 123.2 49.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -106.68 129.59 54.55 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.48 -167.77 1.84 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -91.64 -10.35 40.7 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.801 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -102.15 -162.43 0.92 Allowed 'General case' 0 N--CA 1.41 -2.47 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.217 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -94.94 36.31 1.21 Allowed 'General case' 0 C--N 1.283 -2.292 0 CA-C-O 121.047 0.451 . . . . 0.0 111.663 -170.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.6 p -113.09 117.55 32.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.956 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -105.68 132.93 51.22 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -109.24 122.83 48.17 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.25 126.96 56.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.517 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 40.1 mm -116.77 118.09 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.498 HG23 ' CD1' ' A' ' 82' ' ' LEU . 31.4 pt -93.41 139.05 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.29 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -91.05 117.15 29.36 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -78.33 63.66 3.6 Favored Glycine 0 C--N 1.311 -0.85 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -100.58 106.05 17.52 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-O 120.868 0.366 . . . . 0.0 110.085 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -175.72 -58.69 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 23.5 ptm -166.48 -53.22 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.07 -1.423 . . . . 0.0 108.535 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 74.8 m . . . . . 0 N--CA 1.439 -1.014 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.646 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 CA--C 1.5 -0.973 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.08 99.21 3.41 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -152.6 113.32 4.13 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.9 m -97.43 -15.18 20.76 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.375 0.607 . . . . 0.0 110.375 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.42 -15.72 60.65 Favored Glycine 0 N--CA 1.461 0.333 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -159.93 119.76 2.91 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.76 142.11 44.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.635 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -121.55 144.4 48.75 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -142.15 147.5 36.75 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -139.84 139.1 36.25 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.99 159.49 31.76 Favored Pre-proline 0 C--N 1.312 -1.045 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.12 147.25 93.98 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.136 2.557 . . . . 0.0 113.082 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' A' ' 82' ' ' LEU . 25.4 m-85 -119.74 139.7 51.88 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.48 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.9 mt -104.08 123.47 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.463 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 23.9 t -61.07 -29.98 70.06 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.12 0.263 . . . . 0.0 111.59 -173.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.84 -43.89 97.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.066 0.46 . . . . 0.0 110.448 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -80.68 -40.34 25.62 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.39 0.614 . . . . 0.0 109.521 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -72.06 -5.53 35.88 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.912 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.2 t -70.9 -23.18 62.23 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 120.884 0.373 . . . . 0.0 110.08 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -127.22 -44.41 1.59 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.595 -174.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.5 p -136.68 151.03 48.82 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 4.1 tt -86.47 114.04 22.9 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.16 126.31 31.91 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.923 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -109.08 127.68 26.83 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.69 137.04 79.5 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.597 2.198 . . . . 0.0 111.148 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.518 ' HA ' HD21 ' A' ' 29' ' ' ASN . 53.3 tp -54.05 -38.74 65.54 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.389 0.676 . . . . 0.0 112.145 -175.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.0 -28.57 72.28 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.578 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 64.2 t80 -87.37 -22.95 24.74 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.518 HD21 ' HA ' ' A' ' 26' ' ' LEU . 52.9 m-80 -73.71 -23.88 59.85 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.787 0.803 . . . . 0.0 109.423 175.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.97 -16.53 59.32 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.421 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 65.6 t80 -77.11 -27.03 53.93 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.108 -177.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -140.88 104.5 6.25 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.76 136.89 15.55 Favored 'Trans proline' 0 N--CA 1.439 -1.699 0 C-N-CA 122.015 1.81 . . . . 0.0 108.064 168.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.17 145.89 19.36 Favored Pre-proline 0 C--N 1.28 -2.434 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.698 -173.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.1 156.02 36.55 Favored 'Trans proline' 0 C--O 1.241 0.655 0 C-N-CA 122.902 2.402 . . . . 0.0 110.085 173.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -69.15 115.28 30.35 Favored Pre-proline 0 N--CA 1.429 -1.516 0 CA-C-O 120.858 0.361 . . . . 0.0 111.874 -176.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -93.88 161.0 2.22 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 123.355 2.704 . . . . 0.0 111.122 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.8 mm -101.25 -53.19 7.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.1 p -129.13 151.43 49.81 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.618 0.723 . . . . 0.0 112.3 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.15 145.84 35.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -109.85 125.86 53.22 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.426 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.17 124.71 52.05 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.726 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.73 142.95 33.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.232 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -110.16 154.63 23.06 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.405 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -59.16 -30.1 67.92 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 124.984 1.313 . . . . 0.0 111.989 -175.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.2 t -82.47 -12.61 57.71 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.732 0.301 . . . . 0.0 110.793 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.32 -2.93 25.17 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.225 -0.988 . . . . 0.0 115.28 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -88.33 149.39 23.79 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 118.138 0.969 . . . . 0.0 110.201 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 p -118.7 146.28 44.85 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.608 0.242 . . . . 0.0 111.538 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.476 ' CE3' ' HD1' ' A' ' 70' ' ' PHE . 23.0 m-90 -131.57 124.95 31.08 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.861 173.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.0 m -92.34 114.03 26.47 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.8 t -105.46 157.6 6.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.234 -174.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -100.0 120.32 39.63 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.7 ttt -115.69 130.26 56.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.954 -173.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -130.7 135.67 48.05 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.477 ' HZ2' ' HB3' ' A' ' 56' ' ' LYS . 1.4 mmmp? -92.73 129.55 38.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -140.12 98.72 3.51 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.134 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.61 -99.31 0.12 Allowed Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.585 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -89.42 -23.29 22.19 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.512 -0.344 . . . . 0.0 110.563 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -134.69 169.79 16.79 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -168.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.402 ' HB ' ' OD1' ' A' ' 29' ' ' ASN . 42.1 t -134.89 142.19 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.81 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -138.09 144.64 41.0 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 6.2 mp -91.44 106.37 18.44 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 172.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.6 p -72.56 -155.23 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.939 -1.028 . . . . 0.0 113.149 -173.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 p -57.78 128.26 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-O 121.743 0.782 . . . . 0.0 111.2 -172.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 136.66 -38.6 1.74 Allowed Glycine 0 CA--C 1.485 -1.79 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -60.87 -26.85 67.7 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.143 0.973 . . . . 0.0 108.864 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.513 ' O ' HG13 ' A' ' 71' ' ' VAL . 33.5 tt0 -56.61 -36.65 69.67 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.887 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.439 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 87.5 m-20 -66.41 -36.25 82.35 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.476 ' HD1' ' CE3' ' A' ' 50' ' ' TRP . 92.2 t80 -72.68 -44.9 61.2 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.909 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 68' ' ' GLU . 7.3 p -62.62 -43.83 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 68' ' ' GLU 0.324 0.0 OUTLIER -72.37 -38.45 68.52 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 177.76 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -77.54 -39.36 46.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -84.18 -19.59 33.81 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.9 t30 65.61 90.3 0.09 Allowed 'General case' 0 C--O 1.247 0.969 0 C-N-CA 124.753 1.221 . . . . 0.0 110.935 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.5 mt -130.72 139.81 50.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.884 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.34 171.1 14.88 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.463 ' H ' ' HB2' ' A' ' 15' ' ' SER . 4.5 p30 -65.99 136.95 56.75 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.217 0.532 . . . . 0.0 110.629 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.31 -30.09 3.93 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -89.39 153.35 20.92 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.402 ' C ' HD13 ' A' ' 82' ' ' LEU . 77.4 m-85 -122.74 147.21 46.75 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -178.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.404 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 6.1 mp -122.34 134.09 54.65 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.136 -177.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -111.07 126.45 54.82 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -114.82 126.93 55.38 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.2 mt -98.06 116.97 42.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.421 ' HA ' ' CD1' ' A' ' 92' ' ' PHE . 64.8 m-85 -106.87 123.92 48.87 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.305 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -105.59 -161.52 0.81 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -93.92 13.55 22.35 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.892 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 13.8 t70 -102.87 -162.91 0.95 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.446 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER -111.44 23.72 13.64 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 m -117.97 118.65 32.54 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 86' ' ' TYR . 19.1 m-85 -122.81 152.4 40.72 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.326 -177.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -111.15 126.49 54.9 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.952 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.15 129.88 55.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.53 0.681 . . . . 0.0 111.44 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.61 119.8 62.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.5 pt -93.26 139.79 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 CA-C-O 121.072 0.463 . . . . 0.0 110.557 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -92.99 112.21 24.09 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 128.79 172.11 13.11 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -156.81 -175.8 5.63 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -57.49 111.04 0.98 Allowed 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.312 0.382 . . . . 0.0 111.05 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.5 tpt 178.11 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.425 -1.706 0 CA-C-N 114.194 -1.366 . . . . 0.0 109.191 176.858 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.675 0 CA-C-O 121.855 0.836 . . . . 0.0 111.586 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.34 -166.53 1.37 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -66.92 105.59 1.66 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.4 m -79.7 -30.8 41.15 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.097 -172.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.36 -143.87 8.43 Favored Glycine 0 N--CA 1.426 -1.994 0 C-N-CA 119.713 -1.232 . . . . 0.0 113.261 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 53.34 77.84 0.16 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 125.224 1.41 . . . . 0.0 112.094 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.5 m -106.78 146.38 13.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.399 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -114.51 144.17 43.79 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.123 0.487 . . . . 0.0 110.392 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -145.5 148.26 33.04 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.497 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 26.7 ptm -139.17 152.22 47.23 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.377 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -154.65 158.66 32.26 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.77 146.21 71.77 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.877 1.718 . . . . 0.0 110.634 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -84.43 122.68 29.31 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.2 mm -110.47 117.06 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.138 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 p -60.61 -12.32 9.78 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -76.28 -44.7 35.95 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -105.3 -42.54 5.23 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.402 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.649 ' HA ' ' O ' ' A' ' 21' ' ' SER . 9.7 m -72.01 0.61 8.96 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.331 -173.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.498 ' O ' HG13 ' A' ' 71' ' ' VAL . 27.7 t -75.04 -28.12 60.31 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 175.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -136.9 -14.4 1.6 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.649 ' O ' ' HA ' ' A' ' 18' ' ' SER . 50.3 m -149.15 169.56 20.43 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 23' ' ' GLU . 2.6 tm? -128.17 133.57 48.93 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.354 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' N ' HD11 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -98.7 129.39 45.16 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.322 -174.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' A' ' 61' ' ' VAL . 46.4 mm -113.05 129.71 24.26 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -65.48 141.96 69.73 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 122.41 2.073 . . . . 0.0 110.061 172.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 6.7 mp -63.23 -22.92 67.18 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.69 -36.41 91.62 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.369 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 68.0 t80 -83.89 -32.92 24.91 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . 17.6 t30 -60.55 -47.89 84.2 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.374 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.77 -11.95 60.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.447 -175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 82.3 t80 -75.17 -25.9 58.67 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.135 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.11 91.93 18.84 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.57 135.88 7.17 Favored 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 122.093 1.862 . . . . 0.0 109.704 171.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.27 160.74 30.58 Favored Pre-proline 0 C--N 1.28 -2.42 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.38 141.95 80.82 Favored 'Trans proline' 0 C--O 1.246 0.881 0 N-CA-C 106.914 -1.995 . . . . 0.0 106.914 166.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -69.02 120.78 78.73 Favored Pre-proline 0 N--CA 1.414 -2.253 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.355 -173.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.59 144.62 50.14 Favored 'Trans proline' 0 C--O 1.256 1.424 0 C-N-CA 122.33 2.02 . . . . 0.0 110.629 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.4 mm -80.9 -57.34 4.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 m -126.94 156.5 41.41 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.168 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 90' ' ' ARG . 74.5 t -137.18 149.18 25.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 125.013 1.325 . . . . 0.0 107.827 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -121.95 145.83 47.73 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.06 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.42 ' CD2' ' HB2' ' A' ' 92' ' ' PHE . 66.3 mt -108.93 138.45 45.25 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.45 153.25 19.86 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.597 0.713 . . . . 0.0 112.905 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.5 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 9.0 t70 -111.25 161.8 15.64 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.992 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.463 ' HH ' ' HA ' ' A' ' 95' ' ' ILE . 28.5 m-85 -70.22 -32.9 70.99 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.437 -173.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 m -102.6 -56.45 2.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.57 -6.43 0.03 OUTLIER Glycine 0 C--N 1.321 -0.274 0 C-N-CA 118.332 -1.89 . . . . 0.0 115.53 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HE ' ' HA ' ' A' ' 48' ' ' ARG . 1.8 mmp_? -73.17 157.69 36.71 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 118.104 0.952 . . . . 0.0 110.918 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.4 m -144.07 134.74 24.95 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.5 ' CH2' ' HB2' ' A' ' 44' ' ' ASP . 19.4 m-90 -112.74 117.52 32.43 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.836 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.6 m -85.89 114.54 22.89 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.681 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.55 154.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.39 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -104.31 118.78 37.46 Favored 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 119.756 -0.778 . . . . 0.0 108.99 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.415 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 55.8 ttp -111.14 146.48 36.77 Favored 'General case' 0 CA--C 1.475 -1.919 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.544 ' HB2' ' HZ2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -140.48 132.37 27.62 Favored 'General case' 0 N--CA 1.406 -2.659 0 C-N-CA 117.814 -1.554 . . . . 0.0 112.065 -176.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.7 ' HD2' ' CG1' ' A' ' 61' ' ' VAL . 29.1 mmmt -91.19 107.72 19.39 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 170.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -120.59 98.8 6.2 Favored 'General case' 0 C--N 1.252 -3.674 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.42 -108.79 2.6 Favored Glycine 0 N--CA 1.422 -2.254 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.213 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.71 2.25 20.0 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 122.969 -0.136 . . . . 0.0 110.926 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -131.31 156.24 45.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.7 ' CG1' ' HD2' ' A' ' 56' ' ' LYS . 16.3 m -122.51 134.46 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 CA-C-O 121.699 0.762 . . . . 0.0 112.221 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -142.81 139.63 31.02 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 54' ' ' MET . 5.6 mp -90.49 109.1 20.24 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.4 p -79.68 -152.25 0.07 Allowed 'General case' 0 N--CA 1.425 -1.723 0 O-C-N 123.846 0.716 . . . . 0.0 111.74 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.13 143.26 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.173 0.989 . . . . 0.0 111.147 -175.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.61 -38.45 2.44 Favored Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -59.64 -23.93 63.44 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.97 0.89 . . . . 0.0 110.24 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.46 ' HA ' HG12 ' A' ' 71' ' ' VAL . 39.1 tt0 -64.03 -26.04 68.39 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.299 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.52 -37.32 87.13 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.266 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.408 ' HA ' ' CD1' ' A' ' 50' ' ' TRP . 66.7 t80 -73.17 -50.13 24.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.699 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 19' ' ' SER . 9.9 p -62.2 -45.1 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.372 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.02 -41.53 67.43 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.89 -39.82 95.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.983 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.54 -13.86 33.75 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.288 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.8 t30 55.29 79.87 0.14 Allowed 'General case' 0 C--O 1.235 0.305 0 O-C-N 124.119 0.887 . . . . 0.0 109.958 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 pp -136.34 158.64 43.94 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.74 174.96 10.35 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.112 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -51.65 142.18 15.05 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 124.051 0.845 . . . . 0.0 111.187 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.04 -27.22 5.93 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -95.21 163.19 13.38 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -128.8 144.1 51.08 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.546 -175.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 0.9 OUTLIER -136.65 145.86 45.29 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.312 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.497 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 69.7 mt-30 -111.53 142.78 43.37 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -108.61 117.42 34.12 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.04 115.8 41.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.437 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 92.7 t80 -119.57 124.98 47.69 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.641 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -114.3 162.05 17.09 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -66.46 89.07 0.14 Allowed 'General case' 0 C--O 1.244 0.777 0 CA-C-N 119.196 0.907 . . . . 0.0 111.83 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -165.36 -157.81 0.35 Allowed 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.506 ' O ' HG11 ' A' ' 40' ' ' VAL . 68.6 mtm180 -124.98 30.43 5.88 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 t -136.71 141.43 43.07 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.467 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 64.9 m-85 -115.62 148.61 39.44 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.354 0.597 . . . . 0.0 111.187 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -108.66 131.57 54.77 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 172.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 61.9 t -112.24 130.71 65.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.034 0.445 . . . . 0.0 112.147 -173.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.463 ' HA ' ' HH ' ' A' ' 45' ' ' TYR . 74.6 mt -105.78 116.14 48.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -100.76 140.24 20.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.14 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -104.26 112.63 25.73 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.777 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 174.17 -122.17 0.88 Allowed Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -98.72 -37.71 9.38 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 67.84 113.54 0.04 OUTLIER 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.719 1.208 . . . . 0.0 111.617 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -81.55 175.65 10.33 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.899 -178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.424 -1.733 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.39 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 tmm? . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.48 81.12 0.13 Allowed 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.89 0.744 . . . . 0.0 110.108 -177.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 65.04 87.66 0.11 Allowed 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.352 -173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.0 m -79.77 -35.71 38.25 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.325 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.19 -178.29 19.65 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.39 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.402 ' H ' ' HA ' ' A' ' 87' ' ' ASP . 39.0 tt0 60.84 85.64 0.11 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.13 0.972 . . . . 0.0 112.162 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.5 m -113.19 159.27 13.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -130.47 143.12 50.56 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.532 ' CZ ' ' HG3' ' A' ' 25' ' ' PRO . 79.1 t80 -142.2 148.87 38.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 82.6 mtp -123.66 140.57 52.86 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -144.38 157.96 55.26 Favored Pre-proline 0 C--N 1.31 -1.144 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.759 178.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.09 147.11 11.61 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.703 2.269 . . . . 0.0 110.363 174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -87.34 126.46 34.87 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.29 117.71 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.6 p -65.9 -14.62 61.85 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -83.82 -37.1 22.96 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.94 0.4 . . . . 0.0 111.104 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -106.2 -41.79 5.25 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.015 -174.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' SER . 19.5 m -77.96 0.41 24.4 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.874 -173.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.9 m -75.38 -18.31 59.98 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.848 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.8 -23.22 0.86 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.975 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 18' ' ' SER . 21.1 m -132.52 142.07 49.03 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.22 0.533 . . . . 0.0 111.523 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 4.1 tt -93.89 126.83 39.32 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -95.83 114.38 26.1 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 123.452 0.701 . . . . 0.0 110.764 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.9 mt -106.36 126.31 30.78 Favored Pre-proline 0 C--O 1.248 1.022 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.083 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.532 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 9.4 Cg_endo -53.55 139.96 65.55 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 123.706 2.937 . . . . 0.0 113.335 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 6.3 tt -58.85 -43.7 90.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.817 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.07 -24.16 71.62 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.299 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.544 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 73.6 t80 -81.73 -34.48 30.5 Favored 'General case' 0 C--O 1.212 -0.871 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.481 HD21 ' C ' ' A' ' 59' ' ' GLU . 41.2 t30 -76.28 -33.51 59.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.295 0.569 . . . . 0.0 109.949 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.44 -24.26 66.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.895 0.855 . . . . 0.0 109.572 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.544 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 24.7 t80 -68.32 -26.4 65.6 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.181 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -143.23 98.32 5.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-O 121.223 0.535 . . . . 0.0 112.313 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.92 133.72 10.27 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 N-CA-C 110.095 -0.771 . . . . 0.0 110.095 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.13 160.33 31.09 Favored Pre-proline 0 C--N 1.274 -2.716 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.689 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.99 144.26 63.44 Favored 'Trans proline' 0 C--O 1.246 0.916 0 N-CA-C 107.467 -1.782 . . . . 0.0 107.467 168.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.431 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 45.1 p90 -68.93 138.48 90.22 Favored Pre-proline 0 N--CA 1.418 -2.029 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -173.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.7 160.76 27.93 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.766 2.311 . . . . 0.0 109.778 173.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.417 ' N ' HD13 ' A' ' 38' ' ' ILE . 2.2 mp -93.22 -37.5 8.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -150.64 152.86 34.64 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.62 163.95 22.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 124.513 1.125 . . . . 0.0 108.846 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -120.11 137.44 54.14 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.261 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.5 mt -108.7 123.42 48.96 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.97 141.84 34.18 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.262 0.553 . . . . 0.0 110.994 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -113.23 145.6 40.73 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -58.43 -27.12 64.03 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.7 t -79.59 -4.58 52.17 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.105 0.478 . . . . 0.0 110.511 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.46 2.16 50.43 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.005 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -82.55 150.66 26.8 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.3 p -144.44 136.64 26.33 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.196 0.522 . . . . 0.0 111.709 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -120.1 123.94 44.61 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.511 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.3 m -89.93 117.73 28.96 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.16 157.94 33.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.613 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -99.68 120.13 39.21 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.046 0.45 . . . . 0.0 110.624 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.411 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 23.7 ttt -122.3 124.16 43.1 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 124.277 1.031 . . . . 0.0 110.044 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -125.51 130.88 52.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.886 0.374 . . . . 0.0 111.916 178.603 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.431 ' H ' ' HB2' ' A' ' 36' ' ' PHE . 55.9 tttp -98.05 122.68 41.47 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 122.121 0.963 . . . . 0.0 109.451 173.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -147.7 98.66 3.0 Favored 'General case' 0 C--N 1.252 -3.65 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.51 -164.29 30.42 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -174.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.481 ' C ' HD21 ' A' ' 29' ' ' ASN . 14.9 mm-40 -90.97 2.39 56.32 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.44 142.68 49.02 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.4 HG23 ' ND2' ' A' ' 29' ' ' ASN . 95.6 t -114.49 131.84 65.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.136 0.493 . . . . 0.0 111.043 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 97.4 m-85 -119.42 131.55 55.67 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 21' ' ' SER . 6.5 mp -86.83 112.3 21.6 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 p -66.11 -164.49 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.138 0 O-C-N 124.777 1.298 . . . . 0.0 112.902 -176.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.24 143.12 10.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.493 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.57 -38.61 2.58 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -173.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 20.1 t-105 -58.48 -24.42 60.37 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.015 0.912 . . . . 0.0 109.636 173.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 71' ' ' VAL . 11.5 pt-20 -57.74 -30.0 65.23 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.39 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -62.24 -35.86 80.23 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.129 0.49 . . . . 0.0 110.668 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -74.29 -48.01 31.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.603 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 68' ' ' GLU . 9.9 p -64.7 -40.38 88.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.19 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -71.07 -33.02 69.83 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.621 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.31 -40.14 45.37 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.062 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 100' ' ' ASN . 13.1 m120 -97.94 -1.74 42.14 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.407 ' HB2' ' ND2' ' A' ' 100' ' ' ASN . 14.2 m120 42.22 80.1 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -176.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.4 mt -103.23 147.35 27.15 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.21 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.8 171.65 13.92 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.107 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.11 138.3 58.51 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.15 -19.66 24.63 Favored Glycine 0 C--N 1.301 -1.392 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -173.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -96.58 159.22 15.05 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -134.1 150.95 51.19 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -173.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HG ' HG21 ' A' ' 96' ' ' ILE . 4.6 mp -130.35 137.11 49.74 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.454 ' CG ' ' HB ' ' A' ' 95' ' ' ILE . 11.6 pt20 -118.75 138.57 52.57 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -116.32 131.0 57.07 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.324 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 65.2 mt -101.54 116.03 44.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 172.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.659 ' CZ ' ' HA ' ' A' ' 88' ' ' ARG . 48.8 t80 -122.07 123.81 42.46 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.757 -173.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.402 ' HA ' ' H ' ' A' ' 6' ' ' GLU . 25.3 m-20 -84.26 -1.38 55.16 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.659 ' HA ' ' CZ ' ' A' ' 86' ' ' TYR . 67.8 ttt180 70.08 81.94 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -171.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 20.4 t70 -177.26 -155.24 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 -167.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.489 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -107.38 11.15 29.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.3 m -109.64 126.37 53.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.54 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -127.62 135.13 49.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.641 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.435 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 84.7 m-85 -109.25 123.49 49.35 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.54 124.15 64.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.433 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.454 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 2.4 mp -114.05 116.85 53.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.421 HG21 ' HG ' ' A' ' 82' ' ' LEU . 35.1 pt -100.8 140.64 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 123.218 0.607 . . . . 0.0 112.231 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -101.52 134.78 44.1 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.33 77.57 1.22 Allowed Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -86.33 96.39 9.96 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 122.786 -0.243 . . . . 0.0 111.41 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 74' ' ' ASN . 5.9 t30 -81.11 104.21 11.44 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -112.58 112.73 24.47 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -177.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 43.5 t . . . . . 0 N--CA 1.428 -1.534 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -178.742 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 CA--C 1.502 -0.874 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.79 88.19 2.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 175.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -108.23 88.51 2.75 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.641 0.734 . . . . 0.0 110.221 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.6 m -93.59 -28.15 16.2 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.69 121.6 0.83 Allowed Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.896 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.84 136.89 15.51 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.904 0.352 . . . . 0.0 110.369 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.8 m -139.99 140.73 35.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -130.64 143.05 50.49 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -149.7 147.0 27.54 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.624 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.423 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 23.3 ptp -141.61 134.93 29.46 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.418 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.6 159.57 31.53 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 166.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.627 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 33.4 Cg_exo -60.82 132.73 43.98 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 N-CA-C 108.295 -1.463 . . . . 0.0 108.295 173.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -86.01 140.26 30.45 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.354 -175.082 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.432 HG23 ' H ' ' A' ' 16' ' ' GLU . 2.0 mp -90.69 125.08 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.467 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 11.9 p -60.57 -19.03 56.31 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.826 0.85 . . . . 0.0 112.708 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 14' ' ' ILE . 41.4 tt0 -63.48 -44.78 93.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.703 176.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -87.73 -40.47 14.08 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.487 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.577 ' HB2' ' CD1' ' A' ' 13' ' ' PHE . 35.6 t -61.96 -10.0 8.53 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 124.119 0.887 . . . . 0.0 112.285 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.5 p -57.85 -43.49 85.93 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.899 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -144.38 -2.05 0.89 Allowed 'General case' 0 C--N 1.344 0.359 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -148.11 153.79 39.33 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 118.943 0.792 . . . . 0.0 112.476 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 5.2 tt -101.21 113.42 26.44 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -71.54 113.99 9.15 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.162 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 61' ' ' VAL . 65.6 mt -93.7 128.5 41.65 Favored Pre-proline 0 C--N 1.288 -2.096 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.448 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 58.7 Cg_exo -53.71 137.74 67.32 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.959 2.439 . . . . 0.0 112.198 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.429 ' O ' HD21 ' A' ' 26' ' ' LEU . 5.8 tt -64.67 -32.4 74.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.48 -29.39 73.31 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.614 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 25' ' ' PRO . 46.6 t80 -65.41 -49.59 68.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -65.8 -39.75 91.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.567 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.06 -38.17 87.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.395 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -73.15 -28.68 62.37 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.947 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -166.18 127.1 1.29 Allowed Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 120.634 0.254 . . . . 0.0 111.629 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.33 136.79 24.72 Favored 'Trans proline' 0 N--CA 1.42 -2.81 0 N-CA-C 107.872 -1.626 . . . . 0.0 107.872 168.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.43 146.86 55.85 Favored Pre-proline 0 C--N 1.266 -3.047 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.536 ' O ' ' HD3' ' A' ' 37' ' ' PRO . 14.3 Cg_endo -59.64 140.68 94.82 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.019 1.813 . . . . 0.0 109.884 175.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -83.45 110.63 25.64 Favored Pre-proline 0 N--CA 1.407 -2.602 0 CA-C-O 121.115 0.483 . . . . 0.0 111.287 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 35' ' ' PRO . 27.1 Cg_endo -87.83 136.02 3.58 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 122.554 2.169 . . . . 0.0 111.57 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.22 -52.74 54.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.245 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.5 p -123.95 150.11 45.15 Favored 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.904 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.3 t -135.9 157.13 38.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -126.46 135.97 52.04 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.678 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.9 mt -108.54 127.52 54.01 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.86 138.16 42.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 120.908 0.385 . . . . 0.0 110.206 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -112.68 142.18 45.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -69.87 -3.71 17.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -175.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -82.86 -14.53 54.12 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.64 -13.88 10.77 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.263 -0.97 . . . . 0.0 115.505 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.424 ' HD3' ' CZ2' ' A' ' 50' ' ' TRP . 75.7 ttt180 -89.97 153.13 20.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.718 1.259 . . . . 0.0 110.806 -176.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.3 p -127.37 140.92 51.86 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.212 0.605 . . . . 0.0 110.963 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CZ2' ' HD3' ' A' ' 48' ' ' ARG . 15.9 m-90 -125.85 128.13 47.14 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.419 0.287 . . . . 0.0 110.227 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.1 m -92.07 121.17 33.38 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.43 0.633 . . . . 0.0 109.779 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 63' ' ' LEU . 34.7 m -126.05 158.34 35.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 124.792 1.237 . . . . 0.0 111.589 -172.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -102.36 127.42 49.37 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.085 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.2 ttt -111.23 120.81 43.5 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -124.95 125.31 43.72 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.713 -175.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -107.9 115.5 30.25 Favored 'General case' 0 CA--C 1.479 -1.761 0 CA-C-O 122.156 0.979 . . . . 0.0 110.038 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -148.82 102.48 3.28 Favored 'General case' 0 C--N 1.247 -3.866 0 CA-C-N 113.45 -1.705 . . . . 0.0 108.408 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.88 -143.53 15.82 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.024 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.88 -6.03 54.73 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.71 0.291 . . . . 0.0 111.641 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.1 170.07 13.96 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 121.004 0.431 . . . . 0.0 110.834 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.412 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 40.9 t -132.46 129.6 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -124.61 131.68 53.46 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 5.7 tt -102.93 113.5 27.01 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 175.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -103.49 -98.47 0.3 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -169.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.25 135.42 28.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -172.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.02 -42.19 1.98 Allowed Glycine 0 N--CA 1.425 -2.081 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.475 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 55.7 t-105 -59.18 -26.45 64.82 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.513 0.673 . . . . 0.0 110.426 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 17.1 pt-20 -71.24 -26.52 62.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.315 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -68.97 -29.42 67.64 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.379 0.609 . . . . 0.0 109.636 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -73.97 -49.16 25.8 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 124.593 1.157 . . . . 0.0 109.388 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.453 HG11 ' HA ' ' A' ' 68' ' ' GLU . 9.8 p -63.47 -37.91 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.275 0.56 . . . . 0.0 109.977 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 68.4 mttm -65.3 -46.71 79.3 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.579 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -77.52 -40.84 41.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.032 -1.067 . . . . 0.0 113.737 -172.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -86.77 -15.12 40.31 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.141 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 46.35 72.7 0.21 Allowed 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.371 1.068 . . . . 0.0 112.629 -174.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.429 HD13 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -112.64 137.52 50.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.757 179.083 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -122.01 164.7 17.2 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.9 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.581 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 7.8 p-10 -55.77 132.56 49.61 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 123.998 0.811 . . . . 0.0 111.896 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.93 -44.63 1.19 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.627 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 33.9 mtmm -80.67 155.03 27.0 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.0 131.26 43.99 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.262 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.424 ' HG ' HG13 ' A' ' 96' ' ' ILE . 6.9 mp -114.45 132.87 56.11 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -109.86 125.91 53.27 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CE1' HD12 ' A' ' 22' ' ' LEU . 91.4 m-85 -114.27 117.54 31.42 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.47 117.9 47.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -120.47 127.22 52.02 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 123.495 0.497 . . . . 0.0 110.114 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -84.07 -100.2 0.05 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -150.43 16.5 0.81 Allowed 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 16.6 t70 -110.16 -177.55 3.28 Favored 'General case' 0 N--CA 1.405 -2.717 0 CA-C-N 114.294 -1.321 . . . . 0.0 107.796 -172.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 8.7 mpt_? -95.91 32.08 1.97 Allowed 'General case' 0 C--N 1.264 -3.112 0 C-N-CA 124.3 1.04 . . . . 0.0 108.512 -178.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.3 m -127.74 122.79 33.76 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.326 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -112.8 143.94 43.19 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -111.59 120.44 42.08 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.0 t -111.2 135.41 50.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.779 0.323 . . . . 0.0 111.426 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.4 mt -130.46 124.39 57.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.424 HG13 ' HG ' ' A' ' 82' ' ' LEU . 1.8 mp -96.5 125.16 49.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -96.99 122.72 40.29 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.26 -162.37 28.17 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -108.49 79.05 1.21 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.611 0.72 . . . . 0.0 110.902 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -115.21 -61.29 1.77 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.52 116.65 19.25 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 67.7 m . . . . . 0 C--N 1.29 -1.983 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.909 -176.425 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 CA--C 1.503 -0.837 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.88 -169.02 0.17 Allowed 'General case' 0 C--O 1.238 0.499 0 O-C-N 124.252 0.97 . . . . 0.0 111.109 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -143.47 166.71 24.02 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.2 m -84.19 -21.68 31.19 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 120.883 0.373 . . . . 0.0 111.876 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.4 -104.14 1.46 Allowed Glycine 0 CA--C 1.487 -1.687 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -174.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.13 131.6 38.04 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 174.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m -99.19 140.52 18.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 120.955 0.407 . . . . 0.0 110.277 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -112.02 144.79 40.79 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -146.26 149.26 33.54 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.8 ptm -127.73 145.44 50.9 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.644 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 25.9 ttpp -153.48 143.35 15.26 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.425 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.72 146.47 83.93 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.5 2.133 . . . . 0.0 109.999 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 8.3 m-85 -103.32 139.25 38.99 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.2 mp -118.72 117.43 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.457 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 20.3 m -57.48 -22.16 41.98 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.782 0.833 . . . . 0.0 112.576 -173.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.07 -38.88 92.67 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.199 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.06 -41.98 8.85 Favored 'General case' 0 CA--C 1.487 -1.46 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.731 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.457 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 79.3 p -65.4 -11.33 41.42 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -170.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.6 t -69.63 -24.03 63.58 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.39 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -138.56 -24.36 0.94 Allowed 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -176.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 77.2 p -143.25 153.76 43.12 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 tt -96.81 122.54 39.88 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.644 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -92.97 122.77 35.67 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.874 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.402 ' HB ' HD22 ' A' ' 29' ' ' ASN . 61.5 mt -103.68 132.15 21.33 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -57.54 139.26 89.63 Favored 'Trans proline' 0 C--O 1.254 1.311 0 C-N-CA 122.19 1.926 . . . . 0.0 110.622 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.493 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.7 tt -56.57 -30.08 62.76 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.187 0.595 . . . . 0.0 110.885 -175.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.41 -31.5 63.01 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.727 -0.273 . . . . 0.0 112.838 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -87.89 -29.92 20.5 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 122.278 -0.543 . . . . 0.0 110.099 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.45 ' ND2' ' HB ' ' A' ' 61' ' ' VAL . 13.4 m120 -65.82 -34.35 77.95 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.505 0.669 . . . . 0.0 109.638 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -74.83 -27.07 60.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.612 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -78.97 -28.08 43.56 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.166 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . 0.267 31.5 p90 -134.51 78.81 55.69 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 177.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -83.97 135.13 6.43 Favored 'Trans proline' 0 N--CA 1.425 -2.551 0 C-N-CA 121.016 1.144 . . . . 0.0 110.204 170.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.66 160.11 31.59 Favored Pre-proline 0 C--N 1.273 -2.752 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -63.02 136.74 58.19 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 N-CA-C 107.505 -1.767 . . . . 0.0 107.505 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -68.81 120.4 75.74 Favored Pre-proline 0 N--CA 1.418 -2.048 0 CA-C-O 121.356 0.598 . . . . 0.0 112.593 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.49 136.67 12.57 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.69 2.26 . . . . 0.0 110.852 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -64.77 -38.59 83.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.019 0.438 . . . . 0.0 110.078 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.3 p -130.88 150.64 51.95 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 121.241 0.543 . . . . 0.0 110.852 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.4 t -141.72 149.39 20.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 125.473 1.509 . . . . 0.0 107.163 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.52 135.37 52.18 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.075 0.464 . . . . 0.0 111.494 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 49' ' ' SER . 79.1 mt -108.84 132.0 54.44 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.64 143.99 32.33 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.267 0.556 . . . . 0.0 112.154 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.466 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 16.7 t70 -110.35 165.32 11.87 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.36 176.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -53.32 -50.82 64.17 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 125.232 1.413 . . . . 0.0 110.273 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.6 m -73.68 -10.32 59.57 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.788 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.0 9.88 35.95 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.496 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -66.94 150.82 48.68 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 74.8 p -138.2 136.33 36.49 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.412 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.466 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 25.5 m-90 -121.15 131.76 54.44 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.829 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.2 m -89.62 114.15 25.71 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.34 157.85 17.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.668 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -102.01 130.98 48.69 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 28.0 ttt -112.3 136.31 51.9 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -142.12 125.88 17.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.389 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -105.17 128.35 53.35 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.98 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.55 100.03 4.84 Favored 'General case' 0 C--N 1.266 -3.039 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.78 -120.75 11.31 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.259 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -90.33 -7.8 52.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -174.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.76 152.73 32.7 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.45 ' HB ' ' ND2' ' A' ' 29' ' ' ASN . 47.4 t -133.97 124.31 46.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -130.37 153.73 48.42 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 21' ' ' SER . 5.9 mp -93.37 103.82 16.02 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.6 t -79.3 -153.82 0.08 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 124.235 0.959 . . . . 0.0 111.008 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.07 121.85 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-O 122.442 1.115 . . . . 0.0 110.939 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 143.77 -38.62 1.34 Allowed Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 -169.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -60.56 -24.2 65.23 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.042 -1.079 . . . . 0.0 109.278 173.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.473 ' O ' HG13 ' A' ' 71' ' ' VAL . 39.0 tt0 -56.2 -39.79 73.0 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.589 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -59.21 -37.06 76.53 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-O 120.918 0.39 . . . . 0.0 110.715 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.511 ' CZ ' HG13 ' A' ' 94' ' ' VAL . 78.6 t80 -74.08 -48.66 28.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 68' ' ' GLU . 9.0 p -62.48 -34.83 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 122.131 0.967 . . . . 0.0 109.165 -177.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.64 -47.07 56.91 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.917 -1.492 . . . . 0.0 111.65 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -77.64 -40.77 40.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -172.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -88.08 -16.2 34.18 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.402 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.9 t30 54.11 95.35 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 O-C-N 124.157 0.91 . . . . 0.0 112.204 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 pp -127.12 158.21 37.64 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.285 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -143.8 168.21 20.47 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.415 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 5.8 p-10 -59.08 133.89 56.5 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.227 0.954 . . . . 0.0 110.038 175.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.7 -18.98 12.73 Favored Glycine 0 C--N 1.307 -1.064 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -101.13 162.81 12.63 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -128.04 140.36 52.0 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.63 142.55 51.45 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.064 0.459 . . . . 0.0 110.786 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -114.19 124.68 52.65 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -112.2 130.7 55.83 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.41 116.0 47.38 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -106.22 123.77 48.55 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.12 -171.21 3.48 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.309 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -86.41 -5.87 59.06 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 23.4 t70 -89.27 -150.74 0.21 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 175.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.541 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 16.7 ptt180 -113.03 17.71 18.62 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 92.5 m -101.81 127.22 48.7 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.56 -170.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.65 131.75 54.79 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.643 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -101.84 127.61 48.57 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.511 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 38.3 t -104.21 119.87 53.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.11 124.24 72.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.4 tt -111.97 137.27 45.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 121.316 0.579 . . . . 0.0 110.103 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -92.21 112.78 24.84 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.19 -65.56 0.27 Allowed Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.5 m80 66.84 98.39 0.05 Allowed 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.669 0.747 . . . . 0.0 112.249 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -81.82 107.15 14.32 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.753 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 51.3 ttm -113.34 86.91 2.48 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.672 0.748 . . . . 0.0 109.981 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.42 -1.941 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.377 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.502 -0.877 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.0 91.64 3.6 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.28 103.0 6.96 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.186 -173.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.0 m -120.71 -17.95 7.85 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.898 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.15 171.44 45.59 Favored Glycine 0 N--CA 1.421 -2.335 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.08 111.47 15.32 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.617 0.722 . . . . 0.0 109.506 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -103.9 140.32 22.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.229 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -111.74 145.74 38.8 Favored 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.954 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -143.55 153.91 43.06 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 61.3 mtm -128.13 158.02 39.17 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -154.26 159.9 31.48 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -64.65 135.44 45.31 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.096 1.864 . . . . 0.0 109.843 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 70.6 t80 -100.16 122.97 43.83 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -114.63 102.15 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.489 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 33.5 t -53.83 -31.8 50.61 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 123.241 0.616 . . . . 0.0 111.367 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.83 -37.39 79.09 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.414 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -101.35 -33.1 10.15 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.907 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 21' ' ' SER . 49.8 p -81.2 1.76 30.7 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.5 m -65.42 -24.77 67.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 119.499 -0.881 . . . . 0.0 111.215 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -116.15 -48.82 2.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.636 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 18' ' ' SER . 43.4 p -130.87 144.98 51.85 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -173.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.446 ' HB2' ' CE2' ' A' ' 67' ' ' TRP . 3.0 tm? -103.0 115.18 30.12 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.79 125.27 28.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.7 mt -95.31 131.01 30.7 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.3 132.71 40.36 Favored 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 122.852 2.368 . . . . 0.0 112.137 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.411 ' O ' HD21 ' A' ' 26' ' ' LEU . 6.7 tt -63.37 -32.71 74.21 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.856 -175.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.46 -32.41 81.67 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.172 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -75.07 -35.8 61.82 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -70.72 -31.64 68.56 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.115 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -74.82 -30.38 61.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.42 -27.63 66.37 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.577 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -160.57 87.16 1.82 Allowed Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.317 0.579 . . . . 0.0 111.713 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.21 142.76 21.82 Favored 'Trans proline' 0 N--CA 1.439 -1.704 0 C-N-CA 121.75 1.634 . . . . 0.0 110.396 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.42 153.04 36.67 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.41 144.52 98.28 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 122.489 2.126 . . . . 0.0 109.969 175.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.421 ' HB3' ' H ' ' A' ' 56' ' ' LYS . 26.8 p90 -70.28 121.33 82.91 Favored Pre-proline 0 N--CA 1.41 -2.474 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.91 159.63 18.49 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.394 2.73 . . . . 0.0 110.219 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.2 mm -70.4 -59.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.349 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.5 p -125.53 151.41 46.38 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.459 HG23 ' SD ' ' A' ' 54' ' ' MET . 97.2 t -139.78 151.42 22.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.53 136.2 52.34 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.557 -0.857 . . . . 0.0 113.285 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' A' ' 92' ' ' PHE . 3.3 mm? -108.54 120.2 41.73 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.03 153.18 20.14 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.121 0.486 . . . . 0.0 110.735 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.492 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 11.5 t70 -112.06 149.22 32.39 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.885 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -70.71 -26.71 63.52 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.734 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.8 m -95.13 -45.87 7.03 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.759 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.07 -32.06 0.04 OUTLIER Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 118.244 -1.932 . . . . 0.0 114.785 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -60.83 158.52 12.84 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 p -149.09 135.78 19.59 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 173.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.492 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 23.7 m-90 -125.75 124.09 40.25 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.546 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.1 m -89.18 114.26 25.54 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 174.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.5 t -115.26 157.77 15.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.944 -172.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -99.91 128.32 46.01 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.459 ' SD ' HG23 ' A' ' 40' ' ' VAL . 27.5 ttt -111.56 123.23 49.8 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -176.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -130.5 129.99 43.6 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.747 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' H ' ' HB3' ' A' ' 36' ' ' PHE . 27.6 tptp -92.62 127.54 38.15 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 125.003 1.321 . . . . 0.0 108.772 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -142.94 103.85 4.24 Favored 'General case' 0 C--N 1.261 -3.275 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.532 -174.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.74 -121.26 5.94 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -108.98 2.9 21.65 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.427 0.632 . . . . 0.0 109.692 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 37.1 ttpt -122.58 159.12 28.45 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.316 -175.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.83 141.04 47.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.502 ' CZ ' ' HE3' ' A' ' 60' ' ' LYS . 96.7 m-85 -123.12 136.45 54.8 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.043 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 98.4 mt -81.93 103.49 11.62 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 167.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.545 HG23 ' H ' ' A' ' 65' ' ' VAL . 2.0 m -86.15 -154.45 0.21 Allowed 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.917 -167.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.545 ' H ' HG23 ' A' ' 64' ' ' THR . 7.7 p -56.44 122.82 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 121.998 0.904 . . . . 0.0 111.639 -172.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.58 -37.2 2.06 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -171.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.446 ' CE2' ' HB2' ' A' ' 22' ' ' LEU . 12.6 t-105 -57.26 -26.2 60.4 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.554 -0.823 . . . . 0.0 110.774 175.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -53.29 -27.43 22.81 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.07 -174.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -63.01 -29.76 71.07 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -73.73 -54.66 7.56 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.581 0.705 . . . . 0.0 109.545 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 57.9 t -67.64 -34.76 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.529 -176.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -71.91 -37.92 69.99 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 174.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.6 -40.67 41.33 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.869 -0.733 . . . . 0.0 112.779 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -84.77 -20.84 30.39 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 60.2 t30 49.13 82.45 0.04 OUTLIER 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.167 1.387 . . . . 0.0 111.757 -176.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.426 ' HG ' ' CZ ' ' A' ' 13' ' ' PHE . 1.9 pt? -127.45 142.81 51.31 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.447 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -113.99 170.39 8.31 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 15' ' ' SER . 6.1 p-10 -60.56 133.51 56.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 172.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.57 -28.15 5.06 Favored Glycine 0 C--N 1.3 -1.442 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 -172.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -100.08 146.74 26.42 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.445 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 95.0 m-85 -133.81 158.63 42.88 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.68 -174.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.496 HD13 ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -125.94 155.72 40.88 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.281 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -129.14 127.24 41.01 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.236 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.496 ' CE2' HD13 ' A' ' 82' ' ' LEU . 99.9 m-85 -106.09 130.73 53.94 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 59.0 mt -107.36 119.8 57.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -106.12 125.27 50.79 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.371 0.605 . . . . 0.0 112.258 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.73 146.21 27.52 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -66.08 83.28 0.08 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.201 0.455 . . . . 0.0 111.722 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 173.54 -148.71 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.483 ' HD2' ' N ' ' A' ' 90' ' ' ARG . 6.3 mpt_? -100.3 24.44 8.78 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 118.426 0.557 . . . . 0.0 109.744 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.0 m -103.54 119.91 39.83 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.461 ' HB2' HD13 ' A' ' 42' ' ' LEU . 80.3 m-85 -125.27 130.71 52.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.39 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.428 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 95.7 m-85 -104.22 132.08 50.84 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.3 t -109.76 124.21 66.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.575 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.15 139.8 34.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.419 ' HB ' ' OD1' ' A' ' 100' ' ' ASN . 64.7 mt -115.28 131.74 66.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 120.973 0.416 . . . . 0.0 110.109 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 81' ' ' TYR . 43.7 p90 -125.23 167.65 14.56 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.62 49.84 4.7 Favored Glycine 0 C--N 1.3 -1.456 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -173.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 39.5 m80 77.36 82.82 0.08 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.212 1.405 . . . . 0.0 111.63 -176.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.419 ' OD1' ' HB ' ' A' ' 96' ' ' ILE . 7.2 t30 -84.84 92.71 8.33 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 83.6 mtp -96.03 145.84 25.12 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.715 -176.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 16.4 p . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.999 -0.525 . . . . 0.0 110.932 179.542 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.507 -0.709 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.02 117.99 14.26 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.109 0.48 . . . . 0.0 109.802 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.98 122.64 48.24 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.305 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.7 m -81.0 -56.66 3.96 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.01 -157.33 46.46 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.578 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.94 121.46 27.79 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m -95.88 140.19 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-O 121.142 0.496 . . . . 0.0 110.448 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 13.5 pt20 -106.23 144.42 32.95 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.897 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -150.19 148.57 29.09 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 25.9 ptm -103.72 133.92 47.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.66 128.72 25.09 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.44 133.2 44.65 Favored 'Trans proline' 0 C--O 1.248 1.005 0 C-N-CA 122.522 2.148 . . . . 0.0 112.882 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -93.65 124.64 37.78 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.9 mt -125.8 115.93 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.425 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 15.2 t -66.67 -11.57 54.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.313 0.577 . . . . 0.0 111.35 -172.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -61.19 -43.14 99.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.796 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -108.68 -40.39 5.09 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.937 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 21' ' ' SER . 18.2 m -74.17 8.6 2.03 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -172.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.451 ' O ' HG12 ' A' ' 71' ' ' VAL . 29.2 t -75.02 -19.23 60.14 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -141.63 -33.91 0.49 Allowed 'General case' 0 C--N 1.353 0.748 0 C-N-CA 119.874 -0.731 . . . . 0.0 112.641 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 18' ' ' SER . 63.4 p -139.04 162.61 34.51 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 120.958 0.409 . . . . 0.0 111.35 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 81.5 mt -103.28 118.21 36.25 Favored 'General case' 0 CA--C 1.485 -1.538 0 O-C-N 120.892 -1.13 . . . . 0.0 113.483 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -77.09 113.98 15.4 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 168.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.477 ' HB ' HG22 ' A' ' 61' ' ' VAL . 66.5 mt -113.18 130.97 23.09 Favored Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 121.49 -0.084 . . . . 0.0 110.827 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -44.36 139.14 6.87 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 124.654 3.569 . . . . 0.0 114.538 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.77 -46.22 90.52 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.133 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.42 -32.73 85.17 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.769 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 76.7 t80 -76.78 -34.9 57.98 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -66.12 -44.7 83.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.991 0.424 . . . . 0.0 110.804 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.85 -13.62 61.8 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.914 0.864 . . . . 0.0 110.457 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 87.2 t80 -74.68 -18.97 60.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.386 176.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -137.92 94.3 11.51 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -83.13 134.01 6.76 Favored 'Trans proline' 0 N--CA 1.432 -2.144 0 C-N-CA 121.549 1.499 . . . . 0.0 110.417 172.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.75 152.98 28.18 Favored Pre-proline 0 C--N 1.272 -2.776 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.486 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -61.87 150.41 86.21 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 107.786 -1.659 . . . . 0.0 107.786 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -68.12 119.63 68.67 Favored Pre-proline 0 N--CA 1.416 -2.142 0 CA-C-O 121.309 0.576 . . . . 0.0 111.712 -174.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -87.28 159.89 8.32 Favored 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.758 2.306 . . . . 0.0 111.084 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.418 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 51.3 mm -85.88 -59.25 2.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.3 p -131.3 156.43 45.46 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.136 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.35 162.44 39.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.27 134.97 55.18 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.688 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.0 mt -108.0 125.53 51.65 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.65 137.53 39.84 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.084 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' OD2' ' HB2' ' A' ' 46' ' ' SER . 0.1 OUTLIER -112.96 142.34 45.75 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 123.517 0.727 . . . . 0.0 110.719 178.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -67.35 -22.16 65.6 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.242 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.457 ' HB2' ' OD2' ' A' ' 44' ' ' ASP . 4.3 m -74.1 -32.46 63.24 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.53 -2.55 4.18 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.962 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -86.28 158.72 19.62 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.043 0.537 . . . . 0.0 110.331 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.8 p -149.66 140.09 22.39 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.6 m-90 -129.32 127.22 40.67 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.786 0.327 . . . . 0.0 111.447 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.8 m -87.66 114.83 24.65 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.3 m -122.17 158.16 26.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.662 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.513 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 25.3 ttp180 -101.16 133.93 44.97 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -177.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 55.8 ttp -131.64 148.12 52.57 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.554 ' HB2' ' HZ2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -152.27 146.27 25.27 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.119 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 63.5 mttm -91.84 128.83 37.82 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -137.45 107.82 6.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.48 -118.59 4.76 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -111.15 -5.46 14.74 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.452 ' HD2' ' CZ ' ' A' ' 62' ' ' PHE . 19.0 ptpt -117.58 170.09 9.03 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.491 0.662 . . . . 0.0 111.273 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' A' ' 24' ' ' ILE . 8.4 m -109.62 141.31 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.417 171.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.452 ' CZ ' ' HD2' ' A' ' 60' ' ' LYS . 97.4 m-85 -114.49 131.56 56.59 Favored 'General case' 0 C--N 1.268 -2.978 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 169.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 6.8 tt -88.13 102.07 14.43 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 173.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.513 ' OG1' ' HG2' ' A' ' 53' ' ' ARG . 20.5 p -71.73 -163.67 0.11 Allowed 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -168.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.403 ' H ' ' HB ' ' A' ' 64' ' ' THR . 27.7 t -65.96 122.29 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.356 -168.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.37 -31.62 1.04 Allowed Glycine 0 CA--C 1.481 -2.032 0 N-CA-C 107.506 -2.238 . . . . 0.0 107.506 -174.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.458 ' HB2' HD22 ' A' ' 63' ' ' LEU . 59.2 t-105 -58.14 -23.78 56.42 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 113.864 -1.168 . . . . 0.0 109.947 173.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 28.5 tt0 -56.51 -32.31 64.93 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.133 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -64.5 -35.87 82.37 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 122.633 0.373 . . . . 0.0 110.956 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -73.55 -49.99 23.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.456 HG11 ' HA ' ' A' ' 68' ' ' GLU . 8.2 p -61.71 -47.48 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.499 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 68' ' ' GLU 0.277 25.6 pttm -73.1 -30.98 64.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 178.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.24 -39.99 65.02 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.591 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -87.24 -21.48 25.81 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 54.22 88.7 0.04 OUTLIER 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.233 1.413 . . . . 0.0 110.438 -176.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.7 165.77 26.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -141.52 172.14 13.1 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.128 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' H ' ' HB2' ' A' ' 15' ' ' SER . 5.9 p-10 -58.71 120.79 9.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.494 0.664 . . . . 0.0 109.925 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.85 -41.01 0.58 Allowed Glycine 0 C--N 1.294 -1.755 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -94.72 155.94 16.62 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -130.42 156.6 44.47 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.964 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.22 153.95 51.07 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 -175.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.538 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 87.3 mt-30 -111.87 145.54 39.31 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.382 176.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -117.36 120.17 37.36 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 23.3 mt -97.49 114.65 35.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -128.47 139.69 52.2 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -129.42 167.71 17.4 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 168.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.587 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 5.3 mpt_? -65.01 96.65 0.2 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 123.394 0.434 . . . . 0.0 110.205 -174.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 20.1 t70 179.27 -159.43 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.448 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 10.5 mpt_? -117.97 19.11 13.78 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.4 m -106.59 117.88 35.2 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.701 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -118.03 133.41 55.94 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.485 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 60.3 m-85 -101.7 116.13 32.05 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 174.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 7.8 p -99.9 132.0 46.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 120.827 0.346 . . . . 0.0 110.422 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.538 ' CG2' ' HB2' ' A' ' 83' ' ' GLN . 11.3 tt -131.74 128.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.183 0.516 . . . . 0.0 109.981 177.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.0 tt -96.66 142.02 14.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.363 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -82.94 113.96 20.89 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.973 0.892 . . . . 0.0 108.699 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 137.12 -120.62 2.14 Favored Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 106.879 -2.489 . . . . 0.0 106.879 -173.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -169.49 131.39 1.14 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 117.298 0.549 . . . . 0.0 110.514 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -95.68 144.93 25.68 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 28.0 ttt -154.38 95.93 1.86 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.815 0.34 . . . . 0.0 111.032 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 C--O 1.257 1.458 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.768 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 C--O 1.241 0.642 0 CA-C-O 120.47 0.176 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.85 129.8 42.69 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -80.65 76.09 7.54 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 122.498 1.142 . . . . 0.0 110.592 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.3 m -124.46 -59.01 1.49 Allowed 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.847 -1.524 . . . . 0.0 107.058 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.24 -153.7 52.06 Favored Glycine 0 N--CA 1.435 -1.396 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.8 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -151.83 114.58 4.63 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 m -114.09 140.68 33.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 121.518 0.675 . . . . 0.0 111.028 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.4 145.59 45.07 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.377 -175.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -142.25 147.33 36.31 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.3 ptm -135.29 143.72 46.38 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' H ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -155.01 159.27 31.96 Favored Pre-proline 0 N--CA 1.433 -1.286 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.24 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -48.76 148.79 8.28 Favored 'Trans proline' 0 C--O 1.251 1.126 0 C-N-CA 124.14 3.227 . . . . 0.0 114.839 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -129.68 124.54 33.87 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.5 117.91 56.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.512 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 26.1 t -59.96 -20.49 57.86 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -172.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -73.11 -44.19 60.65 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.948 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.75 -37.11 11.96 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.678 0.752 . . . . 0.0 109.831 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 21' ' ' SER . 14.5 m -84.98 15.23 4.16 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.634 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 15' ' ' SER . 46.2 t -74.44 -21.95 59.37 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.82 -28.18 1.1 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.15 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.669 ' O ' ' HA ' ' A' ' 18' ' ' SER . 21.3 p -147.33 152.79 38.81 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -172.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.404 HD13 HD23 ' A' ' 63' ' ' LEU . 54.0 mt -111.37 141.86 44.36 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 120.793 0.33 . . . . 0.0 111.602 176.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -100.52 125.26 46.84 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.422 ' CB ' ' HB ' ' A' ' 61' ' ' VAL . 48.1 mm -105.2 132.09 21.19 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.608 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.93 147.06 83.99 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 123.142 2.562 . . . . 0.0 111.919 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 mp -58.5 -38.29 77.34 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.121 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.38 -28.14 66.73 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.568 -0.742 . . . . 0.0 113.28 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -85.79 -25.69 26.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.126 0.488 . . . . 0.0 110.04 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -69.47 -45.74 68.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.107 0.479 . . . . 0.0 110.105 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.54 -10.51 59.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.811 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -68.35 -27.49 66.31 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.756 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -158.72 103.64 1.62 Allowed Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 120.959 0.409 . . . . 0.0 111.814 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.58 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 6.0 Cg_exo -82.59 134.89 7.74 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.07 1.847 . . . . 0.0 111.08 172.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.95 159.24 32.53 Favored Pre-proline 0 C--N 1.271 -2.809 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.54 130.07 35.52 Favored 'Trans proline' 0 C--O 1.26 1.58 0 N-CA-C 107.843 -1.637 . . . . 0.0 107.843 172.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -71.71 128.48 89.6 Favored Pre-proline 0 N--CA 1.403 -2.818 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -172.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.89 160.1 40.9 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.225 2.616 . . . . 0.0 112.344 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.81 -48.53 15.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 174.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.0 p -136.46 151.63 49.68 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.932 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.15 162.37 38.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.76 137.98 52.35 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.53 0.681 . . . . 0.0 111.844 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 49' ' ' SER . 65.1 mt -109.17 122.78 48.05 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.29 148.08 31.6 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.368 0.604 . . . . 0.0 111.662 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -111.75 165.15 12.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.384 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -52.27 -38.26 57.77 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.805 0.842 . . . . 0.0 110.782 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 m -67.06 -10.29 48.33 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.139 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.27 7.64 63.58 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.418 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -80.37 138.03 36.63 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 35.1 p -124.78 135.26 52.81 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 123.463 0.477 . . . . 0.0 110.594 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -113.88 130.65 56.47 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.4 m -90.86 119.35 30.99 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -119.64 156.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.531 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 65' ' ' VAL . 68.6 mtt180 -100.82 120.18 39.75 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.416 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 20.4 ttt -133.07 121.69 23.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.855 -173.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.2 OUTLIER -132.26 142.32 49.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.029 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.58 ' NZ ' ' HA ' ' A' ' 33' ' ' PRO . 26.2 mtmt -92.08 126.41 37.15 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -130.21 98.89 4.86 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.652 -172.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.22 -107.22 2.42 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.45 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.94 -1.99 16.18 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.866 0.365 . . . . 0.0 110.317 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -132.53 160.17 37.3 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-O 121.271 0.558 . . . . 0.0 111.169 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.422 ' HB ' ' CB ' ' A' ' 24' ' ' ILE . 53.0 t -105.57 142.2 19.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 173.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -135.71 131.39 35.57 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.404 HD23 HD13 ' A' ' 22' ' ' LEU . 6.2 mp -96.02 113.92 25.58 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.7 p -82.41 -170.24 2.84 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.421 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.545 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 47.9 t -66.42 122.09 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.68 0.752 . . . . 0.0 110.496 -173.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.53 -27.24 1.07 Allowed Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.4 ' CH2' HD11 ' A' ' 22' ' ' LEU . 41.4 t-105 -60.75 -21.38 62.95 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 113.577 -1.312 . . . . 0.0 110.184 172.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.72 ' O ' ' HG2' ' A' ' 72' ' ' LYS 0.293 0.0 OUTLIER -63.54 -26.53 68.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -175.859 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -56.18 -38.06 70.42 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.543 0.737 . . . . 0.0 110.114 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -74.05 -49.05 25.92 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.446 -175.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.446 HG11 ' HA ' ' A' ' 68' ' ' GLU . 8.7 p -67.52 -40.69 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.361 -175.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.72 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 20.5 ptmt -70.41 -38.77 74.67 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.771 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.59 -38.08 62.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.258 -0.977 . . . . 0.0 112.528 -175.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -86.12 -20.77 28.18 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.838 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.1 t30 50.87 83.53 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.15 0.98 . . . . 0.0 111.432 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 pp -138.8 174.67 10.28 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -143.19 172.04 13.27 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.867 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.512 ' HB3' ' H ' ' A' ' 15' ' ' SER . 9.3 p-10 -65.79 142.1 58.08 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.145 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.24 -21.55 15.05 Favored Glycine 0 C--N 1.295 -1.7 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -173.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -116.54 134.46 54.82 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 87.2 m-85 -130.28 158.91 38.48 Favored 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.264 -170.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 pp -132.29 144.59 50.69 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.537 ' CG ' ' HB ' ' A' ' 95' ' ' ILE . 10.3 pt20 -119.02 145.85 45.52 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.909 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.02 124.28 51.17 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.5 mt -106.31 117.18 51.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.406 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 30.6 p90 -127.68 152.76 47.3 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.531 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -81.16 -78.75 0.17 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.162 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -162.23 24.32 0.11 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 21.1 t70 -120.55 -168.93 1.72 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -174.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.459 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 11.3 mpt_? -95.83 15.76 19.43 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 123.496 0.718 . . . . 0.0 110.186 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.7 m -102.76 116.11 31.91 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.406 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 82.8 m-85 -117.13 132.08 56.75 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.884 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -101.55 129.2 47.59 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -98.71 141.08 16.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -174.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.537 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 57.8 mt -127.06 117.66 48.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.97 113.9 41.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 81' ' ' TYR . 49.2 p90 -100.53 124.94 46.74 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -148.62 121.83 1.39 Allowed Glycine 0 N--CA 1.409 -3.1 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -91.43 87.57 6.48 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -74.23 96.78 2.84 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.511 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.2 mtt -96.43 75.97 2.91 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.631 0.729 . . . . 0.0 109.193 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 52.3 t . . . . . 0 N--CA 1.429 -1.525 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -178.656 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttm . . . . . 0 C--O 1.238 0.487 0 CA-C-O 120.895 0.379 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.4 146.33 4.98 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.92 137.52 55.27 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.4 m -61.62 -62.01 2.12 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 123.743 0.652 . . . . 0.0 110.778 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.13 -172.47 33.57 Favored Glycine 0 C--N 1.292 -1.868 0 C-N-CA 120.243 -0.979 . . . . 0.0 110.772 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -179.67 114.25 0.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 m -123.61 145.81 30.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.09 0.472 . . . . 0.0 112.048 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -99.85 146.97 26.02 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.469 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -142.98 149.21 38.03 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.6 ttt -131.7 144.78 51.24 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 24.1 ttpp -146.86 143.78 19.03 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.42 146.35 42.0 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 123.056 2.504 . . . . 0.0 111.632 173.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -122.07 121.69 37.54 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt -128.32 115.98 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.506 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 24.0 t -61.29 -17.49 53.82 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.925 0.89 . . . . 0.0 112.369 -171.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.22 -42.07 93.83 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.428 ' HD2' ' CD ' ' A' ' 23' ' ' GLU . 37.5 ttmt -101.48 -30.3 11.5 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.212 -177.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.9 p -80.08 7.31 9.42 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 120.927 0.394 . . . . 0.0 111.386 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.9 p -72.18 -29.87 64.42 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.436 0.636 . . . . 0.0 109.631 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -114.28 -39.79 3.8 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.382 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.2 p -157.5 155.39 30.25 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.659 -174.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 76.9 mt -96.25 138.7 33.46 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.947 0.403 . . . . 0.0 110.744 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.483 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 39.5 mt-10 -79.24 117.81 20.6 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.432 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.9 mt -97.19 118.92 64.15 Favored Pre-proline 0 C--N 1.281 -2.382 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 174.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.74 138.8 32.84 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.581 2.854 . . . . 0.0 114.635 -171.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.05 -37.83 88.77 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.72 -28.91 73.47 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.334 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -72.86 -42.89 63.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -62.98 -40.12 96.78 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.71 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.22 -25.46 68.34 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.649 0.779 . . . . 0.0 110.328 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -80.61 -27.58 37.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.165 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -173.4 100.5 0.32 Allowed Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.433 ' CB ' ' HE2' ' A' ' 56' ' ' LYS . 14.4 Cg_endo -89.06 149.19 5.65 Favored 'Trans proline' 0 N--CA 1.426 -2.5 0 C-N-CA 121.377 1.384 . . . . 0.0 111.297 171.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.0 158.66 36.69 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.25 137.07 76.6 Favored 'Trans proline' 0 C--N 1.354 0.816 0 N-CA-C 107.68 -1.7 . . . . 0.0 107.68 172.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -70.95 127.41 91.74 Favored Pre-proline 0 N--CA 1.407 -2.609 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -172.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.38 136.91 45.12 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.563 2.175 . . . . 0.0 110.338 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.23 -48.71 87.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.201 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.463 ' O ' ' HD3' ' A' ' 90' ' ' ARG . 25.6 p -127.53 150.69 49.58 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.356 176.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.8 t -132.1 155.2 41.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -108.42 125.14 51.42 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 120.746 0.308 . . . . 0.0 110.361 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.6 mt -109.18 120.16 41.7 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 173.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.61 149.88 26.75 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 120.852 0.358 . . . . 0.0 110.375 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.468 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 11.3 t70 -111.27 158.78 18.59 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.428 ' CE1' HG13 ' A' ' 95' ' ' ILE . 26.9 p90 -73.68 -13.28 60.96 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.253 0.549 . . . . 0.0 111.676 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.2 t -93.52 -162.28 0.92 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.71 6.79 44.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.115 -0.564 . . . . 0.0 114.113 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -81.41 145.61 30.7 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.1 p -150.01 136.52 19.07 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 113.903 -1.498 . . . . 0.0 107.921 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.468 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 23.3 m-90 -126.97 140.3 52.42 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.169 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -96.68 114.29 25.92 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.2 t -125.25 155.62 34.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.0 -174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -101.84 139.41 37.51 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.0 ttt -120.12 138.76 53.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -143.84 132.42 22.32 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.254 -0.978 . . . . 0.0 112.58 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.433 ' HE2' ' CB ' ' A' ' 33' ' ' PRO . 48.8 tttp -91.88 128.08 37.58 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -138.86 98.24 3.5 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.302 -173.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.08 -134.72 13.56 Favored Glycine 0 N--CA 1.422 -2.259 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.875 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -90.89 -0.47 57.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.214 0.53 . . . . 0.0 110.48 -175.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -132.52 171.05 14.29 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.7 t -124.84 148.01 29.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -124.42 137.13 54.48 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.4 tp -91.69 102.95 15.58 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.419 ' HB ' ' H ' ' A' ' 65' ' ' VAL . 34.9 p -78.94 -157.38 0.12 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -170.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' H ' ' HB ' ' A' ' 64' ' ' THR . 13.5 p -55.9 144.73 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.154 0.981 . . . . 0.0 111.834 -173.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.28 -36.26 3.59 Favored Glycine 0 CA--C 1.485 -1.816 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 -172.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.401 ' CZ2' HG23 ' A' ' 71' ' ' VAL . 12.0 t-105 -59.76 -25.29 64.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.704 -1.248 . . . . 0.0 109.382 171.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.491 ' OE2' ' HD3' ' A' ' 72' ' ' LYS . 2.8 tm-20 -53.23 -31.41 43.14 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.605 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.444 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 2.1 m-20 -67.29 -30.55 70.44 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 123.346 0.659 . . . . 0.0 111.991 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -73.44 -53.06 11.58 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 40.2 t -63.63 -39.1 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.98 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.491 ' HD3' ' OE2' ' A' ' 68' ' ' GLU . 59.9 pttt -71.46 -39.01 71.21 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.4 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -77.64 -40.66 41.06 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -175.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.424 HD22 HD11 ' A' ' 96' ' ' ILE . 45.7 t-20 -84.96 -20.87 29.92 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 20.2 t-20 47.65 88.73 0.02 OUTLIER 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.794 1.637 . . . . 0.0 112.374 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.79 168.8 24.51 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.849 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -143.56 174.24 10.94 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 124.073 0.949 . . . . 0.0 108.97 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 15' ' ' SER . 5.6 p-10 -51.95 130.6 29.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.941 0.877 . . . . 0.0 111.717 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.51 -39.93 1.25 Allowed Glycine 0 C--N 1.294 -1.756 0 N-CA-C 107.189 -2.365 . . . . 0.0 107.189 -175.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -94.42 146.14 24.28 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -118.98 158.94 24.77 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.204 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.1 mt -110.57 137.44 48.25 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.526 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.498 ' HB3' ' CG2' ' A' ' 95' ' ' ILE . 57.8 tt0 -111.68 130.71 55.68 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -109.57 117.33 33.67 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 62.5 mt -99.65 114.18 37.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 106.185 -1.784 . . . . 0.0 106.185 174.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -129.11 154.06 47.07 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -172.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -143.56 149.69 37.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 93.9 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.334 1.054 . . . . 0.0 111.82 -177.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.496 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 23.2 t70 -174.64 -159.04 0.08 Allowed 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -176.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.496 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 36.7 ttm180 -116.39 25.45 10.62 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.4 m -125.69 125.97 43.9 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.405 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -119.89 132.9 55.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.49 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 93.7 m-85 -104.97 115.04 29.61 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 174.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.77 149.48 8.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-O 121.357 0.599 . . . . 0.0 112.137 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.498 ' CG2' ' HB3' ' A' ' 83' ' ' GLN . 13.2 tt -142.06 135.44 28.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.424 HD11 HD22 ' A' ' 74' ' ' ASN . 38.1 pt -93.71 141.63 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.471 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -83.08 112.79 20.12 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.2 -113.01 0.55 Allowed Glycine 0 N--CA 1.41 -3.073 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.7 t60 56.51 83.08 0.1 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.469 0.652 . . . . 0.0 110.108 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -169.41 -48.29 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -174.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.4 ttt -118.21 67.31 0.76 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 171.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.3 m . . . . . 0 C--N 1.306 -1.287 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.328 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.03 67.0 1.4 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.028 0.442 . . . . 0.0 110.569 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -142.66 157.78 44.33 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.357 0.599 . . . . 0.0 112.313 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.0 m -157.93 -43.96 0.06 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.73 -140.78 11.04 Favored Glycine 0 CA--C 1.494 -1.261 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.97 104.95 7.75 Favored 'General case' 0 C--O 1.255 1.35 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 175.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.8 m -129.4 139.88 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.784 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 85' ' ' ILE . 8.6 pt20 -136.95 144.91 43.65 Favored 'General case' 0 N--CA 1.399 -3.022 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.361 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 83' ' ' GLN . 67.9 t80 -136.26 148.99 48.29 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.511 -174.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.418 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 27.1 ptm -102.56 157.29 17.03 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -154.57 144.32 15.43 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.83 134.79 16.85 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 122.856 2.37 . . . . 0.0 112.343 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.448 ' CE2' ' HG ' ' A' ' 22' ' ' LEU . 32.0 m-85 -107.11 140.34 40.11 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.659 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.9 mt -120.17 113.52 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 t -56.92 -31.79 65.29 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 123.411 0.444 . . . . 0.0 111.473 -173.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.76 -44.17 97.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -89.09 -40.07 13.19 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.7 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 21' ' ' SER . 25.8 m -75.22 4.55 6.8 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.372 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.2 t -74.26 -17.08 60.92 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -135.25 -35.97 0.82 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.555 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 18' ' ' SER . 26.5 p -144.23 144.0 31.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.402 0.62 . . . . 0.0 112.63 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.448 ' HG ' ' CE2' ' A' ' 13' ' ' PHE . 3.3 tt -100.05 121.11 40.88 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -86.11 127.02 34.62 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.982 0.42 . . . . 0.0 110.607 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.43 ' HB ' HG23 ' A' ' 61' ' ' VAL . 45.7 mm -97.56 132.7 24.71 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.45 148.15 87.61 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.266 1.977 . . . . 0.0 111.384 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.64 -22.51 66.66 Favored 'General case' 0 C--O 1.213 -0.819 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.97 -21.62 61.51 Favored Glycine 0 C--O 1.22 -0.734 0 C-N-CA 121.342 -0.456 . . . . 0.0 111.984 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.437 ' HE2' ' CZ ' ' A' ' 86' ' ' TYR . 28.3 t80 -76.44 -51.72 11.25 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -68.18 -35.86 78.69 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.449 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -69.17 -26.42 64.84 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -85.35 -28.23 25.35 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.379 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -172.87 114.67 0.37 Allowed Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 176.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 1.9 Cg_endo -85.0 150.83 10.96 Favored 'Trans proline' 0 N--CA 1.427 -2.396 0 C-N-CA 121.646 1.564 . . . . 0.0 109.672 168.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.68 152.07 67.6 Favored Pre-proline 0 C--N 1.282 -2.34 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.4 130.54 32.34 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 N-CA-C 108.212 -1.495 . . . . 0.0 108.212 175.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -69.71 114.18 22.72 Favored Pre-proline 0 N--CA 1.412 -2.337 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -172.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -78.61 136.63 13.88 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.798 2.332 . . . . 0.0 110.618 177.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.452 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 47.4 mm -69.93 -46.44 73.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.746 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.5 p -123.38 148.98 45.52 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.736 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.2 t -134.87 143.39 37.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -115.4 131.34 56.96 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.811 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.9 mt -109.24 129.15 55.51 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.39 152.4 20.77 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.584 0.707 . . . . 0.0 112.328 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.511 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 12.3 t70 -112.1 166.91 10.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.196 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HH ' ' HA ' ' A' ' 95' ' ' ILE . 18.3 m-85 -76.54 -49.31 16.77 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.747 0.819 . . . . 0.0 110.717 -175.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 m -80.58 -50.51 9.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.568 -172.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -174.04 -11.29 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 118.263 -1.922 . . . . 0.0 114.716 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -73.72 157.86 35.73 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.1 p -150.94 135.3 16.96 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.511 ' CH2' ' HB2' ' A' ' 44' ' ' ASP . 18.7 m-90 -128.7 134.52 48.5 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.461 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.2 m -98.39 120.05 38.14 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 67' ' ' TRP . 8.5 p -119.18 155.24 21.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.471 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 77.7 ttt180 -103.25 135.95 43.94 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.9 ttt -117.53 146.0 43.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -147.55 131.45 17.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.506 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 33' ' ' PRO . 53.4 tttp -114.47 110.56 20.03 Favored 'General case' 0 CA--C 1.471 -2.082 0 CA-C-O 122.198 0.999 . . . . 0.0 109.089 173.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -140.66 104.82 4.81 Favored 'General case' 1 C--N 1.242 -4.071 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.81 -158.32 20.78 Favored Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -173.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -94.81 3.38 55.07 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.643 0.735 . . . . 0.0 109.55 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -112.73 156.65 22.45 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.43 HG23 ' HB ' ' A' ' 24' ' ' ILE . 27.5 m -129.6 139.89 50.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.897 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -136.91 148.06 46.79 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.024 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 5.9 mp -100.7 109.93 22.01 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.4 p -89.48 -144.55 0.16 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.858 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -55.73 129.06 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 121.484 0.659 . . . . 0.0 109.78 -175.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.92 -38.4 2.11 Favored Glycine 0 N--CA 1.414 -2.796 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 -170.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.437 ' N ' HG23 ' A' ' 52' ' ' VAL . 60.9 t-105 -66.23 -25.5 66.93 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.685 -0.758 . . . . 0.0 109.188 174.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.664 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 32.1 tt0 -59.58 -37.0 77.32 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.201 -178.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -57.45 -39.55 76.52 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 123.716 0.807 . . . . 0.0 110.935 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -74.05 -50.88 17.73 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.825 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 68' ' ' GLU . 7.8 p -62.43 -47.15 94.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.544 -174.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 64.2 pttt -72.44 -33.57 67.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.13 -40.39 38.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 118.575 -1.25 . . . . 0.0 113.471 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -88.25 -19.91 26.17 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.579 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.9 t30 57.73 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.902 1.281 . . . . 0.0 112.061 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 pp -139.45 155.25 47.71 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.638 0.732 . . . . 0.0 112.845 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.94 171.96 13.64 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.78 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -60.94 141.46 57.24 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.612 0.57 . . . . 0.0 110.587 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.76 -6.05 13.95 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -121.1 153.0 38.03 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -132.54 139.65 47.96 Favored 'General case' 0 CA--C 1.474 -1.964 0 CA-C-O 121.043 0.449 . . . . 0.0 109.839 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.435 ' N ' HD23 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -135.55 144.38 46.21 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.979 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 75.9 mt-30 -110.5 145.0 38.47 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.155 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -112.92 131.14 55.85 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' HB3' ' A' ' 8' ' ' GLN . 59.3 mt -95.31 121.49 45.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.437 ' CZ ' ' HE2' ' A' ' 28' ' ' PHE . 23.0 m-85 -105.5 123.42 47.86 Favored 'General case' 0 N--CA 1.421 -1.925 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -104.37 14.5 30.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.583 0.706 . . . . 0.0 109.638 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.12 72.7 0.49 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.612 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.43 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 18.2 t70 -175.67 -171.49 0.47 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.459 ' HD2' ' N ' ' A' ' 90' ' ' ARG . 5.5 mpt_? -106.56 26.93 9.33 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.6 m -127.51 117.81 22.79 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -125.26 155.23 40.45 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.337 0.589 . . . . 0.0 110.906 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -115.07 135.11 54.57 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -104.55 129.63 56.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.112 0.482 . . . . 0.0 112.271 -174.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.454 ' HA ' ' HH ' ' A' ' 45' ' ' TYR . 51.7 mm -111.99 115.29 49.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 174.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.5 tt -118.12 137.87 50.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.431 0.634 . . . . 0.0 112.7 -173.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -99.08 135.78 40.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.91 -1.88 35.77 Favored Glycine 0 C--N 1.29 -2.015 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.697 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -86.19 103.36 14.75 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -88.12 136.87 32.77 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.144 -0.935 . . . . 0.0 113.019 -171.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -76.75 -30.19 56.46 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.042 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.4 m . . . . . 0 N--CA 1.432 -1.363 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.845 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.414 -2.274 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -123.7 143.92 49.97 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.465 ' CE2' ' HG2' ' A' ' 25' ' ' PRO . 72.2 t80 -148.24 151.89 36.23 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.3 ptm -121.22 141.79 50.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' HD2' ' HD2' ' A' ' 12' ' ' PRO . 58.8 tptt -135.94 129.4 18.13 Favored Pre-proline 0 C--N 1.295 -1.786 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.786 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.441 ' HD2' ' HD2' ' A' ' 11' ' ' LYS . 6.1 Cg_exo -79.66 133.94 10.69 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.436 2.091 . . . . 0.0 109.006 170.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 43.4 m-85 -102.64 139.31 38.4 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -176.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.6 mt -104.71 110.26 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.7 t -57.41 -30.42 64.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.342 0.591 . . . . 0.0 111.003 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.35 -34.18 73.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.22 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -103.03 -29.93 11.08 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.527 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 t -70.27 -11.26 60.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.84 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 p -60.55 -30.44 69.77 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.568 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -136.11 -9.72 2.01 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.9 p -157.27 145.1 19.01 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.5 tt -99.44 119.52 38.13 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.77 122.39 32.81 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.097 0.475 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.7 mm -95.53 124.51 52.83 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HG2' ' CE2' ' A' ' 9' ' ' PHE . 84.2 Cg_exo -50.8 134.03 40.52 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.539 2.826 . . . . 0.0 112.073 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.54 -43.03 89.1 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.592 0.757 . . . . 0.0 111.209 -173.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.32 -32.26 83.61 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.83 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.564 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 74.9 t80 -82.8 -36.16 25.81 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.596 HD21 ' HA ' ' A' ' 60' ' ' LYS . 13.7 t30 -59.86 -43.55 94.62 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.968 0.907 . . . . 0.0 110.693 175.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.73 -22.22 66.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.912 0.863 . . . . 0.0 110.587 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.564 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 92.6 t80 -75.63 -26.72 58.02 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.729 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -134.01 93.85 19.41 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 119.433 -0.907 . . . . 0.0 113.065 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.6 Cg_exo -81.63 136.2 9.53 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 121.592 1.528 . . . . 0.0 110.269 171.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.49 153.34 32.1 Favored Pre-proline 0 C--N 1.283 -2.305 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.684 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.27 154.59 62.32 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 121.977 1.785 . . . . 0.0 109.156 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -68.67 126.08 92.4 Favored Pre-proline 0 N--CA 1.419 -1.985 0 CA-C-O 121.231 0.538 . . . . 0.0 110.915 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -87.47 160.54 8.08 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 122.442 2.094 . . . . 0.0 111.243 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.73 -59.14 2.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.4 p -134.6 151.7 51.26 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.487 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -128.82 148.15 33.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -109.94 136.85 48.57 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.201 -0.599 . . . . 0.0 111.53 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 92' ' ' PHE . 76.5 mt -108.39 122.53 47.2 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.07 137.75 39.02 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -113.42 139.35 48.98 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.266 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -58.92 -21.64 58.25 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -85.89 -13.23 48.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.587 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.04 -9.22 7.53 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 119.843 -1.17 . . . . 0.0 114.68 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -88.07 157.85 18.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.567 0.683 . . . . 0.0 111.239 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.7 p -143.04 136.21 28.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 18.1 m-90 -114.73 126.77 55.24 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.391 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.0 m -89.09 114.76 26.04 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.405 HG21 HD23 ' A' ' 63' ' ' LEU . 31.1 m -112.15 156.47 13.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.118 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -101.9 120.43 40.38 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.588 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -123.95 137.07 54.67 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.074 -172.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.588 ' HD2' ' C ' ' A' ' 54' ' ' MET . 4.5 mptp? -133.9 140.68 46.97 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.019 0.438 . . . . 0.0 112.069 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 33' ' ' PRO . 54.6 tttp -105.49 107.89 19.12 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 172.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -108.79 99.87 9.17 Favored 'General case' 1 C--N 1.243 -4.064 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.325 -172.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.44 -116.75 6.76 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.47 -21.16 22.0 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.596 ' HA ' HD21 ' A' ' 29' ' ' ASN . 17.7 ptpt -112.21 165.87 11.78 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -168.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.411 HG12 ' CB ' ' A' ' 56' ' ' LYS . 25.8 m -134.56 146.33 31.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.551 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -142.02 136.55 30.36 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.774 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 3.1 mp -96.75 104.04 16.0 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 169.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.2 p -94.49 -98.7 0.15 Allowed 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -169.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.5 133.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.655 0.74 . . . . 0.0 110.625 -175.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.05 -37.66 3.63 Favored Glycine 0 CA--C 1.481 -2.074 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -63.01 -25.62 68.47 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.851 0.834 . . . . 0.0 109.254 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.671 ' HA ' HG12 ' A' ' 71' ' ' VAL . 16.9 pt-20 -68.58 -26.32 65.33 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.57 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -68.99 -31.64 70.62 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.543 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -74.3 -52.04 13.45 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 68' ' ' GLU . 7.2 p -59.73 -46.88 93.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.431 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.24 -43.35 64.51 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -77.24 -40.2 45.72 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.201 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -84.83 -18.47 34.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.24 0.543 . . . . 0.0 109.582 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 50.4 t30 60.11 90.96 0.05 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.182 1.393 . . . . 0.0 112.846 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.413 ' CD1' HG23 ' A' ' 71' ' ' VAL . 3.8 pp -127.18 151.13 49.09 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.437 ' HG2' ' HD3' ' A' ' 80' ' ' LYS . 15.5 pt-20 -144.06 172.65 12.6 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.652 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 12.2 t70 -53.05 120.42 5.86 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.47 -25.15 6.67 Favored Glycine 0 C--N 1.306 -1.122 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HD3' ' HG2' ' A' ' 77' ' ' GLU . 14.5 mptt -80.8 147.54 30.42 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -126.6 140.65 52.26 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.433 HD22 HG13 ' A' ' 96' ' ' ILE . 61.4 mt -119.66 147.4 44.59 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.103 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 14.9 mm100 -110.72 124.85 52.74 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -112.51 117.67 33.01 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 123.556 0.535 . . . . 0.0 109.761 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 mp -103.91 122.67 56.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.422 ' HE2' ' CE2' ' A' ' 92' ' ' PHE . 64.2 m-85 -109.45 144.61 37.46 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -88.37 -97.47 0.09 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.673 173.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -154.11 20.27 0.5 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 16.2 t70 -143.56 -154.61 0.54 Allowed 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -174.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.506 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 5.6 mpt_? -95.58 29.15 2.7 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.11 0.964 . . . . 0.0 109.252 -175.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -101.98 116.61 33.06 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.313 0.578 . . . . 0.0 110.394 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.422 ' CE2' ' HE2' ' A' ' 86' ' ' TYR . 1.5 m-30 -116.43 122.29 44.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.034 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.441 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 38.5 m-85 -105.74 120.09 40.8 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 32.6 t -111.08 134.32 53.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.995 0.426 . . . . 0.0 112.068 -173.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 2.1 mp -116.2 131.47 68.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.433 HG13 HD22 ' A' ' 82' ' ' LEU . 2.8 mp -105.92 128.01 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 122.432 0.293 . . . . 0.0 111.005 -174.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 C--N 1.311 -1.068 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.89 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.408 HG11 ' OH ' ' A' ' 31' ' ' TYR . 32.9 m . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -130.44 146.6 52.03 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -142.05 148.97 39.33 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.473 ' HG2' ' HG2' ' A' ' 83' ' ' GLN . 64.2 mtt -114.88 137.59 51.79 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HB3' ' NZ ' ' A' ' 11' ' ' LYS . 1.8 ttpm? -142.06 130.8 12.01 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.11 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.61 147.38 86.24 Favored 'Trans proline' 0 C--O 1.248 1.005 0 C-N-CA 122.86 2.373 . . . . 0.0 111.066 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' A' ' 15' ' ' SER . 76.8 t80 -95.41 117.99 31.34 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.1 mm -97.32 106.87 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.772 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.593 ' HB2' ' N ' ' A' ' 78' ' ' ASP . 20.2 t -55.89 -37.57 69.02 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.549 0.531 . . . . 0.0 111.416 -172.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -61.17 -44.01 97.98 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 123.633 0.583 . . . . 0.0 110.626 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -86.46 -40.77 15.0 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.171 -173.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 21' ' ' SER . 26.1 m -84.21 11.9 7.44 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.516 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.3 m -63.13 -33.45 75.49 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 168.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -121.54 -41.83 2.47 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.499 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 18' ' ' SER . 45.7 m -144.84 152.81 40.87 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.189 -175.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 54.9 mt -87.91 132.03 34.37 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-O 121.171 0.51 . . . . 0.0 111.657 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -96.07 117.36 30.54 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.809 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.3 mm -98.49 132.61 23.82 Favored Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.533 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -56.24 142.13 87.65 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 123.195 2.597 . . . . 0.0 112.052 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.513 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 5.7 tt -54.17 -38.98 66.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.984 0.914 . . . . 0.0 111.761 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.5 -35.41 85.35 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.877 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -88.3 -25.02 23.01 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 60' ' ' LYS . 87.8 m-20 -62.71 -46.27 88.88 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.581 0.705 . . . . 0.0 110.034 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -73.68 -12.04 60.6 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.608 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.408 ' OH ' HG11 ' A' ' 7' ' ' VAL . 91.3 t80 -75.99 -28.7 57.92 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -175.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . 0.251 24.7 p90 -130.97 68.28 81.75 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -57.0 135.45 70.93 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 121.957 1.771 . . . . 0.0 111.046 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.69 161.3 29.56 Favored Pre-proline 0 C--N 1.278 -2.516 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.646 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.55 148.94 60.71 Favored 'Trans proline' 0 C--O 1.25 1.12 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 167.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 44.5 p90 -67.85 121.42 79.52 Favored Pre-proline 0 N--CA 1.413 -2.321 0 CA-C-O 121.626 0.727 . . . . 0.0 111.709 -171.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 90' ' ' ARG . 66.4 Cg_endo -96.76 160.74 1.12 Allowed 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 123.628 2.885 . . . . 0.0 112.697 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -108.01 -38.71 4.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.237 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 64.0 p -123.86 159.97 28.46 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.212 0.53 . . . . 0.0 111.9 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 90' ' ' ARG . 7.1 p -146.02 141.88 21.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 173.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -110.0 131.78 54.75 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.158 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -109.92 126.42 53.86 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.92 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.8 145.27 31.4 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.103 0.477 . . . . 0.0 111.914 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 19.2 t70 -113.87 154.93 26.65 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 173.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -91.67 -5.72 53.3 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.6 t -92.55 -23.44 19.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.909 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.87 -37.93 0.76 Allowed Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 118.896 -1.621 . . . . 0.0 114.196 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 84.6 mtm-85 -78.92 158.84 27.96 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 117.849 0.824 . . . . 0.0 113.123 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.6 m -146.38 150.44 35.67 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.284 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.544 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 12.8 m-90 -132.03 120.78 22.87 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.0 m -92.57 114.22 26.71 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 174.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 66' ' ' GLY . 18.2 m -114.83 158.79 15.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.642 -174.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 99.5 mtt180 -99.73 127.4 45.87 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.504 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.431 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 56.5 ttp -114.73 144.33 43.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.414 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -128.9 127.81 42.54 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -99.12 124.53 44.22 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.85 102.03 3.95 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.6 -105.22 0.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.352 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.28 -0.79 52.56 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 123.331 0.652 . . . . 0.0 112.151 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.528 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 84.8 tttt -142.17 147.09 36.03 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 118.515 -1.274 . . . . 0.0 112.922 -172.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.0 t -109.31 132.48 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -121.88 132.01 54.34 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 5.8 mp -101.19 102.61 13.55 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.269 168.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -85.21 -150.52 0.13 Allowed 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 124.62 1.168 . . . . 0.0 111.271 -170.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 62.0 t -55.47 125.9 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-O 121.838 0.827 . . . . 0.0 109.124 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 52' ' ' VAL . . . 135.22 -40.85 1.51 Allowed Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 -169.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.405 ' CZ2' HD21 ' A' ' 22' ' ' LEU . 63.7 t-105 -65.48 -24.84 67.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.729 -0.735 . . . . 0.0 109.64 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.611 ' HA ' HG12 ' A' ' 71' ' ' VAL . 37.2 tt0 -61.29 -30.34 70.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.382 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -58.56 -44.59 89.76 Favored 'General case' 0 C--O 1.198 -1.63 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.757 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -73.0 -46.43 52.28 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.081 0.553 . . . . 0.0 110.062 -176.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.7 p -62.76 -43.25 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.571 0.7 . . . . 0.0 110.058 -175.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -72.07 -43.22 65.2 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.273 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.96 -40.37 54.06 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.11 -21.01 27.86 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 57.8 94.89 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.577 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -142.73 146.18 34.08 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.696 -0.628 . . . . 0.0 111.993 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.21 170.86 8.2 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.188 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.593 ' N ' ' HB2' ' A' ' 15' ' ' SER . 14.8 t70 -53.52 136.74 37.85 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.568 1.147 . . . . 0.0 111.923 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.91 -11.39 22.79 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.421 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.51 161.38 16.25 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.388 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -125.81 137.74 53.79 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.24 144.65 48.49 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.257 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.473 ' HG2' ' HG2' ' A' ' 10' ' ' MET . 50.0 mt-30 -109.72 126.22 53.49 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -110.39 117.33 33.33 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 65.5 mt -97.95 122.51 49.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -105.75 123.4 47.87 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -125.64 80.25 1.88 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 52.25 30.11 7.5 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.285 170.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -161.7 -177.56 5.97 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 40' ' ' VAL . 42.2 ttm180 -95.52 41.74 1.1 Allowed 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 87.5 m -127.14 132.63 50.51 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.802 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 95.7 m-85 -125.29 140.09 53.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.134 0.492 . . . . 0.0 110.805 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.472 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 82.0 m-85 -101.76 126.43 48.62 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.8 t -108.1 119.49 57.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.177 0.513 . . . . 0.0 112.298 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 60.0 mt -112.08 123.82 68.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.6 tt -114.66 139.25 41.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 120.947 0.403 . . . . 0.0 110.667 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.868 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.439 -0.984 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -132.91 154.43 50.41 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -172.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 69.2 t80 -124.77 147.76 48.5 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.21 -1.359 . . . . 0.0 107.552 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -140.18 134.02 30.58 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -153.91 151.1 24.09 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.542 174.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -77.08 136.75 16.63 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.752 2.301 . . . . 0.0 108.69 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 24.5 p90 -103.09 137.39 41.33 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.188 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 16' ' ' GLU . 2.3 mp -101.97 123.75 55.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 19.5 m -53.49 -25.31 15.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.005 0.922 . . . . 0.0 112.584 -173.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.404 ' H ' HG22 ' A' ' 14' ' ' ILE . 43.9 tt0 -60.73 -40.49 92.57 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.277 1.031 . . . . 0.0 110.655 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -103.05 -36.78 8.04 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.574 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 89.4 p -66.05 -8.07 21.13 Favored 'General case' 0 C--O 1.215 -0.763 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -172.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.0 m -73.9 -17.66 61.01 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.8 173.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -134.55 -33.35 0.97 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 18' ' ' SER . 49.4 p -147.36 170.23 17.78 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -171.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 3.1 tm? -133.72 113.44 12.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.8 131.49 35.91 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.725 ' HB ' HG23 ' A' ' 61' ' ' VAL . 58.8 mt -113.41 132.48 22.47 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -57.14 148.79 67.36 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 123.126 2.55 . . . . 0.0 113.407 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.5 tt -62.74 -33.87 76.03 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.064 0.946 . . . . 0.0 108.871 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.25 -35.96 86.79 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.511 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.429 ' CE2' ' HE1' ' A' ' 32' ' ' PHE . 57.8 t80 -80.15 -20.51 44.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.364 0.602 . . . . 0.0 109.551 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -66.51 -43.34 85.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.3 -11.14 60.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.491 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -72.18 -25.31 61.63 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.429 ' HE1' ' CE2' ' A' ' 28' ' ' PHE . 5.1 p90 -167.74 95.94 0.63 Allowed Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 121.063 0.459 . . . . 0.0 111.683 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.99 135.35 13.89 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.852 1.702 . . . . 0.0 110.202 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.431 ' H ' ' HE2' ' A' ' 56' ' ' LYS . . . -152.77 160.38 31.16 Favored Pre-proline 0 C--N 1.28 -2.427 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.54 153.61 73.83 Favored 'Trans proline' 0 C--O 1.251 1.168 0 C-N-CA 121.449 1.433 . . . . 0.0 108.386 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -69.07 131.8 90.55 Favored Pre-proline 0 N--CA 1.411 -2.412 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.444 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.6 156.18 28.04 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 122.211 1.941 . . . . 0.0 110.313 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.3 mm -83.53 -39.76 15.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -154.75 160.5 41.36 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' NH2' ' A' ' 90' ' ' ARG . 34.2 m -135.5 158.75 40.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -113.35 134.4 54.65 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.876 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -108.89 120.73 43.37 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -104.22 157.61 17.01 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.497 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 4.5 t70 -111.74 146.06 38.23 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.09 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -64.72 -26.88 68.56 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.789 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 m -89.89 -47.69 7.72 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 122.33 -0.231 . . . . 0.0 111.023 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.22 -8.21 0.05 OUTLIER Glycine 0 CA--C 1.525 0.707 0 C-N-CA 119.396 -1.383 . . . . 0.0 114.679 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -73.76 159.47 32.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.162 0.481 . . . . 0.0 111.501 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 p -147.13 136.72 22.89 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.497 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 16.8 m-90 -131.64 142.41 49.85 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.826 0.346 . . . . 0.0 110.378 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 73.4 m -106.59 114.44 28.54 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.2 m -125.74 156.94 35.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.391 -174.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -100.85 128.68 46.79 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.277 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 1.1 tmt? -127.84 143.73 51.11 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -135.0 143.57 46.88 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.012 0.434 . . . . 0.0 111.899 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HA ' HG12 ' A' ' 61' ' ' VAL . 29.1 mmmt -92.43 121.27 33.73 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 102.873 -3.01 . . . . 0.0 102.873 169.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -134.65 98.0 3.94 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.374 -170.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.45 -109.82 3.12 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.947 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.621 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -105.86 -7.93 17.98 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.979 0.419 . . . . 0.0 110.275 -178.544 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 61' ' ' VAL . 41.7 ttmt -118.78 167.7 11.44 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.725 HG23 ' HB ' ' A' ' 24' ' ' ILE . 32.7 m -128.65 142.27 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -140.74 132.39 27.2 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -173.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 67' ' ' TRP . 5.5 tt -97.47 115.81 28.49 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 176.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.7 t -101.31 -142.73 0.34 Allowed 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.085 -170.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.6 m -56.1 143.78 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 124.397 1.079 . . . . 0.0 112.811 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.89 -31.86 6.31 Favored Glycine 0 N--CA 1.421 -2.357 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.475 ' HB2' HD22 ' A' ' 63' ' ' LEU . 57.1 t-105 -54.61 -27.04 36.51 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.609 0.719 . . . . 0.0 110.467 177.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.669 ' HA ' HG12 ' A' ' 71' ' ' VAL . 13.8 pt-20 -63.83 -26.63 68.7 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.204 -175.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -61.58 -37.71 84.89 Favored 'General case' 0 C--O 1.2 -1.552 0 CA-C-O 120.973 0.415 . . . . 0.0 110.098 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -73.95 -48.13 32.7 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.825 0.85 . . . . 0.0 110.765 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.2 p -65.54 -42.25 92.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.351 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -71.29 -39.81 71.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.752 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -71.8 -38.62 70.22 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -95.56 0.27 52.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.5 t30 55.63 82.81 0.1 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.99 0.9 . . . . 0.0 109.681 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 92.8 mt -120.86 136.0 55.03 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.891 -173.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -138.78 158.67 43.8 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -54.32 128.32 30.96 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 124.348 1.03 . . . . 0.0 111.009 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.24 -35.75 1.93 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -92.56 164.31 13.48 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.411 ' HB2' ' HB2' ' A' ' 97' ' ' TYR . 37.9 m-85 -132.67 154.4 50.17 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -113.2 147.59 37.17 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.403 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.466 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 49.5 tt0 -115.25 123.98 50.19 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 171.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 86.2 m-85 -109.2 116.32 31.68 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.3 mt -110.64 125.29 67.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.411 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 34.3 p90 -119.72 155.58 32.18 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.025 -1.47 . . . . 0.0 108.844 173.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -96.31 -79.92 0.44 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.271 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -143.42 16.49 1.85 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.909 0.385 . . . . 0.0 110.053 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 33.6 t70 -133.44 -175.07 3.69 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -174.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.475 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -95.09 20.51 8.97 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 125.439 1.495 . . . . 0.0 111.762 -177.773 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.3 t -110.33 132.98 53.7 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 81.3 m-85 -112.96 140.57 47.66 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.185 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -98.32 117.6 33.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 43.1 t -104.67 134.63 45.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.325 0.584 . . . . 0.0 112.258 -173.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.2 mt -120.29 134.33 64.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 96' ' ' ILE . 2.1 mp -100.65 121.5 51.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 120.643 0.259 . . . . 0.0 110.465 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 83' ' ' GLN . 97.1 m-85 . . . . . 0 CA--C 1.506 -0.739 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.869 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.421 -1.891 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -137.04 151.81 49.37 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.743 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -142.66 149.37 38.8 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.9 ptp -138.23 154.74 49.08 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.579 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 24.3 ttpp -152.98 145.96 17.61 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.42 142.7 16.86 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.102 2.534 . . . . 0.0 111.341 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.46 ' CZ ' HD13 ' A' ' 76' ' ' LEU . 71.4 t80 -110.75 123.88 50.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 16' ' ' GLU . 61.4 mt -126.26 113.09 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.6 p -58.38 -9.46 1.58 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' H ' HG22 ' A' ' 14' ' ' ILE . 42.1 mt-10 -81.4 -28.23 34.42 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 122.148 -0.345 . . . . 0.0 110.921 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -110.61 -38.01 5.3 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.321 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 21' ' ' SER . 65.0 p -75.24 -0.45 19.51 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.225 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.5 p -75.18 -25.08 57.98 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.513 0.673 . . . . 0.0 110.409 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -115.94 -37.45 3.87 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.492 -175.593 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 18' ' ' SER . 34.5 p -153.67 169.6 22.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -171.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 4.2 tt -108.04 115.13 29.57 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.579 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 14.8 pt-20 -75.15 115.51 14.87 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.46 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 61' ' ' VAL . 68.0 mt -106.63 123.42 38.75 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.54 147.11 88.27 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 123.396 2.731 . . . . 0.0 114.376 -176.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 4.9 tt -59.12 -39.78 83.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.513 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.51 -31.16 69.85 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.749 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -82.62 -24.22 33.94 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.5 0.667 . . . . 0.0 109.759 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.439 ' HB2' HG23 ' A' ' 61' ' ' VAL . 55.1 t30 -76.08 -46.3 29.7 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.54 -20.0 66.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.038 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.39 -26.98 65.83 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.717 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -168.54 103.24 0.52 Allowed Pre-proline 0 C--O 1.248 1.009 0 CA-C-O 121.239 0.542 . . . . 0.0 110.555 177.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.21 135.14 14.9 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 120.968 1.112 . . . . 0.0 109.797 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.65 148.97 21.39 Favored Pre-proline 0 C--N 1.276 -2.6 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.74 133.85 41.18 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 121.811 1.674 . . . . 0.0 108.534 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.71 ' HB3' ' H ' ' A' ' 56' ' ' LYS . 39.4 p90 -69.78 139.92 88.78 Favored Pre-proline 0 N--CA 1.414 -2.268 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -75.72 158.63 39.3 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.874 2.383 . . . . 0.0 109.905 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.36 -54.89 12.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.5 p -133.44 150.44 51.75 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.601 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 m -131.94 157.18 43.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -109.98 139.59 44.91 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.641 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.461 HD23 ' HB2' ' A' ' 92' ' ' PHE . 77.7 mt -108.24 121.89 45.82 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.3 137.96 38.95 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.94 150.95 29.79 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.024 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.58 -22.95 65.66 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.281 0.633 . . . . 0.0 112.445 -175.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.9 t -82.46 3.05 29.81 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.099 0.476 . . . . 0.0 110.175 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 8.9 67.66 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 121.358 -0.448 . . . . 0.0 112.264 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -89.27 154.97 19.68 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.1 p -141.19 137.84 32.94 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 120.863 0.363 . . . . 0.0 111.402 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -124.3 142.13 51.51 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.217 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.5 m -100.18 120.39 39.82 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.518 ' HB ' HD21 ' A' ' 63' ' ' LEU . 22.9 m -123.31 157.25 29.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.596 -174.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -101.2 139.82 36.35 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.829 0.347 . . . . 0.0 110.258 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 25.3 ttt -134.26 127.22 31.4 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.517 -172.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -120.69 124.93 46.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.018 0.437 . . . . 0.0 111.31 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.71 ' H ' ' HB3' ' A' ' 36' ' ' PHE . 25.3 mmmt -100.39 105.49 16.99 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 175.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -149.93 115.47 5.53 Favored 'General case' 0 C--N 1.265 -3.102 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.94 -120.17 5.15 Favored Glycine 0 N--CA 1.418 -2.541 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.441 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.434 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 31.0 mt-10 -96.03 -27.97 14.86 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.521 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -120.99 170.32 9.62 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.883 0.849 . . . . 0.0 112.876 -172.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.541 HG22 ' HD2' ' A' ' 56' ' ' LYS . 47.5 t -120.69 127.3 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 173.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -119.8 129.1 54.29 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 6.6 tt -103.96 118.09 35.86 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.4 p -99.16 -144.38 0.32 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.9 m -54.77 144.88 5.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.89 1.276 . . . . 0.0 113.154 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.464 ' C ' HG12 ' A' ' 52' ' ' VAL . . . 114.94 -41.54 2.14 Favored Glycine 0 N--CA 1.418 -2.532 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 -170.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.514 ' CZ3' HD12 ' A' ' 22' ' ' LEU . 58.0 t-105 -62.38 -26.9 68.71 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 114.259 -0.971 . . . . 0.0 109.248 174.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.571 ' HA ' HG12 ' A' ' 71' ' ' VAL . 30.5 tt0 -69.39 -26.77 64.81 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.524 -177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -70.28 -30.84 67.96 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 67' ' ' TRP . 53.1 t80 -73.03 -52.47 14.26 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 124.527 1.131 . . . . 0.0 109.278 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.1 p -64.61 -41.21 91.61 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.973 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -70.59 -48.14 56.69 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.679 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.83 -40.36 69.15 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.709 -173.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -88.62 -19.08 26.71 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.973 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.0 t30 56.22 92.38 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.041 0.936 . . . . 0.0 110.993 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.46 HD13 ' CZ ' ' A' ' 13' ' ' PHE 0.289 0.9 OUTLIER -142.09 132.1 24.55 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -176.977 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.83 173.46 9.54 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 125.849 1.66 . . . . 0.0 109.017 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -52.71 135.92 34.29 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.693 0.62 . . . . 0.0 110.54 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.68 -28.22 3.27 Favored Glycine 0 C--N 1.301 -1.414 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -107.67 150.47 26.88 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.834 -0.683 . . . . 0.0 109.447 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -122.31 146.65 47.1 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.1 mt -110.76 135.88 50.67 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.104 0.478 . . . . 0.0 112.004 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -118.02 124.42 48.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.87 117.88 34.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.936 0.398 . . . . 0.0 110.969 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.775 HG13 ' HB2' ' A' ' 93' ' ' TYR . 11.7 pt -105.36 130.19 57.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -106.41 143.77 34.05 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.267 0.556 . . . . 0.0 111.41 -173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -92.59 -0.75 57.27 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 74.96 8.4 4.13 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.932 1.693 . . . . 0.0 109.175 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 31.5 t70 -106.08 -159.36 0.7 Allowed 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.553 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 53.4 ttp180 -95.7 11.95 31.61 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 p -108.39 117.84 35.22 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.626 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.461 ' HB2' HD23 ' A' ' 42' ' ' LEU . 3.4 m-85 -107.42 126.46 52.52 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.491 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.775 ' HB2' HG13 ' A' ' 85' ' ' ILE . 78.9 m-85 -104.27 126.98 51.83 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.1 p -119.32 135.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.167 0.508 . . . . 0.0 111.724 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.1 mt -114.45 123.01 69.71 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.4 mt -103.56 112.69 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.578 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 25.2 p90 . . . . . 0 C--N 1.307 -1.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.807 176.655 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -125.23 159.6 31.22 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-O 121.082 0.468 . . . . 0.0 112.195 -172.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -148.89 148.83 30.32 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.9 ptp -138.28 141.01 39.85 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.652 0.263 . . . . 0.0 111.348 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.66 157.05 31.39 Favored Pre-proline 0 C--N 1.312 -1.025 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.82 132.53 15.79 Favored 'Trans proline' 0 N--CA 1.439 -1.728 0 C-N-CA 120.989 1.126 . . . . 0.0 109.681 172.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' A' ' 76' ' ' LEU . 30.3 p90 -84.44 140.47 31.49 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 123.564 0.746 . . . . 0.0 110.232 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.6 mt -90.59 120.88 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.439 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 28.8 t -53.44 -37.11 62.28 Favored 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.716 0.635 . . . . 0.0 111.89 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.76 -40.57 97.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -87.02 -39.32 15.75 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.823 0.821 . . . . 0.0 108.933 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 21' ' ' SER . 48.4 m -76.04 4.14 9.0 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 114.45 -1.25 . . . . 0.0 113.016 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.1 m -71.61 -20.02 62.04 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.227 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -136.22 -36.17 0.74 Allowed 'General case' 0 C--O 1.214 -0.808 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.628 ' O ' ' HA ' ' A' ' 18' ' ' SER . 58.4 p -138.95 168.06 20.66 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.608 -0.437 . . . . 0.0 112.138 -175.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.07 131.73 47.34 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -89.34 131.82 35.24 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 121.41 0.624 . . . . 0.0 111.922 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 47.3 mm -94.89 132.93 27.28 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.1 144.43 69.42 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.883 2.389 . . . . 0.0 112.984 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.0 tp -65.58 -33.41 75.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.326 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.66 -36.21 93.04 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . 45.2 m-85 -77.84 -25.71 48.92 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -59.21 -46.33 88.74 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.19 -31.98 62.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.211 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 64.0 t80 -68.81 -28.55 66.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.369 -174.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -151.09 93.51 3.64 Favored Pre-proline 0 C--O 1.247 0.95 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -83.64 136.0 7.16 Favored 'Trans proline' 0 N--CA 1.429 -2.274 0 C-N-CA 122.264 1.976 . . . . 0.0 108.812 167.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.71 160.53 31.54 Favored Pre-proline 0 C--N 1.264 -3.127 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -175.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.2 132.78 53.3 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 107.342 -1.83 . . . . 0.0 107.342 172.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -68.22 115.74 32.16 Favored Pre-proline 0 N--CA 1.41 -2.446 0 CA-C-O 121.285 0.564 . . . . 0.0 112.002 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -80.45 135.48 10.58 Favored 'Trans proline' 0 N--CA 1.433 -2.079 0 C-N-CA 121.942 1.762 . . . . 0.0 110.062 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.9 mm -81.48 -28.79 10.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.6 p -127.66 148.73 50.39 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 121.497 0.665 . . . . 0.0 110.15 173.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 90' ' ' ARG . 53.4 t -142.83 147.31 20.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -115.83 133.96 55.49 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.725 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt -108.15 121.78 45.56 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -101.23 137.47 39.54 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.962 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -113.11 141.6 46.71 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.242 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -57.93 -29.78 65.42 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 125.353 1.461 . . . . 0.0 113.717 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.5 t -86.1 -4.57 59.2 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 122.094 -0.379 . . . . 0.0 110.487 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.21 -4.85 23.62 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.651 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -80.73 158.51 25.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.775 0.322 . . . . 0.0 110.568 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 p -156.34 135.38 11.98 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.219 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -125.51 135.77 52.64 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.687 0.279 . . . . 0.0 110.91 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.2 m -92.32 114.8 27.45 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.427 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 33.6 m -115.63 157.66 16.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.343 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 53' ' ' ARG . 23.8 ttt180 -101.34 127.39 47.98 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.398 0.618 . . . . 0.0 109.768 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.5 ttt -110.13 144.33 38.9 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.547 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HG3' ' HB2' ' A' ' 57' ' ' ARG . 59.7 tptt -139.32 125.69 20.3 Favored 'General case' 0 N--CA 1.412 -2.366 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.156 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.56 ' HD2' HG22 ' A' ' 61' ' ' VAL . 28.5 mmmt -92.01 113.25 25.47 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 79.6 ttt180 -135.84 97.99 3.78 Favored 'General case' 0 C--N 1.272 -2.79 0 CA-C-O 120.985 0.421 . . . . 0.0 112.096 -173.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.92 -87.92 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 116.638 1.415 . . . . 0.0 116.638 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -89.57 -24.84 21.62 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.614 -0.293 . . . . 0.0 111.612 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -154.08 171.09 19.65 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.927 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.56 HG22 ' HD2' ' A' ' 56' ' ' LYS . 48.5 t -108.31 131.3 59.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -120.97 132.48 54.95 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 tt -102.34 103.8 14.27 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 53.4 p -95.03 -103.65 0.15 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.5 m -69.84 144.21 14.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.455 0.645 . . . . 0.0 112.083 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 109.61 -37.77 3.63 Favored Glycine 0 CA--C 1.483 -1.954 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.411 ' O ' ' HB3' ' A' ' 70' ' ' PHE . 63.6 t-105 -61.23 -24.9 66.69 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 122.084 0.945 . . . . 0.0 109.191 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.546 ' HA ' HG12 ' A' ' 71' ' ' VAL . 13.0 pt-20 -65.68 -30.12 70.77 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.357 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -74.68 -29.46 61.24 Favored 'General case' 0 C--O 1.202 -1.413 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 67' ' ' TRP . 16.1 t80 -73.28 -52.36 14.24 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 124.763 1.225 . . . . 0.0 108.454 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.1 p -61.1 -45.32 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.443 -177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -71.91 -34.06 68.8 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.21 -39.55 63.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.387 -174.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -90.25 -18.75 25.09 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.898 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.1 t30 54.82 83.92 0.08 Allowed 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.164 0.986 . . . . 0.0 109.698 -172.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.489 HD13 ' CE2' ' A' ' 13' ' ' PHE . 1.3 pp -133.98 148.54 51.15 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -175.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -143.85 172.31 13.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.126 -174.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.439 ' H ' ' HB2' ' A' ' 15' ' ' SER . 5.4 p-10 -56.78 141.11 45.52 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 123.704 0.627 . . . . 0.0 111.38 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 117.51 -16.01 12.75 Favored Glycine 0 C--N 1.302 -1.318 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -174.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -104.39 159.22 15.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 97' ' ' TYR . 33.2 m-85 -120.99 136.82 54.89 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -173.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.8 pp -114.92 138.97 50.19 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.966 176.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.551 ' NE2' HD12 ' A' ' 95' ' ' ILE . 27.2 tt0 -124.24 124.01 41.5 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.455 ' CE2' HD13 ' A' ' 82' ' ' LEU . 86.9 m-85 -108.7 131.86 54.5 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 59.2 mt -97.65 116.05 39.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HD2' ' CE1' ' A' ' 92' ' ' PHE . 53.8 m-85 -107.05 126.79 52.8 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -110.63 16.95 21.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 118.596 -1.241 . . . . 0.0 109.282 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 63.75 80.4 0.23 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.583 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -172.82 -168.67 0.51 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.46 ' O ' HG13 ' A' ' 40' ' ' VAL . 51.5 ptt85 -107.55 24.87 12.21 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 118.412 0.551 . . . . 0.0 109.749 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -129.27 117.35 20.54 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.414 ' CE1' ' HD2' ' A' ' 86' ' ' TYR . 26.9 m-85 -121.45 137.88 54.53 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.576 -176.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -100.4 125.99 46.72 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.6 p -109.66 137.98 39.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-O 121.599 0.714 . . . . 0.0 112.5 -175.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.551 HD12 ' NE2' ' A' ' 83' ' ' GLN . 66.7 mt -118.61 125.89 74.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.6 mt -113.01 125.43 70.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.549 0.69 . . . . 0.0 111.158 -174.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 62.6 m-85 . . . . . 0 C--N 1.294 -1.845 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.444 -0.751 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -121.84 148.01 45.24 Favored 'General case' 0 N--CA 1.406 -2.652 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -147.09 148.95 32.14 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -134.68 138.54 44.52 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.571 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -148.48 144.88 19.07 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.9 133.56 5.02 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 121.988 1.792 . . . . 0.0 108.105 168.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -100.3 142.34 31.91 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 122.336 -0.227 . . . . 0.0 110.621 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.442 ' HB ' ' HG2' ' A' ' 17' ' ' LYS . 81.5 mt -88.36 114.67 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.527 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 28.9 t -53.68 -34.18 57.85 Favored 'General case' 0 C--O 1.212 -0.872 0 O-C-N 123.648 0.592 . . . . 0.0 111.121 -174.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.5 -39.83 89.15 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.667 -177.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HG2' ' HB ' ' A' ' 14' ' ' ILE . 20.7 ptmt -104.77 -26.88 12.08 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.811 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 21' ' ' SER . 68.4 m -92.56 14.44 16.86 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.8 m -74.2 -16.39 60.98 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 118.885 -1.126 . . . . 0.0 109.919 166.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -114.51 -47.67 2.9 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 18' ' ' SER . 49.2 m -143.35 168.68 19.23 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 122.972 0.509 . . . . 0.0 110.39 -172.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.494 HD22 ' CZ3' ' A' ' 67' ' ' TRP . 43.9 tp -126.24 142.17 51.63 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.305 0.242 . . . . 0.0 110.751 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -98.37 124.69 43.17 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 120.681 0.276 . . . . 0.0 110.661 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 2.1 mp -97.25 133.38 24.02 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.53 139.29 17.89 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 123.925 3.083 . . . . 0.0 114.787 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.5 tt -62.7 -41.08 98.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.163 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.1 -36.11 92.45 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.406 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 75.7 t80 -73.72 -34.2 64.69 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -63.51 -46.46 85.94 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.853 0.835 . . . . 0.0 110.021 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -72.88 -11.07 60.45 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.842 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 89.1 t80 -74.76 -27.68 60.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.377 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 27.6 p90 -147.07 121.07 5.05 Favored Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.817 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 4.5 Cg_exo -76.74 134.64 15.2 Favored 'Trans proline' 0 N--CA 1.44 -1.676 0 C-N-CA 121.832 1.688 . . . . 0.0 108.87 172.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.08 138.46 11.59 Favored Pre-proline 0 C--N 1.271 -2.805 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.92 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 143.85 96.72 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 106.557 -2.132 . . . . 0.0 106.557 167.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 51.8 p90 -68.79 121.93 83.08 Favored Pre-proline 0 N--CA 1.41 -2.471 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.162 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 36' ' ' PHE . 11.9 Cg_exo -71.09 152.56 62.47 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 121.913 1.742 . . . . 0.0 110.086 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.0 mm -86.78 -59.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -124.72 151.01 45.58 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.706 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.48 162.29 29.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 91' ' ' THR . 24.8 t70 -124.89 140.09 53.24 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.042 -175.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.3 mt -107.79 127.58 53.83 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.15 147.72 25.91 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.798 0.809 . . . . 0.0 111.793 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 2.3 t70 -112.14 137.14 50.63 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.528 173.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -70.31 -8.88 53.87 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.5 t -92.18 -41.73 10.28 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.87 0.03 0.11 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.11 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 17.9 mmt180 -88.88 158.95 17.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 117.643 0.722 . . . . 0.0 110.731 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.7 p -149.51 146.56 27.45 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.46 ' CE3' ' HD1' ' A' ' 70' ' ' PHE . 24.3 m-90 -130.04 123.71 31.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.415 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.9 m -89.68 117.0 28.22 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.585 ' HB ' HD21 ' A' ' 63' ' ' LEU . 22.2 m -124.95 157.23 33.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.686 -172.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -102.62 122.93 45.39 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.255 0.55 . . . . 0.0 111.517 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.428 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 50.8 ttp -124.82 131.18 53.47 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.63 161.84 38.15 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 61' ' ' VAL . 78.8 mttt -91.29 129.86 37.23 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -132.11 103.15 6.11 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.392 0.615 . . . . 0.0 110.951 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.27 -101.27 0.73 Allowed Glycine 0 N--CA 1.431 -1.65 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.565 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.432 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 39.7 mt-10 -95.23 -20.68 19.0 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.383 -0.408 . . . . 0.0 111.061 -175.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -131.56 166.64 20.94 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.487 0.66 . . . . 0.0 112.623 -170.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.538 HG22 ' HG2' ' A' ' 56' ' ' LYS . 90.1 t -97.42 136.92 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 170.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -135.19 132.88 38.48 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.132 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.696 HD22 ' HB2' ' A' ' 67' ' ' TRP . 3.7 tt -99.14 116.86 32.31 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.3 p -90.0 -92.16 0.13 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.67 145.15 8.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 C-N-CA 124.967 1.307 . . . . 0.0 113.205 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.414 ' C ' HG12 ' A' ' 52' ' ' VAL . . . 109.28 -36.4 4.36 Favored Glycine 0 CA--C 1.477 -2.311 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.566 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.696 ' HB2' HD22 ' A' ' 63' ' ' LEU . 64.5 t-105 -58.68 -26.15 63.54 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.706 0.765 . . . . 0.0 109.906 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.642 ' HA ' HG12 ' A' ' 71' ' ' VAL . 15.8 pt-20 -72.39 -26.22 61.8 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.535 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -71.99 -37.92 69.76 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.46 ' HD1' ' CE3' ' A' ' 50' ' ' TRP . 69.0 t80 -72.89 -51.29 19.21 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.072 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -62.66 -44.59 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.65 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -73.47 -43.72 59.6 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.12 -40.05 78.55 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.532 -0.867 . . . . 0.0 112.891 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -85.14 -14.56 46.63 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t30 60.77 82.75 0.16 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 125.204 1.402 . . . . 0.0 112.173 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -115.64 159.08 21.79 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.388 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -143.96 165.06 28.8 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.527 ' H ' ' HB2' ' A' ' 15' ' ' SER . 14.1 t70 -53.16 120.95 6.56 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 124.072 0.858 . . . . 0.0 109.414 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.98 -29.38 3.73 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -80.85 154.48 27.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.477 ' C ' HD12 ' A' ' 82' ' ' LEU . 94.8 m-85 -122.05 135.15 54.8 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 81' ' ' TYR . 6.4 mp -123.26 130.75 53.18 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.111 0.481 . . . . 0.0 111.224 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -112.83 124.11 51.84 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -108.99 118.04 35.77 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.355 -173.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 63.2 mt -98.23 118.29 44.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.29 -0.413 . . . . 0.0 109.937 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -106.47 123.48 48.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -81.79 -78.78 0.18 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -176.82 24.23 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.59 -172.99 2.43 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.97 29.44 2.4 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-O 121.638 0.732 . . . . 0.0 109.078 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 17.5 p -125.38 136.66 53.67 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.078 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -118.13 135.25 54.33 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.375 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 57.2 m-85 -100.48 113.64 26.59 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.0 t -98.7 124.79 52.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.693 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.1 mm -105.75 116.46 49.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 96' ' ' ILE . 3.0 mp -102.15 130.28 52.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--N 1.304 -1.378 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.223 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 9.8 pt20 -121.9 146.1 47.44 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.37 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 83' ' ' GLN . 88.6 t80 -129.63 148.59 51.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -124.9 146.24 49.43 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 120.641 0.257 . . . . 0.0 110.676 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HE2' ' HG3' ' A' ' 23' ' ' GLU . 24.1 ttpp -154.14 139.88 12.32 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 174.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.03 146.19 81.6 Favored 'Trans proline' 0 C--O 1.257 1.467 0 C-N-CA 122.032 1.821 . . . . 0.0 110.709 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -78.62 119.45 21.9 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 16' ' ' GLU . 68.1 mt -107.52 120.2 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.239 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 78' ' ' ASP . 32.1 t -66.74 -10.9 51.87 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 123.273 0.629 . . . . 0.0 111.413 -172.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.467 ' H ' HG22 ' A' ' 14' ' ' ILE . 46.6 mt-10 -75.5 -46.18 33.85 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.531 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.498 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 3.5 mppt? -113.17 -41.89 3.62 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 118.394 -1.322 . . . . 0.0 113.543 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 21' ' ' SER . 15.6 m -69.43 -3.74 15.68 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 123.57 0.544 . . . . 0.0 111.091 -174.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.0 p -74.31 -25.51 59.62 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -133.13 -23.33 1.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.975 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.562 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 51.0 m -150.48 169.16 22.15 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -175.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 63' ' ' LEU 0.308 42.7 mt -103.86 131.35 51.15 Favored 'General case' 0 CA--C 1.488 -1.408 0 CA-C-O 122.391 1.091 . . . . 0.0 113.875 177.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.498 ' OE2' ' HB2' ' A' ' 17' ' ' LYS . 6.7 pt-20 -91.33 111.27 22.68 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 112.324 -2.216 . . . . 0.0 108.973 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.86 121.68 36.46 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.614 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.51 153.75 76.87 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 123.045 2.497 . . . . 0.0 113.154 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.88 -34.8 74.05 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.882 -175.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.21 -28.8 73.96 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.688 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -75.88 -31.21 59.14 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.276 0.631 . . . . 0.0 110.166 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -76.16 -26.23 56.04 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.565 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -75.32 -17.42 60.26 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.662 0.744 . . . . 0.0 109.324 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -74.1 -28.24 61.27 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.92 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -161.35 80.45 2.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 121.617 0.722 . . . . 0.0 112.1 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.37 140.62 15.43 Favored 'Trans proline' 0 N--CA 1.43 -2.244 0 C-N-CA 122.343 2.029 . . . . 0.0 111.499 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.8 159.21 36.36 Favored Pre-proline 0 C--N 1.278 -2.519 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.93 146.34 87.24 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 121.888 1.725 . . . . 0.0 108.935 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -69.05 117.42 51.63 Favored Pre-proline 0 N--CA 1.415 -2.178 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -175.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.66 159.84 31.61 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.878 2.385 . . . . 0.0 111.534 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.17 -41.34 22.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -137.03 150.53 48.15 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.671 0.748 . . . . 0.0 112.219 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 90' ' ' ARG . 74.2 t -132.45 160.04 42.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.88 130.96 34.63 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.48 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.402 ' CD2' ' HB2' ' A' ' 92' ' ' PHE . 79.7 mt -109.62 133.81 52.67 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.208 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.44 143.32 32.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.877 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.512 ' HB2' ' HZ3' ' A' ' 50' ' ' TRP . 9.7 t70 -112.9 147.69 36.51 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.681 174.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -60.34 -23.81 64.55 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 124.228 1.011 . . . . 0.0 112.866 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -80.28 -12.75 59.58 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.847 -0.533 . . . . 0.0 110.404 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.25 1.35 25.02 Favored Glycine 0 C--O 1.239 0.445 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.299 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 98.1 mtt180 -80.6 157.42 26.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.2 p -150.53 136.75 18.62 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 120.59 0.233 . . . . 0.0 110.512 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.512 ' HZ3' ' HB2' ' A' ' 44' ' ' ASP . 15.8 m-90 -124.53 130.47 52.52 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.145 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.1 m -89.98 114.48 26.33 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HB ' HD21 ' A' ' 63' ' ' LEU . 28.6 m -112.03 156.81 13.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.814 -173.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.546 ' HB2' HG23 ' A' ' 64' ' ' THR . 85.6 mtt180 -102.79 119.96 39.76 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.473 ' HB3' HG21 ' A' ' 40' ' ' VAL . 60.4 ttp -124.62 123.72 40.67 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -136.75 162.68 32.53 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HD3' HG22 ' A' ' 61' ' ' VAL . 29.7 mmtp -88.72 128.62 35.62 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 175.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.49 100.62 5.21 Favored 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -175.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.84 -112.2 3.61 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -175.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -112.3 -5.77 14.12 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.886 0.85 . . . . 0.0 110.321 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -113.69 170.67 8.09 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.213 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.529 HG22 ' HD3' ' A' ' 56' ' ' LYS . 57.9 t -108.58 127.28 65.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -126.68 130.59 50.7 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 6.7 tt -103.15 120.96 41.66 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.546 HG23 ' HB2' ' A' ' 53' ' ' ARG . 5.6 t -96.43 -144.55 0.28 Allowed 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 123.161 0.584 . . . . 0.0 111.546 -172.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.47 143.88 6.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 125.43 1.492 . . . . 0.0 111.689 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 125.35 -48.42 0.96 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -65.36 -24.91 67.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.394 -0.903 . . . . 0.0 110.176 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.459 ' HA ' HG12 ' A' ' 71' ' ' VAL . 35.2 tt0 -65.5 -29.87 70.57 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.796 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -69.48 -35.89 76.02 Favored 'General case' 0 C--O 1.198 -1.634 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.347 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -68.57 -49.7 57.41 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 123.409 0.683 . . . . 0.0 109.204 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 6.8 p -63.67 -33.68 63.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.223 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -71.23 -48.64 50.07 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.039 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -72.34 -39.56 68.06 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -96.96 -10.0 27.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.749 -0.595 . . . . 0.0 111.278 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 7.9 t30 53.99 94.86 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.233 1.413 . . . . 0.0 112.932 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 71' ' ' VAL . 3.8 mp -122.21 133.75 54.72 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.749 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.09 169.99 10.65 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 124.21 1.004 . . . . 0.0 108.979 174.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 6.3 p-10 -60.66 141.47 56.73 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.216 0.531 . . . . 0.0 111.302 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.09 -29.45 5.99 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -80.84 154.33 27.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.862 0.363 . . . . 0.0 110.404 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -122.56 140.73 52.46 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mp -124.51 144.12 50.29 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.745 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 14.6 pt20 -116.23 137.27 52.28 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 85.9 m-85 -111.81 117.61 33.29 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 48.9 mt -97.62 114.72 35.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.482 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 24.3 p90 -130.56 157.86 41.55 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.734 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -107.66 25.1 11.92 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.61 13.49 2.94 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 125.145 1.378 . . . . 0.0 111.82 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.556 ' OD2' HG22 ' A' ' 91' ' ' THR . 7.8 p-10 -96.35 -159.63 0.74 Allowed 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.585 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -105.5 15.72 26.64 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -176.012 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.556 HG22 ' OD2' ' A' ' 89' ' ' ASP . 5.5 t -121.41 139.8 52.98 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 117.789 -1.564 . . . . 0.0 109.197 172.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.482 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 71.6 m-85 -128.13 136.46 51.17 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 122.122 -0.361 . . . . 0.0 110.67 -175.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.435 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 61.3 m-85 -94.59 120.46 34.85 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.5 t -103.71 117.71 49.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 120.99 0.424 . . . . 0.0 111.496 -174.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.439 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 65.0 mt -114.61 124.49 71.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 96' ' ' ILE . 2.6 mp -94.15 140.66 16.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 121.583 0.706 . . . . 0.0 111.328 177.928 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -116.42 145.63 43.11 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.019 0.438 . . . . 0.0 111.781 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -140.37 149.81 43.14 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.574 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 23.6 ptp -126.18 144.47 50.75 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -151.57 146.2 18.61 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 178.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 7.0 Cg_exo -76.35 147.21 28.81 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.692 2.262 . . . . 0.0 109.257 170.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -108.4 136.07 48.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.1 mp -110.13 114.1 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.431 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 22.3 t -61.93 -11.93 15.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.547 0.739 . . . . 0.0 112.797 -170.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 17' ' ' LYS . 48.7 mt-10 -77.15 -28.05 54.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.463 ' HD2' ' HB2' ' A' ' 16' ' ' GLU . 12.1 mptt -107.13 -35.76 6.76 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 120.815 0.34 . . . . 0.0 110.932 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.4 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 80.5 p -75.73 3.48 9.71 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.899 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 p -74.19 -30.96 62.47 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -120.0 -42.06 2.62 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.58 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.9 p -134.93 146.22 48.94 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -173.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.3 tt -91.93 115.05 27.73 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.1 125.35 30.75 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.549 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.1 mm -100.13 119.25 59.79 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.54 143.71 97.89 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.919 2.413 . . . . 0.0 111.671 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 30' ' ' GLU . 62.9 tp -51.09 -41.73 60.17 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.626 0.77 . . . . 0.0 112.468 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.86 -34.08 76.43 Favored Glycine 0 C--N 1.319 -0.391 0 N-CA-C 113.926 0.33 . . . . 0.0 113.926 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -88.68 -22.72 23.25 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -72.76 -43.6 62.67 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.255 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 45.1 mt-10 -61.99 -17.24 56.47 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.257 0.623 . . . . 0.0 110.483 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -77.89 -27.28 49.58 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.59 -174.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -147.18 72.95 12.08 Favored Pre-proline 0 CA--C 1.56 1.348 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -54.36 136.49 69.24 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.806 1.671 . . . . 0.0 110.304 165.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.06 160.64 31.69 Favored Pre-proline 0 C--N 1.277 -2.567 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.269 -173.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.86 137.96 83.61 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 108.232 -1.488 . . . . 0.0 108.232 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 47.4 p90 -69.46 117.24 50.84 Favored Pre-proline 0 N--CA 1.416 -2.164 0 CA-C-O 121.1 0.476 . . . . 0.0 111.375 -175.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 36' ' ' PHE . 90.5 Cg_endo -91.86 159.23 3.39 Favored 'Trans proline' 0 N--CA 1.429 -2.269 0 C-N-CA 122.289 1.993 . . . . 0.0 111.672 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 38' ' ' ILE . 2.1 mp -98.6 -31.75 3.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 m -137.6 151.91 48.84 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.278 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.8 t -147.97 157.67 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 126.719 2.008 . . . . 0.0 106.969 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -119.48 140.45 50.45 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 118.765 0.711 . . . . 0.0 111.704 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.0 mt -111.61 126.3 54.86 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.021 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.1 147.67 26.7 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -111.97 136.98 50.6 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -67.52 -15.45 63.67 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.353 -173.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.8 t -96.71 -14.29 22.14 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.426 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.81 -23.9 2.9 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 119.848 -1.168 . . . . 0.0 114.115 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -67.8 159.22 30.74 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -150.86 136.82 18.26 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.481 ' HE1' ' HB3' ' A' ' 73' ' ' ASP . 32.3 m-90 -130.67 137.19 49.46 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.661 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.6 m -93.26 125.31 37.8 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.434 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 14.2 p -125.58 155.91 34.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.111 0.481 . . . . 0.0 111.213 -173.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.429 ' HD2' HG13 ' A' ' 65' ' ' VAL . 90.3 mtt180 -104.52 120.27 40.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -126.86 127.5 45.05 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.93 134.52 54.84 Favored 'General case' 0 C--O 1.25 1.08 0 O-C-N 123.38 0.425 . . . . 0.0 111.035 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.58 ' HA ' HG12 ' A' ' 61' ' ' VAL . 13.3 mmmm -91.91 112.01 23.77 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 175.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -147.47 120.86 9.02 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.99 -136.73 18.13 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.428 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -111.28 -3.49 15.31 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.115 0.484 . . . . 0.0 111.495 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -128.85 129.15 45.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.177 0.513 . . . . 0.0 109.691 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 56' ' ' LYS . 16.4 m -111.49 146.69 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.97 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -137.58 142.38 41.31 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.017 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 4.7 mp -88.05 103.26 15.56 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 170.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.8 p -78.21 -141.53 0.03 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 124.269 1.028 . . . . 0.0 111.652 -173.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.429 HG13 ' HD2' ' A' ' 53' ' ' ARG . 13.3 p -55.57 140.64 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.546 0.689 . . . . 0.0 109.875 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 117.0 -40.02 2.5 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 -171.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.486 ' CZ3' HD12 ' A' ' 22' ' ' LEU . 54.3 t-105 -67.24 -21.02 65.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.685 0.755 . . . . 0.0 109.147 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.538 ' HA ' HG12 ' A' ' 71' ' ' VAL . 41.9 tt0 -68.01 -32.75 73.35 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.777 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -65.15 -33.11 75.24 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-O 121.394 0.616 . . . . 0.0 109.844 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.28 -52.53 18.42 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.359 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 68' ' ' GLU . 6.8 p -64.06 -40.54 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.804 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -71.16 -48.38 52.21 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.84 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.481 ' HB3' ' HE1' ' A' ' 50' ' ' TRP . 28.5 t70 -77.1 -35.57 56.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -173.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -86.6 -20.94 27.16 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.0 t30 56.74 83.82 0.1 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.578 1.151 . . . . 0.0 111.543 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.512 ' CD2' ' HA ' ' A' ' 71' ' ' VAL . 1.6 pt? -125.44 155.39 40.53 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.832 0.825 . . . . 0.0 112.282 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.49 172.43 12.97 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.18 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.431 ' H ' ' HB2' ' A' ' 15' ' ' SER . 4.6 p30 -58.74 130.21 45.82 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.35 -20.35 7.02 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -99.2 146.27 26.35 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.485 ' C ' HD12 ' A' ' 82' ' ' LEU . 96.4 m-85 -119.96 140.93 50.16 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -175.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.485 HD12 ' C ' ' A' ' 81' ' ' TYR . 4.9 mp -131.85 137.8 48.21 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.005 0.431 . . . . 0.0 111.008 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.574 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 42.9 mt-30 -111.87 135.08 52.96 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.95 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.523 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 95.0 m-85 -115.19 125.04 52.93 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.4 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 2.4 mp -105.0 118.98 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.489 ' CE2' ' HA ' ' A' ' 88' ' ' ARG . 87.3 t80 -106.74 124.64 49.9 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 7.9 p-10 -107.52 12.87 27.36 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -175.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.489 ' HA ' ' CE2' ' A' ' 86' ' ' TYR 0.27 6.1 mpt_? 84.47 -0.05 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -101.13 -165.18 1.18 Allowed 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 174.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.48 39.26 1.54 Allowed 'General case' 0 C--N 1.256 -3.486 0 CA-C-O 121.839 0.828 . . . . 0.0 108.817 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -126.01 117.93 24.27 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.148 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.81 126.8 52.6 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 174.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 68.6 m-85 -91.7 118.9 31.07 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.66 125.72 62.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 120.787 0.327 . . . . 0.0 111.067 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.516 ' CG2' ' HB2' ' A' ' 83' ' ' GLN . 13.9 tt -112.54 118.41 57.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.415 HG12 ' HG ' ' A' ' 82' ' ' LEU . 55.6 mt -103.48 133.84 46.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.734 -173.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.798 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.445 -0.699 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -130.81 149.46 52.44 Favored 'General case' 0 N--CA 1.415 -2.196 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.57 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -137.98 149.31 46.01 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.618 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 47.6 ttm -136.51 136.48 39.41 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -154.37 133.06 6.97 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-O 119.832 -0.128 . . . . 0.0 111.181 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.43 132.32 17.48 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 N-CA-C 108.259 -1.477 . . . . 0.0 108.259 168.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -100.01 140.52 34.12 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 120.58 0.229 . . . . 0.0 110.558 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 16' ' ' GLU . 63.7 mt -103.44 124.49 57.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.7 t -62.77 -11.54 18.4 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.858 0.863 . . . . 0.0 111.895 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -73.96 -45.28 51.17 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -110.5 -40.65 4.56 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.983 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.692 ' HA ' ' O ' ' A' ' 21' ' ' SER . 15.8 m -72.58 0.08 11.49 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 m -74.62 -16.24 60.79 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HG3' ' OE2' ' A' ' 68' ' ' GLU . 54.8 tttp -125.84 -28.19 3.25 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 118.93 -1.108 . . . . 0.0 111.176 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 18' ' ' SER . 46.4 m -151.98 148.75 28.1 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.526 HD12 ' CH2' ' A' ' 67' ' ' TRP . 5.6 tt -101.73 119.21 38.43 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -82.02 131.57 35.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.714 -178.699 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 48.0 mm -96.06 126.45 44.42 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.71 144.6 86.0 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.931 2.42 . . . . 0.0 112.267 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -62.17 -32.43 73.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.506 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.22 -31.2 69.05 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.393 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -80.61 -29.28 36.85 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.42 -38.28 84.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.877 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.04 -28.76 70.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -67.98 -27.42 66.56 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.816 -175.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -157.17 116.01 1.98 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 120.406 -0.518 . . . . 0.0 112.101 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.51 145.04 32.96 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.284 1.989 . . . . 0.0 109.756 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.86 143.0 16.26 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.91 156.39 64.57 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.543 2.162 . . . . 0.0 110.045 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -68.72 115.08 27.05 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.676 0.274 . . . . 0.0 111.221 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -95.73 160.02 1.47 Allowed 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 123.308 2.672 . . . . 0.0 111.186 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -90.19 -62.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.7 p -126.76 151.38 48.29 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.965 0.412 . . . . 0.0 111.997 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.619 HG12 ' HB2' ' A' ' 90' ' ' ARG . 22.1 m -136.52 162.34 35.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -113.59 143.99 43.63 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.033 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -108.86 120.1 41.5 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.63 137.61 43.2 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.205 0.526 . . . . 0.0 111.16 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 46' ' ' SER . 0.1 OUTLIER -112.46 145.87 39.44 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.048 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -73.43 -19.14 61.04 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.703 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.437 ' HB3' ' OD2' ' A' ' 44' ' ' ASP . 38.6 t -74.79 -36.77 62.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.37 -0.32 2.23 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.204 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 97.7 mtt180 -89.53 157.94 17.87 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.241 0.543 . . . . 0.0 111.642 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.8 p -142.56 136.64 29.45 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.501 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -121.08 131.77 54.47 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.5 m -96.92 120.24 36.89 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.519 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 7.7 p -110.29 153.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -100.78 122.12 42.85 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.5 ttt -110.02 130.44 55.53 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.422 -170.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -121.16 125.47 47.26 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.339 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -106.9 126.63 52.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -133.36 97.45 3.97 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.025 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.73 -97.75 0.04 OUTLIER Glycine 0 C--N 1.304 -1.218 0 O-C-N 124.174 0.921 . . . . 0.0 115.012 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -95.81 -6.5 39.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.5 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -138.13 163.69 31.02 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.523 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 67.2 t -134.46 145.39 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -128.34 132.4 48.6 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.679 0.276 . . . . 0.0 110.569 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.98 103.39 15.31 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.7 p -94.01 -106.49 0.13 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -169.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.15 136.11 27.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.305 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 108.75 -47.2 1.07 Allowed Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.526 ' CH2' HD12 ' A' ' 22' ' ' LEU . 36.5 t-105 -62.46 -31.95 72.75 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.566 ' HA ' HG12 ' A' ' 71' ' ' VAL . 41.1 tt0 -61.78 -33.65 74.48 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 113.548 -1.66 . . . . 0.0 109.917 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -69.07 -37.76 78.67 Favored 'General case' 0 C--O 1.197 -1.68 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.425 ' CE2' HD21 ' A' ' 76' ' ' LEU . 85.5 t80 -73.0 -47.47 44.87 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 123.706 0.802 . . . . 0.0 110.683 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -61.06 -44.76 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.62 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 31.6 mmmt -72.41 -48.25 42.79 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.403 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.85 -38.15 67.15 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -84.39 -18.72 35.19 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.34 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 64.18 95.18 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.86 0.838 . . . . 0.0 112.067 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.425 HD21 ' CE2' ' A' ' 70' ' ' PHE 0.261 1.5 pp -152.18 134.75 15.35 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.192 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -132.96 170.89 14.69 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -54.47 126.15 22.35 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.244 0.545 . . . . 0.0 111.112 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.25 -21.29 4.89 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -94.72 163.34 13.4 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -134.01 138.86 45.66 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.941 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 82' ' ' LEU . 1.4 pt? -136.4 149.52 48.34 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.92 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -127.29 135.77 51.02 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -107.23 129.94 54.8 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.432 0.158 . . . . 0.0 111.057 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.21 125.89 60.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.411 ' HE2' ' CE2' ' A' ' 92' ' ' PHE . 58.5 m-85 -109.58 126.91 54.09 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -87.5 9.36 21.2 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 72.24 81.31 0.14 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.892 1.277 . . . . 0.0 109.304 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 21.8 t70 -179.2 -160.75 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 -174.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.619 ' HB2' HG12 ' A' ' 40' ' ' VAL . 34.1 ptt180 -104.78 23.08 14.01 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -103.65 117.79 35.22 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.107 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.411 ' CE2' ' HE2' ' A' ' 86' ' ' TYR . 2.0 m-85 -105.83 122.61 46.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.764 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -100.29 116.7 32.88 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.88 121.3 49.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.759 0.79 . . . . 0.0 112.913 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 65.1 mt -105.9 116.25 49.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.1 mt -99.63 140.29 19.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 C--N 1.295 -1.777 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.658 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.441 -0.894 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -137.65 163.7 30.63 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -151.4 149.53 29.41 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.757 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 25.5 ptm -132.03 142.33 49.53 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -153.04 159.68 31.91 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.72 146.6 97.01 Favored 'Trans proline' 0 C--O 1.258 1.525 0 C-N-CA 122.894 2.396 . . . . 0.0 114.455 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -105.13 136.58 44.36 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.556 HG13 ' H ' ' A' ' 16' ' ' GLU . 6.4 tp -122.42 125.01 72.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 175.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 19' ' ' SER . 19.5 m -61.67 -20.43 63.42 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 121.179 0.514 . . . . 0.0 111.316 -176.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.556 ' H ' HG13 ' A' ' 14' ' ' ILE . 34.6 tt0 -79.66 -44.33 21.09 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.451 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.478 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 13.4 mptt -95.94 -40.19 9.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.11 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 21' ' ' SER . 25.8 m -77.07 10.11 2.57 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.319 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 15' ' ' SER . 37.9 t -70.19 -27.23 64.34 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 171.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -135.99 -29.4 1.02 Allowed 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.826 179.048 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 18' ' ' SER . 29.0 p -142.38 153.72 44.02 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -175.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 34.7 mt -89.6 126.18 35.52 Favored 'General case' 0 CA--C 1.481 -1.711 0 CA-C-O 121.318 0.58 . . . . 0.0 110.095 171.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.01 108.92 20.69 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -177.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 61' ' ' VAL . 66.8 mt -106.41 120.26 49.16 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 24' ' ' ILE . 31.5 Cg_exo -61.42 158.23 37.12 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.5 2.8 . . . . 0.0 114.156 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.65 -39.19 64.83 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.376 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.54 -36.85 79.68 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.721 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -88.47 -29.17 20.36 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.567 -0.453 . . . . 0.0 109.81 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.12 -45.61 93.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.685 0.755 . . . . 0.0 109.107 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.88 -21.58 63.32 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.815 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -67.92 -28.05 67.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.238 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -149.15 84.33 6.3 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-O 121.77 0.795 . . . . 0.0 111.711 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -86.6 134.34 3.94 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 C-N-CA 121.896 1.73 . . . . 0.0 111.559 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.47 161.13 29.94 Favored Pre-proline 0 C--N 1.275 -2.672 0 CA-C-N 114.051 -1.431 . . . . 0.0 107.199 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -55.23 140.18 81.22 Favored 'Trans proline' 0 C--N 1.354 0.849 0 N-CA-C 107.603 -1.73 . . . . 0.0 107.603 170.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.498 ' HB3' ' HB2' ' A' ' 56' ' ' LYS . 54.1 p90 -69.09 124.2 89.86 Favored Pre-proline 0 N--CA 1.413 -2.302 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -171.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -84.86 160.51 11.97 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 123.08 2.52 . . . . 0.0 108.796 172.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.04 -46.83 13.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.888 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 m -128.73 151.89 49.03 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.702 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 m -146.95 163.24 8.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 125.543 1.537 . . . . 0.0 107.857 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -118.91 143.26 47.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.3 mt -109.26 120.94 44.04 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.49 139.54 47.98 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.05 0.452 . . . . 0.0 110.79 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 29.0 t70 -120.86 156.02 32.87 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.896 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.33 -12.24 59.93 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 m -91.21 8.84 33.84 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.242 0.544 . . . . 0.0 110.393 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.01 -6.87 69.56 Favored Glycine 0 CA--C 1.497 -1.058 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.559 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 27.9 mmt180 -73.53 146.84 44.53 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.6 p -152.11 137.8 17.88 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -132.06 115.73 16.16 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.8 m -86.02 114.76 23.16 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.529 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 9.5 p -116.68 152.87 18.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.403 -172.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -101.07 129.0 46.87 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.419 0.628 . . . . 0.0 110.796 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.462 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 25.2 ttt -110.0 138.13 46.81 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.172 -172.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.2 OUTLIER -130.91 127.09 37.78 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.938 175.399 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 27.3 mmmt -92.73 116.8 29.35 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 169.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -144.79 103.86 3.95 Favored 'General case' 0 C--N 1.269 -2.929 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.046 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.85 -106.07 1.28 Allowed Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.885 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.44 -18.02 26.14 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.153 -0.524 . . . . 0.0 111.464 -175.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -137.01 170.39 16.19 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -172.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.47 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 58.8 t -113.56 129.22 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 174.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -118.32 130.48 56.05 Favored 'General case' 0 C--N 1.28 -2.428 0 C-N-CA 119.086 -1.045 . . . . 0.0 108.959 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 92.5 mt -103.06 102.96 13.0 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.1 p -87.54 -127.01 0.05 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.68 139.68 15.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.681 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 115.26 -44.13 1.54 Allowed Glycine 0 N--CA 1.417 -2.629 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -172.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -67.98 -27.98 67.04 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.549 ' HA ' HG12 ' A' ' 71' ' ' VAL 0.264 0.0 OUTLIER -68.17 -26.37 65.72 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.922 -179.733 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -72.25 -32.72 66.94 Favored 'General case' 0 C--O 1.196 -1.756 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -70.8 -51.64 25.57 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 122.959 0.504 . . . . 0.0 110.161 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 68' ' ' GLU . 7.7 p -59.61 -39.52 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.2 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.659 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 9.7 mmpt? -72.5 -48.01 44.03 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.487 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.49 -39.65 74.06 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.05 -18.75 24.05 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.5 t30 50.98 89.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.085 1.354 . . . . 0.0 112.965 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.8 mt -129.18 169.12 15.18 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.045 0.45 . . . . 0.0 111.475 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -143.6 170.39 15.93 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 124.363 1.065 . . . . 0.0 108.652 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -65.58 139.97 58.49 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.619 0.574 . . . . 0.0 109.57 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.05 -36.73 3.33 Favored Glycine 0 C--N 1.299 -1.488 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -93.22 147.31 23.01 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -124.39 158.76 31.96 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.497 -170.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.507 ' CD1' HG22 ' A' ' 96' ' ' ILE . 1.8 mm? -119.1 129.33 55.0 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.536 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.519 ' CG ' ' HB ' ' A' ' 95' ' ' ILE . 19.0 pt20 -111.87 124.77 53.06 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 169.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -107.08 130.48 54.67 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.7 mt -96.92 123.2 49.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -106.68 129.59 54.55 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.48 -167.77 1.84 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -91.64 -10.35 40.7 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.801 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 90' ' ' ARG . 8.5 m-20 -102.15 -162.43 0.92 Allowed 'General case' 0 N--CA 1.41 -2.47 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.217 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.423 ' H ' ' HB3' ' A' ' 89' ' ' ASP . 95.9 mtt180 -94.94 36.31 1.21 Allowed 'General case' 0 C--N 1.283 -2.292 0 CA-C-O 121.047 0.451 . . . . 0.0 111.663 -170.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.6 p -113.09 117.55 32.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.956 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -105.68 132.93 51.22 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -109.24 122.83 48.17 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.25 126.96 56.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.519 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 40.1 mm -116.77 118.09 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.507 HG22 ' CD1' ' A' ' 82' ' ' LEU . 31.4 pt -93.41 139.05 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.29 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--N 1.3 -1.558 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.621 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.502 -0.871 0 CA-C-O 120.624 0.25 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 13.0 pt20 -121.55 144.4 48.75 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -142.15 147.5 36.75 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -139.84 139.1 36.25 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.99 159.49 31.76 Favored Pre-proline 0 C--N 1.312 -1.045 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.12 147.25 93.98 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.136 2.557 . . . . 0.0 113.082 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 82' ' ' LEU . 25.4 m-85 -119.74 139.7 51.88 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.48 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.9 mt -104.08 123.47 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.503 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 23.9 t -61.07 -29.98 70.06 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.12 0.263 . . . . 0.0 111.59 -173.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.84 -43.89 97.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.066 0.46 . . . . 0.0 110.448 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -80.68 -40.34 25.62 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.39 0.614 . . . . 0.0 109.521 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -72.06 -5.53 35.88 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.912 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.2 t -70.9 -23.18 62.23 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 120.884 0.373 . . . . 0.0 110.08 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -127.22 -44.41 1.59 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.595 -174.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.5 p -136.68 151.03 48.82 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 4.1 tt -86.47 114.04 22.9 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.16 126.31 31.91 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.923 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -109.08 127.68 26.83 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.69 137.04 79.5 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.597 2.198 . . . . 0.0 111.148 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.565 ' HA ' HD22 ' A' ' 29' ' ' ASN . 53.3 tp -54.05 -38.74 65.54 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.389 0.676 . . . . 0.0 112.145 -175.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.0 -28.57 72.28 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.578 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.481 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 64.2 t80 -87.37 -22.95 24.74 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.565 HD22 ' HA ' ' A' ' 26' ' ' LEU . 52.9 m-80 -73.71 -23.88 59.85 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.787 0.803 . . . . 0.0 109.423 175.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.97 -16.53 59.32 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.421 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 65.6 t80 -77.11 -27.03 53.93 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.108 -177.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -140.88 104.5 6.25 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.76 136.89 15.55 Favored 'Trans proline' 0 N--CA 1.439 -1.699 0 C-N-CA 122.015 1.81 . . . . 0.0 108.064 168.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.17 145.89 19.36 Favored Pre-proline 0 C--N 1.28 -2.434 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.698 -173.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.1 156.02 36.55 Favored 'Trans proline' 0 C--O 1.241 0.655 0 C-N-CA 122.902 2.402 . . . . 0.0 110.085 173.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.412 ' CD1' ' HB2' ' A' ' 56' ' ' LYS . 98.4 m-85 -69.15 115.28 30.35 Favored Pre-proline 0 N--CA 1.429 -1.516 0 CA-C-O 120.858 0.361 . . . . 0.0 111.874 -176.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -93.88 161.0 2.22 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 123.355 2.704 . . . . 0.0 111.122 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.8 mm -101.25 -53.19 7.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.1 p -129.13 151.43 49.81 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.618 0.723 . . . . 0.0 112.3 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.15 145.84 35.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -109.85 125.86 53.22 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.426 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.17 124.71 52.05 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.726 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.73 142.95 33.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.232 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -110.16 154.63 23.06 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.405 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -59.16 -30.1 67.92 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 124.984 1.313 . . . . 0.0 111.989 -175.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.2 t -82.47 -12.61 57.71 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.732 0.301 . . . . 0.0 110.793 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.32 -2.93 25.17 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.225 -0.988 . . . . 0.0 115.28 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -88.33 149.39 23.79 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 118.138 0.969 . . . . 0.0 110.201 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 p -118.7 146.28 44.85 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.608 0.242 . . . . 0.0 111.538 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.478 ' CE3' ' HD1' ' A' ' 70' ' ' PHE . 23.0 m-90 -131.57 124.95 31.08 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.861 173.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.0 m -92.34 114.03 26.47 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.8 t -105.46 157.6 6.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.234 -174.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -100.0 120.32 39.63 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.7 ttt -115.69 130.26 56.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.954 -173.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -130.7 135.67 48.05 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HD2' HG22 ' A' ' 61' ' ' VAL . 1.4 mmmp? -92.73 129.55 38.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -140.12 98.72 3.51 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.134 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.61 -99.31 0.12 Allowed Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.585 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -89.42 -23.29 22.19 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.512 -0.344 . . . . 0.0 110.563 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -134.69 169.79 16.79 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -168.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.478 HG22 ' HD2' ' A' ' 56' ' ' LYS . 42.1 t -134.89 142.19 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.81 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -138.09 144.64 41.0 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 6.2 mp -91.44 106.37 18.44 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 172.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.6 p -72.56 -155.23 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.939 -1.028 . . . . 0.0 113.149 -173.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 p -57.78 128.26 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-O 121.743 0.782 . . . . 0.0 111.2 -172.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 136.66 -38.6 1.74 Allowed Glycine 0 CA--C 1.485 -1.79 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -60.87 -26.85 67.7 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.143 0.973 . . . . 0.0 108.864 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 33.5 tt0 -56.61 -36.65 69.67 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.887 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.481 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 87.5 m-20 -66.41 -36.25 82.35 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.478 ' HD1' ' CE3' ' A' ' 50' ' ' TRP . 92.2 t80 -72.68 -44.9 61.2 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.909 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 68' ' ' GLU . 7.3 p -62.62 -43.83 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 68' ' ' GLU 0.324 0.0 OUTLIER -72.37 -38.45 68.52 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 177.76 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -77.54 -39.36 46.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -84.18 -19.59 33.81 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.9 t30 65.61 90.3 0.09 Allowed 'General case' 0 C--O 1.247 0.969 0 C-N-CA 124.753 1.221 . . . . 0.0 110.935 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.5 mt -130.72 139.81 50.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.884 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.34 171.1 14.88 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.503 ' H ' ' HB2' ' A' ' 15' ' ' SER . 4.5 p30 -65.99 136.95 56.75 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.217 0.532 . . . . 0.0 110.629 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.31 -30.09 3.93 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -89.39 153.35 20.92 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.403 ' C ' HD12 ' A' ' 82' ' ' LEU . 77.4 m-85 -122.74 147.21 46.75 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -178.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.413 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 6.1 mp -122.34 134.09 54.65 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.136 -177.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -111.07 126.45 54.82 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 85.6 m-85 -114.82 126.93 55.38 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.2 mt -98.06 116.97 42.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.409 ' HA ' ' CD1' ' A' ' 92' ' ' PHE . 64.8 m-85 -106.87 123.92 48.87 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.305 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -105.59 -161.52 0.81 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -93.92 13.55 22.35 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.892 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -102.87 -162.91 0.95 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.44 23.72 13.64 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 m -117.97 118.65 32.54 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 86' ' ' TYR . 19.1 m-85 -122.81 152.4 40.72 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.326 -177.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -111.15 126.49 54.9 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.952 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.15 129.88 55.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.53 0.681 . . . . 0.0 111.44 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.61 119.8 62.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.401 HG22 ' HG ' ' A' ' 82' ' ' LEU . 34.5 pt -93.26 139.79 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 CA-C-O 121.072 0.463 . . . . 0.0 110.557 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 C--N 1.297 -1.677 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.543 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.429 -1.5 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -114.51 144.17 43.79 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.123 0.487 . . . . 0.0 110.392 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -145.5 148.26 33.04 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.577 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 26.7 ptm -139.17 152.22 47.23 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.377 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -154.65 158.66 32.26 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.77 146.21 71.77 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.877 1.718 . . . . 0.0 110.634 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -84.43 122.68 29.31 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 16' ' ' GLU . 49.2 mm -110.47 117.06 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.138 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 p -60.61 -12.32 9.78 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.2 tm-20 -76.28 -44.7 35.95 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -105.3 -42.54 5.23 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.402 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.66 ' HA ' ' O ' ' A' ' 21' ' ' SER . 9.7 m -72.01 0.61 8.96 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.331 -173.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.511 ' O ' HG11 ' A' ' 71' ' ' VAL . 27.7 t -75.04 -28.12 60.31 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 175.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -136.9 -14.4 1.6 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 18' ' ' SER . 50.3 m -149.15 169.56 20.43 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 23' ' ' GLU . 2.6 tm? -128.17 133.57 48.93 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.354 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.431 ' N ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -98.7 129.39 45.16 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.322 -174.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.546 ' HB ' HG23 ' A' ' 61' ' ' VAL . 46.4 mm -113.05 129.71 24.26 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -65.48 141.96 69.73 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 122.41 2.073 . . . . 0.0 110.061 172.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 6.7 mp -63.23 -22.92 67.18 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.69 -36.41 91.62 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.369 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 68.0 t80 -83.89 -32.92 24.91 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . 17.6 t30 -60.55 -47.89 84.2 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.374 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.77 -11.95 60.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.447 -175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 82.3 t80 -75.17 -25.9 58.67 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.135 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.11 91.93 18.84 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.57 135.88 7.17 Favored 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 122.093 1.862 . . . . 0.0 109.704 171.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.27 160.74 30.58 Favored Pre-proline 0 C--N 1.28 -2.42 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.38 141.95 80.82 Favored 'Trans proline' 0 C--O 1.246 0.881 0 N-CA-C 106.914 -1.995 . . . . 0.0 106.914 166.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -69.02 120.78 78.73 Favored Pre-proline 0 N--CA 1.414 -2.253 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.355 -173.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.59 144.62 50.14 Favored 'Trans proline' 0 C--O 1.256 1.424 0 C-N-CA 122.33 2.02 . . . . 0.0 110.629 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.4 mm -80.9 -57.34 4.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 m -126.94 156.5 41.41 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.168 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 90' ' ' ARG . 74.5 t -137.18 149.18 25.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 125.013 1.325 . . . . 0.0 107.827 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -121.95 145.83 47.73 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.06 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.432 ' CD2' ' HB2' ' A' ' 92' ' ' PHE . 66.3 mt -108.93 138.45 45.25 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.45 153.25 19.86 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.597 0.713 . . . . 0.0 112.905 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.501 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 9.0 t70 -111.25 161.8 15.64 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.992 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -70.22 -32.9 70.99 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.437 -173.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 m -102.6 -56.45 2.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.57 -6.43 0.03 OUTLIER Glycine 0 C--N 1.321 -0.274 0 C-N-CA 118.332 -1.89 . . . . 0.0 115.53 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.531 ' HA ' ' HE ' ' A' ' 48' ' ' ARG . 1.8 mmp_? -73.17 157.69 36.71 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 118.104 0.952 . . . . 0.0 110.918 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.4 m -144.07 134.74 24.95 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.501 ' CH2' ' HB2' ' A' ' 44' ' ' ASP . 19.4 m-90 -112.74 117.52 32.43 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.836 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.6 m -85.89 114.54 22.89 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.681 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.55 154.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.39 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -104.31 118.78 37.46 Favored 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 119.756 -0.778 . . . . 0.0 108.99 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.47 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 55.8 ttp -111.14 146.48 36.77 Favored 'General case' 0 CA--C 1.475 -1.919 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.48 132.37 27.62 Favored 'General case' 0 N--CA 1.406 -2.659 0 C-N-CA 117.814 -1.554 . . . . 0.0 112.065 -176.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.725 ' HD2' ' CG1' ' A' ' 61' ' ' VAL . 29.1 mmmt -91.19 107.72 19.39 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 170.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -120.59 98.8 6.2 Favored 'General case' 0 C--N 1.252 -3.674 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.42 -108.79 2.6 Favored Glycine 0 N--CA 1.422 -2.254 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.213 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.71 2.25 20.0 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 122.969 -0.136 . . . . 0.0 110.926 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.43 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.8 ptpt -131.31 156.24 45.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.725 ' CG1' ' HD2' ' A' ' 56' ' ' LYS . 16.3 m -122.51 134.46 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 CA-C-O 121.699 0.762 . . . . 0.0 112.221 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -142.81 139.63 31.02 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 54' ' ' MET . 5.6 mp -90.49 109.1 20.24 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.4 p -79.68 -152.25 0.07 Allowed 'General case' 0 N--CA 1.425 -1.723 0 O-C-N 123.846 0.716 . . . . 0.0 111.74 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.13 143.26 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.173 0.989 . . . . 0.0 111.147 -175.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.61 -38.45 2.44 Favored Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -59.64 -23.93 63.44 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.97 0.89 . . . . 0.0 110.24 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.648 ' HA ' HG12 ' A' ' 71' ' ' VAL . 39.1 tt0 -64.03 -26.04 68.39 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.299 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.52 -37.32 87.13 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.266 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.408 ' HA ' ' CD1' ' A' ' 50' ' ' TRP . 66.7 t80 -73.17 -50.13 24.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.699 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -62.2 -45.1 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.372 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.02 -41.53 67.43 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.89 -39.82 95.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.983 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -90.54 -13.86 33.75 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.288 177.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.8 t30 55.29 79.87 0.14 Allowed 'General case' 0 C--O 1.235 0.305 0 O-C-N 124.119 0.887 . . . . 0.0 109.958 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 pp -136.34 158.64 43.94 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.74 174.96 10.35 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.112 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -51.65 142.18 15.05 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 124.051 0.845 . . . . 0.0 111.187 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.04 -27.22 5.93 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -95.21 163.19 13.38 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -128.8 144.1 51.08 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.546 -175.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 0.9 OUTLIER -136.65 145.86 45.29 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.312 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.577 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 69.7 mt-30 -111.53 142.78 43.37 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -108.61 117.42 34.12 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 93' ' ' TYR . 1.9 mp -100.04 115.8 41.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.436 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 92.7 t80 -119.57 124.98 47.69 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.641 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -114.3 162.05 17.09 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -66.46 89.07 0.14 Allowed 'General case' 0 C--O 1.244 0.777 0 CA-C-N 119.196 0.907 . . . . 0.0 111.83 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -165.36 -157.81 0.35 Allowed 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.516 ' O ' HG13 ' A' ' 40' ' ' VAL . 68.6 mtm180 -124.98 30.43 5.88 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 t -136.71 141.43 43.07 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.467 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 64.9 m-85 -115.62 148.61 39.44 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.354 0.597 . . . . 0.0 111.187 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.415 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 91.2 t80 -108.66 131.57 54.77 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 172.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 61.9 t -112.24 130.71 65.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.034 0.445 . . . . 0.0 112.147 -173.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 74.6 mt -105.78 116.14 48.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -100.76 140.24 20.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.14 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 N--CA 1.429 -1.495 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.777 172.917 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.438 -1.068 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -130.47 143.12 50.56 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.546 ' CZ ' ' HG3' ' A' ' 25' ' ' PRO . 79.1 t80 -142.2 148.87 38.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.441 ' HG2' ' HB3' ' A' ' 83' ' ' GLN . 82.6 mtp -123.66 140.57 52.86 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.38 157.96 55.26 Favored Pre-proline 0 C--N 1.31 -1.144 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.759 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.09 147.11 11.61 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.703 2.269 . . . . 0.0 110.363 174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -87.34 126.46 34.87 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.29 117.71 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.6 p -65.9 -14.62 61.85 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -83.82 -37.1 22.96 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.94 0.4 . . . . 0.0 111.104 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -106.2 -41.79 5.25 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.015 -174.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 21' ' ' SER . 19.5 m -77.96 0.41 24.4 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.874 -173.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.9 m -75.38 -18.31 59.98 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.848 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.8 -23.22 0.86 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.975 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 18' ' ' SER . 21.1 m -132.52 142.07 49.03 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.22 0.533 . . . . 0.0 111.523 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 4.1 tt -93.89 126.83 39.32 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -95.83 114.38 26.1 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 123.452 0.701 . . . . 0.0 110.764 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.9 mt -106.36 126.31 30.78 Favored Pre-proline 0 C--O 1.248 1.022 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.083 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.546 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 9.4 Cg_endo -53.55 139.96 65.55 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 123.706 2.937 . . . . 0.0 113.335 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 6.3 tt -58.85 -43.7 90.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.817 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.07 -24.16 71.62 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.299 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.553 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 73.6 t80 -81.73 -34.48 30.5 Favored 'General case' 0 C--O 1.212 -0.871 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.686 HD22 ' HD2' ' A' ' 56' ' ' LYS . 2.3 t-20 -76.28 -33.51 59.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.295 0.569 . . . . 0.0 109.949 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.44 -24.26 66.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.895 0.855 . . . . 0.0 109.572 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.553 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 24.7 t80 -68.32 -26.4 65.6 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.181 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -143.23 98.32 5.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-O 121.223 0.535 . . . . 0.0 112.313 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.472 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.3 Cg_exo -79.92 133.72 10.27 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 N-CA-C 110.095 -0.771 . . . . 0.0 110.095 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.13 160.33 31.09 Favored Pre-proline 0 C--N 1.274 -2.716 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.689 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.99 144.26 63.44 Favored 'Trans proline' 0 C--O 1.246 0.916 0 N-CA-C 107.467 -1.782 . . . . 0.0 107.467 168.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.523 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 45.1 p90 -68.93 138.48 90.22 Favored Pre-proline 0 N--CA 1.418 -2.029 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -173.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 36' ' ' PHE . 6.0 Cg_exo -78.7 160.76 27.93 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.766 2.311 . . . . 0.0 109.778 173.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 38' ' ' ILE . 2.2 mp -93.22 -37.5 8.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -150.64 152.86 34.64 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -178.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.62 163.95 22.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 124.513 1.125 . . . . 0.0 108.846 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -120.11 137.44 54.14 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.261 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.5 mt -108.7 123.42 48.96 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.97 141.84 34.18 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.262 0.553 . . . . 0.0 110.994 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -113.23 145.6 40.73 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -58.43 -27.12 64.03 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.7 t -79.59 -4.58 52.17 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.105 0.478 . . . . 0.0 110.511 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.46 2.16 50.43 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.005 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -82.55 150.66 26.8 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.3 p -144.44 136.64 26.33 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.196 0.522 . . . . 0.0 111.709 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -120.1 123.94 44.61 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.511 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.3 m -89.93 117.73 28.96 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.16 157.94 33.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.613 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -99.68 120.13 39.21 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.046 0.45 . . . . 0.0 110.624 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.422 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 23.7 ttt -122.3 124.16 43.1 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 124.277 1.031 . . . . 0.0 110.044 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -125.51 130.88 52.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.886 0.374 . . . . 0.0 111.916 178.603 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.686 ' HD2' HD22 ' A' ' 29' ' ' ASN . 55.9 tttp -98.05 122.68 41.47 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 122.121 0.963 . . . . 0.0 109.451 173.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -147.7 98.66 3.0 Favored 'General case' 0 C--N 1.252 -3.65 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.51 -164.29 30.42 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -174.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 26' ' ' LEU . 14.9 mm-40 -90.97 2.39 56.32 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.44 142.68 49.02 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.6 t -114.49 131.84 65.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.136 0.493 . . . . 0.0 111.043 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 97.4 m-85 -119.42 131.55 55.67 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 6.5 mp -86.83 112.3 21.6 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 p -66.11 -164.49 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.138 0 O-C-N 124.777 1.298 . . . . 0.0 112.902 -176.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.24 143.12 10.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.493 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.57 -38.61 2.58 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -173.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 20.1 t-105 -58.48 -24.42 60.37 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.015 0.912 . . . . 0.0 109.636 173.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.602 ' HA ' HG12 ' A' ' 71' ' ' VAL . 11.5 pt-20 -57.74 -30.0 65.23 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.39 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -62.24 -35.86 80.23 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.129 0.49 . . . . 0.0 110.668 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -74.29 -48.01 31.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.603 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -64.7 -40.38 88.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.19 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -71.07 -33.02 69.83 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.621 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.31 -40.14 45.37 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.062 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -97.94 -1.74 42.14 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 42.22 80.1 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -176.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.4 mt -103.23 147.35 27.15 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.21 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.418 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 11.4 pt-20 -143.8 171.65 13.92 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.107 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.11 138.3 58.51 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.15 -19.66 24.63 Favored Glycine 0 C--N 1.301 -1.392 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -173.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HD2' ' H ' ' A' ' 77' ' ' GLU . 57.3 mttp -96.58 159.22 15.05 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -134.1 150.95 51.19 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -173.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HG ' HG22 ' A' ' 96' ' ' ILE . 4.6 mp -130.35 137.11 49.74 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.459 ' HG3' ' HB ' ' A' ' 95' ' ' ILE . 11.6 pt20 -118.75 138.57 52.57 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -116.32 131.0 57.07 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.324 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 65.2 mt -101.54 116.03 44.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 172.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.639 ' CE2' ' HA ' ' A' ' 88' ' ' ARG . 48.8 t80 -122.07 123.81 42.46 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.757 -173.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -84.26 -1.38 55.16 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.639 ' HA ' ' CE2' ' A' ' 86' ' ' TYR . 67.8 ttt180 70.08 81.94 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -171.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 20.4 t70 -177.26 -155.24 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 -167.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.433 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -107.38 11.15 29.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.527 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.3 m -109.64 126.37 53.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.54 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -127.62 135.13 49.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.641 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.46 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 84.7 m-85 -109.25 123.49 49.35 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.54 124.15 64.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.433 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.459 ' HB ' ' HG3' ' A' ' 83' ' ' GLN . 2.4 mp -114.05 116.85 53.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.438 HG22 ' HG ' ' A' ' 82' ' ' LEU . 35.1 pt -100.8 140.64 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 123.218 0.607 . . . . 0.0 112.231 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.304 -1.411 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 173.673 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.436 -1.145 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -130.64 143.05 50.49 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -149.7 147.0 27.54 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.624 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 23.3 ptp -141.61 134.93 29.46 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.418 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.6 159.57 31.53 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 166.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 33.4 Cg_exo -60.82 132.73 43.98 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 N-CA-C 108.295 -1.463 . . . . 0.0 108.295 173.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -86.01 140.26 30.45 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.354 -175.082 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.503 HG22 ' H ' ' A' ' 16' ' ' GLU . 2.0 mp -90.69 125.08 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.509 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 11.9 p -60.57 -19.03 56.31 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.826 0.85 . . . . 0.0 112.708 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.503 ' H ' HG22 ' A' ' 14' ' ' ILE . 41.4 tt0 -63.48 -44.78 93.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.703 176.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -87.73 -40.47 14.08 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.487 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.576 ' HB2' ' CD1' ' A' ' 13' ' ' PHE . 35.6 t -61.96 -10.0 8.53 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 124.119 0.887 . . . . 0.0 112.285 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.5 p -57.85 -43.49 85.93 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.899 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 68' ' ' GLU . 64.4 mttm -144.38 -2.05 0.89 Allowed 'General case' 0 C--N 1.344 0.359 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -148.11 153.79 39.33 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 118.943 0.792 . . . . 0.0 112.476 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 5.2 tt -101.21 113.42 26.44 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -71.54 113.99 9.15 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.162 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.424 HD12 HG12 ' A' ' 61' ' ' VAL . 65.6 mt -93.7 128.5 41.65 Favored Pre-proline 0 C--N 1.288 -2.096 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.453 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 58.7 Cg_exo -53.71 137.74 67.32 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.959 2.439 . . . . 0.0 112.198 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.435 ' O ' HD23 ' A' ' 26' ' ' LEU . 5.8 tt -64.67 -32.4 74.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.48 -29.39 73.31 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.614 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 25' ' ' PRO . 46.6 t80 -65.41 -49.59 68.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -65.8 -39.75 91.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.567 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.06 -38.17 87.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.395 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -73.15 -28.68 62.37 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.947 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -166.18 127.1 1.29 Allowed Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 120.634 0.254 . . . . 0.0 111.629 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.33 136.79 24.72 Favored 'Trans proline' 0 N--CA 1.42 -2.81 0 N-CA-C 107.872 -1.626 . . . . 0.0 107.872 168.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.43 146.86 55.85 Favored Pre-proline 0 C--N 1.266 -3.047 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.527 ' O ' ' HD3' ' A' ' 37' ' ' PRO . 14.3 Cg_endo -59.64 140.68 94.82 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.019 1.813 . . . . 0.0 109.884 175.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 26.8 p90 -83.45 110.63 25.64 Favored Pre-proline 0 N--CA 1.407 -2.602 0 CA-C-O 121.115 0.483 . . . . 0.0 111.287 -178.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 35' ' ' PRO . 27.1 Cg_endo -87.83 136.02 3.58 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 122.554 2.169 . . . . 0.0 111.57 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.22 -52.74 54.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.245 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.5 p -123.95 150.11 45.15 Favored 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.904 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.3 t -135.9 157.13 38.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -126.46 135.97 52.04 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.678 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.9 mt -108.54 127.52 54.01 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.86 138.16 42.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 120.908 0.385 . . . . 0.0 110.206 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -112.68 142.18 45.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -69.87 -3.71 17.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -175.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -82.86 -14.53 54.12 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.64 -13.88 10.77 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.263 -0.97 . . . . 0.0 115.505 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HD3' ' CZ2' ' A' ' 50' ' ' TRP . 75.7 ttt180 -89.97 153.13 20.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.718 1.259 . . . . 0.0 110.806 -176.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.3 p -127.37 140.92 51.86 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.212 0.605 . . . . 0.0 110.963 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.423 ' CZ2' ' HD3' ' A' ' 48' ' ' ARG . 15.9 m-90 -125.85 128.13 47.14 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.419 0.287 . . . . 0.0 110.227 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.1 m -92.07 121.17 33.38 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.43 0.633 . . . . 0.0 109.779 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HB ' HD21 ' A' ' 63' ' ' LEU . 34.7 m -126.05 158.34 35.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 124.792 1.237 . . . . 0.0 111.589 -172.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -102.36 127.42 49.37 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.085 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.2 ttt -111.23 120.81 43.5 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -124.95 125.31 43.72 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.713 -175.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -107.9 115.5 30.25 Favored 'General case' 0 CA--C 1.479 -1.761 0 CA-C-O 122.156 0.979 . . . . 0.0 110.038 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -148.82 102.48 3.28 Favored 'General case' 0 C--N 1.247 -3.866 0 CA-C-N 113.45 -1.705 . . . . 0.0 108.408 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.88 -143.53 15.82 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.024 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.88 -6.03 54.73 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.71 0.291 . . . . 0.0 111.641 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.1 170.07 13.96 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 121.004 0.431 . . . . 0.0 110.834 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.424 HG12 HD12 ' A' ' 24' ' ' ILE . 40.9 t -132.46 129.6 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -124.61 131.68 53.46 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 5.7 tt -102.93 113.5 27.01 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 175.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -103.49 -98.47 0.3 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -169.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.25 135.42 28.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -172.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' C ' HG12 ' A' ' 52' ' ' VAL . . . 115.02 -42.19 1.98 Allowed Glycine 0 N--CA 1.425 -2.081 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.475 -176.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' A' ' 18' ' ' SER . 55.7 t-105 -59.18 -26.45 64.82 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.513 0.673 . . . . 0.0 110.426 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.54 ' HA ' HG12 ' A' ' 71' ' ' VAL . 17.1 pt-20 -71.24 -26.52 62.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.315 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -68.97 -29.42 67.64 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.379 0.609 . . . . 0.0 109.636 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -73.97 -49.16 25.8 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 124.593 1.157 . . . . 0.0 109.388 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.8 p -63.47 -37.91 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.275 0.56 . . . . 0.0 109.977 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 68.4 mttm -65.3 -46.71 79.3 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.579 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -77.52 -40.84 41.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.032 -1.067 . . . . 0.0 113.737 -172.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -86.77 -15.12 40.31 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.141 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 46.35 72.7 0.21 Allowed 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.371 1.068 . . . . 0.0 112.629 -174.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.506 HD13 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -112.64 137.52 50.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.757 179.083 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -122.01 164.7 17.2 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.9 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 7.8 p-10 -55.77 132.56 49.61 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 123.998 0.811 . . . . 0.0 111.896 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.93 -44.63 1.19 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 33.9 mtmm -80.67 155.03 27.0 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.0 131.26 43.99 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.262 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.449 ' HG ' HG13 ' A' ' 96' ' ' ILE . 6.9 mp -114.45 132.87 56.11 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -109.86 125.91 53.27 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -114.27 117.54 31.42 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.47 117.9 47.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -120.47 127.22 52.02 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 123.495 0.497 . . . . 0.0 110.114 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -84.07 -100.2 0.05 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -150.43 16.5 0.81 Allowed 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -110.16 -177.55 3.28 Favored 'General case' 0 N--CA 1.405 -2.717 0 CA-C-N 114.294 -1.321 . . . . 0.0 107.796 -172.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -95.91 32.08 1.97 Allowed 'General case' 0 C--N 1.264 -3.112 0 C-N-CA 124.3 1.04 . . . . 0.0 108.512 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.3 m -127.74 122.79 33.76 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.326 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -112.8 143.94 43.19 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -111.59 120.44 42.08 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.0 t -111.2 135.41 50.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.779 0.323 . . . . 0.0 111.426 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.4 mt -130.46 124.39 57.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.449 HG13 ' HG ' ' A' ' 82' ' ' LEU . 1.8 mp -96.5 125.16 49.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 . . . . . 0 C--N 1.305 -1.338 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.099 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.439 -0.975 0 CA-C-O 120.955 0.407 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -112.02 144.79 40.79 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 83' ' ' GLN . 50.3 p90 -146.26 149.26 33.54 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.8 ptm -127.73 145.44 50.9 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.66 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 25.9 ttpp -153.48 143.35 15.26 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.425 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.72 146.47 83.93 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.5 2.133 . . . . 0.0 109.999 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 8.3 m-85 -103.32 139.25 38.99 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.2 mp -118.72 117.43 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.499 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 20.3 m -57.48 -22.16 41.98 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.782 0.833 . . . . 0.0 112.576 -173.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.07 -38.88 92.67 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.199 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.06 -41.98 8.85 Favored 'General case' 0 CA--C 1.487 -1.46 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.731 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 79.3 p -65.4 -11.33 41.42 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -170.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.6 t -69.63 -24.03 63.58 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.39 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -138.56 -24.36 0.94 Allowed 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -176.403 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.45 ' N ' ' HD2' ' A' ' 20' ' ' LYS . 77.2 p -143.25 153.76 43.12 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.6 tt -96.81 122.54 39.88 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 174.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.66 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -92.97 122.77 35.67 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.874 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.446 ' HB ' HD21 ' A' ' 29' ' ' ASN . 61.5 mt -103.68 132.15 21.33 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -57.54 139.26 89.63 Favored 'Trans proline' 0 C--O 1.254 1.311 0 C-N-CA 122.19 1.926 . . . . 0.0 110.622 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.506 ' O ' HD23 ' A' ' 26' ' ' LEU . 5.7 tt -56.57 -30.08 62.76 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.187 0.595 . . . . 0.0 110.885 -175.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.41 -31.5 63.01 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.727 -0.273 . . . . 0.0 112.838 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -87.89 -29.92 20.5 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 122.278 -0.543 . . . . 0.0 110.099 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.475 ' ND2' ' HB ' ' A' ' 61' ' ' VAL . 13.4 m120 -65.82 -34.35 77.95 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.505 0.669 . . . . 0.0 109.638 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -74.83 -27.07 60.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.612 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -78.97 -28.08 43.56 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.166 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . 0.267 31.5 p90 -134.51 78.81 55.69 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 177.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -83.97 135.13 6.43 Favored 'Trans proline' 0 N--CA 1.425 -2.551 0 C-N-CA 121.016 1.144 . . . . 0.0 110.204 170.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.66 160.11 31.59 Favored Pre-proline 0 C--N 1.273 -2.752 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -63.02 136.74 58.19 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 N-CA-C 107.505 -1.767 . . . . 0.0 107.505 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -68.81 120.4 75.74 Favored Pre-proline 0 N--CA 1.418 -2.048 0 CA-C-O 121.356 0.598 . . . . 0.0 112.593 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.49 136.67 12.57 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.69 2.26 . . . . 0.0 110.852 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -64.77 -38.59 83.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.019 0.438 . . . . 0.0 110.078 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.3 p -130.88 150.64 51.95 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 121.241 0.543 . . . . 0.0 110.852 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 90' ' ' ARG . 79.4 t -141.72 149.39 20.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 125.473 1.509 . . . . 0.0 107.163 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.52 135.37 52.18 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.075 0.464 . . . . 0.0 111.494 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' SER . 79.1 mt -108.84 132.0 54.44 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.64 143.99 32.33 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.267 0.556 . . . . 0.0 112.154 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 16.7 t70 -110.35 165.32 11.87 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.36 176.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -53.32 -50.82 64.17 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 125.232 1.413 . . . . 0.0 110.273 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.6 m -73.68 -10.32 59.57 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.788 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.0 9.88 35.95 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.496 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.426 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 98.4 mtt180 -66.94 150.82 48.68 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 74.8 p -138.2 136.33 36.49 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.412 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.487 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 25.5 m-90 -121.15 131.76 54.44 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.829 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.2 m -89.62 114.15 25.71 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.443 HG21 HD23 ' A' ' 63' ' ' LEU . 33.6 m -116.34 157.85 17.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.668 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.401 ' NH2' HG13 ' A' ' 65' ' ' VAL . 7.0 ttp180 -102.01 130.98 48.69 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 28.0 ttt -112.3 136.31 51.9 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -142.12 125.88 17.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.389 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -105.17 128.35 53.35 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.98 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.55 100.03 4.84 Favored 'General case' 0 C--N 1.266 -3.039 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.78 -120.75 11.31 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.259 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -90.33 -7.8 52.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -174.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.76 152.73 32.7 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.475 ' HB ' ' ND2' ' A' ' 29' ' ' ASN . 47.4 t -133.97 124.31 46.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -130.37 153.73 48.42 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 52' ' ' VAL . 5.9 mp -93.37 103.82 16.02 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.6 t -79.3 -153.82 0.08 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 124.235 0.959 . . . . 0.0 111.008 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.401 HG13 ' NH2' ' A' ' 53' ' ' ARG . 7.1 p -61.07 121.85 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-O 122.442 1.115 . . . . 0.0 110.939 -170.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 143.77 -38.62 1.34 Allowed Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 -169.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -60.56 -24.2 65.23 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.042 -1.079 . . . . 0.0 109.278 173.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.536 ' HA ' HG12 ' A' ' 71' ' ' VAL . 39.0 tt0 -56.2 -39.79 73.0 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.589 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -59.21 -37.06 76.53 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-O 120.918 0.39 . . . . 0.0 110.715 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.535 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 78.6 t80 -74.08 -48.66 28.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.0 p -62.48 -34.83 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 122.131 0.967 . . . . 0.0 109.165 -177.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.64 -47.07 56.91 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.917 -1.492 . . . . 0.0 111.65 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -77.64 -40.77 40.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -172.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -88.08 -16.2 34.18 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.402 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.9 t30 54.11 95.35 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 O-C-N 124.157 0.91 . . . . 0.0 112.204 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 pp -127.12 158.21 37.64 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.285 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -143.8 168.21 20.47 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.415 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 5.8 p-10 -59.08 133.89 56.5 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.227 0.954 . . . . 0.0 110.038 175.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.7 -18.98 12.73 Favored Glycine 0 C--N 1.307 -1.064 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -101.13 162.81 12.63 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -128.04 140.36 52.0 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.63 142.55 51.45 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.064 0.459 . . . . 0.0 110.786 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 64.5 tt0 -114.19 124.68 52.65 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -112.2 130.7 55.83 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.41 116.0 47.38 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -106.22 123.77 48.55 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.12 -171.21 3.48 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.309 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -86.41 -5.87 59.06 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 23.4 t70 -89.27 -150.74 0.21 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 175.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.494 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 16.7 ptt180 -113.03 17.71 18.62 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 92.5 m -101.81 127.22 48.7 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.56 -170.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.65 131.75 54.79 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.643 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -101.84 127.61 48.57 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.535 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 38.3 t -104.21 119.87 53.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.11 124.24 72.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.4 tt -111.97 137.27 45.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 121.316 0.579 . . . . 0.0 110.103 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 N--CA 1.424 -1.735 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.484 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.442 -0.857 0 CA-C-O 121.259 0.552 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -111.74 145.74 38.8 Favored 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.954 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -143.55 153.91 43.06 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 61.3 mtm -128.13 158.02 39.17 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -154.26 159.9 31.48 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -64.65 135.44 45.31 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.096 1.864 . . . . 0.0 109.843 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.415 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 70.6 t80 -100.16 122.97 43.83 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -114.63 102.15 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.514 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 33.5 t -53.83 -31.8 50.61 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 123.241 0.616 . . . . 0.0 111.367 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.83 -37.39 79.09 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.414 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -101.35 -33.1 10.15 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.907 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' SER . 49.8 p -81.2 1.76 30.7 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.5 m -65.42 -24.77 67.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 119.499 -0.881 . . . . 0.0 111.215 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -116.15 -48.82 2.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.636 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 18' ' ' SER . 43.4 p -130.87 144.98 51.85 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -173.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.0 tm? -103.0 115.18 30.12 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.79 125.27 28.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.7 mt -95.31 131.01 30.7 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.3 132.71 40.36 Favored 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 122.852 2.368 . . . . 0.0 112.137 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.418 ' O ' HD23 ' A' ' 26' ' ' LEU . 6.7 tt -63.37 -32.71 74.21 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.856 -175.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.46 -32.41 81.67 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.172 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -75.07 -35.8 61.82 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -70.72 -31.64 68.56 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.115 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -74.82 -30.38 61.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.42 -27.63 66.37 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.577 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -160.57 87.16 1.82 Allowed Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.317 0.579 . . . . 0.0 111.713 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.21 142.76 21.82 Favored 'Trans proline' 0 N--CA 1.439 -1.704 0 C-N-CA 121.75 1.634 . . . . 0.0 110.396 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.42 153.04 36.67 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.41 144.52 98.28 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 122.489 2.126 . . . . 0.0 109.969 175.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 56' ' ' LYS . 26.8 p90 -70.28 121.33 82.91 Favored Pre-proline 0 N--CA 1.41 -2.474 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.91 159.63 18.49 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.394 2.73 . . . . 0.0 110.219 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.2 mm -70.4 -59.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.349 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.5 p -125.53 151.41 46.38 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.467 HG21 ' SD ' ' A' ' 54' ' ' MET . 97.2 t -139.78 151.42 22.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.53 136.2 52.34 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.557 -0.857 . . . . 0.0 113.285 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 92' ' ' PHE . 3.3 mm? -108.54 120.2 41.73 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.03 153.18 20.14 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.121 0.486 . . . . 0.0 110.735 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 11.5 t70 -112.06 149.22 32.39 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.885 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -70.71 -26.71 63.52 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.734 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.8 m -95.13 -45.87 7.03 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.759 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.07 -32.06 0.04 OUTLIER Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 118.244 -1.932 . . . . 0.0 114.785 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -60.83 158.52 12.84 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 p -149.09 135.78 19.59 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 173.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.51 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 23.7 m-90 -125.75 124.09 40.25 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.546 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.1 m -89.18 114.26 25.54 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 174.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.5 t -115.26 157.77 15.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.944 -172.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -99.91 128.32 46.01 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.467 ' SD ' HG21 ' A' ' 40' ' ' VAL . 27.5 ttt -111.56 123.23 49.8 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -176.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -130.5 129.99 43.6 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.747 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.471 ' H ' ' HB3' ' A' ' 36' ' ' PHE . 27.6 tptp -92.62 127.54 38.15 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 125.003 1.321 . . . . 0.0 108.772 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -142.94 103.85 4.24 Favored 'General case' 0 C--N 1.261 -3.275 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.532 -174.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.74 -121.26 5.94 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -108.98 2.9 21.65 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.427 0.632 . . . . 0.0 109.692 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.504 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 37.1 ttpt -122.58 159.12 28.45 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.316 -175.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.414 HG22 ' HD3' ' A' ' 56' ' ' LYS . 61.4 t -127.83 141.04 47.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.504 ' CZ ' ' HE3' ' A' ' 60' ' ' LYS . 96.7 m-85 -123.12 136.45 54.8 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.043 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 98.4 mt -81.93 103.49 11.62 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 167.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 65' ' ' VAL . 2.0 m -86.15 -154.45 0.21 Allowed 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.917 -167.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.617 ' H ' HG22 ' A' ' 64' ' ' THR . 7.7 p -56.44 122.82 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 121.998 0.904 . . . . 0.0 111.639 -172.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.58 -37.2 2.06 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -171.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.455 ' CE2' ' HB2' ' A' ' 22' ' ' LEU . 12.6 t-105 -57.26 -26.2 60.4 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.554 -0.823 . . . . 0.0 110.774 175.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -53.29 -27.43 22.81 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.07 -174.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -63.01 -29.76 71.07 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.411 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 44.7 t80 -73.73 -54.66 7.56 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.581 0.705 . . . . 0.0 109.545 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.64 -34.76 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.529 -176.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -71.91 -37.92 69.99 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 174.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.6 -40.67 41.33 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.869 -0.733 . . . . 0.0 112.779 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -84.77 -20.84 30.39 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.2 t30 49.13 82.45 0.04 OUTLIER 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.167 1.387 . . . . 0.0 111.757 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.9 pt? -127.45 142.81 51.31 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.447 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -113.99 170.39 8.31 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 15' ' ' SER . 6.1 p-10 -60.56 133.51 56.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 172.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.57 -28.15 5.06 Favored Glycine 0 C--N 1.3 -1.442 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 -172.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -100.08 146.74 26.42 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.462 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 95.0 m-85 -133.81 158.63 42.88 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.68 -174.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.514 HD13 ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -125.94 155.72 40.88 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.281 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -129.14 127.24 41.01 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.236 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.514 ' CE2' HD13 ' A' ' 82' ' ' LEU . 99.9 m-85 -106.09 130.73 53.94 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 59.0 mt -107.36 119.8 57.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -106.12 125.27 50.79 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.371 0.605 . . . . 0.0 112.258 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.73 146.21 27.52 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 89' ' ' ASP . 9.2 mmm180 -66.08 83.28 0.08 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.201 0.455 . . . . 0.0 111.722 -177.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 88' ' ' ARG . 8.6 t70 173.54 -148.71 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 6.3 mpt_? -100.3 24.44 8.78 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 118.426 0.557 . . . . 0.0 109.744 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.0 m -103.54 119.91 39.83 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.56 ' HB2' HD13 ' A' ' 42' ' ' LEU . 80.3 m-85 -125.27 130.71 52.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.39 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 95.7 m-85 -104.22 132.08 50.84 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.411 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 18.3 t -109.76 124.21 66.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.575 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.15 139.8 34.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.7 mt -115.28 131.74 66.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 120.973 0.416 . . . . 0.0 110.109 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' A' ' 81' ' ' TYR . 43.7 p90 . . . . . 0 C--N 1.297 -1.71 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.428 -1.541 0 CA-C-O 121.142 0.496 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 13.5 pt20 -106.23 144.42 32.95 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.897 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -150.19 148.57 29.09 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 83' ' ' GLN . 25.9 ptm -103.72 133.92 47.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.66 128.72 25.09 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.44 133.2 44.65 Favored 'Trans proline' 0 C--O 1.248 1.005 0 C-N-CA 122.522 2.148 . . . . 0.0 112.882 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -93.65 124.64 37.78 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.9 mt -125.8 115.93 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.467 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 15.2 t -66.67 -11.57 54.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.313 0.577 . . . . 0.0 111.35 -172.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -61.19 -43.14 99.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.796 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -108.68 -40.39 5.09 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.937 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' SER . 18.2 m -74.17 8.6 2.03 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -172.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.476 ' O ' HG11 ' A' ' 71' ' ' VAL . 29.2 t -75.02 -19.23 60.14 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -141.63 -33.91 0.49 Allowed 'General case' 0 C--N 1.353 0.748 0 C-N-CA 119.874 -0.731 . . . . 0.0 112.641 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 18' ' ' SER . 63.4 p -139.04 162.61 34.51 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 120.958 0.409 . . . . 0.0 111.35 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.615 HD12 HD13 ' A' ' 63' ' ' LEU . 81.5 mt -103.28 118.21 36.25 Favored 'General case' 0 CA--C 1.485 -1.538 0 O-C-N 120.892 -1.13 . . . . 0.0 113.483 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -77.09 113.98 15.4 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 168.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.546 ' HB ' HG23 ' A' ' 61' ' ' VAL . 66.5 mt -113.18 130.97 23.09 Favored Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 121.49 -0.084 . . . . 0.0 110.827 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -44.36 139.14 6.87 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 124.654 3.569 . . . . 0.0 114.538 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.77 -46.22 90.52 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.133 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.42 -32.73 85.17 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.769 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.5 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 76.7 t80 -76.78 -34.9 57.98 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.483 HD22 ' HA ' ' A' ' 60' ' ' LYS . 40.3 t30 -66.12 -44.7 83.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.991 0.424 . . . . 0.0 110.804 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.85 -13.62 61.8 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.914 0.864 . . . . 0.0 110.457 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.5 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 87.2 t80 -74.68 -18.97 60.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.386 176.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -137.92 94.3 11.51 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -83.13 134.01 6.76 Favored 'Trans proline' 0 N--CA 1.432 -2.144 0 C-N-CA 121.549 1.499 . . . . 0.0 110.417 172.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.75 152.98 28.18 Favored Pre-proline 0 C--N 1.272 -2.776 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.486 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -61.87 150.41 86.21 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 107.786 -1.659 . . . . 0.0 107.786 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -68.12 119.63 68.67 Favored Pre-proline 0 N--CA 1.416 -2.142 0 CA-C-O 121.309 0.576 . . . . 0.0 111.712 -174.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -87.28 159.89 8.32 Favored 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.758 2.306 . . . . 0.0 111.084 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 51.3 mm -85.88 -59.25 2.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.3 p -131.3 156.43 45.46 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.136 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.35 162.44 39.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.27 134.97 55.18 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.688 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.402 HD23 ' HB2' ' A' ' 92' ' ' PHE . 75.0 mt -108.0 125.53 51.65 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.65 137.53 39.84 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.084 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 46' ' ' SER . 0.1 OUTLIER -112.96 142.34 45.75 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 123.517 0.727 . . . . 0.0 110.719 178.812 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -67.35 -22.16 65.6 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.242 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.44 ' HB2' ' OD2' ' A' ' 44' ' ' ASP . 4.3 m -74.1 -32.46 63.24 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.53 -2.55 4.18 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.962 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -86.28 158.72 19.62 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.043 0.537 . . . . 0.0 110.331 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.8 p -149.66 140.09 22.39 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.6 m-90 -129.32 127.22 40.67 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.786 0.327 . . . . 0.0 111.447 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.8 m -87.66 114.83 24.65 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.3 m -122.17 158.16 26.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.662 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 25.3 ttp180 -101.16 133.93 44.97 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -177.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 55.8 ttp -131.64 148.12 52.57 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.27 146.27 25.27 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.119 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.513 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 63.5 mttm -91.84 128.83 37.82 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -137.45 107.82 6.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.48 -118.59 4.76 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -111.15 -5.46 14.74 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.483 ' HA ' HD22 ' A' ' 29' ' ' ASN . 19.0 ptpt -117.58 170.09 9.03 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.491 0.662 . . . . 0.0 111.273 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.546 HG23 ' HB ' ' A' ' 24' ' ' ILE . 8.4 m -109.62 141.31 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.417 171.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.473 ' CZ ' ' HD2' ' A' ' 60' ' ' LYS . 97.4 m-85 -114.49 131.56 56.59 Favored 'General case' 0 C--N 1.268 -2.978 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 169.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.615 HD13 HD12 ' A' ' 22' ' ' LEU . 6.8 tt -88.13 102.07 14.43 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 173.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.52 ' OG1' ' HG2' ' A' ' 53' ' ' ARG . 20.5 p -71.73 -163.67 0.11 Allowed 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -168.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.7 t -65.96 122.29 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.356 -168.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.37 -31.62 1.04 Allowed Glycine 0 CA--C 1.481 -2.032 0 N-CA-C 107.506 -2.238 . . . . 0.0 107.506 -174.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.509 ' HB2' HD22 ' A' ' 63' ' ' LEU . 59.2 t-105 -58.14 -23.78 56.42 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 113.864 -1.168 . . . . 0.0 109.947 173.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.665 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 28.5 tt0 -56.51 -32.31 64.93 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.133 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -64.5 -35.87 82.37 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 122.633 0.373 . . . . 0.0 110.956 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -73.55 -49.99 23.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.2 p -61.71 -47.48 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.499 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 68' ' ' GLU 0.277 25.6 pttm -73.1 -30.98 64.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 178.688 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.24 -39.99 65.02 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.591 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -87.24 -21.48 25.81 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 54.22 88.7 0.04 OUTLIER 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.233 1.413 . . . . 0.0 110.438 -176.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.7 165.77 26.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -141.52 172.14 13.1 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.128 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.467 ' H ' ' HB2' ' A' ' 15' ' ' SER . 5.9 p-10 -58.71 120.79 9.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.494 0.664 . . . . 0.0 109.925 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.85 -41.01 0.58 Allowed Glycine 0 C--N 1.294 -1.755 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -94.72 155.94 16.62 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -130.42 156.6 44.47 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.964 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.22 153.95 51.07 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 -175.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.576 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 87.3 mt-30 -111.87 145.54 39.31 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.382 176.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -117.36 120.17 37.36 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 23.3 mt -97.49 114.65 35.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -128.47 139.69 52.2 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -129.42 167.71 17.4 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 168.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.657 ' H ' ' HD2' ' A' ' 88' ' ' ARG . 5.3 mpt_? -65.01 96.65 0.2 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 123.394 0.434 . . . . 0.0 110.205 -174.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.401 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 20.1 t70 179.27 -159.43 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.401 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 10.5 mpt_? -117.97 19.11 13.78 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.4 m -106.59 117.88 35.2 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.701 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.402 ' HB2' HD23 ' A' ' 42' ' ' LEU . 47.7 m-85 -118.03 133.41 55.94 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 60.3 m-85 -101.7 116.13 32.05 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 174.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 7.8 p -99.9 132.0 46.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 120.827 0.346 . . . . 0.0 110.422 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.576 ' CG2' ' HB2' ' A' ' 83' ' ' GLN . 11.3 tt -131.74 128.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.183 0.516 . . . . 0.0 109.981 177.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.0 tt -96.66 142.02 14.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.363 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 N--CA 1.442 -0.862 0 CA-C-O 121.973 0.892 . . . . 0.0 108.699 176.312 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.433 -1.296 0 CA-C-O 121.518 0.675 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.4 145.59 45.07 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.377 -175.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -142.25 147.33 36.31 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.401 ' HB3' ' HB3' ' A' ' 83' ' ' GLN . 23.3 ptm -135.29 143.72 46.38 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -177.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.567 ' H ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -155.01 159.27 31.96 Favored Pre-proline 0 N--CA 1.433 -1.286 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.24 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -48.76 148.79 8.28 Favored 'Trans proline' 0 C--O 1.251 1.126 0 C-N-CA 124.14 3.227 . . . . 0.0 114.839 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -129.68 124.54 33.87 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.5 117.91 56.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.52 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 26.1 t -59.96 -20.49 57.86 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -172.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -73.11 -44.19 60.65 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.948 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.75 -37.11 11.96 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.678 0.752 . . . . 0.0 109.831 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 21' ' ' SER . 14.5 m -84.98 15.23 4.16 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.634 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 15' ' ' SER . 46.2 t -74.44 -21.95 59.37 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.82 -28.18 1.1 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.15 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 18' ' ' SER . 21.3 p -147.33 152.79 38.81 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -172.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.463 HD12 HD22 ' A' ' 63' ' ' LEU . 54.0 mt -111.37 141.86 44.36 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 120.793 0.33 . . . . 0.0 111.602 176.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -100.52 125.26 46.84 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.443 ' CB ' ' HB ' ' A' ' 61' ' ' VAL . 48.1 mm -105.2 132.09 21.19 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.608 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.93 147.06 83.99 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 123.142 2.562 . . . . 0.0 111.919 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 mp -58.5 -38.29 77.34 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.121 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.38 -28.14 66.73 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.568 -0.742 . . . . 0.0 113.28 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -85.79 -25.69 26.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.126 0.488 . . . . 0.0 110.04 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -69.47 -45.74 68.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.107 0.479 . . . . 0.0 110.105 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.54 -10.51 59.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.811 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -68.35 -27.49 66.31 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.756 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -158.72 103.64 1.62 Allowed Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 120.959 0.409 . . . . 0.0 111.814 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.574 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 6.0 Cg_exo -82.59 134.89 7.74 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.07 1.847 . . . . 0.0 111.08 172.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.95 159.24 32.53 Favored Pre-proline 0 C--N 1.271 -2.809 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.54 130.07 35.52 Favored 'Trans proline' 0 C--O 1.26 1.58 0 N-CA-C 107.843 -1.637 . . . . 0.0 107.843 172.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -71.71 128.48 89.6 Favored Pre-proline 0 N--CA 1.403 -2.818 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -172.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.89 160.1 40.9 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.225 2.616 . . . . 0.0 112.344 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.81 -48.53 15.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 174.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.0 p -136.46 151.63 49.68 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.932 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.15 162.37 38.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.76 137.98 52.35 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.53 0.681 . . . . 0.0 111.844 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 49' ' ' SER . 65.1 mt -109.17 122.78 48.05 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.29 148.08 31.6 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.368 0.604 . . . . 0.0 111.662 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -111.75 165.15 12.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.384 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -52.27 -38.26 57.77 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.805 0.842 . . . . 0.0 110.782 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 m -67.06 -10.29 48.33 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.139 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.27 7.64 63.58 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.418 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -80.37 138.03 36.63 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 35.1 p -124.78 135.26 52.81 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 123.463 0.477 . . . . 0.0 110.594 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -113.88 130.65 56.47 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.4 m -90.86 119.35 30.99 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -119.64 156.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.531 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 65' ' ' VAL . 68.6 mtt180 -100.82 120.18 39.75 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.425 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 20.4 ttt -133.07 121.69 23.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.855 -173.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.2 OUTLIER -132.26 142.32 49.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.029 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.574 ' NZ ' ' HA ' ' A' ' 33' ' ' PRO . 26.2 mtmt -92.08 126.41 37.15 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -130.21 98.89 4.86 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.652 -172.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.22 -107.22 2.42 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.45 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.94 -1.99 16.18 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.866 0.365 . . . . 0.0 110.317 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -132.53 160.17 37.3 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-O 121.271 0.558 . . . . 0.0 111.169 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' A' ' 24' ' ' ILE . 53.0 t -105.57 142.2 19.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 173.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -135.71 131.39 35.57 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 22' ' ' LEU . 6.2 mp -96.02 113.92 25.58 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.7 p -82.41 -170.24 2.84 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.421 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 47.9 t -66.42 122.09 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.68 0.752 . . . . 0.0 110.496 -173.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.53 -27.24 1.07 Allowed Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.401 ' CH2' HD11 ' A' ' 22' ' ' LEU . 41.4 t-105 -60.75 -21.38 62.95 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 113.577 -1.312 . . . . 0.0 110.184 172.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.734 ' O ' ' HG2' ' A' ' 72' ' ' LYS 0.293 0.0 OUTLIER -63.54 -26.53 68.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -175.859 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -56.18 -38.06 70.42 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.543 0.737 . . . . 0.0 110.114 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -74.05 -49.05 25.92 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.446 -175.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.7 p -67.52 -40.69 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.361 -175.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 20.5 ptmt -70.41 -38.77 74.67 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.771 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.59 -38.08 62.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.258 -0.977 . . . . 0.0 112.528 -175.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -86.12 -20.77 28.18 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.838 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.1 t30 50.87 83.53 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.15 0.98 . . . . 0.0 111.432 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 pp -138.8 174.67 10.28 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -143.19 172.04 13.27 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.867 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.52 ' HB3' ' H ' ' A' ' 15' ' ' SER . 9.3 p-10 -65.79 142.1 58.08 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.145 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.24 -21.55 15.05 Favored Glycine 0 C--N 1.295 -1.7 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -173.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -116.54 134.46 54.82 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 87.2 m-85 -130.28 158.91 38.48 Favored 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.264 -170.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 pp -132.29 144.59 50.69 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.552 ' CG ' ' HB ' ' A' ' 95' ' ' ILE . 10.3 pt20 -119.02 145.85 45.52 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.909 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.02 124.28 51.17 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.5 mt -106.31 117.18 51.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.413 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 30.6 p90 -127.68 152.76 47.3 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.531 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -81.16 -78.75 0.17 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.162 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -162.23 24.32 0.11 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -120.55 -168.93 1.72 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -95.83 15.76 19.43 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 123.496 0.718 . . . . 0.0 110.186 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.7 m -102.76 116.11 31.91 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 82.8 m-85 -117.13 132.08 56.75 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.884 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -101.55 129.2 47.59 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -98.71 141.08 16.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -174.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.552 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 57.8 mt -127.06 117.66 48.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.97 113.9 41.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 81' ' ' TYR . 49.2 p90 . . . . . 0 N--CA 1.422 -1.84 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 CA--C 1.522 -0.134 0 CA-C-O 121.09 0.472 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.408 ' HG3' HG12 ' A' ' 85' ' ' ILE . 1.6 mp0 -99.85 146.97 26.02 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.469 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -142.98 149.21 38.03 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.6 ttt -131.7 144.78 51.24 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 24.1 ttpp -146.86 143.78 19.03 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.42 146.35 42.0 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 123.056 2.504 . . . . 0.0 111.632 173.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -122.07 121.69 37.54 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt -128.32 115.98 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.518 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 24.0 t -61.29 -17.49 53.82 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.925 0.89 . . . . 0.0 112.369 -171.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.22 -42.07 93.83 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HD2' ' CD ' ' A' ' 23' ' ' GLU . 37.5 ttmt -101.48 -30.3 11.5 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.212 -177.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.9 p -80.08 7.31 9.42 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 120.927 0.394 . . . . 0.0 111.386 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.9 p -72.18 -29.87 64.42 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.436 0.636 . . . . 0.0 109.631 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -114.28 -39.79 3.8 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.382 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.2 p -157.5 155.39 30.25 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.659 -174.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 76.9 mt -96.25 138.7 33.46 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.947 0.403 . . . . 0.0 110.744 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.476 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 39.5 mt-10 -79.24 117.81 20.6 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.432 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.464 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 62.9 mt -97.19 118.92 64.15 Favored Pre-proline 0 C--N 1.281 -2.382 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.74 138.8 32.84 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.581 2.854 . . . . 0.0 114.635 -171.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.4 tt -63.05 -37.83 88.77 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.72 -28.91 73.47 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.334 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -72.86 -42.89 63.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -62.98 -40.12 96.78 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.71 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.22 -25.46 68.34 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.649 0.779 . . . . 0.0 110.328 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -80.61 -27.58 37.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.165 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -173.4 100.5 0.32 Allowed Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' CB ' ' HE2' ' A' ' 56' ' ' LYS . 14.4 Cg_endo -89.06 149.19 5.65 Favored 'Trans proline' 0 N--CA 1.426 -2.5 0 C-N-CA 121.377 1.384 . . . . 0.0 111.297 171.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.0 158.66 36.69 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.25 137.07 76.6 Favored 'Trans proline' 0 C--N 1.354 0.816 0 N-CA-C 107.68 -1.7 . . . . 0.0 107.68 172.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -70.95 127.41 91.74 Favored Pre-proline 0 N--CA 1.407 -2.609 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -172.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.38 136.91 45.12 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.563 2.175 . . . . 0.0 110.338 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.23 -48.71 87.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.201 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.474 ' O ' ' HD3' ' A' ' 90' ' ' ARG . 25.6 p -127.53 150.69 49.58 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.356 176.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.8 t -132.1 155.2 41.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -108.42 125.14 51.42 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 120.746 0.308 . . . . 0.0 110.361 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.6 mt -109.18 120.16 41.7 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 173.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.61 149.88 26.75 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 120.852 0.358 . . . . 0.0 110.375 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.481 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 11.3 t70 -111.27 158.78 18.59 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.433 ' CE1' HG13 ' A' ' 95' ' ' ILE . 26.9 p90 -73.68 -13.28 60.96 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.253 0.549 . . . . 0.0 111.676 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.2 t -93.52 -162.28 0.92 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.71 6.79 44.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.115 -0.564 . . . . 0.0 114.113 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -81.41 145.61 30.7 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.1 p -150.01 136.52 19.07 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 113.903 -1.498 . . . . 0.0 107.921 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.481 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 23.3 m-90 -126.97 140.3 52.42 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.169 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -96.68 114.29 25.92 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 67' ' ' TRP . 48.2 t -125.25 155.62 34.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.0 -174.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -101.84 139.41 37.51 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.0 ttt -120.12 138.76 53.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -143.84 132.42 22.32 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.254 -0.978 . . . . 0.0 112.58 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.407 ' HE2' ' CB ' ' A' ' 33' ' ' PRO . 48.8 tttp -91.88 128.08 37.58 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -138.86 98.24 3.5 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.302 -173.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.08 -134.72 13.56 Favored Glycine 0 N--CA 1.422 -2.259 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.875 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.429 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 4.9 mp0 -90.89 -0.47 57.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.214 0.53 . . . . 0.0 110.48 -175.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -132.52 171.05 14.29 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 61.7 t -124.84 148.01 29.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -124.42 137.13 54.48 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 21.4 tp -91.69 102.95 15.58 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.419 ' HB ' ' H ' ' A' ' 65' ' ' VAL . 34.9 p -78.94 -157.38 0.12 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -170.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' H ' ' HB ' ' A' ' 64' ' ' THR . 13.5 p -55.9 144.73 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.154 0.981 . . . . 0.0 111.834 -173.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.28 -36.26 3.59 Favored Glycine 0 CA--C 1.485 -1.816 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 -172.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.411 ' CZ2' HG23 ' A' ' 71' ' ' VAL . 12.0 t-105 -59.76 -25.29 64.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.704 -1.248 . . . . 0.0 109.382 171.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.493 ' OE2' ' HD3' ' A' ' 72' ' ' LYS . 2.8 tm-20 -53.23 -31.41 43.14 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.605 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.529 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 2.1 m-20 -67.29 -30.55 70.44 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 123.346 0.659 . . . . 0.0 111.991 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -73.44 -53.06 11.58 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 40.2 t -63.63 -39.1 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.98 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 69' ' ' ASN . 59.9 pttt -71.46 -39.01 71.21 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.4 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -77.64 -40.66 41.06 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -175.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.96 -20.87 29.92 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 20.2 t-20 47.65 88.73 0.02 OUTLIER 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.794 1.637 . . . . 0.0 112.374 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.79 168.8 24.51 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.849 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -143.56 174.24 10.94 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 124.073 0.949 . . . . 0.0 108.97 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.518 ' HB3' ' H ' ' A' ' 15' ' ' SER . 5.6 p-10 -51.95 130.6 29.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.941 0.877 . . . . 0.0 111.717 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.51 -39.93 1.25 Allowed Glycine 0 C--N 1.294 -1.756 0 N-CA-C 107.189 -2.365 . . . . 0.0 107.189 -175.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -94.42 146.14 24.28 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -118.98 158.94 24.77 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.204 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.1 mt -110.57 137.44 48.25 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.526 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.603 ' HB3' ' CG2' ' A' ' 95' ' ' ILE . 57.8 tt0 -111.68 130.71 55.68 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -109.57 117.33 33.67 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 62.5 mt -99.65 114.18 37.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 106.185 -1.784 . . . . 0.0 106.185 174.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -129.11 154.06 47.07 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -172.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -143.56 149.69 37.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.448 ' H ' ' NE ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -54.17 93.9 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.334 1.054 . . . . 0.0 111.82 -177.009 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 23.2 t70 -174.64 -159.04 0.08 Allowed 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -176.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 39' ' ' THR . 36.7 ttm180 -116.39 25.45 10.62 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.4 m -125.69 125.97 43.9 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.405 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -119.89 132.9 55.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.538 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 93.7 m-85 -104.97 115.04 29.61 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 174.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.77 149.48 8.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-O 121.357 0.599 . . . . 0.0 112.137 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.603 ' CG2' ' HB3' ' A' ' 83' ' ' GLN . 13.2 tt -142.06 135.44 28.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.1 pt -93.71 141.63 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.471 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 . . . . . 0 C--N 1.3 -1.586 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.033 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.425 -1.676 0 CA-C-O 121.398 0.618 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 85' ' ' ILE . 15.0 pt20 -136.95 144.91 43.65 Favored 'General case' 0 N--CA 1.399 -3.022 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.361 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -136.26 148.99 48.29 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.511 -174.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.477 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 27.1 ptm -102.56 157.29 17.03 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 12.7 ptpt -154.57 144.32 15.43 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 6.5 Cg_exo -75.83 134.79 16.85 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 122.856 2.37 . . . . 0.0 112.343 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.432 ' CE2' ' HG ' ' A' ' 22' ' ' LEU . 32.0 m-85 -107.11 140.34 40.11 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.659 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.9 mt -120.17 113.52 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 t -56.92 -31.79 65.29 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 123.411 0.444 . . . . 0.0 111.473 -173.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.76 -44.17 97.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -89.09 -40.07 13.19 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.7 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 21' ' ' SER . 25.8 m -75.22 4.55 6.8 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.372 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.2 t -74.26 -17.08 60.92 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -135.25 -35.97 0.82 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.555 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 18' ' ' SER . 26.5 p -144.23 144.0 31.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.402 0.62 . . . . 0.0 112.63 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.3 tt -100.05 121.11 40.88 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -86.11 127.02 34.62 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.982 0.42 . . . . 0.0 110.607 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.535 ' HB ' HG23 ' A' ' 61' ' ' VAL . 45.7 mm -97.56 132.7 24.71 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.45 148.15 87.61 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.266 1.977 . . . . 0.0 111.384 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.64 -22.51 66.66 Favored 'General case' 0 C--O 1.213 -0.819 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.97 -21.62 61.51 Favored Glycine 0 C--O 1.22 -0.734 0 C-N-CA 121.342 -0.456 . . . . 0.0 111.984 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.438 ' HE2' ' CZ ' ' A' ' 86' ' ' TYR . 28.3 t80 -76.44 -51.72 11.25 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -68.18 -35.86 78.69 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.449 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -69.17 -26.42 64.84 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -85.35 -28.23 25.35 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.379 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -172.87 114.67 0.37 Allowed Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 176.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.47 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 1.9 Cg_endo -85.0 150.83 10.96 Favored 'Trans proline' 0 N--CA 1.427 -2.396 0 C-N-CA 121.646 1.564 . . . . 0.0 109.672 168.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.68 152.07 67.6 Favored Pre-proline 0 C--N 1.282 -2.34 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.4 130.54 32.34 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 N-CA-C 108.212 -1.495 . . . . 0.0 108.212 175.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -69.71 114.18 22.72 Favored Pre-proline 0 N--CA 1.412 -2.337 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -172.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -78.61 136.63 13.88 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.798 2.332 . . . . 0.0 110.618 177.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.459 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 47.4 mm -69.93 -46.44 73.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.746 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.5 p -123.38 148.98 45.52 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.736 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.2 t -134.87 143.39 37.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -115.4 131.34 56.96 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.811 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.9 mt -109.24 129.15 55.51 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.39 152.4 20.77 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.584 0.707 . . . . 0.0 112.328 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.517 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 12.3 t70 -112.1 166.91 10.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.196 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -76.54 -49.31 16.77 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.747 0.819 . . . . 0.0 110.717 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 m -80.58 -50.51 9.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.568 -172.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -174.04 -11.29 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 118.263 -1.922 . . . . 0.0 114.716 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.418 ' HB2' ' CB ' ' A' ' 44' ' ' ASP . 17.5 mmt180 -73.72 157.86 35.73 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.1 p -150.94 135.3 16.96 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.517 ' CH2' ' HB2' ' A' ' 44' ' ' ASP . 18.7 m-90 -128.7 134.52 48.5 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.461 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.2 m -98.39 120.05 38.14 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 67' ' ' TRP . 8.5 p -119.18 155.24 21.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.471 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 77.7 ttt180 -103.25 135.95 43.94 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.9 ttt -117.53 146.0 43.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -147.55 131.45 17.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.506 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 33' ' ' PRO . 53.4 tttp -114.47 110.56 20.03 Favored 'General case' 0 CA--C 1.471 -2.082 0 CA-C-O 122.198 0.999 . . . . 0.0 109.089 173.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -140.66 104.82 4.81 Favored 'General case' 1 C--N 1.242 -4.071 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.81 -158.32 20.78 Favored Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -173.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -94.81 3.38 55.07 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.643 0.735 . . . . 0.0 109.55 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -112.73 156.65 22.45 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.535 HG23 ' HB ' ' A' ' 24' ' ' ILE . 27.5 m -129.6 139.89 50.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.897 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -136.91 148.06 46.79 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.024 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 5.9 mp -100.7 109.93 22.01 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.4 p -89.48 -144.55 0.16 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.858 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -55.73 129.06 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 121.484 0.659 . . . . 0.0 109.78 -175.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.92 -38.4 2.11 Favored Glycine 0 N--CA 1.414 -2.796 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 -170.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.45 ' N ' HG23 ' A' ' 52' ' ' VAL . 60.9 t-105 -66.23 -25.5 66.93 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.685 -0.758 . . . . 0.0 109.188 174.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.661 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 32.1 tt0 -59.58 -37.0 77.32 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.201 -178.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -57.45 -39.55 76.52 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 123.716 0.807 . . . . 0.0 110.935 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -74.05 -50.88 17.73 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.825 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 68' ' ' GLU . 7.8 p -62.43 -47.15 94.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.544 -174.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 64.2 pttt -72.44 -33.57 67.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.13 -40.39 38.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 118.575 -1.25 . . . . 0.0 113.471 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -88.25 -19.91 26.17 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.579 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.9 t30 57.73 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.902 1.281 . . . . 0.0 112.061 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 pp -139.45 155.25 47.71 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.638 0.732 . . . . 0.0 112.845 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.94 171.96 13.64 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.78 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -60.94 141.46 57.24 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.612 0.57 . . . . 0.0 110.587 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.76 -6.05 13.95 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -121.1 153.0 38.03 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -132.54 139.65 47.96 Favored 'General case' 0 CA--C 1.474 -1.964 0 CA-C-O 121.043 0.449 . . . . 0.0 109.839 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -135.55 144.38 46.21 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.979 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.477 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 75.9 mt-30 -110.5 145.0 38.47 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.155 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 37.8 m-85 -112.92 131.14 55.85 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.464 ' HA ' ' HB3' ' A' ' 8' ' ' GLN . 59.3 mt -95.31 121.49 45.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.438 ' CZ ' ' HE2' ' A' ' 28' ' ' PHE . 23.0 m-85 -105.5 123.42 47.86 Favored 'General case' 0 N--CA 1.421 -1.925 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -104.37 14.5 30.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.583 0.706 . . . . 0.0 109.638 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.12 72.7 0.49 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.612 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -175.67 -171.49 0.47 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 -176.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.469 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 5.5 mpt_? -106.56 26.93 9.33 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.6 m -127.51 117.81 22.79 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -125.26 155.23 40.45 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.337 0.589 . . . . 0.0 110.906 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -115.07 135.11 54.57 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -104.55 129.63 56.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.112 0.482 . . . . 0.0 112.271 -174.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.7 mm -111.99 115.29 49.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.5 tt -118.12 137.87 50.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.431 0.634 . . . . 0.0 112.7 -173.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 . . . . . 0 N--CA 1.433 -1.282 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.846 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 CA--C 1.517 -0.323 0 CA-C-O 120.984 0.421 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.56 102.36 10.7 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.981 0.419 . . . . 0.0 110.631 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -154.59 105.92 2.67 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.6 m -72.28 -45.23 60.96 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.553 0.692 . . . . 0.0 110.307 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.79 134.9 3.12 Favored Glycine 0 N--CA 1.402 -3.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.01 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 35.0 tt0 -155.05 97.23 1.91 Allowed 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m -108.25 139.28 31.13 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.525 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -123.7 143.92 49.97 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.465 ' CE2' ' HG2' ' A' ' 25' ' ' PRO . 72.2 t80 -148.24 151.89 36.23 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.3 ptm -121.22 141.79 50.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' HD2' ' HD2' ' A' ' 12' ' ' PRO . 58.8 tptt -135.94 129.4 18.13 Favored Pre-proline 0 C--N 1.295 -1.786 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.786 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.441 ' HD2' ' HD2' ' A' ' 11' ' ' LYS . 6.1 Cg_exo -79.66 133.94 10.69 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.436 2.091 . . . . 0.0 109.006 170.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 43.4 m-85 -102.64 139.31 38.4 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -176.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.6 mt -104.71 110.26 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.7 t -57.41 -30.42 64.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.342 0.591 . . . . 0.0 111.003 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.35 -34.18 73.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.22 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -103.03 -29.93 11.08 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.527 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 t -70.27 -11.26 60.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.84 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 p -60.55 -30.44 69.77 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.568 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -136.11 -9.72 2.01 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.9 p -157.27 145.1 19.01 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.5 tt -99.44 119.52 38.13 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.77 122.39 32.81 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.097 0.475 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.7 mm -95.53 124.51 52.83 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HG2' ' CE2' ' A' ' 9' ' ' PHE . 84.2 Cg_exo -50.8 134.03 40.52 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.539 2.826 . . . . 0.0 112.073 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.54 -43.03 89.1 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.592 0.757 . . . . 0.0 111.209 -173.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.32 -32.26 83.61 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.83 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.564 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 74.9 t80 -82.8 -36.16 25.81 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.596 HD21 ' HA ' ' A' ' 60' ' ' LYS . 13.7 t30 -59.86 -43.55 94.62 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.968 0.907 . . . . 0.0 110.693 175.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.73 -22.22 66.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.912 0.863 . . . . 0.0 110.587 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.564 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 92.6 t80 -75.63 -26.72 58.02 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.729 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -134.01 93.85 19.41 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 119.433 -0.907 . . . . 0.0 113.065 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.6 Cg_exo -81.63 136.2 9.53 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 121.592 1.528 . . . . 0.0 110.269 171.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.49 153.34 32.1 Favored Pre-proline 0 C--N 1.283 -2.305 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.684 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.27 154.59 62.32 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 121.977 1.785 . . . . 0.0 109.156 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -68.67 126.08 92.4 Favored Pre-proline 0 N--CA 1.419 -1.985 0 CA-C-O 121.231 0.538 . . . . 0.0 110.915 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -87.47 160.54 8.08 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 122.442 2.094 . . . . 0.0 111.243 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.73 -59.14 2.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.4 p -134.6 151.7 51.26 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.487 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -128.82 148.15 33.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -109.94 136.85 48.57 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.201 -0.599 . . . . 0.0 111.53 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 92' ' ' PHE . 76.5 mt -108.39 122.53 47.2 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.07 137.75 39.02 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -113.42 139.35 48.98 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.266 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -58.92 -21.64 58.25 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -85.89 -13.23 48.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.587 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.04 -9.22 7.53 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 119.843 -1.17 . . . . 0.0 114.68 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -88.07 157.85 18.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.567 0.683 . . . . 0.0 111.239 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.7 p -143.04 136.21 28.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 18.1 m-90 -114.73 126.77 55.24 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.391 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.0 m -89.09 114.76 26.04 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.405 HG21 HD23 ' A' ' 63' ' ' LEU . 31.1 m -112.15 156.47 13.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.118 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -101.9 120.43 40.38 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.588 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -123.95 137.07 54.67 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.074 -172.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.588 ' HD2' ' C ' ' A' ' 54' ' ' MET . 4.5 mptp? -133.9 140.68 46.97 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.019 0.438 . . . . 0.0 112.069 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 33' ' ' PRO . 54.6 tttp -105.49 107.89 19.12 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 172.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -108.79 99.87 9.17 Favored 'General case' 1 C--N 1.243 -4.064 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.325 -172.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.44 -116.75 6.76 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.47 -21.16 22.0 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.596 ' HA ' HD21 ' A' ' 29' ' ' ASN . 17.7 ptpt -112.21 165.87 11.78 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -168.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.411 HG12 ' CB ' ' A' ' 56' ' ' LYS . 25.8 m -134.56 146.33 31.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.551 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -142.02 136.55 30.36 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.774 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 3.1 mp -96.75 104.04 16.0 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 169.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.2 p -94.49 -98.7 0.15 Allowed 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -169.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.5 133.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.655 0.74 . . . . 0.0 110.625 -175.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.05 -37.66 3.63 Favored Glycine 0 CA--C 1.481 -2.074 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -63.01 -25.62 68.47 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.851 0.834 . . . . 0.0 109.254 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.671 ' HA ' HG12 ' A' ' 71' ' ' VAL . 16.9 pt-20 -68.58 -26.32 65.33 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.57 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -68.99 -31.64 70.62 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.543 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -74.3 -52.04 13.45 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 68' ' ' GLU . 7.2 p -59.73 -46.88 93.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.431 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.24 -43.35 64.51 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -77.24 -40.2 45.72 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.201 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -84.83 -18.47 34.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.24 0.543 . . . . 0.0 109.582 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 50.4 t30 60.11 90.96 0.05 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.182 1.393 . . . . 0.0 112.846 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.413 ' CD1' HG23 ' A' ' 71' ' ' VAL . 3.8 pp -127.18 151.13 49.09 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.437 ' HG2' ' HD3' ' A' ' 80' ' ' LYS . 15.5 pt-20 -144.06 172.65 12.6 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.652 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 12.2 t70 -53.05 120.42 5.86 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.47 -25.15 6.67 Favored Glycine 0 C--N 1.306 -1.122 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HD3' ' HG2' ' A' ' 77' ' ' GLU . 14.5 mptt -80.8 147.54 30.42 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -126.6 140.65 52.26 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.433 HD22 HG13 ' A' ' 96' ' ' ILE . 61.4 mt -119.66 147.4 44.59 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.103 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 14.9 mm100 -110.72 124.85 52.74 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -112.51 117.67 33.01 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 123.556 0.535 . . . . 0.0 109.761 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 mp -103.91 122.67 56.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 64.2 m-85 -109.45 144.61 37.46 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -88.37 -97.47 0.09 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.673 173.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -154.11 20.27 0.5 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 16.2 t70 -143.56 -154.61 0.54 Allowed 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -174.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.506 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 5.6 mpt_? -95.58 29.15 2.7 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.11 0.964 . . . . 0.0 109.252 -175.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -101.98 116.61 33.06 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.313 0.578 . . . . 0.0 110.394 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.422 ' CE2' ' HE2' ' A' ' 86' ' ' TYR . 1.5 m-30 -116.43 122.29 44.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.034 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.441 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 38.5 m-85 -105.74 120.09 40.8 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 32.6 t -111.08 134.32 53.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.995 0.426 . . . . 0.0 112.068 -173.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 2.1 mp -116.2 131.47 68.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.433 HG13 HD22 ' A' ' 82' ' ' LEU . 2.8 mp -105.92 128.01 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 122.432 0.293 . . . . 0.0 111.005 -174.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -102.51 119.3 38.58 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.19 -85.13 0.15 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.131 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 170.89 -42.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -177.51 -32.08 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -135.04 155.64 50.4 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.478 -1.692 . . . . 0.0 106.633 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.8 m . . . . . 0 C--N 1.295 -1.799 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.903 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 CA--C 1.509 -0.597 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.36 133.02 53.36 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.246 0.341 . . . . 0.0 110.473 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -117.67 110.25 17.64 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.5 p -74.79 -72.91 0.26 Allowed 'General case' 0 N--CA 1.409 -2.518 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.955 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.75 50.61 3.28 Favored Glycine 0 CA--C 1.495 -1.214 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.763 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -91.03 153.25 20.27 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 114.597 -0.802 . . . . 0.0 109.766 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.408 HG11 ' OH ' ' A' ' 31' ' ' TYR . 32.9 m -130.43 157.03 42.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -130.44 146.6 52.03 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -142.05 148.97 39.33 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.473 ' HG2' ' HG2' ' A' ' 83' ' ' GLN . 64.2 mtt -114.88 137.59 51.79 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HB3' ' NZ ' ' A' ' 11' ' ' LYS . 1.8 ttpm? -142.06 130.8 12.01 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.11 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.61 147.38 86.24 Favored 'Trans proline' 0 C--O 1.248 1.005 0 C-N-CA 122.86 2.373 . . . . 0.0 111.066 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' A' ' 15' ' ' SER . 76.8 t80 -95.41 117.99 31.34 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.1 mm -97.32 106.87 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.772 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.593 ' HB2' ' N ' ' A' ' 78' ' ' ASP . 20.2 t -55.89 -37.57 69.02 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.549 0.531 . . . . 0.0 111.416 -172.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -61.17 -44.01 97.98 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 123.633 0.583 . . . . 0.0 110.626 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -86.46 -40.77 15.0 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.171 -173.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 21' ' ' SER . 26.1 m -84.21 11.9 7.44 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.516 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.3 m -63.13 -33.45 75.49 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 168.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -121.54 -41.83 2.47 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.499 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 18' ' ' SER . 45.7 m -144.84 152.81 40.87 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.189 -175.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 54.9 mt -87.91 132.03 34.37 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-O 121.171 0.51 . . . . 0.0 111.657 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -96.07 117.36 30.54 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.809 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.3 mm -98.49 132.61 23.82 Favored Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.533 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -56.24 142.13 87.65 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 123.195 2.597 . . . . 0.0 112.052 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.513 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 5.7 tt -54.17 -38.98 66.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.984 0.914 . . . . 0.0 111.761 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.5 -35.41 85.35 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.877 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -88.3 -25.02 23.01 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 60' ' ' LYS . 87.8 m-20 -62.71 -46.27 88.88 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.581 0.705 . . . . 0.0 110.034 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -73.68 -12.04 60.6 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.608 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.408 ' OH ' HG11 ' A' ' 7' ' ' VAL . 91.3 t80 -75.99 -28.7 57.92 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -175.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . 0.251 24.7 p90 -130.97 68.28 81.75 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -57.0 135.45 70.93 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 121.957 1.771 . . . . 0.0 111.046 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.69 161.3 29.56 Favored Pre-proline 0 C--N 1.278 -2.516 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.646 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.55 148.94 60.71 Favored 'Trans proline' 0 C--O 1.25 1.12 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 167.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 44.5 p90 -67.85 121.42 79.52 Favored Pre-proline 0 N--CA 1.413 -2.321 0 CA-C-O 121.626 0.727 . . . . 0.0 111.709 -171.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 90' ' ' ARG . 66.4 Cg_endo -96.76 160.74 1.12 Allowed 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 123.628 2.885 . . . . 0.0 112.697 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -108.01 -38.71 4.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.237 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 64.0 p -123.86 159.97 28.46 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.212 0.53 . . . . 0.0 111.9 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 90' ' ' ARG . 7.1 p -146.02 141.88 21.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 173.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -110.0 131.78 54.75 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.158 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -109.92 126.42 53.86 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.92 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.8 145.27 31.4 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.103 0.477 . . . . 0.0 111.914 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 19.2 t70 -113.87 154.93 26.65 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 173.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -91.67 -5.72 53.3 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.6 t -92.55 -23.44 19.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.909 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.87 -37.93 0.76 Allowed Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 118.896 -1.621 . . . . 0.0 114.196 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 84.6 mtm-85 -78.92 158.84 27.96 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 117.849 0.824 . . . . 0.0 113.123 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.6 m -146.38 150.44 35.67 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.284 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.544 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 12.8 m-90 -132.03 120.78 22.87 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.0 m -92.57 114.22 26.71 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 174.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 66' ' ' GLY . 18.2 m -114.83 158.79 15.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.642 -174.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 99.5 mtt180 -99.73 127.4 45.87 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.504 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.431 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 56.5 ttp -114.73 144.33 43.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.414 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -128.9 127.81 42.54 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -99.12 124.53 44.22 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.85 102.03 3.95 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.6 -105.22 0.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.352 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.28 -0.79 52.56 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 123.331 0.652 . . . . 0.0 112.151 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.528 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 84.8 tttt -142.17 147.09 36.03 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 118.515 -1.274 . . . . 0.0 112.922 -172.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.0 t -109.31 132.48 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -121.88 132.01 54.34 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 5.8 mp -101.19 102.61 13.55 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.269 168.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -85.21 -150.52 0.13 Allowed 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 124.62 1.168 . . . . 0.0 111.271 -170.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 62.0 t -55.47 125.9 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-O 121.838 0.827 . . . . 0.0 109.124 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 52' ' ' VAL . . . 135.22 -40.85 1.51 Allowed Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 -169.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.405 ' CZ2' HD21 ' A' ' 22' ' ' LEU . 63.7 t-105 -65.48 -24.84 67.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.729 -0.735 . . . . 0.0 109.64 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.611 ' HA ' HG12 ' A' ' 71' ' ' VAL . 37.2 tt0 -61.29 -30.34 70.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.382 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -58.56 -44.59 89.76 Favored 'General case' 0 C--O 1.198 -1.63 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.757 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -73.0 -46.43 52.28 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.081 0.553 . . . . 0.0 110.062 -176.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.7 p -62.76 -43.25 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.571 0.7 . . . . 0.0 110.058 -175.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -72.07 -43.22 65.2 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.273 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.96 -40.37 54.06 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.11 -21.01 27.86 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 57.8 94.89 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.577 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -142.73 146.18 34.08 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.696 -0.628 . . . . 0.0 111.993 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.21 170.86 8.2 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.188 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.593 ' N ' ' HB2' ' A' ' 15' ' ' SER . 14.8 t70 -53.52 136.74 37.85 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.568 1.147 . . . . 0.0 111.923 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.91 -11.39 22.79 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.421 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.51 161.38 16.25 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.388 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -125.81 137.74 53.79 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.24 144.65 48.49 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.257 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.473 ' HG2' ' HG2' ' A' ' 10' ' ' MET . 50.0 mt-30 -109.72 126.22 53.49 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -110.39 117.33 33.33 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 65.5 mt -97.95 122.51 49.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -105.75 123.4 47.87 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -125.64 80.25 1.88 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 52.25 30.11 7.5 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.285 170.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -161.7 -177.56 5.97 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 40' ' ' VAL . 42.2 ttm180 -95.52 41.74 1.1 Allowed 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 87.5 m -127.14 132.63 50.51 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.802 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 95.7 m-85 -125.29 140.09 53.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.134 0.492 . . . . 0.0 110.805 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.472 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 82.0 m-85 -101.76 126.43 48.62 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.8 t -108.1 119.49 57.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.177 0.513 . . . . 0.0 112.298 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 60.0 mt -112.08 123.82 68.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.406 HG23 ' HB3' ' A' ' 99' ' ' HIS . 8.6 tt -114.66 139.25 41.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 120.947 0.403 . . . . 0.0 110.667 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -87.58 113.37 23.2 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.74 67.75 1.02 Allowed Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.406 ' HB3' HG23 ' A' ' 96' ' ' ILE . 28.1 p-80 -93.21 113.43 25.64 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.974 0.416 . . . . 0.0 110.362 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -72.14 125.84 28.31 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.91 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 51.9 ttm -113.57 -8.18 13.33 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.547 0.689 . . . . 0.0 110.102 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 C--O 1.254 1.292 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.53 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.363 0.125 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.4 89.51 0.09 Allowed 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.872 0.844 . . . . 0.0 111.64 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -88.54 153.88 20.79 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.5 m -55.04 -37.78 67.13 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.044 0.449 . . . . 0.0 111.077 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.92 -52.62 3.64 Favored Glycine 0 CA--C 1.498 -0.978 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.67 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.38 93.85 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.022 0 C-N-CA 125.879 1.672 . . . . 0.0 111.838 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.68 140.0 45.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -132.91 154.43 50.41 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -172.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 69.2 t80 -124.77 147.76 48.5 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.21 -1.359 . . . . 0.0 107.552 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -140.18 134.02 30.58 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -153.91 151.1 24.09 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.542 174.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -77.08 136.75 16.63 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.752 2.301 . . . . 0.0 108.69 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 24.5 p90 -103.09 137.39 41.33 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.188 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 16' ' ' GLU . 2.3 mp -101.97 123.75 55.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 19.5 m -53.49 -25.31 15.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.005 0.922 . . . . 0.0 112.584 -173.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.404 ' H ' HG22 ' A' ' 14' ' ' ILE . 43.9 tt0 -60.73 -40.49 92.57 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.277 1.031 . . . . 0.0 110.655 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -103.05 -36.78 8.04 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.574 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 89.4 p -66.05 -8.07 21.13 Favored 'General case' 0 C--O 1.215 -0.763 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -172.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.0 m -73.9 -17.66 61.01 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.8 173.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -134.55 -33.35 0.97 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 18' ' ' SER . 49.4 p -147.36 170.23 17.78 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -171.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 3.1 tm? -133.72 113.44 12.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.8 131.49 35.91 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.725 ' HB ' HG23 ' A' ' 61' ' ' VAL . 58.8 mt -113.41 132.48 22.47 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -57.14 148.79 67.36 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 123.126 2.55 . . . . 0.0 113.407 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.5 tt -62.74 -33.87 76.03 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.064 0.946 . . . . 0.0 108.871 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.25 -35.96 86.79 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.511 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.429 ' CE2' ' HE1' ' A' ' 32' ' ' PHE . 57.8 t80 -80.15 -20.51 44.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.364 0.602 . . . . 0.0 109.551 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -66.51 -43.34 85.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.3 -11.14 60.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.491 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -72.18 -25.31 61.63 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.429 ' HE1' ' CE2' ' A' ' 28' ' ' PHE . 5.1 p90 -167.74 95.94 0.63 Allowed Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 121.063 0.459 . . . . 0.0 111.683 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.99 135.35 13.89 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.852 1.702 . . . . 0.0 110.202 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.431 ' H ' ' HE2' ' A' ' 56' ' ' LYS . . . -152.77 160.38 31.16 Favored Pre-proline 0 C--N 1.28 -2.427 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.54 153.61 73.83 Favored 'Trans proline' 0 C--O 1.251 1.168 0 C-N-CA 121.449 1.433 . . . . 0.0 108.386 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -69.07 131.8 90.55 Favored Pre-proline 0 N--CA 1.411 -2.412 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.444 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.6 156.18 28.04 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 122.211 1.941 . . . . 0.0 110.313 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.3 mm -83.53 -39.76 15.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -154.75 160.5 41.36 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' NH2' ' A' ' 90' ' ' ARG . 34.2 m -135.5 158.75 40.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -113.35 134.4 54.65 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.876 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -108.89 120.73 43.37 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -104.22 157.61 17.01 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.497 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 4.5 t70 -111.74 146.06 38.23 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.09 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -64.72 -26.88 68.56 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.789 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 m -89.89 -47.69 7.72 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 122.33 -0.231 . . . . 0.0 111.023 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.22 -8.21 0.05 OUTLIER Glycine 0 CA--C 1.525 0.707 0 C-N-CA 119.396 -1.383 . . . . 0.0 114.679 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -73.76 159.47 32.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.162 0.481 . . . . 0.0 111.501 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 p -147.13 136.72 22.89 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.497 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 16.8 m-90 -131.64 142.41 49.85 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.826 0.346 . . . . 0.0 110.378 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 73.4 m -106.59 114.44 28.54 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.2 m -125.74 156.94 35.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.391 -174.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -100.85 128.68 46.79 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.277 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 1.1 tmt? -127.84 143.73 51.11 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -135.0 143.57 46.88 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.012 0.434 . . . . 0.0 111.899 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HA ' HG12 ' A' ' 61' ' ' VAL . 29.1 mmmt -92.43 121.27 33.73 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 102.873 -3.01 . . . . 0.0 102.873 169.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -134.65 98.0 3.94 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.374 -170.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.45 -109.82 3.12 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.947 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.621 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -105.86 -7.93 17.98 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.979 0.419 . . . . 0.0 110.275 -178.544 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 61' ' ' VAL . 41.7 ttmt -118.78 167.7 11.44 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.725 HG23 ' HB ' ' A' ' 24' ' ' ILE . 32.7 m -128.65 142.27 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -140.74 132.39 27.2 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -173.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 67' ' ' TRP . 5.5 tt -97.47 115.81 28.49 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 176.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.7 t -101.31 -142.73 0.34 Allowed 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.085 -170.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.6 m -56.1 143.78 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 124.397 1.079 . . . . 0.0 112.811 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.89 -31.86 6.31 Favored Glycine 0 N--CA 1.421 -2.357 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.475 ' HB2' HD22 ' A' ' 63' ' ' LEU . 57.1 t-105 -54.61 -27.04 36.51 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.609 0.719 . . . . 0.0 110.467 177.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.669 ' HA ' HG12 ' A' ' 71' ' ' VAL . 13.8 pt-20 -63.83 -26.63 68.7 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.204 -175.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -61.58 -37.71 84.89 Favored 'General case' 0 C--O 1.2 -1.552 0 CA-C-O 120.973 0.415 . . . . 0.0 110.098 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -73.95 -48.13 32.7 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.825 0.85 . . . . 0.0 110.765 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.2 p -65.54 -42.25 92.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.351 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -71.29 -39.81 71.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.752 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -71.8 -38.62 70.22 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -95.56 0.27 52.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.5 t30 55.63 82.81 0.1 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.99 0.9 . . . . 0.0 109.681 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 92.8 mt -120.86 136.0 55.03 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.891 -173.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -138.78 158.67 43.8 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -54.32 128.32 30.96 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 124.348 1.03 . . . . 0.0 111.009 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.24 -35.75 1.93 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -92.56 164.31 13.48 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.411 ' HB2' ' HB2' ' A' ' 97' ' ' TYR . 37.9 m-85 -132.67 154.4 50.17 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -113.2 147.59 37.17 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.403 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.466 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 49.5 tt0 -115.25 123.98 50.19 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 171.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 86.2 m-85 -109.2 116.32 31.68 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.3 mt -110.64 125.29 67.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.411 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 34.3 p90 -119.72 155.58 32.18 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.025 -1.47 . . . . 0.0 108.844 173.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -96.31 -79.92 0.44 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.271 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -143.42 16.49 1.85 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.909 0.385 . . . . 0.0 110.053 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 33.6 t70 -133.44 -175.07 3.69 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -174.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.475 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -95.09 20.51 8.97 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 125.439 1.495 . . . . 0.0 111.762 -177.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.3 t -110.33 132.98 53.7 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 81.3 m-85 -112.96 140.57 47.66 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.185 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -98.32 117.6 33.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 43.1 t -104.67 134.63 45.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.325 0.584 . . . . 0.0 112.258 -173.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.2 mt -120.29 134.33 64.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 96' ' ' ILE . 2.1 mp -100.65 121.5 51.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 120.643 0.259 . . . . 0.0 110.465 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 83' ' ' GLN . 97.1 m-85 -85.22 160.41 19.89 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.869 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 102' ' ' CYS . . . -179.55 -133.58 2.0 Favored Glycine 0 N--CA 1.417 -2.592 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -144.08 -48.46 0.28 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.522 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -76.95 -19.46 57.33 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.39 0.614 . . . . 0.0 110.611 -175.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 27.5 ttt 169.83 -44.94 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.513 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 74.0 m . . . . . 0 N--CA 1.417 -2.117 0 CA-C-N 111.83 -2.441 . . . . 0.0 104.755 170.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.25 106.45 9.88 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -76.51 129.1 36.0 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.377 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 32.5 m -71.09 -34.85 71.52 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.62 65.54 0.26 Allowed Glycine 0 CA--C 1.483 -1.964 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.374 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.77 101.68 7.72 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -128.01 146.7 33.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -137.04 151.81 49.37 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.743 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -142.66 149.37 38.8 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.9 ptp -138.23 154.74 49.08 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.579 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 24.3 ttpp -152.98 145.96 17.61 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.42 142.7 16.86 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.102 2.534 . . . . 0.0 111.341 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.46 ' CZ ' HD13 ' A' ' 76' ' ' LEU . 71.4 t80 -110.75 123.88 50.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 16' ' ' GLU . 61.4 mt -126.26 113.09 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.6 p -58.38 -9.46 1.58 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' H ' HG22 ' A' ' 14' ' ' ILE . 42.1 mt-10 -81.4 -28.23 34.42 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 122.148 -0.345 . . . . 0.0 110.921 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -110.61 -38.01 5.3 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.321 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 21' ' ' SER . 65.0 p -75.24 -0.45 19.51 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.225 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.5 p -75.18 -25.08 57.98 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.513 0.673 . . . . 0.0 110.409 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -115.94 -37.45 3.87 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.492 -175.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 18' ' ' SER . 34.5 p -153.67 169.6 22.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -171.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 4.2 tt -108.04 115.13 29.57 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.579 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 14.8 pt-20 -75.15 115.51 14.87 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.46 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 61' ' ' VAL . 68.0 mt -106.63 123.42 38.75 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.54 147.11 88.27 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 123.396 2.731 . . . . 0.0 114.376 -176.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 4.9 tt -59.12 -39.78 83.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.513 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.51 -31.16 69.85 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.749 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -82.62 -24.22 33.94 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.5 0.667 . . . . 0.0 109.759 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.439 ' HB2' HG23 ' A' ' 61' ' ' VAL . 55.1 t30 -76.08 -46.3 29.7 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.54 -20.0 66.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.038 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.39 -26.98 65.83 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.717 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -168.54 103.24 0.52 Allowed Pre-proline 0 C--O 1.248 1.009 0 CA-C-O 121.239 0.542 . . . . 0.0 110.555 177.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.21 135.14 14.9 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 120.968 1.112 . . . . 0.0 109.797 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.65 148.97 21.39 Favored Pre-proline 0 C--N 1.276 -2.6 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.74 133.85 41.18 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 121.811 1.674 . . . . 0.0 108.534 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.71 ' HB3' ' H ' ' A' ' 56' ' ' LYS . 39.4 p90 -69.78 139.92 88.78 Favored Pre-proline 0 N--CA 1.414 -2.268 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -75.72 158.63 39.3 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.874 2.383 . . . . 0.0 109.905 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.36 -54.89 12.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.5 p -133.44 150.44 51.75 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.601 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 m -131.94 157.18 43.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -109.98 139.59 44.91 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.641 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.461 HD23 ' HB2' ' A' ' 92' ' ' PHE . 77.7 mt -108.24 121.89 45.82 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.3 137.96 38.95 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.94 150.95 29.79 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.024 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.58 -22.95 65.66 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.281 0.633 . . . . 0.0 112.445 -175.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.9 t -82.46 3.05 29.81 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.099 0.476 . . . . 0.0 110.175 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 8.9 67.66 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 121.358 -0.448 . . . . 0.0 112.264 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -89.27 154.97 19.68 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.1 p -141.19 137.84 32.94 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 120.863 0.363 . . . . 0.0 111.402 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -124.3 142.13 51.51 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.217 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.5 m -100.18 120.39 39.82 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.518 ' HB ' HD21 ' A' ' 63' ' ' LEU . 22.9 m -123.31 157.25 29.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.596 -174.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -101.2 139.82 36.35 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.829 0.347 . . . . 0.0 110.258 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 25.3 ttt -134.26 127.22 31.4 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.517 -172.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -120.69 124.93 46.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.018 0.437 . . . . 0.0 111.31 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.71 ' H ' ' HB3' ' A' ' 36' ' ' PHE . 25.3 mmmt -100.39 105.49 16.99 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 175.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -149.93 115.47 5.53 Favored 'General case' 0 C--N 1.265 -3.102 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.94 -120.17 5.15 Favored Glycine 0 N--CA 1.418 -2.541 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.441 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.434 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 31.0 mt-10 -96.03 -27.97 14.86 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.521 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -120.99 170.32 9.62 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.883 0.849 . . . . 0.0 112.876 -172.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.541 HG22 ' HD2' ' A' ' 56' ' ' LYS . 47.5 t -120.69 127.3 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 173.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -119.8 129.1 54.29 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 6.6 tt -103.96 118.09 35.86 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.4 p -99.16 -144.38 0.32 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.9 m -54.77 144.88 5.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.89 1.276 . . . . 0.0 113.154 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.464 ' C ' HG12 ' A' ' 52' ' ' VAL . . . 114.94 -41.54 2.14 Favored Glycine 0 N--CA 1.418 -2.532 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 -170.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.514 ' CZ3' HD12 ' A' ' 22' ' ' LEU . 58.0 t-105 -62.38 -26.9 68.71 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 114.259 -0.971 . . . . 0.0 109.248 174.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.571 ' HA ' HG12 ' A' ' 71' ' ' VAL . 30.5 tt0 -69.39 -26.77 64.81 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.524 -177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -70.28 -30.84 67.96 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 67' ' ' TRP . 53.1 t80 -73.03 -52.47 14.26 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 124.527 1.131 . . . . 0.0 109.278 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.1 p -64.61 -41.21 91.61 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.973 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -70.59 -48.14 56.69 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.679 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.83 -40.36 69.15 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.709 -173.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -88.62 -19.08 26.71 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.973 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.0 t30 56.22 92.38 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.041 0.936 . . . . 0.0 110.993 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.46 HD13 ' CZ ' ' A' ' 13' ' ' PHE 0.289 0.9 OUTLIER -142.09 132.1 24.55 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -176.977 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.83 173.46 9.54 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 125.849 1.66 . . . . 0.0 109.017 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -52.71 135.92 34.29 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.693 0.62 . . . . 0.0 110.54 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.68 -28.22 3.27 Favored Glycine 0 C--N 1.301 -1.414 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -107.67 150.47 26.88 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.834 -0.683 . . . . 0.0 109.447 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -122.31 146.65 47.1 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.1 mt -110.76 135.88 50.67 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.104 0.478 . . . . 0.0 112.004 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -118.02 124.42 48.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.87 117.88 34.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.936 0.398 . . . . 0.0 110.969 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.775 HG13 ' HB2' ' A' ' 93' ' ' TYR . 11.7 pt -105.36 130.19 57.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -106.41 143.77 34.05 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.267 0.556 . . . . 0.0 111.41 -173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -92.59 -0.75 57.27 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 4' ' ' THR . 7.3 tpt180 74.96 8.4 4.13 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.932 1.693 . . . . 0.0 109.175 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 31.5 t70 -106.08 -159.36 0.7 Allowed 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.553 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 53.4 ttp180 -95.7 11.95 31.61 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 p -108.39 117.84 35.22 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.626 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.461 ' HB2' HD23 ' A' ' 42' ' ' LEU . 3.4 m-85 -107.42 126.46 52.52 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.491 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.775 ' HB2' HG13 ' A' ' 85' ' ' ILE . 78.9 m-85 -104.27 126.98 51.83 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.1 p -119.32 135.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.167 0.508 . . . . 0.0 111.724 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.1 mt -114.45 123.01 69.71 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.4 mt -103.56 112.69 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.578 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -126.62 167.59 15.47 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.807 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.97 117.71 1.46 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.614 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 49.8 m80 65.51 -74.88 0.05 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.719 1.208 . . . . 0.0 112.167 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -169.68 85.65 0.13 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.26 -40.18 8.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 84.2 m . . . . . 0 C--N 1.313 -0.986 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 174.589 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 111.209 0.077 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.27 124.69 20.84 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 68.42 78.39 0.23 Allowed 'General case' 0 C--O 1.245 0.847 0 O-C-N 124.332 1.02 . . . . 0.0 109.868 -172.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.8 m -83.43 -41.08 18.51 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.426 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.78 -154.24 20.44 Favored Glycine 0 N--CA 1.416 -2.669 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' A' ' 87' ' ' ASP . 42.0 tt0 59.97 29.6 19.16 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 122.088 0.947 . . . . 0.0 110.052 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.29 140.7 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -125.23 159.6 31.22 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-O 121.082 0.468 . . . . 0.0 112.195 -172.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -148.89 148.83 30.32 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.9 ptp -138.28 141.01 39.85 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.652 0.263 . . . . 0.0 111.348 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.66 157.05 31.39 Favored Pre-proline 0 C--N 1.312 -1.025 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.82 132.53 15.79 Favored 'Trans proline' 0 N--CA 1.439 -1.728 0 C-N-CA 120.989 1.126 . . . . 0.0 109.681 172.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' A' ' 76' ' ' LEU . 30.3 p90 -84.44 140.47 31.49 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 123.564 0.746 . . . . 0.0 110.232 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.6 mt -90.59 120.88 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.439 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 28.8 t -53.44 -37.11 62.28 Favored 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.716 0.635 . . . . 0.0 111.89 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.76 -40.57 97.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -87.02 -39.32 15.75 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.823 0.821 . . . . 0.0 108.933 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 21' ' ' SER . 48.4 m -76.04 4.14 9.0 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 114.45 -1.25 . . . . 0.0 113.016 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.1 m -71.61 -20.02 62.04 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.227 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -136.22 -36.17 0.74 Allowed 'General case' 0 C--O 1.214 -0.808 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.628 ' O ' ' HA ' ' A' ' 18' ' ' SER . 58.4 p -138.95 168.06 20.66 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.608 -0.437 . . . . 0.0 112.138 -175.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.07 131.73 47.34 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -89.34 131.82 35.24 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 121.41 0.624 . . . . 0.0 111.922 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 47.3 mm -94.89 132.93 27.28 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.1 144.43 69.42 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.883 2.389 . . . . 0.0 112.984 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.0 tp -65.58 -33.41 75.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.326 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.66 -36.21 93.04 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . 45.2 m-85 -77.84 -25.71 48.92 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -59.21 -46.33 88.74 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.19 -31.98 62.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.211 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 64.0 t80 -68.81 -28.55 66.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.369 -174.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -151.09 93.51 3.64 Favored Pre-proline 0 C--O 1.247 0.95 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -83.64 136.0 7.16 Favored 'Trans proline' 0 N--CA 1.429 -2.274 0 C-N-CA 122.264 1.976 . . . . 0.0 108.812 167.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.71 160.53 31.54 Favored Pre-proline 0 C--N 1.264 -3.127 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -175.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.2 132.78 53.3 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 107.342 -1.83 . . . . 0.0 107.342 172.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -68.22 115.74 32.16 Favored Pre-proline 0 N--CA 1.41 -2.446 0 CA-C-O 121.285 0.564 . . . . 0.0 112.002 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -80.45 135.48 10.58 Favored 'Trans proline' 0 N--CA 1.433 -2.079 0 C-N-CA 121.942 1.762 . . . . 0.0 110.062 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.9 mm -81.48 -28.79 10.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.6 p -127.66 148.73 50.39 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 121.497 0.665 . . . . 0.0 110.15 173.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 90' ' ' ARG . 53.4 t -142.83 147.31 20.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -115.83 133.96 55.49 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.725 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt -108.15 121.78 45.56 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -101.23 137.47 39.54 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.962 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -113.11 141.6 46.71 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.242 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -57.93 -29.78 65.42 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 125.353 1.461 . . . . 0.0 113.717 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.5 t -86.1 -4.57 59.2 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 122.094 -0.379 . . . . 0.0 110.487 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.21 -4.85 23.62 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.651 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -80.73 158.51 25.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.775 0.322 . . . . 0.0 110.568 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 p -156.34 135.38 11.98 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.219 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -125.51 135.77 52.64 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.687 0.279 . . . . 0.0 110.91 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.2 m -92.32 114.8 27.45 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.427 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 33.6 m -115.63 157.66 16.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.343 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 53' ' ' ARG . 23.8 ttt180 -101.34 127.39 47.98 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.398 0.618 . . . . 0.0 109.768 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.5 ttt -110.13 144.33 38.9 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.547 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HG3' ' HB2' ' A' ' 57' ' ' ARG . 59.7 tptt -139.32 125.69 20.3 Favored 'General case' 0 N--CA 1.412 -2.366 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.156 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.56 ' HD2' HG22 ' A' ' 61' ' ' VAL . 28.5 mmmt -92.01 113.25 25.47 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 79.6 ttt180 -135.84 97.99 3.78 Favored 'General case' 0 C--N 1.272 -2.79 0 CA-C-O 120.985 0.421 . . . . 0.0 112.096 -173.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.92 -87.92 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 116.638 1.415 . . . . 0.0 116.638 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -89.57 -24.84 21.62 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.614 -0.293 . . . . 0.0 111.612 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -154.08 171.09 19.65 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.927 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.56 HG22 ' HD2' ' A' ' 56' ' ' LYS . 48.5 t -108.31 131.3 59.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -120.97 132.48 54.95 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 tt -102.34 103.8 14.27 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 53.4 p -95.03 -103.65 0.15 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.5 m -69.84 144.21 14.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.455 0.645 . . . . 0.0 112.083 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 109.61 -37.77 3.63 Favored Glycine 0 CA--C 1.483 -1.954 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.411 ' O ' ' HB3' ' A' ' 70' ' ' PHE . 63.6 t-105 -61.23 -24.9 66.69 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 122.084 0.945 . . . . 0.0 109.191 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.546 ' HA ' HG12 ' A' ' 71' ' ' VAL . 13.0 pt-20 -65.68 -30.12 70.77 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.357 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -74.68 -29.46 61.24 Favored 'General case' 0 C--O 1.202 -1.413 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 67' ' ' TRP . 16.1 t80 -73.28 -52.36 14.24 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 124.763 1.225 . . . . 0.0 108.454 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.1 p -61.1 -45.32 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.443 -177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -71.91 -34.06 68.8 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.21 -39.55 63.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.387 -174.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -90.25 -18.75 25.09 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.898 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.1 t30 54.82 83.92 0.08 Allowed 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.164 0.986 . . . . 0.0 109.698 -172.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.489 HD13 ' CE2' ' A' ' 13' ' ' PHE . 1.3 pp -133.98 148.54 51.15 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -175.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -143.85 172.31 13.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.126 -174.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' H ' ' HB2' ' A' ' 15' ' ' SER . 5.4 p-10 -56.78 141.11 45.52 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 123.704 0.627 . . . . 0.0 111.38 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 117.51 -16.01 12.75 Favored Glycine 0 C--N 1.302 -1.318 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -174.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 98' ' ' GLY . 65.9 mttm -104.39 159.22 15.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 97' ' ' TYR . 33.2 m-85 -120.99 136.82 54.89 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -173.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.8 pp -114.92 138.97 50.19 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.966 176.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.551 ' NE2' HD12 ' A' ' 95' ' ' ILE . 27.2 tt0 -124.24 124.01 41.5 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.455 ' CE2' HD13 ' A' ' 82' ' ' LEU . 86.9 m-85 -108.7 131.86 54.5 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 59.2 mt -97.65 116.05 39.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HD2' ' CE1' ' A' ' 92' ' ' PHE . 53.8 m-85 -107.05 126.79 52.8 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.422 ' HA ' ' H ' ' A' ' 6' ' ' GLU . 6.1 p-10 -110.63 16.95 21.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 118.596 -1.241 . . . . 0.0 109.282 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 63.75 80.4 0.23 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.583 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -172.82 -168.67 0.51 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.46 ' O ' HG13 ' A' ' 40' ' ' VAL . 51.5 ptt85 -107.55 24.87 12.21 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 118.412 0.551 . . . . 0.0 109.749 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -129.27 117.35 20.54 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.414 ' CE1' ' HD2' ' A' ' 86' ' ' TYR . 26.9 m-85 -121.45 137.88 54.53 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.576 -176.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -100.4 125.99 46.72 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.6 p -109.66 137.98 39.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-O 121.599 0.714 . . . . 0.0 112.5 -175.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.551 HD12 ' NE2' ' A' ' 83' ' ' GLN . 66.7 mt -118.61 125.89 74.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.6 mt -113.01 125.43 70.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.549 0.69 . . . . 0.0 111.158 -174.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 62.6 m-85 -98.58 119.47 37.35 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 80' ' ' LYS . . . 103.6 82.37 1.61 Allowed Glycine 0 C--N 1.294 -1.789 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 -170.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -125.99 147.87 49.42 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.835 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -64.88 121.09 13.8 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.8 ttt -81.43 81.36 7.58 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.467 0.651 . . . . 0.0 110.597 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.6 m . . . . . 0 C--N 1.303 -1.432 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.402 179.097 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 CA--C 1.504 -0.822 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.78 91.56 8.68 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.206 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.8 t70 71.08 149.29 0.09 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.307 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.1 m -92.88 -22.7 19.11 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.552 0.691 . . . . 0.0 109.907 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.51 -42.89 1.09 Allowed Glycine 0 CA--C 1.48 -2.124 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.36 166.58 16.5 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 113.612 -1.294 . . . . 0.0 109.042 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.4 m -129.21 140.3 49.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -121.84 148.01 45.24 Favored 'General case' 0 N--CA 1.406 -2.652 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -147.09 148.95 32.14 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -134.68 138.54 44.52 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.571 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -148.48 144.88 19.07 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.9 133.56 5.02 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 121.988 1.792 . . . . 0.0 108.105 168.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -100.3 142.34 31.91 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 122.336 -0.227 . . . . 0.0 110.621 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.442 ' HB ' ' HG2' ' A' ' 17' ' ' LYS . 81.5 mt -88.36 114.67 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.527 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 28.9 t -53.68 -34.18 57.85 Favored 'General case' 0 C--O 1.212 -0.872 0 O-C-N 123.648 0.592 . . . . 0.0 111.121 -174.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.5 -39.83 89.15 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.667 -177.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HG2' ' HB ' ' A' ' 14' ' ' ILE . 20.7 ptmt -104.77 -26.88 12.08 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.811 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 21' ' ' SER . 68.4 m -92.56 14.44 16.86 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.8 m -74.2 -16.39 60.98 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 118.885 -1.126 . . . . 0.0 109.919 166.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -114.51 -47.67 2.9 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 18' ' ' SER . 49.2 m -143.35 168.68 19.23 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 122.972 0.509 . . . . 0.0 110.39 -172.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.494 HD22 ' CZ3' ' A' ' 67' ' ' TRP . 43.9 tp -126.24 142.17 51.63 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.305 0.242 . . . . 0.0 110.751 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -98.37 124.69 43.17 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 120.681 0.276 . . . . 0.0 110.661 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 2.1 mp -97.25 133.38 24.02 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.53 139.29 17.89 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 123.925 3.083 . . . . 0.0 114.787 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.5 tt -62.7 -41.08 98.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.163 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.1 -36.11 92.45 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.406 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 75.7 t80 -73.72 -34.2 64.69 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -63.51 -46.46 85.94 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.853 0.835 . . . . 0.0 110.021 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -72.88 -11.07 60.45 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.842 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 89.1 t80 -74.76 -27.68 60.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.377 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 27.6 p90 -147.07 121.07 5.05 Favored Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.817 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 4.5 Cg_exo -76.74 134.64 15.2 Favored 'Trans proline' 0 N--CA 1.44 -1.676 0 C-N-CA 121.832 1.688 . . . . 0.0 108.87 172.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.08 138.46 11.59 Favored Pre-proline 0 C--N 1.271 -2.805 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.92 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 143.85 96.72 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 106.557 -2.132 . . . . 0.0 106.557 167.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 51.8 p90 -68.79 121.93 83.08 Favored Pre-proline 0 N--CA 1.41 -2.471 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.162 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 36' ' ' PHE . 11.9 Cg_exo -71.09 152.56 62.47 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 121.913 1.742 . . . . 0.0 110.086 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.0 mm -86.78 -59.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -124.72 151.01 45.58 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.706 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.48 162.29 29.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 91' ' ' THR . 24.8 t70 -124.89 140.09 53.24 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.042 -175.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.3 mt -107.79 127.58 53.83 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.15 147.72 25.91 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.798 0.809 . . . . 0.0 111.793 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 2.3 t70 -112.14 137.14 50.63 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.528 173.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -70.31 -8.88 53.87 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.5 t -92.18 -41.73 10.28 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.87 0.03 0.11 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.11 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 17.9 mmt180 -88.88 158.95 17.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 117.643 0.722 . . . . 0.0 110.731 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.7 p -149.51 146.56 27.45 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.46 ' CE3' ' HD1' ' A' ' 70' ' ' PHE . 24.3 m-90 -130.04 123.71 31.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.415 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.9 m -89.68 117.0 28.22 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.585 ' HB ' HD21 ' A' ' 63' ' ' LEU . 22.2 m -124.95 157.23 33.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.686 -172.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -102.62 122.93 45.39 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.255 0.55 . . . . 0.0 111.517 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.428 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 50.8 ttp -124.82 131.18 53.47 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.63 161.84 38.15 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 61' ' ' VAL . 78.8 mttt -91.29 129.86 37.23 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -132.11 103.15 6.11 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.392 0.615 . . . . 0.0 110.951 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.27 -101.27 0.73 Allowed Glycine 0 N--CA 1.431 -1.65 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.565 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.432 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 39.7 mt-10 -95.23 -20.68 19.0 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.383 -0.408 . . . . 0.0 111.061 -175.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -131.56 166.64 20.94 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.487 0.66 . . . . 0.0 112.623 -170.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.538 HG22 ' HG2' ' A' ' 56' ' ' LYS . 90.1 t -97.42 136.92 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 170.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -135.19 132.88 38.48 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.132 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.696 HD22 ' HB2' ' A' ' 67' ' ' TRP . 3.7 tt -99.14 116.86 32.31 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.3 p -90.0 -92.16 0.13 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.67 145.15 8.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 C-N-CA 124.967 1.307 . . . . 0.0 113.205 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.414 ' C ' HG12 ' A' ' 52' ' ' VAL . . . 109.28 -36.4 4.36 Favored Glycine 0 CA--C 1.477 -2.311 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.566 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.696 ' HB2' HD22 ' A' ' 63' ' ' LEU . 64.5 t-105 -58.68 -26.15 63.54 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.706 0.765 . . . . 0.0 109.906 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.642 ' HA ' HG12 ' A' ' 71' ' ' VAL . 15.8 pt-20 -72.39 -26.22 61.8 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.535 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -71.99 -37.92 69.76 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.46 ' HD1' ' CE3' ' A' ' 50' ' ' TRP . 69.0 t80 -72.89 -51.29 19.21 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.072 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -62.66 -44.59 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.65 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -73.47 -43.72 59.6 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.12 -40.05 78.55 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.532 -0.867 . . . . 0.0 112.891 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -85.14 -14.56 46.63 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t30 60.77 82.75 0.16 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 125.204 1.402 . . . . 0.0 112.173 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -115.64 159.08 21.79 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.388 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -143.96 165.06 28.8 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.527 ' H ' ' HB2' ' A' ' 15' ' ' SER . 14.1 t70 -53.16 120.95 6.56 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 124.072 0.858 . . . . 0.0 109.414 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.98 -29.38 3.73 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -80.85 154.48 27.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.477 ' C ' HD12 ' A' ' 82' ' ' LEU . 94.8 m-85 -122.05 135.15 54.8 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 81' ' ' TYR . 6.4 mp -123.26 130.75 53.18 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.111 0.481 . . . . 0.0 111.224 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -112.83 124.11 51.84 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -108.99 118.04 35.77 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.355 -173.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 63.2 mt -98.23 118.29 44.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.29 -0.413 . . . . 0.0 109.937 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -106.47 123.48 48.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -81.79 -78.78 0.18 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -176.82 24.23 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.59 -172.99 2.43 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.97 29.44 2.4 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-O 121.638 0.732 . . . . 0.0 109.078 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 17.5 p -125.38 136.66 53.67 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.078 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -118.13 135.25 54.33 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.375 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 57.2 m-85 -100.48 113.64 26.59 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.0 t -98.7 124.79 52.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.693 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.1 mm -105.75 116.46 49.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 96' ' ' ILE . 3.0 mp -102.15 130.28 52.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -85.39 112.72 21.1 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.38 -83.98 0.19 Allowed Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 84.1 t60 68.04 125.9 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.227 1.011 . . . . 0.0 113.709 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -89.62 129.68 36.03 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.55 112.04 16.42 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -176.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 46.2 t . . . . . 0 C--N 1.312 -1.039 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.43 113.24 25.88 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 120.992 0.425 . . . . 0.0 110.78 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -114.13 97.43 6.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.609 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.9 m -99.72 -34.65 10.09 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.52 -145.11 9.29 Favored Glycine 0 N--CA 1.422 -2.278 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 42.76 80.95 0.03 OUTLIER 'General case' 0 C--O 1.256 1.42 0 C-N-CA 124.963 1.305 . . . . 0.0 113.573 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.27 140.68 46.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.902 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 9.8 pt20 -121.9 146.1 47.44 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.37 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 83' ' ' GLN . 88.6 t80 -129.63 148.59 51.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -124.9 146.24 49.43 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 120.641 0.257 . . . . 0.0 110.676 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HE2' ' HG3' ' A' ' 23' ' ' GLU . 24.1 ttpp -154.14 139.88 12.32 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 174.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.03 146.19 81.6 Favored 'Trans proline' 0 C--O 1.257 1.467 0 C-N-CA 122.032 1.821 . . . . 0.0 110.709 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -78.62 119.45 21.9 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 16' ' ' GLU . 68.1 mt -107.52 120.2 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.239 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 78' ' ' ASP . 32.1 t -66.74 -10.9 51.87 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 123.273 0.629 . . . . 0.0 111.413 -172.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.467 ' H ' HG22 ' A' ' 14' ' ' ILE . 46.6 mt-10 -75.5 -46.18 33.85 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.531 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.498 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 3.5 mppt? -113.17 -41.89 3.62 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 118.394 -1.322 . . . . 0.0 113.543 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 21' ' ' SER . 15.6 m -69.43 -3.74 15.68 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 123.57 0.544 . . . . 0.0 111.091 -174.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.0 p -74.31 -25.51 59.62 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -133.13 -23.33 1.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.975 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.562 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 51.0 m -150.48 169.16 22.15 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -175.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 63' ' ' LEU 0.308 42.7 mt -103.86 131.35 51.15 Favored 'General case' 0 CA--C 1.488 -1.408 0 CA-C-O 122.391 1.091 . . . . 0.0 113.875 177.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.498 ' OE2' ' HB2' ' A' ' 17' ' ' LYS . 6.7 pt-20 -91.33 111.27 22.68 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 112.324 -2.216 . . . . 0.0 108.973 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.86 121.68 36.46 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.614 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.51 153.75 76.87 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 123.045 2.497 . . . . 0.0 113.154 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.88 -34.8 74.05 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.882 -175.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.21 -28.8 73.96 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.688 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -75.88 -31.21 59.14 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.276 0.631 . . . . 0.0 110.166 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -76.16 -26.23 56.04 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.565 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -75.32 -17.42 60.26 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.662 0.744 . . . . 0.0 109.324 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -74.1 -28.24 61.27 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.92 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -161.35 80.45 2.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 121.617 0.722 . . . . 0.0 112.1 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.37 140.62 15.43 Favored 'Trans proline' 0 N--CA 1.43 -2.244 0 C-N-CA 122.343 2.029 . . . . 0.0 111.499 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.8 159.21 36.36 Favored Pre-proline 0 C--N 1.278 -2.519 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.93 146.34 87.24 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 121.888 1.725 . . . . 0.0 108.935 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -69.05 117.42 51.63 Favored Pre-proline 0 N--CA 1.415 -2.178 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -175.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.66 159.84 31.61 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.878 2.385 . . . . 0.0 111.534 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.17 -41.34 22.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -137.03 150.53 48.15 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.671 0.748 . . . . 0.0 112.219 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 90' ' ' ARG . 74.2 t -132.45 160.04 42.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.88 130.96 34.63 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.48 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.402 ' CD2' ' HB2' ' A' ' 92' ' ' PHE . 79.7 mt -109.62 133.81 52.67 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.208 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.44 143.32 32.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.877 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.512 ' HB2' ' HZ3' ' A' ' 50' ' ' TRP . 9.7 t70 -112.9 147.69 36.51 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.681 174.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -60.34 -23.81 64.55 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 124.228 1.011 . . . . 0.0 112.866 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -80.28 -12.75 59.58 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.847 -0.533 . . . . 0.0 110.404 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.25 1.35 25.02 Favored Glycine 0 C--O 1.239 0.445 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.299 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 98.1 mtt180 -80.6 157.42 26.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.2 p -150.53 136.75 18.62 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 120.59 0.233 . . . . 0.0 110.512 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.512 ' HZ3' ' HB2' ' A' ' 44' ' ' ASP . 15.8 m-90 -124.53 130.47 52.52 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.145 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.1 m -89.98 114.48 26.33 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HB ' HD21 ' A' ' 63' ' ' LEU . 28.6 m -112.03 156.81 13.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.814 -173.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.546 ' HB2' HG23 ' A' ' 64' ' ' THR . 85.6 mtt180 -102.79 119.96 39.76 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.473 ' HB3' HG21 ' A' ' 40' ' ' VAL . 60.4 ttp -124.62 123.72 40.67 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -136.75 162.68 32.53 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HD3' HG22 ' A' ' 61' ' ' VAL . 29.7 mmtp -88.72 128.62 35.62 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 175.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.49 100.62 5.21 Favored 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -175.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.84 -112.2 3.61 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -175.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -112.3 -5.77 14.12 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.886 0.85 . . . . 0.0 110.321 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -113.69 170.67 8.09 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.213 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.529 HG22 ' HD3' ' A' ' 56' ' ' LYS . 57.9 t -108.58 127.28 65.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -126.68 130.59 50.7 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 6.7 tt -103.15 120.96 41.66 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.546 HG23 ' HB2' ' A' ' 53' ' ' ARG . 5.6 t -96.43 -144.55 0.28 Allowed 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 123.161 0.584 . . . . 0.0 111.546 -172.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.47 143.88 6.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 125.43 1.492 . . . . 0.0 111.689 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 125.35 -48.42 0.96 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -65.36 -24.91 67.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.394 -0.903 . . . . 0.0 110.176 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.459 ' HA ' HG12 ' A' ' 71' ' ' VAL . 35.2 tt0 -65.5 -29.87 70.57 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.796 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -69.48 -35.89 76.02 Favored 'General case' 0 C--O 1.198 -1.634 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.347 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -68.57 -49.7 57.41 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 123.409 0.683 . . . . 0.0 109.204 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 6.8 p -63.67 -33.68 63.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.223 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -71.23 -48.64 50.07 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.039 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -72.34 -39.56 68.06 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -96.96 -10.0 27.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.749 -0.595 . . . . 0.0 111.278 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 7.9 t30 53.99 94.86 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.233 1.413 . . . . 0.0 112.932 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 71' ' ' VAL . 3.8 mp -122.21 133.75 54.72 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.749 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.09 169.99 10.65 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 124.21 1.004 . . . . 0.0 108.979 174.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 6.3 p-10 -60.66 141.47 56.73 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.216 0.531 . . . . 0.0 111.302 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.09 -29.45 5.99 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -80.84 154.33 27.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.862 0.363 . . . . 0.0 110.404 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -122.56 140.73 52.46 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mp -124.51 144.12 50.29 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.745 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 14.6 pt20 -116.23 137.27 52.28 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 85.9 m-85 -111.81 117.61 33.29 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 48.9 mt -97.62 114.72 35.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.482 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 24.3 p90 -130.56 157.86 41.55 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.734 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -107.66 25.1 11.92 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.61 13.49 2.94 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 125.145 1.378 . . . . 0.0 111.82 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.556 ' OD2' HG22 ' A' ' 91' ' ' THR . 7.8 p-10 -96.35 -159.63 0.74 Allowed 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.585 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -105.5 15.72 26.64 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -176.012 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.556 HG22 ' OD2' ' A' ' 89' ' ' ASP . 5.5 t -121.41 139.8 52.98 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 117.789 -1.564 . . . . 0.0 109.197 172.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.482 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 71.6 m-85 -128.13 136.46 51.17 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 122.122 -0.361 . . . . 0.0 110.67 -175.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.435 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 61.3 m-85 -94.59 120.46 34.85 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.5 t -103.71 117.71 49.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 120.99 0.424 . . . . 0.0 111.496 -174.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.439 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 65.0 mt -114.61 124.49 71.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 96' ' ' ILE . 2.6 mp -94.15 140.66 16.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -84.45 141.78 30.56 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.583 0.706 . . . . 0.0 111.328 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.91 173.32 21.49 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -98.46 -47.28 5.45 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -160.08 100.79 1.4 Allowed 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 69.9 mtm -61.89 113.26 2.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.417 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.249 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.498 -1.037 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.53 94.55 1.59 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -111.37 92.72 4.15 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.801 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.6 m -88.78 -14.37 37.25 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.837 0.827 . . . . 0.0 109.774 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.3 -114.74 1.04 Allowed Glycine 0 N--CA 1.425 -2.08 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.889 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 85' ' ' ILE . 11.3 pt-20 -90.23 129.03 36.53 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.107 0.479 . . . . 0.0 111.973 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.3 m -118.68 142.29 34.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 175.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -116.42 145.63 43.11 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.019 0.438 . . . . 0.0 111.781 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -140.37 149.81 43.14 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.574 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 23.6 ptp -126.18 144.47 50.75 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -151.57 146.2 18.61 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 178.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 7.0 Cg_exo -76.35 147.21 28.81 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.692 2.262 . . . . 0.0 109.257 170.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -108.4 136.07 48.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.1 mp -110.13 114.1 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.431 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 22.3 t -61.93 -11.93 15.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.547 0.739 . . . . 0.0 112.797 -170.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 17' ' ' LYS . 48.7 mt-10 -77.15 -28.05 54.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.463 ' HD2' ' HB2' ' A' ' 16' ' ' GLU . 12.1 mptt -107.13 -35.76 6.76 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 120.815 0.34 . . . . 0.0 110.932 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.4 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 80.5 p -75.73 3.48 9.71 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.899 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 p -74.19 -30.96 62.47 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -120.0 -42.06 2.62 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.58 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.9 p -134.93 146.22 48.94 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -173.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.3 tt -91.93 115.05 27.73 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.1 125.35 30.75 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.549 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.1 mm -100.13 119.25 59.79 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.54 143.71 97.89 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.919 2.413 . . . . 0.0 111.671 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 30' ' ' GLU . 62.9 tp -51.09 -41.73 60.17 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.626 0.77 . . . . 0.0 112.468 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.86 -34.08 76.43 Favored Glycine 0 C--N 1.319 -0.391 0 N-CA-C 113.926 0.33 . . . . 0.0 113.926 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -88.68 -22.72 23.25 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -72.76 -43.6 62.67 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.255 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 45.1 mt-10 -61.99 -17.24 56.47 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.257 0.623 . . . . 0.0 110.483 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -77.89 -27.28 49.58 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.59 -174.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -147.18 72.95 12.08 Favored Pre-proline 0 CA--C 1.56 1.348 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -54.36 136.49 69.24 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.806 1.671 . . . . 0.0 110.304 165.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.06 160.64 31.69 Favored Pre-proline 0 C--N 1.277 -2.567 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.269 -173.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.86 137.96 83.61 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 108.232 -1.488 . . . . 0.0 108.232 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 47.4 p90 -69.46 117.24 50.84 Favored Pre-proline 0 N--CA 1.416 -2.164 0 CA-C-O 121.1 0.476 . . . . 0.0 111.375 -175.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 36' ' ' PHE . 90.5 Cg_endo -91.86 159.23 3.39 Favored 'Trans proline' 0 N--CA 1.429 -2.269 0 C-N-CA 122.289 1.993 . . . . 0.0 111.672 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 38' ' ' ILE . 2.1 mp -98.6 -31.75 3.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 m -137.6 151.91 48.84 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.278 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.8 t -147.97 157.67 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 126.719 2.008 . . . . 0.0 106.969 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -119.48 140.45 50.45 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 118.765 0.711 . . . . 0.0 111.704 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.0 mt -111.61 126.3 54.86 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.021 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.1 147.67 26.7 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -111.97 136.98 50.6 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -67.52 -15.45 63.67 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.353 -173.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.8 t -96.71 -14.29 22.14 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.426 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.81 -23.9 2.9 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 119.848 -1.168 . . . . 0.0 114.115 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -67.8 159.22 30.74 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -150.86 136.82 18.26 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.481 ' HE1' ' HB3' ' A' ' 73' ' ' ASP . 32.3 m-90 -130.67 137.19 49.46 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.661 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.6 m -93.26 125.31 37.8 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.434 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 14.2 p -125.58 155.91 34.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.111 0.481 . . . . 0.0 111.213 -173.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.429 ' HD2' HG13 ' A' ' 65' ' ' VAL . 90.3 mtt180 -104.52 120.27 40.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -126.86 127.5 45.05 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.93 134.52 54.84 Favored 'General case' 0 C--O 1.25 1.08 0 O-C-N 123.38 0.425 . . . . 0.0 111.035 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.58 ' HA ' HG12 ' A' ' 61' ' ' VAL . 13.3 mmmm -91.91 112.01 23.77 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 175.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -147.47 120.86 9.02 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.99 -136.73 18.13 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.428 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -111.28 -3.49 15.31 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.115 0.484 . . . . 0.0 111.495 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -128.85 129.15 45.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.177 0.513 . . . . 0.0 109.691 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 56' ' ' LYS . 16.4 m -111.49 146.69 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.97 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -137.58 142.38 41.31 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.017 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 4.7 mp -88.05 103.26 15.56 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 170.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.8 p -78.21 -141.53 0.03 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 124.269 1.028 . . . . 0.0 111.652 -173.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.429 HG13 ' HD2' ' A' ' 53' ' ' ARG . 13.3 p -55.57 140.64 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.546 0.689 . . . . 0.0 109.875 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 117.0 -40.02 2.5 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 -171.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.486 ' CZ3' HD12 ' A' ' 22' ' ' LEU . 54.3 t-105 -67.24 -21.02 65.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.685 0.755 . . . . 0.0 109.147 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.538 ' HA ' HG12 ' A' ' 71' ' ' VAL . 41.9 tt0 -68.01 -32.75 73.35 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.777 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -65.15 -33.11 75.24 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-O 121.394 0.616 . . . . 0.0 109.844 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.28 -52.53 18.42 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.359 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 68' ' ' GLU . 6.8 p -64.06 -40.54 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.804 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -71.16 -48.38 52.21 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.84 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.481 ' HB3' ' HE1' ' A' ' 50' ' ' TRP . 28.5 t70 -77.1 -35.57 56.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -173.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -86.6 -20.94 27.16 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.0 t30 56.74 83.82 0.1 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.578 1.151 . . . . 0.0 111.543 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.512 ' CD2' ' HA ' ' A' ' 71' ' ' VAL . 1.6 pt? -125.44 155.39 40.53 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.832 0.825 . . . . 0.0 112.282 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.49 172.43 12.97 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.18 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.431 ' H ' ' HB2' ' A' ' 15' ' ' SER . 4.6 p30 -58.74 130.21 45.82 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.35 -20.35 7.02 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -99.2 146.27 26.35 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.485 ' C ' HD12 ' A' ' 82' ' ' LEU . 96.4 m-85 -119.96 140.93 50.16 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -175.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.485 HD12 ' C ' ' A' ' 81' ' ' TYR . 4.9 mp -131.85 137.8 48.21 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.005 0.431 . . . . 0.0 111.008 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.574 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 42.9 mt-30 -111.87 135.08 52.96 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.95 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.523 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 95.0 m-85 -115.19 125.04 52.93 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.4 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 2.4 mp -105.0 118.98 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.489 ' CE2' ' HA ' ' A' ' 88' ' ' ARG . 87.3 t80 -106.74 124.64 49.9 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 7.9 p-10 -107.52 12.87 27.36 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -175.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.489 ' HA ' ' CE2' ' A' ' 86' ' ' TYR 0.27 6.1 mpt_? 84.47 -0.05 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -101.13 -165.18 1.18 Allowed 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 174.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.48 39.26 1.54 Allowed 'General case' 0 C--N 1.256 -3.486 0 CA-C-O 121.839 0.828 . . . . 0.0 108.817 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -126.01 117.93 24.27 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.148 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.81 126.8 52.6 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 174.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 68.6 m-85 -91.7 118.9 31.07 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.66 125.72 62.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 120.787 0.327 . . . . 0.0 111.067 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.516 ' CG2' ' HB2' ' A' ' 83' ' ' GLN . 13.9 tt -112.54 118.41 57.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.415 HG12 ' HG ' ' A' ' 82' ' ' LEU . 55.6 mt -103.48 133.84 46.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.734 -173.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -105.87 113.88 27.7 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.03 114.41 2.56 Favored Glycine 0 N--CA 1.424 -2.156 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -139.65 134.79 32.51 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -85.29 135.76 33.78 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 123.277 0.361 . . . . 0.0 110.261 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 50.3 ttm -102.12 -32.71 9.99 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 120.957 0.408 . . . . 0.0 110.686 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.253 1.267 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.831 -178.506 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.85 -22.52 62.3 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.383 1.087 . . . . 0.0 109.094 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -89.01 103.51 16.11 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 113.453 -1.703 . . . . 0.0 108.66 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.3 m -95.21 -62.54 1.29 Allowed 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.825 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.04 52.88 0.04 OUTLIER Glycine 0 CA--C 1.486 -1.773 0 C-N-CA 119.276 -1.44 . . . . 0.0 113.537 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -164.95 120.93 1.42 Allowed 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 123.551 0.74 . . . . 0.0 109.064 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m -135.24 151.55 30.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -130.81 149.46 52.44 Favored 'General case' 0 N--CA 1.415 -2.196 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.57 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -137.98 149.31 46.01 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.618 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 47.6 ttm -136.51 136.48 39.41 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -154.37 133.06 6.97 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-O 119.832 -0.128 . . . . 0.0 111.181 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.43 132.32 17.48 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 N-CA-C 108.259 -1.477 . . . . 0.0 108.259 168.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -100.01 140.52 34.12 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 120.58 0.229 . . . . 0.0 110.558 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 16' ' ' GLU . 63.7 mt -103.44 124.49 57.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.7 t -62.77 -11.54 18.4 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.858 0.863 . . . . 0.0 111.895 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -73.96 -45.28 51.17 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -110.5 -40.65 4.56 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.983 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.692 ' HA ' ' O ' ' A' ' 21' ' ' SER . 15.8 m -72.58 0.08 11.49 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 m -74.62 -16.24 60.79 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HG3' ' OE2' ' A' ' 68' ' ' GLU . 54.8 tttp -125.84 -28.19 3.25 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 118.93 -1.108 . . . . 0.0 111.176 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 18' ' ' SER . 46.4 m -151.98 148.75 28.1 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.526 HD12 ' CH2' ' A' ' 67' ' ' TRP . 5.6 tt -101.73 119.21 38.43 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -82.02 131.57 35.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.714 -178.699 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 48.0 mm -96.06 126.45 44.42 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.71 144.6 86.0 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.931 2.42 . . . . 0.0 112.267 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -62.17 -32.43 73.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.506 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.22 -31.2 69.05 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.393 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -80.61 -29.28 36.85 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.42 -38.28 84.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.877 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.04 -28.76 70.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -67.98 -27.42 66.56 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.816 -175.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -157.17 116.01 1.98 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 120.406 -0.518 . . . . 0.0 112.101 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.51 145.04 32.96 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.284 1.989 . . . . 0.0 109.756 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.86 143.0 16.26 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.91 156.39 64.57 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.543 2.162 . . . . 0.0 110.045 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -68.72 115.08 27.05 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.676 0.274 . . . . 0.0 111.221 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -95.73 160.02 1.47 Allowed 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 123.308 2.672 . . . . 0.0 111.186 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -90.19 -62.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.7 p -126.76 151.38 48.29 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.965 0.412 . . . . 0.0 111.997 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.619 HG12 ' HB2' ' A' ' 90' ' ' ARG . 22.1 m -136.52 162.34 35.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -113.59 143.99 43.63 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.033 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -108.86 120.1 41.5 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.63 137.61 43.2 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.205 0.526 . . . . 0.0 111.16 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 46' ' ' SER . 0.1 OUTLIER -112.46 145.87 39.44 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.048 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -73.43 -19.14 61.04 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.703 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.437 ' HB3' ' OD2' ' A' ' 44' ' ' ASP . 38.6 t -74.79 -36.77 62.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.37 -0.32 2.23 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.204 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 97.7 mtt180 -89.53 157.94 17.87 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.241 0.543 . . . . 0.0 111.642 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.8 p -142.56 136.64 29.45 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.501 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -121.08 131.77 54.47 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.5 m -96.92 120.24 36.89 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.519 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 7.7 p -110.29 153.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -100.78 122.12 42.85 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.5 ttt -110.02 130.44 55.53 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.422 -170.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -121.16 125.47 47.26 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.339 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -106.9 126.63 52.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -133.36 97.45 3.97 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.025 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.73 -97.75 0.04 OUTLIER Glycine 0 C--N 1.304 -1.218 0 O-C-N 124.174 0.921 . . . . 0.0 115.012 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -95.81 -6.5 39.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.5 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -138.13 163.69 31.02 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.523 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 67.2 t -134.46 145.39 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -128.34 132.4 48.6 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.679 0.276 . . . . 0.0 110.569 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.98 103.39 15.31 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.7 p -94.01 -106.49 0.13 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -169.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.15 136.11 27.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.305 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 108.75 -47.2 1.07 Allowed Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.526 ' CH2' HD12 ' A' ' 22' ' ' LEU . 36.5 t-105 -62.46 -31.95 72.75 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.566 ' HA ' HG12 ' A' ' 71' ' ' VAL . 41.1 tt0 -61.78 -33.65 74.48 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 113.548 -1.66 . . . . 0.0 109.917 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -69.07 -37.76 78.67 Favored 'General case' 0 C--O 1.197 -1.68 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.425 ' CE2' HD21 ' A' ' 76' ' ' LEU . 85.5 t80 -73.0 -47.47 44.87 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 123.706 0.802 . . . . 0.0 110.683 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -61.06 -44.76 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.62 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 31.6 mmmt -72.41 -48.25 42.79 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.403 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.85 -38.15 67.15 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -84.39 -18.72 35.19 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.34 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 64.18 95.18 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.86 0.838 . . . . 0.0 112.067 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.425 HD21 ' CE2' ' A' ' 70' ' ' PHE 0.261 1.5 pp -152.18 134.75 15.35 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.192 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -132.96 170.89 14.69 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -54.47 126.15 22.35 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.244 0.545 . . . . 0.0 111.112 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.25 -21.29 4.89 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 101' ' ' MET . 92.0 mttt -94.72 163.34 13.4 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -134.01 138.86 45.66 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.941 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 82' ' ' LEU . 1.4 pt? -136.4 149.52 48.34 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.92 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -127.29 135.77 51.02 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -107.23 129.94 54.8 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.432 0.158 . . . . 0.0 111.057 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.21 125.89 60.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.411 ' HE2' ' CE2' ' A' ' 92' ' ' PHE . 58.5 m-85 -109.58 126.91 54.09 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -87.5 9.36 21.2 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 72.24 81.31 0.14 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.892 1.277 . . . . 0.0 109.304 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 21.8 t70 -179.2 -160.75 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 -174.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.619 ' HB2' HG12 ' A' ' 40' ' ' VAL . 34.1 ptt180 -104.78 23.08 14.01 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -103.65 117.79 35.22 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.107 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.411 ' CE2' ' HE2' ' A' ' 86' ' ' TYR . 2.0 m-85 -105.83 122.61 46.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.764 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -100.29 116.7 32.88 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.88 121.3 49.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.759 0.79 . . . . 0.0 112.913 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 65.1 mt -105.9 116.25 49.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.1 mt -99.63 140.29 19.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -84.36 124.51 31.37 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.6 -167.33 42.52 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 107.756 -2.137 . . . . 0.0 107.756 -169.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -86.53 -47.55 9.14 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.255 -1.378 . . . . 0.0 107.609 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 42.2 t30 171.86 113.76 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.447 ' O ' ' HE2' ' A' ' 80' ' ' LYS . 28.0 ttt -72.36 89.31 1.22 Allowed 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.361 0.601 . . . . 0.0 109.728 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.291 -1.938 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -177.275 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.28 -16.37 59.8 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 1' ' ' MET . 19.6 t70 -105.46 168.44 9.09 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.4 m -77.22 -28.6 53.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 118.93 0.787 . . . . 0.0 110.386 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.64 94.23 0.2 Allowed Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -76.31 119.74 20.61 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 123.211 0.605 . . . . 0.0 111.06 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.2 139.91 50.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -137.65 163.7 30.63 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -151.4 149.53 29.41 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.757 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 25.5 ptm -132.03 142.33 49.53 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -153.04 159.68 31.91 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.72 146.6 97.01 Favored 'Trans proline' 0 C--O 1.258 1.525 0 C-N-CA 122.894 2.396 . . . . 0.0 114.455 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -105.13 136.58 44.36 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.556 HG13 ' H ' ' A' ' 16' ' ' GLU . 6.4 tp -122.42 125.01 72.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 175.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 19' ' ' SER . 19.5 m -61.67 -20.43 63.42 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 121.179 0.514 . . . . 0.0 111.316 -176.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.556 ' H ' HG13 ' A' ' 14' ' ' ILE . 34.6 tt0 -79.66 -44.33 21.09 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.451 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.478 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 13.4 mptt -95.94 -40.19 9.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.11 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 21' ' ' SER . 25.8 m -77.07 10.11 2.57 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.319 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 15' ' ' SER . 37.9 t -70.19 -27.23 64.34 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 171.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -135.99 -29.4 1.02 Allowed 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.826 179.048 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 18' ' ' SER . 29.0 p -142.38 153.72 44.02 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -175.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 34.7 mt -89.6 126.18 35.52 Favored 'General case' 0 CA--C 1.481 -1.711 0 CA-C-O 121.318 0.58 . . . . 0.0 110.095 171.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.01 108.92 20.69 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -177.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 61' ' ' VAL . 66.8 mt -106.41 120.26 49.16 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 24' ' ' ILE . 31.5 Cg_exo -61.42 158.23 37.12 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.5 2.8 . . . . 0.0 114.156 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.65 -39.19 64.83 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.376 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.54 -36.85 79.68 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.721 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -88.47 -29.17 20.36 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.567 -0.453 . . . . 0.0 109.81 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.12 -45.61 93.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.685 0.755 . . . . 0.0 109.107 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.88 -21.58 63.32 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.815 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -67.92 -28.05 67.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.238 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -149.15 84.33 6.3 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-O 121.77 0.795 . . . . 0.0 111.711 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -86.6 134.34 3.94 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 C-N-CA 121.896 1.73 . . . . 0.0 111.559 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.47 161.13 29.94 Favored Pre-proline 0 C--N 1.275 -2.672 0 CA-C-N 114.051 -1.431 . . . . 0.0 107.199 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -55.23 140.18 81.22 Favored 'Trans proline' 0 C--N 1.354 0.849 0 N-CA-C 107.603 -1.73 . . . . 0.0 107.603 170.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.498 ' HB3' ' HB2' ' A' ' 56' ' ' LYS . 54.1 p90 -69.09 124.2 89.86 Favored Pre-proline 0 N--CA 1.413 -2.302 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -171.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -84.86 160.51 11.97 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 123.08 2.52 . . . . 0.0 108.796 172.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.04 -46.83 13.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.888 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 m -128.73 151.89 49.03 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.702 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 m -146.95 163.24 8.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 125.543 1.537 . . . . 0.0 107.857 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -118.91 143.26 47.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.3 mt -109.26 120.94 44.04 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.49 139.54 47.98 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.05 0.452 . . . . 0.0 110.79 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 29.0 t70 -120.86 156.02 32.87 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.896 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.33 -12.24 59.93 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 m -91.21 8.84 33.84 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.242 0.544 . . . . 0.0 110.393 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.01 -6.87 69.56 Favored Glycine 0 CA--C 1.497 -1.058 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.559 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 27.9 mmt180 -73.53 146.84 44.53 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.6 p -152.11 137.8 17.88 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -132.06 115.73 16.16 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.8 m -86.02 114.76 23.16 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.529 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 9.5 p -116.68 152.87 18.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.403 -172.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -101.07 129.0 46.87 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.419 0.628 . . . . 0.0 110.796 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.462 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 25.2 ttt -110.0 138.13 46.81 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.172 -172.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.2 OUTLIER -130.91 127.09 37.78 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.938 175.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 27.3 mmmt -92.73 116.8 29.35 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 169.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -144.79 103.86 3.95 Favored 'General case' 0 C--N 1.269 -2.929 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.046 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.85 -106.07 1.28 Allowed Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.885 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.44 -18.02 26.14 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.153 -0.524 . . . . 0.0 111.464 -175.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -137.01 170.39 16.19 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -172.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.47 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 58.8 t -113.56 129.22 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 174.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -118.32 130.48 56.05 Favored 'General case' 0 C--N 1.28 -2.428 0 C-N-CA 119.086 -1.045 . . . . 0.0 108.959 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 92.5 mt -103.06 102.96 13.0 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.1 p -87.54 -127.01 0.05 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.68 139.68 15.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.681 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 115.26 -44.13 1.54 Allowed Glycine 0 N--CA 1.417 -2.629 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -172.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -67.98 -27.98 67.04 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.549 ' HA ' HG12 ' A' ' 71' ' ' VAL 0.264 0.0 OUTLIER -68.17 -26.37 65.72 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.922 -179.733 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -72.25 -32.72 66.94 Favored 'General case' 0 C--O 1.196 -1.756 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -70.8 -51.64 25.57 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 122.959 0.504 . . . . 0.0 110.161 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 68' ' ' GLU . 7.7 p -59.61 -39.52 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.2 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.659 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 9.7 mmpt? -72.5 -48.01 44.03 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.487 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.49 -39.65 74.06 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.05 -18.75 24.05 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.5 t30 50.98 89.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.085 1.354 . . . . 0.0 112.965 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.8 mt -129.18 169.12 15.18 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.045 0.45 . . . . 0.0 111.475 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -143.6 170.39 15.93 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 124.363 1.065 . . . . 0.0 108.652 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -65.58 139.97 58.49 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.619 0.574 . . . . 0.0 109.57 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.05 -36.73 3.33 Favored Glycine 0 C--N 1.299 -1.488 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -93.22 147.31 23.01 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -124.39 158.76 31.96 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.497 -170.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.507 ' CD1' HG22 ' A' ' 96' ' ' ILE . 1.8 mm? -119.1 129.33 55.0 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.536 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.519 ' CG ' ' HB ' ' A' ' 95' ' ' ILE . 19.0 pt20 -111.87 124.77 53.06 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 169.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -107.08 130.48 54.67 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.7 mt -96.92 123.2 49.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -106.68 129.59 54.55 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.48 -167.77 1.84 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -91.64 -10.35 40.7 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.801 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 90' ' ' ARG . 8.5 m-20 -102.15 -162.43 0.92 Allowed 'General case' 0 N--CA 1.41 -2.47 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.217 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.423 ' H ' ' HB3' ' A' ' 89' ' ' ASP . 95.9 mtt180 -94.94 36.31 1.21 Allowed 'General case' 0 C--N 1.283 -2.292 0 CA-C-O 121.047 0.451 . . . . 0.0 111.663 -170.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.6 p -113.09 117.55 32.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.956 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -105.68 132.93 51.22 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -109.24 122.83 48.17 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.25 126.96 56.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.519 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 40.1 mm -116.77 118.09 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.507 HG22 ' CD1' ' A' ' 82' ' ' LEU . 31.4 pt -93.41 139.05 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.29 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -91.05 117.15 29.36 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -78.33 63.66 3.6 Favored Glycine 0 C--N 1.311 -0.85 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -100.58 106.05 17.52 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-O 120.868 0.366 . . . . 0.0 110.085 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -175.72 -58.69 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.406 ' HG3' ' N ' ' A' ' 102' ' ' CYS . 23.5 ptm -166.48 -53.22 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.07 -1.423 . . . . 0.0 108.535 173.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.406 ' N ' ' HG3' ' A' ' 101' ' ' MET . 74.8 m . . . . . 0 N--CA 1.439 -1.014 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 CA--C 1.5 -0.973 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.08 99.21 3.41 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -152.6 113.32 4.13 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.9 m -97.43 -15.18 20.76 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.375 0.607 . . . . 0.0 110.375 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.42 -15.72 60.65 Favored Glycine 0 N--CA 1.461 0.333 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -159.93 119.76 2.91 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.76 142.11 44.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.635 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 13.0 pt20 -121.55 144.4 48.75 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -142.15 147.5 36.75 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -139.84 139.1 36.25 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.99 159.49 31.76 Favored Pre-proline 0 C--N 1.312 -1.045 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.12 147.25 93.98 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.136 2.557 . . . . 0.0 113.082 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 82' ' ' LEU . 25.4 m-85 -119.74 139.7 51.88 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.48 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.9 mt -104.08 123.47 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.503 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 23.9 t -61.07 -29.98 70.06 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.12 0.263 . . . . 0.0 111.59 -173.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.84 -43.89 97.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.066 0.46 . . . . 0.0 110.448 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -80.68 -40.34 25.62 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.39 0.614 . . . . 0.0 109.521 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -72.06 -5.53 35.88 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.912 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.2 t -70.9 -23.18 62.23 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 120.884 0.373 . . . . 0.0 110.08 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -127.22 -44.41 1.59 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.595 -174.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.5 p -136.68 151.03 48.82 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 4.1 tt -86.47 114.04 22.9 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.16 126.31 31.91 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.923 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -109.08 127.68 26.83 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.69 137.04 79.5 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.597 2.198 . . . . 0.0 111.148 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.565 ' HA ' HD22 ' A' ' 29' ' ' ASN . 53.3 tp -54.05 -38.74 65.54 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.389 0.676 . . . . 0.0 112.145 -175.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.0 -28.57 72.28 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.578 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.481 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 64.2 t80 -87.37 -22.95 24.74 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.565 HD22 ' HA ' ' A' ' 26' ' ' LEU . 52.9 m-80 -73.71 -23.88 59.85 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.787 0.803 . . . . 0.0 109.423 175.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.97 -16.53 59.32 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.421 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 65.6 t80 -77.11 -27.03 53.93 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.108 -177.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -140.88 104.5 6.25 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.76 136.89 15.55 Favored 'Trans proline' 0 N--CA 1.439 -1.699 0 C-N-CA 122.015 1.81 . . . . 0.0 108.064 168.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.17 145.89 19.36 Favored Pre-proline 0 C--N 1.28 -2.434 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.698 -173.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.1 156.02 36.55 Favored 'Trans proline' 0 C--O 1.241 0.655 0 C-N-CA 122.902 2.402 . . . . 0.0 110.085 173.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.412 ' CD1' ' HB2' ' A' ' 56' ' ' LYS . 98.4 m-85 -69.15 115.28 30.35 Favored Pre-proline 0 N--CA 1.429 -1.516 0 CA-C-O 120.858 0.361 . . . . 0.0 111.874 -176.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -93.88 161.0 2.22 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 123.355 2.704 . . . . 0.0 111.122 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.8 mm -101.25 -53.19 7.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.1 p -129.13 151.43 49.81 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.618 0.723 . . . . 0.0 112.3 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.15 145.84 35.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -109.85 125.86 53.22 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.426 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.17 124.71 52.05 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.726 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.73 142.95 33.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.232 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -110.16 154.63 23.06 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.405 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -59.16 -30.1 67.92 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 124.984 1.313 . . . . 0.0 111.989 -175.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.2 t -82.47 -12.61 57.71 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.732 0.301 . . . . 0.0 110.793 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.32 -2.93 25.17 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.225 -0.988 . . . . 0.0 115.28 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -88.33 149.39 23.79 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 118.138 0.969 . . . . 0.0 110.201 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 p -118.7 146.28 44.85 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.608 0.242 . . . . 0.0 111.538 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.478 ' CE3' ' HD1' ' A' ' 70' ' ' PHE . 23.0 m-90 -131.57 124.95 31.08 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.861 173.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.0 m -92.34 114.03 26.47 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.8 t -105.46 157.6 6.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.234 -174.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -100.0 120.32 39.63 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.7 ttt -115.69 130.26 56.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.954 -173.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -130.7 135.67 48.05 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HD2' HG22 ' A' ' 61' ' ' VAL . 1.4 mmmp? -92.73 129.55 38.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -140.12 98.72 3.51 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.134 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.61 -99.31 0.12 Allowed Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.585 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -89.42 -23.29 22.19 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.512 -0.344 . . . . 0.0 110.563 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -134.69 169.79 16.79 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -168.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.478 HG22 ' HD2' ' A' ' 56' ' ' LYS . 42.1 t -134.89 142.19 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.81 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -138.09 144.64 41.0 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 6.2 mp -91.44 106.37 18.44 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 172.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.6 p -72.56 -155.23 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.939 -1.028 . . . . 0.0 113.149 -173.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 p -57.78 128.26 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-O 121.743 0.782 . . . . 0.0 111.2 -172.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 136.66 -38.6 1.74 Allowed Glycine 0 CA--C 1.485 -1.79 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -60.87 -26.85 67.7 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.143 0.973 . . . . 0.0 108.864 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 33.5 tt0 -56.61 -36.65 69.67 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.887 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.481 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 87.5 m-20 -66.41 -36.25 82.35 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.478 ' HD1' ' CE3' ' A' ' 50' ' ' TRP . 92.2 t80 -72.68 -44.9 61.2 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.909 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 68' ' ' GLU . 7.3 p -62.62 -43.83 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 68' ' ' GLU 0.324 0.0 OUTLIER -72.37 -38.45 68.52 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 177.76 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -77.54 -39.36 46.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -84.18 -19.59 33.81 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.9 t30 65.61 90.3 0.09 Allowed 'General case' 0 C--O 1.247 0.969 0 C-N-CA 124.753 1.221 . . . . 0.0 110.935 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.5 mt -130.72 139.81 50.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.884 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.34 171.1 14.88 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.503 ' H ' ' HB2' ' A' ' 15' ' ' SER . 4.5 p30 -65.99 136.95 56.75 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.217 0.532 . . . . 0.0 110.629 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.31 -30.09 3.93 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -89.39 153.35 20.92 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.403 ' C ' HD12 ' A' ' 82' ' ' LEU . 77.4 m-85 -122.74 147.21 46.75 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -178.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.413 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 6.1 mp -122.34 134.09 54.65 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.136 -177.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -111.07 126.45 54.82 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 85.6 m-85 -114.82 126.93 55.38 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.2 mt -98.06 116.97 42.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.409 ' HA ' ' CD1' ' A' ' 92' ' ' PHE . 64.8 m-85 -106.87 123.92 48.87 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.305 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -105.59 -161.52 0.81 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -93.92 13.55 22.35 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.892 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -102.87 -162.91 0.95 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.44 23.72 13.64 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 m -117.97 118.65 32.54 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 86' ' ' TYR . 19.1 m-85 -122.81 152.4 40.72 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.326 -177.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -111.15 126.49 54.9 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.952 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.15 129.88 55.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.53 0.681 . . . . 0.0 111.44 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.61 119.8 62.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.401 HG22 ' HG ' ' A' ' 82' ' ' LEU . 34.5 pt -93.26 139.79 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 CA-C-O 121.072 0.463 . . . . 0.0 110.557 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -92.99 112.21 24.09 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 128.79 172.11 13.11 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -156.81 -175.8 5.63 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -57.49 111.04 0.98 Allowed 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.312 0.382 . . . . 0.0 111.05 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.5 tpt 178.11 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.425 -1.706 0 CA-C-N 114.194 -1.366 . . . . 0.0 109.191 176.858 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.675 0 CA-C-O 121.855 0.836 . . . . 0.0 111.586 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.34 -166.53 1.37 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -66.92 105.59 1.66 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.4 m -79.7 -30.8 41.15 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.097 -172.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.36 -143.87 8.43 Favored Glycine 0 N--CA 1.426 -1.994 0 C-N-CA 119.713 -1.232 . . . . 0.0 113.261 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' A' ' 87' ' ' ASP . 42.5 tt0 53.34 77.84 0.16 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 125.224 1.41 . . . . 0.0 112.094 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.5 m -106.78 146.38 13.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.399 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -114.51 144.17 43.79 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.123 0.487 . . . . 0.0 110.392 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -145.5 148.26 33.04 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.577 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 26.7 ptm -139.17 152.22 47.23 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.377 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -154.65 158.66 32.26 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.77 146.21 71.77 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.877 1.718 . . . . 0.0 110.634 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -84.43 122.68 29.31 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 16' ' ' GLU . 49.2 mm -110.47 117.06 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.138 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 p -60.61 -12.32 9.78 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.2 tm-20 -76.28 -44.7 35.95 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -105.3 -42.54 5.23 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.402 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.66 ' HA ' ' O ' ' A' ' 21' ' ' SER . 9.7 m -72.01 0.61 8.96 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.331 -173.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.511 ' O ' HG11 ' A' ' 71' ' ' VAL . 27.7 t -75.04 -28.12 60.31 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 175.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -136.9 -14.4 1.6 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 18' ' ' SER . 50.3 m -149.15 169.56 20.43 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 23' ' ' GLU . 2.6 tm? -128.17 133.57 48.93 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.354 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.431 ' N ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -98.7 129.39 45.16 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.322 -174.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.546 ' HB ' HG23 ' A' ' 61' ' ' VAL . 46.4 mm -113.05 129.71 24.26 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -65.48 141.96 69.73 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 122.41 2.073 . . . . 0.0 110.061 172.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 6.7 mp -63.23 -22.92 67.18 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.69 -36.41 91.62 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.369 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 68.0 t80 -83.89 -32.92 24.91 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . 17.6 t30 -60.55 -47.89 84.2 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.374 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.77 -11.95 60.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.447 -175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 82.3 t80 -75.17 -25.9 58.67 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.135 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.11 91.93 18.84 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.57 135.88 7.17 Favored 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 122.093 1.862 . . . . 0.0 109.704 171.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.27 160.74 30.58 Favored Pre-proline 0 C--N 1.28 -2.42 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.38 141.95 80.82 Favored 'Trans proline' 0 C--O 1.246 0.881 0 N-CA-C 106.914 -1.995 . . . . 0.0 106.914 166.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -69.02 120.78 78.73 Favored Pre-proline 0 N--CA 1.414 -2.253 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.355 -173.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.59 144.62 50.14 Favored 'Trans proline' 0 C--O 1.256 1.424 0 C-N-CA 122.33 2.02 . . . . 0.0 110.629 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.4 mm -80.9 -57.34 4.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 m -126.94 156.5 41.41 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.168 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 90' ' ' ARG . 74.5 t -137.18 149.18 25.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 125.013 1.325 . . . . 0.0 107.827 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -121.95 145.83 47.73 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.06 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.432 ' CD2' ' HB2' ' A' ' 92' ' ' PHE . 66.3 mt -108.93 138.45 45.25 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.45 153.25 19.86 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.597 0.713 . . . . 0.0 112.905 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.501 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 9.0 t70 -111.25 161.8 15.64 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.992 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -70.22 -32.9 70.99 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.437 -173.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 m -102.6 -56.45 2.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.57 -6.43 0.03 OUTLIER Glycine 0 C--N 1.321 -0.274 0 C-N-CA 118.332 -1.89 . . . . 0.0 115.53 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.531 ' HA ' ' HE ' ' A' ' 48' ' ' ARG . 1.8 mmp_? -73.17 157.69 36.71 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 118.104 0.952 . . . . 0.0 110.918 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.4 m -144.07 134.74 24.95 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.501 ' CH2' ' HB2' ' A' ' 44' ' ' ASP . 19.4 m-90 -112.74 117.52 32.43 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.836 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.6 m -85.89 114.54 22.89 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.681 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.55 154.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.39 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -104.31 118.78 37.46 Favored 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 119.756 -0.778 . . . . 0.0 108.99 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.47 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 55.8 ttp -111.14 146.48 36.77 Favored 'General case' 0 CA--C 1.475 -1.919 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.48 132.37 27.62 Favored 'General case' 0 N--CA 1.406 -2.659 0 C-N-CA 117.814 -1.554 . . . . 0.0 112.065 -176.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.725 ' HD2' ' CG1' ' A' ' 61' ' ' VAL . 29.1 mmmt -91.19 107.72 19.39 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 170.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -120.59 98.8 6.2 Favored 'General case' 0 C--N 1.252 -3.674 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.42 -108.79 2.6 Favored Glycine 0 N--CA 1.422 -2.254 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.213 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.71 2.25 20.0 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 122.969 -0.136 . . . . 0.0 110.926 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.43 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.8 ptpt -131.31 156.24 45.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.725 ' CG1' ' HD2' ' A' ' 56' ' ' LYS . 16.3 m -122.51 134.46 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 CA-C-O 121.699 0.762 . . . . 0.0 112.221 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -142.81 139.63 31.02 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 54' ' ' MET . 5.6 mp -90.49 109.1 20.24 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.4 p -79.68 -152.25 0.07 Allowed 'General case' 0 N--CA 1.425 -1.723 0 O-C-N 123.846 0.716 . . . . 0.0 111.74 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.13 143.26 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.173 0.989 . . . . 0.0 111.147 -175.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.61 -38.45 2.44 Favored Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -59.64 -23.93 63.44 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.97 0.89 . . . . 0.0 110.24 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.648 ' HA ' HG12 ' A' ' 71' ' ' VAL . 39.1 tt0 -64.03 -26.04 68.39 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.299 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.52 -37.32 87.13 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.266 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.408 ' HA ' ' CD1' ' A' ' 50' ' ' TRP . 66.7 t80 -73.17 -50.13 24.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.699 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -62.2 -45.1 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.372 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.02 -41.53 67.43 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.89 -39.82 95.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.983 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -90.54 -13.86 33.75 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.288 177.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.8 t30 55.29 79.87 0.14 Allowed 'General case' 0 C--O 1.235 0.305 0 O-C-N 124.119 0.887 . . . . 0.0 109.958 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 pp -136.34 158.64 43.94 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.74 174.96 10.35 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.112 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -51.65 142.18 15.05 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 124.051 0.845 . . . . 0.0 111.187 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.04 -27.22 5.93 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -95.21 163.19 13.38 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -128.8 144.1 51.08 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.546 -175.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 0.9 OUTLIER -136.65 145.86 45.29 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.312 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.577 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 69.7 mt-30 -111.53 142.78 43.37 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -108.61 117.42 34.12 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 93' ' ' TYR . 1.9 mp -100.04 115.8 41.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.436 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 92.7 t80 -119.57 124.98 47.69 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.641 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.453 ' HA ' ' H ' ' A' ' 6' ' ' GLU . 34.4 t70 -114.3 162.05 17.09 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 173.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -66.46 89.07 0.14 Allowed 'General case' 0 C--O 1.244 0.777 0 CA-C-N 119.196 0.907 . . . . 0.0 111.83 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -165.36 -157.81 0.35 Allowed 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.516 ' O ' HG13 ' A' ' 40' ' ' VAL . 68.6 mtm180 -124.98 30.43 5.88 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 t -136.71 141.43 43.07 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.467 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 64.9 m-85 -115.62 148.61 39.44 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.354 0.597 . . . . 0.0 111.187 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.415 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 91.2 t80 -108.66 131.57 54.77 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 172.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 61.9 t -112.24 130.71 65.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.034 0.445 . . . . 0.0 112.147 -173.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 74.6 mt -105.78 116.14 48.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -100.76 140.24 20.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.14 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -104.26 112.63 25.73 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.777 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 174.17 -122.17 0.88 Allowed Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -98.72 -37.71 9.38 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 67.84 113.54 0.04 OUTLIER 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.719 1.208 . . . . 0.0 111.617 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -81.55 175.65 10.33 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.899 -178.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.424 -1.733 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.39 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 tmm? . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.48 81.12 0.13 Allowed 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.89 0.744 . . . . 0.0 110.108 -177.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 65.04 87.66 0.11 Allowed 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.352 -173.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.0 m -79.77 -35.71 38.25 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.325 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.19 -178.29 19.65 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.39 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 87' ' ' ASP . 39.0 tt0 60.84 85.64 0.11 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.13 0.972 . . . . 0.0 112.162 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.5 m -113.19 159.27 13.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -130.47 143.12 50.56 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.546 ' CZ ' ' HG3' ' A' ' 25' ' ' PRO . 79.1 t80 -142.2 148.87 38.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.441 ' HG2' ' HB3' ' A' ' 83' ' ' GLN . 82.6 mtp -123.66 140.57 52.86 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.38 157.96 55.26 Favored Pre-proline 0 C--N 1.31 -1.144 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.759 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.09 147.11 11.61 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.703 2.269 . . . . 0.0 110.363 174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -87.34 126.46 34.87 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.29 117.71 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.6 p -65.9 -14.62 61.85 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -83.82 -37.1 22.96 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.94 0.4 . . . . 0.0 111.104 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -106.2 -41.79 5.25 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.015 -174.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 21' ' ' SER . 19.5 m -77.96 0.41 24.4 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.874 -173.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.9 m -75.38 -18.31 59.98 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.848 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.8 -23.22 0.86 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.975 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 18' ' ' SER . 21.1 m -132.52 142.07 49.03 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.22 0.533 . . . . 0.0 111.523 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 4.1 tt -93.89 126.83 39.32 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -95.83 114.38 26.1 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 123.452 0.701 . . . . 0.0 110.764 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.9 mt -106.36 126.31 30.78 Favored Pre-proline 0 C--O 1.248 1.022 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.083 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.546 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 9.4 Cg_endo -53.55 139.96 65.55 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 123.706 2.937 . . . . 0.0 113.335 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 6.3 tt -58.85 -43.7 90.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.817 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.07 -24.16 71.62 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.299 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.553 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 73.6 t80 -81.73 -34.48 30.5 Favored 'General case' 0 C--O 1.212 -0.871 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.686 HD22 ' HD2' ' A' ' 56' ' ' LYS . 2.3 t-20 -76.28 -33.51 59.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.295 0.569 . . . . 0.0 109.949 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.44 -24.26 66.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.895 0.855 . . . . 0.0 109.572 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.553 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 24.7 t80 -68.32 -26.4 65.6 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.181 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -143.23 98.32 5.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-O 121.223 0.535 . . . . 0.0 112.313 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.472 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.3 Cg_exo -79.92 133.72 10.27 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 N-CA-C 110.095 -0.771 . . . . 0.0 110.095 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.13 160.33 31.09 Favored Pre-proline 0 C--N 1.274 -2.716 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.689 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.99 144.26 63.44 Favored 'Trans proline' 0 C--O 1.246 0.916 0 N-CA-C 107.467 -1.782 . . . . 0.0 107.467 168.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.523 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 45.1 p90 -68.93 138.48 90.22 Favored Pre-proline 0 N--CA 1.418 -2.029 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -173.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 36' ' ' PHE . 6.0 Cg_exo -78.7 160.76 27.93 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.766 2.311 . . . . 0.0 109.778 173.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 38' ' ' ILE . 2.2 mp -93.22 -37.5 8.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -150.64 152.86 34.64 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -178.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.62 163.95 22.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 124.513 1.125 . . . . 0.0 108.846 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -120.11 137.44 54.14 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.261 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.5 mt -108.7 123.42 48.96 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.97 141.84 34.18 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.262 0.553 . . . . 0.0 110.994 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -113.23 145.6 40.73 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -58.43 -27.12 64.03 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.7 t -79.59 -4.58 52.17 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.105 0.478 . . . . 0.0 110.511 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.46 2.16 50.43 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.005 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -82.55 150.66 26.8 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.3 p -144.44 136.64 26.33 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.196 0.522 . . . . 0.0 111.709 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -120.1 123.94 44.61 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.511 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.3 m -89.93 117.73 28.96 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.16 157.94 33.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.613 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -99.68 120.13 39.21 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.046 0.45 . . . . 0.0 110.624 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.422 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 23.7 ttt -122.3 124.16 43.1 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 124.277 1.031 . . . . 0.0 110.044 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -125.51 130.88 52.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.886 0.374 . . . . 0.0 111.916 178.603 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.686 ' HD2' HD22 ' A' ' 29' ' ' ASN . 55.9 tttp -98.05 122.68 41.47 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 122.121 0.963 . . . . 0.0 109.451 173.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -147.7 98.66 3.0 Favored 'General case' 0 C--N 1.252 -3.65 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.51 -164.29 30.42 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -174.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 26' ' ' LEU . 14.9 mm-40 -90.97 2.39 56.32 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.44 142.68 49.02 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.6 t -114.49 131.84 65.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.136 0.493 . . . . 0.0 111.043 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 97.4 m-85 -119.42 131.55 55.67 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 6.5 mp -86.83 112.3 21.6 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 p -66.11 -164.49 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.138 0 O-C-N 124.777 1.298 . . . . 0.0 112.902 -176.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.24 143.12 10.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.493 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.57 -38.61 2.58 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -173.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 20.1 t-105 -58.48 -24.42 60.37 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.015 0.912 . . . . 0.0 109.636 173.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.602 ' HA ' HG12 ' A' ' 71' ' ' VAL . 11.5 pt-20 -57.74 -30.0 65.23 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.39 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -62.24 -35.86 80.23 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.129 0.49 . . . . 0.0 110.668 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -74.29 -48.01 31.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.603 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -64.7 -40.38 88.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.19 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -71.07 -33.02 69.83 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.621 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.31 -40.14 45.37 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.062 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 100' ' ' ASN . 81.7 m-20 -97.94 -1.74 42.14 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 42.22 80.1 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -176.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.4 mt -103.23 147.35 27.15 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.21 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.418 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 11.4 pt-20 -143.8 171.65 13.92 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.107 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.11 138.3 58.51 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.15 -19.66 24.63 Favored Glycine 0 C--N 1.301 -1.392 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -173.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HD2' ' H ' ' A' ' 77' ' ' GLU . 57.3 mttp -96.58 159.22 15.05 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -134.1 150.95 51.19 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -173.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HG ' HG22 ' A' ' 96' ' ' ILE . 4.6 mp -130.35 137.11 49.74 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.459 ' HG3' ' HB ' ' A' ' 95' ' ' ILE . 11.6 pt20 -118.75 138.57 52.57 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -116.32 131.0 57.07 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.324 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 65.2 mt -101.54 116.03 44.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 172.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.639 ' CE2' ' HA ' ' A' ' 88' ' ' ARG . 48.8 t80 -122.07 123.81 42.46 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.757 -173.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.48 ' HA ' ' H ' ' A' ' 6' ' ' GLU . 25.3 m-20 -84.26 -1.38 55.16 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.639 ' HA ' ' CE2' ' A' ' 86' ' ' TYR . 67.8 ttt180 70.08 81.94 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -171.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 20.4 t70 -177.26 -155.24 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 -167.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.433 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -107.38 11.15 29.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.3 m -109.64 126.37 53.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.54 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -127.62 135.13 49.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.641 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.46 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 84.7 m-85 -109.25 123.49 49.35 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.54 124.15 64.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.433 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.459 ' HB ' ' HG3' ' A' ' 83' ' ' GLN . 2.4 mp -114.05 116.85 53.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.438 HG22 ' HG ' ' A' ' 82' ' ' LEU . 35.1 pt -100.8 140.64 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 123.218 0.607 . . . . 0.0 112.231 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -101.52 134.78 44.1 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.33 77.57 1.22 Allowed Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -86.33 96.39 9.96 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 122.786 -0.243 . . . . 0.0 111.41 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 74' ' ' ASN . 26.3 t-20 -81.11 104.21 11.44 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -112.58 112.73 24.47 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -177.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 43.5 t . . . . . 0 N--CA 1.428 -1.534 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -178.742 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 CA--C 1.502 -0.874 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.79 88.19 2.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 175.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -108.23 88.51 2.75 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.641 0.734 . . . . 0.0 110.221 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.6 m -93.59 -28.15 16.2 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.69 121.6 0.83 Allowed Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.896 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.84 136.89 15.51 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.904 0.352 . . . . 0.0 110.369 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.8 m -139.99 140.73 35.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -130.64 143.05 50.49 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -149.7 147.0 27.54 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.624 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 23.3 ptp -141.61 134.93 29.46 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.418 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.6 159.57 31.53 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 166.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 33.4 Cg_exo -60.82 132.73 43.98 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 N-CA-C 108.295 -1.463 . . . . 0.0 108.295 173.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -86.01 140.26 30.45 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.354 -175.082 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.503 HG22 ' H ' ' A' ' 16' ' ' GLU . 2.0 mp -90.69 125.08 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.509 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 11.9 p -60.57 -19.03 56.31 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.826 0.85 . . . . 0.0 112.708 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.503 ' H ' HG22 ' A' ' 14' ' ' ILE . 41.4 tt0 -63.48 -44.78 93.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.703 176.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -87.73 -40.47 14.08 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.487 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.576 ' HB2' ' CD1' ' A' ' 13' ' ' PHE . 35.6 t -61.96 -10.0 8.53 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 124.119 0.887 . . . . 0.0 112.285 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.5 p -57.85 -43.49 85.93 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.899 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 68' ' ' GLU . 64.4 mttm -144.38 -2.05 0.89 Allowed 'General case' 0 C--N 1.344 0.359 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -148.11 153.79 39.33 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 118.943 0.792 . . . . 0.0 112.476 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 5.2 tt -101.21 113.42 26.44 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -71.54 113.99 9.15 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.162 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.424 HD12 HG12 ' A' ' 61' ' ' VAL . 65.6 mt -93.7 128.5 41.65 Favored Pre-proline 0 C--N 1.288 -2.096 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.453 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 58.7 Cg_exo -53.71 137.74 67.32 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.959 2.439 . . . . 0.0 112.198 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.435 ' O ' HD23 ' A' ' 26' ' ' LEU . 5.8 tt -64.67 -32.4 74.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.48 -29.39 73.31 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.614 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 25' ' ' PRO . 46.6 t80 -65.41 -49.59 68.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -65.8 -39.75 91.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.567 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.06 -38.17 87.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.395 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -73.15 -28.68 62.37 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.947 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -166.18 127.1 1.29 Allowed Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 120.634 0.254 . . . . 0.0 111.629 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.33 136.79 24.72 Favored 'Trans proline' 0 N--CA 1.42 -2.81 0 N-CA-C 107.872 -1.626 . . . . 0.0 107.872 168.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.43 146.86 55.85 Favored Pre-proline 0 C--N 1.266 -3.047 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.527 ' O ' ' HD3' ' A' ' 37' ' ' PRO . 14.3 Cg_endo -59.64 140.68 94.82 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.019 1.813 . . . . 0.0 109.884 175.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 26.8 p90 -83.45 110.63 25.64 Favored Pre-proline 0 N--CA 1.407 -2.602 0 CA-C-O 121.115 0.483 . . . . 0.0 111.287 -178.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 35' ' ' PRO . 27.1 Cg_endo -87.83 136.02 3.58 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 122.554 2.169 . . . . 0.0 111.57 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.22 -52.74 54.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.245 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.5 p -123.95 150.11 45.15 Favored 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.904 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.3 t -135.9 157.13 38.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -126.46 135.97 52.04 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.678 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.9 mt -108.54 127.52 54.01 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.86 138.16 42.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 120.908 0.385 . . . . 0.0 110.206 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -112.68 142.18 45.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -69.87 -3.71 17.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -175.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -82.86 -14.53 54.12 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.64 -13.88 10.77 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.263 -0.97 . . . . 0.0 115.505 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HD3' ' CZ2' ' A' ' 50' ' ' TRP . 75.7 ttt180 -89.97 153.13 20.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.718 1.259 . . . . 0.0 110.806 -176.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.3 p -127.37 140.92 51.86 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.212 0.605 . . . . 0.0 110.963 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.423 ' CZ2' ' HD3' ' A' ' 48' ' ' ARG . 15.9 m-90 -125.85 128.13 47.14 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.419 0.287 . . . . 0.0 110.227 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.1 m -92.07 121.17 33.38 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.43 0.633 . . . . 0.0 109.779 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HB ' HD21 ' A' ' 63' ' ' LEU . 34.7 m -126.05 158.34 35.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 124.792 1.237 . . . . 0.0 111.589 -172.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -102.36 127.42 49.37 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.085 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.2 ttt -111.23 120.81 43.5 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -124.95 125.31 43.72 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.713 -175.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -107.9 115.5 30.25 Favored 'General case' 0 CA--C 1.479 -1.761 0 CA-C-O 122.156 0.979 . . . . 0.0 110.038 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -148.82 102.48 3.28 Favored 'General case' 0 C--N 1.247 -3.866 0 CA-C-N 113.45 -1.705 . . . . 0.0 108.408 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.88 -143.53 15.82 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.024 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.88 -6.03 54.73 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.71 0.291 . . . . 0.0 111.641 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.1 170.07 13.96 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 121.004 0.431 . . . . 0.0 110.834 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.424 HG12 HD12 ' A' ' 24' ' ' ILE . 40.9 t -132.46 129.6 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -124.61 131.68 53.46 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 5.7 tt -102.93 113.5 27.01 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 175.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -103.49 -98.47 0.3 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -169.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.25 135.42 28.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -172.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' C ' HG12 ' A' ' 52' ' ' VAL . . . 115.02 -42.19 1.98 Allowed Glycine 0 N--CA 1.425 -2.081 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.475 -176.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' A' ' 18' ' ' SER . 55.7 t-105 -59.18 -26.45 64.82 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.513 0.673 . . . . 0.0 110.426 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.54 ' HA ' HG12 ' A' ' 71' ' ' VAL . 17.1 pt-20 -71.24 -26.52 62.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.315 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -68.97 -29.42 67.64 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.379 0.609 . . . . 0.0 109.636 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -73.97 -49.16 25.8 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 124.593 1.157 . . . . 0.0 109.388 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.8 p -63.47 -37.91 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.275 0.56 . . . . 0.0 109.977 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 68.4 mttm -65.3 -46.71 79.3 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.579 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -77.52 -40.84 41.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.032 -1.067 . . . . 0.0 113.737 -172.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -86.77 -15.12 40.31 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.141 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 46.35 72.7 0.21 Allowed 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.371 1.068 . . . . 0.0 112.629 -174.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.506 HD13 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -112.64 137.52 50.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.757 179.083 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -122.01 164.7 17.2 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.9 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 7.8 p-10 -55.77 132.56 49.61 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 123.998 0.811 . . . . 0.0 111.896 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.93 -44.63 1.19 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 33.9 mtmm -80.67 155.03 27.0 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.0 131.26 43.99 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.262 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.449 ' HG ' HG13 ' A' ' 96' ' ' ILE . 6.9 mp -114.45 132.87 56.11 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -109.86 125.91 53.27 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -114.27 117.54 31.42 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.47 117.9 47.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -120.47 127.22 52.02 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 123.495 0.497 . . . . 0.0 110.114 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -84.07 -100.2 0.05 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -150.43 16.5 0.81 Allowed 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -110.16 -177.55 3.28 Favored 'General case' 0 N--CA 1.405 -2.717 0 CA-C-N 114.294 -1.321 . . . . 0.0 107.796 -172.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -95.91 32.08 1.97 Allowed 'General case' 0 C--N 1.264 -3.112 0 C-N-CA 124.3 1.04 . . . . 0.0 108.512 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.3 m -127.74 122.79 33.76 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.326 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -112.8 143.94 43.19 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -111.59 120.44 42.08 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.0 t -111.2 135.41 50.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.779 0.323 . . . . 0.0 111.426 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.4 mt -130.46 124.39 57.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.449 HG13 ' HG ' ' A' ' 82' ' ' LEU . 1.8 mp -96.5 125.16 49.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -96.99 122.72 40.29 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.26 -162.37 28.17 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -108.49 79.05 1.21 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.611 0.72 . . . . 0.0 110.902 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -115.21 -61.29 1.77 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.52 116.65 19.25 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 67.7 m . . . . . 0 C--N 1.29 -1.983 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.909 -176.425 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 CA--C 1.503 -0.837 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.88 -169.02 0.17 Allowed 'General case' 0 C--O 1.238 0.499 0 O-C-N 124.252 0.97 . . . . 0.0 111.109 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -143.47 166.71 24.02 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.2 m -84.19 -21.68 31.19 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 120.883 0.373 . . . . 0.0 111.876 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.4 -104.14 1.46 Allowed Glycine 0 CA--C 1.487 -1.687 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -174.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.13 131.6 38.04 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 174.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m -99.19 140.52 18.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 120.955 0.407 . . . . 0.0 110.277 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -112.02 144.79 40.79 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 83' ' ' GLN . 50.3 p90 -146.26 149.26 33.54 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.8 ptm -127.73 145.44 50.9 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.66 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 25.9 ttpp -153.48 143.35 15.26 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.425 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.72 146.47 83.93 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.5 2.133 . . . . 0.0 109.999 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 8.3 m-85 -103.32 139.25 38.99 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.2 mp -118.72 117.43 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.499 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 20.3 m -57.48 -22.16 41.98 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.782 0.833 . . . . 0.0 112.576 -173.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.07 -38.88 92.67 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.199 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.06 -41.98 8.85 Favored 'General case' 0 CA--C 1.487 -1.46 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.731 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 79.3 p -65.4 -11.33 41.42 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -170.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.6 t -69.63 -24.03 63.58 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.39 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -138.56 -24.36 0.94 Allowed 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -176.403 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.45 ' N ' ' HD2' ' A' ' 20' ' ' LYS . 77.2 p -143.25 153.76 43.12 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.6 tt -96.81 122.54 39.88 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 174.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.66 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -92.97 122.77 35.67 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.874 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.446 ' HB ' HD21 ' A' ' 29' ' ' ASN . 61.5 mt -103.68 132.15 21.33 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -57.54 139.26 89.63 Favored 'Trans proline' 0 C--O 1.254 1.311 0 C-N-CA 122.19 1.926 . . . . 0.0 110.622 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.506 ' O ' HD23 ' A' ' 26' ' ' LEU . 5.7 tt -56.57 -30.08 62.76 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.187 0.595 . . . . 0.0 110.885 -175.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.41 -31.5 63.01 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.727 -0.273 . . . . 0.0 112.838 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -87.89 -29.92 20.5 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 122.278 -0.543 . . . . 0.0 110.099 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.475 ' ND2' ' HB ' ' A' ' 61' ' ' VAL . 13.4 m120 -65.82 -34.35 77.95 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.505 0.669 . . . . 0.0 109.638 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -74.83 -27.07 60.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.612 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -78.97 -28.08 43.56 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.166 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . 0.267 31.5 p90 -134.51 78.81 55.69 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 177.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -83.97 135.13 6.43 Favored 'Trans proline' 0 N--CA 1.425 -2.551 0 C-N-CA 121.016 1.144 . . . . 0.0 110.204 170.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.66 160.11 31.59 Favored Pre-proline 0 C--N 1.273 -2.752 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -63.02 136.74 58.19 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 N-CA-C 107.505 -1.767 . . . . 0.0 107.505 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -68.81 120.4 75.74 Favored Pre-proline 0 N--CA 1.418 -2.048 0 CA-C-O 121.356 0.598 . . . . 0.0 112.593 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.49 136.67 12.57 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.69 2.26 . . . . 0.0 110.852 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -64.77 -38.59 83.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.019 0.438 . . . . 0.0 110.078 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.3 p -130.88 150.64 51.95 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 121.241 0.543 . . . . 0.0 110.852 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 90' ' ' ARG . 79.4 t -141.72 149.39 20.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 125.473 1.509 . . . . 0.0 107.163 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.52 135.37 52.18 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.075 0.464 . . . . 0.0 111.494 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' SER . 79.1 mt -108.84 132.0 54.44 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.64 143.99 32.33 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.267 0.556 . . . . 0.0 112.154 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 16.7 t70 -110.35 165.32 11.87 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.36 176.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -53.32 -50.82 64.17 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 125.232 1.413 . . . . 0.0 110.273 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.6 m -73.68 -10.32 59.57 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.788 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.0 9.88 35.95 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.496 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.426 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 98.4 mtt180 -66.94 150.82 48.68 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 74.8 p -138.2 136.33 36.49 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.412 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.487 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 25.5 m-90 -121.15 131.76 54.44 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.829 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.2 m -89.62 114.15 25.71 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.443 HG21 HD23 ' A' ' 63' ' ' LEU . 33.6 m -116.34 157.85 17.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.668 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.401 ' NH2' HG13 ' A' ' 65' ' ' VAL . 7.0 ttp180 -102.01 130.98 48.69 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 28.0 ttt -112.3 136.31 51.9 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -142.12 125.88 17.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.389 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -105.17 128.35 53.35 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.98 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.55 100.03 4.84 Favored 'General case' 0 C--N 1.266 -3.039 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.78 -120.75 11.31 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.259 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -90.33 -7.8 52.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -174.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.76 152.73 32.7 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.475 ' HB ' ' ND2' ' A' ' 29' ' ' ASN . 47.4 t -133.97 124.31 46.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -130.37 153.73 48.42 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 52' ' ' VAL . 5.9 mp -93.37 103.82 16.02 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.6 t -79.3 -153.82 0.08 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 124.235 0.959 . . . . 0.0 111.008 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.401 HG13 ' NH2' ' A' ' 53' ' ' ARG . 7.1 p -61.07 121.85 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-O 122.442 1.115 . . . . 0.0 110.939 -170.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 143.77 -38.62 1.34 Allowed Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 -169.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -60.56 -24.2 65.23 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.042 -1.079 . . . . 0.0 109.278 173.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.536 ' HA ' HG12 ' A' ' 71' ' ' VAL . 39.0 tt0 -56.2 -39.79 73.0 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.589 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -59.21 -37.06 76.53 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-O 120.918 0.39 . . . . 0.0 110.715 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.535 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 78.6 t80 -74.08 -48.66 28.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.0 p -62.48 -34.83 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 122.131 0.967 . . . . 0.0 109.165 -177.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.64 -47.07 56.91 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.917 -1.492 . . . . 0.0 111.65 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -77.64 -40.77 40.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -172.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -88.08 -16.2 34.18 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.402 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.9 t30 54.11 95.35 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 O-C-N 124.157 0.91 . . . . 0.0 112.204 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 pp -127.12 158.21 37.64 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.285 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -143.8 168.21 20.47 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.415 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 5.8 p-10 -59.08 133.89 56.5 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.227 0.954 . . . . 0.0 110.038 175.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.7 -18.98 12.73 Favored Glycine 0 C--N 1.307 -1.064 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -101.13 162.81 12.63 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -128.04 140.36 52.0 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.63 142.55 51.45 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.064 0.459 . . . . 0.0 110.786 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 64.5 tt0 -114.19 124.68 52.65 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -112.2 130.7 55.83 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.41 116.0 47.38 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -106.22 123.77 48.55 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.12 -171.21 3.48 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.309 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -86.41 -5.87 59.06 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 23.4 t70 -89.27 -150.74 0.21 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 175.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.494 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 16.7 ptt180 -113.03 17.71 18.62 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 92.5 m -101.81 127.22 48.7 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.56 -170.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.65 131.75 54.79 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.643 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -101.84 127.61 48.57 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.535 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 38.3 t -104.21 119.87 53.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.11 124.24 72.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.4 tt -111.97 137.27 45.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 121.316 0.579 . . . . 0.0 110.103 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -92.21 112.78 24.84 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.19 -65.56 0.27 Allowed Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.5 m80 66.84 98.39 0.05 Allowed 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.669 0.747 . . . . 0.0 112.249 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -81.82 107.15 14.32 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.753 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 51.3 ttm -113.34 86.91 2.48 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.672 0.748 . . . . 0.0 109.981 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.42 -1.941 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.377 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.502 -0.877 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.0 91.64 3.6 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.28 103.0 6.96 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.186 -173.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.0 m -120.71 -17.95 7.85 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.898 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.15 171.44 45.59 Favored Glycine 0 N--CA 1.421 -2.335 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.08 111.47 15.32 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.617 0.722 . . . . 0.0 109.506 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -103.9 140.32 22.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.229 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -111.74 145.74 38.8 Favored 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.954 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -143.55 153.91 43.06 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 61.3 mtm -128.13 158.02 39.17 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -154.26 159.9 31.48 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -64.65 135.44 45.31 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.096 1.864 . . . . 0.0 109.843 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.415 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 70.6 t80 -100.16 122.97 43.83 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -114.63 102.15 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.514 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 33.5 t -53.83 -31.8 50.61 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 123.241 0.616 . . . . 0.0 111.367 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.83 -37.39 79.09 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.414 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -101.35 -33.1 10.15 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.907 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' SER . 49.8 p -81.2 1.76 30.7 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.5 m -65.42 -24.77 67.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 119.499 -0.881 . . . . 0.0 111.215 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -116.15 -48.82 2.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.636 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 18' ' ' SER . 43.4 p -130.87 144.98 51.85 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -173.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.0 tm? -103.0 115.18 30.12 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.79 125.27 28.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.7 mt -95.31 131.01 30.7 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.3 132.71 40.36 Favored 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 122.852 2.368 . . . . 0.0 112.137 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.418 ' O ' HD23 ' A' ' 26' ' ' LEU . 6.7 tt -63.37 -32.71 74.21 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.856 -175.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.46 -32.41 81.67 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.172 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -75.07 -35.8 61.82 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -70.72 -31.64 68.56 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.115 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -74.82 -30.38 61.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.42 -27.63 66.37 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.577 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -160.57 87.16 1.82 Allowed Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.317 0.579 . . . . 0.0 111.713 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.21 142.76 21.82 Favored 'Trans proline' 0 N--CA 1.439 -1.704 0 C-N-CA 121.75 1.634 . . . . 0.0 110.396 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.42 153.04 36.67 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.41 144.52 98.28 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 122.489 2.126 . . . . 0.0 109.969 175.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 56' ' ' LYS . 26.8 p90 -70.28 121.33 82.91 Favored Pre-proline 0 N--CA 1.41 -2.474 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.91 159.63 18.49 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.394 2.73 . . . . 0.0 110.219 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.2 mm -70.4 -59.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.349 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.5 p -125.53 151.41 46.38 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.467 HG21 ' SD ' ' A' ' 54' ' ' MET . 97.2 t -139.78 151.42 22.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.53 136.2 52.34 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.557 -0.857 . . . . 0.0 113.285 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 92' ' ' PHE . 3.3 mm? -108.54 120.2 41.73 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.03 153.18 20.14 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.121 0.486 . . . . 0.0 110.735 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 11.5 t70 -112.06 149.22 32.39 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.885 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -70.71 -26.71 63.52 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.734 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.8 m -95.13 -45.87 7.03 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.759 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.07 -32.06 0.04 OUTLIER Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 118.244 -1.932 . . . . 0.0 114.785 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -60.83 158.52 12.84 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 p -149.09 135.78 19.59 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 173.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.51 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 23.7 m-90 -125.75 124.09 40.25 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.546 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.1 m -89.18 114.26 25.54 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 174.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.5 t -115.26 157.77 15.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.944 -172.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -99.91 128.32 46.01 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.467 ' SD ' HG21 ' A' ' 40' ' ' VAL . 27.5 ttt -111.56 123.23 49.8 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -176.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -130.5 129.99 43.6 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.747 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.471 ' H ' ' HB3' ' A' ' 36' ' ' PHE . 27.6 tptp -92.62 127.54 38.15 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 125.003 1.321 . . . . 0.0 108.772 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -142.94 103.85 4.24 Favored 'General case' 0 C--N 1.261 -3.275 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.532 -174.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.74 -121.26 5.94 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -108.98 2.9 21.65 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.427 0.632 . . . . 0.0 109.692 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.504 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 37.1 ttpt -122.58 159.12 28.45 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.316 -175.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.414 HG22 ' HD3' ' A' ' 56' ' ' LYS . 61.4 t -127.83 141.04 47.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.504 ' CZ ' ' HE3' ' A' ' 60' ' ' LYS . 96.7 m-85 -123.12 136.45 54.8 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.043 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 98.4 mt -81.93 103.49 11.62 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 167.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 65' ' ' VAL . 2.0 m -86.15 -154.45 0.21 Allowed 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.917 -167.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.617 ' H ' HG22 ' A' ' 64' ' ' THR . 7.7 p -56.44 122.82 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 121.998 0.904 . . . . 0.0 111.639 -172.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.58 -37.2 2.06 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -171.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.455 ' CE2' ' HB2' ' A' ' 22' ' ' LEU . 12.6 t-105 -57.26 -26.2 60.4 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.554 -0.823 . . . . 0.0 110.774 175.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -53.29 -27.43 22.81 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.07 -174.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -63.01 -29.76 71.07 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.411 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 44.7 t80 -73.73 -54.66 7.56 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.581 0.705 . . . . 0.0 109.545 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.64 -34.76 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.529 -176.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -71.91 -37.92 69.99 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 174.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.6 -40.67 41.33 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.869 -0.733 . . . . 0.0 112.779 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -84.77 -20.84 30.39 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.2 t30 49.13 82.45 0.04 OUTLIER 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.167 1.387 . . . . 0.0 111.757 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.9 pt? -127.45 142.81 51.31 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.447 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -113.99 170.39 8.31 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 15' ' ' SER . 6.1 p-10 -60.56 133.51 56.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 172.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.57 -28.15 5.06 Favored Glycine 0 C--N 1.3 -1.442 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 -172.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -100.08 146.74 26.42 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.462 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 95.0 m-85 -133.81 158.63 42.88 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.68 -174.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.514 HD13 ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -125.94 155.72 40.88 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.281 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -129.14 127.24 41.01 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.236 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.514 ' CE2' HD13 ' A' ' 82' ' ' LEU . 99.9 m-85 -106.09 130.73 53.94 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 59.0 mt -107.36 119.8 57.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -106.12 125.27 50.79 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.371 0.605 . . . . 0.0 112.258 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.73 146.21 27.52 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 89' ' ' ASP . 9.2 mmm180 -66.08 83.28 0.08 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.201 0.455 . . . . 0.0 111.722 -177.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 88' ' ' ARG . 8.6 t70 173.54 -148.71 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 6.3 mpt_? -100.3 24.44 8.78 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 118.426 0.557 . . . . 0.0 109.744 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.0 m -103.54 119.91 39.83 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.56 ' HB2' HD13 ' A' ' 42' ' ' LEU . 80.3 m-85 -125.27 130.71 52.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.39 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 95.7 m-85 -104.22 132.08 50.84 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.411 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 18.3 t -109.76 124.21 66.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.575 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.15 139.8 34.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.429 ' HB ' ' OD1' ' A' ' 100' ' ' ASN . 64.7 mt -115.28 131.74 66.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 120.973 0.416 . . . . 0.0 110.109 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' A' ' 81' ' ' TYR . 43.7 p90 -125.23 167.65 14.56 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.62 49.84 4.7 Favored Glycine 0 C--N 1.3 -1.456 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -173.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 39.5 m80 77.36 82.82 0.08 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.212 1.405 . . . . 0.0 111.63 -176.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.429 ' OD1' ' HB ' ' A' ' 96' ' ' ILE . 7.2 t30 -84.84 92.71 8.33 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 83.6 mtp -96.03 145.84 25.12 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.715 -176.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 16.4 p . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.999 -0.525 . . . . 0.0 110.932 179.542 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.507 -0.709 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.02 117.99 14.26 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.109 0.48 . . . . 0.0 109.802 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.98 122.64 48.24 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.305 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.7 m -81.0 -56.66 3.96 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.01 -157.33 46.46 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.578 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -84.94 121.46 27.79 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m -95.88 140.19 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-O 121.142 0.496 . . . . 0.0 110.448 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 13.5 pt20 -106.23 144.42 32.95 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.897 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -150.19 148.57 29.09 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 83' ' ' GLN . 25.9 ptm -103.72 133.92 47.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.66 128.72 25.09 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.44 133.2 44.65 Favored 'Trans proline' 0 C--O 1.248 1.005 0 C-N-CA 122.522 2.148 . . . . 0.0 112.882 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -93.65 124.64 37.78 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.9 mt -125.8 115.93 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.467 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 15.2 t -66.67 -11.57 54.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.313 0.577 . . . . 0.0 111.35 -172.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -61.19 -43.14 99.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.796 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -108.68 -40.39 5.09 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.937 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' SER . 18.2 m -74.17 8.6 2.03 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -172.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.476 ' O ' HG11 ' A' ' 71' ' ' VAL . 29.2 t -75.02 -19.23 60.14 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -141.63 -33.91 0.49 Allowed 'General case' 0 C--N 1.353 0.748 0 C-N-CA 119.874 -0.731 . . . . 0.0 112.641 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 18' ' ' SER . 63.4 p -139.04 162.61 34.51 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 120.958 0.409 . . . . 0.0 111.35 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.615 HD12 HD13 ' A' ' 63' ' ' LEU . 81.5 mt -103.28 118.21 36.25 Favored 'General case' 0 CA--C 1.485 -1.538 0 O-C-N 120.892 -1.13 . . . . 0.0 113.483 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -77.09 113.98 15.4 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 168.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.546 ' HB ' HG23 ' A' ' 61' ' ' VAL . 66.5 mt -113.18 130.97 23.09 Favored Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 121.49 -0.084 . . . . 0.0 110.827 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -44.36 139.14 6.87 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 124.654 3.569 . . . . 0.0 114.538 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.77 -46.22 90.52 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.133 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.42 -32.73 85.17 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.769 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.5 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 76.7 t80 -76.78 -34.9 57.98 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.483 HD22 ' HA ' ' A' ' 60' ' ' LYS . 40.3 t30 -66.12 -44.7 83.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.991 0.424 . . . . 0.0 110.804 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.85 -13.62 61.8 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.914 0.864 . . . . 0.0 110.457 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.5 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 87.2 t80 -74.68 -18.97 60.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.386 176.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -137.92 94.3 11.51 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -83.13 134.01 6.76 Favored 'Trans proline' 0 N--CA 1.432 -2.144 0 C-N-CA 121.549 1.499 . . . . 0.0 110.417 172.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.75 152.98 28.18 Favored Pre-proline 0 C--N 1.272 -2.776 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.486 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -61.87 150.41 86.21 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 107.786 -1.659 . . . . 0.0 107.786 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -68.12 119.63 68.67 Favored Pre-proline 0 N--CA 1.416 -2.142 0 CA-C-O 121.309 0.576 . . . . 0.0 111.712 -174.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -87.28 159.89 8.32 Favored 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.758 2.306 . . . . 0.0 111.084 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 51.3 mm -85.88 -59.25 2.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.3 p -131.3 156.43 45.46 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.136 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.35 162.44 39.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.27 134.97 55.18 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.688 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.402 HD23 ' HB2' ' A' ' 92' ' ' PHE . 75.0 mt -108.0 125.53 51.65 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.65 137.53 39.84 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.084 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 46' ' ' SER . 0.1 OUTLIER -112.96 142.34 45.75 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 123.517 0.727 . . . . 0.0 110.719 178.812 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -67.35 -22.16 65.6 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.242 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.44 ' HB2' ' OD2' ' A' ' 44' ' ' ASP . 4.3 m -74.1 -32.46 63.24 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.53 -2.55 4.18 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.962 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -86.28 158.72 19.62 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.043 0.537 . . . . 0.0 110.331 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.8 p -149.66 140.09 22.39 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.6 m-90 -129.32 127.22 40.67 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.786 0.327 . . . . 0.0 111.447 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.8 m -87.66 114.83 24.65 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.3 m -122.17 158.16 26.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.662 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 25.3 ttp180 -101.16 133.93 44.97 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -177.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 55.8 ttp -131.64 148.12 52.57 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.27 146.27 25.27 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.119 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.513 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 63.5 mttm -91.84 128.83 37.82 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -137.45 107.82 6.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.48 -118.59 4.76 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -111.15 -5.46 14.74 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.483 ' HA ' HD22 ' A' ' 29' ' ' ASN . 19.0 ptpt -117.58 170.09 9.03 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.491 0.662 . . . . 0.0 111.273 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.546 HG23 ' HB ' ' A' ' 24' ' ' ILE . 8.4 m -109.62 141.31 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.417 171.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.473 ' CZ ' ' HD2' ' A' ' 60' ' ' LYS . 97.4 m-85 -114.49 131.56 56.59 Favored 'General case' 0 C--N 1.268 -2.978 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 169.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.615 HD13 HD12 ' A' ' 22' ' ' LEU . 6.8 tt -88.13 102.07 14.43 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 173.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.52 ' OG1' ' HG2' ' A' ' 53' ' ' ARG . 20.5 p -71.73 -163.67 0.11 Allowed 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -168.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.7 t -65.96 122.29 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.356 -168.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.37 -31.62 1.04 Allowed Glycine 0 CA--C 1.481 -2.032 0 N-CA-C 107.506 -2.238 . . . . 0.0 107.506 -174.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.509 ' HB2' HD22 ' A' ' 63' ' ' LEU . 59.2 t-105 -58.14 -23.78 56.42 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 113.864 -1.168 . . . . 0.0 109.947 173.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.665 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 28.5 tt0 -56.51 -32.31 64.93 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.133 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -64.5 -35.87 82.37 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 122.633 0.373 . . . . 0.0 110.956 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -73.55 -49.99 23.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.2 p -61.71 -47.48 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.499 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 68' ' ' GLU 0.277 25.6 pttm -73.1 -30.98 64.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 178.688 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.24 -39.99 65.02 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.591 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -87.24 -21.48 25.81 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 54.22 88.7 0.04 OUTLIER 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.233 1.413 . . . . 0.0 110.438 -176.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.7 165.77 26.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -141.52 172.14 13.1 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.128 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.467 ' H ' ' HB2' ' A' ' 15' ' ' SER . 5.9 p-10 -58.71 120.79 9.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.494 0.664 . . . . 0.0 109.925 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.85 -41.01 0.58 Allowed Glycine 0 C--N 1.294 -1.755 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -94.72 155.94 16.62 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -130.42 156.6 44.47 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.964 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.22 153.95 51.07 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 -175.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.576 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 87.3 mt-30 -111.87 145.54 39.31 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.382 176.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -117.36 120.17 37.36 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 23.3 mt -97.49 114.65 35.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -128.47 139.69 52.2 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.47 ' HB2' ' HA ' ' A' ' 6' ' ' GLU . 27.8 t70 -129.42 167.71 17.4 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 168.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.657 ' H ' ' HD2' ' A' ' 88' ' ' ARG . 5.3 mpt_? -65.01 96.65 0.2 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 123.394 0.434 . . . . 0.0 110.205 -174.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.401 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 20.1 t70 179.27 -159.43 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 10.5 mpt_? -117.97 19.11 13.78 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.4 m -106.59 117.88 35.2 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.701 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.402 ' HB2' HD23 ' A' ' 42' ' ' LEU . 47.7 m-85 -118.03 133.41 55.94 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 60.3 m-85 -101.7 116.13 32.05 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 174.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 7.8 p -99.9 132.0 46.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 120.827 0.346 . . . . 0.0 110.422 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.576 ' CG2' ' HB2' ' A' ' 83' ' ' GLN . 11.3 tt -131.74 128.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.183 0.516 . . . . 0.0 109.981 177.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.0 tt -96.66 142.02 14.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.363 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -82.94 113.96 20.89 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.973 0.892 . . . . 0.0 108.699 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 137.12 -120.62 2.14 Favored Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 106.879 -2.489 . . . . 0.0 106.879 -173.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -169.49 131.39 1.14 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 117.298 0.549 . . . . 0.0 110.514 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -95.68 144.93 25.68 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 28.0 ttt -154.38 95.93 1.86 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.815 0.34 . . . . 0.0 111.032 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 C--O 1.257 1.458 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.768 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 C--O 1.241 0.642 0 CA-C-O 120.47 0.176 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.85 129.8 42.69 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -80.65 76.09 7.54 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 122.498 1.142 . . . . 0.0 110.592 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.3 m -124.46 -59.01 1.49 Allowed 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.847 -1.524 . . . . 0.0 107.058 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.24 -153.7 52.06 Favored Glycine 0 N--CA 1.435 -1.396 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.8 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -151.83 114.58 4.63 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 m -114.09 140.68 33.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 121.518 0.675 . . . . 0.0 111.028 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.4 145.59 45.07 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.377 -175.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -142.25 147.33 36.31 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.401 ' HB3' ' HB3' ' A' ' 83' ' ' GLN . 23.3 ptm -135.29 143.72 46.38 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -177.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.567 ' H ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -155.01 159.27 31.96 Favored Pre-proline 0 N--CA 1.433 -1.286 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.24 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -48.76 148.79 8.28 Favored 'Trans proline' 0 C--O 1.251 1.126 0 C-N-CA 124.14 3.227 . . . . 0.0 114.839 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -129.68 124.54 33.87 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.5 117.91 56.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.52 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 26.1 t -59.96 -20.49 57.86 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -172.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -73.11 -44.19 60.65 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.948 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.75 -37.11 11.96 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.678 0.752 . . . . 0.0 109.831 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 21' ' ' SER . 14.5 m -84.98 15.23 4.16 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.634 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 15' ' ' SER . 46.2 t -74.44 -21.95 59.37 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.82 -28.18 1.1 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.15 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 18' ' ' SER . 21.3 p -147.33 152.79 38.81 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -172.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.463 HD12 HD22 ' A' ' 63' ' ' LEU . 54.0 mt -111.37 141.86 44.36 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 120.793 0.33 . . . . 0.0 111.602 176.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -100.52 125.26 46.84 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.443 ' CB ' ' HB ' ' A' ' 61' ' ' VAL . 48.1 mm -105.2 132.09 21.19 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.608 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.93 147.06 83.99 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 123.142 2.562 . . . . 0.0 111.919 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 mp -58.5 -38.29 77.34 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.121 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.38 -28.14 66.73 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.568 -0.742 . . . . 0.0 113.28 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -85.79 -25.69 26.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.126 0.488 . . . . 0.0 110.04 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -69.47 -45.74 68.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.107 0.479 . . . . 0.0 110.105 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.54 -10.51 59.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.811 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -68.35 -27.49 66.31 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.756 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -158.72 103.64 1.62 Allowed Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 120.959 0.409 . . . . 0.0 111.814 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.574 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 6.0 Cg_exo -82.59 134.89 7.74 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.07 1.847 . . . . 0.0 111.08 172.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.95 159.24 32.53 Favored Pre-proline 0 C--N 1.271 -2.809 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.54 130.07 35.52 Favored 'Trans proline' 0 C--O 1.26 1.58 0 N-CA-C 107.843 -1.637 . . . . 0.0 107.843 172.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -71.71 128.48 89.6 Favored Pre-proline 0 N--CA 1.403 -2.818 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -172.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.89 160.1 40.9 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.225 2.616 . . . . 0.0 112.344 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.81 -48.53 15.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 174.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.0 p -136.46 151.63 49.68 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.932 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.15 162.37 38.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.76 137.98 52.35 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.53 0.681 . . . . 0.0 111.844 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 49' ' ' SER . 65.1 mt -109.17 122.78 48.05 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.29 148.08 31.6 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.368 0.604 . . . . 0.0 111.662 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -111.75 165.15 12.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.384 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -52.27 -38.26 57.77 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.805 0.842 . . . . 0.0 110.782 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 m -67.06 -10.29 48.33 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.139 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.27 7.64 63.58 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.418 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -80.37 138.03 36.63 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 35.1 p -124.78 135.26 52.81 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 123.463 0.477 . . . . 0.0 110.594 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -113.88 130.65 56.47 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.4 m -90.86 119.35 30.99 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -119.64 156.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.531 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 65' ' ' VAL . 68.6 mtt180 -100.82 120.18 39.75 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.425 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 20.4 ttt -133.07 121.69 23.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.855 -173.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.2 OUTLIER -132.26 142.32 49.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.029 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.574 ' NZ ' ' HA ' ' A' ' 33' ' ' PRO . 26.2 mtmt -92.08 126.41 37.15 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -130.21 98.89 4.86 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.652 -172.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.22 -107.22 2.42 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.45 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.94 -1.99 16.18 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.866 0.365 . . . . 0.0 110.317 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -132.53 160.17 37.3 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-O 121.271 0.558 . . . . 0.0 111.169 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' A' ' 24' ' ' ILE . 53.0 t -105.57 142.2 19.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 173.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -135.71 131.39 35.57 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 22' ' ' LEU . 6.2 mp -96.02 113.92 25.58 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.7 p -82.41 -170.24 2.84 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.421 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 47.9 t -66.42 122.09 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.68 0.752 . . . . 0.0 110.496 -173.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.53 -27.24 1.07 Allowed Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.401 ' CH2' HD11 ' A' ' 22' ' ' LEU . 41.4 t-105 -60.75 -21.38 62.95 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 113.577 -1.312 . . . . 0.0 110.184 172.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.734 ' O ' ' HG2' ' A' ' 72' ' ' LYS 0.293 0.0 OUTLIER -63.54 -26.53 68.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -175.859 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -56.18 -38.06 70.42 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.543 0.737 . . . . 0.0 110.114 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -74.05 -49.05 25.92 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.446 -175.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.7 p -67.52 -40.69 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.361 -175.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 20.5 ptmt -70.41 -38.77 74.67 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.771 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.59 -38.08 62.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.258 -0.977 . . . . 0.0 112.528 -175.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -86.12 -20.77 28.18 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.838 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.1 t30 50.87 83.53 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.15 0.98 . . . . 0.0 111.432 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 pp -138.8 174.67 10.28 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -143.19 172.04 13.27 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.867 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.52 ' HB3' ' H ' ' A' ' 15' ' ' SER . 9.3 p-10 -65.79 142.1 58.08 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.145 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.24 -21.55 15.05 Favored Glycine 0 C--N 1.295 -1.7 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -173.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -116.54 134.46 54.82 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 87.2 m-85 -130.28 158.91 38.48 Favored 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.264 -170.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 pp -132.29 144.59 50.69 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.552 ' CG ' ' HB ' ' A' ' 95' ' ' ILE . 10.3 pt20 -119.02 145.85 45.52 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.909 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.02 124.28 51.17 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.5 mt -106.31 117.18 51.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.413 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 30.6 p90 -127.68 152.76 47.3 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.531 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -81.16 -78.75 0.17 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.162 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -162.23 24.32 0.11 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -120.55 -168.93 1.72 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -95.83 15.76 19.43 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 123.496 0.718 . . . . 0.0 110.186 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.7 m -102.76 116.11 31.91 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 82.8 m-85 -117.13 132.08 56.75 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.884 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -101.55 129.2 47.59 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -98.71 141.08 16.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -174.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.552 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 57.8 mt -127.06 117.66 48.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.97 113.9 41.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 81' ' ' TYR . 49.2 p90 -100.53 124.94 46.74 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -148.62 121.83 1.39 Allowed Glycine 0 N--CA 1.409 -3.1 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -91.43 87.57 6.48 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -74.23 96.78 2.84 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.511 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.2 mtt -96.43 75.97 2.91 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.631 0.729 . . . . 0.0 109.193 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 52.3 t . . . . . 0 N--CA 1.429 -1.525 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -178.656 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttm . . . . . 0 C--O 1.238 0.487 0 CA-C-O 120.895 0.379 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.4 146.33 4.98 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.92 137.52 55.27 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.4 m -61.62 -62.01 2.12 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 123.743 0.652 . . . . 0.0 110.778 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.13 -172.47 33.57 Favored Glycine 0 C--N 1.292 -1.868 0 C-N-CA 120.243 -0.979 . . . . 0.0 110.772 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -179.67 114.25 0.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 m -123.61 145.81 30.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.09 0.472 . . . . 0.0 112.048 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.408 ' HG3' HG12 ' A' ' 85' ' ' ILE . 1.6 mp0 -99.85 146.97 26.02 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.469 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -142.98 149.21 38.03 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.6 ttt -131.7 144.78 51.24 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 24.1 ttpp -146.86 143.78 19.03 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.42 146.35 42.0 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 123.056 2.504 . . . . 0.0 111.632 173.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -122.07 121.69 37.54 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt -128.32 115.98 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.518 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 24.0 t -61.29 -17.49 53.82 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.925 0.89 . . . . 0.0 112.369 -171.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.22 -42.07 93.83 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HD2' ' CD ' ' A' ' 23' ' ' GLU . 37.5 ttmt -101.48 -30.3 11.5 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.212 -177.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.9 p -80.08 7.31 9.42 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 120.927 0.394 . . . . 0.0 111.386 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.9 p -72.18 -29.87 64.42 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.436 0.636 . . . . 0.0 109.631 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -114.28 -39.79 3.8 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.382 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.2 p -157.5 155.39 30.25 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.659 -174.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 76.9 mt -96.25 138.7 33.46 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.947 0.403 . . . . 0.0 110.744 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.476 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 39.5 mt-10 -79.24 117.81 20.6 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.432 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.464 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 62.9 mt -97.19 118.92 64.15 Favored Pre-proline 0 C--N 1.281 -2.382 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.74 138.8 32.84 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.581 2.854 . . . . 0.0 114.635 -171.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.4 tt -63.05 -37.83 88.77 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.72 -28.91 73.47 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.334 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -72.86 -42.89 63.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -62.98 -40.12 96.78 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.71 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.22 -25.46 68.34 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.649 0.779 . . . . 0.0 110.328 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -80.61 -27.58 37.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.165 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -173.4 100.5 0.32 Allowed Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' CB ' ' HE2' ' A' ' 56' ' ' LYS . 14.4 Cg_endo -89.06 149.19 5.65 Favored 'Trans proline' 0 N--CA 1.426 -2.5 0 C-N-CA 121.377 1.384 . . . . 0.0 111.297 171.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.0 158.66 36.69 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.25 137.07 76.6 Favored 'Trans proline' 0 C--N 1.354 0.816 0 N-CA-C 107.68 -1.7 . . . . 0.0 107.68 172.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -70.95 127.41 91.74 Favored Pre-proline 0 N--CA 1.407 -2.609 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -172.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.38 136.91 45.12 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.563 2.175 . . . . 0.0 110.338 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.23 -48.71 87.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.201 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.474 ' O ' ' HD3' ' A' ' 90' ' ' ARG . 25.6 p -127.53 150.69 49.58 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.356 176.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.8 t -132.1 155.2 41.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -108.42 125.14 51.42 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 120.746 0.308 . . . . 0.0 110.361 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.6 mt -109.18 120.16 41.7 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 173.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.61 149.88 26.75 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 120.852 0.358 . . . . 0.0 110.375 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.481 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 11.3 t70 -111.27 158.78 18.59 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.433 ' CE1' HG13 ' A' ' 95' ' ' ILE . 26.9 p90 -73.68 -13.28 60.96 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.253 0.549 . . . . 0.0 111.676 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.2 t -93.52 -162.28 0.92 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.71 6.79 44.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.115 -0.564 . . . . 0.0 114.113 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -81.41 145.61 30.7 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.1 p -150.01 136.52 19.07 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 113.903 -1.498 . . . . 0.0 107.921 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.481 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 23.3 m-90 -126.97 140.3 52.42 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.169 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -96.68 114.29 25.92 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 67' ' ' TRP . 48.2 t -125.25 155.62 34.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.0 -174.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -101.84 139.41 37.51 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.0 ttt -120.12 138.76 53.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -143.84 132.42 22.32 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.254 -0.978 . . . . 0.0 112.58 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.407 ' HE2' ' CB ' ' A' ' 33' ' ' PRO . 48.8 tttp -91.88 128.08 37.58 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -138.86 98.24 3.5 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.302 -173.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.08 -134.72 13.56 Favored Glycine 0 N--CA 1.422 -2.259 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.875 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.429 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 4.9 mp0 -90.89 -0.47 57.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.214 0.53 . . . . 0.0 110.48 -175.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -132.52 171.05 14.29 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 61.7 t -124.84 148.01 29.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -124.42 137.13 54.48 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 21.4 tp -91.69 102.95 15.58 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.419 ' HB ' ' H ' ' A' ' 65' ' ' VAL . 34.9 p -78.94 -157.38 0.12 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -170.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' H ' ' HB ' ' A' ' 64' ' ' THR . 13.5 p -55.9 144.73 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.154 0.981 . . . . 0.0 111.834 -173.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.28 -36.26 3.59 Favored Glycine 0 CA--C 1.485 -1.816 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 -172.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.411 ' CZ2' HG23 ' A' ' 71' ' ' VAL . 12.0 t-105 -59.76 -25.29 64.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.704 -1.248 . . . . 0.0 109.382 171.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.493 ' OE2' ' HD3' ' A' ' 72' ' ' LYS . 2.8 tm-20 -53.23 -31.41 43.14 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.605 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.529 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 2.1 m-20 -67.29 -30.55 70.44 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 123.346 0.659 . . . . 0.0 111.991 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -73.44 -53.06 11.58 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 40.2 t -63.63 -39.1 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.98 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 69' ' ' ASN . 59.9 pttt -71.46 -39.01 71.21 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.4 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -77.64 -40.66 41.06 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -175.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.96 -20.87 29.92 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 20.2 t-20 47.65 88.73 0.02 OUTLIER 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.794 1.637 . . . . 0.0 112.374 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.79 168.8 24.51 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.849 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -143.56 174.24 10.94 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 124.073 0.949 . . . . 0.0 108.97 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.518 ' HB3' ' H ' ' A' ' 15' ' ' SER . 5.6 p-10 -51.95 130.6 29.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.941 0.877 . . . . 0.0 111.717 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.51 -39.93 1.25 Allowed Glycine 0 C--N 1.294 -1.756 0 N-CA-C 107.189 -2.365 . . . . 0.0 107.189 -175.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -94.42 146.14 24.28 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -118.98 158.94 24.77 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.204 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.1 mt -110.57 137.44 48.25 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.526 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.603 ' HB3' ' CG2' ' A' ' 95' ' ' ILE . 57.8 tt0 -111.68 130.71 55.68 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -109.57 117.33 33.67 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 62.5 mt -99.65 114.18 37.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 106.185 -1.784 . . . . 0.0 106.185 174.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -129.11 154.06 47.07 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -172.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -143.56 149.69 37.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.448 ' H ' ' NE ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -54.17 93.9 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.334 1.054 . . . . 0.0 111.82 -177.009 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 23.2 t70 -174.64 -159.04 0.08 Allowed 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -176.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 39' ' ' THR . 36.7 ttm180 -116.39 25.45 10.62 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.4 m -125.69 125.97 43.9 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.405 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -119.89 132.9 55.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.538 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 93.7 m-85 -104.97 115.04 29.61 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 174.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.77 149.48 8.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-O 121.357 0.599 . . . . 0.0 112.137 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.603 ' CG2' ' HB3' ' A' ' 83' ' ' GLN . 13.2 tt -142.06 135.44 28.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.1 pt -93.71 141.63 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.471 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -83.08 112.79 20.12 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.2 -113.01 0.55 Allowed Glycine 0 N--CA 1.41 -3.073 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.7 t60 56.51 83.08 0.1 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.469 0.652 . . . . 0.0 110.108 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -169.41 -48.29 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -174.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.4 ttt -118.21 67.31 0.76 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 171.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.3 m . . . . . 0 C--N 1.306 -1.287 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.328 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 32' ' ' PHE . . . -139.03 67.0 1.4 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.028 0.442 . . . . 0.0 110.569 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -142.66 157.78 44.33 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.357 0.599 . . . . 0.0 112.313 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.0 m -157.93 -43.96 0.06 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.73 -140.78 11.04 Favored Glycine 0 CA--C 1.494 -1.261 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.97 104.95 7.75 Favored 'General case' 0 C--O 1.255 1.35 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 175.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.8 m -129.4 139.88 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.784 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 85' ' ' ILE . 8.6 pt20 -136.95 144.91 43.65 Favored 'General case' 0 N--CA 1.399 -3.022 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.361 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -136.26 148.99 48.29 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.511 -174.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.477 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 27.1 ptm -102.56 157.29 17.03 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 12.7 ptpt -154.57 144.32 15.43 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 6.5 Cg_exo -75.83 134.79 16.85 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 122.856 2.37 . . . . 0.0 112.343 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.432 ' CE2' ' HG ' ' A' ' 22' ' ' LEU . 32.0 m-85 -107.11 140.34 40.11 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.659 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.9 mt -120.17 113.52 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 t -56.92 -31.79 65.29 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 123.411 0.444 . . . . 0.0 111.473 -173.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.76 -44.17 97.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -89.09 -40.07 13.19 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.7 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 21' ' ' SER . 25.8 m -75.22 4.55 6.8 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.372 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.2 t -74.26 -17.08 60.92 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -135.25 -35.97 0.82 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.555 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 18' ' ' SER . 26.5 p -144.23 144.0 31.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.402 0.62 . . . . 0.0 112.63 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.3 tt -100.05 121.11 40.88 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -86.11 127.02 34.62 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.982 0.42 . . . . 0.0 110.607 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.535 ' HB ' HG23 ' A' ' 61' ' ' VAL . 45.7 mm -97.56 132.7 24.71 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.45 148.15 87.61 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.266 1.977 . . . . 0.0 111.384 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.64 -22.51 66.66 Favored 'General case' 0 C--O 1.213 -0.819 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.97 -21.62 61.51 Favored Glycine 0 C--O 1.22 -0.734 0 C-N-CA 121.342 -0.456 . . . . 0.0 111.984 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.438 ' HE2' ' CZ ' ' A' ' 86' ' ' TYR . 28.3 t80 -76.44 -51.72 11.25 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -68.18 -35.86 78.69 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.449 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -69.17 -26.42 64.84 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -85.35 -28.23 25.35 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.379 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.424 ' HB2' ' HB1' ' A' ' 2' ' ' ALA . 4.9 p90 -172.87 114.67 0.37 Allowed Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 1.9 Cg_endo -85.0 150.83 10.96 Favored 'Trans proline' 0 N--CA 1.427 -2.396 0 C-N-CA 121.646 1.564 . . . . 0.0 109.672 168.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.68 152.07 67.6 Favored Pre-proline 0 C--N 1.282 -2.34 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.4 130.54 32.34 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 N-CA-C 108.212 -1.495 . . . . 0.0 108.212 175.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -69.71 114.18 22.72 Favored Pre-proline 0 N--CA 1.412 -2.337 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -172.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -78.61 136.63 13.88 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.798 2.332 . . . . 0.0 110.618 177.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.459 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 47.4 mm -69.93 -46.44 73.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.746 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.5 p -123.38 148.98 45.52 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.736 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.2 t -134.87 143.39 37.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -115.4 131.34 56.96 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.811 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.9 mt -109.24 129.15 55.51 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.39 152.4 20.77 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.584 0.707 . . . . 0.0 112.328 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.517 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 12.3 t70 -112.1 166.91 10.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.196 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -76.54 -49.31 16.77 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.747 0.819 . . . . 0.0 110.717 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 m -80.58 -50.51 9.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.568 -172.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -174.04 -11.29 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 118.263 -1.922 . . . . 0.0 114.716 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.418 ' HB2' ' CB ' ' A' ' 44' ' ' ASP . 17.5 mmt180 -73.72 157.86 35.73 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.1 p -150.94 135.3 16.96 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.517 ' CH2' ' HB2' ' A' ' 44' ' ' ASP . 18.7 m-90 -128.7 134.52 48.5 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.461 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.2 m -98.39 120.05 38.14 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 67' ' ' TRP . 8.5 p -119.18 155.24 21.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.471 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 77.7 ttt180 -103.25 135.95 43.94 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.9 ttt -117.53 146.0 43.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -147.55 131.45 17.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.506 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 33' ' ' PRO . 53.4 tttp -114.47 110.56 20.03 Favored 'General case' 0 CA--C 1.471 -2.082 0 CA-C-O 122.198 0.999 . . . . 0.0 109.089 173.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -140.66 104.82 4.81 Favored 'General case' 1 C--N 1.242 -4.071 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.81 -158.32 20.78 Favored Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -173.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -94.81 3.38 55.07 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.643 0.735 . . . . 0.0 109.55 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -112.73 156.65 22.45 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.535 HG23 ' HB ' ' A' ' 24' ' ' ILE . 27.5 m -129.6 139.89 50.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.897 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -136.91 148.06 46.79 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.024 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 5.9 mp -100.7 109.93 22.01 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.4 p -89.48 -144.55 0.16 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.858 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -55.73 129.06 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 121.484 0.659 . . . . 0.0 109.78 -175.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.92 -38.4 2.11 Favored Glycine 0 N--CA 1.414 -2.796 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 -170.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.45 ' N ' HG23 ' A' ' 52' ' ' VAL . 60.9 t-105 -66.23 -25.5 66.93 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.685 -0.758 . . . . 0.0 109.188 174.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.661 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 32.1 tt0 -59.58 -37.0 77.32 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.201 -178.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -57.45 -39.55 76.52 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 123.716 0.807 . . . . 0.0 110.935 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -74.05 -50.88 17.73 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.825 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 68' ' ' GLU . 7.8 p -62.43 -47.15 94.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.544 -174.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 64.2 pttt -72.44 -33.57 67.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.13 -40.39 38.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 118.575 -1.25 . . . . 0.0 113.471 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -88.25 -19.91 26.17 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.579 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.9 t30 57.73 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.902 1.281 . . . . 0.0 112.061 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 pp -139.45 155.25 47.71 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.638 0.732 . . . . 0.0 112.845 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.94 171.96 13.64 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.78 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -60.94 141.46 57.24 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.612 0.57 . . . . 0.0 110.587 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.76 -6.05 13.95 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -121.1 153.0 38.03 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -132.54 139.65 47.96 Favored 'General case' 0 CA--C 1.474 -1.964 0 CA-C-O 121.043 0.449 . . . . 0.0 109.839 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -135.55 144.38 46.21 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.979 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.477 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 75.9 mt-30 -110.5 145.0 38.47 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.155 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 37.8 m-85 -112.92 131.14 55.85 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.464 ' HA ' ' HB3' ' A' ' 8' ' ' GLN . 59.3 mt -95.31 121.49 45.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.438 ' CZ ' ' HE2' ' A' ' 28' ' ' PHE . 23.0 m-85 -105.5 123.42 47.86 Favored 'General case' 0 N--CA 1.421 -1.925 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -104.37 14.5 30.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.583 0.706 . . . . 0.0 109.638 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.12 72.7 0.49 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.612 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -175.67 -171.49 0.47 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 -176.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.469 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 5.5 mpt_? -106.56 26.93 9.33 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.6 m -127.51 117.81 22.79 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -125.26 155.23 40.45 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.337 0.589 . . . . 0.0 110.906 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -115.07 135.11 54.57 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -104.55 129.63 56.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.112 0.482 . . . . 0.0 112.271 -174.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.7 mm -111.99 115.29 49.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.5 tt -118.12 137.87 50.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.431 0.634 . . . . 0.0 112.7 -173.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -99.08 135.78 40.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.91 -1.88 35.77 Favored Glycine 0 C--N 1.29 -2.015 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.697 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -86.19 103.36 14.75 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -88.12 136.87 32.77 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.144 -0.935 . . . . 0.0 113.019 -171.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -76.75 -30.19 56.46 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.042 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.4 m . . . . . 0 N--CA 1.432 -1.363 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.845 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.414 -2.274 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -123.7 143.92 49.97 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.465 ' CE2' ' HG2' ' A' ' 25' ' ' PRO . 72.2 t80 -148.24 151.89 36.23 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.3 ptm -121.22 141.79 50.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' HD2' ' HD2' ' A' ' 12' ' ' PRO . 58.8 tptt -135.94 129.4 18.13 Favored Pre-proline 0 C--N 1.295 -1.786 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.786 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.441 ' HD2' ' HD2' ' A' ' 11' ' ' LYS . 6.1 Cg_exo -79.66 133.94 10.69 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.436 2.091 . . . . 0.0 109.006 170.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 43.4 m-85 -102.64 139.31 38.4 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -176.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.6 mt -104.71 110.26 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.7 t -57.41 -30.42 64.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.342 0.591 . . . . 0.0 111.003 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.35 -34.18 73.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.22 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -103.03 -29.93 11.08 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.527 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 t -70.27 -11.26 60.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.84 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 p -60.55 -30.44 69.77 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.568 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -136.11 -9.72 2.01 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.9 p -157.27 145.1 19.01 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.5 tt -99.44 119.52 38.13 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.77 122.39 32.81 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.097 0.475 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.7 mm -95.53 124.51 52.83 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HG2' ' CE2' ' A' ' 9' ' ' PHE . 84.2 Cg_exo -50.8 134.03 40.52 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.539 2.826 . . . . 0.0 112.073 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.54 -43.03 89.1 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.592 0.757 . . . . 0.0 111.209 -173.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.32 -32.26 83.61 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.83 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.564 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 74.9 t80 -82.8 -36.16 25.81 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.596 HD21 ' HA ' ' A' ' 60' ' ' LYS . 13.7 t30 -59.86 -43.55 94.62 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.968 0.907 . . . . 0.0 110.693 175.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.73 -22.22 66.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.912 0.863 . . . . 0.0 110.587 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.564 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 92.6 t80 -75.63 -26.72 58.02 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.729 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -134.01 93.85 19.41 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 119.433 -0.907 . . . . 0.0 113.065 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.6 Cg_exo -81.63 136.2 9.53 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 121.592 1.528 . . . . 0.0 110.269 171.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.49 153.34 32.1 Favored Pre-proline 0 C--N 1.283 -2.305 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.684 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.27 154.59 62.32 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 121.977 1.785 . . . . 0.0 109.156 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -68.67 126.08 92.4 Favored Pre-proline 0 N--CA 1.419 -1.985 0 CA-C-O 121.231 0.538 . . . . 0.0 110.915 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -87.47 160.54 8.08 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 122.442 2.094 . . . . 0.0 111.243 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.73 -59.14 2.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.4 p -134.6 151.7 51.26 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.487 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -128.82 148.15 33.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -109.94 136.85 48.57 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.201 -0.599 . . . . 0.0 111.53 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 92' ' ' PHE . 76.5 mt -108.39 122.53 47.2 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.07 137.75 39.02 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -113.42 139.35 48.98 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.266 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -58.92 -21.64 58.25 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -85.89 -13.23 48.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.587 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.04 -9.22 7.53 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 119.843 -1.17 . . . . 0.0 114.68 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -88.07 157.85 18.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.567 0.683 . . . . 0.0 111.239 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.7 p -143.04 136.21 28.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 18.1 m-90 -114.73 126.77 55.24 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.391 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.0 m -89.09 114.76 26.04 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.405 HG21 HD23 ' A' ' 63' ' ' LEU . 31.1 m -112.15 156.47 13.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.118 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -101.9 120.43 40.38 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.588 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -123.95 137.07 54.67 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.074 -172.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.588 ' HD2' ' C ' ' A' ' 54' ' ' MET . 4.5 mptp? -133.9 140.68 46.97 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.019 0.438 . . . . 0.0 112.069 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 33' ' ' PRO . 54.6 tttp -105.49 107.89 19.12 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 172.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -108.79 99.87 9.17 Favored 'General case' 1 C--N 1.243 -4.064 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.325 -172.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.44 -116.75 6.76 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.47 -21.16 22.0 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.596 ' HA ' HD21 ' A' ' 29' ' ' ASN . 17.7 ptpt -112.21 165.87 11.78 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -168.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.411 HG12 ' CB ' ' A' ' 56' ' ' LYS . 25.8 m -134.56 146.33 31.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.551 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -142.02 136.55 30.36 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.774 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 3.1 mp -96.75 104.04 16.0 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 169.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.2 p -94.49 -98.7 0.15 Allowed 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -169.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.5 133.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.655 0.74 . . . . 0.0 110.625 -175.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.05 -37.66 3.63 Favored Glycine 0 CA--C 1.481 -2.074 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -63.01 -25.62 68.47 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.851 0.834 . . . . 0.0 109.254 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.671 ' HA ' HG12 ' A' ' 71' ' ' VAL . 16.9 pt-20 -68.58 -26.32 65.33 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.57 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -68.99 -31.64 70.62 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.543 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -74.3 -52.04 13.45 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 68' ' ' GLU . 7.2 p -59.73 -46.88 93.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.431 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.24 -43.35 64.51 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -77.24 -40.2 45.72 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.201 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.478 ' ND2' HG12 ' A' ' 96' ' ' ILE . 7.3 t30 -84.83 -18.47 34.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.24 0.543 . . . . 0.0 109.582 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 50.4 t30 60.11 90.96 0.05 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.182 1.393 . . . . 0.0 112.846 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.413 ' CD1' HG23 ' A' ' 71' ' ' VAL . 3.8 pp -127.18 151.13 49.09 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.437 ' HG2' ' HD3' ' A' ' 80' ' ' LYS . 15.5 pt-20 -144.06 172.65 12.6 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.652 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 12.2 t70 -53.05 120.42 5.86 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.47 -25.15 6.67 Favored Glycine 0 C--N 1.306 -1.122 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HD3' ' HG2' ' A' ' 77' ' ' GLU . 14.5 mptt -80.8 147.54 30.42 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -126.6 140.65 52.26 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.433 HD22 HG13 ' A' ' 96' ' ' ILE . 61.4 mt -119.66 147.4 44.59 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.103 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 14.9 mm100 -110.72 124.85 52.74 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -112.51 117.67 33.01 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 123.556 0.535 . . . . 0.0 109.761 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 mp -103.91 122.67 56.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.422 ' HE2' ' CE2' ' A' ' 92' ' ' PHE . 64.2 m-85 -109.45 144.61 37.46 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -88.37 -97.47 0.09 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.673 173.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -154.11 20.27 0.5 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 16.2 t70 -143.56 -154.61 0.54 Allowed 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -174.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.506 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 5.6 mpt_? -95.58 29.15 2.7 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.11 0.964 . . . . 0.0 109.252 -175.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -101.98 116.61 33.06 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.313 0.578 . . . . 0.0 110.394 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.422 ' CE2' ' HE2' ' A' ' 86' ' ' TYR . 1.5 m-30 -116.43 122.29 44.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.034 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.441 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 38.5 m-85 -105.74 120.09 40.8 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 32.6 t -111.08 134.32 53.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.995 0.426 . . . . 0.0 112.068 -173.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 2.1 mp -116.2 131.47 68.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.478 HG12 ' ND2' ' A' ' 74' ' ' ASN . 2.8 mp -105.92 128.01 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 122.432 0.293 . . . . 0.0 111.005 -174.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 C--N 1.311 -1.068 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.89 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.408 HG11 ' OH ' ' A' ' 31' ' ' TYR . 32.9 m . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.44 146.6 52.03 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -142.05 148.97 39.33 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.473 ' HG2' ' HG2' ' A' ' 83' ' ' GLN . 64.2 mtt -114.88 137.59 51.79 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HB3' ' NZ ' ' A' ' 11' ' ' LYS . 1.8 ttpm? -142.06 130.8 12.01 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.11 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.61 147.38 86.24 Favored 'Trans proline' 0 C--O 1.248 1.005 0 C-N-CA 122.86 2.373 . . . . 0.0 111.066 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' A' ' 15' ' ' SER . 76.8 t80 -95.41 117.99 31.34 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.1 mm -97.32 106.87 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.772 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.593 ' HB2' ' N ' ' A' ' 78' ' ' ASP . 20.2 t -55.89 -37.57 69.02 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.549 0.531 . . . . 0.0 111.416 -172.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -61.17 -44.01 97.98 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 123.633 0.583 . . . . 0.0 110.626 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -86.46 -40.77 15.0 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.171 -173.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 21' ' ' SER . 26.1 m -84.21 11.9 7.44 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.516 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.3 m -63.13 -33.45 75.49 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 168.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -121.54 -41.83 2.47 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.499 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 18' ' ' SER . 45.7 m -144.84 152.81 40.87 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.189 -175.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 54.9 mt -87.91 132.03 34.37 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-O 121.171 0.51 . . . . 0.0 111.657 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -96.07 117.36 30.54 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.809 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.3 mm -98.49 132.61 23.82 Favored Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.533 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -56.24 142.13 87.65 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 123.195 2.597 . . . . 0.0 112.052 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.513 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 5.7 tt -54.17 -38.98 66.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.984 0.914 . . . . 0.0 111.761 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.5 -35.41 85.35 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.877 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -88.3 -25.02 23.01 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 60' ' ' LYS . 87.8 m-20 -62.71 -46.27 88.88 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.581 0.705 . . . . 0.0 110.034 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -73.68 -12.04 60.6 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.608 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.408 ' OH ' HG11 ' A' ' 7' ' ' VAL . 91.3 t80 -75.99 -28.7 57.92 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -175.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . 0.251 24.7 p90 -130.97 68.28 81.75 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -57.0 135.45 70.93 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 121.957 1.771 . . . . 0.0 111.046 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.69 161.3 29.56 Favored Pre-proline 0 C--N 1.278 -2.516 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.646 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.55 148.94 60.71 Favored 'Trans proline' 0 C--O 1.25 1.12 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 167.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 44.5 p90 -67.85 121.42 79.52 Favored Pre-proline 0 N--CA 1.413 -2.321 0 CA-C-O 121.626 0.727 . . . . 0.0 111.709 -171.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 90' ' ' ARG . 66.4 Cg_endo -96.76 160.74 1.12 Allowed 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 123.628 2.885 . . . . 0.0 112.697 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -108.01 -38.71 4.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.237 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 64.0 p -123.86 159.97 28.46 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.212 0.53 . . . . 0.0 111.9 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 90' ' ' ARG . 7.1 p -146.02 141.88 21.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 173.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -110.0 131.78 54.75 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.158 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -109.92 126.42 53.86 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.92 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.8 145.27 31.4 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.103 0.477 . . . . 0.0 111.914 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 19.2 t70 -113.87 154.93 26.65 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 173.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -91.67 -5.72 53.3 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.6 t -92.55 -23.44 19.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.909 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.87 -37.93 0.76 Allowed Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 118.896 -1.621 . . . . 0.0 114.196 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 84.6 mtm-85 -78.92 158.84 27.96 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 117.849 0.824 . . . . 0.0 113.123 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.6 m -146.38 150.44 35.67 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.284 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.544 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 12.8 m-90 -132.03 120.78 22.87 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.0 m -92.57 114.22 26.71 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 174.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 66' ' ' GLY . 18.2 m -114.83 158.79 15.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.642 -174.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 99.5 mtt180 -99.73 127.4 45.87 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.504 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.431 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 56.5 ttp -114.73 144.33 43.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.414 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -128.9 127.81 42.54 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -99.12 124.53 44.22 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.85 102.03 3.95 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.6 -105.22 0.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.352 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.28 -0.79 52.56 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 123.331 0.652 . . . . 0.0 112.151 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.528 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 84.8 tttt -142.17 147.09 36.03 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 118.515 -1.274 . . . . 0.0 112.922 -172.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.0 t -109.31 132.48 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -121.88 132.01 54.34 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 5.8 mp -101.19 102.61 13.55 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.269 168.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -85.21 -150.52 0.13 Allowed 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 124.62 1.168 . . . . 0.0 111.271 -170.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 62.0 t -55.47 125.9 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-O 121.838 0.827 . . . . 0.0 109.124 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 52' ' ' VAL . . . 135.22 -40.85 1.51 Allowed Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 -169.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.405 ' CZ2' HD21 ' A' ' 22' ' ' LEU . 63.7 t-105 -65.48 -24.84 67.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.729 -0.735 . . . . 0.0 109.64 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.611 ' HA ' HG12 ' A' ' 71' ' ' VAL . 37.2 tt0 -61.29 -30.34 70.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.382 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -58.56 -44.59 89.76 Favored 'General case' 0 C--O 1.198 -1.63 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.757 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -73.0 -46.43 52.28 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.081 0.553 . . . . 0.0 110.062 -176.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.7 p -62.76 -43.25 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.571 0.7 . . . . 0.0 110.058 -175.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -72.07 -43.22 65.2 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.273 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.96 -40.37 54.06 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -86.11 -21.01 27.86 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 57.8 94.89 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.577 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -142.73 146.18 34.08 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.696 -0.628 . . . . 0.0 111.993 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.21 170.86 8.2 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.188 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.593 ' N ' ' HB2' ' A' ' 15' ' ' SER . 14.8 t70 -53.52 136.74 37.85 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.568 1.147 . . . . 0.0 111.923 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.91 -11.39 22.79 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.421 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.51 161.38 16.25 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.388 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -125.81 137.74 53.79 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.24 144.65 48.49 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.257 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.473 ' HG2' ' HG2' ' A' ' 10' ' ' MET . 50.0 mt-30 -109.72 126.22 53.49 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -110.39 117.33 33.33 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 65.5 mt -97.95 122.51 49.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -105.75 123.4 47.87 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -125.64 80.25 1.88 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 52.25 30.11 7.5 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.285 170.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -161.7 -177.56 5.97 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 40' ' ' VAL . 42.2 ttm180 -95.52 41.74 1.1 Allowed 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 87.5 m -127.14 132.63 50.51 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.802 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 95.7 m-85 -125.29 140.09 53.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.134 0.492 . . . . 0.0 110.805 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.472 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 82.0 m-85 -101.76 126.43 48.62 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.8 t -108.1 119.49 57.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.177 0.513 . . . . 0.0 112.298 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 60.0 mt -112.08 123.82 68.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.6 tt -114.66 139.25 41.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 120.947 0.403 . . . . 0.0 110.667 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.868 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.439 -0.984 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.454 ' H ' ' NE2' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -132.91 154.43 50.41 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -172.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 69.2 t80 -124.77 147.76 48.5 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.21 -1.359 . . . . 0.0 107.552 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -140.18 134.02 30.58 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -153.91 151.1 24.09 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.542 174.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -77.08 136.75 16.63 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.752 2.301 . . . . 0.0 108.69 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 24.5 p90 -103.09 137.39 41.33 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.188 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 16' ' ' GLU . 2.3 mp -101.97 123.75 55.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 19.5 m -53.49 -25.31 15.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.005 0.922 . . . . 0.0 112.584 -173.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.404 ' H ' HG22 ' A' ' 14' ' ' ILE . 43.9 tt0 -60.73 -40.49 92.57 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.277 1.031 . . . . 0.0 110.655 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -103.05 -36.78 8.04 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.574 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 89.4 p -66.05 -8.07 21.13 Favored 'General case' 0 C--O 1.215 -0.763 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -172.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.0 m -73.9 -17.66 61.01 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.8 173.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -134.55 -33.35 0.97 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 18' ' ' SER . 49.4 p -147.36 170.23 17.78 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -171.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 3.1 tm? -133.72 113.44 12.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.8 131.49 35.91 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.725 ' HB ' HG23 ' A' ' 61' ' ' VAL . 58.8 mt -113.41 132.48 22.47 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -57.14 148.79 67.36 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 123.126 2.55 . . . . 0.0 113.407 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.5 tt -62.74 -33.87 76.03 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.064 0.946 . . . . 0.0 108.871 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.25 -35.96 86.79 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.511 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.429 ' CE2' ' HE1' ' A' ' 32' ' ' PHE . 57.8 t80 -80.15 -20.51 44.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.364 0.602 . . . . 0.0 109.551 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -66.51 -43.34 85.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.3 -11.14 60.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.491 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -72.18 -25.31 61.63 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.429 ' HE1' ' CE2' ' A' ' 28' ' ' PHE . 5.1 p90 -167.74 95.94 0.63 Allowed Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 121.063 0.459 . . . . 0.0 111.683 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.99 135.35 13.89 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.852 1.702 . . . . 0.0 110.202 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.431 ' H ' ' HE2' ' A' ' 56' ' ' LYS . . . -152.77 160.38 31.16 Favored Pre-proline 0 C--N 1.28 -2.427 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.54 153.61 73.83 Favored 'Trans proline' 0 C--O 1.251 1.168 0 C-N-CA 121.449 1.433 . . . . 0.0 108.386 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -69.07 131.8 90.55 Favored Pre-proline 0 N--CA 1.411 -2.412 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.444 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.6 156.18 28.04 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 122.211 1.941 . . . . 0.0 110.313 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.3 mm -83.53 -39.76 15.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -154.75 160.5 41.36 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' NH2' ' A' ' 90' ' ' ARG . 34.2 m -135.5 158.75 40.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -113.35 134.4 54.65 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.876 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -108.89 120.73 43.37 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -104.22 157.61 17.01 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.497 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 4.5 t70 -111.74 146.06 38.23 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.09 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -64.72 -26.88 68.56 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.789 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 m -89.89 -47.69 7.72 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 122.33 -0.231 . . . . 0.0 111.023 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.22 -8.21 0.05 OUTLIER Glycine 0 CA--C 1.525 0.707 0 C-N-CA 119.396 -1.383 . . . . 0.0 114.679 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -73.76 159.47 32.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.162 0.481 . . . . 0.0 111.501 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 p -147.13 136.72 22.89 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.497 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 16.8 m-90 -131.64 142.41 49.85 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.826 0.346 . . . . 0.0 110.378 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 73.4 m -106.59 114.44 28.54 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.2 m -125.74 156.94 35.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.391 -174.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -100.85 128.68 46.79 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.277 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 1.1 tmt? -127.84 143.73 51.11 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -135.0 143.57 46.88 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.012 0.434 . . . . 0.0 111.899 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HA ' HG12 ' A' ' 61' ' ' VAL . 29.1 mmmt -92.43 121.27 33.73 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 102.873 -3.01 . . . . 0.0 102.873 169.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -134.65 98.0 3.94 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.374 -170.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.45 -109.82 3.12 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.947 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.621 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -105.86 -7.93 17.98 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.979 0.419 . . . . 0.0 110.275 -178.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 61' ' ' VAL . 41.7 ttmt -118.78 167.7 11.44 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.725 HG23 ' HB ' ' A' ' 24' ' ' ILE . 32.7 m -128.65 142.27 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -140.74 132.39 27.2 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -173.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 67' ' ' TRP . 5.5 tt -97.47 115.81 28.49 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 176.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.7 t -101.31 -142.73 0.34 Allowed 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.085 -170.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.6 m -56.1 143.78 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 124.397 1.079 . . . . 0.0 112.811 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.89 -31.86 6.31 Favored Glycine 0 N--CA 1.421 -2.357 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.475 ' HB2' HD22 ' A' ' 63' ' ' LEU . 57.1 t-105 -54.61 -27.04 36.51 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.609 0.719 . . . . 0.0 110.467 177.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.669 ' HA ' HG12 ' A' ' 71' ' ' VAL . 13.8 pt-20 -63.83 -26.63 68.7 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.204 -175.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -61.58 -37.71 84.89 Favored 'General case' 0 C--O 1.2 -1.552 0 CA-C-O 120.973 0.415 . . . . 0.0 110.098 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -73.95 -48.13 32.7 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.825 0.85 . . . . 0.0 110.765 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.2 p -65.54 -42.25 92.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.351 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -71.29 -39.81 71.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.752 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -71.8 -38.62 70.22 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -95.56 0.27 52.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.5 t30 55.63 82.81 0.1 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.99 0.9 . . . . 0.0 109.681 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 92.8 mt -120.86 136.0 55.03 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.891 -173.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -138.78 158.67 43.8 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -54.32 128.32 30.96 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 124.348 1.03 . . . . 0.0 111.009 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.24 -35.75 1.93 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -92.56 164.31 13.48 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.411 ' HB2' ' HB2' ' A' ' 97' ' ' TYR . 37.9 m-85 -132.67 154.4 50.17 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -113.2 147.59 37.17 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.403 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.466 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 49.5 tt0 -115.25 123.98 50.19 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 171.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 86.2 m-85 -109.2 116.32 31.68 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.3 mt -110.64 125.29 67.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.411 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 34.3 p90 -119.72 155.58 32.18 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.025 -1.47 . . . . 0.0 108.844 173.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -96.31 -79.92 0.44 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.271 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -143.42 16.49 1.85 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.909 0.385 . . . . 0.0 110.053 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 33.6 t70 -133.44 -175.07 3.69 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -174.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.475 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -95.09 20.51 8.97 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 125.439 1.495 . . . . 0.0 111.762 -177.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.3 t -110.33 132.98 53.7 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 81.3 m-85 -112.96 140.57 47.66 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.185 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -98.32 117.6 33.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 43.1 t -104.67 134.63 45.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.325 0.584 . . . . 0.0 112.258 -173.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.2 mt -120.29 134.33 64.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 96' ' ' ILE . 2.1 mp -100.65 121.5 51.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 120.643 0.259 . . . . 0.0 110.465 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 83' ' ' GLN . 97.1 m-85 . . . . . 0 CA--C 1.506 -0.739 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.869 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.421 -1.891 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -137.04 151.81 49.37 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.743 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -142.66 149.37 38.8 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.9 ptp -138.23 154.74 49.08 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.579 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 24.3 ttpp -152.98 145.96 17.61 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.42 142.7 16.86 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.102 2.534 . . . . 0.0 111.341 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.46 ' CZ ' HD13 ' A' ' 76' ' ' LEU . 71.4 t80 -110.75 123.88 50.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 16' ' ' GLU . 61.4 mt -126.26 113.09 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.6 p -58.38 -9.46 1.58 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' H ' HG22 ' A' ' 14' ' ' ILE . 42.1 mt-10 -81.4 -28.23 34.42 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 122.148 -0.345 . . . . 0.0 110.921 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -110.61 -38.01 5.3 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.321 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 21' ' ' SER . 65.0 p -75.24 -0.45 19.51 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.225 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.5 p -75.18 -25.08 57.98 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.513 0.673 . . . . 0.0 110.409 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -115.94 -37.45 3.87 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.492 -175.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 18' ' ' SER . 34.5 p -153.67 169.6 22.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -171.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 4.2 tt -108.04 115.13 29.57 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.579 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 14.8 pt-20 -75.15 115.51 14.87 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.46 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 61' ' ' VAL . 68.0 mt -106.63 123.42 38.75 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.54 147.11 88.27 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 123.396 2.731 . . . . 0.0 114.376 -176.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 4.9 tt -59.12 -39.78 83.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.513 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.51 -31.16 69.85 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.749 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -82.62 -24.22 33.94 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.5 0.667 . . . . 0.0 109.759 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.439 ' HB2' HG23 ' A' ' 61' ' ' VAL . 55.1 t30 -76.08 -46.3 29.7 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.54 -20.0 66.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.038 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.39 -26.98 65.83 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.717 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -168.54 103.24 0.52 Allowed Pre-proline 0 C--O 1.248 1.009 0 CA-C-O 121.239 0.542 . . . . 0.0 110.555 177.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.21 135.14 14.9 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 120.968 1.112 . . . . 0.0 109.797 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.65 148.97 21.39 Favored Pre-proline 0 C--N 1.276 -2.6 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.74 133.85 41.18 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 121.811 1.674 . . . . 0.0 108.534 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.71 ' HB3' ' H ' ' A' ' 56' ' ' LYS . 39.4 p90 -69.78 139.92 88.78 Favored Pre-proline 0 N--CA 1.414 -2.268 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -75.72 158.63 39.3 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.874 2.383 . . . . 0.0 109.905 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.36 -54.89 12.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.5 p -133.44 150.44 51.75 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.601 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 m -131.94 157.18 43.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -109.98 139.59 44.91 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.641 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.461 HD23 ' HB2' ' A' ' 92' ' ' PHE . 77.7 mt -108.24 121.89 45.82 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.3 137.96 38.95 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.94 150.95 29.79 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.024 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.58 -22.95 65.66 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.281 0.633 . . . . 0.0 112.445 -175.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.9 t -82.46 3.05 29.81 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.099 0.476 . . . . 0.0 110.175 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 8.9 67.66 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 121.358 -0.448 . . . . 0.0 112.264 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -89.27 154.97 19.68 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.1 p -141.19 137.84 32.94 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 120.863 0.363 . . . . 0.0 111.402 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -124.3 142.13 51.51 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.217 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.5 m -100.18 120.39 39.82 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.518 ' HB ' HD21 ' A' ' 63' ' ' LEU . 22.9 m -123.31 157.25 29.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.596 -174.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -101.2 139.82 36.35 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.829 0.347 . . . . 0.0 110.258 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 25.3 ttt -134.26 127.22 31.4 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.517 -172.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -120.69 124.93 46.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.018 0.437 . . . . 0.0 111.31 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.71 ' H ' ' HB3' ' A' ' 36' ' ' PHE . 25.3 mmmt -100.39 105.49 16.99 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 175.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -149.93 115.47 5.53 Favored 'General case' 0 C--N 1.265 -3.102 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.94 -120.17 5.15 Favored Glycine 0 N--CA 1.418 -2.541 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.441 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.434 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 31.0 mt-10 -96.03 -27.97 14.86 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.521 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -120.99 170.32 9.62 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.883 0.849 . . . . 0.0 112.876 -172.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.541 HG22 ' HD2' ' A' ' 56' ' ' LYS . 47.5 t -120.69 127.3 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 173.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -119.8 129.1 54.29 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 6.6 tt -103.96 118.09 35.86 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.4 p -99.16 -144.38 0.32 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.9 m -54.77 144.88 5.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.89 1.276 . . . . 0.0 113.154 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.464 ' C ' HG12 ' A' ' 52' ' ' VAL . . . 114.94 -41.54 2.14 Favored Glycine 0 N--CA 1.418 -2.532 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 -170.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.514 ' CZ3' HD12 ' A' ' 22' ' ' LEU . 58.0 t-105 -62.38 -26.9 68.71 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 114.259 -0.971 . . . . 0.0 109.248 174.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.571 ' HA ' HG12 ' A' ' 71' ' ' VAL . 30.5 tt0 -69.39 -26.77 64.81 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.524 -177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -70.28 -30.84 67.96 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 67' ' ' TRP . 53.1 t80 -73.03 -52.47 14.26 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 124.527 1.131 . . . . 0.0 109.278 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.1 p -64.61 -41.21 91.61 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.973 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -70.59 -48.14 56.69 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.679 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.83 -40.36 69.15 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.709 -173.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -88.62 -19.08 26.71 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.973 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 56.22 92.38 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.041 0.936 . . . . 0.0 110.993 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.46 HD13 ' CZ ' ' A' ' 13' ' ' PHE 0.289 0.9 OUTLIER -142.09 132.1 24.55 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -176.977 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.83 173.46 9.54 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 125.849 1.66 . . . . 0.0 109.017 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -52.71 135.92 34.29 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.693 0.62 . . . . 0.0 110.54 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.68 -28.22 3.27 Favored Glycine 0 C--N 1.301 -1.414 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -107.67 150.47 26.88 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.834 -0.683 . . . . 0.0 109.447 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -122.31 146.65 47.1 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.1 mt -110.76 135.88 50.67 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.104 0.478 . . . . 0.0 112.004 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -118.02 124.42 48.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.87 117.88 34.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.936 0.398 . . . . 0.0 110.969 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.775 HG13 ' HB2' ' A' ' 93' ' ' TYR . 11.7 pt -105.36 130.19 57.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -106.41 143.77 34.05 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.267 0.556 . . . . 0.0 111.41 -173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -92.59 -0.75 57.27 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 74.96 8.4 4.13 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.932 1.693 . . . . 0.0 109.175 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 31.5 t70 -106.08 -159.36 0.7 Allowed 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.553 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 53.4 ttp180 -95.7 11.95 31.61 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 p -108.39 117.84 35.22 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.626 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.461 ' HB2' HD23 ' A' ' 42' ' ' LEU . 3.4 m-85 -107.42 126.46 52.52 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.491 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.775 ' HB2' HG13 ' A' ' 85' ' ' ILE . 78.9 m-85 -104.27 126.98 51.83 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.1 p -119.32 135.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.167 0.508 . . . . 0.0 111.724 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.1 mt -114.45 123.01 69.71 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.4 mt -103.56 112.69 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.578 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 25.2 p90 . . . . . 0 C--N 1.307 -1.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.807 176.655 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -125.23 159.6 31.22 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-O 121.082 0.468 . . . . 0.0 112.195 -172.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -148.89 148.83 30.32 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.9 ptp -138.28 141.01 39.85 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.652 0.263 . . . . 0.0 111.348 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.66 157.05 31.39 Favored Pre-proline 0 C--N 1.312 -1.025 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.82 132.53 15.79 Favored 'Trans proline' 0 N--CA 1.439 -1.728 0 C-N-CA 120.989 1.126 . . . . 0.0 109.681 172.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' A' ' 76' ' ' LEU . 30.3 p90 -84.44 140.47 31.49 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 123.564 0.746 . . . . 0.0 110.232 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.6 mt -90.59 120.88 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.439 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 28.8 t -53.44 -37.11 62.28 Favored 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.716 0.635 . . . . 0.0 111.89 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.76 -40.57 97.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -87.02 -39.32 15.75 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.823 0.821 . . . . 0.0 108.933 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 21' ' ' SER . 48.4 m -76.04 4.14 9.0 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 114.45 -1.25 . . . . 0.0 113.016 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.1 m -71.61 -20.02 62.04 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.227 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -136.22 -36.17 0.74 Allowed 'General case' 0 C--O 1.214 -0.808 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.628 ' O ' ' HA ' ' A' ' 18' ' ' SER . 58.4 p -138.95 168.06 20.66 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.608 -0.437 . . . . 0.0 112.138 -175.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.07 131.73 47.34 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -89.34 131.82 35.24 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 121.41 0.624 . . . . 0.0 111.922 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 47.3 mm -94.89 132.93 27.28 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.1 144.43 69.42 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.883 2.389 . . . . 0.0 112.984 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.0 tp -65.58 -33.41 75.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.326 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.66 -36.21 93.04 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . 45.2 m-85 -77.84 -25.71 48.92 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -59.21 -46.33 88.74 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.19 -31.98 62.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.211 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 64.0 t80 -68.81 -28.55 66.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.369 -174.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -151.09 93.51 3.64 Favored Pre-proline 0 C--O 1.247 0.95 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -83.64 136.0 7.16 Favored 'Trans proline' 0 N--CA 1.429 -2.274 0 C-N-CA 122.264 1.976 . . . . 0.0 108.812 167.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.71 160.53 31.54 Favored Pre-proline 0 C--N 1.264 -3.127 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -175.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.2 132.78 53.3 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 107.342 -1.83 . . . . 0.0 107.342 172.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -68.22 115.74 32.16 Favored Pre-proline 0 N--CA 1.41 -2.446 0 CA-C-O 121.285 0.564 . . . . 0.0 112.002 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -80.45 135.48 10.58 Favored 'Trans proline' 0 N--CA 1.433 -2.079 0 C-N-CA 121.942 1.762 . . . . 0.0 110.062 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.9 mm -81.48 -28.79 10.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.6 p -127.66 148.73 50.39 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 121.497 0.665 . . . . 0.0 110.15 173.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 90' ' ' ARG . 53.4 t -142.83 147.31 20.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -115.83 133.96 55.49 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.725 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt -108.15 121.78 45.56 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -101.23 137.47 39.54 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.962 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -113.11 141.6 46.71 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.242 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -57.93 -29.78 65.42 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 125.353 1.461 . . . . 0.0 113.717 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.5 t -86.1 -4.57 59.2 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 122.094 -0.379 . . . . 0.0 110.487 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.21 -4.85 23.62 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.651 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -80.73 158.51 25.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.775 0.322 . . . . 0.0 110.568 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 p -156.34 135.38 11.98 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.219 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -125.51 135.77 52.64 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.687 0.279 . . . . 0.0 110.91 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.2 m -92.32 114.8 27.45 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.427 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 33.6 m -115.63 157.66 16.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.343 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 53' ' ' ARG . 23.8 ttt180 -101.34 127.39 47.98 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.398 0.618 . . . . 0.0 109.768 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.5 ttt -110.13 144.33 38.9 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.547 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HG3' ' HB2' ' A' ' 57' ' ' ARG . 59.7 tptt -139.32 125.69 20.3 Favored 'General case' 0 N--CA 1.412 -2.366 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.156 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.56 ' HD2' HG22 ' A' ' 61' ' ' VAL . 28.5 mmmt -92.01 113.25 25.47 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 79.6 ttt180 -135.84 97.99 3.78 Favored 'General case' 0 C--N 1.272 -2.79 0 CA-C-O 120.985 0.421 . . . . 0.0 112.096 -173.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.92 -87.92 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 116.638 1.415 . . . . 0.0 116.638 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -89.57 -24.84 21.62 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.614 -0.293 . . . . 0.0 111.612 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -154.08 171.09 19.65 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.927 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.56 HG22 ' HD2' ' A' ' 56' ' ' LYS . 48.5 t -108.31 131.3 59.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -120.97 132.48 54.95 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 tt -102.34 103.8 14.27 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 53.4 p -95.03 -103.65 0.15 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.5 m -69.84 144.21 14.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.455 0.645 . . . . 0.0 112.083 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 109.61 -37.77 3.63 Favored Glycine 0 CA--C 1.483 -1.954 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.411 ' O ' ' HB3' ' A' ' 70' ' ' PHE . 63.6 t-105 -61.23 -24.9 66.69 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 122.084 0.945 . . . . 0.0 109.191 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.546 ' HA ' HG12 ' A' ' 71' ' ' VAL . 13.0 pt-20 -65.68 -30.12 70.77 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.357 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -74.68 -29.46 61.24 Favored 'General case' 0 C--O 1.202 -1.413 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 67' ' ' TRP . 16.1 t80 -73.28 -52.36 14.24 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 124.763 1.225 . . . . 0.0 108.454 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.1 p -61.1 -45.32 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.443 -177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -71.91 -34.06 68.8 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.21 -39.55 63.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.387 -174.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -90.25 -18.75 25.09 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.898 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.1 t30 54.82 83.92 0.08 Allowed 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.164 0.986 . . . . 0.0 109.698 -172.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.489 HD13 ' CE2' ' A' ' 13' ' ' PHE . 1.3 pp -133.98 148.54 51.15 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -175.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -143.85 172.31 13.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.126 -174.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.439 ' H ' ' HB2' ' A' ' 15' ' ' SER . 5.4 p-10 -56.78 141.11 45.52 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 123.704 0.627 . . . . 0.0 111.38 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 117.51 -16.01 12.75 Favored Glycine 0 C--N 1.302 -1.318 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -174.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -104.39 159.22 15.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 97' ' ' TYR . 33.2 m-85 -120.99 136.82 54.89 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -173.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.8 pp -114.92 138.97 50.19 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.966 176.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.551 ' NE2' HD12 ' A' ' 95' ' ' ILE . 27.2 tt0 -124.24 124.01 41.5 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.455 ' CE2' HD13 ' A' ' 82' ' ' LEU . 86.9 m-85 -108.7 131.86 54.5 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 59.2 mt -97.65 116.05 39.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HD2' ' CE1' ' A' ' 92' ' ' PHE . 53.8 m-85 -107.05 126.79 52.8 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -110.63 16.95 21.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 118.596 -1.241 . . . . 0.0 109.282 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 63.75 80.4 0.23 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.583 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -172.82 -168.67 0.51 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.46 ' O ' HG13 ' A' ' 40' ' ' VAL . 51.5 ptt85 -107.55 24.87 12.21 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 118.412 0.551 . . . . 0.0 109.749 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -129.27 117.35 20.54 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.414 ' CE1' ' HD2' ' A' ' 86' ' ' TYR . 26.9 m-85 -121.45 137.88 54.53 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.576 -176.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -100.4 125.99 46.72 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.6 p -109.66 137.98 39.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-O 121.599 0.714 . . . . 0.0 112.5 -175.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.551 HD12 ' NE2' ' A' ' 83' ' ' GLN . 66.7 mt -118.61 125.89 74.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.6 mt -113.01 125.43 70.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.549 0.69 . . . . 0.0 111.158 -174.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 62.6 m-85 . . . . . 0 C--N 1.294 -1.845 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.444 -0.751 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -121.84 148.01 45.24 Favored 'General case' 0 N--CA 1.406 -2.652 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -147.09 148.95 32.14 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -134.68 138.54 44.52 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.571 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -148.48 144.88 19.07 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.9 133.56 5.02 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 121.988 1.792 . . . . 0.0 108.105 168.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -100.3 142.34 31.91 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 122.336 -0.227 . . . . 0.0 110.621 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.442 ' HB ' ' HG2' ' A' ' 17' ' ' LYS . 81.5 mt -88.36 114.67 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.527 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 28.9 t -53.68 -34.18 57.85 Favored 'General case' 0 C--O 1.212 -0.872 0 O-C-N 123.648 0.592 . . . . 0.0 111.121 -174.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.5 -39.83 89.15 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.667 -177.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HG2' ' HB ' ' A' ' 14' ' ' ILE . 20.7 ptmt -104.77 -26.88 12.08 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.811 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 21' ' ' SER . 68.4 m -92.56 14.44 16.86 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.8 m -74.2 -16.39 60.98 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 118.885 -1.126 . . . . 0.0 109.919 166.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -114.51 -47.67 2.9 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 18' ' ' SER . 49.2 m -143.35 168.68 19.23 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 122.972 0.509 . . . . 0.0 110.39 -172.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.494 HD22 ' CZ3' ' A' ' 67' ' ' TRP . 43.9 tp -126.24 142.17 51.63 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.305 0.242 . . . . 0.0 110.751 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -98.37 124.69 43.17 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 120.681 0.276 . . . . 0.0 110.661 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 2.1 mp -97.25 133.38 24.02 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.53 139.29 17.89 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 123.925 3.083 . . . . 0.0 114.787 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.5 tt -62.7 -41.08 98.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.163 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.1 -36.11 92.45 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.406 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 75.7 t80 -73.72 -34.2 64.69 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -63.51 -46.46 85.94 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.853 0.835 . . . . 0.0 110.021 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -72.88 -11.07 60.45 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.842 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 89.1 t80 -74.76 -27.68 60.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.377 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 27.6 p90 -147.07 121.07 5.05 Favored Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.817 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 4.5 Cg_exo -76.74 134.64 15.2 Favored 'Trans proline' 0 N--CA 1.44 -1.676 0 C-N-CA 121.832 1.688 . . . . 0.0 108.87 172.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.08 138.46 11.59 Favored Pre-proline 0 C--N 1.271 -2.805 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.92 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 143.85 96.72 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 106.557 -2.132 . . . . 0.0 106.557 167.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 51.8 p90 -68.79 121.93 83.08 Favored Pre-proline 0 N--CA 1.41 -2.471 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.162 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 36' ' ' PHE . 11.9 Cg_exo -71.09 152.56 62.47 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 121.913 1.742 . . . . 0.0 110.086 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.0 mm -86.78 -59.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -124.72 151.01 45.58 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.706 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.48 162.29 29.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 91' ' ' THR . 24.8 t70 -124.89 140.09 53.24 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.042 -175.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.3 mt -107.79 127.58 53.83 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.15 147.72 25.91 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.798 0.809 . . . . 0.0 111.793 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 2.3 t70 -112.14 137.14 50.63 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.528 173.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -70.31 -8.88 53.87 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.5 t -92.18 -41.73 10.28 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.87 0.03 0.11 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.11 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 17.9 mmt180 -88.88 158.95 17.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 117.643 0.722 . . . . 0.0 110.731 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.7 p -149.51 146.56 27.45 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.46 ' CE3' ' HD1' ' A' ' 70' ' ' PHE . 24.3 m-90 -130.04 123.71 31.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.415 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.9 m -89.68 117.0 28.22 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.585 ' HB ' HD21 ' A' ' 63' ' ' LEU . 22.2 m -124.95 157.23 33.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.686 -172.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -102.62 122.93 45.39 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.255 0.55 . . . . 0.0 111.517 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.428 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 50.8 ttp -124.82 131.18 53.47 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.63 161.84 38.15 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 61' ' ' VAL . 78.8 mttt -91.29 129.86 37.23 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -132.11 103.15 6.11 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.392 0.615 . . . . 0.0 110.951 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.27 -101.27 0.73 Allowed Glycine 0 N--CA 1.431 -1.65 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.565 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.432 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 39.7 mt-10 -95.23 -20.68 19.0 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.383 -0.408 . . . . 0.0 111.061 -175.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -131.56 166.64 20.94 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.487 0.66 . . . . 0.0 112.623 -170.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.538 HG22 ' HG2' ' A' ' 56' ' ' LYS . 90.1 t -97.42 136.92 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 170.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -135.19 132.88 38.48 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.132 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.696 HD22 ' HB2' ' A' ' 67' ' ' TRP . 3.7 tt -99.14 116.86 32.31 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.3 p -90.0 -92.16 0.13 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.67 145.15 8.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 C-N-CA 124.967 1.307 . . . . 0.0 113.205 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.414 ' C ' HG12 ' A' ' 52' ' ' VAL . . . 109.28 -36.4 4.36 Favored Glycine 0 CA--C 1.477 -2.311 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.566 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.696 ' HB2' HD22 ' A' ' 63' ' ' LEU . 64.5 t-105 -58.68 -26.15 63.54 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.706 0.765 . . . . 0.0 109.906 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.642 ' HA ' HG12 ' A' ' 71' ' ' VAL . 15.8 pt-20 -72.39 -26.22 61.8 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.535 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -71.99 -37.92 69.76 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.46 ' HD1' ' CE3' ' A' ' 50' ' ' TRP . 69.0 t80 -72.89 -51.29 19.21 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.072 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -62.66 -44.59 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.65 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -73.47 -43.72 59.6 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.12 -40.05 78.55 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.532 -0.867 . . . . 0.0 112.891 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -85.14 -14.56 46.63 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t30 60.77 82.75 0.16 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 125.204 1.402 . . . . 0.0 112.173 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -115.64 159.08 21.79 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.388 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -143.96 165.06 28.8 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.527 ' H ' ' HB2' ' A' ' 15' ' ' SER . 14.1 t70 -53.16 120.95 6.56 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 124.072 0.858 . . . . 0.0 109.414 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.98 -29.38 3.73 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -80.85 154.48 27.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.477 ' C ' HD12 ' A' ' 82' ' ' LEU . 94.8 m-85 -122.05 135.15 54.8 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 81' ' ' TYR . 6.4 mp -123.26 130.75 53.18 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.111 0.481 . . . . 0.0 111.224 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -112.83 124.11 51.84 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -108.99 118.04 35.77 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.355 -173.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 63.2 mt -98.23 118.29 44.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.29 -0.413 . . . . 0.0 109.937 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -106.47 123.48 48.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -81.79 -78.78 0.18 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -176.82 24.23 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.59 -172.99 2.43 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.97 29.44 2.4 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-O 121.638 0.732 . . . . 0.0 109.078 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 17.5 p -125.38 136.66 53.67 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.078 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -118.13 135.25 54.33 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.375 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 57.2 m-85 -100.48 113.64 26.59 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.0 t -98.7 124.79 52.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.693 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.1 mm -105.75 116.46 49.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 96' ' ' ILE . 3.0 mp -102.15 130.28 52.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--N 1.304 -1.378 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.223 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 9.8 pt20 -121.9 146.1 47.44 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.37 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 83' ' ' GLN . 88.6 t80 -129.63 148.59 51.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -124.9 146.24 49.43 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 120.641 0.257 . . . . 0.0 110.676 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HE2' ' HG3' ' A' ' 23' ' ' GLU . 24.1 ttpp -154.14 139.88 12.32 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 174.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.03 146.19 81.6 Favored 'Trans proline' 0 C--O 1.257 1.467 0 C-N-CA 122.032 1.821 . . . . 0.0 110.709 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -78.62 119.45 21.9 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 16' ' ' GLU . 68.1 mt -107.52 120.2 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.239 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 78' ' ' ASP . 32.1 t -66.74 -10.9 51.87 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 123.273 0.629 . . . . 0.0 111.413 -172.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.467 ' H ' HG22 ' A' ' 14' ' ' ILE . 46.6 mt-10 -75.5 -46.18 33.85 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.531 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.498 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 3.5 mppt? -113.17 -41.89 3.62 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 118.394 -1.322 . . . . 0.0 113.543 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 21' ' ' SER . 15.6 m -69.43 -3.74 15.68 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 123.57 0.544 . . . . 0.0 111.091 -174.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.0 p -74.31 -25.51 59.62 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -133.13 -23.33 1.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.975 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.562 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 51.0 m -150.48 169.16 22.15 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -175.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 63' ' ' LEU 0.308 42.7 mt -103.86 131.35 51.15 Favored 'General case' 0 CA--C 1.488 -1.408 0 CA-C-O 122.391 1.091 . . . . 0.0 113.875 177.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.498 ' OE2' ' HB2' ' A' ' 17' ' ' LYS . 6.7 pt-20 -91.33 111.27 22.68 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 112.324 -2.216 . . . . 0.0 108.973 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.86 121.68 36.46 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.614 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.51 153.75 76.87 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 123.045 2.497 . . . . 0.0 113.154 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.88 -34.8 74.05 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.882 -175.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.21 -28.8 73.96 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.688 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -75.88 -31.21 59.14 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.276 0.631 . . . . 0.0 110.166 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -76.16 -26.23 56.04 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.565 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -75.32 -17.42 60.26 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.662 0.744 . . . . 0.0 109.324 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -74.1 -28.24 61.27 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.92 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -161.35 80.45 2.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 121.617 0.722 . . . . 0.0 112.1 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.37 140.62 15.43 Favored 'Trans proline' 0 N--CA 1.43 -2.244 0 C-N-CA 122.343 2.029 . . . . 0.0 111.499 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.8 159.21 36.36 Favored Pre-proline 0 C--N 1.278 -2.519 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.93 146.34 87.24 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 121.888 1.725 . . . . 0.0 108.935 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -69.05 117.42 51.63 Favored Pre-proline 0 N--CA 1.415 -2.178 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -175.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.66 159.84 31.61 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.878 2.385 . . . . 0.0 111.534 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.17 -41.34 22.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -137.03 150.53 48.15 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.671 0.748 . . . . 0.0 112.219 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 90' ' ' ARG . 74.2 t -132.45 160.04 42.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.88 130.96 34.63 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.48 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.402 ' CD2' ' HB2' ' A' ' 92' ' ' PHE . 79.7 mt -109.62 133.81 52.67 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.208 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.44 143.32 32.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.877 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.512 ' HB2' ' HZ3' ' A' ' 50' ' ' TRP . 9.7 t70 -112.9 147.69 36.51 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.681 174.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -60.34 -23.81 64.55 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 124.228 1.011 . . . . 0.0 112.866 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -80.28 -12.75 59.58 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.847 -0.533 . . . . 0.0 110.404 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.25 1.35 25.02 Favored Glycine 0 C--O 1.239 0.445 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.299 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 98.1 mtt180 -80.6 157.42 26.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.2 p -150.53 136.75 18.62 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 120.59 0.233 . . . . 0.0 110.512 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.512 ' HZ3' ' HB2' ' A' ' 44' ' ' ASP . 15.8 m-90 -124.53 130.47 52.52 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.145 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.1 m -89.98 114.48 26.33 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HB ' HD21 ' A' ' 63' ' ' LEU . 28.6 m -112.03 156.81 13.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.814 -173.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.546 ' HB2' HG23 ' A' ' 64' ' ' THR . 85.6 mtt180 -102.79 119.96 39.76 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.473 ' HB3' HG21 ' A' ' 40' ' ' VAL . 60.4 ttp -124.62 123.72 40.67 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -136.75 162.68 32.53 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HD3' HG22 ' A' ' 61' ' ' VAL . 29.7 mmtp -88.72 128.62 35.62 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 175.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.49 100.62 5.21 Favored 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -175.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.84 -112.2 3.61 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -175.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -112.3 -5.77 14.12 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.886 0.85 . . . . 0.0 110.321 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -113.69 170.67 8.09 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.213 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.529 HG22 ' HD3' ' A' ' 56' ' ' LYS . 57.9 t -108.58 127.28 65.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -126.68 130.59 50.7 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 6.7 tt -103.15 120.96 41.66 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.546 HG23 ' HB2' ' A' ' 53' ' ' ARG . 5.6 t -96.43 -144.55 0.28 Allowed 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 123.161 0.584 . . . . 0.0 111.546 -172.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.47 143.88 6.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 125.43 1.492 . . . . 0.0 111.689 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 125.35 -48.42 0.96 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -65.36 -24.91 67.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.394 -0.903 . . . . 0.0 110.176 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.459 ' HA ' HG12 ' A' ' 71' ' ' VAL . 35.2 tt0 -65.5 -29.87 70.57 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.796 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -69.48 -35.89 76.02 Favored 'General case' 0 C--O 1.198 -1.634 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.347 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -68.57 -49.7 57.41 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 123.409 0.683 . . . . 0.0 109.204 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 6.8 p -63.67 -33.68 63.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.223 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -71.23 -48.64 50.07 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.039 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -72.34 -39.56 68.06 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -96.96 -10.0 27.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.749 -0.595 . . . . 0.0 111.278 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 7.9 t30 53.99 94.86 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.233 1.413 . . . . 0.0 112.932 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 71' ' ' VAL . 3.8 mp -122.21 133.75 54.72 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.749 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.09 169.99 10.65 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 124.21 1.004 . . . . 0.0 108.979 174.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 6.3 p-10 -60.66 141.47 56.73 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.216 0.531 . . . . 0.0 111.302 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.09 -29.45 5.99 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -80.84 154.33 27.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.862 0.363 . . . . 0.0 110.404 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -122.56 140.73 52.46 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mp -124.51 144.12 50.29 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.745 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 8.9 pt20 -116.23 137.27 52.28 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 85.9 m-85 -111.81 117.61 33.29 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 48.9 mt -97.62 114.72 35.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.482 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 24.3 p90 -130.56 157.86 41.55 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.734 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -107.66 25.1 11.92 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.61 13.49 2.94 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 125.145 1.378 . . . . 0.0 111.82 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.556 ' OD2' HG22 ' A' ' 91' ' ' THR . 7.8 p-10 -96.35 -159.63 0.74 Allowed 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.585 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -105.5 15.72 26.64 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -176.012 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.556 HG22 ' OD2' ' A' ' 89' ' ' ASP . 5.5 t -121.41 139.8 52.98 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 117.789 -1.564 . . . . 0.0 109.197 172.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.482 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 71.6 m-85 -128.13 136.46 51.17 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 122.122 -0.361 . . . . 0.0 110.67 -175.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.435 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 61.3 m-85 -94.59 120.46 34.85 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.5 t -103.71 117.71 49.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 120.99 0.424 . . . . 0.0 111.496 -174.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.439 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 65.0 mt -114.61 124.49 71.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 96' ' ' ILE . 2.6 mp -94.15 140.66 16.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 121.583 0.706 . . . . 0.0 111.328 177.928 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -116.42 145.63 43.11 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.019 0.438 . . . . 0.0 111.781 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -140.37 149.81 43.14 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.574 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 23.6 ptp -126.18 144.47 50.75 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -151.57 146.2 18.61 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 178.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 7.0 Cg_exo -76.35 147.21 28.81 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.692 2.262 . . . . 0.0 109.257 170.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -108.4 136.07 48.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.1 mp -110.13 114.1 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.431 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 22.3 t -61.93 -11.93 15.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.547 0.739 . . . . 0.0 112.797 -170.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 17' ' ' LYS . 48.7 mt-10 -77.15 -28.05 54.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.463 ' HD2' ' HB2' ' A' ' 16' ' ' GLU . 12.1 mptt -107.13 -35.76 6.76 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 120.815 0.34 . . . . 0.0 110.932 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.4 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 80.5 p -75.73 3.48 9.71 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.899 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 p -74.19 -30.96 62.47 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -120.0 -42.06 2.62 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.58 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.9 p -134.93 146.22 48.94 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -173.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.3 tt -91.93 115.05 27.73 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.1 125.35 30.75 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.549 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.1 mm -100.13 119.25 59.79 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.54 143.71 97.89 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.919 2.413 . . . . 0.0 111.671 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 30' ' ' GLU . 62.9 tp -51.09 -41.73 60.17 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.626 0.77 . . . . 0.0 112.468 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.86 -34.08 76.43 Favored Glycine 0 C--N 1.319 -0.391 0 N-CA-C 113.926 0.33 . . . . 0.0 113.926 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -88.68 -22.72 23.25 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -72.76 -43.6 62.67 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.255 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 45.1 mt-10 -61.99 -17.24 56.47 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.257 0.623 . . . . 0.0 110.483 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -77.89 -27.28 49.58 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.59 -174.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -147.18 72.95 12.08 Favored Pre-proline 0 CA--C 1.56 1.348 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -54.36 136.49 69.24 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.806 1.671 . . . . 0.0 110.304 165.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.06 160.64 31.69 Favored Pre-proline 0 C--N 1.277 -2.567 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.269 -173.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.86 137.96 83.61 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 108.232 -1.488 . . . . 0.0 108.232 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 47.4 p90 -69.46 117.24 50.84 Favored Pre-proline 0 N--CA 1.416 -2.164 0 CA-C-O 121.1 0.476 . . . . 0.0 111.375 -175.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 36' ' ' PHE . 90.5 Cg_endo -91.86 159.23 3.39 Favored 'Trans proline' 0 N--CA 1.429 -2.269 0 C-N-CA 122.289 1.993 . . . . 0.0 111.672 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 38' ' ' ILE . 2.1 mp -98.6 -31.75 3.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 m -137.6 151.91 48.84 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.278 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.8 t -147.97 157.67 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 126.719 2.008 . . . . 0.0 106.969 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -119.48 140.45 50.45 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 118.765 0.711 . . . . 0.0 111.704 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.0 mt -111.61 126.3 54.86 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.021 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.1 147.67 26.7 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -111.97 136.98 50.6 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -67.52 -15.45 63.67 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.353 -173.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.8 t -96.71 -14.29 22.14 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.426 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.81 -23.9 2.9 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 119.848 -1.168 . . . . 0.0 114.115 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -67.8 159.22 30.74 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -150.86 136.82 18.26 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.481 ' HE1' ' HB3' ' A' ' 73' ' ' ASP . 32.3 m-90 -130.67 137.19 49.46 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.661 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.6 m -93.26 125.31 37.8 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.434 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 14.2 p -125.58 155.91 34.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.111 0.481 . . . . 0.0 111.213 -173.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.429 ' HD2' HG13 ' A' ' 65' ' ' VAL . 90.3 mtt180 -104.52 120.27 40.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -126.86 127.5 45.05 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.93 134.52 54.84 Favored 'General case' 0 C--O 1.25 1.08 0 O-C-N 123.38 0.425 . . . . 0.0 111.035 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.58 ' HA ' HG12 ' A' ' 61' ' ' VAL . 13.3 mmmm -91.91 112.01 23.77 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 175.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -147.47 120.86 9.02 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.99 -136.73 18.13 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.428 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -111.28 -3.49 15.31 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.115 0.484 . . . . 0.0 111.495 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -128.85 129.15 45.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.177 0.513 . . . . 0.0 109.691 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 56' ' ' LYS . 16.4 m -111.49 146.69 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.97 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -137.58 142.38 41.31 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.017 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 4.7 mp -88.05 103.26 15.56 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 170.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.8 p -78.21 -141.53 0.03 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 124.269 1.028 . . . . 0.0 111.652 -173.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.429 HG13 ' HD2' ' A' ' 53' ' ' ARG . 13.3 p -55.57 140.64 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.546 0.689 . . . . 0.0 109.875 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 117.0 -40.02 2.5 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 -171.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.486 ' CZ3' HD12 ' A' ' 22' ' ' LEU . 54.3 t-105 -67.24 -21.02 65.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.685 0.755 . . . . 0.0 109.147 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.538 ' HA ' HG12 ' A' ' 71' ' ' VAL . 41.9 tt0 -68.01 -32.75 73.35 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.777 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -65.15 -33.11 75.24 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-O 121.394 0.616 . . . . 0.0 109.844 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.28 -52.53 18.42 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.359 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 68' ' ' GLU . 6.8 p -64.06 -40.54 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.804 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -71.16 -48.38 52.21 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.84 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.481 ' HB3' ' HE1' ' A' ' 50' ' ' TRP . 28.5 t70 -77.1 -35.57 56.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -173.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -86.6 -20.94 27.16 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 56.74 83.82 0.1 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.578 1.151 . . . . 0.0 111.543 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.512 ' CD2' ' HA ' ' A' ' 71' ' ' VAL . 1.6 pt? -125.44 155.39 40.53 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.832 0.825 . . . . 0.0 112.282 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.49 172.43 12.97 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.18 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.431 ' H ' ' HB2' ' A' ' 15' ' ' SER . 4.6 p30 -58.74 130.21 45.82 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.35 -20.35 7.02 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -99.2 146.27 26.35 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.485 ' C ' HD12 ' A' ' 82' ' ' LEU . 96.4 m-85 -119.96 140.93 50.16 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -175.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.485 HD12 ' C ' ' A' ' 81' ' ' TYR . 4.9 mp -131.85 137.8 48.21 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.005 0.431 . . . . 0.0 111.008 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.574 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 42.9 mt-30 -111.87 135.08 52.96 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.95 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.523 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 95.0 m-85 -115.19 125.04 52.93 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.4 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 2.4 mp -105.0 118.98 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.489 ' CE2' ' HA ' ' A' ' 88' ' ' ARG . 87.3 t80 -106.74 124.64 49.9 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 7.9 p-10 -107.52 12.87 27.36 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -175.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.489 ' HA ' ' CE2' ' A' ' 86' ' ' TYR 0.27 6.1 mpt_? 84.47 -0.05 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -101.13 -165.18 1.18 Allowed 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 174.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.48 39.26 1.54 Allowed 'General case' 0 C--N 1.256 -3.486 0 CA-C-O 121.839 0.828 . . . . 0.0 108.817 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -126.01 117.93 24.27 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.148 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.81 126.8 52.6 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 174.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 68.6 m-85 -91.7 118.9 31.07 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.66 125.72 62.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 120.787 0.327 . . . . 0.0 111.067 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.516 ' CG2' ' HB2' ' A' ' 83' ' ' GLN . 13.9 tt -112.54 118.41 57.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.415 HG12 ' HG ' ' A' ' 82' ' ' LEU . 55.6 mt -103.48 133.84 46.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.734 -173.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.798 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.445 -0.699 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -130.81 149.46 52.44 Favored 'General case' 0 N--CA 1.415 -2.196 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.57 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -137.98 149.31 46.01 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.618 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 47.6 ttm -136.51 136.48 39.41 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -154.37 133.06 6.97 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-O 119.832 -0.128 . . . . 0.0 111.181 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.43 132.32 17.48 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 N-CA-C 108.259 -1.477 . . . . 0.0 108.259 168.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -100.01 140.52 34.12 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 120.58 0.229 . . . . 0.0 110.558 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 16' ' ' GLU . 63.7 mt -103.44 124.49 57.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.7 t -62.77 -11.54 18.4 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.858 0.863 . . . . 0.0 111.895 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -73.96 -45.28 51.17 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -110.5 -40.65 4.56 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.983 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.692 ' HA ' ' O ' ' A' ' 21' ' ' SER . 15.8 m -72.58 0.08 11.49 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 m -74.62 -16.24 60.79 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HG3' ' OE2' ' A' ' 68' ' ' GLU . 54.8 tttp -125.84 -28.19 3.25 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 118.93 -1.108 . . . . 0.0 111.176 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 18' ' ' SER . 46.4 m -151.98 148.75 28.1 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.526 HD12 ' CH2' ' A' ' 67' ' ' TRP . 5.6 tt -101.73 119.21 38.43 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -82.02 131.57 35.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.714 -178.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 48.0 mm -96.06 126.45 44.42 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.71 144.6 86.0 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.931 2.42 . . . . 0.0 112.267 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -62.17 -32.43 73.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.506 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.22 -31.2 69.05 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.393 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -80.61 -29.28 36.85 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.42 -38.28 84.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.877 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.04 -28.76 70.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -67.98 -27.42 66.56 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.816 -175.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -157.17 116.01 1.98 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 120.406 -0.518 . . . . 0.0 112.101 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.51 145.04 32.96 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.284 1.989 . . . . 0.0 109.756 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.86 143.0 16.26 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.91 156.39 64.57 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.543 2.162 . . . . 0.0 110.045 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -68.72 115.08 27.05 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.676 0.274 . . . . 0.0 111.221 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -95.73 160.02 1.47 Allowed 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 123.308 2.672 . . . . 0.0 111.186 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -90.19 -62.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.7 p -126.76 151.38 48.29 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.965 0.412 . . . . 0.0 111.997 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.619 HG12 ' HB2' ' A' ' 90' ' ' ARG . 22.1 m -136.52 162.34 35.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -113.59 143.99 43.63 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.033 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -108.86 120.1 41.5 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.63 137.61 43.2 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.205 0.526 . . . . 0.0 111.16 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 46' ' ' SER . 0.1 OUTLIER -112.46 145.87 39.44 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.048 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -73.43 -19.14 61.04 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.703 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.437 ' HB3' ' OD2' ' A' ' 44' ' ' ASP . 38.6 t -74.79 -36.77 62.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.37 -0.32 2.23 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.204 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 97.7 mtt180 -89.53 157.94 17.87 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.241 0.543 . . . . 0.0 111.642 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.8 p -142.56 136.64 29.45 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.501 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -121.08 131.77 54.47 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.5 m -96.92 120.24 36.89 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.519 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 7.7 p -110.29 153.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -100.78 122.12 42.85 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.5 ttt -110.02 130.44 55.53 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.422 -170.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -121.16 125.47 47.26 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.339 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -106.9 126.63 52.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -133.36 97.45 3.97 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.025 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.73 -97.75 0.04 OUTLIER Glycine 0 C--N 1.304 -1.218 0 O-C-N 124.174 0.921 . . . . 0.0 115.012 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -95.81 -6.5 39.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.5 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -138.13 163.69 31.02 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.523 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 67.2 t -134.46 145.39 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -128.34 132.4 48.6 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.679 0.276 . . . . 0.0 110.569 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.98 103.39 15.31 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.7 p -94.01 -106.49 0.13 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -169.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.15 136.11 27.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.305 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 108.75 -47.2 1.07 Allowed Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.526 ' CH2' HD12 ' A' ' 22' ' ' LEU . 36.5 t-105 -62.46 -31.95 72.75 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.566 ' HA ' HG12 ' A' ' 71' ' ' VAL . 41.1 tt0 -61.78 -33.65 74.48 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 113.548 -1.66 . . . . 0.0 109.917 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -69.07 -37.76 78.67 Favored 'General case' 0 C--O 1.197 -1.68 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.425 ' CE2' HD21 ' A' ' 76' ' ' LEU . 85.5 t80 -73.0 -47.47 44.87 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 123.706 0.802 . . . . 0.0 110.683 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -61.06 -44.76 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.62 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 31.6 mmmt -72.41 -48.25 42.79 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.403 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.85 -38.15 67.15 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -84.39 -18.72 35.19 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.34 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 64.18 95.18 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.86 0.838 . . . . 0.0 112.067 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.425 HD21 ' CE2' ' A' ' 70' ' ' PHE 0.261 1.5 pp -152.18 134.75 15.35 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.192 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -132.96 170.89 14.69 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -54.47 126.15 22.35 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.244 0.545 . . . . 0.0 111.112 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.25 -21.29 4.89 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -94.72 163.34 13.4 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -134.01 138.86 45.66 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.941 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 82' ' ' LEU . 1.4 pt? -136.4 149.52 48.34 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.92 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -127.29 135.77 51.02 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -107.23 129.94 54.8 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.432 0.158 . . . . 0.0 111.057 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.21 125.89 60.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.411 ' HE2' ' CE2' ' A' ' 92' ' ' PHE . 58.5 m-85 -109.58 126.91 54.09 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -87.5 9.36 21.2 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 72.24 81.31 0.14 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.892 1.277 . . . . 0.0 109.304 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 21.8 t70 -179.2 -160.75 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 -174.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.619 ' HB2' HG12 ' A' ' 40' ' ' VAL . 34.1 ptt180 -104.78 23.08 14.01 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -103.65 117.79 35.22 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.107 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.411 ' CE2' ' HE2' ' A' ' 86' ' ' TYR . 2.0 m-85 -105.83 122.61 46.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.764 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -100.29 116.7 32.88 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.88 121.3 49.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.759 0.79 . . . . 0.0 112.913 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 65.1 mt -105.9 116.25 49.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.1 mt -99.63 140.29 19.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 C--N 1.295 -1.777 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.658 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.441 -0.894 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -137.65 163.7 30.63 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -151.4 149.53 29.41 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.757 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 25.5 ptm -132.03 142.33 49.53 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -153.04 159.68 31.91 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.72 146.6 97.01 Favored 'Trans proline' 0 C--O 1.258 1.525 0 C-N-CA 122.894 2.396 . . . . 0.0 114.455 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -105.13 136.58 44.36 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.556 HG13 ' H ' ' A' ' 16' ' ' GLU . 6.4 tp -122.42 125.01 72.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 175.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 19' ' ' SER . 19.5 m -61.67 -20.43 63.42 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 121.179 0.514 . . . . 0.0 111.316 -176.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.556 ' H ' HG13 ' A' ' 14' ' ' ILE . 34.6 tt0 -79.66 -44.33 21.09 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.451 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.478 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 13.4 mptt -95.94 -40.19 9.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.11 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 21' ' ' SER . 25.8 m -77.07 10.11 2.57 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.319 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 15' ' ' SER . 37.9 t -70.19 -27.23 64.34 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 171.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -135.99 -29.4 1.02 Allowed 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.826 179.048 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 18' ' ' SER . 29.0 p -142.38 153.72 44.02 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -175.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 34.7 mt -89.6 126.18 35.52 Favored 'General case' 0 CA--C 1.481 -1.711 0 CA-C-O 121.318 0.58 . . . . 0.0 110.095 171.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.01 108.92 20.69 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -177.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 61' ' ' VAL . 66.8 mt -106.41 120.26 49.16 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 24' ' ' ILE . 31.5 Cg_exo -61.42 158.23 37.12 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.5 2.8 . . . . 0.0 114.156 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.65 -39.19 64.83 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.376 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.54 -36.85 79.68 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.721 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -88.47 -29.17 20.36 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.567 -0.453 . . . . 0.0 109.81 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.12 -45.61 93.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.685 0.755 . . . . 0.0 109.107 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.88 -21.58 63.32 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.815 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -67.92 -28.05 67.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.238 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -149.15 84.33 6.3 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-O 121.77 0.795 . . . . 0.0 111.711 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -86.6 134.34 3.94 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 C-N-CA 121.896 1.73 . . . . 0.0 111.559 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.47 161.13 29.94 Favored Pre-proline 0 C--N 1.275 -2.672 0 CA-C-N 114.051 -1.431 . . . . 0.0 107.199 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -55.23 140.18 81.22 Favored 'Trans proline' 0 C--N 1.354 0.849 0 N-CA-C 107.603 -1.73 . . . . 0.0 107.603 170.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.498 ' HB3' ' HB2' ' A' ' 56' ' ' LYS . 54.1 p90 -69.09 124.2 89.86 Favored Pre-proline 0 N--CA 1.413 -2.302 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -171.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -84.86 160.51 11.97 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 123.08 2.52 . . . . 0.0 108.796 172.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.04 -46.83 13.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.888 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 m -128.73 151.89 49.03 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.702 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 m -146.95 163.24 8.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 125.543 1.537 . . . . 0.0 107.857 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -118.91 143.26 47.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.3 mt -109.26 120.94 44.04 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.49 139.54 47.98 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.05 0.452 . . . . 0.0 110.79 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 29.0 t70 -120.86 156.02 32.87 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.896 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.33 -12.24 59.93 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 m -91.21 8.84 33.84 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.242 0.544 . . . . 0.0 110.393 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.01 -6.87 69.56 Favored Glycine 0 CA--C 1.497 -1.058 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.559 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 27.9 mmt180 -73.53 146.84 44.53 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.6 p -152.11 137.8 17.88 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -132.06 115.73 16.16 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.8 m -86.02 114.76 23.16 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.529 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 9.5 p -116.68 152.87 18.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.403 -172.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -101.07 129.0 46.87 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.419 0.628 . . . . 0.0 110.796 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.462 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 25.2 ttt -110.0 138.13 46.81 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.172 -172.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.2 OUTLIER -130.91 127.09 37.78 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.938 175.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 27.3 mmmt -92.73 116.8 29.35 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 169.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -144.79 103.86 3.95 Favored 'General case' 0 C--N 1.269 -2.929 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.046 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.85 -106.07 1.28 Allowed Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.885 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.44 -18.02 26.14 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.153 -0.524 . . . . 0.0 111.464 -175.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -137.01 170.39 16.19 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -172.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.47 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 58.8 t -113.56 129.22 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 174.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -118.32 130.48 56.05 Favored 'General case' 0 C--N 1.28 -2.428 0 C-N-CA 119.086 -1.045 . . . . 0.0 108.959 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 92.5 mt -103.06 102.96 13.0 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.1 p -87.54 -127.01 0.05 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.68 139.68 15.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.681 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 115.26 -44.13 1.54 Allowed Glycine 0 N--CA 1.417 -2.629 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -172.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -67.98 -27.98 67.04 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.549 ' HA ' HG12 ' A' ' 71' ' ' VAL 0.264 0.0 OUTLIER -68.17 -26.37 65.72 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.922 -179.733 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -72.25 -32.72 66.94 Favored 'General case' 0 C--O 1.196 -1.756 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -70.8 -51.64 25.57 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 122.959 0.504 . . . . 0.0 110.161 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 68' ' ' GLU . 7.7 p -59.61 -39.52 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.2 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.659 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 9.7 mmpt? -72.5 -48.01 44.03 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.487 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.49 -39.65 74.06 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.05 -18.75 24.05 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.5 t30 50.98 89.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.085 1.354 . . . . 0.0 112.965 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.8 mt -129.18 169.12 15.18 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.045 0.45 . . . . 0.0 111.475 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -143.6 170.39 15.93 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 124.363 1.065 . . . . 0.0 108.652 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -65.58 139.97 58.49 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.619 0.574 . . . . 0.0 109.57 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.05 -36.73 3.33 Favored Glycine 0 C--N 1.299 -1.488 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -93.22 147.31 23.01 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -124.39 158.76 31.96 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.497 -170.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.507 ' CD1' HG22 ' A' ' 96' ' ' ILE . 1.8 mm? -119.1 129.33 55.0 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.536 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.519 ' CG ' ' HB ' ' A' ' 95' ' ' ILE . 19.0 pt20 -111.87 124.77 53.06 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 169.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -107.08 130.48 54.67 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.7 mt -96.92 123.2 49.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -106.68 129.59 54.55 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.48 -167.77 1.84 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -91.64 -10.35 40.7 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.801 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 90' ' ' ARG . 8.5 m-20 -102.15 -162.43 0.92 Allowed 'General case' 0 N--CA 1.41 -2.47 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.217 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.423 ' H ' ' HB3' ' A' ' 89' ' ' ASP . 95.9 mtt180 -94.94 36.31 1.21 Allowed 'General case' 0 C--N 1.283 -2.292 0 CA-C-O 121.047 0.451 . . . . 0.0 111.663 -170.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.6 p -113.09 117.55 32.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.956 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -105.68 132.93 51.22 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -109.24 122.83 48.17 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.25 126.96 56.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.519 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 40.1 mm -116.77 118.09 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.507 HG22 ' CD1' ' A' ' 82' ' ' LEU . 31.4 pt -93.41 139.05 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.29 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--N 1.3 -1.558 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.621 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.502 -0.871 0 CA-C-O 120.624 0.25 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 13.0 pt20 -121.55 144.4 48.75 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -142.15 147.5 36.75 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -139.84 139.1 36.25 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.99 159.49 31.76 Favored Pre-proline 0 C--N 1.312 -1.045 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.12 147.25 93.98 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.136 2.557 . . . . 0.0 113.082 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 82' ' ' LEU . 25.4 m-85 -119.74 139.7 51.88 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.48 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.9 mt -104.08 123.47 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.503 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 23.9 t -61.07 -29.98 70.06 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.12 0.263 . . . . 0.0 111.59 -173.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.84 -43.89 97.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.066 0.46 . . . . 0.0 110.448 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -80.68 -40.34 25.62 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.39 0.614 . . . . 0.0 109.521 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -72.06 -5.53 35.88 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.912 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.2 t -70.9 -23.18 62.23 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 120.884 0.373 . . . . 0.0 110.08 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -127.22 -44.41 1.59 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.595 -174.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.5 p -136.68 151.03 48.82 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 4.1 tt -86.47 114.04 22.9 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.16 126.31 31.91 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.923 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -109.08 127.68 26.83 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.69 137.04 79.5 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.597 2.198 . . . . 0.0 111.148 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.565 ' HA ' HD22 ' A' ' 29' ' ' ASN . 53.3 tp -54.05 -38.74 65.54 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.389 0.676 . . . . 0.0 112.145 -175.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.0 -28.57 72.28 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.578 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.481 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 64.2 t80 -87.37 -22.95 24.74 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.565 HD22 ' HA ' ' A' ' 26' ' ' LEU . 52.9 m-80 -73.71 -23.88 59.85 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.787 0.803 . . . . 0.0 109.423 175.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.97 -16.53 59.32 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.421 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 65.6 t80 -77.11 -27.03 53.93 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.108 -177.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -140.88 104.5 6.25 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.76 136.89 15.55 Favored 'Trans proline' 0 N--CA 1.439 -1.699 0 C-N-CA 122.015 1.81 . . . . 0.0 108.064 168.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.17 145.89 19.36 Favored Pre-proline 0 C--N 1.28 -2.434 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.698 -173.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.1 156.02 36.55 Favored 'Trans proline' 0 C--O 1.241 0.655 0 C-N-CA 122.902 2.402 . . . . 0.0 110.085 173.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.412 ' CD1' ' HB2' ' A' ' 56' ' ' LYS . 98.4 m-85 -69.15 115.28 30.35 Favored Pre-proline 0 N--CA 1.429 -1.516 0 CA-C-O 120.858 0.361 . . . . 0.0 111.874 -176.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -93.88 161.0 2.22 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 123.355 2.704 . . . . 0.0 111.122 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.8 mm -101.25 -53.19 7.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.1 p -129.13 151.43 49.81 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.618 0.723 . . . . 0.0 112.3 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.15 145.84 35.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -109.85 125.86 53.22 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.426 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.17 124.71 52.05 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.726 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.73 142.95 33.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.232 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -110.16 154.63 23.06 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.405 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -59.16 -30.1 67.92 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 124.984 1.313 . . . . 0.0 111.989 -175.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.2 t -82.47 -12.61 57.71 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.732 0.301 . . . . 0.0 110.793 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.32 -2.93 25.17 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.225 -0.988 . . . . 0.0 115.28 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -88.33 149.39 23.79 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 118.138 0.969 . . . . 0.0 110.201 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 p -118.7 146.28 44.85 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.608 0.242 . . . . 0.0 111.538 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.478 ' CE3' ' HD1' ' A' ' 70' ' ' PHE . 23.0 m-90 -131.57 124.95 31.08 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.861 173.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.0 m -92.34 114.03 26.47 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.8 t -105.46 157.6 6.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.234 -174.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -100.0 120.32 39.63 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.7 ttt -115.69 130.26 56.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.954 -173.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -130.7 135.67 48.05 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HD2' HG22 ' A' ' 61' ' ' VAL . 1.4 mmmp? -92.73 129.55 38.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -140.12 98.72 3.51 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.134 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.61 -99.31 0.12 Allowed Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.585 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -89.42 -23.29 22.19 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.512 -0.344 . . . . 0.0 110.563 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -134.69 169.79 16.79 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -168.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.478 HG22 ' HD2' ' A' ' 56' ' ' LYS . 42.1 t -134.89 142.19 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.81 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -138.09 144.64 41.0 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 6.2 mp -91.44 106.37 18.44 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 172.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.6 p -72.56 -155.23 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.939 -1.028 . . . . 0.0 113.149 -173.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 p -57.78 128.26 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-O 121.743 0.782 . . . . 0.0 111.2 -172.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 136.66 -38.6 1.74 Allowed Glycine 0 CA--C 1.485 -1.79 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -60.87 -26.85 67.7 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.143 0.973 . . . . 0.0 108.864 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 33.5 tt0 -56.61 -36.65 69.67 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.887 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.481 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 87.5 m-20 -66.41 -36.25 82.35 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.478 ' HD1' ' CE3' ' A' ' 50' ' ' TRP . 92.2 t80 -72.68 -44.9 61.2 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.909 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 68' ' ' GLU . 7.3 p -62.62 -43.83 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 68' ' ' GLU 0.324 0.0 OUTLIER -72.37 -38.45 68.52 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 177.76 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -77.54 -39.36 46.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -84.18 -19.59 33.81 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.9 t30 65.61 90.3 0.09 Allowed 'General case' 0 C--O 1.247 0.969 0 C-N-CA 124.753 1.221 . . . . 0.0 110.935 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.5 mt -130.72 139.81 50.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.884 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.34 171.1 14.88 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.503 ' H ' ' HB2' ' A' ' 15' ' ' SER . 4.5 p30 -65.99 136.95 56.75 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.217 0.532 . . . . 0.0 110.629 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.31 -30.09 3.93 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -89.39 153.35 20.92 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.403 ' C ' HD12 ' A' ' 82' ' ' LEU . 77.4 m-85 -122.74 147.21 46.75 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -178.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.413 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 6.1 mp -122.34 134.09 54.65 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.136 -177.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -111.07 126.45 54.82 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 85.6 m-85 -114.82 126.93 55.38 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.2 mt -98.06 116.97 42.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.409 ' HA ' ' CD1' ' A' ' 92' ' ' PHE . 64.8 m-85 -106.87 123.92 48.87 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.305 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -105.59 -161.52 0.81 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -93.92 13.55 22.35 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.892 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -102.87 -162.91 0.95 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.44 23.72 13.64 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 m -117.97 118.65 32.54 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 86' ' ' TYR . 19.1 m-85 -122.81 152.4 40.72 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.326 -177.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -111.15 126.49 54.9 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.952 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.15 129.88 55.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.53 0.681 . . . . 0.0 111.44 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.61 119.8 62.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.401 HG22 ' HG ' ' A' ' 82' ' ' LEU . 34.5 pt -93.26 139.79 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 CA-C-O 121.072 0.463 . . . . 0.0 110.557 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 C--N 1.297 -1.677 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.543 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.429 -1.5 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -114.51 144.17 43.79 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.123 0.487 . . . . 0.0 110.392 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -145.5 148.26 33.04 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.577 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 26.7 ptm -139.17 152.22 47.23 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.377 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -154.65 158.66 32.26 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.77 146.21 71.77 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.877 1.718 . . . . 0.0 110.634 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -84.43 122.68 29.31 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 16' ' ' GLU . 49.2 mm -110.47 117.06 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.138 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 p -60.61 -12.32 9.78 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.2 tm-20 -76.28 -44.7 35.95 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -105.3 -42.54 5.23 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.402 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.66 ' HA ' ' O ' ' A' ' 21' ' ' SER . 9.7 m -72.01 0.61 8.96 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.331 -173.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.511 ' O ' HG11 ' A' ' 71' ' ' VAL . 27.7 t -75.04 -28.12 60.31 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 175.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -136.9 -14.4 1.6 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 18' ' ' SER . 50.3 m -149.15 169.56 20.43 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 23' ' ' GLU . 2.6 tm? -128.17 133.57 48.93 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.354 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.431 ' N ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -98.7 129.39 45.16 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.322 -174.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.546 ' HB ' HG23 ' A' ' 61' ' ' VAL . 46.4 mm -113.05 129.71 24.26 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -65.48 141.96 69.73 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 122.41 2.073 . . . . 0.0 110.061 172.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 6.7 mp -63.23 -22.92 67.18 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.69 -36.41 91.62 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.369 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 68.0 t80 -83.89 -32.92 24.91 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . 17.6 t30 -60.55 -47.89 84.2 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.374 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.77 -11.95 60.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.447 -175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 82.3 t80 -75.17 -25.9 58.67 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.135 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.11 91.93 18.84 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.57 135.88 7.17 Favored 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 122.093 1.862 . . . . 0.0 109.704 171.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.27 160.74 30.58 Favored Pre-proline 0 C--N 1.28 -2.42 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.38 141.95 80.82 Favored 'Trans proline' 0 C--O 1.246 0.881 0 N-CA-C 106.914 -1.995 . . . . 0.0 106.914 166.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -69.02 120.78 78.73 Favored Pre-proline 0 N--CA 1.414 -2.253 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.355 -173.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.59 144.62 50.14 Favored 'Trans proline' 0 C--O 1.256 1.424 0 C-N-CA 122.33 2.02 . . . . 0.0 110.629 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.4 mm -80.9 -57.34 4.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 m -126.94 156.5 41.41 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.168 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 90' ' ' ARG . 74.5 t -137.18 149.18 25.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 125.013 1.325 . . . . 0.0 107.827 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -121.95 145.83 47.73 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.06 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.432 ' CD2' ' HB2' ' A' ' 92' ' ' PHE . 66.3 mt -108.93 138.45 45.25 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.45 153.25 19.86 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.597 0.713 . . . . 0.0 112.905 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.501 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 9.0 t70 -111.25 161.8 15.64 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.992 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -70.22 -32.9 70.99 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.437 -173.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 m -102.6 -56.45 2.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.57 -6.43 0.03 OUTLIER Glycine 0 C--N 1.321 -0.274 0 C-N-CA 118.332 -1.89 . . . . 0.0 115.53 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.531 ' HA ' ' HE ' ' A' ' 48' ' ' ARG . 1.8 mmp_? -73.17 157.69 36.71 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 118.104 0.952 . . . . 0.0 110.918 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.4 m -144.07 134.74 24.95 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.501 ' CH2' ' HB2' ' A' ' 44' ' ' ASP . 19.4 m-90 -112.74 117.52 32.43 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.836 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.6 m -85.89 114.54 22.89 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.681 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.55 154.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.39 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -104.31 118.78 37.46 Favored 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 119.756 -0.778 . . . . 0.0 108.99 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.47 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 55.8 ttp -111.14 146.48 36.77 Favored 'General case' 0 CA--C 1.475 -1.919 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.48 132.37 27.62 Favored 'General case' 0 N--CA 1.406 -2.659 0 C-N-CA 117.814 -1.554 . . . . 0.0 112.065 -176.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.725 ' HD2' ' CG1' ' A' ' 61' ' ' VAL . 29.1 mmmt -91.19 107.72 19.39 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 170.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -120.59 98.8 6.2 Favored 'General case' 0 C--N 1.252 -3.674 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.42 -108.79 2.6 Favored Glycine 0 N--CA 1.422 -2.254 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.213 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.71 2.25 20.0 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 122.969 -0.136 . . . . 0.0 110.926 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.43 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.8 ptpt -131.31 156.24 45.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.725 ' CG1' ' HD2' ' A' ' 56' ' ' LYS . 16.3 m -122.51 134.46 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 CA-C-O 121.699 0.762 . . . . 0.0 112.221 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -142.81 139.63 31.02 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 54' ' ' MET . 5.6 mp -90.49 109.1 20.24 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.4 p -79.68 -152.25 0.07 Allowed 'General case' 0 N--CA 1.425 -1.723 0 O-C-N 123.846 0.716 . . . . 0.0 111.74 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.13 143.26 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.173 0.989 . . . . 0.0 111.147 -175.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.61 -38.45 2.44 Favored Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -59.64 -23.93 63.44 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.97 0.89 . . . . 0.0 110.24 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.648 ' HA ' HG12 ' A' ' 71' ' ' VAL . 39.1 tt0 -64.03 -26.04 68.39 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.299 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.52 -37.32 87.13 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.266 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.408 ' HA ' ' CD1' ' A' ' 50' ' ' TRP . 66.7 t80 -73.17 -50.13 24.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.699 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -62.2 -45.1 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.372 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.02 -41.53 67.43 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.89 -39.82 95.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.983 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.54 -13.86 33.75 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.288 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.8 t30 55.29 79.87 0.14 Allowed 'General case' 0 C--O 1.235 0.305 0 O-C-N 124.119 0.887 . . . . 0.0 109.958 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 pp -136.34 158.64 43.94 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.74 174.96 10.35 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.112 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -51.65 142.18 15.05 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 124.051 0.845 . . . . 0.0 111.187 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.04 -27.22 5.93 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -95.21 163.19 13.38 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -128.8 144.1 51.08 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.546 -175.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 0.9 OUTLIER -136.65 145.86 45.29 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.312 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.577 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 69.7 mt-30 -111.53 142.78 43.37 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -108.61 117.42 34.12 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 93' ' ' TYR . 1.9 mp -100.04 115.8 41.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.436 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 92.7 t80 -119.57 124.98 47.69 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.641 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -114.3 162.05 17.09 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -66.46 89.07 0.14 Allowed 'General case' 0 C--O 1.244 0.777 0 CA-C-N 119.196 0.907 . . . . 0.0 111.83 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -165.36 -157.81 0.35 Allowed 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.516 ' O ' HG13 ' A' ' 40' ' ' VAL . 68.6 mtm180 -124.98 30.43 5.88 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 t -136.71 141.43 43.07 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.467 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 64.9 m-85 -115.62 148.61 39.44 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.354 0.597 . . . . 0.0 111.187 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.415 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 91.2 t80 -108.66 131.57 54.77 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 172.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 61.9 t -112.24 130.71 65.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.034 0.445 . . . . 0.0 112.147 -173.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 74.6 mt -105.78 116.14 48.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -100.76 140.24 20.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.14 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 N--CA 1.429 -1.495 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.777 172.917 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.438 -1.068 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -130.47 143.12 50.56 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.546 ' CZ ' ' HG3' ' A' ' 25' ' ' PRO . 79.1 t80 -142.2 148.87 38.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.441 ' HG2' ' HB3' ' A' ' 83' ' ' GLN . 82.6 mtp -123.66 140.57 52.86 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.38 157.96 55.26 Favored Pre-proline 0 C--N 1.31 -1.144 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.759 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.09 147.11 11.61 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.703 2.269 . . . . 0.0 110.363 174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -87.34 126.46 34.87 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.29 117.71 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.6 p -65.9 -14.62 61.85 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -83.82 -37.1 22.96 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.94 0.4 . . . . 0.0 111.104 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -106.2 -41.79 5.25 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.015 -174.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 21' ' ' SER . 19.5 m -77.96 0.41 24.4 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.874 -173.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.9 m -75.38 -18.31 59.98 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.848 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.8 -23.22 0.86 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.975 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 18' ' ' SER . 21.1 m -132.52 142.07 49.03 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.22 0.533 . . . . 0.0 111.523 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 4.1 tt -93.89 126.83 39.32 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -95.83 114.38 26.1 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 123.452 0.701 . . . . 0.0 110.764 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.9 mt -106.36 126.31 30.78 Favored Pre-proline 0 C--O 1.248 1.022 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.083 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.546 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 9.4 Cg_endo -53.55 139.96 65.55 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 123.706 2.937 . . . . 0.0 113.335 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 6.3 tt -58.85 -43.7 90.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.817 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.07 -24.16 71.62 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.299 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.553 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 73.6 t80 -81.73 -34.48 30.5 Favored 'General case' 0 C--O 1.212 -0.871 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.547 HD22 ' C ' ' A' ' 59' ' ' GLU . 41.2 t30 -76.28 -33.51 59.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.295 0.569 . . . . 0.0 109.949 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.44 -24.26 66.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.895 0.855 . . . . 0.0 109.572 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.553 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 24.7 t80 -68.32 -26.4 65.6 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.181 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -143.23 98.32 5.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-O 121.223 0.535 . . . . 0.0 112.313 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.472 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.3 Cg_exo -79.92 133.72 10.27 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 N-CA-C 110.095 -0.771 . . . . 0.0 110.095 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.13 160.33 31.09 Favored Pre-proline 0 C--N 1.274 -2.716 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.689 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.99 144.26 63.44 Favored 'Trans proline' 0 C--O 1.246 0.916 0 N-CA-C 107.467 -1.782 . . . . 0.0 107.467 168.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.523 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 45.1 p90 -68.93 138.48 90.22 Favored Pre-proline 0 N--CA 1.418 -2.029 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -173.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 36' ' ' PHE . 6.0 Cg_exo -78.7 160.76 27.93 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.766 2.311 . . . . 0.0 109.778 173.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 38' ' ' ILE . 2.2 mp -93.22 -37.5 8.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -150.64 152.86 34.64 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -178.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.62 163.95 22.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 124.513 1.125 . . . . 0.0 108.846 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -120.11 137.44 54.14 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.261 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.5 mt -108.7 123.42 48.96 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.97 141.84 34.18 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.262 0.553 . . . . 0.0 110.994 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -113.23 145.6 40.73 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -58.43 -27.12 64.03 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.7 t -79.59 -4.58 52.17 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.105 0.478 . . . . 0.0 110.511 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.46 2.16 50.43 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.005 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -82.55 150.66 26.8 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.3 p -144.44 136.64 26.33 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.196 0.522 . . . . 0.0 111.709 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -120.1 123.94 44.61 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.511 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.3 m -89.93 117.73 28.96 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.16 157.94 33.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.613 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -99.68 120.13 39.21 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.046 0.45 . . . . 0.0 110.624 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.422 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 23.7 ttt -122.3 124.16 43.1 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 124.277 1.031 . . . . 0.0 110.044 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -125.51 130.88 52.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.886 0.374 . . . . 0.0 111.916 178.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.523 ' H ' ' HB2' ' A' ' 36' ' ' PHE . 55.9 tttp -98.05 122.68 41.47 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 122.121 0.963 . . . . 0.0 109.451 173.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -147.7 98.66 3.0 Favored 'General case' 0 C--N 1.252 -3.65 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.51 -164.29 30.42 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -174.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.547 ' C ' HD22 ' A' ' 29' ' ' ASN . 14.9 mm-40 -90.97 2.39 56.32 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.44 142.68 49.02 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.406 HG23 ' ND2' ' A' ' 29' ' ' ASN . 95.6 t -114.49 131.84 65.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.136 0.493 . . . . 0.0 111.043 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 97.4 m-85 -119.42 131.55 55.67 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 6.5 mp -86.83 112.3 21.6 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 p -66.11 -164.49 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.138 0 O-C-N 124.777 1.298 . . . . 0.0 112.902 -176.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.24 143.12 10.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.493 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.57 -38.61 2.58 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -173.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 20.1 t-105 -58.48 -24.42 60.37 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.015 0.912 . . . . 0.0 109.636 173.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.602 ' HA ' HG12 ' A' ' 71' ' ' VAL . 11.5 pt-20 -57.74 -30.0 65.23 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.39 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -62.24 -35.86 80.23 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.129 0.49 . . . . 0.0 110.668 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -74.29 -48.01 31.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.603 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -64.7 -40.38 88.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.19 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -71.07 -33.02 69.83 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.621 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.31 -40.14 45.37 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.062 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -97.94 -1.74 42.14 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.2 m120 42.22 80.1 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -176.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.4 mt -103.23 147.35 27.15 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.21 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.418 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 11.4 pt-20 -143.8 171.65 13.92 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.107 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.11 138.3 58.51 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.15 -19.66 24.63 Favored Glycine 0 C--N 1.301 -1.392 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -173.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HD2' ' H ' ' A' ' 77' ' ' GLU . 57.3 mttp -96.58 159.22 15.05 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -134.1 150.95 51.19 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -173.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HG ' HG22 ' A' ' 96' ' ' ILE . 4.6 mp -130.35 137.11 49.74 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.459 ' HG3' ' HB ' ' A' ' 95' ' ' ILE . 11.6 pt20 -118.75 138.57 52.57 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -116.32 131.0 57.07 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.324 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 65.2 mt -101.54 116.03 44.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 172.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.639 ' CE2' ' HA ' ' A' ' 88' ' ' ARG . 48.8 t80 -122.07 123.81 42.46 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.757 -173.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -84.26 -1.38 55.16 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.639 ' HA ' ' CE2' ' A' ' 86' ' ' TYR . 67.8 ttt180 70.08 81.94 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -171.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 20.4 t70 -177.26 -155.24 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 -167.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.433 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -107.38 11.15 29.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.3 m -109.64 126.37 53.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.54 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -127.62 135.13 49.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.641 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.46 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 84.7 m-85 -109.25 123.49 49.35 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.54 124.15 64.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.433 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.459 ' HB ' ' HG3' ' A' ' 83' ' ' GLN . 2.4 mp -114.05 116.85 53.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.438 HG22 ' HG ' ' A' ' 82' ' ' LEU . 35.1 pt -100.8 140.64 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 123.218 0.607 . . . . 0.0 112.231 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.304 -1.411 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 173.673 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.436 -1.145 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -130.64 143.05 50.49 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -149.7 147.0 27.54 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.624 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 23.3 ptp -141.61 134.93 29.46 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.418 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.6 159.57 31.53 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 166.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 33.4 Cg_exo -60.82 132.73 43.98 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 N-CA-C 108.295 -1.463 . . . . 0.0 108.295 173.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -86.01 140.26 30.45 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.354 -175.082 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.503 HG22 ' H ' ' A' ' 16' ' ' GLU . 2.0 mp -90.69 125.08 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.509 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 11.9 p -60.57 -19.03 56.31 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.826 0.85 . . . . 0.0 112.708 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.503 ' H ' HG22 ' A' ' 14' ' ' ILE . 41.4 tt0 -63.48 -44.78 93.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.703 176.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -87.73 -40.47 14.08 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.487 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.576 ' HB2' ' CD1' ' A' ' 13' ' ' PHE . 35.6 t -61.96 -10.0 8.53 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 124.119 0.887 . . . . 0.0 112.285 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.5 p -57.85 -43.49 85.93 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.899 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 68' ' ' GLU . 64.4 mttm -144.38 -2.05 0.89 Allowed 'General case' 0 C--N 1.344 0.359 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -148.11 153.79 39.33 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 118.943 0.792 . . . . 0.0 112.476 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 5.2 tt -101.21 113.42 26.44 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -71.54 113.99 9.15 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.162 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.424 HD12 HG12 ' A' ' 61' ' ' VAL . 65.6 mt -93.7 128.5 41.65 Favored Pre-proline 0 C--N 1.288 -2.096 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.453 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 58.7 Cg_exo -53.71 137.74 67.32 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.959 2.439 . . . . 0.0 112.198 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.435 ' O ' HD23 ' A' ' 26' ' ' LEU . 5.8 tt -64.67 -32.4 74.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.48 -29.39 73.31 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.614 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 25' ' ' PRO . 46.6 t80 -65.41 -49.59 68.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -65.8 -39.75 91.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.567 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.06 -38.17 87.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.395 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -73.15 -28.68 62.37 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.947 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -166.18 127.1 1.29 Allowed Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 120.634 0.254 . . . . 0.0 111.629 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.33 136.79 24.72 Favored 'Trans proline' 0 N--CA 1.42 -2.81 0 N-CA-C 107.872 -1.626 . . . . 0.0 107.872 168.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.43 146.86 55.85 Favored Pre-proline 0 C--N 1.266 -3.047 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.527 ' O ' ' HD3' ' A' ' 37' ' ' PRO . 14.3 Cg_endo -59.64 140.68 94.82 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.019 1.813 . . . . 0.0 109.884 175.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 26.8 p90 -83.45 110.63 25.64 Favored Pre-proline 0 N--CA 1.407 -2.602 0 CA-C-O 121.115 0.483 . . . . 0.0 111.287 -178.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 35' ' ' PRO . 27.1 Cg_endo -87.83 136.02 3.58 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 122.554 2.169 . . . . 0.0 111.57 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.22 -52.74 54.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.245 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.5 p -123.95 150.11 45.15 Favored 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.904 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.3 t -135.9 157.13 38.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -126.46 135.97 52.04 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.678 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.9 mt -108.54 127.52 54.01 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.86 138.16 42.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 120.908 0.385 . . . . 0.0 110.206 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -112.68 142.18 45.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -69.87 -3.71 17.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -175.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -82.86 -14.53 54.12 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.64 -13.88 10.77 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.263 -0.97 . . . . 0.0 115.505 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HD3' ' CZ2' ' A' ' 50' ' ' TRP . 75.7 ttt180 -89.97 153.13 20.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.718 1.259 . . . . 0.0 110.806 -176.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.3 p -127.37 140.92 51.86 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.212 0.605 . . . . 0.0 110.963 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.423 ' CZ2' ' HD3' ' A' ' 48' ' ' ARG . 15.9 m-90 -125.85 128.13 47.14 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.419 0.287 . . . . 0.0 110.227 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.1 m -92.07 121.17 33.38 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.43 0.633 . . . . 0.0 109.779 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HB ' HD21 ' A' ' 63' ' ' LEU . 34.7 m -126.05 158.34 35.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 124.792 1.237 . . . . 0.0 111.589 -172.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -102.36 127.42 49.37 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.085 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.2 ttt -111.23 120.81 43.5 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -124.95 125.31 43.72 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.713 -175.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -107.9 115.5 30.25 Favored 'General case' 0 CA--C 1.479 -1.761 0 CA-C-O 122.156 0.979 . . . . 0.0 110.038 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -148.82 102.48 3.28 Favored 'General case' 0 C--N 1.247 -3.866 0 CA-C-N 113.45 -1.705 . . . . 0.0 108.408 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.88 -143.53 15.82 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.024 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.88 -6.03 54.73 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.71 0.291 . . . . 0.0 111.641 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.1 170.07 13.96 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 121.004 0.431 . . . . 0.0 110.834 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.424 HG12 HD12 ' A' ' 24' ' ' ILE . 40.9 t -132.46 129.6 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -124.61 131.68 53.46 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 5.7 tt -102.93 113.5 27.01 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 175.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -103.49 -98.47 0.3 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -169.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.25 135.42 28.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -172.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' C ' HG12 ' A' ' 52' ' ' VAL . . . 115.02 -42.19 1.98 Allowed Glycine 0 N--CA 1.425 -2.081 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.475 -176.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' A' ' 18' ' ' SER . 55.7 t-105 -59.18 -26.45 64.82 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.513 0.673 . . . . 0.0 110.426 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.54 ' HA ' HG12 ' A' ' 71' ' ' VAL . 17.1 pt-20 -71.24 -26.52 62.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.315 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -68.97 -29.42 67.64 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.379 0.609 . . . . 0.0 109.636 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -73.97 -49.16 25.8 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 124.593 1.157 . . . . 0.0 109.388 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.8 p -63.47 -37.91 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.275 0.56 . . . . 0.0 109.977 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 68.4 mttm -65.3 -46.71 79.3 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.579 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -77.52 -40.84 41.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.032 -1.067 . . . . 0.0 113.737 -172.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -86.77 -15.12 40.31 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.141 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 46.35 72.7 0.21 Allowed 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.371 1.068 . . . . 0.0 112.629 -174.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.506 HD13 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -112.64 137.52 50.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.757 179.083 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -122.01 164.7 17.2 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.9 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 7.8 p-10 -55.77 132.56 49.61 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 123.998 0.811 . . . . 0.0 111.896 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.93 -44.63 1.19 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 33.9 mtmm -80.67 155.03 27.0 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.0 131.26 43.99 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.262 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.449 ' HG ' HG13 ' A' ' 96' ' ' ILE . 6.9 mp -114.45 132.87 56.11 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -109.86 125.91 53.27 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -114.27 117.54 31.42 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.47 117.9 47.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -120.47 127.22 52.02 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 123.495 0.497 . . . . 0.0 110.114 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -84.07 -100.2 0.05 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -150.43 16.5 0.81 Allowed 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -110.16 -177.55 3.28 Favored 'General case' 0 N--CA 1.405 -2.717 0 CA-C-N 114.294 -1.321 . . . . 0.0 107.796 -172.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -95.91 32.08 1.97 Allowed 'General case' 0 C--N 1.264 -3.112 0 C-N-CA 124.3 1.04 . . . . 0.0 108.512 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.3 m -127.74 122.79 33.76 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.326 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -112.8 143.94 43.19 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -111.59 120.44 42.08 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.0 t -111.2 135.41 50.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.779 0.323 . . . . 0.0 111.426 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.4 mt -130.46 124.39 57.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.449 HG13 ' HG ' ' A' ' 82' ' ' LEU . 1.8 mp -96.5 125.16 49.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 . . . . . 0 C--N 1.305 -1.338 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.099 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.439 -0.975 0 CA-C-O 120.955 0.407 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -112.02 144.79 40.79 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 83' ' ' GLN . 50.3 p90 -146.26 149.26 33.54 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.8 ptm -127.73 145.44 50.9 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.66 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 25.9 ttpp -153.48 143.35 15.26 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.425 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.72 146.47 83.93 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.5 2.133 . . . . 0.0 109.999 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 8.3 m-85 -103.32 139.25 38.99 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.2 mp -118.72 117.43 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.499 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 20.3 m -57.48 -22.16 41.98 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.782 0.833 . . . . 0.0 112.576 -173.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.07 -38.88 92.67 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.199 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.06 -41.98 8.85 Favored 'General case' 0 CA--C 1.487 -1.46 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.731 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 79.3 p -65.4 -11.33 41.42 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -170.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.6 t -69.63 -24.03 63.58 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.39 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -138.56 -24.36 0.94 Allowed 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -176.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.45 ' N ' ' HD2' ' A' ' 20' ' ' LYS . 77.2 p -143.25 153.76 43.12 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.6 tt -96.81 122.54 39.88 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 174.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.66 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -92.97 122.77 35.67 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.874 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.446 ' HB ' HD21 ' A' ' 29' ' ' ASN . 61.5 mt -103.68 132.15 21.33 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -57.54 139.26 89.63 Favored 'Trans proline' 0 C--O 1.254 1.311 0 C-N-CA 122.19 1.926 . . . . 0.0 110.622 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.506 ' O ' HD23 ' A' ' 26' ' ' LEU . 5.7 tt -56.57 -30.08 62.76 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.187 0.595 . . . . 0.0 110.885 -175.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.41 -31.5 63.01 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.727 -0.273 . . . . 0.0 112.838 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -87.89 -29.92 20.5 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 122.278 -0.543 . . . . 0.0 110.099 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.475 ' ND2' ' HB ' ' A' ' 61' ' ' VAL . 13.4 m120 -65.82 -34.35 77.95 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.505 0.669 . . . . 0.0 109.638 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -74.83 -27.07 60.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.612 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -78.97 -28.08 43.56 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.166 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . 0.267 31.5 p90 -134.51 78.81 55.69 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 177.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -83.97 135.13 6.43 Favored 'Trans proline' 0 N--CA 1.425 -2.551 0 C-N-CA 121.016 1.144 . . . . 0.0 110.204 170.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.66 160.11 31.59 Favored Pre-proline 0 C--N 1.273 -2.752 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -63.02 136.74 58.19 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 N-CA-C 107.505 -1.767 . . . . 0.0 107.505 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -68.81 120.4 75.74 Favored Pre-proline 0 N--CA 1.418 -2.048 0 CA-C-O 121.356 0.598 . . . . 0.0 112.593 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.49 136.67 12.57 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.69 2.26 . . . . 0.0 110.852 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -64.77 -38.59 83.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.019 0.438 . . . . 0.0 110.078 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.3 p -130.88 150.64 51.95 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 121.241 0.543 . . . . 0.0 110.852 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 90' ' ' ARG . 79.4 t -141.72 149.39 20.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 125.473 1.509 . . . . 0.0 107.163 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.52 135.37 52.18 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.075 0.464 . . . . 0.0 111.494 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' SER . 79.1 mt -108.84 132.0 54.44 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.64 143.99 32.33 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.267 0.556 . . . . 0.0 112.154 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 16.7 t70 -110.35 165.32 11.87 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.36 176.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -53.32 -50.82 64.17 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 125.232 1.413 . . . . 0.0 110.273 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.6 m -73.68 -10.32 59.57 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.788 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.0 9.88 35.95 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.496 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.426 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 98.4 mtt180 -66.94 150.82 48.68 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 74.8 p -138.2 136.33 36.49 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.412 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.487 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 25.5 m-90 -121.15 131.76 54.44 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.829 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.2 m -89.62 114.15 25.71 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.443 HG21 HD23 ' A' ' 63' ' ' LEU . 33.6 m -116.34 157.85 17.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.668 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.401 ' NH2' HG13 ' A' ' 65' ' ' VAL . 7.0 ttp180 -102.01 130.98 48.69 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 28.0 ttt -112.3 136.31 51.9 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -142.12 125.88 17.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.389 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -105.17 128.35 53.35 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.98 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.55 100.03 4.84 Favored 'General case' 0 C--N 1.266 -3.039 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.78 -120.75 11.31 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.259 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -90.33 -7.8 52.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -174.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.76 152.73 32.7 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.475 ' HB ' ' ND2' ' A' ' 29' ' ' ASN . 47.4 t -133.97 124.31 46.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -130.37 153.73 48.42 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 52' ' ' VAL . 5.9 mp -93.37 103.82 16.02 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.6 t -79.3 -153.82 0.08 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 124.235 0.959 . . . . 0.0 111.008 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.401 HG13 ' NH2' ' A' ' 53' ' ' ARG . 7.1 p -61.07 121.85 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-O 122.442 1.115 . . . . 0.0 110.939 -170.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 143.77 -38.62 1.34 Allowed Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 -169.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -60.56 -24.2 65.23 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.042 -1.079 . . . . 0.0 109.278 173.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.536 ' HA ' HG12 ' A' ' 71' ' ' VAL . 39.0 tt0 -56.2 -39.79 73.0 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.589 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -59.21 -37.06 76.53 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-O 120.918 0.39 . . . . 0.0 110.715 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.535 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 78.6 t80 -74.08 -48.66 28.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.0 p -62.48 -34.83 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 122.131 0.967 . . . . 0.0 109.165 -177.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.64 -47.07 56.91 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.917 -1.492 . . . . 0.0 111.65 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -77.64 -40.77 40.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -172.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -88.08 -16.2 34.18 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.402 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.9 t30 54.11 95.35 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 O-C-N 124.157 0.91 . . . . 0.0 112.204 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 pp -127.12 158.21 37.64 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.285 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -143.8 168.21 20.47 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.415 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 5.8 p-10 -59.08 133.89 56.5 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.227 0.954 . . . . 0.0 110.038 175.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.7 -18.98 12.73 Favored Glycine 0 C--N 1.307 -1.064 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -101.13 162.81 12.63 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -128.04 140.36 52.0 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.63 142.55 51.45 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.064 0.459 . . . . 0.0 110.786 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 64.5 tt0 -114.19 124.68 52.65 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -112.2 130.7 55.83 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.41 116.0 47.38 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -106.22 123.77 48.55 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.12 -171.21 3.48 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.309 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -86.41 -5.87 59.06 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 23.4 t70 -89.27 -150.74 0.21 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 175.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.494 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 16.7 ptt180 -113.03 17.71 18.62 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 92.5 m -101.81 127.22 48.7 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.56 -170.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.65 131.75 54.79 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.643 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -101.84 127.61 48.57 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.535 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 38.3 t -104.21 119.87 53.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.11 124.24 72.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.4 tt -111.97 137.27 45.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 121.316 0.579 . . . . 0.0 110.103 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 N--CA 1.424 -1.735 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.484 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.442 -0.857 0 CA-C-O 121.259 0.552 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -111.74 145.74 38.8 Favored 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.954 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -143.55 153.91 43.06 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 61.3 mtm -128.13 158.02 39.17 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -154.26 159.9 31.48 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -64.65 135.44 45.31 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.096 1.864 . . . . 0.0 109.843 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.415 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 70.6 t80 -100.16 122.97 43.83 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -114.63 102.15 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.514 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 33.5 t -53.83 -31.8 50.61 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 123.241 0.616 . . . . 0.0 111.367 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.83 -37.39 79.09 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.414 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -101.35 -33.1 10.15 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.907 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' SER . 49.8 p -81.2 1.76 30.7 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.5 m -65.42 -24.77 67.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 119.499 -0.881 . . . . 0.0 111.215 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -116.15 -48.82 2.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.636 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 18' ' ' SER . 43.4 p -130.87 144.98 51.85 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -173.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.0 tm? -103.0 115.18 30.12 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.79 125.27 28.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.7 mt -95.31 131.01 30.7 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.3 132.71 40.36 Favored 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 122.852 2.368 . . . . 0.0 112.137 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.418 ' O ' HD23 ' A' ' 26' ' ' LEU . 6.7 tt -63.37 -32.71 74.21 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.856 -175.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.46 -32.41 81.67 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.172 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -75.07 -35.8 61.82 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -70.72 -31.64 68.56 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.115 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -74.82 -30.38 61.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.42 -27.63 66.37 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.577 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -160.57 87.16 1.82 Allowed Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.317 0.579 . . . . 0.0 111.713 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.21 142.76 21.82 Favored 'Trans proline' 0 N--CA 1.439 -1.704 0 C-N-CA 121.75 1.634 . . . . 0.0 110.396 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.42 153.04 36.67 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.41 144.52 98.28 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 122.489 2.126 . . . . 0.0 109.969 175.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 56' ' ' LYS . 26.8 p90 -70.28 121.33 82.91 Favored Pre-proline 0 N--CA 1.41 -2.474 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.91 159.63 18.49 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.394 2.73 . . . . 0.0 110.219 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.2 mm -70.4 -59.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.349 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.5 p -125.53 151.41 46.38 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.467 HG21 ' SD ' ' A' ' 54' ' ' MET . 97.2 t -139.78 151.42 22.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.53 136.2 52.34 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.557 -0.857 . . . . 0.0 113.285 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 92' ' ' PHE . 3.3 mm? -108.54 120.2 41.73 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.03 153.18 20.14 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.121 0.486 . . . . 0.0 110.735 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 11.5 t70 -112.06 149.22 32.39 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.885 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -70.71 -26.71 63.52 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.734 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.8 m -95.13 -45.87 7.03 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.759 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.07 -32.06 0.04 OUTLIER Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 118.244 -1.932 . . . . 0.0 114.785 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -60.83 158.52 12.84 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 p -149.09 135.78 19.59 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 173.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.51 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 23.7 m-90 -125.75 124.09 40.25 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.546 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.1 m -89.18 114.26 25.54 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 174.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.5 t -115.26 157.77 15.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.944 -172.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -99.91 128.32 46.01 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.467 ' SD ' HG21 ' A' ' 40' ' ' VAL . 27.5 ttt -111.56 123.23 49.8 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -176.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -130.5 129.99 43.6 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.747 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.471 ' H ' ' HB3' ' A' ' 36' ' ' PHE . 27.6 tptp -92.62 127.54 38.15 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 125.003 1.321 . . . . 0.0 108.772 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -142.94 103.85 4.24 Favored 'General case' 0 C--N 1.261 -3.275 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.532 -174.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.74 -121.26 5.94 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -108.98 2.9 21.65 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.427 0.632 . . . . 0.0 109.692 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.504 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 37.1 ttpt -122.58 159.12 28.45 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.316 -175.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.414 HG22 ' HD3' ' A' ' 56' ' ' LYS . 61.4 t -127.83 141.04 47.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.504 ' CZ ' ' HE3' ' A' ' 60' ' ' LYS . 96.7 m-85 -123.12 136.45 54.8 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.043 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 98.4 mt -81.93 103.49 11.62 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 167.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 65' ' ' VAL . 2.0 m -86.15 -154.45 0.21 Allowed 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.917 -167.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.617 ' H ' HG22 ' A' ' 64' ' ' THR . 7.7 p -56.44 122.82 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 121.998 0.904 . . . . 0.0 111.639 -172.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.58 -37.2 2.06 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -171.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.455 ' CE2' ' HB2' ' A' ' 22' ' ' LEU . 12.6 t-105 -57.26 -26.2 60.4 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.554 -0.823 . . . . 0.0 110.774 175.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -53.29 -27.43 22.81 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.07 -174.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -63.01 -29.76 71.07 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.411 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 44.7 t80 -73.73 -54.66 7.56 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.581 0.705 . . . . 0.0 109.545 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.64 -34.76 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.529 -176.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -71.91 -37.92 69.99 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 174.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.6 -40.67 41.33 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.869 -0.733 . . . . 0.0 112.779 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -84.77 -20.84 30.39 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.2 t30 49.13 82.45 0.04 OUTLIER 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.167 1.387 . . . . 0.0 111.757 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.9 pt? -127.45 142.81 51.31 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.447 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -113.99 170.39 8.31 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 15' ' ' SER . 6.1 p-10 -60.56 133.51 56.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 172.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.57 -28.15 5.06 Favored Glycine 0 C--N 1.3 -1.442 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 -172.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -100.08 146.74 26.42 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.462 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 95.0 m-85 -133.81 158.63 42.88 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.68 -174.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.514 HD13 ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -125.94 155.72 40.88 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.281 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -129.14 127.24 41.01 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.236 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.514 ' CE2' HD13 ' A' ' 82' ' ' LEU . 99.9 m-85 -106.09 130.73 53.94 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 59.0 mt -107.36 119.8 57.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -106.12 125.27 50.79 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.371 0.605 . . . . 0.0 112.258 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.73 146.21 27.52 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 89' ' ' ASP . 9.2 mmm180 -66.08 83.28 0.08 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.201 0.455 . . . . 0.0 111.722 -177.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 88' ' ' ARG . 8.6 t70 173.54 -148.71 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 6.3 mpt_? -100.3 24.44 8.78 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 118.426 0.557 . . . . 0.0 109.744 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.0 m -103.54 119.91 39.83 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.56 ' HB2' HD13 ' A' ' 42' ' ' LEU . 80.3 m-85 -125.27 130.71 52.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.39 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 95.7 m-85 -104.22 132.08 50.84 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.411 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 18.3 t -109.76 124.21 66.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.575 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.15 139.8 34.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.7 mt -115.28 131.74 66.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 120.973 0.416 . . . . 0.0 110.109 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' A' ' 81' ' ' TYR . 43.7 p90 . . . . . 0 C--N 1.297 -1.71 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.428 -1.541 0 CA-C-O 121.142 0.496 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 13.5 pt20 -106.23 144.42 32.95 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.897 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -150.19 148.57 29.09 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 83' ' ' GLN . 25.9 ptm -103.72 133.92 47.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.66 128.72 25.09 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.44 133.2 44.65 Favored 'Trans proline' 0 C--O 1.248 1.005 0 C-N-CA 122.522 2.148 . . . . 0.0 112.882 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -93.65 124.64 37.78 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.9 mt -125.8 115.93 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.467 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 15.2 t -66.67 -11.57 54.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.313 0.577 . . . . 0.0 111.35 -172.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -61.19 -43.14 99.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.796 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -108.68 -40.39 5.09 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.937 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' SER . 18.2 m -74.17 8.6 2.03 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -172.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.476 ' O ' HG11 ' A' ' 71' ' ' VAL . 29.2 t -75.02 -19.23 60.14 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -141.63 -33.91 0.49 Allowed 'General case' 0 C--N 1.353 0.748 0 C-N-CA 119.874 -0.731 . . . . 0.0 112.641 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 18' ' ' SER . 63.4 p -139.04 162.61 34.51 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 120.958 0.409 . . . . 0.0 111.35 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.615 HD12 HD13 ' A' ' 63' ' ' LEU . 81.5 mt -103.28 118.21 36.25 Favored 'General case' 0 CA--C 1.485 -1.538 0 O-C-N 120.892 -1.13 . . . . 0.0 113.483 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -77.09 113.98 15.4 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 168.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.546 ' HB ' HG23 ' A' ' 61' ' ' VAL . 66.5 mt -113.18 130.97 23.09 Favored Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 121.49 -0.084 . . . . 0.0 110.827 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -44.36 139.14 6.87 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 124.654 3.569 . . . . 0.0 114.538 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.77 -46.22 90.52 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.133 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.42 -32.73 85.17 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.769 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.5 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 76.7 t80 -76.78 -34.9 57.98 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.483 HD22 ' HA ' ' A' ' 60' ' ' LYS . 40.3 t30 -66.12 -44.7 83.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.991 0.424 . . . . 0.0 110.804 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.85 -13.62 61.8 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.914 0.864 . . . . 0.0 110.457 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.5 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 87.2 t80 -74.68 -18.97 60.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.386 176.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -137.92 94.3 11.51 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -83.13 134.01 6.76 Favored 'Trans proline' 0 N--CA 1.432 -2.144 0 C-N-CA 121.549 1.499 . . . . 0.0 110.417 172.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.75 152.98 28.18 Favored Pre-proline 0 C--N 1.272 -2.776 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.486 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -61.87 150.41 86.21 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 107.786 -1.659 . . . . 0.0 107.786 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -68.12 119.63 68.67 Favored Pre-proline 0 N--CA 1.416 -2.142 0 CA-C-O 121.309 0.576 . . . . 0.0 111.712 -174.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -87.28 159.89 8.32 Favored 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.758 2.306 . . . . 0.0 111.084 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 51.3 mm -85.88 -59.25 2.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.3 p -131.3 156.43 45.46 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.136 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.35 162.44 39.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.27 134.97 55.18 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.688 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.402 HD23 ' HB2' ' A' ' 92' ' ' PHE . 75.0 mt -108.0 125.53 51.65 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.65 137.53 39.84 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.084 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 46' ' ' SER . 0.1 OUTLIER -112.96 142.34 45.75 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 123.517 0.727 . . . . 0.0 110.719 178.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -67.35 -22.16 65.6 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.242 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.44 ' HB2' ' OD2' ' A' ' 44' ' ' ASP . 4.3 m -74.1 -32.46 63.24 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.53 -2.55 4.18 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.962 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -86.28 158.72 19.62 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.043 0.537 . . . . 0.0 110.331 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.8 p -149.66 140.09 22.39 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.6 m-90 -129.32 127.22 40.67 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.786 0.327 . . . . 0.0 111.447 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.8 m -87.66 114.83 24.65 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.3 m -122.17 158.16 26.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.662 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 25.3 ttp180 -101.16 133.93 44.97 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -177.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 55.8 ttp -131.64 148.12 52.57 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.27 146.27 25.27 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.119 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.513 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 63.5 mttm -91.84 128.83 37.82 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -137.45 107.82 6.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.48 -118.59 4.76 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -111.15 -5.46 14.74 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.483 ' HA ' HD22 ' A' ' 29' ' ' ASN . 19.0 ptpt -117.58 170.09 9.03 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.491 0.662 . . . . 0.0 111.273 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.546 HG23 ' HB ' ' A' ' 24' ' ' ILE . 8.4 m -109.62 141.31 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.417 171.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.473 ' CZ ' ' HD2' ' A' ' 60' ' ' LYS . 97.4 m-85 -114.49 131.56 56.59 Favored 'General case' 0 C--N 1.268 -2.978 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 169.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.615 HD13 HD12 ' A' ' 22' ' ' LEU . 6.8 tt -88.13 102.07 14.43 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 173.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.52 ' OG1' ' HG2' ' A' ' 53' ' ' ARG . 20.5 p -71.73 -163.67 0.11 Allowed 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -168.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.7 t -65.96 122.29 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.356 -168.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.37 -31.62 1.04 Allowed Glycine 0 CA--C 1.481 -2.032 0 N-CA-C 107.506 -2.238 . . . . 0.0 107.506 -174.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.509 ' HB2' HD22 ' A' ' 63' ' ' LEU . 59.2 t-105 -58.14 -23.78 56.42 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 113.864 -1.168 . . . . 0.0 109.947 173.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.665 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 28.5 tt0 -56.51 -32.31 64.93 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.133 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -64.5 -35.87 82.37 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 122.633 0.373 . . . . 0.0 110.956 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -73.55 -49.99 23.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.2 p -61.71 -47.48 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.499 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 68' ' ' GLU 0.277 25.6 pttm -73.1 -30.98 64.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 178.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.24 -39.99 65.02 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.591 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -87.24 -21.48 25.81 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 54.22 88.7 0.04 OUTLIER 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.233 1.413 . . . . 0.0 110.438 -176.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.7 165.77 26.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -141.52 172.14 13.1 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.128 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.467 ' H ' ' HB2' ' A' ' 15' ' ' SER . 5.9 p-10 -58.71 120.79 9.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.494 0.664 . . . . 0.0 109.925 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.85 -41.01 0.58 Allowed Glycine 0 C--N 1.294 -1.755 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -94.72 155.94 16.62 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -130.42 156.6 44.47 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.964 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.22 153.95 51.07 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 -175.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.576 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 87.3 mt-30 -111.87 145.54 39.31 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.382 176.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -117.36 120.17 37.36 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 23.3 mt -97.49 114.65 35.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -128.47 139.69 52.2 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -129.42 167.71 17.4 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 168.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.657 ' H ' ' HD2' ' A' ' 88' ' ' ARG . 5.3 mpt_? -65.01 96.65 0.2 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 123.394 0.434 . . . . 0.0 110.205 -174.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.401 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 20.1 t70 179.27 -159.43 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.401 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 10.5 mpt_? -117.97 19.11 13.78 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.4 m -106.59 117.88 35.2 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.701 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.402 ' HB2' HD23 ' A' ' 42' ' ' LEU . 47.7 m-85 -118.03 133.41 55.94 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 60.3 m-85 -101.7 116.13 32.05 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 174.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 7.8 p -99.9 132.0 46.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 120.827 0.346 . . . . 0.0 110.422 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.576 ' CG2' ' HB2' ' A' ' 83' ' ' GLN . 11.3 tt -131.74 128.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.183 0.516 . . . . 0.0 109.981 177.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.0 tt -96.66 142.02 14.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.363 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 N--CA 1.442 -0.862 0 CA-C-O 121.973 0.892 . . . . 0.0 108.699 176.312 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.433 -1.296 0 CA-C-O 121.518 0.675 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.4 145.59 45.07 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.377 -175.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -142.25 147.33 36.31 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.401 ' HB3' ' HB3' ' A' ' 83' ' ' GLN . 23.3 ptm -135.29 143.72 46.38 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -177.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.567 ' H ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -155.01 159.27 31.96 Favored Pre-proline 0 N--CA 1.433 -1.286 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.24 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -48.76 148.79 8.28 Favored 'Trans proline' 0 C--O 1.251 1.126 0 C-N-CA 124.14 3.227 . . . . 0.0 114.839 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -129.68 124.54 33.87 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.5 117.91 56.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.52 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 26.1 t -59.96 -20.49 57.86 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -172.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -73.11 -44.19 60.65 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.948 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.75 -37.11 11.96 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.678 0.752 . . . . 0.0 109.831 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 21' ' ' SER . 14.5 m -84.98 15.23 4.16 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.634 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 15' ' ' SER . 46.2 t -74.44 -21.95 59.37 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.82 -28.18 1.1 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.15 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 18' ' ' SER . 21.3 p -147.33 152.79 38.81 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -172.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.463 HD12 HD22 ' A' ' 63' ' ' LEU . 54.0 mt -111.37 141.86 44.36 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 120.793 0.33 . . . . 0.0 111.602 176.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -100.52 125.26 46.84 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.443 ' CB ' ' HB ' ' A' ' 61' ' ' VAL . 48.1 mm -105.2 132.09 21.19 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.608 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.93 147.06 83.99 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 123.142 2.562 . . . . 0.0 111.919 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 mp -58.5 -38.29 77.34 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.121 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.38 -28.14 66.73 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.568 -0.742 . . . . 0.0 113.28 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -85.79 -25.69 26.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.126 0.488 . . . . 0.0 110.04 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -69.47 -45.74 68.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.107 0.479 . . . . 0.0 110.105 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.54 -10.51 59.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.811 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -68.35 -27.49 66.31 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.756 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -158.72 103.64 1.62 Allowed Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 120.959 0.409 . . . . 0.0 111.814 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.574 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 6.0 Cg_exo -82.59 134.89 7.74 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.07 1.847 . . . . 0.0 111.08 172.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.95 159.24 32.53 Favored Pre-proline 0 C--N 1.271 -2.809 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.54 130.07 35.52 Favored 'Trans proline' 0 C--O 1.26 1.58 0 N-CA-C 107.843 -1.637 . . . . 0.0 107.843 172.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -71.71 128.48 89.6 Favored Pre-proline 0 N--CA 1.403 -2.818 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -172.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.89 160.1 40.9 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.225 2.616 . . . . 0.0 112.344 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.81 -48.53 15.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 174.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.0 p -136.46 151.63 49.68 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.932 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.15 162.37 38.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.76 137.98 52.35 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.53 0.681 . . . . 0.0 111.844 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 49' ' ' SER . 65.1 mt -109.17 122.78 48.05 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.29 148.08 31.6 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.368 0.604 . . . . 0.0 111.662 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -111.75 165.15 12.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.384 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -52.27 -38.26 57.77 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.805 0.842 . . . . 0.0 110.782 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 m -67.06 -10.29 48.33 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.139 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.27 7.64 63.58 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.418 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -80.37 138.03 36.63 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 35.1 p -124.78 135.26 52.81 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 123.463 0.477 . . . . 0.0 110.594 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -113.88 130.65 56.47 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.4 m -90.86 119.35 30.99 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -119.64 156.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.531 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 65' ' ' VAL . 68.6 mtt180 -100.82 120.18 39.75 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.425 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 20.4 ttt -133.07 121.69 23.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.855 -173.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.2 OUTLIER -132.26 142.32 49.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.029 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.574 ' NZ ' ' HA ' ' A' ' 33' ' ' PRO . 26.2 mtmt -92.08 126.41 37.15 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -130.21 98.89 4.86 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.652 -172.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.22 -107.22 2.42 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.45 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.94 -1.99 16.18 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.866 0.365 . . . . 0.0 110.317 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -132.53 160.17 37.3 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-O 121.271 0.558 . . . . 0.0 111.169 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' A' ' 24' ' ' ILE . 53.0 t -105.57 142.2 19.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 173.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -135.71 131.39 35.57 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 22' ' ' LEU . 6.2 mp -96.02 113.92 25.58 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.7 p -82.41 -170.24 2.84 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.421 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 47.9 t -66.42 122.09 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.68 0.752 . . . . 0.0 110.496 -173.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.53 -27.24 1.07 Allowed Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.401 ' CH2' HD11 ' A' ' 22' ' ' LEU . 41.4 t-105 -60.75 -21.38 62.95 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 113.577 -1.312 . . . . 0.0 110.184 172.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.734 ' O ' ' HG2' ' A' ' 72' ' ' LYS 0.293 0.0 OUTLIER -63.54 -26.53 68.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -175.859 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -56.18 -38.06 70.42 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.543 0.737 . . . . 0.0 110.114 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -74.05 -49.05 25.92 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.446 -175.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.7 p -67.52 -40.69 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.361 -175.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 20.5 ptmt -70.41 -38.77 74.67 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.771 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.59 -38.08 62.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.258 -0.977 . . . . 0.0 112.528 -175.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -86.12 -20.77 28.18 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.838 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.1 t30 50.87 83.53 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.15 0.98 . . . . 0.0 111.432 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 pp -138.8 174.67 10.28 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -143.19 172.04 13.27 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.867 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.52 ' HB3' ' H ' ' A' ' 15' ' ' SER . 9.3 p-10 -65.79 142.1 58.08 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.145 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.24 -21.55 15.05 Favored Glycine 0 C--N 1.295 -1.7 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -173.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -116.54 134.46 54.82 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 87.2 m-85 -130.28 158.91 38.48 Favored 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.264 -170.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 pp -132.29 144.59 50.69 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.552 ' CG ' ' HB ' ' A' ' 95' ' ' ILE . 10.3 pt20 -119.02 145.85 45.52 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.909 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.02 124.28 51.17 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.5 mt -106.31 117.18 51.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.413 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 30.6 p90 -127.68 152.76 47.3 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.531 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -81.16 -78.75 0.17 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.162 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -162.23 24.32 0.11 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -120.55 -168.93 1.72 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -95.83 15.76 19.43 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 123.496 0.718 . . . . 0.0 110.186 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.7 m -102.76 116.11 31.91 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 82.8 m-85 -117.13 132.08 56.75 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.884 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -101.55 129.2 47.59 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -98.71 141.08 16.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -174.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.552 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 57.8 mt -127.06 117.66 48.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.97 113.9 41.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 81' ' ' TYR . 49.2 p90 . . . . . 0 N--CA 1.422 -1.84 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 CA--C 1.522 -0.134 0 CA-C-O 121.09 0.472 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.408 ' HG3' HG12 ' A' ' 85' ' ' ILE . 1.6 mp0 -99.85 146.97 26.02 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.469 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -142.98 149.21 38.03 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.6 ttt -131.7 144.78 51.24 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 24.1 ttpp -146.86 143.78 19.03 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.42 146.35 42.0 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 123.056 2.504 . . . . 0.0 111.632 173.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -122.07 121.69 37.54 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt -128.32 115.98 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.518 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 24.0 t -61.29 -17.49 53.82 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.925 0.89 . . . . 0.0 112.369 -171.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.22 -42.07 93.83 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HD2' ' CD ' ' A' ' 23' ' ' GLU . 37.5 ttmt -101.48 -30.3 11.5 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.212 -177.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.9 p -80.08 7.31 9.42 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 120.927 0.394 . . . . 0.0 111.386 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.9 p -72.18 -29.87 64.42 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.436 0.636 . . . . 0.0 109.631 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -114.28 -39.79 3.8 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.382 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.2 p -157.5 155.39 30.25 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.659 -174.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 76.9 mt -96.25 138.7 33.46 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.947 0.403 . . . . 0.0 110.744 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.476 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 39.5 mt-10 -79.24 117.81 20.6 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.432 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.464 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 62.9 mt -97.19 118.92 64.15 Favored Pre-proline 0 C--N 1.281 -2.382 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.74 138.8 32.84 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.581 2.854 . . . . 0.0 114.635 -171.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.4 tt -63.05 -37.83 88.77 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.72 -28.91 73.47 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.334 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -72.86 -42.89 63.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -62.98 -40.12 96.78 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.71 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.22 -25.46 68.34 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.649 0.779 . . . . 0.0 110.328 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -80.61 -27.58 37.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.165 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -173.4 100.5 0.32 Allowed Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' CB ' ' HE2' ' A' ' 56' ' ' LYS . 14.4 Cg_endo -89.06 149.19 5.65 Favored 'Trans proline' 0 N--CA 1.426 -2.5 0 C-N-CA 121.377 1.384 . . . . 0.0 111.297 171.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.0 158.66 36.69 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.25 137.07 76.6 Favored 'Trans proline' 0 C--N 1.354 0.816 0 N-CA-C 107.68 -1.7 . . . . 0.0 107.68 172.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -70.95 127.41 91.74 Favored Pre-proline 0 N--CA 1.407 -2.609 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -172.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.38 136.91 45.12 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.563 2.175 . . . . 0.0 110.338 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.23 -48.71 87.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.201 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.474 ' O ' ' HD3' ' A' ' 90' ' ' ARG . 25.6 p -127.53 150.69 49.58 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.356 176.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.8 t -132.1 155.2 41.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -108.42 125.14 51.42 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 120.746 0.308 . . . . 0.0 110.361 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.6 mt -109.18 120.16 41.7 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 173.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.61 149.88 26.75 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 120.852 0.358 . . . . 0.0 110.375 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.481 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 11.3 t70 -111.27 158.78 18.59 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.433 ' CE1' HG13 ' A' ' 95' ' ' ILE . 26.9 p90 -73.68 -13.28 60.96 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.253 0.549 . . . . 0.0 111.676 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.2 t -93.52 -162.28 0.92 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.71 6.79 44.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.115 -0.564 . . . . 0.0 114.113 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -81.41 145.61 30.7 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.1 p -150.01 136.52 19.07 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 113.903 -1.498 . . . . 0.0 107.921 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.481 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 23.3 m-90 -126.97 140.3 52.42 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.169 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -96.68 114.29 25.92 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 67' ' ' TRP . 48.2 t -125.25 155.62 34.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.0 -174.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -101.84 139.41 37.51 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.0 ttt -120.12 138.76 53.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -143.84 132.42 22.32 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.254 -0.978 . . . . 0.0 112.58 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.407 ' HE2' ' CB ' ' A' ' 33' ' ' PRO . 48.8 tttp -91.88 128.08 37.58 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -138.86 98.24 3.5 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.302 -173.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.08 -134.72 13.56 Favored Glycine 0 N--CA 1.422 -2.259 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.875 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.429 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 4.9 mp0 -90.89 -0.47 57.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.214 0.53 . . . . 0.0 110.48 -175.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -132.52 171.05 14.29 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 61.7 t -124.84 148.01 29.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -124.42 137.13 54.48 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 21.4 tp -91.69 102.95 15.58 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.419 ' HB ' ' H ' ' A' ' 65' ' ' VAL . 34.9 p -78.94 -157.38 0.12 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -170.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' H ' ' HB ' ' A' ' 64' ' ' THR . 13.5 p -55.9 144.73 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.154 0.981 . . . . 0.0 111.834 -173.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.28 -36.26 3.59 Favored Glycine 0 CA--C 1.485 -1.816 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 -172.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.411 ' CZ2' HG23 ' A' ' 71' ' ' VAL . 12.0 t-105 -59.76 -25.29 64.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.704 -1.248 . . . . 0.0 109.382 171.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.493 ' OE2' ' HD3' ' A' ' 72' ' ' LYS . 2.8 tm-20 -53.23 -31.41 43.14 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.605 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.529 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 2.1 m-20 -67.29 -30.55 70.44 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 123.346 0.659 . . . . 0.0 111.991 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -73.44 -53.06 11.58 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 40.2 t -63.63 -39.1 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.98 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 69' ' ' ASN . 59.9 pttt -71.46 -39.01 71.21 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.4 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -77.64 -40.66 41.06 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -175.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.456 HD21 HD13 ' A' ' 96' ' ' ILE . 45.7 t-20 -84.96 -20.87 29.92 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 20.2 t-20 47.65 88.73 0.02 OUTLIER 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.794 1.637 . . . . 0.0 112.374 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.79 168.8 24.51 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.849 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -143.56 174.24 10.94 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 124.073 0.949 . . . . 0.0 108.97 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.518 ' HB3' ' H ' ' A' ' 15' ' ' SER . 5.6 p-10 -51.95 130.6 29.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.941 0.877 . . . . 0.0 111.717 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.51 -39.93 1.25 Allowed Glycine 0 C--N 1.294 -1.756 0 N-CA-C 107.189 -2.365 . . . . 0.0 107.189 -175.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -94.42 146.14 24.28 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -118.98 158.94 24.77 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.204 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.1 mt -110.57 137.44 48.25 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.526 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.603 ' HB3' ' CG2' ' A' ' 95' ' ' ILE . 57.8 tt0 -111.68 130.71 55.68 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -109.57 117.33 33.67 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 62.5 mt -99.65 114.18 37.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 106.185 -1.784 . . . . 0.0 106.185 174.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -129.11 154.06 47.07 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -172.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -143.56 149.69 37.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.448 ' H ' ' NE ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -54.17 93.9 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.334 1.054 . . . . 0.0 111.82 -177.009 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 23.2 t70 -174.64 -159.04 0.08 Allowed 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -176.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 39' ' ' THR . 36.7 ttm180 -116.39 25.45 10.62 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.4 m -125.69 125.97 43.9 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.405 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -119.89 132.9 55.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.538 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 93.7 m-85 -104.97 115.04 29.61 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 174.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.77 149.48 8.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-O 121.357 0.599 . . . . 0.0 112.137 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.603 ' CG2' ' HB3' ' A' ' 83' ' ' GLN . 13.2 tt -142.06 135.44 28.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.456 HD13 HD21 ' A' ' 74' ' ' ASN . 38.1 pt -93.71 141.63 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.471 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 . . . . . 0 C--N 1.3 -1.586 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.033 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.425 -1.676 0 CA-C-O 121.398 0.618 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 85' ' ' ILE . 8.6 pt20 -136.95 144.91 43.65 Favored 'General case' 0 N--CA 1.399 -3.022 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.361 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -136.26 148.99 48.29 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.511 -174.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.477 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 27.1 ptm -102.56 157.29 17.03 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 12.7 ptpt -154.57 144.32 15.43 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 6.5 Cg_exo -75.83 134.79 16.85 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 122.856 2.37 . . . . 0.0 112.343 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.432 ' CE2' ' HG ' ' A' ' 22' ' ' LEU . 32.0 m-85 -107.11 140.34 40.11 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.659 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.9 mt -120.17 113.52 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 t -56.92 -31.79 65.29 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 123.411 0.444 . . . . 0.0 111.473 -173.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.76 -44.17 97.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -89.09 -40.07 13.19 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.7 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 21' ' ' SER . 25.8 m -75.22 4.55 6.8 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.372 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.2 t -74.26 -17.08 60.92 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -135.25 -35.97 0.82 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.555 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 18' ' ' SER . 26.5 p -144.23 144.0 31.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.402 0.62 . . . . 0.0 112.63 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.3 tt -100.05 121.11 40.88 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -86.11 127.02 34.62 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.982 0.42 . . . . 0.0 110.607 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.535 ' HB ' HG23 ' A' ' 61' ' ' VAL . 45.7 mm -97.56 132.7 24.71 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.45 148.15 87.61 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.266 1.977 . . . . 0.0 111.384 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.64 -22.51 66.66 Favored 'General case' 0 C--O 1.213 -0.819 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.97 -21.62 61.51 Favored Glycine 0 C--O 1.22 -0.734 0 C-N-CA 121.342 -0.456 . . . . 0.0 111.984 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.438 ' HE2' ' CZ ' ' A' ' 86' ' ' TYR . 28.3 t80 -76.44 -51.72 11.25 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -68.18 -35.86 78.69 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.449 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -69.17 -26.42 64.84 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -85.35 -28.23 25.35 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.379 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -172.87 114.67 0.37 Allowed Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 176.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.47 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 1.9 Cg_endo -85.0 150.83 10.96 Favored 'Trans proline' 0 N--CA 1.427 -2.396 0 C-N-CA 121.646 1.564 . . . . 0.0 109.672 168.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.68 152.07 67.6 Favored Pre-proline 0 C--N 1.282 -2.34 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.4 130.54 32.34 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 N-CA-C 108.212 -1.495 . . . . 0.0 108.212 175.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -69.71 114.18 22.72 Favored Pre-proline 0 N--CA 1.412 -2.337 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -172.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -78.61 136.63 13.88 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.798 2.332 . . . . 0.0 110.618 177.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.459 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 47.4 mm -69.93 -46.44 73.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.746 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.5 p -123.38 148.98 45.52 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.736 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.2 t -134.87 143.39 37.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -115.4 131.34 56.96 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.811 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.9 mt -109.24 129.15 55.51 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.39 152.4 20.77 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.584 0.707 . . . . 0.0 112.328 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.517 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 12.3 t70 -112.1 166.91 10.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.196 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -76.54 -49.31 16.77 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.747 0.819 . . . . 0.0 110.717 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 m -80.58 -50.51 9.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.568 -172.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -174.04 -11.29 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 118.263 -1.922 . . . . 0.0 114.716 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.418 ' HB2' ' CB ' ' A' ' 44' ' ' ASP . 17.5 mmt180 -73.72 157.86 35.73 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.1 p -150.94 135.3 16.96 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.517 ' CH2' ' HB2' ' A' ' 44' ' ' ASP . 18.7 m-90 -128.7 134.52 48.5 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.461 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.2 m -98.39 120.05 38.14 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 67' ' ' TRP . 8.5 p -119.18 155.24 21.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.471 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 77.7 ttt180 -103.25 135.95 43.94 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.9 ttt -117.53 146.0 43.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -147.55 131.45 17.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.506 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 33' ' ' PRO . 53.4 tttp -114.47 110.56 20.03 Favored 'General case' 0 CA--C 1.471 -2.082 0 CA-C-O 122.198 0.999 . . . . 0.0 109.089 173.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -140.66 104.82 4.81 Favored 'General case' 1 C--N 1.242 -4.071 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.81 -158.32 20.78 Favored Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -173.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -94.81 3.38 55.07 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.643 0.735 . . . . 0.0 109.55 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -112.73 156.65 22.45 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.535 HG23 ' HB ' ' A' ' 24' ' ' ILE . 27.5 m -129.6 139.89 50.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.897 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -136.91 148.06 46.79 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.024 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 5.9 mp -100.7 109.93 22.01 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.4 p -89.48 -144.55 0.16 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.858 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -55.73 129.06 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 121.484 0.659 . . . . 0.0 109.78 -175.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.92 -38.4 2.11 Favored Glycine 0 N--CA 1.414 -2.796 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 -170.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.45 ' N ' HG23 ' A' ' 52' ' ' VAL . 60.9 t-105 -66.23 -25.5 66.93 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.685 -0.758 . . . . 0.0 109.188 174.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.661 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 32.1 tt0 -59.58 -37.0 77.32 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.201 -178.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -57.45 -39.55 76.52 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 123.716 0.807 . . . . 0.0 110.935 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -74.05 -50.88 17.73 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.825 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 68' ' ' GLU . 7.8 p -62.43 -47.15 94.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.544 -174.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 64.2 pttt -72.44 -33.57 67.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.13 -40.39 38.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 118.575 -1.25 . . . . 0.0 113.471 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -88.25 -19.91 26.17 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.579 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.9 t30 57.73 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.902 1.281 . . . . 0.0 112.061 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 pp -139.45 155.25 47.71 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.638 0.732 . . . . 0.0 112.845 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.94 171.96 13.64 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.78 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -60.94 141.46 57.24 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.612 0.57 . . . . 0.0 110.587 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.76 -6.05 13.95 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -121.1 153.0 38.03 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -132.54 139.65 47.96 Favored 'General case' 0 CA--C 1.474 -1.964 0 CA-C-O 121.043 0.449 . . . . 0.0 109.839 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -135.55 144.38 46.21 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.979 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.477 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 75.9 mt-30 -110.5 145.0 38.47 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.155 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 37.8 m-85 -112.92 131.14 55.85 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.464 ' HA ' ' HB3' ' A' ' 8' ' ' GLN . 59.3 mt -95.31 121.49 45.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.438 ' CZ ' ' HE2' ' A' ' 28' ' ' PHE . 23.0 m-85 -105.5 123.42 47.86 Favored 'General case' 0 N--CA 1.421 -1.925 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -104.37 14.5 30.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.583 0.706 . . . . 0.0 109.638 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.12 72.7 0.49 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.612 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -175.67 -171.49 0.47 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 -176.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.469 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 5.5 mpt_? -106.56 26.93 9.33 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.6 m -127.51 117.81 22.79 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -125.26 155.23 40.45 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.337 0.589 . . . . 0.0 110.906 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -115.07 135.11 54.57 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -104.55 129.63 56.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.112 0.482 . . . . 0.0 112.271 -174.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.7 mm -111.99 115.29 49.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.5 tt -118.12 137.87 50.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.431 0.634 . . . . 0.0 112.7 -173.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 . . . . . 0 N--CA 1.433 -1.282 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.846 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 CA--C 1.517 -0.323 0 CA-C-O 120.984 0.421 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.56 102.36 10.7 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.981 0.419 . . . . 0.0 110.631 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -154.59 105.92 2.67 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.6 m -72.28 -45.23 60.96 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.553 0.692 . . . . 0.0 110.307 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.79 134.9 3.12 Favored Glycine 0 N--CA 1.402 -3.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.01 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 35.0 tt0 -155.05 97.23 1.91 Allowed 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m -108.25 139.28 31.13 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.525 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -123.7 143.92 49.97 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.465 ' CE2' ' HG2' ' A' ' 25' ' ' PRO . 72.2 t80 -148.24 151.89 36.23 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.3 ptm -121.22 141.79 50.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' HD2' ' HD2' ' A' ' 12' ' ' PRO . 58.8 tptt -135.94 129.4 18.13 Favored Pre-proline 0 C--N 1.295 -1.786 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.786 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.441 ' HD2' ' HD2' ' A' ' 11' ' ' LYS . 6.1 Cg_exo -79.66 133.94 10.69 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.436 2.091 . . . . 0.0 109.006 170.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 43.4 m-85 -102.64 139.31 38.4 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -176.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.6 mt -104.71 110.26 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.7 t -57.41 -30.42 64.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.342 0.591 . . . . 0.0 111.003 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.35 -34.18 73.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.22 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -103.03 -29.93 11.08 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.527 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 t -70.27 -11.26 60.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.84 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 p -60.55 -30.44 69.77 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.568 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -136.11 -9.72 2.01 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.9 p -157.27 145.1 19.01 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.5 tt -99.44 119.52 38.13 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.77 122.39 32.81 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.097 0.475 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.7 mm -95.53 124.51 52.83 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HG2' ' CE2' ' A' ' 9' ' ' PHE . 84.2 Cg_exo -50.8 134.03 40.52 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.539 2.826 . . . . 0.0 112.073 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.54 -43.03 89.1 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.592 0.757 . . . . 0.0 111.209 -173.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.32 -32.26 83.61 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.83 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.564 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 74.9 t80 -82.8 -36.16 25.81 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.596 HD21 ' HA ' ' A' ' 60' ' ' LYS . 13.7 t30 -59.86 -43.55 94.62 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.968 0.907 . . . . 0.0 110.693 175.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.73 -22.22 66.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.912 0.863 . . . . 0.0 110.587 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.564 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 92.6 t80 -75.63 -26.72 58.02 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.729 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -134.01 93.85 19.41 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 119.433 -0.907 . . . . 0.0 113.065 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.6 Cg_exo -81.63 136.2 9.53 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 121.592 1.528 . . . . 0.0 110.269 171.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.49 153.34 32.1 Favored Pre-proline 0 C--N 1.283 -2.305 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.684 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.27 154.59 62.32 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 121.977 1.785 . . . . 0.0 109.156 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -68.67 126.08 92.4 Favored Pre-proline 0 N--CA 1.419 -1.985 0 CA-C-O 121.231 0.538 . . . . 0.0 110.915 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -87.47 160.54 8.08 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 122.442 2.094 . . . . 0.0 111.243 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.73 -59.14 2.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.4 p -134.6 151.7 51.26 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.487 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -128.82 148.15 33.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -109.94 136.85 48.57 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.201 -0.599 . . . . 0.0 111.53 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 92' ' ' PHE . 76.5 mt -108.39 122.53 47.2 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.07 137.75 39.02 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -113.42 139.35 48.98 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.266 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -58.92 -21.64 58.25 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -85.89 -13.23 48.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.587 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.04 -9.22 7.53 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 119.843 -1.17 . . . . 0.0 114.68 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -88.07 157.85 18.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.567 0.683 . . . . 0.0 111.239 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.7 p -143.04 136.21 28.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 18.1 m-90 -114.73 126.77 55.24 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.391 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.0 m -89.09 114.76 26.04 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.405 HG21 HD23 ' A' ' 63' ' ' LEU . 31.1 m -112.15 156.47 13.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.118 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -101.9 120.43 40.38 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.588 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -123.95 137.07 54.67 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.074 -172.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.588 ' HD2' ' C ' ' A' ' 54' ' ' MET . 4.5 mptp? -133.9 140.68 46.97 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.019 0.438 . . . . 0.0 112.069 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 33' ' ' PRO . 54.6 tttp -105.49 107.89 19.12 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 172.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -108.79 99.87 9.17 Favored 'General case' 1 C--N 1.243 -4.064 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.325 -172.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.44 -116.75 6.76 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.47 -21.16 22.0 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.596 ' HA ' HD21 ' A' ' 29' ' ' ASN . 17.7 ptpt -112.21 165.87 11.78 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -168.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.411 HG12 ' CB ' ' A' ' 56' ' ' LYS . 25.8 m -134.56 146.33 31.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.551 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -142.02 136.55 30.36 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.774 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 3.1 mp -96.75 104.04 16.0 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 169.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.2 p -94.49 -98.7 0.15 Allowed 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -169.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.5 133.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.655 0.74 . . . . 0.0 110.625 -175.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.05 -37.66 3.63 Favored Glycine 0 CA--C 1.481 -2.074 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -63.01 -25.62 68.47 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.851 0.834 . . . . 0.0 109.254 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.671 ' HA ' HG12 ' A' ' 71' ' ' VAL . 16.9 pt-20 -68.58 -26.32 65.33 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.57 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -68.99 -31.64 70.62 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.543 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -74.3 -52.04 13.45 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 68' ' ' GLU . 7.2 p -59.73 -46.88 93.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.431 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.24 -43.35 64.51 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -77.24 -40.2 45.72 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.201 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.478 ' ND2' HG12 ' A' ' 96' ' ' ILE . 7.3 t30 -84.83 -18.47 34.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.24 0.543 . . . . 0.0 109.582 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 50.4 t30 60.11 90.96 0.05 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.182 1.393 . . . . 0.0 112.846 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.413 ' CD1' HG23 ' A' ' 71' ' ' VAL . 3.8 pp -127.18 151.13 49.09 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.437 ' HG2' ' HD3' ' A' ' 80' ' ' LYS . 15.5 pt-20 -144.06 172.65 12.6 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.652 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 12.2 t70 -53.05 120.42 5.86 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.47 -25.15 6.67 Favored Glycine 0 C--N 1.306 -1.122 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HD3' ' HG2' ' A' ' 77' ' ' GLU . 14.5 mptt -80.8 147.54 30.42 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -126.6 140.65 52.26 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.433 HD22 HG13 ' A' ' 96' ' ' ILE . 61.4 mt -119.66 147.4 44.59 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.103 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 14.9 mm100 -110.72 124.85 52.74 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -112.51 117.67 33.01 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 123.556 0.535 . . . . 0.0 109.761 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 mp -103.91 122.67 56.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 64.2 m-85 -109.45 144.61 37.46 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -88.37 -97.47 0.09 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.673 173.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -154.11 20.27 0.5 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 16.2 t70 -143.56 -154.61 0.54 Allowed 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -174.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.506 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 5.6 mpt_? -95.58 29.15 2.7 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.11 0.964 . . . . 0.0 109.252 -175.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -101.98 116.61 33.06 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.313 0.578 . . . . 0.0 110.394 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.422 ' CE2' ' HE2' ' A' ' 86' ' ' TYR . 1.5 m-30 -116.43 122.29 44.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.034 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.441 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 38.5 m-85 -105.74 120.09 40.8 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 32.6 t -111.08 134.32 53.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.995 0.426 . . . . 0.0 112.068 -173.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 2.1 mp -116.2 131.47 68.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.478 HG12 ' ND2' ' A' ' 74' ' ' ASN . 2.8 mp -105.92 128.01 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 122.432 0.293 . . . . 0.0 111.005 -174.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -102.51 119.3 38.58 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.19 -85.13 0.15 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.131 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 170.89 -42.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -177.51 -32.08 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -135.04 155.64 50.4 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.478 -1.692 . . . . 0.0 106.633 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.8 m . . . . . 0 C--N 1.295 -1.799 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.903 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 CA--C 1.509 -0.597 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.36 133.02 53.36 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.246 0.341 . . . . 0.0 110.473 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -117.67 110.25 17.64 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.5 p -74.79 -72.91 0.26 Allowed 'General case' 0 N--CA 1.409 -2.518 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.955 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.75 50.61 3.28 Favored Glycine 0 CA--C 1.495 -1.214 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.763 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -91.03 153.25 20.27 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 114.597 -0.802 . . . . 0.0 109.766 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.408 HG11 ' OH ' ' A' ' 31' ' ' TYR . 32.9 m -130.43 157.03 42.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.44 146.6 52.03 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -142.05 148.97 39.33 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.473 ' HG2' ' HG2' ' A' ' 83' ' ' GLN . 64.2 mtt -114.88 137.59 51.79 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HB3' ' NZ ' ' A' ' 11' ' ' LYS . 1.8 ttpm? -142.06 130.8 12.01 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.11 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.61 147.38 86.24 Favored 'Trans proline' 0 C--O 1.248 1.005 0 C-N-CA 122.86 2.373 . . . . 0.0 111.066 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' A' ' 15' ' ' SER . 76.8 t80 -95.41 117.99 31.34 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.1 mm -97.32 106.87 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.772 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.593 ' HB2' ' N ' ' A' ' 78' ' ' ASP . 20.2 t -55.89 -37.57 69.02 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.549 0.531 . . . . 0.0 111.416 -172.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -61.17 -44.01 97.98 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 123.633 0.583 . . . . 0.0 110.626 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -86.46 -40.77 15.0 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.171 -173.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 21' ' ' SER . 26.1 m -84.21 11.9 7.44 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.516 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.3 m -63.13 -33.45 75.49 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 168.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -121.54 -41.83 2.47 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.499 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 18' ' ' SER . 45.7 m -144.84 152.81 40.87 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.189 -175.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 54.9 mt -87.91 132.03 34.37 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-O 121.171 0.51 . . . . 0.0 111.657 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -96.07 117.36 30.54 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.809 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.3 mm -98.49 132.61 23.82 Favored Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.533 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -56.24 142.13 87.65 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 123.195 2.597 . . . . 0.0 112.052 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.513 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 5.7 tt -54.17 -38.98 66.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.984 0.914 . . . . 0.0 111.761 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.5 -35.41 85.35 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.877 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -88.3 -25.02 23.01 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 60' ' ' LYS . 87.8 m-20 -62.71 -46.27 88.88 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.581 0.705 . . . . 0.0 110.034 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -73.68 -12.04 60.6 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.608 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.408 ' OH ' HG11 ' A' ' 7' ' ' VAL . 91.3 t80 -75.99 -28.7 57.92 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -175.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . 0.251 24.7 p90 -130.97 68.28 81.75 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -57.0 135.45 70.93 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 121.957 1.771 . . . . 0.0 111.046 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.69 161.3 29.56 Favored Pre-proline 0 C--N 1.278 -2.516 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.646 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.55 148.94 60.71 Favored 'Trans proline' 0 C--O 1.25 1.12 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 167.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 44.5 p90 -67.85 121.42 79.52 Favored Pre-proline 0 N--CA 1.413 -2.321 0 CA-C-O 121.626 0.727 . . . . 0.0 111.709 -171.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 90' ' ' ARG . 66.4 Cg_endo -96.76 160.74 1.12 Allowed 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 123.628 2.885 . . . . 0.0 112.697 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -108.01 -38.71 4.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.237 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 64.0 p -123.86 159.97 28.46 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.212 0.53 . . . . 0.0 111.9 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 90' ' ' ARG . 7.1 p -146.02 141.88 21.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 173.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -110.0 131.78 54.75 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.158 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -109.92 126.42 53.86 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.92 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.8 145.27 31.4 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.103 0.477 . . . . 0.0 111.914 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 19.2 t70 -113.87 154.93 26.65 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 173.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -91.67 -5.72 53.3 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.6 t -92.55 -23.44 19.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.909 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.87 -37.93 0.76 Allowed Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 118.896 -1.621 . . . . 0.0 114.196 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 84.6 mtm-85 -78.92 158.84 27.96 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 117.849 0.824 . . . . 0.0 113.123 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.6 m -146.38 150.44 35.67 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.284 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.544 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 12.8 m-90 -132.03 120.78 22.87 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.0 m -92.57 114.22 26.71 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 174.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 66' ' ' GLY . 18.2 m -114.83 158.79 15.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.642 -174.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 99.5 mtt180 -99.73 127.4 45.87 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.504 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.431 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 56.5 ttp -114.73 144.33 43.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.414 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -128.9 127.81 42.54 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -99.12 124.53 44.22 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.85 102.03 3.95 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.6 -105.22 0.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.352 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.28 -0.79 52.56 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 123.331 0.652 . . . . 0.0 112.151 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.528 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 84.8 tttt -142.17 147.09 36.03 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 118.515 -1.274 . . . . 0.0 112.922 -172.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.0 t -109.31 132.48 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -121.88 132.01 54.34 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 5.8 mp -101.19 102.61 13.55 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.269 168.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -85.21 -150.52 0.13 Allowed 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 124.62 1.168 . . . . 0.0 111.271 -170.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 62.0 t -55.47 125.9 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-O 121.838 0.827 . . . . 0.0 109.124 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 52' ' ' VAL . . . 135.22 -40.85 1.51 Allowed Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 -169.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.405 ' CZ2' HD21 ' A' ' 22' ' ' LEU . 63.7 t-105 -65.48 -24.84 67.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.729 -0.735 . . . . 0.0 109.64 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.611 ' HA ' HG12 ' A' ' 71' ' ' VAL . 37.2 tt0 -61.29 -30.34 70.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.382 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -58.56 -44.59 89.76 Favored 'General case' 0 C--O 1.198 -1.63 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.757 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -73.0 -46.43 52.28 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.081 0.553 . . . . 0.0 110.062 -176.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.7 p -62.76 -43.25 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.571 0.7 . . . . 0.0 110.058 -175.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -72.07 -43.22 65.2 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.273 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.96 -40.37 54.06 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -86.11 -21.01 27.86 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 57.8 94.89 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.577 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -142.73 146.18 34.08 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.696 -0.628 . . . . 0.0 111.993 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.21 170.86 8.2 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.188 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.593 ' N ' ' HB2' ' A' ' 15' ' ' SER . 14.8 t70 -53.52 136.74 37.85 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.568 1.147 . . . . 0.0 111.923 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.91 -11.39 22.79 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.421 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.51 161.38 16.25 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.388 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -125.81 137.74 53.79 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.24 144.65 48.49 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.257 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.473 ' HG2' ' HG2' ' A' ' 10' ' ' MET . 50.0 mt-30 -109.72 126.22 53.49 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -110.39 117.33 33.33 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 65.5 mt -97.95 122.51 49.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -105.75 123.4 47.87 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -125.64 80.25 1.88 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 52.25 30.11 7.5 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.285 170.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -161.7 -177.56 5.97 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 40' ' ' VAL . 42.2 ttm180 -95.52 41.74 1.1 Allowed 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 87.5 m -127.14 132.63 50.51 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.802 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 95.7 m-85 -125.29 140.09 53.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.134 0.492 . . . . 0.0 110.805 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.472 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 82.0 m-85 -101.76 126.43 48.62 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.8 t -108.1 119.49 57.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.177 0.513 . . . . 0.0 112.298 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 60.0 mt -112.08 123.82 68.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.406 HG23 ' HB3' ' A' ' 99' ' ' HIS . 8.6 tt -114.66 139.25 41.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 120.947 0.403 . . . . 0.0 110.667 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -87.58 113.37 23.2 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.74 67.75 1.02 Allowed Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.406 ' HB3' HG23 ' A' ' 96' ' ' ILE . 28.1 p-80 -93.21 113.43 25.64 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.974 0.416 . . . . 0.0 110.362 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -72.14 125.84 28.31 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.91 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 51.9 ttm -113.57 -8.18 13.33 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.547 0.689 . . . . 0.0 110.102 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 C--O 1.254 1.292 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.53 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.363 0.125 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.4 89.51 0.09 Allowed 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.872 0.844 . . . . 0.0 111.64 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -88.54 153.88 20.79 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.5 m -55.04 -37.78 67.13 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.044 0.449 . . . . 0.0 111.077 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.92 -52.62 3.64 Favored Glycine 0 CA--C 1.498 -0.978 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.67 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.38 93.85 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.022 0 C-N-CA 125.879 1.672 . . . . 0.0 111.838 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.68 140.0 45.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.454 ' H ' ' NE2' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -132.91 154.43 50.41 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -172.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 69.2 t80 -124.77 147.76 48.5 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.21 -1.359 . . . . 0.0 107.552 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -140.18 134.02 30.58 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -153.91 151.1 24.09 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.542 174.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -77.08 136.75 16.63 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.752 2.301 . . . . 0.0 108.69 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 24.5 p90 -103.09 137.39 41.33 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.188 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 16' ' ' GLU . 2.3 mp -101.97 123.75 55.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 19.5 m -53.49 -25.31 15.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.005 0.922 . . . . 0.0 112.584 -173.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.404 ' H ' HG22 ' A' ' 14' ' ' ILE . 43.9 tt0 -60.73 -40.49 92.57 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.277 1.031 . . . . 0.0 110.655 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -103.05 -36.78 8.04 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.574 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 89.4 p -66.05 -8.07 21.13 Favored 'General case' 0 C--O 1.215 -0.763 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -172.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.0 m -73.9 -17.66 61.01 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.8 173.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -134.55 -33.35 0.97 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 18' ' ' SER . 49.4 p -147.36 170.23 17.78 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -171.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 3.1 tm? -133.72 113.44 12.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.8 131.49 35.91 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.725 ' HB ' HG23 ' A' ' 61' ' ' VAL . 58.8 mt -113.41 132.48 22.47 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -57.14 148.79 67.36 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 123.126 2.55 . . . . 0.0 113.407 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.5 tt -62.74 -33.87 76.03 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.064 0.946 . . . . 0.0 108.871 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.25 -35.96 86.79 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.511 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.429 ' CE2' ' HE1' ' A' ' 32' ' ' PHE . 57.8 t80 -80.15 -20.51 44.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.364 0.602 . . . . 0.0 109.551 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -66.51 -43.34 85.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.3 -11.14 60.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.491 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -72.18 -25.31 61.63 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.429 ' HE1' ' CE2' ' A' ' 28' ' ' PHE . 5.1 p90 -167.74 95.94 0.63 Allowed Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 121.063 0.459 . . . . 0.0 111.683 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.99 135.35 13.89 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.852 1.702 . . . . 0.0 110.202 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.431 ' H ' ' HE2' ' A' ' 56' ' ' LYS . . . -152.77 160.38 31.16 Favored Pre-proline 0 C--N 1.28 -2.427 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.54 153.61 73.83 Favored 'Trans proline' 0 C--O 1.251 1.168 0 C-N-CA 121.449 1.433 . . . . 0.0 108.386 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -69.07 131.8 90.55 Favored Pre-proline 0 N--CA 1.411 -2.412 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.444 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.6 156.18 28.04 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 122.211 1.941 . . . . 0.0 110.313 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.3 mm -83.53 -39.76 15.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -154.75 160.5 41.36 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' NH2' ' A' ' 90' ' ' ARG . 34.2 m -135.5 158.75 40.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -113.35 134.4 54.65 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.876 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -108.89 120.73 43.37 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -104.22 157.61 17.01 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.497 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 4.5 t70 -111.74 146.06 38.23 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.09 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -64.72 -26.88 68.56 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.789 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 m -89.89 -47.69 7.72 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 122.33 -0.231 . . . . 0.0 111.023 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.22 -8.21 0.05 OUTLIER Glycine 0 CA--C 1.525 0.707 0 C-N-CA 119.396 -1.383 . . . . 0.0 114.679 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -73.76 159.47 32.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.162 0.481 . . . . 0.0 111.501 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 p -147.13 136.72 22.89 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.497 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 16.8 m-90 -131.64 142.41 49.85 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.826 0.346 . . . . 0.0 110.378 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 73.4 m -106.59 114.44 28.54 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.2 m -125.74 156.94 35.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.391 -174.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -100.85 128.68 46.79 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.277 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 1.1 tmt? -127.84 143.73 51.11 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -135.0 143.57 46.88 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.012 0.434 . . . . 0.0 111.899 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HA ' HG12 ' A' ' 61' ' ' VAL . 29.1 mmmt -92.43 121.27 33.73 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 102.873 -3.01 . . . . 0.0 102.873 169.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -134.65 98.0 3.94 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.374 -170.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.45 -109.82 3.12 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.947 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.621 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -105.86 -7.93 17.98 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.979 0.419 . . . . 0.0 110.275 -178.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 61' ' ' VAL . 41.7 ttmt -118.78 167.7 11.44 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.725 HG23 ' HB ' ' A' ' 24' ' ' ILE . 32.7 m -128.65 142.27 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -140.74 132.39 27.2 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -173.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 67' ' ' TRP . 5.5 tt -97.47 115.81 28.49 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 176.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.7 t -101.31 -142.73 0.34 Allowed 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.085 -170.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.6 m -56.1 143.78 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 124.397 1.079 . . . . 0.0 112.811 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.89 -31.86 6.31 Favored Glycine 0 N--CA 1.421 -2.357 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.475 ' HB2' HD22 ' A' ' 63' ' ' LEU . 57.1 t-105 -54.61 -27.04 36.51 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.609 0.719 . . . . 0.0 110.467 177.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.669 ' HA ' HG12 ' A' ' 71' ' ' VAL . 13.8 pt-20 -63.83 -26.63 68.7 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.204 -175.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -61.58 -37.71 84.89 Favored 'General case' 0 C--O 1.2 -1.552 0 CA-C-O 120.973 0.415 . . . . 0.0 110.098 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -73.95 -48.13 32.7 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.825 0.85 . . . . 0.0 110.765 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.2 p -65.54 -42.25 92.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.351 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -71.29 -39.81 71.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.752 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -71.8 -38.62 70.22 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -95.56 0.27 52.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.5 t30 55.63 82.81 0.1 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.99 0.9 . . . . 0.0 109.681 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 92.8 mt -120.86 136.0 55.03 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.891 -173.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -138.78 158.67 43.8 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -54.32 128.32 30.96 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 124.348 1.03 . . . . 0.0 111.009 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.24 -35.75 1.93 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -92.56 164.31 13.48 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.411 ' HB2' ' HB2' ' A' ' 97' ' ' TYR . 37.9 m-85 -132.67 154.4 50.17 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -113.2 147.59 37.17 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.403 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.466 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 49.5 tt0 -115.25 123.98 50.19 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 171.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 86.2 m-85 -109.2 116.32 31.68 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.3 mt -110.64 125.29 67.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.411 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 34.3 p90 -119.72 155.58 32.18 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.025 -1.47 . . . . 0.0 108.844 173.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -96.31 -79.92 0.44 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.271 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -143.42 16.49 1.85 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.909 0.385 . . . . 0.0 110.053 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 33.6 t70 -133.44 -175.07 3.69 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -174.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.475 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -95.09 20.51 8.97 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 125.439 1.495 . . . . 0.0 111.762 -177.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.3 t -110.33 132.98 53.7 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 81.3 m-85 -112.96 140.57 47.66 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.185 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -98.32 117.6 33.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 43.1 t -104.67 134.63 45.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.325 0.584 . . . . 0.0 112.258 -173.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.2 mt -120.29 134.33 64.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 96' ' ' ILE . 2.1 mp -100.65 121.5 51.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 120.643 0.259 . . . . 0.0 110.465 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 83' ' ' GLN . 97.1 m-85 -85.22 160.41 19.89 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.869 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 102' ' ' CYS . . . -179.55 -133.58 2.0 Favored Glycine 0 N--CA 1.417 -2.592 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -144.08 -48.46 0.28 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.522 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -76.95 -19.46 57.33 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.39 0.614 . . . . 0.0 110.611 -175.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 27.5 ttt 169.83 -44.94 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.513 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 74.0 m . . . . . 0 N--CA 1.417 -2.117 0 CA-C-N 111.83 -2.441 . . . . 0.0 104.755 170.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.25 106.45 9.88 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -76.51 129.1 36.0 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.377 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 32.5 m -71.09 -34.85 71.52 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.62 65.54 0.26 Allowed Glycine 0 CA--C 1.483 -1.964 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.374 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.77 101.68 7.72 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -128.01 146.7 33.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -137.04 151.81 49.37 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.743 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -142.66 149.37 38.8 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.9 ptp -138.23 154.74 49.08 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.579 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 24.3 ttpp -152.98 145.96 17.61 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.42 142.7 16.86 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.102 2.534 . . . . 0.0 111.341 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.46 ' CZ ' HD13 ' A' ' 76' ' ' LEU . 71.4 t80 -110.75 123.88 50.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 16' ' ' GLU . 61.4 mt -126.26 113.09 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.6 p -58.38 -9.46 1.58 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' H ' HG22 ' A' ' 14' ' ' ILE . 42.1 mt-10 -81.4 -28.23 34.42 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 122.148 -0.345 . . . . 0.0 110.921 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -110.61 -38.01 5.3 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.321 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 21' ' ' SER . 65.0 p -75.24 -0.45 19.51 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.225 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.5 p -75.18 -25.08 57.98 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.513 0.673 . . . . 0.0 110.409 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -115.94 -37.45 3.87 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.492 -175.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 18' ' ' SER . 34.5 p -153.67 169.6 22.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -171.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 4.2 tt -108.04 115.13 29.57 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.579 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 14.8 pt-20 -75.15 115.51 14.87 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.46 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 61' ' ' VAL . 68.0 mt -106.63 123.42 38.75 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.54 147.11 88.27 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 123.396 2.731 . . . . 0.0 114.376 -176.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 4.9 tt -59.12 -39.78 83.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.513 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.51 -31.16 69.85 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.749 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -82.62 -24.22 33.94 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.5 0.667 . . . . 0.0 109.759 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.439 ' HB2' HG23 ' A' ' 61' ' ' VAL . 55.1 t30 -76.08 -46.3 29.7 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.54 -20.0 66.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.038 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.39 -26.98 65.83 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.717 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -168.54 103.24 0.52 Allowed Pre-proline 0 C--O 1.248 1.009 0 CA-C-O 121.239 0.542 . . . . 0.0 110.555 177.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.21 135.14 14.9 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 120.968 1.112 . . . . 0.0 109.797 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.65 148.97 21.39 Favored Pre-proline 0 C--N 1.276 -2.6 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.74 133.85 41.18 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 121.811 1.674 . . . . 0.0 108.534 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.71 ' HB3' ' H ' ' A' ' 56' ' ' LYS . 39.4 p90 -69.78 139.92 88.78 Favored Pre-proline 0 N--CA 1.414 -2.268 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -75.72 158.63 39.3 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.874 2.383 . . . . 0.0 109.905 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.36 -54.89 12.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.5 p -133.44 150.44 51.75 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.601 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 m -131.94 157.18 43.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -109.98 139.59 44.91 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.641 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.461 HD23 ' HB2' ' A' ' 92' ' ' PHE . 77.7 mt -108.24 121.89 45.82 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.3 137.96 38.95 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.94 150.95 29.79 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.024 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.58 -22.95 65.66 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.281 0.633 . . . . 0.0 112.445 -175.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.9 t -82.46 3.05 29.81 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.099 0.476 . . . . 0.0 110.175 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 8.9 67.66 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 121.358 -0.448 . . . . 0.0 112.264 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -89.27 154.97 19.68 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.1 p -141.19 137.84 32.94 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 120.863 0.363 . . . . 0.0 111.402 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -124.3 142.13 51.51 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.217 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.5 m -100.18 120.39 39.82 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.518 ' HB ' HD21 ' A' ' 63' ' ' LEU . 22.9 m -123.31 157.25 29.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.596 -174.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -101.2 139.82 36.35 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.829 0.347 . . . . 0.0 110.258 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 25.3 ttt -134.26 127.22 31.4 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.517 -172.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -120.69 124.93 46.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.018 0.437 . . . . 0.0 111.31 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.71 ' H ' ' HB3' ' A' ' 36' ' ' PHE . 25.3 mmmt -100.39 105.49 16.99 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 175.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -149.93 115.47 5.53 Favored 'General case' 0 C--N 1.265 -3.102 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.94 -120.17 5.15 Favored Glycine 0 N--CA 1.418 -2.541 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.441 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.434 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 31.0 mt-10 -96.03 -27.97 14.86 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.521 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -120.99 170.32 9.62 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.883 0.849 . . . . 0.0 112.876 -172.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.541 HG22 ' HD2' ' A' ' 56' ' ' LYS . 47.5 t -120.69 127.3 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 173.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -119.8 129.1 54.29 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 6.6 tt -103.96 118.09 35.86 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.4 p -99.16 -144.38 0.32 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.9 m -54.77 144.88 5.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.89 1.276 . . . . 0.0 113.154 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.464 ' C ' HG12 ' A' ' 52' ' ' VAL . . . 114.94 -41.54 2.14 Favored Glycine 0 N--CA 1.418 -2.532 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 -170.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.514 ' CZ3' HD12 ' A' ' 22' ' ' LEU . 58.0 t-105 -62.38 -26.9 68.71 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 114.259 -0.971 . . . . 0.0 109.248 174.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.571 ' HA ' HG12 ' A' ' 71' ' ' VAL . 30.5 tt0 -69.39 -26.77 64.81 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.524 -177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -70.28 -30.84 67.96 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 67' ' ' TRP . 53.1 t80 -73.03 -52.47 14.26 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 124.527 1.131 . . . . 0.0 109.278 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.1 p -64.61 -41.21 91.61 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.973 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -70.59 -48.14 56.69 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.679 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.83 -40.36 69.15 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.709 -173.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -88.62 -19.08 26.71 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.973 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 56.22 92.38 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.041 0.936 . . . . 0.0 110.993 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.46 HD13 ' CZ ' ' A' ' 13' ' ' PHE 0.289 0.9 OUTLIER -142.09 132.1 24.55 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -176.977 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.83 173.46 9.54 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 125.849 1.66 . . . . 0.0 109.017 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -52.71 135.92 34.29 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.693 0.62 . . . . 0.0 110.54 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.68 -28.22 3.27 Favored Glycine 0 C--N 1.301 -1.414 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -107.67 150.47 26.88 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.834 -0.683 . . . . 0.0 109.447 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -122.31 146.65 47.1 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.1 mt -110.76 135.88 50.67 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.104 0.478 . . . . 0.0 112.004 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -118.02 124.42 48.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.87 117.88 34.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.936 0.398 . . . . 0.0 110.969 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.775 HG13 ' HB2' ' A' ' 93' ' ' TYR . 11.7 pt -105.36 130.19 57.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -106.41 143.77 34.05 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.267 0.556 . . . . 0.0 111.41 -173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -92.59 -0.75 57.27 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 4' ' ' THR . 7.3 tpt180 74.96 8.4 4.13 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.932 1.693 . . . . 0.0 109.175 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 31.5 t70 -106.08 -159.36 0.7 Allowed 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.553 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 53.4 ttp180 -95.7 11.95 31.61 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 p -108.39 117.84 35.22 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.626 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.461 ' HB2' HD23 ' A' ' 42' ' ' LEU . 3.4 m-85 -107.42 126.46 52.52 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.491 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.775 ' HB2' HG13 ' A' ' 85' ' ' ILE . 78.9 m-85 -104.27 126.98 51.83 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.1 p -119.32 135.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.167 0.508 . . . . 0.0 111.724 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.1 mt -114.45 123.01 69.71 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.4 mt -103.56 112.69 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.578 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -126.62 167.59 15.47 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.807 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.97 117.71 1.46 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.614 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 49.8 m80 65.51 -74.88 0.05 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.719 1.208 . . . . 0.0 112.167 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -169.68 85.65 0.13 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.26 -40.18 8.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 84.2 m . . . . . 0 C--N 1.313 -0.986 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 174.589 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 111.209 0.077 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.27 124.69 20.84 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 68.42 78.39 0.23 Allowed 'General case' 0 C--O 1.245 0.847 0 O-C-N 124.332 1.02 . . . . 0.0 109.868 -172.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.8 m -83.43 -41.08 18.51 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.426 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.78 -154.24 20.44 Favored Glycine 0 N--CA 1.416 -2.669 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' A' ' 87' ' ' ASP . 42.0 tt0 59.97 29.6 19.16 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 122.088 0.947 . . . . 0.0 110.052 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.29 140.7 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -125.23 159.6 31.22 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-O 121.082 0.468 . . . . 0.0 112.195 -172.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -148.89 148.83 30.32 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.9 ptp -138.28 141.01 39.85 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.652 0.263 . . . . 0.0 111.348 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.66 157.05 31.39 Favored Pre-proline 0 C--N 1.312 -1.025 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.82 132.53 15.79 Favored 'Trans proline' 0 N--CA 1.439 -1.728 0 C-N-CA 120.989 1.126 . . . . 0.0 109.681 172.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' A' ' 76' ' ' LEU . 30.3 p90 -84.44 140.47 31.49 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 123.564 0.746 . . . . 0.0 110.232 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.6 mt -90.59 120.88 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.439 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 28.8 t -53.44 -37.11 62.28 Favored 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.716 0.635 . . . . 0.0 111.89 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.76 -40.57 97.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -87.02 -39.32 15.75 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.823 0.821 . . . . 0.0 108.933 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 21' ' ' SER . 48.4 m -76.04 4.14 9.0 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 114.45 -1.25 . . . . 0.0 113.016 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.1 m -71.61 -20.02 62.04 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.227 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -136.22 -36.17 0.74 Allowed 'General case' 0 C--O 1.214 -0.808 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.628 ' O ' ' HA ' ' A' ' 18' ' ' SER . 58.4 p -138.95 168.06 20.66 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.608 -0.437 . . . . 0.0 112.138 -175.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.07 131.73 47.34 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -89.34 131.82 35.24 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 121.41 0.624 . . . . 0.0 111.922 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 47.3 mm -94.89 132.93 27.28 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.1 144.43 69.42 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.883 2.389 . . . . 0.0 112.984 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.0 tp -65.58 -33.41 75.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.326 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.66 -36.21 93.04 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . 45.2 m-85 -77.84 -25.71 48.92 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -59.21 -46.33 88.74 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.19 -31.98 62.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.211 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 64.0 t80 -68.81 -28.55 66.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.369 -174.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -151.09 93.51 3.64 Favored Pre-proline 0 C--O 1.247 0.95 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -83.64 136.0 7.16 Favored 'Trans proline' 0 N--CA 1.429 -2.274 0 C-N-CA 122.264 1.976 . . . . 0.0 108.812 167.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.71 160.53 31.54 Favored Pre-proline 0 C--N 1.264 -3.127 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -175.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.2 132.78 53.3 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 107.342 -1.83 . . . . 0.0 107.342 172.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -68.22 115.74 32.16 Favored Pre-proline 0 N--CA 1.41 -2.446 0 CA-C-O 121.285 0.564 . . . . 0.0 112.002 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -80.45 135.48 10.58 Favored 'Trans proline' 0 N--CA 1.433 -2.079 0 C-N-CA 121.942 1.762 . . . . 0.0 110.062 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.9 mm -81.48 -28.79 10.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.6 p -127.66 148.73 50.39 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 121.497 0.665 . . . . 0.0 110.15 173.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 90' ' ' ARG . 53.4 t -142.83 147.31 20.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -115.83 133.96 55.49 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.725 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt -108.15 121.78 45.56 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -101.23 137.47 39.54 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.962 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -113.11 141.6 46.71 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.242 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -57.93 -29.78 65.42 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 125.353 1.461 . . . . 0.0 113.717 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.5 t -86.1 -4.57 59.2 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 122.094 -0.379 . . . . 0.0 110.487 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.21 -4.85 23.62 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.651 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -80.73 158.51 25.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.775 0.322 . . . . 0.0 110.568 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 p -156.34 135.38 11.98 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.219 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -125.51 135.77 52.64 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.687 0.279 . . . . 0.0 110.91 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.2 m -92.32 114.8 27.45 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.427 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 33.6 m -115.63 157.66 16.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.343 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 53' ' ' ARG . 23.8 ttt180 -101.34 127.39 47.98 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.398 0.618 . . . . 0.0 109.768 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.5 ttt -110.13 144.33 38.9 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.547 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HG3' ' HB2' ' A' ' 57' ' ' ARG . 59.7 tptt -139.32 125.69 20.3 Favored 'General case' 0 N--CA 1.412 -2.366 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.156 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.56 ' HD2' HG22 ' A' ' 61' ' ' VAL . 28.5 mmmt -92.01 113.25 25.47 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 79.6 ttt180 -135.84 97.99 3.78 Favored 'General case' 0 C--N 1.272 -2.79 0 CA-C-O 120.985 0.421 . . . . 0.0 112.096 -173.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.92 -87.92 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 116.638 1.415 . . . . 0.0 116.638 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -89.57 -24.84 21.62 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.614 -0.293 . . . . 0.0 111.612 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -154.08 171.09 19.65 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.927 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.56 HG22 ' HD2' ' A' ' 56' ' ' LYS . 48.5 t -108.31 131.3 59.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -120.97 132.48 54.95 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 tt -102.34 103.8 14.27 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 53.4 p -95.03 -103.65 0.15 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.5 m -69.84 144.21 14.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.455 0.645 . . . . 0.0 112.083 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 109.61 -37.77 3.63 Favored Glycine 0 CA--C 1.483 -1.954 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.411 ' O ' ' HB3' ' A' ' 70' ' ' PHE . 63.6 t-105 -61.23 -24.9 66.69 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 122.084 0.945 . . . . 0.0 109.191 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.546 ' HA ' HG12 ' A' ' 71' ' ' VAL . 13.0 pt-20 -65.68 -30.12 70.77 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.357 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -74.68 -29.46 61.24 Favored 'General case' 0 C--O 1.202 -1.413 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 67' ' ' TRP . 16.1 t80 -73.28 -52.36 14.24 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 124.763 1.225 . . . . 0.0 108.454 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.1 p -61.1 -45.32 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.443 -177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -71.91 -34.06 68.8 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.21 -39.55 63.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.387 -174.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -90.25 -18.75 25.09 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.898 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.1 t30 54.82 83.92 0.08 Allowed 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.164 0.986 . . . . 0.0 109.698 -172.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.489 HD13 ' CE2' ' A' ' 13' ' ' PHE . 1.3 pp -133.98 148.54 51.15 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -175.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -143.85 172.31 13.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.126 -174.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' H ' ' HB2' ' A' ' 15' ' ' SER . 5.4 p-10 -56.78 141.11 45.52 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 123.704 0.627 . . . . 0.0 111.38 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 117.51 -16.01 12.75 Favored Glycine 0 C--N 1.302 -1.318 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -174.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 98' ' ' GLY . 65.9 mttm -104.39 159.22 15.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 97' ' ' TYR . 33.2 m-85 -120.99 136.82 54.89 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -173.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.8 pp -114.92 138.97 50.19 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.966 176.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.551 ' NE2' HD12 ' A' ' 95' ' ' ILE . 27.2 tt0 -124.24 124.01 41.5 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.455 ' CE2' HD13 ' A' ' 82' ' ' LEU . 86.9 m-85 -108.7 131.86 54.5 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 59.2 mt -97.65 116.05 39.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HD2' ' CE1' ' A' ' 92' ' ' PHE . 53.8 m-85 -107.05 126.79 52.8 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.422 ' HA ' ' H ' ' A' ' 6' ' ' GLU . 6.1 p-10 -110.63 16.95 21.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 118.596 -1.241 . . . . 0.0 109.282 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 63.75 80.4 0.23 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.583 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -172.82 -168.67 0.51 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.46 ' O ' HG13 ' A' ' 40' ' ' VAL . 51.5 ptt85 -107.55 24.87 12.21 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 118.412 0.551 . . . . 0.0 109.749 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -129.27 117.35 20.54 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.414 ' CE1' ' HD2' ' A' ' 86' ' ' TYR . 26.9 m-85 -121.45 137.88 54.53 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.576 -176.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -100.4 125.99 46.72 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.6 p -109.66 137.98 39.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-O 121.599 0.714 . . . . 0.0 112.5 -175.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.551 HD12 ' NE2' ' A' ' 83' ' ' GLN . 66.7 mt -118.61 125.89 74.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.6 mt -113.01 125.43 70.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.549 0.69 . . . . 0.0 111.158 -174.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 62.6 m-85 -98.58 119.47 37.35 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 80' ' ' LYS . . . 103.6 82.37 1.61 Allowed Glycine 0 C--N 1.294 -1.789 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 -170.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -125.99 147.87 49.42 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.835 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -64.88 121.09 13.8 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.8 ttt -81.43 81.36 7.58 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.467 0.651 . . . . 0.0 110.597 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.6 m . . . . . 0 C--N 1.303 -1.432 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.402 179.097 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 CA--C 1.504 -0.822 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.78 91.56 8.68 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.206 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.8 t70 71.08 149.29 0.09 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.307 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.1 m -92.88 -22.7 19.11 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.552 0.691 . . . . 0.0 109.907 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.51 -42.89 1.09 Allowed Glycine 0 CA--C 1.48 -2.124 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.36 166.58 16.5 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 113.612 -1.294 . . . . 0.0 109.042 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.4 m -129.21 140.3 49.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -121.84 148.01 45.24 Favored 'General case' 0 N--CA 1.406 -2.652 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -147.09 148.95 32.14 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -134.68 138.54 44.52 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.571 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -148.48 144.88 19.07 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.9 133.56 5.02 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 121.988 1.792 . . . . 0.0 108.105 168.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -100.3 142.34 31.91 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 122.336 -0.227 . . . . 0.0 110.621 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.442 ' HB ' ' HG2' ' A' ' 17' ' ' LYS . 81.5 mt -88.36 114.67 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.527 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 28.9 t -53.68 -34.18 57.85 Favored 'General case' 0 C--O 1.212 -0.872 0 O-C-N 123.648 0.592 . . . . 0.0 111.121 -174.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.5 -39.83 89.15 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.667 -177.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HG2' ' HB ' ' A' ' 14' ' ' ILE . 20.7 ptmt -104.77 -26.88 12.08 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.811 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 21' ' ' SER . 68.4 m -92.56 14.44 16.86 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.8 m -74.2 -16.39 60.98 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 118.885 -1.126 . . . . 0.0 109.919 166.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -114.51 -47.67 2.9 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 18' ' ' SER . 49.2 m -143.35 168.68 19.23 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 122.972 0.509 . . . . 0.0 110.39 -172.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.494 HD22 ' CZ3' ' A' ' 67' ' ' TRP . 43.9 tp -126.24 142.17 51.63 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.305 0.242 . . . . 0.0 110.751 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -98.37 124.69 43.17 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 120.681 0.276 . . . . 0.0 110.661 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 2.1 mp -97.25 133.38 24.02 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.53 139.29 17.89 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 123.925 3.083 . . . . 0.0 114.787 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.5 tt -62.7 -41.08 98.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.163 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.1 -36.11 92.45 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.406 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 75.7 t80 -73.72 -34.2 64.69 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -63.51 -46.46 85.94 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.853 0.835 . . . . 0.0 110.021 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -72.88 -11.07 60.45 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.842 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 89.1 t80 -74.76 -27.68 60.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.377 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 27.6 p90 -147.07 121.07 5.05 Favored Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.817 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 4.5 Cg_exo -76.74 134.64 15.2 Favored 'Trans proline' 0 N--CA 1.44 -1.676 0 C-N-CA 121.832 1.688 . . . . 0.0 108.87 172.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.08 138.46 11.59 Favored Pre-proline 0 C--N 1.271 -2.805 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.92 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 143.85 96.72 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 106.557 -2.132 . . . . 0.0 106.557 167.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 51.8 p90 -68.79 121.93 83.08 Favored Pre-proline 0 N--CA 1.41 -2.471 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.162 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 36' ' ' PHE . 11.9 Cg_exo -71.09 152.56 62.47 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 121.913 1.742 . . . . 0.0 110.086 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.0 mm -86.78 -59.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -124.72 151.01 45.58 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.706 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.48 162.29 29.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 91' ' ' THR . 24.8 t70 -124.89 140.09 53.24 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.042 -175.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.3 mt -107.79 127.58 53.83 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.15 147.72 25.91 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.798 0.809 . . . . 0.0 111.793 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 2.3 t70 -112.14 137.14 50.63 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.528 173.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -70.31 -8.88 53.87 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.5 t -92.18 -41.73 10.28 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.87 0.03 0.11 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.11 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 17.9 mmt180 -88.88 158.95 17.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 117.643 0.722 . . . . 0.0 110.731 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.7 p -149.51 146.56 27.45 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.46 ' CE3' ' HD1' ' A' ' 70' ' ' PHE . 24.3 m-90 -130.04 123.71 31.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.415 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.9 m -89.68 117.0 28.22 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.585 ' HB ' HD21 ' A' ' 63' ' ' LEU . 22.2 m -124.95 157.23 33.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.686 -172.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -102.62 122.93 45.39 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.255 0.55 . . . . 0.0 111.517 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.428 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 50.8 ttp -124.82 131.18 53.47 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.63 161.84 38.15 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 61' ' ' VAL . 78.8 mttt -91.29 129.86 37.23 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -132.11 103.15 6.11 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.392 0.615 . . . . 0.0 110.951 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.27 -101.27 0.73 Allowed Glycine 0 N--CA 1.431 -1.65 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.565 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.432 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 39.7 mt-10 -95.23 -20.68 19.0 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.383 -0.408 . . . . 0.0 111.061 -175.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -131.56 166.64 20.94 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.487 0.66 . . . . 0.0 112.623 -170.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.538 HG22 ' HG2' ' A' ' 56' ' ' LYS . 90.1 t -97.42 136.92 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 170.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -135.19 132.88 38.48 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.132 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.696 HD22 ' HB2' ' A' ' 67' ' ' TRP . 3.7 tt -99.14 116.86 32.31 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.3 p -90.0 -92.16 0.13 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.67 145.15 8.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 C-N-CA 124.967 1.307 . . . . 0.0 113.205 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.414 ' C ' HG12 ' A' ' 52' ' ' VAL . . . 109.28 -36.4 4.36 Favored Glycine 0 CA--C 1.477 -2.311 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.566 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.696 ' HB2' HD22 ' A' ' 63' ' ' LEU . 64.5 t-105 -58.68 -26.15 63.54 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.706 0.765 . . . . 0.0 109.906 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.642 ' HA ' HG12 ' A' ' 71' ' ' VAL . 15.8 pt-20 -72.39 -26.22 61.8 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.535 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -71.99 -37.92 69.76 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.46 ' HD1' ' CE3' ' A' ' 50' ' ' TRP . 69.0 t80 -72.89 -51.29 19.21 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.072 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -62.66 -44.59 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.65 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -73.47 -43.72 59.6 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.12 -40.05 78.55 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.532 -0.867 . . . . 0.0 112.891 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -85.14 -14.56 46.63 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t30 60.77 82.75 0.16 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 125.204 1.402 . . . . 0.0 112.173 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -115.64 159.08 21.79 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.388 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -143.96 165.06 28.8 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.527 ' H ' ' HB2' ' A' ' 15' ' ' SER . 14.1 t70 -53.16 120.95 6.56 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 124.072 0.858 . . . . 0.0 109.414 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.98 -29.38 3.73 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -80.85 154.48 27.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.477 ' C ' HD12 ' A' ' 82' ' ' LEU . 94.8 m-85 -122.05 135.15 54.8 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 81' ' ' TYR . 6.4 mp -123.26 130.75 53.18 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.111 0.481 . . . . 0.0 111.224 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -112.83 124.11 51.84 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -108.99 118.04 35.77 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.355 -173.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 63.2 mt -98.23 118.29 44.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.29 -0.413 . . . . 0.0 109.937 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -106.47 123.48 48.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -81.79 -78.78 0.18 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -176.82 24.23 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.59 -172.99 2.43 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.97 29.44 2.4 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-O 121.638 0.732 . . . . 0.0 109.078 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 17.5 p -125.38 136.66 53.67 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.078 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -118.13 135.25 54.33 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.375 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 57.2 m-85 -100.48 113.64 26.59 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.0 t -98.7 124.79 52.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.693 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.1 mm -105.75 116.46 49.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 96' ' ' ILE . 3.0 mp -102.15 130.28 52.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -85.39 112.72 21.1 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.38 -83.98 0.19 Allowed Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 68.04 125.9 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.227 1.011 . . . . 0.0 113.709 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -89.62 129.68 36.03 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.55 112.04 16.42 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -176.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 46.2 t . . . . . 0 C--N 1.312 -1.039 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.43 113.24 25.88 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 120.992 0.425 . . . . 0.0 110.78 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -114.13 97.43 6.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.609 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.9 m -99.72 -34.65 10.09 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.52 -145.11 9.29 Favored Glycine 0 N--CA 1.422 -2.278 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 42.76 80.95 0.03 OUTLIER 'General case' 0 C--O 1.256 1.42 0 C-N-CA 124.963 1.305 . . . . 0.0 113.573 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.27 140.68 46.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.902 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 9.8 pt20 -121.9 146.1 47.44 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.37 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 83' ' ' GLN . 88.6 t80 -129.63 148.59 51.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -124.9 146.24 49.43 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 120.641 0.257 . . . . 0.0 110.676 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HE2' ' HG3' ' A' ' 23' ' ' GLU . 24.1 ttpp -154.14 139.88 12.32 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 174.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.03 146.19 81.6 Favored 'Trans proline' 0 C--O 1.257 1.467 0 C-N-CA 122.032 1.821 . . . . 0.0 110.709 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -78.62 119.45 21.9 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 16' ' ' GLU . 68.1 mt -107.52 120.2 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.239 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 78' ' ' ASP . 32.1 t -66.74 -10.9 51.87 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 123.273 0.629 . . . . 0.0 111.413 -172.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.467 ' H ' HG22 ' A' ' 14' ' ' ILE . 46.6 mt-10 -75.5 -46.18 33.85 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.531 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.498 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 3.5 mppt? -113.17 -41.89 3.62 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 118.394 -1.322 . . . . 0.0 113.543 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 21' ' ' SER . 15.6 m -69.43 -3.74 15.68 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 123.57 0.544 . . . . 0.0 111.091 -174.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.0 p -74.31 -25.51 59.62 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -133.13 -23.33 1.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.975 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.562 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 51.0 m -150.48 169.16 22.15 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -175.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 63' ' ' LEU 0.308 42.7 mt -103.86 131.35 51.15 Favored 'General case' 0 CA--C 1.488 -1.408 0 CA-C-O 122.391 1.091 . . . . 0.0 113.875 177.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.498 ' OE2' ' HB2' ' A' ' 17' ' ' LYS . 6.7 pt-20 -91.33 111.27 22.68 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 112.324 -2.216 . . . . 0.0 108.973 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.86 121.68 36.46 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.614 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.51 153.75 76.87 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 123.045 2.497 . . . . 0.0 113.154 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.88 -34.8 74.05 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.882 -175.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.21 -28.8 73.96 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.688 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -75.88 -31.21 59.14 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.276 0.631 . . . . 0.0 110.166 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -76.16 -26.23 56.04 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.565 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -75.32 -17.42 60.26 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.662 0.744 . . . . 0.0 109.324 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -74.1 -28.24 61.27 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.92 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -161.35 80.45 2.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 121.617 0.722 . . . . 0.0 112.1 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.37 140.62 15.43 Favored 'Trans proline' 0 N--CA 1.43 -2.244 0 C-N-CA 122.343 2.029 . . . . 0.0 111.499 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.8 159.21 36.36 Favored Pre-proline 0 C--N 1.278 -2.519 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.93 146.34 87.24 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 121.888 1.725 . . . . 0.0 108.935 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -69.05 117.42 51.63 Favored Pre-proline 0 N--CA 1.415 -2.178 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -175.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.66 159.84 31.61 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.878 2.385 . . . . 0.0 111.534 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.17 -41.34 22.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -137.03 150.53 48.15 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.671 0.748 . . . . 0.0 112.219 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 90' ' ' ARG . 74.2 t -132.45 160.04 42.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.88 130.96 34.63 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.48 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.402 ' CD2' ' HB2' ' A' ' 92' ' ' PHE . 79.7 mt -109.62 133.81 52.67 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.208 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.44 143.32 32.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.877 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.512 ' HB2' ' HZ3' ' A' ' 50' ' ' TRP . 9.7 t70 -112.9 147.69 36.51 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.681 174.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -60.34 -23.81 64.55 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 124.228 1.011 . . . . 0.0 112.866 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -80.28 -12.75 59.58 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.847 -0.533 . . . . 0.0 110.404 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.25 1.35 25.02 Favored Glycine 0 C--O 1.239 0.445 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.299 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 98.1 mtt180 -80.6 157.42 26.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.2 p -150.53 136.75 18.62 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 120.59 0.233 . . . . 0.0 110.512 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.512 ' HZ3' ' HB2' ' A' ' 44' ' ' ASP . 15.8 m-90 -124.53 130.47 52.52 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.145 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.1 m -89.98 114.48 26.33 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HB ' HD21 ' A' ' 63' ' ' LEU . 28.6 m -112.03 156.81 13.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.814 -173.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.546 ' HB2' HG23 ' A' ' 64' ' ' THR . 85.6 mtt180 -102.79 119.96 39.76 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.473 ' HB3' HG21 ' A' ' 40' ' ' VAL . 60.4 ttp -124.62 123.72 40.67 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -136.75 162.68 32.53 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HD3' HG22 ' A' ' 61' ' ' VAL . 29.7 mmtp -88.72 128.62 35.62 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 175.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.49 100.62 5.21 Favored 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -175.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.84 -112.2 3.61 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -175.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -112.3 -5.77 14.12 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.886 0.85 . . . . 0.0 110.321 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -113.69 170.67 8.09 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.213 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.529 HG22 ' HD3' ' A' ' 56' ' ' LYS . 57.9 t -108.58 127.28 65.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -126.68 130.59 50.7 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 6.7 tt -103.15 120.96 41.66 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.546 HG23 ' HB2' ' A' ' 53' ' ' ARG . 5.6 t -96.43 -144.55 0.28 Allowed 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 123.161 0.584 . . . . 0.0 111.546 -172.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.47 143.88 6.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 125.43 1.492 . . . . 0.0 111.689 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 125.35 -48.42 0.96 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -65.36 -24.91 67.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.394 -0.903 . . . . 0.0 110.176 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.459 ' HA ' HG12 ' A' ' 71' ' ' VAL . 35.2 tt0 -65.5 -29.87 70.57 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.796 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -69.48 -35.89 76.02 Favored 'General case' 0 C--O 1.198 -1.634 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.347 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -68.57 -49.7 57.41 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 123.409 0.683 . . . . 0.0 109.204 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 6.8 p -63.67 -33.68 63.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.223 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -71.23 -48.64 50.07 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.039 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -72.34 -39.56 68.06 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -96.96 -10.0 27.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.749 -0.595 . . . . 0.0 111.278 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 7.9 t30 53.99 94.86 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.233 1.413 . . . . 0.0 112.932 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 71' ' ' VAL . 3.8 mp -122.21 133.75 54.72 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.749 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.09 169.99 10.65 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 124.21 1.004 . . . . 0.0 108.979 174.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 6.3 p-10 -60.66 141.47 56.73 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.216 0.531 . . . . 0.0 111.302 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.09 -29.45 5.99 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -80.84 154.33 27.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.862 0.363 . . . . 0.0 110.404 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -122.56 140.73 52.46 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mp -124.51 144.12 50.29 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.745 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 8.9 pt20 -116.23 137.27 52.28 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 85.9 m-85 -111.81 117.61 33.29 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 48.9 mt -97.62 114.72 35.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.482 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 24.3 p90 -130.56 157.86 41.55 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.734 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -107.66 25.1 11.92 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.61 13.49 2.94 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 125.145 1.378 . . . . 0.0 111.82 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.556 ' OD2' HG22 ' A' ' 91' ' ' THR . 7.8 p-10 -96.35 -159.63 0.74 Allowed 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.585 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -105.5 15.72 26.64 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -176.012 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.556 HG22 ' OD2' ' A' ' 89' ' ' ASP . 5.5 t -121.41 139.8 52.98 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 117.789 -1.564 . . . . 0.0 109.197 172.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.482 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 71.6 m-85 -128.13 136.46 51.17 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 122.122 -0.361 . . . . 0.0 110.67 -175.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.435 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 61.3 m-85 -94.59 120.46 34.85 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.5 t -103.71 117.71 49.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 120.99 0.424 . . . . 0.0 111.496 -174.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.439 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 65.0 mt -114.61 124.49 71.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 96' ' ' ILE . 2.6 mp -94.15 140.66 16.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -84.45 141.78 30.56 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.583 0.706 . . . . 0.0 111.328 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.91 173.32 21.49 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -98.46 -47.28 5.45 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -160.08 100.79 1.4 Allowed 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 69.9 mtm -61.89 113.26 2.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.417 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.249 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.498 -1.037 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.53 94.55 1.59 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -111.37 92.72 4.15 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.801 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.6 m -88.78 -14.37 37.25 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.837 0.827 . . . . 0.0 109.774 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.3 -114.74 1.04 Allowed Glycine 0 N--CA 1.425 -2.08 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.889 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 85' ' ' ILE . 11.3 pt-20 -90.23 129.03 36.53 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.107 0.479 . . . . 0.0 111.973 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.3 m -118.68 142.29 34.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 175.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -116.42 145.63 43.11 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.019 0.438 . . . . 0.0 111.781 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -140.37 149.81 43.14 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.574 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 23.6 ptp -126.18 144.47 50.75 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -151.57 146.2 18.61 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 178.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 7.0 Cg_exo -76.35 147.21 28.81 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.692 2.262 . . . . 0.0 109.257 170.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -108.4 136.07 48.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.1 mp -110.13 114.1 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.431 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 22.3 t -61.93 -11.93 15.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.547 0.739 . . . . 0.0 112.797 -170.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 17' ' ' LYS . 48.7 mt-10 -77.15 -28.05 54.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.463 ' HD2' ' HB2' ' A' ' 16' ' ' GLU . 12.1 mptt -107.13 -35.76 6.76 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 120.815 0.34 . . . . 0.0 110.932 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.4 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 80.5 p -75.73 3.48 9.71 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.899 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 p -74.19 -30.96 62.47 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -120.0 -42.06 2.62 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.58 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.9 p -134.93 146.22 48.94 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -173.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.3 tt -91.93 115.05 27.73 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.1 125.35 30.75 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.549 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.1 mm -100.13 119.25 59.79 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.54 143.71 97.89 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.919 2.413 . . . . 0.0 111.671 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 30' ' ' GLU . 62.9 tp -51.09 -41.73 60.17 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.626 0.77 . . . . 0.0 112.468 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.86 -34.08 76.43 Favored Glycine 0 C--N 1.319 -0.391 0 N-CA-C 113.926 0.33 . . . . 0.0 113.926 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -88.68 -22.72 23.25 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -72.76 -43.6 62.67 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.255 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 45.1 mt-10 -61.99 -17.24 56.47 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.257 0.623 . . . . 0.0 110.483 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -77.89 -27.28 49.58 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.59 -174.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -147.18 72.95 12.08 Favored Pre-proline 0 CA--C 1.56 1.348 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -54.36 136.49 69.24 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.806 1.671 . . . . 0.0 110.304 165.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.06 160.64 31.69 Favored Pre-proline 0 C--N 1.277 -2.567 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.269 -173.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.86 137.96 83.61 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 108.232 -1.488 . . . . 0.0 108.232 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 47.4 p90 -69.46 117.24 50.84 Favored Pre-proline 0 N--CA 1.416 -2.164 0 CA-C-O 121.1 0.476 . . . . 0.0 111.375 -175.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 36' ' ' PHE . 90.5 Cg_endo -91.86 159.23 3.39 Favored 'Trans proline' 0 N--CA 1.429 -2.269 0 C-N-CA 122.289 1.993 . . . . 0.0 111.672 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 38' ' ' ILE . 2.1 mp -98.6 -31.75 3.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 m -137.6 151.91 48.84 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.278 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.8 t -147.97 157.67 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 126.719 2.008 . . . . 0.0 106.969 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -119.48 140.45 50.45 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 118.765 0.711 . . . . 0.0 111.704 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.0 mt -111.61 126.3 54.86 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.021 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.1 147.67 26.7 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -111.97 136.98 50.6 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -67.52 -15.45 63.67 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.353 -173.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.8 t -96.71 -14.29 22.14 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.426 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.81 -23.9 2.9 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 119.848 -1.168 . . . . 0.0 114.115 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -67.8 159.22 30.74 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -150.86 136.82 18.26 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.481 ' HE1' ' HB3' ' A' ' 73' ' ' ASP . 32.3 m-90 -130.67 137.19 49.46 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.661 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.6 m -93.26 125.31 37.8 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.434 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 14.2 p -125.58 155.91 34.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.111 0.481 . . . . 0.0 111.213 -173.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.429 ' HD2' HG13 ' A' ' 65' ' ' VAL . 90.3 mtt180 -104.52 120.27 40.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -126.86 127.5 45.05 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.93 134.52 54.84 Favored 'General case' 0 C--O 1.25 1.08 0 O-C-N 123.38 0.425 . . . . 0.0 111.035 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.58 ' HA ' HG12 ' A' ' 61' ' ' VAL . 13.3 mmmm -91.91 112.01 23.77 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 175.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -147.47 120.86 9.02 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.99 -136.73 18.13 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.428 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -111.28 -3.49 15.31 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.115 0.484 . . . . 0.0 111.495 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -128.85 129.15 45.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.177 0.513 . . . . 0.0 109.691 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 56' ' ' LYS . 16.4 m -111.49 146.69 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.97 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -137.58 142.38 41.31 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.017 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 4.7 mp -88.05 103.26 15.56 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 170.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.8 p -78.21 -141.53 0.03 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 124.269 1.028 . . . . 0.0 111.652 -173.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.429 HG13 ' HD2' ' A' ' 53' ' ' ARG . 13.3 p -55.57 140.64 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.546 0.689 . . . . 0.0 109.875 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 117.0 -40.02 2.5 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 -171.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.486 ' CZ3' HD12 ' A' ' 22' ' ' LEU . 54.3 t-105 -67.24 -21.02 65.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.685 0.755 . . . . 0.0 109.147 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.538 ' HA ' HG12 ' A' ' 71' ' ' VAL . 41.9 tt0 -68.01 -32.75 73.35 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.777 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -65.15 -33.11 75.24 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-O 121.394 0.616 . . . . 0.0 109.844 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.28 -52.53 18.42 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.359 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 68' ' ' GLU . 6.8 p -64.06 -40.54 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.804 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -71.16 -48.38 52.21 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.84 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.481 ' HB3' ' HE1' ' A' ' 50' ' ' TRP . 28.5 t70 -77.1 -35.57 56.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -173.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -86.6 -20.94 27.16 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 56.74 83.82 0.1 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.578 1.151 . . . . 0.0 111.543 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.512 ' CD2' ' HA ' ' A' ' 71' ' ' VAL . 1.6 pt? -125.44 155.39 40.53 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.832 0.825 . . . . 0.0 112.282 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.49 172.43 12.97 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.18 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.431 ' H ' ' HB2' ' A' ' 15' ' ' SER . 4.6 p30 -58.74 130.21 45.82 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.35 -20.35 7.02 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -99.2 146.27 26.35 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.485 ' C ' HD12 ' A' ' 82' ' ' LEU . 96.4 m-85 -119.96 140.93 50.16 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -175.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.485 HD12 ' C ' ' A' ' 81' ' ' TYR . 4.9 mp -131.85 137.8 48.21 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.005 0.431 . . . . 0.0 111.008 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.574 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 42.9 mt-30 -111.87 135.08 52.96 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.95 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.523 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 95.0 m-85 -115.19 125.04 52.93 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.4 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 2.4 mp -105.0 118.98 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.489 ' CE2' ' HA ' ' A' ' 88' ' ' ARG . 87.3 t80 -106.74 124.64 49.9 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 7.9 p-10 -107.52 12.87 27.36 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -175.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.489 ' HA ' ' CE2' ' A' ' 86' ' ' TYR 0.27 6.1 mpt_? 84.47 -0.05 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -101.13 -165.18 1.18 Allowed 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 174.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.48 39.26 1.54 Allowed 'General case' 0 C--N 1.256 -3.486 0 CA-C-O 121.839 0.828 . . . . 0.0 108.817 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -126.01 117.93 24.27 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.148 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.81 126.8 52.6 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 174.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 68.6 m-85 -91.7 118.9 31.07 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.66 125.72 62.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 120.787 0.327 . . . . 0.0 111.067 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.516 ' CG2' ' HB2' ' A' ' 83' ' ' GLN . 13.9 tt -112.54 118.41 57.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.415 HG12 ' HG ' ' A' ' 82' ' ' LEU . 55.6 mt -103.48 133.84 46.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.734 -173.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -105.87 113.88 27.7 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.03 114.41 2.56 Favored Glycine 0 N--CA 1.424 -2.156 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -139.65 134.79 32.51 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -85.29 135.76 33.78 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 123.277 0.361 . . . . 0.0 110.261 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 50.3 ttm -102.12 -32.71 9.99 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 120.957 0.408 . . . . 0.0 110.686 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.253 1.267 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.831 -178.506 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.85 -22.52 62.3 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.383 1.087 . . . . 0.0 109.094 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -89.01 103.51 16.11 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 113.453 -1.703 . . . . 0.0 108.66 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.3 m -95.21 -62.54 1.29 Allowed 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.825 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.04 52.88 0.04 OUTLIER Glycine 0 CA--C 1.486 -1.773 0 C-N-CA 119.276 -1.44 . . . . 0.0 113.537 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -164.95 120.93 1.42 Allowed 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 123.551 0.74 . . . . 0.0 109.064 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m -135.24 151.55 30.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -130.81 149.46 52.44 Favored 'General case' 0 N--CA 1.415 -2.196 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.57 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -137.98 149.31 46.01 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.618 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 47.6 ttm -136.51 136.48 39.41 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -154.37 133.06 6.97 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-O 119.832 -0.128 . . . . 0.0 111.181 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.43 132.32 17.48 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 N-CA-C 108.259 -1.477 . . . . 0.0 108.259 168.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -100.01 140.52 34.12 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 120.58 0.229 . . . . 0.0 110.558 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 16' ' ' GLU . 63.7 mt -103.44 124.49 57.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.7 t -62.77 -11.54 18.4 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.858 0.863 . . . . 0.0 111.895 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -73.96 -45.28 51.17 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -110.5 -40.65 4.56 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.983 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.692 ' HA ' ' O ' ' A' ' 21' ' ' SER . 15.8 m -72.58 0.08 11.49 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 m -74.62 -16.24 60.79 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HG3' ' OE2' ' A' ' 68' ' ' GLU . 54.8 tttp -125.84 -28.19 3.25 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 118.93 -1.108 . . . . 0.0 111.176 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 18' ' ' SER . 46.4 m -151.98 148.75 28.1 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.526 HD12 ' CH2' ' A' ' 67' ' ' TRP . 5.6 tt -101.73 119.21 38.43 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -82.02 131.57 35.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.714 -178.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 48.0 mm -96.06 126.45 44.42 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.71 144.6 86.0 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.931 2.42 . . . . 0.0 112.267 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -62.17 -32.43 73.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.506 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.22 -31.2 69.05 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.393 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -80.61 -29.28 36.85 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.42 -38.28 84.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.877 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.04 -28.76 70.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -67.98 -27.42 66.56 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.816 -175.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -157.17 116.01 1.98 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 120.406 -0.518 . . . . 0.0 112.101 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.51 145.04 32.96 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.284 1.989 . . . . 0.0 109.756 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.86 143.0 16.26 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.91 156.39 64.57 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.543 2.162 . . . . 0.0 110.045 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -68.72 115.08 27.05 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.676 0.274 . . . . 0.0 111.221 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -95.73 160.02 1.47 Allowed 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 123.308 2.672 . . . . 0.0 111.186 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -90.19 -62.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.7 p -126.76 151.38 48.29 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.965 0.412 . . . . 0.0 111.997 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.619 HG12 ' HB2' ' A' ' 90' ' ' ARG . 22.1 m -136.52 162.34 35.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -113.59 143.99 43.63 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.033 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -108.86 120.1 41.5 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.63 137.61 43.2 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.205 0.526 . . . . 0.0 111.16 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 46' ' ' SER . 0.1 OUTLIER -112.46 145.87 39.44 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.048 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -73.43 -19.14 61.04 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.703 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.437 ' HB3' ' OD2' ' A' ' 44' ' ' ASP . 38.6 t -74.79 -36.77 62.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.37 -0.32 2.23 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.204 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 97.7 mtt180 -89.53 157.94 17.87 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.241 0.543 . . . . 0.0 111.642 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.8 p -142.56 136.64 29.45 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.501 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -121.08 131.77 54.47 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.5 m -96.92 120.24 36.89 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.519 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 7.7 p -110.29 153.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -100.78 122.12 42.85 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.5 ttt -110.02 130.44 55.53 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.422 -170.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -121.16 125.47 47.26 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.339 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -106.9 126.63 52.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -133.36 97.45 3.97 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.025 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.73 -97.75 0.04 OUTLIER Glycine 0 C--N 1.304 -1.218 0 O-C-N 124.174 0.921 . . . . 0.0 115.012 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -95.81 -6.5 39.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.5 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -138.13 163.69 31.02 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.523 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 67.2 t -134.46 145.39 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -128.34 132.4 48.6 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.679 0.276 . . . . 0.0 110.569 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.98 103.39 15.31 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.7 p -94.01 -106.49 0.13 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -169.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.15 136.11 27.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.305 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 108.75 -47.2 1.07 Allowed Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.526 ' CH2' HD12 ' A' ' 22' ' ' LEU . 36.5 t-105 -62.46 -31.95 72.75 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.566 ' HA ' HG12 ' A' ' 71' ' ' VAL . 41.1 tt0 -61.78 -33.65 74.48 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 113.548 -1.66 . . . . 0.0 109.917 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -69.07 -37.76 78.67 Favored 'General case' 0 C--O 1.197 -1.68 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.425 ' CE2' HD21 ' A' ' 76' ' ' LEU . 85.5 t80 -73.0 -47.47 44.87 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 123.706 0.802 . . . . 0.0 110.683 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -61.06 -44.76 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.62 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 31.6 mmmt -72.41 -48.25 42.79 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.403 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.85 -38.15 67.15 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -84.39 -18.72 35.19 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.34 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 64.18 95.18 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.86 0.838 . . . . 0.0 112.067 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.425 HD21 ' CE2' ' A' ' 70' ' ' PHE 0.261 1.5 pp -152.18 134.75 15.35 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.192 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -132.96 170.89 14.69 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -54.47 126.15 22.35 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.244 0.545 . . . . 0.0 111.112 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.25 -21.29 4.89 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 101' ' ' MET . 92.0 mttt -94.72 163.34 13.4 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -134.01 138.86 45.66 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.941 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 82' ' ' LEU . 1.4 pt? -136.4 149.52 48.34 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.92 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -127.29 135.77 51.02 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -107.23 129.94 54.8 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.432 0.158 . . . . 0.0 111.057 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.21 125.89 60.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.411 ' HE2' ' CE2' ' A' ' 92' ' ' PHE . 58.5 m-85 -109.58 126.91 54.09 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -87.5 9.36 21.2 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 72.24 81.31 0.14 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.892 1.277 . . . . 0.0 109.304 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 21.8 t70 -179.2 -160.75 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 -174.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.619 ' HB2' HG12 ' A' ' 40' ' ' VAL . 34.1 ptt180 -104.78 23.08 14.01 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -103.65 117.79 35.22 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.107 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.411 ' CE2' ' HE2' ' A' ' 86' ' ' TYR . 2.0 m-85 -105.83 122.61 46.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.764 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -100.29 116.7 32.88 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.88 121.3 49.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.759 0.79 . . . . 0.0 112.913 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 65.1 mt -105.9 116.25 49.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.1 mt -99.63 140.29 19.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -84.36 124.51 31.37 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.6 -167.33 42.52 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 107.756 -2.137 . . . . 0.0 107.756 -169.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -86.53 -47.55 9.14 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.255 -1.378 . . . . 0.0 107.609 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 42.2 t30 171.86 113.76 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.447 ' O ' ' HE2' ' A' ' 80' ' ' LYS . 28.0 ttt -72.36 89.31 1.22 Allowed 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.361 0.601 . . . . 0.0 109.728 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.291 -1.938 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -177.275 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.28 -16.37 59.8 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 1' ' ' MET . 19.6 t70 -105.46 168.44 9.09 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.4 m -77.22 -28.6 53.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 118.93 0.787 . . . . 0.0 110.386 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.64 94.23 0.2 Allowed Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -76.31 119.74 20.61 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 123.211 0.605 . . . . 0.0 111.06 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.2 139.91 50.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -137.65 163.7 30.63 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -151.4 149.53 29.41 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.757 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 25.5 ptm -132.03 142.33 49.53 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -153.04 159.68 31.91 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.72 146.6 97.01 Favored 'Trans proline' 0 C--O 1.258 1.525 0 C-N-CA 122.894 2.396 . . . . 0.0 114.455 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -105.13 136.58 44.36 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.556 HG13 ' H ' ' A' ' 16' ' ' GLU . 6.4 tp -122.42 125.01 72.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 175.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 19' ' ' SER . 19.5 m -61.67 -20.43 63.42 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 121.179 0.514 . . . . 0.0 111.316 -176.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.556 ' H ' HG13 ' A' ' 14' ' ' ILE . 34.6 tt0 -79.66 -44.33 21.09 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.451 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.478 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 13.4 mptt -95.94 -40.19 9.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.11 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 21' ' ' SER . 25.8 m -77.07 10.11 2.57 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.319 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 15' ' ' SER . 37.9 t -70.19 -27.23 64.34 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 171.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -135.99 -29.4 1.02 Allowed 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.826 179.048 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 18' ' ' SER . 29.0 p -142.38 153.72 44.02 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -175.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 34.7 mt -89.6 126.18 35.52 Favored 'General case' 0 CA--C 1.481 -1.711 0 CA-C-O 121.318 0.58 . . . . 0.0 110.095 171.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.01 108.92 20.69 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -177.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 61' ' ' VAL . 66.8 mt -106.41 120.26 49.16 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 24' ' ' ILE . 31.5 Cg_exo -61.42 158.23 37.12 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.5 2.8 . . . . 0.0 114.156 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.65 -39.19 64.83 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.376 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.54 -36.85 79.68 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.721 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -88.47 -29.17 20.36 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.567 -0.453 . . . . 0.0 109.81 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.12 -45.61 93.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.685 0.755 . . . . 0.0 109.107 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.88 -21.58 63.32 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.815 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -67.92 -28.05 67.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.238 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -149.15 84.33 6.3 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-O 121.77 0.795 . . . . 0.0 111.711 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -86.6 134.34 3.94 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 C-N-CA 121.896 1.73 . . . . 0.0 111.559 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.47 161.13 29.94 Favored Pre-proline 0 C--N 1.275 -2.672 0 CA-C-N 114.051 -1.431 . . . . 0.0 107.199 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -55.23 140.18 81.22 Favored 'Trans proline' 0 C--N 1.354 0.849 0 N-CA-C 107.603 -1.73 . . . . 0.0 107.603 170.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.498 ' HB3' ' HB2' ' A' ' 56' ' ' LYS . 54.1 p90 -69.09 124.2 89.86 Favored Pre-proline 0 N--CA 1.413 -2.302 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -171.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -84.86 160.51 11.97 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 123.08 2.52 . . . . 0.0 108.796 172.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.04 -46.83 13.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.888 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 m -128.73 151.89 49.03 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.702 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 m -146.95 163.24 8.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 125.543 1.537 . . . . 0.0 107.857 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -118.91 143.26 47.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.3 mt -109.26 120.94 44.04 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.49 139.54 47.98 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.05 0.452 . . . . 0.0 110.79 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 29.0 t70 -120.86 156.02 32.87 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.896 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.33 -12.24 59.93 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 m -91.21 8.84 33.84 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.242 0.544 . . . . 0.0 110.393 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.01 -6.87 69.56 Favored Glycine 0 CA--C 1.497 -1.058 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.559 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 27.9 mmt180 -73.53 146.84 44.53 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.6 p -152.11 137.8 17.88 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -132.06 115.73 16.16 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.8 m -86.02 114.76 23.16 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.529 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 9.5 p -116.68 152.87 18.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.403 -172.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -101.07 129.0 46.87 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.419 0.628 . . . . 0.0 110.796 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.462 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 25.2 ttt -110.0 138.13 46.81 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.172 -172.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.2 OUTLIER -130.91 127.09 37.78 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.938 175.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 27.3 mmmt -92.73 116.8 29.35 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 169.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -144.79 103.86 3.95 Favored 'General case' 0 C--N 1.269 -2.929 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.046 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.85 -106.07 1.28 Allowed Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.885 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.44 -18.02 26.14 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.153 -0.524 . . . . 0.0 111.464 -175.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -137.01 170.39 16.19 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -172.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.47 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 58.8 t -113.56 129.22 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 174.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -118.32 130.48 56.05 Favored 'General case' 0 C--N 1.28 -2.428 0 C-N-CA 119.086 -1.045 . . . . 0.0 108.959 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 92.5 mt -103.06 102.96 13.0 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.1 p -87.54 -127.01 0.05 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.68 139.68 15.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.681 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 52' ' ' VAL . . . 115.26 -44.13 1.54 Allowed Glycine 0 N--CA 1.417 -2.629 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -172.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -67.98 -27.98 67.04 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.549 ' HA ' HG12 ' A' ' 71' ' ' VAL 0.264 0.0 OUTLIER -68.17 -26.37 65.72 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.922 -179.733 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -72.25 -32.72 66.94 Favored 'General case' 0 C--O 1.196 -1.756 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -70.8 -51.64 25.57 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 122.959 0.504 . . . . 0.0 110.161 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 68' ' ' GLU . 7.7 p -59.61 -39.52 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.2 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.659 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 9.7 mmpt? -72.5 -48.01 44.03 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.487 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.49 -39.65 74.06 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.05 -18.75 24.05 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.5 t30 50.98 89.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.085 1.354 . . . . 0.0 112.965 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.8 mt -129.18 169.12 15.18 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.045 0.45 . . . . 0.0 111.475 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -143.6 170.39 15.93 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 124.363 1.065 . . . . 0.0 108.652 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -65.58 139.97 58.49 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.619 0.574 . . . . 0.0 109.57 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.05 -36.73 3.33 Favored Glycine 0 C--N 1.299 -1.488 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -93.22 147.31 23.01 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -124.39 158.76 31.96 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.497 -170.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.507 ' CD1' HG22 ' A' ' 96' ' ' ILE . 1.8 mm? -119.1 129.33 55.0 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.536 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.519 ' CG ' ' HB ' ' A' ' 95' ' ' ILE . 19.0 pt20 -111.87 124.77 53.06 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 169.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -107.08 130.48 54.67 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.7 mt -96.92 123.2 49.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -106.68 129.59 54.55 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.48 -167.77 1.84 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -91.64 -10.35 40.7 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.801 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 90' ' ' ARG . 8.5 m-20 -102.15 -162.43 0.92 Allowed 'General case' 0 N--CA 1.41 -2.47 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.217 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.423 ' H ' ' HB3' ' A' ' 89' ' ' ASP . 95.9 mtt180 -94.94 36.31 1.21 Allowed 'General case' 0 C--N 1.283 -2.292 0 CA-C-O 121.047 0.451 . . . . 0.0 111.663 -170.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.6 p -113.09 117.55 32.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.956 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -105.68 132.93 51.22 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -109.24 122.83 48.17 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.25 126.96 56.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.519 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 40.1 mm -116.77 118.09 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.507 HG22 ' CD1' ' A' ' 82' ' ' LEU . 31.4 pt -93.41 139.05 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.29 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -91.05 117.15 29.36 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -78.33 63.66 3.6 Favored Glycine 0 C--N 1.311 -0.85 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -100.58 106.05 17.52 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-O 120.868 0.366 . . . . 0.0 110.085 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -175.72 -58.69 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.406 ' HG3' ' N ' ' A' ' 102' ' ' CYS . 23.5 ptm -166.48 -53.22 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.07 -1.423 . . . . 0.0 108.535 173.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.406 ' N ' ' HG3' ' A' ' 101' ' ' MET . 74.8 m . . . . . 0 N--CA 1.439 -1.014 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 CA--C 1.5 -0.973 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.08 99.21 3.41 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -152.6 113.32 4.13 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.9 m -97.43 -15.18 20.76 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.375 0.607 . . . . 0.0 110.375 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.42 -15.72 60.65 Favored Glycine 0 N--CA 1.461 0.333 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -159.93 119.76 2.91 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.76 142.11 44.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.635 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 13.0 pt20 -121.55 144.4 48.75 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -142.15 147.5 36.75 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -139.84 139.1 36.25 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.99 159.49 31.76 Favored Pre-proline 0 C--N 1.312 -1.045 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.12 147.25 93.98 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.136 2.557 . . . . 0.0 113.082 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 82' ' ' LEU . 25.4 m-85 -119.74 139.7 51.88 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.48 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.9 mt -104.08 123.47 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.503 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 23.9 t -61.07 -29.98 70.06 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.12 0.263 . . . . 0.0 111.59 -173.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.84 -43.89 97.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.066 0.46 . . . . 0.0 110.448 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -80.68 -40.34 25.62 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.39 0.614 . . . . 0.0 109.521 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -72.06 -5.53 35.88 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.912 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.2 t -70.9 -23.18 62.23 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 120.884 0.373 . . . . 0.0 110.08 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -127.22 -44.41 1.59 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.595 -174.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.5 p -136.68 151.03 48.82 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 4.1 tt -86.47 114.04 22.9 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.16 126.31 31.91 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.923 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -109.08 127.68 26.83 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.69 137.04 79.5 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.597 2.198 . . . . 0.0 111.148 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.565 ' HA ' HD22 ' A' ' 29' ' ' ASN . 53.3 tp -54.05 -38.74 65.54 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.389 0.676 . . . . 0.0 112.145 -175.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.0 -28.57 72.28 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.578 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.481 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 64.2 t80 -87.37 -22.95 24.74 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.565 HD22 ' HA ' ' A' ' 26' ' ' LEU . 52.9 m-80 -73.71 -23.88 59.85 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.787 0.803 . . . . 0.0 109.423 175.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.97 -16.53 59.32 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.421 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 65.6 t80 -77.11 -27.03 53.93 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.108 -177.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -140.88 104.5 6.25 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.76 136.89 15.55 Favored 'Trans proline' 0 N--CA 1.439 -1.699 0 C-N-CA 122.015 1.81 . . . . 0.0 108.064 168.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.17 145.89 19.36 Favored Pre-proline 0 C--N 1.28 -2.434 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.698 -173.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.1 156.02 36.55 Favored 'Trans proline' 0 C--O 1.241 0.655 0 C-N-CA 122.902 2.402 . . . . 0.0 110.085 173.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.412 ' CD1' ' HB2' ' A' ' 56' ' ' LYS . 98.4 m-85 -69.15 115.28 30.35 Favored Pre-proline 0 N--CA 1.429 -1.516 0 CA-C-O 120.858 0.361 . . . . 0.0 111.874 -176.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -93.88 161.0 2.22 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 123.355 2.704 . . . . 0.0 111.122 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.8 mm -101.25 -53.19 7.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.1 p -129.13 151.43 49.81 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.618 0.723 . . . . 0.0 112.3 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.15 145.84 35.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -109.85 125.86 53.22 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.426 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.17 124.71 52.05 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.726 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.73 142.95 33.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.232 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -110.16 154.63 23.06 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.405 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -59.16 -30.1 67.92 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 124.984 1.313 . . . . 0.0 111.989 -175.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.2 t -82.47 -12.61 57.71 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.732 0.301 . . . . 0.0 110.793 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.32 -2.93 25.17 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.225 -0.988 . . . . 0.0 115.28 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -88.33 149.39 23.79 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 118.138 0.969 . . . . 0.0 110.201 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 p -118.7 146.28 44.85 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.608 0.242 . . . . 0.0 111.538 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.478 ' CE3' ' HD1' ' A' ' 70' ' ' PHE . 23.0 m-90 -131.57 124.95 31.08 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.861 173.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.0 m -92.34 114.03 26.47 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.8 t -105.46 157.6 6.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.234 -174.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -100.0 120.32 39.63 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.7 ttt -115.69 130.26 56.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.954 -173.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -130.7 135.67 48.05 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HD2' HG22 ' A' ' 61' ' ' VAL . 1.4 mmmp? -92.73 129.55 38.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -140.12 98.72 3.51 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.134 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.61 -99.31 0.12 Allowed Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.585 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -89.42 -23.29 22.19 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.512 -0.344 . . . . 0.0 110.563 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -134.69 169.79 16.79 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -168.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.478 HG22 ' HD2' ' A' ' 56' ' ' LYS . 42.1 t -134.89 142.19 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.81 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -138.09 144.64 41.0 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 6.2 mp -91.44 106.37 18.44 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 172.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.6 p -72.56 -155.23 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.939 -1.028 . . . . 0.0 113.149 -173.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 p -57.78 128.26 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-O 121.743 0.782 . . . . 0.0 111.2 -172.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 136.66 -38.6 1.74 Allowed Glycine 0 CA--C 1.485 -1.79 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -60.87 -26.85 67.7 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.143 0.973 . . . . 0.0 108.864 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 33.5 tt0 -56.61 -36.65 69.67 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.887 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.481 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 87.5 m-20 -66.41 -36.25 82.35 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.478 ' HD1' ' CE3' ' A' ' 50' ' ' TRP . 92.2 t80 -72.68 -44.9 61.2 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.909 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 68' ' ' GLU . 7.3 p -62.62 -43.83 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 68' ' ' GLU 0.324 0.0 OUTLIER -72.37 -38.45 68.52 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 177.76 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -77.54 -39.36 46.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -84.18 -19.59 33.81 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.9 t30 65.61 90.3 0.09 Allowed 'General case' 0 C--O 1.247 0.969 0 C-N-CA 124.753 1.221 . . . . 0.0 110.935 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.5 mt -130.72 139.81 50.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.884 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.34 171.1 14.88 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.503 ' H ' ' HB2' ' A' ' 15' ' ' SER . 4.5 p30 -65.99 136.95 56.75 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.217 0.532 . . . . 0.0 110.629 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.31 -30.09 3.93 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -89.39 153.35 20.92 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.403 ' C ' HD12 ' A' ' 82' ' ' LEU . 77.4 m-85 -122.74 147.21 46.75 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -178.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.413 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 6.1 mp -122.34 134.09 54.65 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.136 -177.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -111.07 126.45 54.82 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 85.6 m-85 -114.82 126.93 55.38 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.2 mt -98.06 116.97 42.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.409 ' HA ' ' CD1' ' A' ' 92' ' ' PHE . 64.8 m-85 -106.87 123.92 48.87 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.305 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -105.59 -161.52 0.81 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -93.92 13.55 22.35 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.892 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -102.87 -162.91 0.95 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.44 23.72 13.64 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 m -117.97 118.65 32.54 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 86' ' ' TYR . 19.1 m-85 -122.81 152.4 40.72 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.326 -177.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -111.15 126.49 54.9 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.952 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.15 129.88 55.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.53 0.681 . . . . 0.0 111.44 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.61 119.8 62.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.401 HG22 ' HG ' ' A' ' 82' ' ' LEU . 34.5 pt -93.26 139.79 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 CA-C-O 121.072 0.463 . . . . 0.0 110.557 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -92.99 112.21 24.09 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 128.79 172.11 13.11 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -156.81 -175.8 5.63 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -57.49 111.04 0.98 Allowed 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.312 0.382 . . . . 0.0 111.05 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.5 tpt 178.11 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.425 -1.706 0 CA-C-N 114.194 -1.366 . . . . 0.0 109.191 176.858 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.675 0 CA-C-O 121.855 0.836 . . . . 0.0 111.586 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.34 -166.53 1.37 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -66.92 105.59 1.66 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.4 m -79.7 -30.8 41.15 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.097 -172.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.36 -143.87 8.43 Favored Glycine 0 N--CA 1.426 -1.994 0 C-N-CA 119.713 -1.232 . . . . 0.0 113.261 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' A' ' 87' ' ' ASP . 42.5 tt0 53.34 77.84 0.16 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 125.224 1.41 . . . . 0.0 112.094 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.5 m -106.78 146.38 13.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.399 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -114.51 144.17 43.79 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.123 0.487 . . . . 0.0 110.392 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -145.5 148.26 33.04 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.577 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 26.7 ptm -139.17 152.22 47.23 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.377 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -154.65 158.66 32.26 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.77 146.21 71.77 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.877 1.718 . . . . 0.0 110.634 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -84.43 122.68 29.31 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 16' ' ' GLU . 49.2 mm -110.47 117.06 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.138 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 p -60.61 -12.32 9.78 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.2 tm-20 -76.28 -44.7 35.95 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -105.3 -42.54 5.23 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.402 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.66 ' HA ' ' O ' ' A' ' 21' ' ' SER . 9.7 m -72.01 0.61 8.96 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.331 -173.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.511 ' O ' HG11 ' A' ' 71' ' ' VAL . 27.7 t -75.04 -28.12 60.31 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 175.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -136.9 -14.4 1.6 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 18' ' ' SER . 50.3 m -149.15 169.56 20.43 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 23' ' ' GLU . 2.6 tm? -128.17 133.57 48.93 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.354 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.431 ' N ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -98.7 129.39 45.16 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.322 -174.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.546 ' HB ' HG23 ' A' ' 61' ' ' VAL . 46.4 mm -113.05 129.71 24.26 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -65.48 141.96 69.73 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 122.41 2.073 . . . . 0.0 110.061 172.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 6.7 mp -63.23 -22.92 67.18 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.69 -36.41 91.62 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.369 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 68.0 t80 -83.89 -32.92 24.91 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . 17.6 t30 -60.55 -47.89 84.2 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.374 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.77 -11.95 60.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.447 -175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 82.3 t80 -75.17 -25.9 58.67 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.135 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.11 91.93 18.84 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.57 135.88 7.17 Favored 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 122.093 1.862 . . . . 0.0 109.704 171.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.27 160.74 30.58 Favored Pre-proline 0 C--N 1.28 -2.42 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.38 141.95 80.82 Favored 'Trans proline' 0 C--O 1.246 0.881 0 N-CA-C 106.914 -1.995 . . . . 0.0 106.914 166.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -69.02 120.78 78.73 Favored Pre-proline 0 N--CA 1.414 -2.253 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.355 -173.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.59 144.62 50.14 Favored 'Trans proline' 0 C--O 1.256 1.424 0 C-N-CA 122.33 2.02 . . . . 0.0 110.629 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.4 mm -80.9 -57.34 4.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 m -126.94 156.5 41.41 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.168 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 90' ' ' ARG . 74.5 t -137.18 149.18 25.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 125.013 1.325 . . . . 0.0 107.827 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -121.95 145.83 47.73 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.06 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.432 ' CD2' ' HB2' ' A' ' 92' ' ' PHE . 66.3 mt -108.93 138.45 45.25 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.45 153.25 19.86 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.597 0.713 . . . . 0.0 112.905 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.501 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 9.0 t70 -111.25 161.8 15.64 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.992 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -70.22 -32.9 70.99 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.437 -173.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 m -102.6 -56.45 2.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.57 -6.43 0.03 OUTLIER Glycine 0 C--N 1.321 -0.274 0 C-N-CA 118.332 -1.89 . . . . 0.0 115.53 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.531 ' HA ' ' HE ' ' A' ' 48' ' ' ARG . 1.8 mmp_? -73.17 157.69 36.71 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 118.104 0.952 . . . . 0.0 110.918 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.4 m -144.07 134.74 24.95 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.501 ' CH2' ' HB2' ' A' ' 44' ' ' ASP . 19.4 m-90 -112.74 117.52 32.43 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.836 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.6 m -85.89 114.54 22.89 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.681 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.55 154.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.39 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -104.31 118.78 37.46 Favored 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 119.756 -0.778 . . . . 0.0 108.99 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.47 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 55.8 ttp -111.14 146.48 36.77 Favored 'General case' 0 CA--C 1.475 -1.919 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.48 132.37 27.62 Favored 'General case' 0 N--CA 1.406 -2.659 0 C-N-CA 117.814 -1.554 . . . . 0.0 112.065 -176.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.725 ' HD2' ' CG1' ' A' ' 61' ' ' VAL . 29.1 mmmt -91.19 107.72 19.39 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 170.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -120.59 98.8 6.2 Favored 'General case' 0 C--N 1.252 -3.674 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.42 -108.79 2.6 Favored Glycine 0 N--CA 1.422 -2.254 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.213 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.71 2.25 20.0 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 122.969 -0.136 . . . . 0.0 110.926 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.43 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.8 ptpt -131.31 156.24 45.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.725 ' CG1' ' HD2' ' A' ' 56' ' ' LYS . 16.3 m -122.51 134.46 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 CA-C-O 121.699 0.762 . . . . 0.0 112.221 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -142.81 139.63 31.02 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 54' ' ' MET . 5.6 mp -90.49 109.1 20.24 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.4 p -79.68 -152.25 0.07 Allowed 'General case' 0 N--CA 1.425 -1.723 0 O-C-N 123.846 0.716 . . . . 0.0 111.74 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.13 143.26 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.173 0.989 . . . . 0.0 111.147 -175.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.61 -38.45 2.44 Favored Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -59.64 -23.93 63.44 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.97 0.89 . . . . 0.0 110.24 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.648 ' HA ' HG12 ' A' ' 71' ' ' VAL . 39.1 tt0 -64.03 -26.04 68.39 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.299 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.52 -37.32 87.13 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.266 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.408 ' HA ' ' CD1' ' A' ' 50' ' ' TRP . 66.7 t80 -73.17 -50.13 24.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.699 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -62.2 -45.1 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.372 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.02 -41.53 67.43 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.89 -39.82 95.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.983 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.54 -13.86 33.75 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.288 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.8 t30 55.29 79.87 0.14 Allowed 'General case' 0 C--O 1.235 0.305 0 O-C-N 124.119 0.887 . . . . 0.0 109.958 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 pp -136.34 158.64 43.94 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.74 174.96 10.35 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.112 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -51.65 142.18 15.05 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 124.051 0.845 . . . . 0.0 111.187 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.04 -27.22 5.93 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -95.21 163.19 13.38 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -128.8 144.1 51.08 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.546 -175.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 0.9 OUTLIER -136.65 145.86 45.29 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.312 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.577 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 69.7 mt-30 -111.53 142.78 43.37 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -108.61 117.42 34.12 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 93' ' ' TYR . 1.9 mp -100.04 115.8 41.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.436 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 92.7 t80 -119.57 124.98 47.69 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.641 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.453 ' HA ' ' H ' ' A' ' 6' ' ' GLU . 34.4 t70 -114.3 162.05 17.09 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 173.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -66.46 89.07 0.14 Allowed 'General case' 0 C--O 1.244 0.777 0 CA-C-N 119.196 0.907 . . . . 0.0 111.83 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -165.36 -157.81 0.35 Allowed 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.516 ' O ' HG13 ' A' ' 40' ' ' VAL . 68.6 mtm180 -124.98 30.43 5.88 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 t -136.71 141.43 43.07 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.467 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 64.9 m-85 -115.62 148.61 39.44 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.354 0.597 . . . . 0.0 111.187 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.415 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 91.2 t80 -108.66 131.57 54.77 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 172.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 61.9 t -112.24 130.71 65.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.034 0.445 . . . . 0.0 112.147 -173.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 74.6 mt -105.78 116.14 48.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -100.76 140.24 20.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.14 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -104.26 112.63 25.73 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.777 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 174.17 -122.17 0.88 Allowed Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -98.72 -37.71 9.38 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 67.84 113.54 0.04 OUTLIER 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.719 1.208 . . . . 0.0 111.617 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -81.55 175.65 10.33 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.899 -178.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.424 -1.733 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.39 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 tmm? . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.48 81.12 0.13 Allowed 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.89 0.744 . . . . 0.0 110.108 -177.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 65.04 87.66 0.11 Allowed 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.352 -173.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.0 m -79.77 -35.71 38.25 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.325 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.19 -178.29 19.65 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.39 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 87' ' ' ASP . 39.0 tt0 60.84 85.64 0.11 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.13 0.972 . . . . 0.0 112.162 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.5 m -113.19 159.27 13.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -130.47 143.12 50.56 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.546 ' CZ ' ' HG3' ' A' ' 25' ' ' PRO . 79.1 t80 -142.2 148.87 38.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.441 ' HG2' ' HB3' ' A' ' 83' ' ' GLN . 82.6 mtp -123.66 140.57 52.86 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.38 157.96 55.26 Favored Pre-proline 0 C--N 1.31 -1.144 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.759 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.09 147.11 11.61 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.703 2.269 . . . . 0.0 110.363 174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -87.34 126.46 34.87 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.29 117.71 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.6 p -65.9 -14.62 61.85 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -83.82 -37.1 22.96 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.94 0.4 . . . . 0.0 111.104 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -106.2 -41.79 5.25 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.015 -174.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 21' ' ' SER . 19.5 m -77.96 0.41 24.4 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.874 -173.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.9 m -75.38 -18.31 59.98 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.848 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.8 -23.22 0.86 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.975 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 18' ' ' SER . 21.1 m -132.52 142.07 49.03 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.22 0.533 . . . . 0.0 111.523 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 4.1 tt -93.89 126.83 39.32 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -95.83 114.38 26.1 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 123.452 0.701 . . . . 0.0 110.764 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.9 mt -106.36 126.31 30.78 Favored Pre-proline 0 C--O 1.248 1.022 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.083 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.546 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 9.4 Cg_endo -53.55 139.96 65.55 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 123.706 2.937 . . . . 0.0 113.335 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 6.3 tt -58.85 -43.7 90.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.817 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.07 -24.16 71.62 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.299 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.553 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 73.6 t80 -81.73 -34.48 30.5 Favored 'General case' 0 C--O 1.212 -0.871 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.547 HD22 ' C ' ' A' ' 59' ' ' GLU . 41.2 t30 -76.28 -33.51 59.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.295 0.569 . . . . 0.0 109.949 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.44 -24.26 66.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.895 0.855 . . . . 0.0 109.572 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.553 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 24.7 t80 -68.32 -26.4 65.6 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.181 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -143.23 98.32 5.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-O 121.223 0.535 . . . . 0.0 112.313 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.472 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.3 Cg_exo -79.92 133.72 10.27 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 N-CA-C 110.095 -0.771 . . . . 0.0 110.095 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.13 160.33 31.09 Favored Pre-proline 0 C--N 1.274 -2.716 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.689 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.99 144.26 63.44 Favored 'Trans proline' 0 C--O 1.246 0.916 0 N-CA-C 107.467 -1.782 . . . . 0.0 107.467 168.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.523 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 45.1 p90 -68.93 138.48 90.22 Favored Pre-proline 0 N--CA 1.418 -2.029 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -173.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 36' ' ' PHE . 6.0 Cg_exo -78.7 160.76 27.93 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.766 2.311 . . . . 0.0 109.778 173.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 38' ' ' ILE . 2.2 mp -93.22 -37.5 8.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -150.64 152.86 34.64 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -178.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.62 163.95 22.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 124.513 1.125 . . . . 0.0 108.846 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -120.11 137.44 54.14 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.261 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.5 mt -108.7 123.42 48.96 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.97 141.84 34.18 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.262 0.553 . . . . 0.0 110.994 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -113.23 145.6 40.73 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -58.43 -27.12 64.03 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.7 t -79.59 -4.58 52.17 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.105 0.478 . . . . 0.0 110.511 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.46 2.16 50.43 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.005 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -82.55 150.66 26.8 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.3 p -144.44 136.64 26.33 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.196 0.522 . . . . 0.0 111.709 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -120.1 123.94 44.61 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.511 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.3 m -89.93 117.73 28.96 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.16 157.94 33.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.613 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -99.68 120.13 39.21 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.046 0.45 . . . . 0.0 110.624 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.422 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 23.7 ttt -122.3 124.16 43.1 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 124.277 1.031 . . . . 0.0 110.044 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -125.51 130.88 52.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.886 0.374 . . . . 0.0 111.916 178.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.523 ' H ' ' HB2' ' A' ' 36' ' ' PHE . 55.9 tttp -98.05 122.68 41.47 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 122.121 0.963 . . . . 0.0 109.451 173.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -147.7 98.66 3.0 Favored 'General case' 0 C--N 1.252 -3.65 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.51 -164.29 30.42 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -174.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.547 ' C ' HD22 ' A' ' 29' ' ' ASN . 14.9 mm-40 -90.97 2.39 56.32 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.44 142.68 49.02 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.406 HG23 ' ND2' ' A' ' 29' ' ' ASN . 95.6 t -114.49 131.84 65.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.136 0.493 . . . . 0.0 111.043 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 97.4 m-85 -119.42 131.55 55.67 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 6.5 mp -86.83 112.3 21.6 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 p -66.11 -164.49 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.138 0 O-C-N 124.777 1.298 . . . . 0.0 112.902 -176.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.24 143.12 10.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.493 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.57 -38.61 2.58 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -173.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 20.1 t-105 -58.48 -24.42 60.37 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.015 0.912 . . . . 0.0 109.636 173.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.602 ' HA ' HG12 ' A' ' 71' ' ' VAL . 11.5 pt-20 -57.74 -30.0 65.23 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.39 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -62.24 -35.86 80.23 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.129 0.49 . . . . 0.0 110.668 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -74.29 -48.01 31.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.603 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.9 p -64.7 -40.38 88.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.19 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -71.07 -33.02 69.83 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.621 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.31 -40.14 45.37 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.062 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 100' ' ' ASN . 13.1 m120 -97.94 -1.74 42.14 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' HB2' ' ND2' ' A' ' 100' ' ' ASN . 14.2 m120 42.22 80.1 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -176.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.4 mt -103.23 147.35 27.15 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.21 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.418 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 11.4 pt-20 -143.8 171.65 13.92 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.107 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.11 138.3 58.51 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.15 -19.66 24.63 Favored Glycine 0 C--N 1.301 -1.392 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -173.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HD2' ' H ' ' A' ' 77' ' ' GLU . 57.3 mttp -96.58 159.22 15.05 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -134.1 150.95 51.19 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -173.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HG ' HG22 ' A' ' 96' ' ' ILE . 4.6 mp -130.35 137.11 49.74 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.459 ' HG3' ' HB ' ' A' ' 95' ' ' ILE . 11.6 pt20 -118.75 138.57 52.57 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -116.32 131.0 57.07 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.324 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 65.2 mt -101.54 116.03 44.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 172.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.639 ' CE2' ' HA ' ' A' ' 88' ' ' ARG . 48.8 t80 -122.07 123.81 42.46 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.757 -173.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.48 ' HA ' ' H ' ' A' ' 6' ' ' GLU . 25.3 m-20 -84.26 -1.38 55.16 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.639 ' HA ' ' CE2' ' A' ' 86' ' ' TYR . 67.8 ttt180 70.08 81.94 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -171.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 20.4 t70 -177.26 -155.24 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 -167.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.433 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -107.38 11.15 29.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.3 m -109.64 126.37 53.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.54 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -127.62 135.13 49.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.641 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.46 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 84.7 m-85 -109.25 123.49 49.35 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.54 124.15 64.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.433 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.459 ' HB ' ' HG3' ' A' ' 83' ' ' GLN . 2.4 mp -114.05 116.85 53.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.438 HG22 ' HG ' ' A' ' 82' ' ' LEU . 35.1 pt -100.8 140.64 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 123.218 0.607 . . . . 0.0 112.231 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -101.52 134.78 44.1 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.33 77.57 1.22 Allowed Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -86.33 96.39 9.96 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 122.786 -0.243 . . . . 0.0 111.41 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 74' ' ' ASN . 5.9 t30 -81.11 104.21 11.44 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -112.58 112.73 24.47 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -177.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 43.5 t . . . . . 0 N--CA 1.428 -1.534 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -178.742 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 CA--C 1.502 -0.874 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.79 88.19 2.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 175.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -108.23 88.51 2.75 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.641 0.734 . . . . 0.0 110.221 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.6 m -93.59 -28.15 16.2 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.69 121.6 0.83 Allowed Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.896 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.84 136.89 15.51 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.904 0.352 . . . . 0.0 110.369 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.8 m -139.99 140.73 35.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -130.64 143.05 50.49 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -149.7 147.0 27.54 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.624 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 23.3 ptp -141.61 134.93 29.46 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.418 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.6 159.57 31.53 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 166.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 33.4 Cg_exo -60.82 132.73 43.98 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 N-CA-C 108.295 -1.463 . . . . 0.0 108.295 173.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -86.01 140.26 30.45 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.354 -175.082 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.503 HG22 ' H ' ' A' ' 16' ' ' GLU . 2.0 mp -90.69 125.08 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.509 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 11.9 p -60.57 -19.03 56.31 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.826 0.85 . . . . 0.0 112.708 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.503 ' H ' HG22 ' A' ' 14' ' ' ILE . 41.4 tt0 -63.48 -44.78 93.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.703 176.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -87.73 -40.47 14.08 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.487 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.576 ' HB2' ' CD1' ' A' ' 13' ' ' PHE . 35.6 t -61.96 -10.0 8.53 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 124.119 0.887 . . . . 0.0 112.285 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.5 p -57.85 -43.49 85.93 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.899 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 68' ' ' GLU . 64.4 mttm -144.38 -2.05 0.89 Allowed 'General case' 0 C--N 1.344 0.359 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -148.11 153.79 39.33 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 118.943 0.792 . . . . 0.0 112.476 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 5.2 tt -101.21 113.42 26.44 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -71.54 113.99 9.15 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.162 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.424 HD12 HG12 ' A' ' 61' ' ' VAL . 65.6 mt -93.7 128.5 41.65 Favored Pre-proline 0 C--N 1.288 -2.096 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.453 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 58.7 Cg_exo -53.71 137.74 67.32 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.959 2.439 . . . . 0.0 112.198 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.435 ' O ' HD23 ' A' ' 26' ' ' LEU . 5.8 tt -64.67 -32.4 74.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.48 -29.39 73.31 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.614 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 25' ' ' PRO . 46.6 t80 -65.41 -49.59 68.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -65.8 -39.75 91.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.567 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.06 -38.17 87.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.395 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -73.15 -28.68 62.37 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.947 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -166.18 127.1 1.29 Allowed Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 120.634 0.254 . . . . 0.0 111.629 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.33 136.79 24.72 Favored 'Trans proline' 0 N--CA 1.42 -2.81 0 N-CA-C 107.872 -1.626 . . . . 0.0 107.872 168.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.43 146.86 55.85 Favored Pre-proline 0 C--N 1.266 -3.047 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.527 ' O ' ' HD3' ' A' ' 37' ' ' PRO . 14.3 Cg_endo -59.64 140.68 94.82 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.019 1.813 . . . . 0.0 109.884 175.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 26.8 p90 -83.45 110.63 25.64 Favored Pre-proline 0 N--CA 1.407 -2.602 0 CA-C-O 121.115 0.483 . . . . 0.0 111.287 -178.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 35' ' ' PRO . 27.1 Cg_endo -87.83 136.02 3.58 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 122.554 2.169 . . . . 0.0 111.57 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.22 -52.74 54.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.245 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.5 p -123.95 150.11 45.15 Favored 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.904 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.3 t -135.9 157.13 38.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -126.46 135.97 52.04 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.678 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.9 mt -108.54 127.52 54.01 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.86 138.16 42.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 120.908 0.385 . . . . 0.0 110.206 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -112.68 142.18 45.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -69.87 -3.71 17.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -175.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -82.86 -14.53 54.12 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.64 -13.88 10.77 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.263 -0.97 . . . . 0.0 115.505 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HD3' ' CZ2' ' A' ' 50' ' ' TRP . 75.7 ttt180 -89.97 153.13 20.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.718 1.259 . . . . 0.0 110.806 -176.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.3 p -127.37 140.92 51.86 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.212 0.605 . . . . 0.0 110.963 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.423 ' CZ2' ' HD3' ' A' ' 48' ' ' ARG . 15.9 m-90 -125.85 128.13 47.14 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.419 0.287 . . . . 0.0 110.227 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.1 m -92.07 121.17 33.38 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.43 0.633 . . . . 0.0 109.779 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HB ' HD21 ' A' ' 63' ' ' LEU . 34.7 m -126.05 158.34 35.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 124.792 1.237 . . . . 0.0 111.589 -172.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -102.36 127.42 49.37 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.085 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.2 ttt -111.23 120.81 43.5 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -124.95 125.31 43.72 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.713 -175.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -107.9 115.5 30.25 Favored 'General case' 0 CA--C 1.479 -1.761 0 CA-C-O 122.156 0.979 . . . . 0.0 110.038 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -148.82 102.48 3.28 Favored 'General case' 0 C--N 1.247 -3.866 0 CA-C-N 113.45 -1.705 . . . . 0.0 108.408 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.88 -143.53 15.82 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.024 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.88 -6.03 54.73 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.71 0.291 . . . . 0.0 111.641 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.1 170.07 13.96 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 121.004 0.431 . . . . 0.0 110.834 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.424 HG12 HD12 ' A' ' 24' ' ' ILE . 40.9 t -132.46 129.6 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -124.61 131.68 53.46 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 5.7 tt -102.93 113.5 27.01 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 175.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -103.49 -98.47 0.3 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -169.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.25 135.42 28.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -172.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' C ' HG12 ' A' ' 52' ' ' VAL . . . 115.02 -42.19 1.98 Allowed Glycine 0 N--CA 1.425 -2.081 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.475 -176.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' A' ' 18' ' ' SER . 55.7 t-105 -59.18 -26.45 64.82 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.513 0.673 . . . . 0.0 110.426 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.54 ' HA ' HG12 ' A' ' 71' ' ' VAL . 17.1 pt-20 -71.24 -26.52 62.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.315 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -68.97 -29.42 67.64 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.379 0.609 . . . . 0.0 109.636 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -73.97 -49.16 25.8 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 124.593 1.157 . . . . 0.0 109.388 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.8 p -63.47 -37.91 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.275 0.56 . . . . 0.0 109.977 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 68.4 mttm -65.3 -46.71 79.3 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.579 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -77.52 -40.84 41.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.032 -1.067 . . . . 0.0 113.737 -172.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -86.77 -15.12 40.31 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.141 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 46.35 72.7 0.21 Allowed 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.371 1.068 . . . . 0.0 112.629 -174.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.506 HD13 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -112.64 137.52 50.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.757 179.083 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -122.01 164.7 17.2 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.9 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 7.8 p-10 -55.77 132.56 49.61 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 123.998 0.811 . . . . 0.0 111.896 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.93 -44.63 1.19 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 33.9 mtmm -80.67 155.03 27.0 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.0 131.26 43.99 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.262 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.449 ' HG ' HG13 ' A' ' 96' ' ' ILE . 6.9 mp -114.45 132.87 56.11 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -109.86 125.91 53.27 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -114.27 117.54 31.42 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.47 117.9 47.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -120.47 127.22 52.02 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 123.495 0.497 . . . . 0.0 110.114 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -84.07 -100.2 0.05 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -150.43 16.5 0.81 Allowed 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -110.16 -177.55 3.28 Favored 'General case' 0 N--CA 1.405 -2.717 0 CA-C-N 114.294 -1.321 . . . . 0.0 107.796 -172.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -95.91 32.08 1.97 Allowed 'General case' 0 C--N 1.264 -3.112 0 C-N-CA 124.3 1.04 . . . . 0.0 108.512 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.3 m -127.74 122.79 33.76 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.326 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -112.8 143.94 43.19 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -111.59 120.44 42.08 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.0 t -111.2 135.41 50.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.779 0.323 . . . . 0.0 111.426 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.4 mt -130.46 124.39 57.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.449 HG13 ' HG ' ' A' ' 82' ' ' LEU . 1.8 mp -96.5 125.16 49.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -96.99 122.72 40.29 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.26 -162.37 28.17 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -108.49 79.05 1.21 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.611 0.72 . . . . 0.0 110.902 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -115.21 -61.29 1.77 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.52 116.65 19.25 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 67.7 m . . . . . 0 C--N 1.29 -1.983 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.909 -176.425 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 CA--C 1.503 -0.837 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.88 -169.02 0.17 Allowed 'General case' 0 C--O 1.238 0.499 0 O-C-N 124.252 0.97 . . . . 0.0 111.109 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -143.47 166.71 24.02 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.2 m -84.19 -21.68 31.19 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 120.883 0.373 . . . . 0.0 111.876 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.4 -104.14 1.46 Allowed Glycine 0 CA--C 1.487 -1.687 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -174.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.13 131.6 38.04 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 174.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m -99.19 140.52 18.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 120.955 0.407 . . . . 0.0 110.277 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -112.02 144.79 40.79 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 83' ' ' GLN . 50.3 p90 -146.26 149.26 33.54 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.8 ptm -127.73 145.44 50.9 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.66 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 25.9 ttpp -153.48 143.35 15.26 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.425 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.72 146.47 83.93 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.5 2.133 . . . . 0.0 109.999 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 8.3 m-85 -103.32 139.25 38.99 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.2 mp -118.72 117.43 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.499 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 20.3 m -57.48 -22.16 41.98 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.782 0.833 . . . . 0.0 112.576 -173.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.07 -38.88 92.67 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.199 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.06 -41.98 8.85 Favored 'General case' 0 CA--C 1.487 -1.46 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.731 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 15' ' ' SER . 79.3 p -65.4 -11.33 41.42 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -170.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.6 t -69.63 -24.03 63.58 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.39 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -138.56 -24.36 0.94 Allowed 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -176.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.45 ' N ' ' HD2' ' A' ' 20' ' ' LYS . 77.2 p -143.25 153.76 43.12 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.6 tt -96.81 122.54 39.88 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 174.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.66 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -92.97 122.77 35.67 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.874 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.446 ' HB ' HD21 ' A' ' 29' ' ' ASN . 61.5 mt -103.68 132.15 21.33 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -57.54 139.26 89.63 Favored 'Trans proline' 0 C--O 1.254 1.311 0 C-N-CA 122.19 1.926 . . . . 0.0 110.622 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.506 ' O ' HD23 ' A' ' 26' ' ' LEU . 5.7 tt -56.57 -30.08 62.76 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.187 0.595 . . . . 0.0 110.885 -175.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.41 -31.5 63.01 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.727 -0.273 . . . . 0.0 112.838 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -87.89 -29.92 20.5 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 122.278 -0.543 . . . . 0.0 110.099 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.475 ' ND2' ' HB ' ' A' ' 61' ' ' VAL . 13.4 m120 -65.82 -34.35 77.95 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.505 0.669 . . . . 0.0 109.638 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -74.83 -27.07 60.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.612 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -78.97 -28.08 43.56 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.166 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . 0.267 31.5 p90 -134.51 78.81 55.69 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 177.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -83.97 135.13 6.43 Favored 'Trans proline' 0 N--CA 1.425 -2.551 0 C-N-CA 121.016 1.144 . . . . 0.0 110.204 170.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.66 160.11 31.59 Favored Pre-proline 0 C--N 1.273 -2.752 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -63.02 136.74 58.19 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 N-CA-C 107.505 -1.767 . . . . 0.0 107.505 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -68.81 120.4 75.74 Favored Pre-proline 0 N--CA 1.418 -2.048 0 CA-C-O 121.356 0.598 . . . . 0.0 112.593 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.49 136.67 12.57 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.69 2.26 . . . . 0.0 110.852 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -64.77 -38.59 83.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.019 0.438 . . . . 0.0 110.078 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.3 p -130.88 150.64 51.95 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 121.241 0.543 . . . . 0.0 110.852 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 90' ' ' ARG . 79.4 t -141.72 149.39 20.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 125.473 1.509 . . . . 0.0 107.163 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.52 135.37 52.18 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.075 0.464 . . . . 0.0 111.494 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' SER . 79.1 mt -108.84 132.0 54.44 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.64 143.99 32.33 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.267 0.556 . . . . 0.0 112.154 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 16.7 t70 -110.35 165.32 11.87 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.36 176.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -53.32 -50.82 64.17 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 125.232 1.413 . . . . 0.0 110.273 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.6 m -73.68 -10.32 59.57 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.788 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.0 9.88 35.95 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.496 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.426 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 98.4 mtt180 -66.94 150.82 48.68 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 74.8 p -138.2 136.33 36.49 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.412 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.487 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 25.5 m-90 -121.15 131.76 54.44 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.829 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.2 m -89.62 114.15 25.71 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.443 HG21 HD23 ' A' ' 63' ' ' LEU . 33.6 m -116.34 157.85 17.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.668 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.401 ' NH2' HG13 ' A' ' 65' ' ' VAL . 7.0 ttp180 -102.01 130.98 48.69 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 28.0 ttt -112.3 136.31 51.9 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -142.12 125.88 17.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.389 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -105.17 128.35 53.35 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.98 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.55 100.03 4.84 Favored 'General case' 0 C--N 1.266 -3.039 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.78 -120.75 11.31 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.259 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -90.33 -7.8 52.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -174.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.76 152.73 32.7 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.475 ' HB ' ' ND2' ' A' ' 29' ' ' ASN . 47.4 t -133.97 124.31 46.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -130.37 153.73 48.42 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 52' ' ' VAL . 5.9 mp -93.37 103.82 16.02 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.6 t -79.3 -153.82 0.08 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 124.235 0.959 . . . . 0.0 111.008 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.401 HG13 ' NH2' ' A' ' 53' ' ' ARG . 7.1 p -61.07 121.85 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-O 122.442 1.115 . . . . 0.0 110.939 -170.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 143.77 -38.62 1.34 Allowed Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 -169.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -60.56 -24.2 65.23 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.042 -1.079 . . . . 0.0 109.278 173.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.536 ' HA ' HG12 ' A' ' 71' ' ' VAL . 39.0 tt0 -56.2 -39.79 73.0 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.589 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -59.21 -37.06 76.53 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-O 120.918 0.39 . . . . 0.0 110.715 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.535 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 78.6 t80 -74.08 -48.66 28.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 68' ' ' GLU . 9.0 p -62.48 -34.83 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 122.131 0.967 . . . . 0.0 109.165 -177.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.64 -47.07 56.91 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.917 -1.492 . . . . 0.0 111.65 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -77.64 -40.77 40.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -172.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -88.08 -16.2 34.18 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.402 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.9 t30 54.11 95.35 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 O-C-N 124.157 0.91 . . . . 0.0 112.204 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 pp -127.12 158.21 37.64 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.285 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -143.8 168.21 20.47 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.415 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 5.8 p-10 -59.08 133.89 56.5 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.227 0.954 . . . . 0.0 110.038 175.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.7 -18.98 12.73 Favored Glycine 0 C--N 1.307 -1.064 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -101.13 162.81 12.63 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -128.04 140.36 52.0 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.63 142.55 51.45 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.064 0.459 . . . . 0.0 110.786 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 64.5 tt0 -114.19 124.68 52.65 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -112.2 130.7 55.83 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.41 116.0 47.38 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -106.22 123.77 48.55 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.12 -171.21 3.48 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.309 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -86.41 -5.87 59.06 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 23.4 t70 -89.27 -150.74 0.21 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 175.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.494 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 16.7 ptt180 -113.03 17.71 18.62 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 92.5 m -101.81 127.22 48.7 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.56 -170.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.65 131.75 54.79 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.643 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -101.84 127.61 48.57 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.535 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 38.3 t -104.21 119.87 53.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.11 124.24 72.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.4 tt -111.97 137.27 45.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 121.316 0.579 . . . . 0.0 110.103 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -92.21 112.78 24.84 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.19 -65.56 0.27 Allowed Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.5 m80 66.84 98.39 0.05 Allowed 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.669 0.747 . . . . 0.0 112.249 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -81.82 107.15 14.32 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.753 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 51.3 ttm -113.34 86.91 2.48 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.672 0.748 . . . . 0.0 109.981 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.42 -1.941 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.377 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.502 -0.877 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.0 91.64 3.6 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.28 103.0 6.96 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.186 -173.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.0 m -120.71 -17.95 7.85 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.898 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.15 171.44 45.59 Favored Glycine 0 N--CA 1.421 -2.335 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.08 111.47 15.32 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.617 0.722 . . . . 0.0 109.506 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -103.9 140.32 22.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.229 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -111.74 145.74 38.8 Favored 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.954 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -143.55 153.91 43.06 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 61.3 mtm -128.13 158.02 39.17 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -154.26 159.9 31.48 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -64.65 135.44 45.31 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.096 1.864 . . . . 0.0 109.843 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.415 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 70.6 t80 -100.16 122.97 43.83 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -114.63 102.15 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.514 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 33.5 t -53.83 -31.8 50.61 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 123.241 0.616 . . . . 0.0 111.367 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.83 -37.39 79.09 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.414 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -101.35 -33.1 10.15 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.907 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' SER . 49.8 p -81.2 1.76 30.7 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.5 m -65.42 -24.77 67.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 119.499 -0.881 . . . . 0.0 111.215 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -116.15 -48.82 2.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.636 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 18' ' ' SER . 43.4 p -130.87 144.98 51.85 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -173.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.0 tm? -103.0 115.18 30.12 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.79 125.27 28.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.7 mt -95.31 131.01 30.7 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.3 132.71 40.36 Favored 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 122.852 2.368 . . . . 0.0 112.137 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.418 ' O ' HD23 ' A' ' 26' ' ' LEU . 6.7 tt -63.37 -32.71 74.21 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.856 -175.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.46 -32.41 81.67 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.172 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -75.07 -35.8 61.82 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -70.72 -31.64 68.56 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.115 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -74.82 -30.38 61.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.42 -27.63 66.37 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.577 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -160.57 87.16 1.82 Allowed Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.317 0.579 . . . . 0.0 111.713 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.21 142.76 21.82 Favored 'Trans proline' 0 N--CA 1.439 -1.704 0 C-N-CA 121.75 1.634 . . . . 0.0 110.396 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.42 153.04 36.67 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.41 144.52 98.28 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 122.489 2.126 . . . . 0.0 109.969 175.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 56' ' ' LYS . 26.8 p90 -70.28 121.33 82.91 Favored Pre-proline 0 N--CA 1.41 -2.474 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.91 159.63 18.49 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.394 2.73 . . . . 0.0 110.219 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.2 mm -70.4 -59.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.349 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.5 p -125.53 151.41 46.38 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.467 HG21 ' SD ' ' A' ' 54' ' ' MET . 97.2 t -139.78 151.42 22.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.53 136.2 52.34 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.557 -0.857 . . . . 0.0 113.285 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 92' ' ' PHE . 3.3 mm? -108.54 120.2 41.73 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.03 153.18 20.14 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.121 0.486 . . . . 0.0 110.735 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 11.5 t70 -112.06 149.22 32.39 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.885 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -70.71 -26.71 63.52 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.734 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.8 m -95.13 -45.87 7.03 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.759 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.07 -32.06 0.04 OUTLIER Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 118.244 -1.932 . . . . 0.0 114.785 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -60.83 158.52 12.84 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 p -149.09 135.78 19.59 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 173.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.51 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 23.7 m-90 -125.75 124.09 40.25 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.546 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.1 m -89.18 114.26 25.54 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 174.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.5 t -115.26 157.77 15.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.944 -172.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -99.91 128.32 46.01 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.467 ' SD ' HG21 ' A' ' 40' ' ' VAL . 27.5 ttt -111.56 123.23 49.8 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -176.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -130.5 129.99 43.6 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.747 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.471 ' H ' ' HB3' ' A' ' 36' ' ' PHE . 27.6 tptp -92.62 127.54 38.15 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 125.003 1.321 . . . . 0.0 108.772 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -142.94 103.85 4.24 Favored 'General case' 0 C--N 1.261 -3.275 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.532 -174.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.74 -121.26 5.94 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -108.98 2.9 21.65 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.427 0.632 . . . . 0.0 109.692 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.504 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 37.1 ttpt -122.58 159.12 28.45 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.316 -175.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.414 HG22 ' HD3' ' A' ' 56' ' ' LYS . 61.4 t -127.83 141.04 47.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.504 ' CZ ' ' HE3' ' A' ' 60' ' ' LYS . 96.7 m-85 -123.12 136.45 54.8 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.043 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 98.4 mt -81.93 103.49 11.62 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 167.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 65' ' ' VAL . 2.0 m -86.15 -154.45 0.21 Allowed 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.917 -167.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.617 ' H ' HG22 ' A' ' 64' ' ' THR . 7.7 p -56.44 122.82 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 121.998 0.904 . . . . 0.0 111.639 -172.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.58 -37.2 2.06 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -171.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.455 ' CE2' ' HB2' ' A' ' 22' ' ' LEU . 12.6 t-105 -57.26 -26.2 60.4 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.554 -0.823 . . . . 0.0 110.774 175.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -53.29 -27.43 22.81 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.07 -174.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -63.01 -29.76 71.07 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.411 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 44.7 t80 -73.73 -54.66 7.56 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.581 0.705 . . . . 0.0 109.545 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.64 -34.76 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.529 -176.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -71.91 -37.92 69.99 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 174.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.6 -40.67 41.33 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.869 -0.733 . . . . 0.0 112.779 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -84.77 -20.84 30.39 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.2 t30 49.13 82.45 0.04 OUTLIER 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.167 1.387 . . . . 0.0 111.757 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.9 pt? -127.45 142.81 51.31 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.447 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -113.99 170.39 8.31 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 15' ' ' SER . 6.1 p-10 -60.56 133.51 56.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 172.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.57 -28.15 5.06 Favored Glycine 0 C--N 1.3 -1.442 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 -172.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -100.08 146.74 26.42 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.462 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 95.0 m-85 -133.81 158.63 42.88 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.68 -174.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.514 HD13 ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -125.94 155.72 40.88 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.281 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -129.14 127.24 41.01 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.236 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.514 ' CE2' HD13 ' A' ' 82' ' ' LEU . 99.9 m-85 -106.09 130.73 53.94 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 59.0 mt -107.36 119.8 57.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -106.12 125.27 50.79 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.371 0.605 . . . . 0.0 112.258 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.73 146.21 27.52 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 89' ' ' ASP . 9.2 mmm180 -66.08 83.28 0.08 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.201 0.455 . . . . 0.0 111.722 -177.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 88' ' ' ARG . 8.6 t70 173.54 -148.71 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 6.3 mpt_? -100.3 24.44 8.78 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 118.426 0.557 . . . . 0.0 109.744 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.0 m -103.54 119.91 39.83 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.56 ' HB2' HD13 ' A' ' 42' ' ' LEU . 80.3 m-85 -125.27 130.71 52.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.39 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 95.7 m-85 -104.22 132.08 50.84 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.411 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 18.3 t -109.76 124.21 66.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.575 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.15 139.8 34.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.429 ' HB ' ' OD1' ' A' ' 100' ' ' ASN . 64.7 mt -115.28 131.74 66.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 120.973 0.416 . . . . 0.0 110.109 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' A' ' 81' ' ' TYR . 43.7 p90 -125.23 167.65 14.56 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.62 49.84 4.7 Favored Glycine 0 C--N 1.3 -1.456 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -173.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 39.5 m80 77.36 82.82 0.08 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.212 1.405 . . . . 0.0 111.63 -176.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.429 ' OD1' ' HB ' ' A' ' 96' ' ' ILE . 7.2 t30 -84.84 92.71 8.33 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 83.6 mtp -96.03 145.84 25.12 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.715 -176.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 16.4 p . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.999 -0.525 . . . . 0.0 110.932 179.542 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.507 -0.709 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.02 117.99 14.26 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.109 0.48 . . . . 0.0 109.802 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.98 122.64 48.24 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.305 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.7 m -81.0 -56.66 3.96 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.01 -157.33 46.46 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.578 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -84.94 121.46 27.79 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m -95.88 140.19 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-O 121.142 0.496 . . . . 0.0 110.448 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 13.5 pt20 -106.23 144.42 32.95 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.897 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -150.19 148.57 29.09 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 83' ' ' GLN . 25.9 ptm -103.72 133.92 47.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.66 128.72 25.09 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.44 133.2 44.65 Favored 'Trans proline' 0 C--O 1.248 1.005 0 C-N-CA 122.522 2.148 . . . . 0.0 112.882 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -93.65 124.64 37.78 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.9 mt -125.8 115.93 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.467 ' HB2' ' H ' ' A' ' 78' ' ' ASP . 15.2 t -66.67 -11.57 54.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.313 0.577 . . . . 0.0 111.35 -172.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -61.19 -43.14 99.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.796 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -108.68 -40.39 5.09 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.937 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' SER . 18.2 m -74.17 8.6 2.03 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -172.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.476 ' O ' HG11 ' A' ' 71' ' ' VAL . 29.2 t -75.02 -19.23 60.14 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -141.63 -33.91 0.49 Allowed 'General case' 0 C--N 1.353 0.748 0 C-N-CA 119.874 -0.731 . . . . 0.0 112.641 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 18' ' ' SER . 63.4 p -139.04 162.61 34.51 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 120.958 0.409 . . . . 0.0 111.35 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.615 HD12 HD13 ' A' ' 63' ' ' LEU . 81.5 mt -103.28 118.21 36.25 Favored 'General case' 0 CA--C 1.485 -1.538 0 O-C-N 120.892 -1.13 . . . . 0.0 113.483 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -77.09 113.98 15.4 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 168.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.546 ' HB ' HG23 ' A' ' 61' ' ' VAL . 66.5 mt -113.18 130.97 23.09 Favored Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 121.49 -0.084 . . . . 0.0 110.827 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -44.36 139.14 6.87 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 124.654 3.569 . . . . 0.0 114.538 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.77 -46.22 90.52 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.133 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.42 -32.73 85.17 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.769 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.5 ' O ' ' HB3' ' A' ' 31' ' ' TYR . 76.7 t80 -76.78 -34.9 57.98 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.483 HD22 ' HA ' ' A' ' 60' ' ' LYS . 40.3 t30 -66.12 -44.7 83.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.991 0.424 . . . . 0.0 110.804 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.85 -13.62 61.8 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.914 0.864 . . . . 0.0 110.457 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.5 ' HB3' ' O ' ' A' ' 28' ' ' PHE . 87.2 t80 -74.68 -18.97 60.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.386 176.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -137.92 94.3 11.51 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -83.13 134.01 6.76 Favored 'Trans proline' 0 N--CA 1.432 -2.144 0 C-N-CA 121.549 1.499 . . . . 0.0 110.417 172.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.75 152.98 28.18 Favored Pre-proline 0 C--N 1.272 -2.776 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.486 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -61.87 150.41 86.21 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 107.786 -1.659 . . . . 0.0 107.786 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -68.12 119.63 68.67 Favored Pre-proline 0 N--CA 1.416 -2.142 0 CA-C-O 121.309 0.576 . . . . 0.0 111.712 -174.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -87.28 159.89 8.32 Favored 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.758 2.306 . . . . 0.0 111.084 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 51.3 mm -85.88 -59.25 2.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.3 p -131.3 156.43 45.46 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.136 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.35 162.44 39.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.27 134.97 55.18 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.688 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.402 HD23 ' HB2' ' A' ' 92' ' ' PHE . 75.0 mt -108.0 125.53 51.65 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.65 137.53 39.84 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.084 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 46' ' ' SER . 0.1 OUTLIER -112.96 142.34 45.75 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 123.517 0.727 . . . . 0.0 110.719 178.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -67.35 -22.16 65.6 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.242 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.44 ' HB2' ' OD2' ' A' ' 44' ' ' ASP . 4.3 m -74.1 -32.46 63.24 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.53 -2.55 4.18 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.962 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -86.28 158.72 19.62 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.043 0.537 . . . . 0.0 110.331 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.8 p -149.66 140.09 22.39 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.6 m-90 -129.32 127.22 40.67 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.786 0.327 . . . . 0.0 111.447 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.8 m -87.66 114.83 24.65 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.3 m -122.17 158.16 26.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.662 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 25.3 ttp180 -101.16 133.93 44.97 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -177.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 55.8 ttp -131.64 148.12 52.57 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.27 146.27 25.27 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.119 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.513 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 63.5 mttm -91.84 128.83 37.82 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -137.45 107.82 6.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.48 -118.59 4.76 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -111.15 -5.46 14.74 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.483 ' HA ' HD22 ' A' ' 29' ' ' ASN . 19.0 ptpt -117.58 170.09 9.03 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.491 0.662 . . . . 0.0 111.273 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.546 HG23 ' HB ' ' A' ' 24' ' ' ILE . 8.4 m -109.62 141.31 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.417 171.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.473 ' CZ ' ' HD2' ' A' ' 60' ' ' LYS . 97.4 m-85 -114.49 131.56 56.59 Favored 'General case' 0 C--N 1.268 -2.978 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 169.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.615 HD13 HD12 ' A' ' 22' ' ' LEU . 6.8 tt -88.13 102.07 14.43 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 173.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.52 ' OG1' ' HG2' ' A' ' 53' ' ' ARG . 20.5 p -71.73 -163.67 0.11 Allowed 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -168.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.7 t -65.96 122.29 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.356 -168.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.37 -31.62 1.04 Allowed Glycine 0 CA--C 1.481 -2.032 0 N-CA-C 107.506 -2.238 . . . . 0.0 107.506 -174.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.509 ' HB2' HD22 ' A' ' 63' ' ' LEU . 59.2 t-105 -58.14 -23.78 56.42 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 113.864 -1.168 . . . . 0.0 109.947 173.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.665 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 28.5 tt0 -56.51 -32.31 64.93 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.133 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -64.5 -35.87 82.37 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 122.633 0.373 . . . . 0.0 110.956 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -73.55 -49.99 23.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.2 p -61.71 -47.48 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.499 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 68' ' ' GLU 0.277 25.6 pttm -73.1 -30.98 64.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 178.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.24 -39.99 65.02 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.591 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -87.24 -21.48 25.81 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 54.22 88.7 0.04 OUTLIER 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.233 1.413 . . . . 0.0 110.438 -176.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.7 165.77 26.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -141.52 172.14 13.1 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.128 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.467 ' H ' ' HB2' ' A' ' 15' ' ' SER . 5.9 p-10 -58.71 120.79 9.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.494 0.664 . . . . 0.0 109.925 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.85 -41.01 0.58 Allowed Glycine 0 C--N 1.294 -1.755 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -94.72 155.94 16.62 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -130.42 156.6 44.47 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.964 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.22 153.95 51.07 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 -175.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.576 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 87.3 mt-30 -111.87 145.54 39.31 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.382 176.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -117.36 120.17 37.36 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 23.3 mt -97.49 114.65 35.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -128.47 139.69 52.2 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.47 ' HB2' ' HA ' ' A' ' 6' ' ' GLU . 27.8 t70 -129.42 167.71 17.4 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 168.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.657 ' H ' ' HD2' ' A' ' 88' ' ' ARG . 5.3 mpt_? -65.01 96.65 0.2 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 123.394 0.434 . . . . 0.0 110.205 -174.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.401 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 20.1 t70 179.27 -159.43 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 10.5 mpt_? -117.97 19.11 13.78 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.4 m -106.59 117.88 35.2 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.701 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.402 ' HB2' HD23 ' A' ' 42' ' ' LEU . 47.7 m-85 -118.03 133.41 55.94 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 60.3 m-85 -101.7 116.13 32.05 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 174.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 7.8 p -99.9 132.0 46.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 120.827 0.346 . . . . 0.0 110.422 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.576 ' CG2' ' HB2' ' A' ' 83' ' ' GLN . 11.3 tt -131.74 128.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.183 0.516 . . . . 0.0 109.981 177.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.0 tt -96.66 142.02 14.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.363 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -82.94 113.96 20.89 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.973 0.892 . . . . 0.0 108.699 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 137.12 -120.62 2.14 Favored Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 106.879 -2.489 . . . . 0.0 106.879 -173.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -169.49 131.39 1.14 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 117.298 0.549 . . . . 0.0 110.514 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -95.68 144.93 25.68 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 28.0 ttt -154.38 95.93 1.86 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.815 0.34 . . . . 0.0 111.032 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 C--O 1.257 1.458 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.768 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 C--O 1.241 0.642 0 CA-C-O 120.47 0.176 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.85 129.8 42.69 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -80.65 76.09 7.54 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 122.498 1.142 . . . . 0.0 110.592 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.3 m -124.46 -59.01 1.49 Allowed 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.847 -1.524 . . . . 0.0 107.058 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.24 -153.7 52.06 Favored Glycine 0 N--CA 1.435 -1.396 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.8 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -151.83 114.58 4.63 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 m -114.09 140.68 33.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 121.518 0.675 . . . . 0.0 111.028 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.4 145.59 45.07 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.377 -175.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -142.25 147.33 36.31 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.401 ' HB3' ' HB3' ' A' ' 83' ' ' GLN . 23.3 ptm -135.29 143.72 46.38 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -177.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.567 ' H ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -155.01 159.27 31.96 Favored Pre-proline 0 N--CA 1.433 -1.286 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.24 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -48.76 148.79 8.28 Favored 'Trans proline' 0 C--O 1.251 1.126 0 C-N-CA 124.14 3.227 . . . . 0.0 114.839 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -129.68 124.54 33.87 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.5 117.91 56.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.52 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 26.1 t -59.96 -20.49 57.86 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -172.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -73.11 -44.19 60.65 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.948 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.75 -37.11 11.96 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.678 0.752 . . . . 0.0 109.831 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 21' ' ' SER . 14.5 m -84.98 15.23 4.16 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.634 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 15' ' ' SER . 46.2 t -74.44 -21.95 59.37 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.82 -28.18 1.1 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.15 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 18' ' ' SER . 21.3 p -147.33 152.79 38.81 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -172.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.463 HD12 HD22 ' A' ' 63' ' ' LEU . 54.0 mt -111.37 141.86 44.36 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 120.793 0.33 . . . . 0.0 111.602 176.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -100.52 125.26 46.84 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.443 ' CB ' ' HB ' ' A' ' 61' ' ' VAL . 48.1 mm -105.2 132.09 21.19 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.608 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.93 147.06 83.99 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 123.142 2.562 . . . . 0.0 111.919 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 mp -58.5 -38.29 77.34 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.121 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.38 -28.14 66.73 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.568 -0.742 . . . . 0.0 113.28 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -85.79 -25.69 26.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.126 0.488 . . . . 0.0 110.04 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -69.47 -45.74 68.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.107 0.479 . . . . 0.0 110.105 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.54 -10.51 59.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.811 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -68.35 -27.49 66.31 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.756 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -158.72 103.64 1.62 Allowed Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 120.959 0.409 . . . . 0.0 111.814 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.574 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 6.0 Cg_exo -82.59 134.89 7.74 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.07 1.847 . . . . 0.0 111.08 172.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.95 159.24 32.53 Favored Pre-proline 0 C--N 1.271 -2.809 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.54 130.07 35.52 Favored 'Trans proline' 0 C--O 1.26 1.58 0 N-CA-C 107.843 -1.637 . . . . 0.0 107.843 172.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -71.71 128.48 89.6 Favored Pre-proline 0 N--CA 1.403 -2.818 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -172.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.89 160.1 40.9 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.225 2.616 . . . . 0.0 112.344 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.81 -48.53 15.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 174.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.0 p -136.46 151.63 49.68 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.932 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.15 162.37 38.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.76 137.98 52.35 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.53 0.681 . . . . 0.0 111.844 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 49' ' ' SER . 65.1 mt -109.17 122.78 48.05 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.29 148.08 31.6 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.368 0.604 . . . . 0.0 111.662 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -111.75 165.15 12.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.384 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -52.27 -38.26 57.77 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.805 0.842 . . . . 0.0 110.782 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 m -67.06 -10.29 48.33 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.139 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.27 7.64 63.58 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.418 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -80.37 138.03 36.63 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 35.1 p -124.78 135.26 52.81 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 123.463 0.477 . . . . 0.0 110.594 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -113.88 130.65 56.47 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.4 m -90.86 119.35 30.99 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -119.64 156.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.531 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 65' ' ' VAL . 68.6 mtt180 -100.82 120.18 39.75 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.425 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 20.4 ttt -133.07 121.69 23.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.855 -173.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HD2' ' C ' ' A' ' 54' ' ' MET . 0.2 OUTLIER -132.26 142.32 49.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.029 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.574 ' NZ ' ' HA ' ' A' ' 33' ' ' PRO . 26.2 mtmt -92.08 126.41 37.15 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -130.21 98.89 4.86 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.652 -172.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.22 -107.22 2.42 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.45 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.94 -1.99 16.18 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.866 0.365 . . . . 0.0 110.317 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -132.53 160.17 37.3 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-O 121.271 0.558 . . . . 0.0 111.169 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' A' ' 24' ' ' ILE . 53.0 t -105.57 142.2 19.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 173.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -135.71 131.39 35.57 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 22' ' ' LEU . 6.2 mp -96.02 113.92 25.58 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.7 p -82.41 -170.24 2.84 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.421 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 47.9 t -66.42 122.09 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.68 0.752 . . . . 0.0 110.496 -173.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.53 -27.24 1.07 Allowed Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.401 ' CH2' HD11 ' A' ' 22' ' ' LEU . 41.4 t-105 -60.75 -21.38 62.95 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 113.577 -1.312 . . . . 0.0 110.184 172.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.734 ' O ' ' HG2' ' A' ' 72' ' ' LYS 0.293 0.0 OUTLIER -63.54 -26.53 68.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -175.859 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -56.18 -38.06 70.42 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.543 0.737 . . . . 0.0 110.114 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -74.05 -49.05 25.92 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.446 -175.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 68' ' ' GLU . 8.7 p -67.52 -40.69 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.361 -175.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 20.5 ptmt -70.41 -38.77 74.67 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.771 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.59 -38.08 62.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.258 -0.977 . . . . 0.0 112.528 -175.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -86.12 -20.77 28.18 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.838 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.1 t30 50.87 83.53 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.15 0.98 . . . . 0.0 111.432 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 pp -138.8 174.67 10.28 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -143.19 172.04 13.27 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.867 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.52 ' HB3' ' H ' ' A' ' 15' ' ' SER . 9.3 p-10 -65.79 142.1 58.08 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.145 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.24 -21.55 15.05 Favored Glycine 0 C--N 1.295 -1.7 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -173.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -116.54 134.46 54.82 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 87.2 m-85 -130.28 158.91 38.48 Favored 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.264 -170.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 pp -132.29 144.59 50.69 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.552 ' CG ' ' HB ' ' A' ' 95' ' ' ILE . 10.3 pt20 -119.02 145.85 45.52 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.909 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.02 124.28 51.17 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.5 mt -106.31 117.18 51.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.413 ' HB3' ' CD2' ' A' ' 92' ' ' PHE . 30.6 p90 -127.68 152.76 47.3 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.531 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -81.16 -78.75 0.17 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.162 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -162.23 24.32 0.11 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -120.55 -168.93 1.72 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -95.83 15.76 19.43 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 123.496 0.718 . . . . 0.0 110.186 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.7 m -102.76 116.11 31.91 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 86' ' ' TYR . 82.8 m-85 -117.13 132.08 56.75 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.884 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -101.55 129.2 47.59 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -98.71 141.08 16.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -174.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.552 ' HB ' ' CG ' ' A' ' 83' ' ' GLN . 57.8 mt -127.06 117.66 48.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.97 113.9 41.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 81' ' ' TYR . 49.2 p90 -100.53 124.94 46.74 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -148.62 121.83 1.39 Allowed Glycine 0 N--CA 1.409 -3.1 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -91.43 87.57 6.48 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -74.23 96.78 2.84 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.511 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.2 mtt -96.43 75.97 2.91 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.631 0.729 . . . . 0.0 109.193 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 52.3 t . . . . . 0 N--CA 1.429 -1.525 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -178.656 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttm . . . . . 0 C--O 1.238 0.487 0 CA-C-O 120.895 0.379 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.4 146.33 4.98 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.92 137.52 55.27 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.4 m -61.62 -62.01 2.12 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 123.743 0.652 . . . . 0.0 110.778 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.13 -172.47 33.57 Favored Glycine 0 C--N 1.292 -1.868 0 C-N-CA 120.243 -0.979 . . . . 0.0 110.772 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -179.67 114.25 0.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 m -123.61 145.81 30.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.09 0.472 . . . . 0.0 112.048 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.408 ' HG3' HG12 ' A' ' 85' ' ' ILE . 1.6 mp0 -99.85 146.97 26.02 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.469 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -142.98 149.21 38.03 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.6 ttt -131.7 144.78 51.24 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HE2' ' O ' ' A' ' 23' ' ' GLU . 24.1 ttpp -146.86 143.78 19.03 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.42 146.35 42.0 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 123.056 2.504 . . . . 0.0 111.632 173.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -122.07 121.69 37.54 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt -128.32 115.98 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.518 ' H ' ' HB3' ' A' ' 78' ' ' ASP . 24.0 t -61.29 -17.49 53.82 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.925 0.89 . . . . 0.0 112.369 -171.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.22 -42.07 93.83 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HD2' ' CD ' ' A' ' 23' ' ' GLU . 37.5 ttmt -101.48 -30.3 11.5 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.212 -177.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.9 p -80.08 7.31 9.42 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 120.927 0.394 . . . . 0.0 111.386 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.9 p -72.18 -29.87 64.42 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.436 0.636 . . . . 0.0 109.631 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -114.28 -39.79 3.8 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.382 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.2 p -157.5 155.39 30.25 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.659 -174.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 76.9 mt -96.25 138.7 33.46 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.947 0.403 . . . . 0.0 110.744 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.476 ' O ' ' HE2' ' A' ' 11' ' ' LYS . 39.5 mt-10 -79.24 117.81 20.6 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.432 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.464 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 62.9 mt -97.19 118.92 64.15 Favored Pre-proline 0 C--N 1.281 -2.382 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.74 138.8 32.84 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.581 2.854 . . . . 0.0 114.635 -171.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 59' ' ' GLU . 5.4 tt -63.05 -37.83 88.77 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.72 -28.91 73.47 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.334 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -72.86 -42.89 63.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -62.98 -40.12 96.78 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.71 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.22 -25.46 68.34 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.649 0.779 . . . . 0.0 110.328 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -80.61 -27.58 37.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.165 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -173.4 100.5 0.32 Allowed Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' CB ' ' HE2' ' A' ' 56' ' ' LYS . 14.4 Cg_endo -89.06 149.19 5.65 Favored 'Trans proline' 0 N--CA 1.426 -2.5 0 C-N-CA 121.377 1.384 . . . . 0.0 111.297 171.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.0 158.66 36.69 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.25 137.07 76.6 Favored 'Trans proline' 0 C--N 1.354 0.816 0 N-CA-C 107.68 -1.7 . . . . 0.0 107.68 172.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -70.95 127.41 91.74 Favored Pre-proline 0 N--CA 1.407 -2.609 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -172.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.38 136.91 45.12 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.563 2.175 . . . . 0.0 110.338 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.23 -48.71 87.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.201 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.474 ' O ' ' HD3' ' A' ' 90' ' ' ARG . 25.6 p -127.53 150.69 49.58 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.356 176.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.8 t -132.1 155.2 41.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -108.42 125.14 51.42 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 120.746 0.308 . . . . 0.0 110.361 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.6 mt -109.18 120.16 41.7 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 173.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.61 149.88 26.75 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 120.852 0.358 . . . . 0.0 110.375 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.481 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 11.3 t70 -111.27 158.78 18.59 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.433 ' CE1' HG13 ' A' ' 95' ' ' ILE . 26.9 p90 -73.68 -13.28 60.96 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.253 0.549 . . . . 0.0 111.676 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.2 t -93.52 -162.28 0.92 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.71 6.79 44.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.115 -0.564 . . . . 0.0 114.113 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -81.41 145.61 30.7 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.1 p -150.01 136.52 19.07 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 113.903 -1.498 . . . . 0.0 107.921 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.481 ' CZ3' ' HB2' ' A' ' 44' ' ' ASP . 23.3 m-90 -126.97 140.3 52.42 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.169 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -96.68 114.29 25.92 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 67' ' ' TRP . 48.2 t -125.25 155.62 34.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.0 -174.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -101.84 139.41 37.51 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.0 ttt -120.12 138.76 53.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -143.84 132.42 22.32 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.254 -0.978 . . . . 0.0 112.58 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.407 ' HE2' ' CB ' ' A' ' 33' ' ' PRO . 48.8 tttp -91.88 128.08 37.58 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -138.86 98.24 3.5 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.302 -173.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.08 -134.72 13.56 Favored Glycine 0 N--CA 1.422 -2.259 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.875 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.429 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 4.9 mp0 -90.89 -0.47 57.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.214 0.53 . . . . 0.0 110.48 -175.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -132.52 171.05 14.29 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 61.7 t -124.84 148.01 29.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -124.42 137.13 54.48 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 21.4 tp -91.69 102.95 15.58 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.419 ' HB ' ' H ' ' A' ' 65' ' ' VAL . 34.9 p -78.94 -157.38 0.12 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -170.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' H ' ' HB ' ' A' ' 64' ' ' THR . 13.5 p -55.9 144.73 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.154 0.981 . . . . 0.0 111.834 -173.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.28 -36.26 3.59 Favored Glycine 0 CA--C 1.485 -1.816 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 -172.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.411 ' CZ2' HG23 ' A' ' 71' ' ' VAL . 12.0 t-105 -59.76 -25.29 64.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.704 -1.248 . . . . 0.0 109.382 171.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.493 ' OE2' ' HD3' ' A' ' 72' ' ' LYS . 2.8 tm-20 -53.23 -31.41 43.14 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.605 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.529 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 2.1 m-20 -67.29 -30.55 70.44 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 123.346 0.659 . . . . 0.0 111.991 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -73.44 -53.06 11.58 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 40.2 t -63.63 -39.1 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.98 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 69' ' ' ASN . 59.9 pttt -71.46 -39.01 71.21 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.4 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -77.64 -40.66 41.06 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -175.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.456 HD21 HD13 ' A' ' 96' ' ' ILE . 45.7 t-20 -84.96 -20.87 29.92 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 20.2 t-20 47.65 88.73 0.02 OUTLIER 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.794 1.637 . . . . 0.0 112.374 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.79 168.8 24.51 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.849 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -143.56 174.24 10.94 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 124.073 0.949 . . . . 0.0 108.97 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.518 ' HB3' ' H ' ' A' ' 15' ' ' SER . 5.6 p-10 -51.95 130.6 29.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.941 0.877 . . . . 0.0 111.717 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.51 -39.93 1.25 Allowed Glycine 0 C--N 1.294 -1.756 0 N-CA-C 107.189 -2.365 . . . . 0.0 107.189 -175.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -94.42 146.14 24.28 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -118.98 158.94 24.77 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.204 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.1 mt -110.57 137.44 48.25 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.526 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.603 ' HB3' ' CG2' ' A' ' 95' ' ' ILE . 57.8 tt0 -111.68 130.71 55.68 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -109.57 117.33 33.67 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 62.5 mt -99.65 114.18 37.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 106.185 -1.784 . . . . 0.0 106.185 174.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -129.11 154.06 47.07 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -172.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -143.56 149.69 37.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.448 ' H ' ' NE ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -54.17 93.9 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.334 1.054 . . . . 0.0 111.82 -177.009 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 90' ' ' ARG . 23.2 t70 -174.64 -159.04 0.08 Allowed 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -176.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 39' ' ' THR . 36.7 ttm180 -116.39 25.45 10.62 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.4 m -125.69 125.97 43.9 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.405 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -119.89 132.9 55.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.538 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 93.7 m-85 -104.97 115.04 29.61 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 174.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.77 149.48 8.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-O 121.357 0.599 . . . . 0.0 112.137 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.603 ' CG2' ' HB3' ' A' ' 83' ' ' GLN . 13.2 tt -142.06 135.44 28.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.456 HD13 HD21 ' A' ' 74' ' ' ASN . 38.1 pt -93.71 141.63 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.471 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -83.08 112.79 20.12 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.2 -113.01 0.55 Allowed Glycine 0 N--CA 1.41 -3.073 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.7 t60 56.51 83.08 0.1 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.469 0.652 . . . . 0.0 110.108 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -169.41 -48.29 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -174.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.4 ttt -118.21 67.31 0.76 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 171.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.3 m . . . . . 0 C--N 1.306 -1.287 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.328 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 32' ' ' PHE . . . -139.03 67.0 1.4 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.028 0.442 . . . . 0.0 110.569 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -142.66 157.78 44.33 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.357 0.599 . . . . 0.0 112.313 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.0 m -157.93 -43.96 0.06 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.73 -140.78 11.04 Favored Glycine 0 CA--C 1.494 -1.261 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.97 104.95 7.75 Favored 'General case' 0 C--O 1.255 1.35 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 175.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.8 m -129.4 139.88 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.784 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 85' ' ' ILE . 8.6 pt20 -136.95 144.91 43.65 Favored 'General case' 0 N--CA 1.399 -3.022 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.361 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -136.26 148.99 48.29 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.511 -174.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.477 ' HB3' ' HG2' ' A' ' 83' ' ' GLN . 27.1 ptm -102.56 157.29 17.03 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 12.7 ptpt -154.57 144.32 15.43 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 6.5 Cg_exo -75.83 134.79 16.85 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 122.856 2.37 . . . . 0.0 112.343 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.432 ' CE2' ' HG ' ' A' ' 22' ' ' LEU . 32.0 m-85 -107.11 140.34 40.11 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.659 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.9 mt -120.17 113.52 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 t -56.92 -31.79 65.29 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 123.411 0.444 . . . . 0.0 111.473 -173.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.76 -44.17 97.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -89.09 -40.07 13.19 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.7 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 21' ' ' SER . 25.8 m -75.22 4.55 6.8 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.372 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.2 t -74.26 -17.08 60.92 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -135.25 -35.97 0.82 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.555 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 18' ' ' SER . 26.5 p -144.23 144.0 31.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.402 0.62 . . . . 0.0 112.63 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.3 tt -100.05 121.11 40.88 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -86.11 127.02 34.62 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.982 0.42 . . . . 0.0 110.607 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.535 ' HB ' HG23 ' A' ' 61' ' ' VAL . 45.7 mm -97.56 132.7 24.71 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.45 148.15 87.61 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.266 1.977 . . . . 0.0 111.384 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.64 -22.51 66.66 Favored 'General case' 0 C--O 1.213 -0.819 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.97 -21.62 61.51 Favored Glycine 0 C--O 1.22 -0.734 0 C-N-CA 121.342 -0.456 . . . . 0.0 111.984 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.438 ' HE2' ' CZ ' ' A' ' 86' ' ' TYR . 28.3 t80 -76.44 -51.72 11.25 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -68.18 -35.86 78.69 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.449 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -69.17 -26.42 64.84 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -85.35 -28.23 25.35 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.379 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.424 ' HB2' ' HB1' ' A' ' 2' ' ' ALA . 4.9 p90 -172.87 114.67 0.37 Allowed Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 1.9 Cg_endo -85.0 150.83 10.96 Favored 'Trans proline' 0 N--CA 1.427 -2.396 0 C-N-CA 121.646 1.564 . . . . 0.0 109.672 168.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.68 152.07 67.6 Favored Pre-proline 0 C--N 1.282 -2.34 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.4 130.54 32.34 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 N-CA-C 108.212 -1.495 . . . . 0.0 108.212 175.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -69.71 114.18 22.72 Favored Pre-proline 0 N--CA 1.412 -2.337 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -172.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -78.61 136.63 13.88 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.798 2.332 . . . . 0.0 110.618 177.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.459 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 47.4 mm -69.93 -46.44 73.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.746 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.5 p -123.38 148.98 45.52 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.736 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.2 t -134.87 143.39 37.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -115.4 131.34 56.96 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.811 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.9 mt -109.24 129.15 55.51 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.39 152.4 20.77 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.584 0.707 . . . . 0.0 112.328 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.517 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 12.3 t70 -112.1 166.91 10.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.196 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -76.54 -49.31 16.77 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.747 0.819 . . . . 0.0 110.717 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 m -80.58 -50.51 9.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.568 -172.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -174.04 -11.29 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 118.263 -1.922 . . . . 0.0 114.716 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.418 ' HB2' ' CB ' ' A' ' 44' ' ' ASP . 17.5 mmt180 -73.72 157.86 35.73 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.1 p -150.94 135.3 16.96 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.517 ' CH2' ' HB2' ' A' ' 44' ' ' ASP . 18.7 m-90 -128.7 134.52 48.5 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.461 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.2 m -98.39 120.05 38.14 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 67' ' ' TRP . 8.5 p -119.18 155.24 21.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.471 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 77.7 ttt180 -103.25 135.95 43.94 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.9 ttt -117.53 146.0 43.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -147.55 131.45 17.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.506 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 33' ' ' PRO . 53.4 tttp -114.47 110.56 20.03 Favored 'General case' 0 CA--C 1.471 -2.082 0 CA-C-O 122.198 0.999 . . . . 0.0 109.089 173.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -140.66 104.82 4.81 Favored 'General case' 1 C--N 1.242 -4.071 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.81 -158.32 20.78 Favored Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -173.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -94.81 3.38 55.07 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.643 0.735 . . . . 0.0 109.55 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -112.73 156.65 22.45 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.535 HG23 ' HB ' ' A' ' 24' ' ' ILE . 27.5 m -129.6 139.89 50.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.897 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -136.91 148.06 46.79 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.024 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 5.9 mp -100.7 109.93 22.01 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.4 p -89.48 -144.55 0.16 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.858 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -55.73 129.06 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 121.484 0.659 . . . . 0.0 109.78 -175.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.92 -38.4 2.11 Favored Glycine 0 N--CA 1.414 -2.796 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 -170.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.45 ' N ' HG23 ' A' ' 52' ' ' VAL . 60.9 t-105 -66.23 -25.5 66.93 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.685 -0.758 . . . . 0.0 109.188 174.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.661 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 32.1 tt0 -59.58 -37.0 77.32 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.201 -178.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -57.45 -39.55 76.52 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 123.716 0.807 . . . . 0.0 110.935 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -74.05 -50.88 17.73 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.825 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 68' ' ' GLU . 7.8 p -62.43 -47.15 94.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.544 -174.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 68' ' ' GLU . 64.2 pttt -72.44 -33.57 67.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.13 -40.39 38.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 118.575 -1.25 . . . . 0.0 113.471 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -88.25 -19.91 26.17 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.579 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.9 t30 57.73 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.902 1.281 . . . . 0.0 112.061 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 pp -139.45 155.25 47.71 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.638 0.732 . . . . 0.0 112.845 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.94 171.96 13.64 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.78 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -60.94 141.46 57.24 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.612 0.57 . . . . 0.0 110.587 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.76 -6.05 13.95 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -121.1 153.0 38.03 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -132.54 139.65 47.96 Favored 'General case' 0 CA--C 1.474 -1.964 0 CA-C-O 121.043 0.449 . . . . 0.0 109.839 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -135.55 144.38 46.21 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.979 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.477 ' HG2' ' HB3' ' A' ' 10' ' ' MET . 75.9 mt-30 -110.5 145.0 38.47 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.155 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 37.8 m-85 -112.92 131.14 55.85 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.464 ' HA ' ' HB3' ' A' ' 8' ' ' GLN . 59.3 mt -95.31 121.49 45.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.438 ' CZ ' ' HE2' ' A' ' 28' ' ' PHE . 23.0 m-85 -105.5 123.42 47.86 Favored 'General case' 0 N--CA 1.421 -1.925 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -104.37 14.5 30.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.583 0.706 . . . . 0.0 109.638 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.12 72.7 0.49 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.612 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -175.67 -171.49 0.47 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 -176.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.469 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 5.5 mpt_? -106.56 26.93 9.33 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.6 m -127.51 117.81 22.79 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -125.26 155.23 40.45 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.337 0.589 . . . . 0.0 110.906 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -115.07 135.11 54.57 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -104.55 129.63 56.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.112 0.482 . . . . 0.0 112.271 -174.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.7 mm -111.99 115.29 49.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.5 tt -118.12 137.87 50.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.431 0.634 . . . . 0.0 112.7 -173.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -99.08 135.78 40.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.91 -1.88 35.77 Favored Glycine 0 C--N 1.29 -2.015 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.697 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -86.19 103.36 14.75 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -88.12 136.87 32.77 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.144 -0.935 . . . . 0.0 113.019 -171.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -76.75 -30.19 56.46 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.042 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.4 m . . . . . 0 N--CA 1.432 -1.363 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.845 . . . . . . . . 0 0 . 1 stop_ save_